Citrus Sinensis ID: 002566
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 907 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGE0 | 1014 | Probable LRR receptor-lik | yes | no | 0.974 | 0.871 | 0.647 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.974 | 0.851 | 0.542 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.970 | 0.862 | 0.533 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.958 | 0.839 | 0.545 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.906 | 0.862 | 0.506 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.944 | 0.839 | 0.483 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.962 | 0.856 | 0.487 | 0.0 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.948 | 0.833 | 0.425 | 0.0 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.963 | 0.846 | 0.424 | 0.0 | |
| O23081 | 665 | Cysteine-rich receptor-li | no | no | 0.297 | 0.406 | 0.463 | 4e-69 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1131 bits (2925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/896 (64%), Positives = 695/896 (77%), Gaps = 12/896 (1%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++ + + F G + NKLH EV+ALK+IG+KLGKKDW+F DPCS +G W +++
Sbjct: 10 IIVLFTLIFHGRLGFSDNNKLHEAEVRALKEIGKKLGKKDWDFNKDPCSGEGTWIVTTYT 69
Query: 76 KKGFESNVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
KGFESN+TCDCS +++CHV+ IALK+QNLTG +P E SKLR+LK LDLSRN LTGS
Sbjct: 70 TKGFESNITCDCSFLPQNSSCHVIRIALKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGS 129
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+WAS++L +LS MGNRLSGPFPKVLT +T L+NLS+EGN F+G IPPDI +L++L+K
Sbjct: 130 IPKEWASMRLEDLSFMGNRLSGPFPKVLTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEK 189
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L L SN+FTG L +L L NL D+RISDNNF+G IP+FI W +I KL + G L+GPI
Sbjct: 190 LHLPSNAFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPI 249
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKN 310
P+SIS+LTSLTDLRISDL G S+FP L + ++KTLIL KC I G IP YIGD+ KLK
Sbjct: 250 PSSISSLTSLTDLRISDLGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKT 309
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
+DLSFN L+G IP++FE + K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS
Sbjct: 310 LDLSFNLLSGEIPSSFENMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSI 369
Query: 371 PI-ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTG- 428
P +C R + NLVES++ NK K C Q PC P + Y L+INCGG ++
Sbjct: 370 PSHDCNRVTSNLVESFAL-GNKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDK 428
Query: 429 HTKYEADMEARGASMFY-SSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLE 486
Y+AD E +GASM+ + + WA SSTG FMD+D D D Y NTS LS S+
Sbjct: 429 EITYQADDEPKGASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFG 488
Query: 487 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 546
LYRTARVSPLSLTYYG+CLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV K
Sbjct: 489 LYRTARVSPLSLTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIK 548
Query: 547 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 606
+FNI++ A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+ N
Sbjct: 549 NFNIQEAARGSGKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPN 608
Query: 607 FKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLY 666
FKPPV + K+ ++ + V A+ LL+ +I+ + WK K DKELRGLDLQTG +
Sbjct: 609 FKPPVYYDTKDIILKVGVPVAAATLLLFIIVGVF-WKK-RRDKNDIDKELRGLDLQTGTF 666
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIKAAT+NFD K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGMI
Sbjct: 667 TLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMI 726
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
SA QHPNLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGKD RLKLDW TRKKI +GI
Sbjct: 727 SALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGI 786
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
A+GL +LHE+SRIKIVHRDIK SNVLLDKDLNAKISDFGLAKL ++ THISTRIAGTIG
Sbjct: 787 AKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIG 846
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
YMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTN+RP EDFVYLLDWAYVLQE
Sbjct: 847 YMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQER 902
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 959 bits (2478), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/910 (54%), Positives = 636/910 (69%), Gaps = 26/910 (2%)
Query: 1 MASLIPILKLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGV 60
M + K++ L+F+ L F + A L +EV+ L+ I RKL + N
Sbjct: 1 MGFIFSTEKVVYVLLLIFVCLENF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIER 55
Query: 61 DPCSQKGNWELSSDDKKGFE-SNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLR 116
CS + NW + SN+TCDC+ S+ C V I LK+ +L G P E L
Sbjct: 56 TSCSDQ-NWNFVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLT 114
Query: 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176
L+++DLSRN L G+ + + L LSV+GNRLSGPFP L +ITTL ++++E NLFT
Sbjct: 115 RLREIDLSRNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLFT 174
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
G +P ++ L +L++L+LS+N+FTG++P L+ L NL + RI N+ SGKIP+FIG W
Sbjct: 175 GPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWTL 234
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFPKL-DKMNLKTLILTKCLI 294
+++L +QG+S+EGPIP SIS LT+LT+LRI+DL+G + +FP L + M +K L+L CLI
Sbjct: 235 LERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLRNLMKMKRLVLRNCLI 294
Query: 295 HGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN 354
G IP+YIG M++LK +DLS N LTG IP TF L NFM+L N LTGPVP++I NS
Sbjct: 295 RGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIINSK 354
Query: 355 KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 414
+N+D+S NNFT + + C + VNL+ SY S + + V CLR+ PC P D
Sbjct: 355 ENLDLSDNNFTQPPT--LSCNQLDVNLISSYPSVTD--NSVQWCLREGLPC--PEDAKQS 408
Query: 415 TLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNT 474
+L INCGG+++ G Y D+ +RG S F S + W +SS+G ++ + Y+ T+
Sbjct: 409 SLFINCGGSRLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLGKEDA--GYLATDR 466
Query: 475 STLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRI 534
L ++ E Y+TAR+SP SL YYGLCL G+Y ++LHFAEI+F ND TFNSLG+RI
Sbjct: 467 FNL--INGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRI 524
Query: 535 FDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPA-EVTSHTLKIHLYWAGRGTTGIPLRGT 593
FDIY+Q L+++DFNI + AGG G P ++ +V TL+IHL W G+GT IP RG
Sbjct: 525 FDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGV 584
Query: 594 YGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSA 652
YGPLISAI++ NFK N + ++ A + LL+L I+R G LGGK V
Sbjct: 585 YGPLISAITITPNFKVDTGKPLSNGA-VAGIVIAACAVFGLLVLVILRLTGYLGGKEVDE 643
Query: 653 DKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS 712
++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS
Sbjct: 644 NEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKS 703
Query: 713 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG + + RL
Sbjct: 704 KQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ-RL 762
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
LDW TR KICIGIA+GLAYLHE+SR+KIVHRDIK +NVLLD LNAKISDFGLAKL ++
Sbjct: 763 HLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDD 822
Query: 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 892
+ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTNYRP E+FVYL
Sbjct: 823 ENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYL 882
Query: 893 LDWAYVLQEE 902
LDWAYVLQE+
Sbjct: 883 LDWAYVLQEQ 892
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/905 (53%), Positives = 631/905 (69%), Gaps = 25/905 (2%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQ--- 65
+ LL ++ +SL+ F + +AT L EEV AL+ + L K +WNF VDPC +
Sbjct: 5 RQLLFTYYFIVSLILFSDFVSSAT---LPKEEVDALQSVATALKKSNWNFSVDPCDETLS 61
Query: 66 KGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
+G W + + KGFE VTC+CSS CHV I LKAQ+L G+LPT+LS L +L++LDL+R
Sbjct: 62 EGGWR-NPNAAKGFEDAVTCNCSSVICHVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTR 120
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N L GS P+W + L+ +S++GNR+SG PK L N+TTL L +E N +G IPP++
Sbjct: 121 NYLNGSIPPEWGASSLLNISLLGNRISGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGN 180
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL++L+LSSN+ +GE+P+ KLT L DLRISDN F+G IP+FI WK ++KL IQ S
Sbjct: 181 LPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQAS 240
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGD 304
L GPIP++I L +LTDLRI+DL G ES FP L M ++K LIL C + G++P Y+G
Sbjct: 241 GLVGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQ 300
Query: 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
KLKN+DLSFN L+G IP T+ L+ +F+Y T N L G VP ++ + +DI+ NNF
Sbjct: 301 NRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNF 360
Query: 365 TWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK 424
+ + ++ EC + SVN S S CL + + C + Y LHINCGG +
Sbjct: 361 SKDKTE--ECQQKSVNTFSSTSPLVANNSSNVSCLSK-YTCP----KTFYGLHINCGGNE 413
Query: 425 INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV--SA 482
I + TKY+AD +Y S W S+TG F+DDD + + + S+ K+ S+
Sbjct: 414 ITSNETKYDAD--TWDTPGYYDSKNGWVSSNTGNFLDDDRTNNGKSKWSNSSELKITNSS 471
Query: 483 VDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
+D LY AR+S +SLTY LCLG GNYTV LHFAEI+F + +++LG+R FDIY+Q K
Sbjct: 472 IDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGK 531
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 602
KDFNI DEA G G +VK FP VT+ L+I L WAG+GT IP+RG YGPLISA+S
Sbjct: 532 REVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVS 591
Query: 603 VKSNFKPP-----VVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELR 657
V +F PP + ++ +++ ++V LVLLI I+ W+GCL K +K+ +
Sbjct: 592 VDPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFK 651
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR 717
LD Q ++LRQIK AT+NFDPANK+GEGGFG V+KGI++DGTVIAVKQLS+KS+QGNR
Sbjct: 652 NLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNR 711
Query: 718 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 777
EF+NEI MISA QHP+LVKLYGCCVEG+QLLLVYEY++NN L+RA+FG E ++ L+WP
Sbjct: 712 EFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQ-ETQIPLNWP 770
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
R+KIC+GIARGLAYLHE+SR+KIVHRDIK +NVLLDK+LN KISDFGLAKL EE+ THI
Sbjct: 771 MRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHI 830
Query: 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 897
STR+AGT GYMAPEYAMRG+LT KADVYSFGVV LEIV GKSNT+ R D YLLDW +
Sbjct: 831 STRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVH 890
Query: 898 VLQEE 902
VL+E+
Sbjct: 891 VLREQ 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/895 (54%), Positives = 623/895 (69%), Gaps = 26/895 (2%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++FI L F + A L +EV+ L+ I RKL + N C + W ++
Sbjct: 14 IIFICLDIF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDR-KWNFVAES 67
Query: 76 KKGFE-SNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
SN+TCDC+ S+ C V I L+ NL G +P E L L ++DL N L+G+
Sbjct: 68 TSKLPTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGT 127
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ + L L+V GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++
Sbjct: 128 IPTTLSQIPLEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKR 187
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L++SSN+ TG +P L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPI
Sbjct: 188 LLISSNNITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPI 247
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLK 309
PASIS L +LT+LRI+DL+G S FP L M N++ L+L CLI IP+YIG MT LK
Sbjct: 248 PASISNLKNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLK 307
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+DLS N L G IP TF L NFMYL N LTGPVP++I +S +N+D+S NNFT +
Sbjct: 308 LLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT 367
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
+ C + VNL+ SY S N + V CLR++ PC P D +H +L INCGG ++
Sbjct: 368 --LSCNQLDVNLISSYPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDK 421
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+Y D+ RGAS F S + W +SS+G ++ +D Y+ T+T L ++ E Y+
Sbjct: 422 DEYADDLNKRGASTFSSVSERWGYSSSGAWLGNDGA--TYLATDTFNL--INESTPEYYK 477
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
TAR++ SL YYGLC+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFN
Sbjct: 478 TARLASQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFN 537
Query: 550 IEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
I AGG G P ++ +V TL+IHL W G+GT IP RG YGPLISAI+V NFK
Sbjct: 538 IAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFK 597
Query: 609 PPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYT 667
N V + ++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +T
Sbjct: 598 VDTGKPLSNGV-VAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFT 656
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
L+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMIS
Sbjct: 657 LKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMIS 716
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
A QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG + + RL LDW TR K+CIGIA
Sbjct: 717 ALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIA 775
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
+GLAYLHE+SR+KIVHRDIK +NVLLD LNAKISDFGLAKL EE+ THISTRIAGTIGY
Sbjct: 776 KGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGY 835
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
MAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTNYRP E+F+YLLDWAYVLQE+
Sbjct: 836 MAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQ 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/876 (50%), Positives = 575/876 (65%), Gaps = 54/876 (6%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSA 90
A++ L +E +A K + L K + + VDPC E+SS +
Sbjct: 22 ASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPC------EVSS--------------TGN 61
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR 150
++ LK +NL G+LP EL L L+++DLSRN L GS P+W L LV + ++GNR
Sbjct: 62 EWSTISRNLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNR 121
Query: 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
L+GP PK NITTL +L +E N +G +P ++ L N+Q++ILSSN+F GE+P+ KL
Sbjct: 122 LTGPIPKEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKL 181
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
T L D R+SDN SG IP+FI KW K+++L IQ S L GPIP +I++L L DLRISDL
Sbjct: 182 TTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLN 241
Query: 271 GSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329
G ES FP+L + ++TLIL C + G++PDY+G +T K +DLSFN L+G IP T+ L
Sbjct: 242 GPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINL 301
Query: 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389
++Y TGN L G VP ++ N +D+S NNF+ + ++ + C
Sbjct: 302 RDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAV-C--------------- 345
Query: 390 NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQ 449
K + V C+R N+ C + LHINCGG +++ T YE+D R S +Y S
Sbjct: 346 -KYNNVLSCMR-NYQCPKTFN----ALHINCGGDEMSINGTIYESDKYDRLES-WYESRN 398
Query: 450 YWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGN 509
W ++ G F+DD + T S S+++ VD LY AR+S +SLTYY LCL NGN
Sbjct: 399 GWFSNNVGVFVDDKHVPERV--TIESNSSELNVVDFGLYTQARISAISLTYYALCLENGN 456
Query: 510 YTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEV 569
Y V LHFAEI+F ++ + SLG+R FDIYIQ KL KDFNI EA G ++K FP E+
Sbjct: 457 YNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEI 516
Query: 570 TSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHV---MIMAAIV 626
L+I LYWAGRGTT IP YGPLISAISV S+ P S +N + + +V
Sbjct: 517 KDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNP----SPRNGMSTGTLHTLVV 572
Query: 627 GASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGE 686
S+ +V L+ + KG L K +K+ + L+L ++LRQIK ATNNFD AN++GE
Sbjct: 573 ILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGE 632
Query: 687 GGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746
GGFG VYKG L DGT+IAVKQLS+ S+QGNREF+NEIGMISA HPNLVKLYGCCVEG Q
Sbjct: 633 GGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQ 692
Query: 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806
LLLVYE+++NN L+RA+FG E +L+LDWPTR+KICIG+ARGLAYLHE+SR+KIVHRDI
Sbjct: 693 LLLVYEFVENNSLARALFGPQ-ETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDI 751
Query: 807 KTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYS 866
K +NVLLDK LN KISDFGLAKL EED THISTRIAGT GYMAPEYAMRG+LT KADVYS
Sbjct: 752 KATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYS 811
Query: 867 FGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
FG+V LEIV G+SN R + YL+DW VL+E+
Sbjct: 812 FGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREK 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/893 (48%), Positives = 576/893 (64%), Gaps = 36/893 (4%)
Query: 19 ISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKG 78
+++ F Y++ A KL +EV AL+QI LG K W F + C + L+
Sbjct: 27 FAIICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPT 83
Query: 79 FESNVTCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ 135
+ + C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +
Sbjct: 84 AKQEIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPRE 142
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195
WAS L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LS
Sbjct: 143 WASSNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLS 201
Query: 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255
SN TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ I
Sbjct: 202 SNKLTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVI 261
Query: 256 SALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
S L++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLS
Sbjct: 262 SVLSNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLS 321
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC 374
FN L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C
Sbjct: 322 FNKLVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRAC 380
Query: 375 -PRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTK-- 431
P ++NL S+ K K PC++ +F C +Y LH+NCGG+ + K
Sbjct: 381 RPNMNLNLNLFQSTSTKKSSKFLPCIK-DFKCP----RYSSCLHVNCGGSDMYVKEKKTK 435
Query: 432 --YEAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLEL 487
YE D +E A F W FSSTG FMDD N + T+ ++ +L
Sbjct: 436 ELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDD-----NNFQNTRFTMFVPASNQSDL 490
Query: 488 YRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKD 547
Y++AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KD
Sbjct: 491 YKSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKD 550
Query: 548 FNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNF 607
FNI DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+
Sbjct: 551 FNIMDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDS 610
Query: 608 KPPVVHSKKNHVMIMAAI---VGASVLLVLLILFIMRW-KGCLGGKVSADKELRGLDLQT 663
KP K + A I +GA L++ ++ F+ W GCL K+ +L +
Sbjct: 611 KP--CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPS 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
G +TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEI
Sbjct: 667 GTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEI 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G IS QHPNLVKL+G CVE QLLL YEYM+NN LS A+F + ++ +DWPTR KIC
Sbjct: 727 GAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
GIA+GLA+LHE+S +K VHRDIK +N+LLDKDL KISDFGLA+L EE+KTHIST++AG
Sbjct: 786 CGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAG 845
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896
TIGYMAPEYA+ GYLT KADVYSFGV+ LEIV+G +N+N+ D V LL++A
Sbjct: 846 TIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFA 898
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/914 (48%), Positives = 578/914 (63%), Gaps = 41/914 (4%)
Query: 8 LKLLLASHLLFISLV--TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNF-GVDPCS 64
+ ++L S LF +++ + A+ + LHA+E+ ALK+I LG K N DPCS
Sbjct: 1 MSIILWSFFLFFTIILSSLTNITTLASFSSLHADELNALKEIATTLGIKRLNLRDEDPCS 60
Query: 65 QKGNWELSSDD---KKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYL 118
K + D + + CDCS + C + +ALK +L G LP EL+KL YL
Sbjct: 61 SKTLKIIQEVDFVPNLDINNTIGCDCSFNNNTICRITELALKTMSLRGKLPPELTKLPYL 120
Query: 119 KQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
K ++L RN L+G+ +WA + L +SV N LSG P L N L L +EGN F+G
Sbjct: 121 KSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQNFKNLTFLGVEGNQFSG 180
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ L +L L L+SN FTG LP L +L NL +RI DNNF+G IP +IG W ++
Sbjct: 181 PIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICDNNFTGIIPAYIGNWTRL 240
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
QKLH+ S L GPIP ++ L +L +L +SD G +S FP L LK LIL + G
Sbjct: 241 QKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS-FPNLSSKGLKRLILRNVGLSGP 299
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-IFNSNKN 356
IP YI ++T LK +DLSFN L G I + K +YLTGN L+G + + NS
Sbjct: 300 IPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPKN--IYLTGNLLSGNIESGGLLNSQSY 356
Query: 357 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD--QYHY 414
+D+S NNF+W SS C +GS S +N L + PC + PA+ +Y
Sbjct: 357 IDLSYNNFSWSSS----CQKGSTINTYQSSYSKNNLTGLPPC-------AVPANCKKYQR 405
Query: 415 TLHINCGGAKINT----GHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYI 470
LHINCGG +++ G Y+ D + + YW S+TG F DD++D D Y
Sbjct: 406 FLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFDYWGVSNTGDFTDDNSDHDEYY 465
Query: 471 RTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSL 530
TST +S +LY+TAR S LSL YY CL NGNY V+LHF EI F + ++ L
Sbjct: 466 ---TSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVKLHFMEIQFSDKEVYSRL 522
Query: 531 GKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPL 590
G+RIFD+Y+Q KL +DFNI EA G P++K A VT+H L+I LYWAG+GTT IP
Sbjct: 523 GRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHMLEIRLYWAGKGTTLIPK 582
Query: 591 RGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGAS---VLLVLLILFIMRWKGCLG 647
RG YGPLISAIS+ + +P K H + I+GAS V +VLL + I
Sbjct: 583 RGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIVLLAVGIYARGIYRR 642
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ 707
+++LR LQT ++ RQ++ ATNNFD ANK+GEGGFGSV+KG LSDGT+IAVKQ
Sbjct: 643 DNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQ 702
Query: 708 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 767
LSSKS QGNREFVNEIGMIS HPNLVKLYGCCVE +QLLLVYEYM+NN L+ A+FG++
Sbjct: 703 LSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQN 762
Query: 768 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ LKLDW R+KIC+GIARGL +LH+ S +++VHRDIKT+NVLLD DLNAKISDFGLA
Sbjct: 763 S---LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLA 819
Query: 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887
+L+E + THIST++AGTIGYMAPEYA+ G LT KADVYSFGVV +EIVSGKSNT + N
Sbjct: 820 RLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNA 879
Query: 888 DFVYLLDWAYVLQE 901
D V L++WA LQ+
Sbjct: 880 DSVSLINWALTLQQ 893
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/894 (42%), Positives = 538/894 (60%), Gaps = 34/894 (3%)
Query: 32 TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I + ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + M +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGAKIN--TGHTKYEADMEA 438
+ + ++V P CL++NFPC+ Y INCGG + TG D +
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 439 RGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 ---SKKNHVMIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
K I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NLVKLYGCC EG +LVYEY+ N L +A+FG T L LDW TR +IC+G+AR
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVAR 801
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GL YLHE++ ++IVHRD+K SN+LLD L +ISDFGLAKLY++ KTHISTR+AGTIGY+
Sbjct: 802 GLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYL 861
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
APEYAMRG+LT K DVY+FGVV LE+VSG+ N++ E+ YLL+WA+ L E+
Sbjct: 862 APEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/917 (42%), Positives = 544/917 (59%), Gaps = 43/917 (4%)
Query: 16 LLFISLVTFFG--YAIAA---TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKG 67
LL + + FG Y + A T H +E AL I R ++WN + CS
Sbjct: 11 LLTVWFLCNFGPVYVVRAQNRTGATTHPDEALALNSIFAAWRIRAPREWNISGELCSGAA 70
Query: 68 NWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLS 124
D + + CDCS S C + I + A + G++P +L L YL L+L
Sbjct: 71 IDASVLDSNPAYNPLIKCDCSFENSTICRITNIKVYAMEVVGSIPQQLWTLEYLTNLNLG 130
Query: 125 RNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+N LTGS P +L + G N LSGP PK + +T L+ LSI N F+GSIP +I
Sbjct: 131 QNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTDLRLLSISSNNFSGSIPDEI 190
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
+ LQ++ + S+ +G LP L L I+D +G+IP+FIG W K+ L I
Sbjct: 191 GRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELTGQIPDFIGDWTKLTTLRIL 250
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYI 302
G+ L GPIPAS S LTSLT+LR+ D+ S+ + M +L L+L + G IP I
Sbjct: 251 GTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNI 310
Query: 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
G+ + L+ +DLSFN L G IP + L + ++L N L G +P S NVD+S N
Sbjct: 311 GEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYN 370
Query: 363 NFT-----WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 417
+ + W S + + N + N++ CL++NFPC+ Y
Sbjct: 371 DLSGSLPSWVSLPNLNLNLVANNF--TLEGLDNRVLSGLNCLQKNFPCNRGKGIYS-DFS 427
Query: 418 INCGGAKINT-GHTKYEADMEARG-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTS 475
INCGG +I + +E + E G AS S+GQ WA SS G F ++ YI T+ S
Sbjct: 428 INCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSVGLFAGSSNNI--YISTSQS 485
Query: 476 TLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKR 533
V+ +D EL+++AR+S SL YYGL L NG YTV L FAEI + +T+ LG+R
Sbjct: 486 QF--VNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRR 543
Query: 534 IFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRG 592
FDIY+Q +LV+KDF++ AG + + V + + A V+ + L+IHL+WAG+GT IP++G
Sbjct: 544 RFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQG 603
Query: 593 TYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVGASVLLVL--LILFIMRWKGC 645
YGPLISA+ +F P P K I+ IVG +L ++ +++FI+R +
Sbjct: 604 AYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRR- 662
Query: 646 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 705
+ + D+E+ +D++ +T ++K+AT +FDP+NK+GEGGFG VYKG L+DG +AV
Sbjct: 663 --KRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAV 720
Query: 706 KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
K LS SRQG +FV EI ISA QH NLVKLYGCC EG LLVYEY+ N L +A+FG
Sbjct: 721 KLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG 780
Query: 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
+ T L LDW TR +IC+G+ARGL YLHE++R++IVHRD+K SN+LLD L K+SDFG
Sbjct: 781 EKT---LHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFG 837
Query: 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885
LAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+FGVV LE+VSG+ N++
Sbjct: 838 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENL 897
Query: 886 NEDFVYLLDWAYVLQEE 902
++ YLL+WA+ L E+
Sbjct: 898 EDEKRYLLEWAWNLHEK 914
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 135/291 (46%), Positives = 193/291 (66%), Gaps = 21/291 (7%)
Query: 619 VMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQ-------- 670
+ + +++G +++ V L F+ R + +A + G DL+ + Q
Sbjct: 283 IATVCSVIGFAIIAVFLYFFMTR------NRRTAKQRHEGKDLEELMIKDAQLLQLDFDT 336
Query: 671 IKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 730
I+ ATN+F N++GEGGFG+VYKG+L G IAVK+LS KS QG+ EF+NE+ +++ Q
Sbjct: 337 IRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKLQ 396
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H NLV+L G C++G + +L+YE+ KN L IF D+ R+ LDW TR +I G+ARGL
Sbjct: 397 HRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIF--DSNRRMILDWETRYRIISGVARGL 454
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED---KTHISTRIAGTIGY 847
YLHEDSR KIVHRD+K SNVLLD +N KI+DFG+AKL++ D +T ++++AGT GY
Sbjct: 455 LYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGY 514
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED-FVYLLDWAY 897
MAPEYAM G + K DV+SFGV+ LEI+ GK N N+ P ED ++LL + +
Sbjct: 515 MAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKN-NWSPEEDSSLFLLSYVW 564
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 907 | ||||||
| 302143484 | 1011 | unnamed protein product [Vitis vinifera] | 0.977 | 0.877 | 0.726 | 0.0 | |
| 449444971 | 1028 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.858 | 0.715 | 0.0 | |
| 224080095 | 977 | predicted protein [Populus trichocarpa] | 0.948 | 0.880 | 0.717 | 0.0 | |
| 359485473 | 999 | PREDICTED: probable LRR receptor-like se | 0.958 | 0.869 | 0.710 | 0.0 | |
| 255584521 | 941 | conserved hypothetical protein [Ricinus | 0.883 | 0.851 | 0.769 | 0.0 | |
| 356501491 | 1025 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.869 | 0.678 | 0.0 | |
| 357494365 | 1039 | BED finger-nbs resistance protein [Medic | 0.972 | 0.848 | 0.671 | 0.0 | |
| 317106662 | 927 | JHL10I11.12 [Jatropha curcas] | 0.865 | 0.846 | 0.759 | 0.0 | |
| 345651730 | 1027 | rfls6 protein [Glycine max] | 0.977 | 0.863 | 0.666 | 0.0 | |
| 297849060 | 1012 | hypothetical protein ARALYDRAFT_470791 [ | 0.971 | 0.870 | 0.658 | 0.0 |
| >gi|302143484|emb|CBI22045.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1311 bits (3393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/895 (72%), Positives = 752/895 (84%), Gaps = 8/895 (0%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
S ++KKG ES+VTCDC+ +A+CHVVTIALKAQNL+G+LP ELSKL +LK LDLSRN
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTIALKAQNLSGSLPPELSKLYHLKHLDLSRNLF 119
Query: 129 TGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+I KLI
Sbjct: 120 SGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPEIGKLIR 179
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHIQGSSLE
Sbjct: 180 IEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHIQGSSLE 239
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTK 307
GPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+YIGDM K
Sbjct: 240 GPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEYIGDMKK 299
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE 367
LK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S NNFTW+
Sbjct: 300 LKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSYNNFTWD 359
Query: 368 SSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKIN- 426
SS P+ECPRGSVNLVESYSS + CL+QNFPCSA ++QYHY+LHINCGG + +
Sbjct: 360 SSSPVECPRGSVNLVESYSSSSVRRSIHS-CLKQNFPCSASSNQYHYSLHINCGGKETSI 418
Query: 427 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLE 486
G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS VS +D+E
Sbjct: 419 NGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNVSVLDVE 477
Query: 487 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 546
LY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ KLV K
Sbjct: 478 LYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQGKLVLK 537
Query: 547 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 606
DFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISAISV N
Sbjct: 538 DFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISAISVDPN 597
Query: 607 FKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLY 666
F+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLDLQTGL+
Sbjct: 598 FEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLDLQTGLF 657
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFVNE+GMI
Sbjct: 658 TLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFVNEVGMI 717
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
SA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+D Y+LKL+W TR+ IC+GI
Sbjct: 718 SALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKLNWSTRQNICVGI 777
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
ARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKISDFGLAKL E+D THISTRIAGTIG
Sbjct: 778 ARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKISDFGLAKLDEDDNTHISTRIAGTIG 837
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 901
YMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 838 YMAPEYAMRGYLTDKADVYSFGVVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 892
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444971|ref|XP_004140247.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] gi|449481221|ref|XP_004156118.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1300 bits (3364), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 639/893 (71%), Positives = 742/893 (83%), Gaps = 10/893 (1%)
Query: 15 HLLF-ISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSS 73
H + I L+ F + +AA A KLH EEVKALK+I +KLGK DW+F +DPCS +G W +
Sbjct: 17 HFFYAILLLQFATFGLAAAA-KLHREEVKALKEIEKKLGKNDWDFNIDPCSGEGKWHVV- 74
Query: 74 DDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG 130
+ +KGFES+VTCDCS ++TCH+V IALK+QNL+G +P E SKLR+LKQLDLSRNCLTG
Sbjct: 75 NGRKGFESSVTCDCSFNHNSTCHIVAIALKSQNLSGIVPPEFSKLRFLKQLDLSRNCLTG 134
Query: 131 SFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190
QWA+++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IPP+I KL+NL+
Sbjct: 135 FVPSQWATMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGRIPPEIGKLVNLE 194
Query: 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250
KL+LSSN TGELP L KL+NL D+RISDNNFSGKIPEFI W +I+KLHIQG SLEGP
Sbjct: 195 KLVLSSNGLTGELPKGLAKLSNLTDMRISDNNFSGKIPEFISNWAQIEKLHIQGCSLEGP 254
Query: 251 IPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLK 309
IP SIS +TSLTDLRISDLKG S FP L + ++KTLIL KC I GEIP YIGDM KLK
Sbjct: 255 IPLSISTMTSLTDLRISDLKGGRSPFPPLSNIKSMKTLILRKCFIFGEIPKYIGDMKKLK 314
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
N+DLS+N+LTG +P TFE+L K ++++LT NKL G +P +I SNKNVD+S NNFTWE+S
Sbjct: 315 NLDLSYNDLTGEVPATFERLDKIDYIFLTANKLNGIIPGWILGSNKNVDLSNNNFTWENS 374
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
P ECPRGSVNLVE+YS KL ++HPCL++NFPCSA +++HY+L INCGG + +
Sbjct: 375 SPAECPRGSVNLVETYSPSAEKLTRIHPCLKRNFPCSASREEHHYSLRINCGGKETSIRG 434
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+YEAD E GASMFY+ GQ WAFSSTG FMD+D D DNYI TNTS LS VSA ELY
Sbjct: 435 ERYEADRE--GASMFYT-GQNWAFSSTGSFMDNDVDADNYIVTNTSALSNVSATYSELYT 491
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
AR SP SLTYYGLCL NGNYTV+LHFAEI+F NDS+FNSLG+R+FD+YIQEKLV KDF+
Sbjct: 492 KARNSPQSLTYYGLCLINGNYTVKLHFAEIVFINDSSFNSLGRRVFDVYIQEKLVLKDFD 551
Query: 550 IEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP 609
IE EAGGTG PI+K VTSHTLKIH YWAGRGTTGIPLRG YGPLISAISV NF P
Sbjct: 552 IEHEAGGTGKPIIKKITVAVTSHTLKIHFYWAGRGTTGIPLRGNYGPLISAISVDPNFTP 611
Query: 610 PVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLR 669
P H KK+ +I+ A+ +L+LL+L IMR KG LGGK S KELRG+DLQTGL+T+R
Sbjct: 612 PKNHGKKDFTIIIIGTAAAAFVLLLLVLCIMRRKGWLGGKASVYKELRGIDLQTGLFTIR 671
Query: 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ 729
QIKAAT NFD ANKVGEGGFG+VYKG+LSDGT+IAVKQLSSKS+QGNREFVNEIGMISA
Sbjct: 672 QIKAATKNFDAANKVGEGGFGAVYKGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 731
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
QHPNLVKLYGCC++GNQL+L+YEYM+NNCLSRA+F D +LKLDWPTR+KIC+GIARG
Sbjct: 732 QHPNLVKLYGCCIDGNQLMLIYEYMENNCLSRALFRNDPGSKLKLDWPTRQKICLGIARG 791
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
LAYLHE+SR+KIVHRDIKTSNVLLDKD +AKISDFGLAKL+E+D THISTR+AGTIGYMA
Sbjct: 792 LAYLHEESRLKIVHRDIKTSNVLLDKDFSAKISDFGLAKLHEDDNTHISTRVAGTIGYMA 851
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
PEYAMRG LTSKADVYSFGVV LEIVSGKSNTNY P EDFVYLLDWA VLQE+
Sbjct: 852 PEYAMRGCLTSKADVYSFGVVALEIVSGKSNTNYMPKEDFVYLLDWASVLQEK 904
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080095|ref|XP_002306015.1| predicted protein [Populus trichocarpa] gi|222848979|gb|EEE86526.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1291 bits (3341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/868 (71%), Positives = 726/868 (83%), Gaps = 8/868 (0%)
Query: 41 VKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTI 97
V+ L++IG+KLGKKDW+F DPCS +GNW + D++KGFE++VTCDCS +++CH+V+I
Sbjct: 1 VRVLREIGKKLGKKDWDFNKDPCSGEGNWSIL-DERKGFENSVTCDCSFNNNSSCHLVSI 59
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P E SK RYLKQLDLSRN TG PQW +L+L E SVMGNRLSGPFPK
Sbjct: 60 ALKSQNLSGIIPPEFSKFRYLKQLDLSRNLFTGVIPPQWGTLRLEEFSVMGNRLSGPFPK 119
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
VLTN+TTL+NLSIEGN F+G IPP+I +LINLQKL+ SSN+ TG LPAEL KL NL D+R
Sbjct: 120 VLTNMTTLRNLSIEGNHFSGPIPPEIGRLINLQKLVFSSNALTGNLPAELGKLVNLTDVR 179
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
I+DNNFSGK+P FI KW K+QKLH+QG+SL+GPIP+SI++LT L+DLRISDL G S FP
Sbjct: 180 INDNNFSGKLPTFISKWTKVQKLHLQGTSLKGPIPSSIASLTKLSDLRISDLTGRGSPFP 239
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L M ++KTLIL CLI+GEIP+Y+G M KLK++D+SFNNL G IP+TF +LA+ +F+Y
Sbjct: 240 PLSDMESMKTLILRNCLIYGEIPEYVGQMEKLKHLDVSFNNLRGEIPSTFIQLARIDFLY 299
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTG VP ++ NKNVD+S NNFTW+SS P EC RGSVN+VES+S P K H
Sbjct: 300 LTGNKLTGSVPPWLLERNKNVDLSYNNFTWQSSSPDECARGSVNIVESFS-PSTIKSKAH 358
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARGASMFYS-SGQYWAFS 454
CL+QNFPCSA +Q HYTLHINCGG +I G+T Y+ D E RGASMFYS Q WAFS
Sbjct: 359 SCLKQNFPCSASRNQQHYTLHINCGGNEITVDGNTTYQDDKEPRGASMFYSHPSQEWAFS 418
Query: 455 STGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRL 514
STG FMDDD++ D Y +TN S +S VSA +LY TARVSPLSLTYYGLCL NGNYTV+L
Sbjct: 419 STGNFMDDDSEADAYTKTNKSAISNVSATIAQLYTTARVSPLSLTYYGLCLMNGNYTVKL 478
Query: 515 HFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTL 574
HFAEIIF NDS+ SLGKRIFD+YIQ KLV KDFNIEDEAGG IP+VK F A VT +TL
Sbjct: 479 HFAEIIFTNDSSLTSLGKRIFDVYIQGKLVLKDFNIEDEAGGVAIPLVKTFIAAVTHNTL 538
Query: 575 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 634
KI LYWAGRGTTGIPLRG YGPLISAISV NFKPP SK+N V+I+ V ++ L
Sbjct: 539 KIRLYWAGRGTTGIPLRGIYGPLISAISVDPNFKPPSNGSKRNVVIIVTGAVAGAIFLAF 598
Query: 635 LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYK 694
L+L +M G L GK +ADKEL+GLDLQTGL+TLRQ+KAATNNFD NKVGEGGFGSVYK
Sbjct: 599 LVLGVMWRNGWLCGKAAADKELKGLDLQTGLFTLRQMKAATNNFDAENKVGEGGFGSVYK 658
Query: 695 GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
G LSDGTVIAVK LSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL++VYEYM
Sbjct: 659 GSLSDGTVIAVKLLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLMIVYEYM 718
Query: 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814
+NNCLSRA+ GK++++R+KLDWPTR+KIC+G+A+GL YLHE+S IKIVHRDIKTSNVLLD
Sbjct: 719 ENNCLSRALLGKESKFRMKLDWPTRQKICLGVAKGLMYLHEESIIKIVHRDIKTSNVLLD 778
Query: 815 KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 874
K+LNAKISDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEI
Sbjct: 779 KELNAKISDFGLAKLNEDDDTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEI 838
Query: 875 VSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
VSGKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 839 VSGKSNTNYRPKEEFVYLLDWAYVLQER 866
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485473|ref|XP_002278131.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/901 (71%), Positives = 741/901 (82%), Gaps = 32/901 (3%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTI------ALKAQNLTGTLPTELSKLRYLKQLD 122
S ++KKG ES+VTCDC+ +A+CHVVT+ ALKAQNL+G+LP ELSKL +LK LD
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTMVYVNCRALKAQNLSGSLPPELSKLYHLKHLD 119
Query: 123 LSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
LSRN +GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+
Sbjct: 120 LSRNLFSGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPE 179
Query: 183 IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
I KLI ++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHI
Sbjct: 180 IGKLIRIEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHI 239
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDY 301
QGSSLEGPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+Y
Sbjct: 240 QGSSLEGPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEY 299
Query: 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 361
IGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S
Sbjct: 300 IGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSY 359
Query: 362 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 421
NNFTW+SS P+ECPRGSVNLVESYSS +R+N HY+LHINCG
Sbjct: 360 NNFTWDSSSPVECPRGSVNLVESYSSS---------SVRRN----------HYSLHINCG 400
Query: 422 GAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV 480
G + + G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS V
Sbjct: 401 GKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNV 459
Query: 481 SAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQ 540
S +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ
Sbjct: 460 SVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQ 519
Query: 541 EKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISA 600
KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISA
Sbjct: 520 GKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISA 579
Query: 601 ISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLD 660
ISV NF+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLD
Sbjct: 580 ISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLD 639
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV 720
LQTGL+TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFV
Sbjct: 640 LQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFV 699
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+D Y+LKL+W TR+
Sbjct: 700 NEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKLNWSTRQ 759
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
IC+GIARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKISDFGLAKL E+D THISTR
Sbjct: 760 NICVGIARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKISDFGLAKLDEDDNTHISTR 819
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 900
IAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTNYRP E+FVYLLDWAYVLQ
Sbjct: 820 IAGTIGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 879
Query: 901 E 901
E
Sbjct: 880 E 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584521|ref|XP_002532988.1| conserved hypothetical protein [Ricinus communis] gi|223527234|gb|EEF29396.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/807 (76%), Positives = 702/807 (86%), Gaps = 6/807 (0%)
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P + SKL Y++ LDLSRNCLTGS QWA+++LV+LS MGN+LSGPFPK
Sbjct: 6 ALKSQNLSGIVPPDFSKLHYIELLDLSRNCLTGSIPSQWATMRLVDLSFMGNQLSGPFPK 65
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
LTNITTLKNLSIEGN F+G IPP+I KLINL+KL LSSN+FTG+LP EL KL NL D+R
Sbjct: 66 ALTNITTLKNLSIEGNNFSGPIPPEIGKLINLEKLTLSSNAFTGKLPRELAKLVNLTDMR 125
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
ISD NFSG+IP+FI +WK+IQKLHIQGSSLEGPIP+SIS LT L+DLRISDLKG S+FP
Sbjct: 126 ISDANFSGQIPDFISRWKQIQKLHIQGSSLEGPIPSSISGLTRLSDLRISDLKGQSSSFP 185
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
LD M ++KTLIL KCL+ G+IP+YIG M KLKN+DLSFNNLTG IP TF LAK +FMY
Sbjct: 186 HLDNMESMKTLILRKCLLSGKIPEYIGHMKKLKNLDLSFNNLTGEIPATFSHLAKVDFMY 245
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTGP+P+++ NKNVDIS NNFTW+SS IECPRGSVNLVESYSS NKL KVH
Sbjct: 246 LTGNKLTGPIPEWVLERNKNVDISDNNFTWDSSSQIECPRGSVNLVESYSSSTNKLSKVH 305
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFYSSGQYWAFSS 455
CL+QNFPCS+ + +Y LHINCGG +I G + Y AD+EARGASM+YSS Q WAFSS
Sbjct: 306 SCLKQNFPCSSKPN--NYALHINCGGKEIIAGSNITYNADLEARGASMYYSS-QNWAFSS 362
Query: 456 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 515
TG FMD+D D D YI+ NTS +S VSA+D +LY+TARVSPLSL+YYGLCL NGNYTV+LH
Sbjct: 363 TGNFMDNDIDADPYIQINTSAISNVSALDAQLYKTARVSPLSLSYYGLCLINGNYTVKLH 422
Query: 516 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 575
FAEI+F +D+TFNSLGKRIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLK
Sbjct: 423 FAEIVFTDDNTFNSLGKRIFDVYIQEKLVLKDFNIAEEAGGTGRPIVKMFTVAVTSHTLK 482
Query: 576 IHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLL 635
IH YWAGRGTTGIP+RG YGPLISAISV NFKPP + KKN V+I+A V A+V LVLL
Sbjct: 483 IHFYWAGRGTTGIPVRGIYGPLISAISVDPNFKPPSDNDKKN-VIIVATTVSAAVFLVLL 541
Query: 636 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 695
IL IM KGCLG VSADKELRGLDLQTG++TLRQIKAAT NFDPANK+GEGGFGSVYKG
Sbjct: 542 ILGIMWRKGCLGDNVSADKELRGLDLQTGIFTLRQIKAATKNFDPANKLGEGGFGSVYKG 601
Query: 696 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
+LSDGT+IAVKQLSSKS+QGNREFVNEIGMIS QHPNLVKLYGCCVEGNQLLL+YEYM+
Sbjct: 602 LLSDGTIIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLYGCCVEGNQLLLIYEYME 661
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815
NNCLSRA+FGK++ RLKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVLLDK
Sbjct: 662 NNCLSRALFGKNSTSRLKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLLDK 721
Query: 816 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 875
DLNAKISDFGLAKL E++ THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIV
Sbjct: 722 DLNAKISDFGLAKLNEDENTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIV 781
Query: 876 SGKSNTNYRPNEDFVYLLDWAYVLQEE 902
SGKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 782 SGKSNTNYRPKEEFVYLLDWAYVLQER 808
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501491|ref|XP_003519558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1247 bits (3227), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 610/899 (67%), Positives = 733/899 (81%), Gaps = 8/899 (0%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
K+L L SL+ FF +A KL+ +EVKALK+IG K+GKKDW+FGVDPCS KGN
Sbjct: 9 KMLFLLLLGSTSLIFFFPQLASAATPKLNTQEVKALKEIGSKIGKKDWDFGVDPCSGKGN 68
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W +S D +KGFES+V CDCS +++CHVV+I+LKAQNL+G+L + SKL +L++LDLSR
Sbjct: 69 WNVS-DARKGFESSVICDCSFDHNSSCHVVSISLKAQNLSGSLSPDFSKLHHLQELDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TG+ PQW +++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGAIPPQWGTMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KLILSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLILSSNGFTGALPPTLSKLTKLIDLRISDNNFFGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRIADLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPAYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P ++ +NKN+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPGWVLANNKNIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P ECPRGS+NLVESYSS N +K+H CL++NFPC++ ++YHY+++INCGG
Sbjct: 368 FSWDSSSPTECPRGSINLVESYSSSVNTQNKIHSCLKRNFPCTSSVNKYHYSMNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y +GQ WA SSTG FMD+D D D Y+ NTS L+ VSA+
Sbjct: 428 EANISGQIYEADREQKGAAMLYYTGQDWALSSTGNFMDNDIDSDPYVVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + SLG+R+FD+YIQ L
Sbjct: 487 NSQLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLYSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I+ EAGGTG PIVK A VT HTL+IH YWAG+GTTGIP RG YGPLISAISV
Sbjct: 547 VLKDFDIQREAGGTGKPIVKTLNASVTQHTLEIHFYWAGKGTTGIPTRGVYGPLISAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ + M+ IV +++VLL+L +MR G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGDGKRTYFMLAIGIVAGVLVVVLLVLVLMRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG V+KG+LSDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDAENKIGEGGFGCVFKGLLSDGTIIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+D + KLDWPTRKKIC
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGRDPN-KTKLDWPTRKKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD NAK+SDFGLAKL E+DKTHISTR+AG
Sbjct: 786 LGIAKALAYLHEESRIKIIHRDIKASNVLLDKDFNAKVSDFGLAKLIEDDKTHISTRVAG 845
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
TIGYMAPEYAMRGYLT KADVYSFGVV LE VSGKSNTN+RPNEDF YLLDWAYVLQE
Sbjct: 846 TIGYMAPEYAMRGYLTDKADVYSFGVVALETVSGKSNTNFRPNEDFFYLLDWAYVLQER 904
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494365|ref|XP_003617471.1| BED finger-nbs resistance protein [Medicago truncatula] gi|355518806|gb|AET00430.1| BED finger-nbs resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1235 bits (3196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 610/908 (67%), Positives = 719/908 (79%), Gaps = 26/908 (2%)
Query: 18 FISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKK 77
F SL+ +A AAT KL+ +EVKALK+IG K+GKKDW+FGVDPCS KG W +S D +K
Sbjct: 14 FTSLIFISHFASAATL-KLNTQEVKALKEIGNKIGKKDWDFGVDPCSGKGKWNVS-DSRK 71
Query: 78 GFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP 134
GFES V C+CS +++CHVV+I LKAQNL+GTL E SKL +LK LDLSRN +TGS
Sbjct: 72 GFESAVICNCSFNHNSSCHVVSIFLKAQNLSGTLSPEFSKLPHLKILDLSRNIITGSIPQ 131
Query: 135 QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLIL 194
QWA + LV+LS MGNR SGPFP VLTNITTLKNLSIEGN F+G IP DI KLINL+KL+L
Sbjct: 132 QWAKMNLVDLSFMGNRFSGPFPTVLTNITTLKNLSIEGNQFSGFIPEDIGKLINLEKLVL 191
Query: 195 SSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
SN FTG LP+ +KLT LNDLRISDN+FSGKIP+FI KW I+KLHI+G SLEGPIP+S
Sbjct: 192 QSNRFTGALPSAFSKLTKLNDLRISDNDFSGKIPDFISKWTLIEKLHIEGCSLEGPIPSS 251
Query: 255 ISALTSLTDLRISDLKGSESA-FPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
ISALT L+DLRI+DL+GS S+ FP L M ++KTL+L KCLI GEIP+YIG+M KLK +D
Sbjct: 252 ISALTVLSDLRITDLRGSRSSTFPPLSNMKSMKTLVLRKCLIKGEIPEYIGEMAKLKVLD 311
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372
LSFN+L+G IP +F L K +FMYLT N L+G +P ++ +NKN+D+S NNF WESS P
Sbjct: 312 LSFNSLSGKIPESFRDLDKVDFMYLTRNNLSGTIPDWVLKNNKNIDVSYNNFEWESSSPT 371
Query: 373 ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKY 432
EC RGSVNLVESYS K +H CL++NFPC++ + HY+L INCGG + N Y
Sbjct: 372 ECQRGSVNLVESYSLSATKKSNIHSCLKRNFPCTS-KNPRHYSLRINCGGNEANVSGNIY 430
Query: 433 EADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTAR 492
AD+E +GASM Y S + WA SSTG FMD+D D D YI TNTS+L VS ++ +LY TAR
Sbjct: 431 TADIERKGASMLYISAEDWALSSTGSFMDNDIDSDPYIVTNTSSLQNVSVINSKLYTTAR 490
Query: 493 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIED 552
VSPLSLTYYGLC+ NGNYTV+LHFAEIIF ND + NSLG+RIFD+YIQ KLV +DF+IE
Sbjct: 491 VSPLSLTYYGLCMINGNYTVQLHFAEIIFINDRSLNSLGRRIFDVYIQGKLVLRDFDIER 550
Query: 553 EAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVV 612
EAGG PIVK F A VT +TLKI YWAG+GTTGIP RG YGPL+SAISV NFKPP
Sbjct: 551 EAGGAEKPIVKKFNATVTENTLKIQFYWAGKGTTGIPTRGVYGPLVSAISVDPNFKPPSE 610
Query: 613 HSKKNHVMIMA-AIVGASVLLVLLILFIMRWKGCLGGKVSADK----------------- 654
H + V+++A IV + +VL+++ +MR KG LGGK K
Sbjct: 611 HGNRTRVILLAVGIVCGFLAVVLIMVAVMRRKGLLGGKDPVYKGKVINFVIESKFPFFFS 670
Query: 655 ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ 714
ELRG+DLQTGL+TLRQIK AT NFD ANK+GEGGFGSVYKG LSDGTVIAVKQLSSKS+Q
Sbjct: 671 ELRGIDLQTGLFTLRQIKVATKNFDAANKLGEGGFGSVYKGQLSDGTVIAVKQLSSKSKQ 730
Query: 715 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 774
GNREFVNEIGMIS QHPNLVKL+GCCVEGNQL+L+YEYM+NNCLSR +FGK +E + KL
Sbjct: 731 GNREFVNEIGMISGLQHPNLVKLHGCCVEGNQLILIYEYMENNCLSRILFGKGSESKKKL 790
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
DW TRKKIC+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD NAK+SDFGLAKL E+DK
Sbjct: 791 DWLTRKKICLGIAKALAYLHEESRIKIIHRDIKASNVLLDKDFNAKVSDFGLAKLIEDDK 850
Query: 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 894
TH+STRIAGT+GYMAPEYAMRGYLT KADVYSFGVV LEI+SGKSNTNYRP+++F YLLD
Sbjct: 851 THVSTRIAGTVGYMAPEYAMRGYLTDKADVYSFGVVALEIISGKSNTNYRPDDEFFYLLD 910
Query: 895 WAYVLQEE 902
WAYVLQE
Sbjct: 911 WAYVLQER 918
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106662|dbj|BAJ53166.1| JHL10I11.12 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 1231 bits (3185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 601/791 (75%), Positives = 678/791 (85%), Gaps = 6/791 (0%)
Query: 114 KLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
KLR+L+ LDLSRNC TGS QWA+L+LV LS MGNRLSG FPKVLTNITTL NLS+EGN
Sbjct: 1 KLRHLQLLDLSRNCFTGSIPSQWATLRLVNLSFMGNRLSGSFPKVLTNITTLTNLSVEGN 60
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
F+GSIP +I KLINLQK ILSSN+FTG+LP EL+KLTNL D+RISDNNFSG IP FI K
Sbjct: 61 RFSGSIPREIGKLINLQKFILSSNAFTGKLPTELSKLTNLTDMRISDNNFSGTIPTFINK 120
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKC 292
W IQKLHIQGS LEGPIP+SISAL +L+DLRISDLKG S FP L M ++K LIL C
Sbjct: 121 WTHIQKLHIQGSGLEGPIPSSISALKNLSDLRISDLKGKGSTFPPLSNMESIKALILRNC 180
Query: 293 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
L+ EIP+YIG M KLKN+DLSFNNLTG IPT+F L K +FMYLTGNKLTG VP+++
Sbjct: 181 LLSDEIPEYIGHMKKLKNLDLSFNNLTGEIPTSFSYLGKADFMYLTGNKLTGSVPEWVLE 240
Query: 353 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 412
NKNVDIS NNF+WESS PIECPRGSVNLVESYSS KL KVH CL+QNFPCS+ ++
Sbjct: 241 RNKNVDISDNNFSWESSSPIECPRGSVNLVESYSSSTEKLSKVHSCLKQNFPCSS--NKK 298
Query: 413 HYTLHINCGGAK-INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
+Y+L+INCGG + I G+T Y+AD+E RGASMFY+S Q WAFSSTG FMD++ D D YI+
Sbjct: 299 YYSLYINCGGEEMIAGGNTTYQADLEPRGASMFYTS-QSWAFSSTGNFMDNNIDSDPYIQ 357
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
NTS +S VS+ D +LY TARVSP+SLTYYGLCL NGNYTV LHFAEI+F NDS+FNSLG
Sbjct: 358 INTSAISNVSSPDAQLYTTARVSPISLTYYGLCLINGNYTVNLHFAEIVFINDSSFNSLG 417
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR 591
+RIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLKIH YWAG+GTTGIP+R
Sbjct: 418 RRIFDVYIQEKLVLKDFNIVEEAGGTGRPIVKKFTVTVTSHTLKIHFYWAGKGTTGIPVR 477
Query: 592 GTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVS 651
GTYGPLISAISV NFKPP + +K +++ + + GA V LVLL+L IM KGCLGGKV
Sbjct: 478 GTYGPLISAISVDPNFKPPSDNDEKEKIIVSSTVAGA-VFLVLLVLCIMWRKGCLGGKVY 536
Query: 652 ADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK 711
ADKELRGLDLQTG++TL+QIKAAT NFD ANKVGEGGFGSVYKG LSDGT+IAVKQLSSK
Sbjct: 537 ADKELRGLDLQTGIFTLKQIKAATKNFDAANKVGEGGFGSVYKGQLSDGTIIAVKQLSSK 596
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
S+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSRA+FGK+ R
Sbjct: 597 SKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSRALFGKNPTSR 656
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
LKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVL+DKDLNAKISDFGLAKL E
Sbjct: 657 LKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLIDKDLNAKISDFGLAKLNE 716
Query: 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
+D THISTR+AGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIVSGKSNTNYRP E+FVY
Sbjct: 717 DDNTHISTRVAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIVSGKSNTNYRPKEEFVY 776
Query: 892 LLDWAYVLQEE 902
LLDWAYVLQE
Sbjct: 777 LLDWAYVLQER 787
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345651730|gb|AEO14875.1| rfls6 protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1214 bits (3142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/899 (66%), Positives = 720/899 (80%), Gaps = 12/899 (1%)
Query: 14 SHLLFISLV-----TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
S +LF+ L+ F + +A KL+ +EVKALK+IG K+GKKDWNFGVDPCS KGN
Sbjct: 8 SKMLFLLLLGSTSLIFLSHLASAATPKLNTQEVKALKEIGSKIGKKDWNFGVDPCSGKGN 67
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W + K S+V CDCS +++CHVV+I KAQNL+G+L E SKL YL++LDLSR
Sbjct: 68 WNVPDARKAFVMSSVICDCSFNHNSSCHVVSIYWKAQNLSGSLSPEFSKLHYLQKLDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TGS PQW +++LVELS+MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGSIPPQWGTMRLVELSLMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KL+LSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLVLSSNGFTGALPPVLSKLTKLIDLRISDNNFLGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP+YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRITDLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPEYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P+++ +N+N+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPRWVLANNENIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P EC RGSVNLVESYSS N K++ CL++NF C+A QY Y+L+INCGG
Sbjct: 368 FSWDSSSPTECQRGSVNLVESYSSSVNTQTKINSCLKKNFLCTASPSQYRYSLNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y + Q WA SSTG F D+D D D YI NTS L+ VSA+
Sbjct: 428 EANVSGNIYEADREQKGAAMLYYTSQDWALSSTGNFTDNDIDSDPYIVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + NSLG+R+FD+YIQ L
Sbjct: 487 NSKLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLNSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I EAGGTG I K F A VT HTLKIH YWAG+GTTGIP RG YGPL+SAISV
Sbjct: 547 VLKDFDIRREAGGTGKSIEKTFNASVTQHTLKIHFYWAGKGTTGIPTRGVYGPLVSAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ ++++ IV +++VLL+L ++R G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGEGKRTYLILAIIIVAGVLVVVLLVLVLLRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG VYKG SDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDALNKIGEGGFGCVYKGQQSDGTMIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+D + KLDWPTRKKIC
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGRDPN-KTKLDWPTRKKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+GIA+ LAYLHE+SRIKI+HRD+K SNVLLDKD NAK+SDFGLAKL E++KTHISTR+AG
Sbjct: 786 LGIAKALAYLHEESRIKIIHRDVKASNVLLDKDFNAKVSDFGLAKLIEDEKTHISTRVAG 845
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
TIGYMAPEYAMRGYLT KADVYSFGVV LE VSGKSNT++RPNEDFVYLLDWAYVLQE
Sbjct: 846 TIGYMAPEYAMRGYLTDKADVYSFGVVALETVSGKSNTDFRPNEDFVYLLDWAYVLQER 904
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849060|ref|XP_002892411.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] gi|297338253|gb|EFH68670.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1163 bits (3009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/897 (65%), Positives = 706/897 (78%), Gaps = 16/897 (1%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++ + +TF G + KLH EV+ALK+IG KLGKKDWNF DPCS +GNW +++
Sbjct: 10 IIVLFTLTFHGRLGFSDNTKLHEAEVRALKEIGEKLGKKDWNFNKDPCSGEGNWVVTTYT 69
Query: 76 KKGFESNVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
K FESN+TCDCS +++CHV+ IALK+QNLTG +P+E SKLR+LK LDLSRN LTGS
Sbjct: 70 TKEFESNITCDCSFLPPNSSCHVIRIALKSQNLTGIVPSEFSKLRHLKVLDLSRNSLTGS 129
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+WAS++L +LS MGNRLSGPFPKVLT ITTL+NLS+EGN F+G IPPDI KL++L+K
Sbjct: 130 IPKEWASMRLEDLSFMGNRLSGPFPKVLTRITTLRNLSLEGNQFSGPIPPDIGKLVHLEK 189
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L L SN+FTG L +L L NL D+RISDNNF+G IP+FIG W ++ KL + G L+GPI
Sbjct: 190 LHLPSNAFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFIGNWTRVMKLQMHGCGLDGPI 249
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKN 310
P+SIS LTSLTDLRISDL G S+FP+L + ++KTLIL KC ++G IP YIGD+ KLK
Sbjct: 250 PSSISTLTSLTDLRISDLGGKPSSFPQLKNLESIKTLILRKCNLNGPIPKYIGDLMKLKT 309
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
+DLSFN L+G IP++FEK+ K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS
Sbjct: 310 LDLSFNLLSGEIPSSFEKMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSYNNFTDESSI 369
Query: 371 PI--ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA--KIN 426
P +C R S N+VE ++ NK K C Q+FPC+ P + Y L+INCGG K++
Sbjct: 370 PKNGDCNRVSFNMVEGFA--LNKSHKNSTCFLQHFPCAHPKRHHTYKLYINCGGGEVKVD 427
Query: 427 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDL 485
G T Y+ D E +GASM Y G++WA SSTG FMD+D D D+Y NTS LS S+
Sbjct: 428 KGIT-YQTDDEPKGASM-YVLGKHWALSSTGNFMDNDDDADDYTVQNTSRLSVNASSPSF 485
Query: 486 ELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVK 545
ELYRTARVSPLSLTYYGLCLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV
Sbjct: 486 ELYRTARVSPLSLTYYGLCLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVI 545
Query: 546 KDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKS 605
K+FNI++ A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+
Sbjct: 546 KNFNIQEAARGSGKPIIKSFMVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEP 605
Query: 606 NFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGL 665
NFKPPV + K ++ V A+ LL+ +I+ + WK K + DKELRGLDLQTG
Sbjct: 606 NFKPPVYYDIKGIILKAGVPVAAATLLLFIIVGVF-WKK-RRDKNAIDKELRGLDLQTGT 663
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
+TLRQIKAAT+NFD A K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGM
Sbjct: 664 FTLRQIKAATDNFDVAKKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGM 723
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
ISA QHPNLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGKD RLKLDW TRKKI +G
Sbjct: 724 ISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLG 783
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
IA+GL +LHE+SRIKIVHRDIK SNVLLDKDLNAKISDFGLAKL ++ THISTRIAGTI
Sbjct: 784 IAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTI 843
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
GYMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTN+RP EDFVYLLDWAYVLQE
Sbjct: 844 GYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQER 900
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 907 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.947 | 0.829 | 0.554 | 2.4e-250 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.930 | 0.782 | 0.497 | 1.1e-211 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.941 | 0.836 | 0.488 | 1e-210 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.607 | 0.568 | 0.438 | 2.2e-209 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.948 | 0.833 | 0.430 | 4.8e-181 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.890 | 0.847 | 0.459 | 1.4e-172 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.862 | 0.746 | 0.389 | 2.8e-137 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.251 | 0.176 | 0.447 | 1.1e-82 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.261 | 0.203 | 0.457 | 5.2e-80 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.291 | 0.273 | 0.382 | 6.8e-79 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2411 (853.8 bits), Expect = 2.4e-250, P = 2.4e-250
Identities = 488/880 (55%), Positives = 618/880 (70%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPC-SQKGNWELSSDDKKGFESNVTCDCS- 88
+ A L +EV+ L+ I RKL + N C +K N+ S K SN+TCDC+
Sbjct: 24 SNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDRKWNFVAESTSKLP-TSNITCDCTF 82
Query: 89 --SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSV 146
S+ C V I L+ NL G +P E L L ++DL N L+G+ + + L L+V
Sbjct: 83 NASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAV 142
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++L++SSN+ TG +P
Sbjct: 143 TGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPES 202
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266
L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPIPASIS L +LT+LRI
Sbjct: 203 LSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRI 262
Query: 267 SDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPT 324
+DL+G S FP L M N++ L+L CLI IP+YIG MT LK +DLS N L G IP
Sbjct: 263 TDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPD 322
Query: 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
TF L NFMYL N LTGPVP++I +S +N+D+S NNFT + + C + VNL+ S
Sbjct: 323 TFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISS 380
Query: 385 YSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF 444
Y S N + V CLR++ PC P D +H +L INCGG ++ +Y D+ RGAS F
Sbjct: 381 YPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTF 436
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
S + W +SS+G ++ +D Y+ T+T L S E Y+TAR++ SL YYGLC
Sbjct: 437 SSVSERWGYSSSGAWLGNDGA--TYLATDTFNLINESTP--EYYKTARLASQSLKYYGLC 492
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFNI AGG G P ++
Sbjct: 493 MRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQ 552
Query: 565 FP-AEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMA 623
+V TL+IHL W G+GT IP RG YGPLISAI+V NFK N V +
Sbjct: 553 VDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAG 611
Query: 624 AIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPAN 682
++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP N
Sbjct: 612 IVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPEN 671
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+
Sbjct: 672 KIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCI 731
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
EG +LLLVYEY++NN L+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIV
Sbjct: 732 EGKELLLVYEYLENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIV 790
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRDIK +NVLLD LNAKISDFGLAKL EE+ THISTRIAGTIGYMAPEYAMRGYLT KA
Sbjct: 791 HRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKA 850
Query: 863 DVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
DVYSFGVV LEIVSGKSNTNYRP E+F+YLLDWAYVLQE+
Sbjct: 851 DVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQ 890
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2046 (725.3 bits), Expect = 1.1e-211, P = 1.1e-211
Identities = 447/898 (49%), Positives = 578/898 (64%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD-KKGFESNVTCDC 87
+ + + LH +EV+ALK I LG K N DPC K ++ D K+G S + CDC
Sbjct: 32 VLSASPSLHPDEVEALKDIALTLGVKHLNLSEDPCLTK-TLVITQDVLKEGQNSTIRCDC 90
Query: 88 ---SSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVE 143
++ TCH+ LK +L G LP E SKLRYL+ +DL RN L GS +WASL L
Sbjct: 91 HFNNNNTCHITHFVLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKS 150
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
+SV NRL+G PK L L L +E N F+G+IP ++ L+NL+ L SSN G +
Sbjct: 151 ISVCANRLTGDIPKGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGV 210
Query: 204 PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263
P L +L L +LR SDN +G IPEFIG K+Q+L + S L+ PIP SI L +L D
Sbjct: 211 PKTLARLKKLTNLRFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLID 270
Query: 264 LRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
LRISD P + +LK L+L + G IP + D+ L +DLSFN LTG +P
Sbjct: 271 LRISDTAAGLGQVPLITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVP 330
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLV 382
+ + YL GN L+G V F ++ N+D+S NNFTW S C N +
Sbjct: 331 AD---ASAPKYTYLAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQS----CKER--NNI 381
Query: 383 ESYSSPR--NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADM 436
+Y+S R N L ++ PC N C Y+ +LHINCGG + N+ G YE D
Sbjct: 382 NTYASSRSTNSLTRLLPCSAINL-CQ----NYNRSLHINCGGPDVTIENSRGRFLYEGDN 436
Query: 437 EARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPL 496
S G+ W FS+TG FMDD D Y S+ S VSA +LY+ AR SPL
Sbjct: 437 YGLTGSATNYYGKNWGFSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPL 493
Query: 497 SLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
SL Y+ +C NG+Y V+LHFAEI F ++ F+ L KR+F+IY+Q KL+ +DF+I +EA G
Sbjct: 494 SLAYFAICFENGSYNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANG 553
Query: 557 TGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV----KSNFKPPV- 611
T ++K VT +TL+I LYWAG+GTT IP RG YG LISAISV +S PV
Sbjct: 554 THKEVIKEVNTTVTDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQ 613
Query: 612 VH--SKKNHVMIMA-AIVGASVLLV---LLILFIMRWKGCLGGKVSADKELRGLDLQTGL 665
+H +K+ H I+G + L+V LIL + W+ C+ +AD E RG
Sbjct: 614 IHPVTKQQHKQRKYHLILGIAALIVSLSFLILGALYWRICVS---NADGEKRGS------ 664
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
++LRQ+K AT++F+P NK+GEGGFGSVYKG L +GT+IAVK+LSSKS QGN+EF+NEIG+
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
I+ QHPNLVKLYGCCVE QLLLVYEY++NNCL+ A+FG+ LKLDW TR KIC+G
Sbjct: 725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGRSG---LKLDWRTRHKICLG 781
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
IARGLA+LHEDS +KI+HRDIK +N+LLDKDLN+KISDFGLA+L+E+D++HI+TR+AGTI
Sbjct: 782 IARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTI 841
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP-NEDFVYLLDWAYVLQEE 902
GYMAPEYAMRG+LT KADVYSFGVV +EIVSGKSN NY P NE V LLDWA+VLQ++
Sbjct: 842 GYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKK 899
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2037 (722.1 bits), Expect = 1.0e-210, P = 1.0e-210
Identities = 435/890 (48%), Positives = 578/890 (64%)
Query: 22 VTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFES 81
+ F Y++ A KL +EV AL+QI LG K W F + C + L+ +
Sbjct: 30 ICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTAKQ 86
Query: 82 NVTCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS 138
+ C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +WAS
Sbjct: 87 EIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWAS 145
Query: 139 LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LSSN
Sbjct: 146 SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNK 204
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ IS L
Sbjct: 205 LTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVL 264
Query: 259 TSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLSFN
Sbjct: 265 SNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNK 324
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PR 376
L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C P
Sbjct: 325 LVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPN 383
Query: 377 GSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK--INTGHTK--Y 432
++NL S+ K K PC++ +F C P +Y LH+NCGG+ + TK Y
Sbjct: 384 MNLNLNLFQSTSTKKSSKFLPCIK-DFKC--P--RYSSCLHVNCGGSDMYVKEKKTKELY 438
Query: 433 EAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRT 490
E D +E A F W FSSTG FMDD+ N+ T T+ ++ +LY++
Sbjct: 439 EGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDN----NFQNTRF-TMFVPASNQSDLYKS 493
Query: 491 ARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNI 550
AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KDFNI
Sbjct: 494 ARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNI 553
Query: 551 EDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPP 610
DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+ KP
Sbjct: 554 MDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP- 612
Query: 611 VVHSKKNHVMIMAAI---VGASVLLVLLILFIMRWK-GCLGGKVSADKELRGLDLQTGLY 666
K + A I +GA L++ ++ F+ W GCL K+ +L +G +
Sbjct: 613 -CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSGTF 669
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG I
Sbjct: 670 TLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAI 729
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
S QHPNLVKL+G CVE QLLL YEYM+NN LS A+F + ++ +DWPTR KIC GI
Sbjct: 730 SCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKICCGI 788
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
A+GLA+LHE+S +K VHRDIK +N+LLDKDL KISDFGLA+L EE+KTHIST++AGTIG
Sbjct: 789 AKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIG 848
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896
YMAPEYA+ GYLT KADVYSFGV+ LEIV+G +N+N+ D V LL++A
Sbjct: 849 YMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFA 898
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 2.2e-209, Sum P(2) = 2.2e-209
Identities = 254/579 (43%), Positives = 330/579 (56%)
Query: 36 LHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDC---SSATC 92
LH +EV+ALK I LG K N DPC K K+G S + CDC + +TC
Sbjct: 39 LHPDEVEALKDITETLGVKHLNLSEDPCLTKTLVISQGVLKEGQNSTIRCDCHFNNYSTC 98
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL 151
H+ L+ NL G LP L K R+L+ +DL N L GS +WASL L +SV NRL
Sbjct: 99 HIKHFVLQKFNLPGRLPPMLYKFRHLESIDLYNNYLYGSIPMEWASLPYLKSISVCANRL 158
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
SG PK L L L +E N F+G+IP ++ L+NLQ L LSSN G LP L KLT
Sbjct: 159 SGDIPKGLGKFINLTLLVLEANQFSGTIPKELGNLVNLQGLGLSSNQLVGGLPKTLAKLT 218
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +L +SDN +G IPEFIGK K+Q+L + S L GPIP SI L +L D+RISD
Sbjct: 219 KLTNLHLSDNRLNGSIPEFIGKLPKLQRLELYASGLRGPIPDSIFHLENLIDVRISDTVA 278
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P++ +LK L+L + G IP I D+ L +DLSFN LTG IP + K
Sbjct: 279 GLGHVPQITSTSLKYLVLRNINLSGPIPTSIWDLPSLMTLDLSFNRLTGEIPA-YATAPK 337
Query: 332 TNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+ YL GN L+G V F ++ N+D+S NNFTW P+ R ++N ES S +N
Sbjct: 338 --YTYLAGNMLSGKVETGAFLTASTNIDLSYNNFTWS---PMCKERKNINTYES-SHSKN 391
Query: 391 KLDKVHPC--LRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMF 444
+L ++ PC ++Q C Y +LHINCGG + N+ G YE D S
Sbjct: 392 RLTRLLPCSAIKQ---CQ----NYSRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSAT 444
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
+ W +S+TG FMDD D Y S+ S VSA +LY+ AR SPLSL YY C
Sbjct: 445 NYYRKNWGYSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYYAFC 501
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
NG+Y V+LHFAEI F + + L KR+F+IYIQ KL+ +DF+I +EA GT +++
Sbjct: 502 FENGSYNVKLHFAEIQFSDVEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIRE 561
Query: 565 FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
VT +TL+I LYWAG+GT IP RG YG LISA+SV
Sbjct: 562 VNTTVTDNTLEIRLYWAGKGTMIIPQRGYYGSLISAVSV 600
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1757 (623.6 bits), Expect = 4.8e-181, P = 4.8e-181
Identities = 385/894 (43%), Positives = 544/894 (60%)
Query: 32 TANKLHAEEVKALKQI--GRKL-GKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I K+ ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + D +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGA-KINTGHTKYEADMEAR 439
+ + ++V P CL++NFPC+ Y INCGG K + +E + E
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 440 G-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
G AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 -SK-KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
SK KN I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NLVKLYGCC EG +LVYEY+ N L +A+FG T L LDW TR +IC+G+AR
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVAR 801
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GL YLHE++ ++IVHRD+K SN+LLD L +ISDFGLAKLY++ KTHISTR+AGTIGY+
Sbjct: 802 GLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYL 861
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
APEYAMRG+LT K DVY+FGVV LE+VSG+ N++ E+ YLL+WA+ L E+
Sbjct: 862 APEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
Identities = 387/843 (45%), Positives = 502/843 (59%)
Query: 79 FESNVTCDCSSATCH-VVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNC----LTGSF 132
F S+ T VV LK N+ + P E+S + +SRN L GS
Sbjct: 21 FASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPCEVSSTGN-EWSTISRNLKRENLQGSL 79
Query: 133 SPQWASLQLV-ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ L L+ E+ + N L+G P + L N+ + GN TG IP + + L
Sbjct: 80 PKELVGLPLLQEIDLSRNYLNGSIPPEW-GVLPLVNIWLLGNRLTGPIPKEFGNITTLTS 138
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L+L +N +GELP EL L N+ + +S NNF+G+IP K ++ + + L G I
Sbjct: 139 LVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTI 198
Query: 252 PASISALTSLTDLRI--SDLKGS-ESAFPKLDKMNLKTLILTKCLIHG-EIP-DYIGDMT 306
P I T L L I S L G A L + LK L ++ ++G E P + ++
Sbjct: 199 PDFIQKWTKLERLFIQASGLVGPIPIAIASL--VELKDLRISD--LNGPESPFPQLRNIK 254
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366
K++ + L NLTG +P K+ F+ L+ NKL+G +P N I
Sbjct: 255 KMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNML 314
Query: 367 ESSDPIECPRGSVNLVESYSS----PRN---KLDKVHPCLRQNFPCSAPADQYHYTLHIN 419
S P + SY++ P N K + V C+R N+ C + LHIN
Sbjct: 315 NGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMR-NYQCPKTFN----ALHIN 369
Query: 420 CGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSK 479
CGG +++ T YE+D R S +Y S W ++ G F+DD + T S S+
Sbjct: 370 CGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESNSSE 426
Query: 480 VSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYI 539
++ VD LY AR+S +SLTYY LCL NGNY V LHFAEI+F ++ + SLG+R FDIYI
Sbjct: 427 LNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYI 486
Query: 540 QEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLIS 599
Q KL KDFNI EA G ++K FP E+ L+I LYWAGRGTT IP YGPLIS
Sbjct: 487 QRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLIS 546
Query: 600 AISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGL 659
AISV S+ P + + ++ S+ +V L+ + KG L K +K+ + L
Sbjct: 547 AISVDSSVNPSPRNGMSTGTLHTLVVI-LSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSL 605
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREF 719
+L ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGNREF
Sbjct: 606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+NEIGMISA HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG E +L+LDWPTR
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ-ETQLRLDWPTR 724
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+KICIG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN KISDFGLAKL EED THIST
Sbjct: 725 RKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHIST 784
Query: 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVL 899
RIAGT GYMAPEYAMRG+LT KADVYSFG+V LEIV G+SN R + YL+DW VL
Sbjct: 785 RIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844
Query: 900 QEE 902
+E+
Sbjct: 845 REK 847
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
Identities = 324/831 (38%), Positives = 480/831 (57%)
Query: 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG 153
+T + A L+G +P E+ L L+ L +S N +GS + S +L ++ + + LSG
Sbjct: 127 MTFGINA--LSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSG 184
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P N L+ I TG IP I L L + +G +P+ + L L
Sbjct: 185 GIPLSFANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIAL 244
Query: 214 NDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL--TDLRISDLK 270
+LR+ D +N S + +FI K + L ++ ++L G IP++I TSL DL + L
Sbjct: 245 TELRLGDISNGSSSL-DFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLH 303
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--- 327
G A + L L L ++G +P G L N+D+S+N+L+G +P+
Sbjct: 304 GPIPA-SLFNLSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPD 360
Query: 328 ---KLAKTNFMY--LTGNKLTG-PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
L NF L L+G + F N+ I N P + +N
Sbjct: 361 LKLNLVANNFTLEGLDNRVLSGLHCLQKNFPCNRGEGICKCN----KKIPSQIMFSMLN- 415
Query: 382 VESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINT--GHTKYEADMEAR 439
V++Y N L + + C + F D Y INCGG +I + G + D +
Sbjct: 416 VQTYGQGSNVLLEKN-CFK-TFAIDWCLD---YNFSINCGGPEIRSVSGALFEKEDADLG 470
Query: 440 GASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLT 499
AS S+ + WA SS G F ++ YI T+ + ++ +D EL+++AR+S SL
Sbjct: 471 PASFVVSAAKRWAASSVGNFAGSSNNI--YIATSLAQF--INTMDSELFQSARLSASSLR 526
Query: 500 YYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGI 559
YYGL L NG YTV L FAE+ + +++ +G+R F+IY+Q +LV+KDF+I AGG+ +
Sbjct: 527 YYGLGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSV 586
Query: 560 PIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK 615
V + + V+ + L++HL+WAG+GT IP++G YGPLI+A+S +F P V + SK
Sbjct: 587 RAVQREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSK 646
Query: 616 -KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQI 671
K+ I+ IVG +L + +++ ++R + + D+E+ +D++ +T ++
Sbjct: 647 GKSRTGTIVGVIVGVGLLSIFAGVVILVIRKRR---KPYTDDEEILSMDVKPYTFTYSEL 703
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 731
K AT +FD +NK+GEGGFG+VYKG L+DG +AVKQLS SRQG +FV EI IS+ H
Sbjct: 704 KNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLH 763
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
NLVKLYGCC EG+ LLVYEY+ N L +A+FG + L LDW TR +IC+G+ARGL
Sbjct: 764 RNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS---LHLDWSTRYEICLGVARGLV 820
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLHE++ ++I+HRD+K SN+LLD +L K+SDFGLAKLY++ KTHISTR+AGTIGY+APE
Sbjct: 821 YLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPE 880
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
YAMRG+LT K DVY+FGVV LE+VSG+ N++ E YLL+WA+ L E+
Sbjct: 881 YAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEK 931
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
Identities = 103/230 (44%), Positives = 145/230 (63%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGM 725
T I AT NF + +G+GGFG+VYK L +G +A+K+L + QG+REF+ E+
Sbjct: 991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
I +HPNLV L G CV G++ L+YEYM+N L + + L WP R KIC+G
Sbjct: 1051 IGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEA-LGWPDRLKICLG 1109
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
ARGLA+LH I+HRD+K+SN+LLD++ ++SDFGLA++ +TH+ST IAGT
Sbjct: 1110 SARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTF 1169
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 895
GY+ PEY + T+K DVYSFGVV LE+++G+ T + L+ W
Sbjct: 1170 GYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGW 1219
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 5.2e-80, Sum P(2) = 5.2e-80
Identities = 109/238 (45%), Positives = 148/238 (62%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
T + ATN F + +G GGFG VYK L+DG+V+A+K+L + QG+REF+ E+ I
Sbjct: 847 TFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETI 906
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+H NLV L G C G + LLVYEYMK L + K + + LDW RKKI IG
Sbjct: 907 GKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGA 966
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGTI 845
ARGLA+LH I+HRD+K+SNVLLD+D A++SDFG+A+L TH+S + +AGT
Sbjct: 967 ARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTP 1026
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEE 903
GY+ PEY T+K DVYS+GV+ LE++SGK + + L+ WA L E+
Sbjct: 1027 GYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREK 1084
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 6.8e-79, Sum P(2) = 6.8e-79
Identities = 104/272 (38%), Positives = 156/272 (57%)
Query: 621 IMAAIVGASVLLVLLILFI---MRWKGCL-GGKVSAD--KELRGLDLQTGLYTLRQIKAA 674
++ ++G LL ++ L + M+ K L G A+ +L L + ++T I
Sbjct: 585 LICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRV 644
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
T N + +G G +VYK L IA+K+L ++ REF E+ I + +H N+
Sbjct: 645 TENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNI 704
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V L+G + LL Y+YM+N L + G + ++KLDW TR KI +G A+GLAYLH
Sbjct: 705 VSLHGYALSPTGNLLFYDYMENGSLWDLLHG--SLKKVKLDWETRLKIAVGAAQGLAYLH 762
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
D +I+HRDIK+SN+LLD++ A +SDFG+AK KTH ST + GTIGY+ PEYA
Sbjct: 763 HDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYAR 822
Query: 855 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886
+ K+D+YSFG+V LE+++GK + N
Sbjct: 823 TSRINEKSDIYSFGIVLLELLTGKKAVDNEAN 854
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGE0 | Y1765_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6473 | 0.9746 | 0.8717 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00018818001 | SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (1010 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 907 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 3e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-33 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-23 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-09 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 3e-58
Identities = 86/192 (44%), Positives = 101/192 (52%), Gaps = 32/192 (16%)
Query: 414 YTLHINCGGAKINTGH-TKYEAD-MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
L INCGG + YEAD G++ +Y S + S G D
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--TTDP-------- 50
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
ELY+T R SP S +YY CL NGNYTV LHFAEI F D LG
Sbjct: 51 --------------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLG 92
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPL 590
+R+FD+Y+Q KLV KDF+I EAGG G K + P VT TL+IH YWAG+GT IP
Sbjct: 93 RRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPF 152
Query: 591 RGTYG-PLISAI 601
RG YG P ISAI
Sbjct: 153 RGVYGNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 74/195 (37%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
+GEGGFG+VY G +A+K + + E + EI ++ HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N L LV EY + L + E KL +I + I GL YLH I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHS---NGI 113
Query: 802 VHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLT 859
+HRD+K N+LLD D K++DFGL+KL DK + I GT YMAPE +GY +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 860 SKADVYSFGVVTLEI 874
K+D++S GV+ E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-50
Identities = 79/207 (38%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L S + ++F+ E ++ HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
L G C E L LV EYM+ L SR +F + L L I IA+G+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD--LLSFAIQIAKGM 118
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMA 849
YL K VHRD+ N L+ +DL KISDFGL++ +D + I +MA
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVS 876
PE G TSK+DV+SFGV+ EI +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 683 KVGEGGFGSVYKGILSD-----GTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G C E L +V EYM+ L + + R KL + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
+HRD+ N L+ ++L KISDFGL++ +D + I +MAPE G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 857 YLTSKADVYSFGVVTLEIVS 876
TSK+DV+SFGV+ EI +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 74/206 (35%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L + + R EF+ E ++ HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAY 792
L G C +G L +V EYM L ++ KL ++ + IA+G+ Y
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLL--------DFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPE 851
L VHRD+ N L+ ++L KISDFGL++ ED + I +MAPE
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSG 877
G TSK+DV+SFGV+ EI +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 73/200 (36%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 683 KVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G C E L++V EYM L + + + +L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPK-ELSLSDLLSFALQIARGMEYLE-- 120
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
+HRD+ N L+ ++L KISDFGL++ +D + I +MAPE G
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 857 YLTSKADVYSFGVVTLEIVS 876
TSK+DV+SFGV+ EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 16/206 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++ K+GEG FG VY G ++A+K + K + +RE + EI ++ +HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+LY + ++L LV EY + L + G+ +E + I L YL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H IVHRD+K N+LLD+D + K++DFGLA+ + + T GT YMAPE
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVL 168
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGKS 879
+ D++S GV+ E+++GK
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+VYK G ++AVK L +S + ++ EI ++ HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + L LV EY + L + L KKI + I RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 858
I+HRD+K N+LLD++ KI+DFGLAK + + ++T GT YMAPE
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176
Query: 859 TSKADVYSFGVVTLEIVSGK 878
K DV+S GV+ E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 77/205 (37%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FGSVY + D G ++AVK LS S + EI ++S+ QHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 739 GCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G E N L + EY+ LS + FGK E P +K I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYLH 118
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYA 853
+ IVHRDIK +N+L+D D K++DFG AK + +T T + GT +MAPE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
AD++S G +E+ +GK
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
F+ K+G+GGFG VYK G +A+K + +S++ + +NEI ++ +HPN+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
YG ++ ++L +V E+ L + K T L +C + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIA--YVCKELLKGLEYLHS- 116
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
I+HRDIK +N+LL D K+ DFGL+ T + GT +MAPE
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGK 172
Query: 857 YLTSKADVYSFGVVTLEIVSGK 878
KAD++S G+ +E+ GK
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-36
Identities = 101/293 (34%), Positives = 150/293 (51%), Gaps = 29/293 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
NLTG +P+ L L+ L+ L L +N L+G P SLQ L+ L + N LSG P+++
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L+ L + N FTG IP + L LQ L L SN F+GE+P L K NL L +S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS-ESAFPK 278
N +G+IPE + + KL + +SLEG IP S+ A SL +R+ D G S F K
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 279 L----------------------DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L D +L+ L L + G +PD G +L+N+DLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485
Query: 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+G +P L++ + L+ NKL+G +P + + K ++D+S N + +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 682 NKVGEGGFGSVYKG-ILSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQHPNLVKLY 738
++G+G FG VY SDG + +K++ S + RE NE+ ++ HPN++K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-------LDWPTRKKICIGIARGLA 791
E +L +V EY LS+ I K + K LDW + + L
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDW------FVQLCLALK 117
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH KI+HRDIK N+ L + K+ DFG++K+ T + GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 852 -YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ Y K+D++S G V E+ + K
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 73/213 (34%), Positives = 112/213 (52%), Gaps = 21/213 (9%)
Query: 684 VGEGGFGSVYKGILS------DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG V+ G D ++AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK-------KICIGIA 787
YG C EG+ ++V+EYM++ L++ + G D + D P + +I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 846
G+ YL + VHRD+ T N L+ DL KI DFG+++ +Y D + I
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GK 878
+M PE M T+++DV+SFGVV EI + GK
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 14/206 (6%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQH 731
+ K+GEG G VYK + G +A+K+ L ++++ +NEI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
PN+V Y + G++L +V EYM L+ I T+ ++++ P +C + +GL
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLE 130
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH + I HRDIK+ N+LL KD + K++DFG A ++K+ ++ + GT +MAPE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPE 186
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSG 877
R K D++S G++ +E+ G
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-34
Identities = 118/396 (29%), Positives = 183/396 (46%), Gaps = 76/396 (19%)
Query: 14 SHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGK-----KDWNFGVDPCSQKG- 67
+L+F+ F +++ LHAEE++ L + +WN D C +G
Sbjct: 10 PYLIFMLFFLFLNFSM------LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGI 63
Query: 68 ----NWELSSDDKKGFESNVTCDCSSATCH---VVTIALKAQNLTGTLPTEL----SKLR 116
+ + S D G N++ SSA + TI L L+G +P ++ S LR
Sbjct: 64 TCNNSSRVVSIDLSG--KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121
Query: 117 YL-------------------KQLDLSRNCLTGSFSPQ----WASLQLVELSVMGNRLSG 153
YL + LDLS N L+G P ++SL++++L GN L G
Sbjct: 122 YLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEI-PNDIGSFSSLKVLDLG--GNVLVG 178
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P LTN+T+L+ L++ N G IP ++ ++ +L+ + L N+ +GE+P E+ LT+L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238
Query: 214 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE 273
N L + NN +G IP +G K +Q L + + L GPIP SI +L L L +SD S
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS- 297
Query: 274 SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
GEIP+ + + L+ + L NN TG IP L +
Sbjct: 298 ----------------------GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335
Query: 334 FMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+ L NK +G +PK + N +D+S NN T E
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 26/200 (13%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G+G FG V G V AVK L S F+ E +++ +HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 744 GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
GN L +V EYM L RA+ + LD + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD----------VCEGMEYLEEK 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
VHRD+ NVL+ +DL AK+SDFGLAK E + S ++ + + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREK 174
Query: 857 YLTSKADVYSFGVVTLEIVS 876
++K+DV+SFG++ EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGN-REFVNEIGMISAQQHPNLVKLY 738
NK+G G FG VY + L G ++AVK++ + +E +E+ ++ +HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G V ++ + EY L + E+ LD + + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG---YMAPEYAMR 855
IVHRDIK +N+ LD + K+ DFG A + + T + + G YMAPE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 856 GYLTSK---ADVYSFGVVTLEIVSGK 878
G AD++S G V LE+ +GK
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 26/212 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPN 733
N+ + +G G FG VYKG+ L G +A+KQ+S + + + EI ++ +HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA---R 788
+VK G + L ++ EY +N L + I FG E L + + + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SL---------VAVYVYQVLQ 110
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 847
GLAYLHE ++HRDIK +N+L KD K++DFG+A KL + K + GT +
Sbjct: 111 GLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165
Query: 848 MAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 878
MAPE M G ++ +D++S G +E+++G
Sbjct: 166 MAPEVIEMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 682 NKVGEGGFGSVYKG---ILSDGT--VIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V L D T +AVK L+ S Q +F EI ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
K G C + G L L+ EY+ + L + +R +++ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 851
+ +HRD+ N+L++ + KISDFGLAK+ EDK + + G I + APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVS 876
+S +DV+SFGV E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKI---CIGIARGLA 791
L G G L+V E M L + + + E L PT +K IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 850
YL K VHRD+ N ++ +DL KI DFG+ + +YE D + + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 880
E G T+K+DV+SFGVV E+ + G SN
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
FD K+GEG +GSVYK I G V+A+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYL 793
YG + L +V EY +S + K T L T ++I +GL YL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTL-----TEEEIAAILYQTLKGLEYL 115
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H K +HRDIK N+LL+++ AK++DFG++ + +T I GT +MAPE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171
Query: 854 MR-GYLTSKADVYSFGVVTLEIVSGK 878
GY +KAD++S G+ +E+ GK
Sbjct: 172 QEIGY-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 71/199 (35%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +AVK L + G F+ E ++ +H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C E + +V EYM L F K E + KL P + IA G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLD--FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAMRGY 857
+HRD+ N+L+ ++L KI+DFGLA+L E+D+ + I + APE A G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGR 180
Query: 858 LTSKADVYSFGVVTLEIVS 876
T K+DV+SFG++ EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 70/204 (34%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FGSVY+G+ L DG AVK++S ++ ++ EI ++S QHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G E + L + E + L++ + +G E ++L TR+ I GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ-----ILLGLEYLHD 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
VHRDIK +N+L+D + K++DFG+AK E S + G+ +MAPE +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQ 175
Query: 856 -GYLTSKADVYSFGVVTLEIVSGK 878
G AD++S G LE+ +GK
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F+ NK+G+G FG V+K + +D V A+KQ LS +R+ E ++E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD--WPTRKKICIGIARGLA 791
+++ Y ++ +L +V EY +N L + L D W + I I GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
+LH KI+HRDIK+ N+ LD N KI D G+AKL D T+ + I GT Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPE 171
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
K+DV++ GVV E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 740
+G+G G VYK G + A+K++ + R + + E+ + + + P +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
+ ++ +V EYM L+ + + K+ P I I +GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMAPEYAM 854
I+HRDIK SN+L++ KI+DFG++K + + GT+ YM+PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
+ AD++S G+ LE GK
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 683 KVGEGGFGSVY----KGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ +L D ++AVK L S ++F E +++ QH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 786
YG C EG LL+V+EYM++ L+R + + ++ +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 845
A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D + R I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+M PE + T+++D++SFGVV EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
F K+G G FG V++G+ + +A+K L S ++F E+ + +H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
+ C G + ++ E M+ L F + E ++ L + + +A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ- 123
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRG 856
+HRD+ N+L+ +DL K++DFGLA+L +ED +I + APE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHG 179
Query: 857 YLTSKADVYSFGVVTLEIVS 876
++K+DV+SFG++ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISA 728
NN + +G+G FG V++ G+L T++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCL-------------SRAIFGKDTEYR 771
HPN+VKL G C G + L++EYM N L S + K
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLY 830
L L + I +A G+AYL E K VHRD+ T N L+ +++ KI+DFGL+ +Y
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
D S A I +M PE T+++DV+++GVV EI S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 19/201 (9%)
Query: 685 GEGGFGSVYKGI---LSDGTVI--AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
G G FG+VYKG+ + I A+K L S + N+E ++E ++++ HP++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHED 796
G C+ +Q+ L+ + M CL + + L+W C+ IA+G++YL E
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEK 128
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMR 855
++VHRD+ NVL+ + KI+DFGLAKL + D+ I +MA E +
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 856 GYLTSKADVYSFGVVTLEIVS 876
T K+DV+S+GV E+++
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 66/212 (31%), Positives = 113/212 (53%), Gaps = 15/212 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + R+G +F+ E ++ HP LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C E + + LV+E+M++ CLS + + R K T +C+ + G+AYL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
++HRD+ N L+ ++ K+SDFG+ + +D+ ST + + +PE +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 860 SKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 890
SK+DV+SFGV+ E+ S GK+ R N + V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L + S R +F+ E ++ HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARGLAYLHE 795
G + ++++ EYM+N L D E K + GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-------DKFLRENDGKFTVGQLVGMLRGIASGMKYL-- 122
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYA 853
S + VHRD+ N+L++ +L K+SDFGL++ E+ + +T+ G I + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAI 180
Query: 854 MRGYLTSKADVYSFGVVTLEIVS 876
TS +DV+SFG+V E++S
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-28
Identities = 88/272 (32%), Positives = 141/272 (51%), Gaps = 9/272 (3%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA---SLQLVELSVMGNRLSGPF 155
L + N TG +P L+ L L+ L L N +G +L +++LS N L+G
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST--NNLTGEI 372
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P+ L + L L + N G IP + +L+++ L NSF+GELP+E TKL +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L IS+NN G+I +Q L + + G +P S + L +L +S + S +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 276 FPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
KL ++ L L L++ + GEIPD + KL ++DLS N L+G IP +F ++ +
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 335 MYLTGNKLTGPVPKYIFN--SNKNVDISLNNF 364
+ L+ N+L+G +PK + N S V+IS N+
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V++G+ ++ T +AVK L + +F+ E ++ +HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ +V E MK L + LKL P + +A G+AYL + I
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKL--PQLIDMAAQVASGMAYLEAQNYI--- 125
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD+ NVL+ ++ K++DFGLA++ +ED I + APE A+ + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 863 DVYSFGVVTLEIVS 876
DV+SFG++ EIV+
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 2e-28
Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISA-QQHPNLVKLY 738
K+GEG FG VY D ++A+K L+ K + F+ EI ++++ PN+VKLY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV EY+ L + K + L I I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS--- 119
Query: 799 IKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTR-----IAGTIGYMAPEY 852
I+HRDIK N+LLD+D K+ DFGLAKL + + S GT GYMAPE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 853 AM---RGYLTSKADVYSFGVVTLEIVSGKS 879
+ Y +S +D++S G+ E+++G
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 684 VGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG VYKG L T +A+K L + +EF E ++S QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIF-----------GKDTEYRLKLDWPTRKKICIG 785
L G C + +++EY+ + L + D + LD I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGT 844
IA G+ YL S VHRD+ N L+ + L KISDFGL++ Y D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +M PE + G T+++D++SFGVV EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 76/221 (34%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 677 NFDPANKVGEGGFGSVYK-GILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F K+G+G +GSVYK LSD A+K+ L S S++ + VNEI ++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGIARGL 790
++ ++GN+L +V EY LS+AI + + +L + W +I I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
LHE KI+HRD+K++N+LL + KI D G++K+ + K T+I GT YMAP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAP 170
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
E + K+D++S G + E+ + R +D Y
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNL 734
++ ++GEG +G VYK G ++A+K++ ++ ++G + EI ++ +HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 735 VKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V+L + +V+EYM ++ L+ + +K K + GL Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHD-LTGLL----DSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 851
LH I+HRDIK SN+L++ D K++DFGLA+ Y + + T T+ Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 852 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y + D++S G + E+ GK
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G G FG V+ G +A+K + + +F+ E ++ HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803
+ +V EYM N CL + ++ + +L +W +C + + YL + I H
Sbjct: 71 QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLL--DMCSDVCEAMEYLESNGFI---H 123
Query: 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKAD 863
RD+ N L+ +D K+SDFGLA+ +D+ S + + PE +SK+D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 864 VYSFGVVTLEIVSG 877
V+SFGV+ E+ S
Sbjct: 184 VWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 20/223 (8%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYG 739
+G G VY I L + +A+K++ + Q + + + E+ +S HPN+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 740 CCVEGNQLLLVYEYMK-NNCLS--RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
V G++L LV Y+ + L ++ + + LD + + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-----LDEAIIATVLKEVLKGLEYLHSN 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHIS-TRIAGTIGYMAPE-- 851
+I HRDIK N+LL +D + KI+DFG+ A L + D+T GT +MAPE
Sbjct: 122 GQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGKSN-TNYRPNEDFVYLL 893
+ GY KAD++SFG+ +E+ +G + + Y P + + L
Sbjct: 179 EQVHGY-DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF----VNEIGMISAQQHPNLVKL 737
K+GEG +G VYK G ++A+K++ + + EI ++ +HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
+L LV+EY + L + + D L K I + RGLAY H
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYL---DK-RPGPLSPNLIKSIMYQLLRGLAYCH--- 115
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 855
+I+HRD+K N+L+++D K++DFGLA+ + + + T+ Y APE +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
Y T+ D++S G + E+++GK
Sbjct: 175 HYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGC 740
+G+G FG VYK I V+A+K + + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 741 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 796
++G++L ++ EY +CL GK E I + GL YLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----------TYIAFILREVLLGLEYLHEE 117
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
+I HRDIK +N+LL ++ + K++DFG++ + +T GT +MAPE +
Sbjct: 118 GKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQS 173
Query: 857 YLTSKADVYSFGVVTLEIVSGK 878
KAD++S G+ +E+ G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 683 KVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++GEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
G+ +LV EYM ++ LS + + L K + +G+AY+H +
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVL----RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMRGY 857
I+HRD+K +N+L+ D KI+DFGLA+L+ E++ + + T Y APE Y R Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 858 LTSKADVYSFGVVTLEIVSG 877
D+++ G + E+++G
Sbjct: 179 -DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 684 VGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 736
+GEG FG V K + T +AVK L + R+ ++E ++ HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL------SRAI----FGKD-TEYRLKLDWPTRKKICIG 785
LYG C + LLL+ EY K L SR + G D LD P + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 786 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 836
I+RG+ YL E +K+VHRD+ NVL+ + KISDFGL++ +YEED
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
++ + +MA E T+++DV+SFGV+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 77/244 (31%), Positives = 120/244 (49%), Gaps = 24/244 (9%)
Query: 683 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L S ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK------ICIGIAR 788
YG CVEG+ L++V+EYMK+ L++ + G D + + P I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 847
G+ YL VHRD+ T N L+ ++L KI DFG+++ +Y D + I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE----- 901
M PE M T+++DV+S GVV EI + GK N + + + VLQ
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248
Query: 902 EEIY 905
+E+Y
Sbjct: 249 KEVY 252
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
D K+GEG G V S G +AVK++ + +Q NE+ ++ QHPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++Y + G++L +V E+++ L+ D +++ +C+ + + L++LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM 854
++HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
R ++ D++S G++ +E+V G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +A+K L +QG+ F+ E ++ QHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
V + ++ EYM+N L + T +KL + IA G+A++ + I
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
HRD++ +N+L+ + L KI+DFGLA+L E+++ I + APE G T
Sbjct: 125 ---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 860 SKADVYSFGVVTLEIVS 876
K+DV+SFG++ EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 683 KVGEGGFGSVYKG------ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L + ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-----------ICIG 785
YG C +G+ L++V+EYMK+ L++ + + + +D R+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 844
IA G+ YL VHRD+ T N L+ +L KI DFG+++ +Y D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
I +M PE M T+++DV+SFGV+ EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V++GIL +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + +++ EYM+N L + + D E+ +L R GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 855
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 856 GYLTSKADVYSFGVVTLEIVS 876
TS +DV+SFG+V E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKG-ILSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 732
++ + ++G G G V K G ++AVK +L ++ + E+ ++ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW-PTR--KKICIGIARG 789
+V YG + + EYM L D + P R KI + + +G
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSL-------DKILKEVQGRIPERILGKIAVAVLKG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
L YLHE KI+HRD+K SN+L++ K+ DFG++ ++ GT YMA
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMA 167
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYVLQEE 902
PE + K+D++S G+ +E+ +G+ N P+ F LL Y++ E
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQ--YIVNEP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ G + T +AVK L + F+ E ++ +H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
E + +V EYM L F KD E R LKL P + +A G+AY+ R+
Sbjct: 72 E-EPIYIVTEYMSKGSL--LDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRD++++N+L+ L KI+DFGLA+L E+++ I + APE A+ G T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 862 ADVYSFGVVTLEIVS 876
+DV+SFG++ E+V+
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
K+G+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
V+ + +V E + L + K +K ++ + A G+ YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNCI-- 115
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYAMRGYLT 859
HRD+ N L+ ++ KISDFG+++ EE + + I + APE G T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 860 SKADVYSFGVVTLEIVSGKS 879
S++DV+S+G++ E S
Sbjct: 174 SESDVWSYGILLWETFSLGD 193
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 683 KVGEGGFGSVY----KGILS-----------DGTVIAVKQLSSKSRQGNR-EFVNEIGMI 726
K+GEG FG V+ +G+ ++AVK L + + R +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKK--- 781
S ++PN+++L G CV + L ++ EYM+N L++ + ++ E + P+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 782 --ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 838
+ + IA G+ YL + + VHRD+ T N L+ KI+DFG+++ LY D I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
R I +MA E + G T+ +DV++FGV E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 682 NKVGEGGFGSVYKGI--LSDGTVI--AVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
++G G FGSV KG+ + G + AVK L G +EF+ E +++ HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 737 LYGCCVEGNQLLLVYE---------YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
L G C +G L+LV E Y+K + LK + +A
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKR-------REIPVSDLKE-LAHQ------VA 105
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--I 845
G+AYL VHRD+ NVLL AKISDFG+++ + AG +
Sbjct: 106 MGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ APE G +SK+DV+S+GV E S
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMIS 727
NF K+G+G F VYK I L DG V+A+K+ + +K+RQ + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
HPN++K +E N+L +V E LSR I + RL + T K + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
L ++H +I+HRDIK +NV + K+ D GL + + KT + + GT Y
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
M+PE K+D++S G + E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
E + +V EYM L + G+ +Y L P + IA G+AY+ R+ V
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G T K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 863 DVYSFGVVTLEIVS 876
DV+SFG++ E+ +
Sbjct: 185 DVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVN---EIGMISAQ 729
++F +GEG F +V A+K L + ++ ++V E+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
HP ++KLY + L V EY N L + I LD + I
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLA 114
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------- 842
L YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + + + S +
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 843 ------------GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
GT Y++PE +D+++ G + ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++ ++G G +G VYK ++ G ++A+K + + EI M+ +HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+G + ++L +V EY L + G +E ++ +C +GLAYL
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYL 117
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGY 847
HE +I HRDIK +N+LL +D + K++DFG++ ++ IA GT +
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYW 167
Query: 848 MAPEYA---MRGYLTSKADVYSFGVVTLEIVSGK 878
MAPE A +G K D+++ G+ +E+ +
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 8/222 (3%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ G ++ T +AVK L + + F+ E ++ QH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + ++ EYM L F K E K+ P IA G+AY+ + I
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYI--- 125
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD++ +NVL+ + L KI+DFGLA++ E+++ I + APE G T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 863 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 903
DV+SFG++ EIV+ GK N D + L Y + E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 73/216 (33%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 684 VGEGGFGSVYK---GILSDGT--VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FGSV L D T V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 739 GCCVEG--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
G C L LV EY+ L R K E +LD I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSL-RDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK 127
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 854
+ VHRD+ T N+L++ + KI DFGL K+ +DK + R G I + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 855 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 890
+ +DV+SFGVV E+ + S+ + P +F+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFM 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQQ 730
++ K+GEG + VYK G ++A+K++ R+ ++ +N EI ++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN++ L + + LV+E+M+ + L + I KD L K + RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTP--ADIKSYMLMTLRGL 115
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
YLH + I+HRD+K +N+L+ D K++DFGLA+ + ++ ++ T Y AP
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171
Query: 851 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
E + R Y D++S G + E++
Sbjct: 172 ELLFGARHY-GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 682 NKVGEGGFGSVYKGILS--DGTV----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G+ DG +AVK L S S Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIAR 788
V+L G E ++ E M L + E R + + P+ +A+
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL----RENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGT 844
G YL E+ +HRDI N LL AKI+DFG+A+ +Y R
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888
I +M PE + G TSK DV+SFGV+ EI S G R N++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYK G ++A+K++ + + + EI ++ HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L LV+E+M + KD + L K + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK---LIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---TH-ISTRIAGTIGYMAPE--YA 853
I+HRD+K N+L++ + K++DFGLA+ + TH + TR Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLG 172
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
+GY ++ D++S G + E++S +
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 23/210 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQL-----SSKSRQGNREFVN----EIGMISAQQHPN 733
+G G FGSVY G+ S G ++AVKQ+ S+ S+ R ++ EI ++ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V+ G ++ + L + EY+ ++ + Y + + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYG-AFEETLVRNFVRQILKGLNYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----GTIGYM 848
H +R I+HRDIK +N+L+D KISDFG++K E + T A G++ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
APE + T KAD++S G + +E+++GK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FG+V K SDG ++ K++ + + + ++ V+E+ ++ +HPN+V+ Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 739 GCCV-EGNQLL-LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 794
+ NQ L +V EY + L++ I K + R ++ +I + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
D ++HRD+K +N+ LD + N K+ DFGLAK+ D + T GT YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQLN 183
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
K+D++S G + E+ +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+G FG V G + A+K L K R+ + E ++S HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+L LV EY L + + + I L YLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLH---SL 112
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
I++RD+K N+LLD D + K++DFGLAK + + +T GT Y+APE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 860 SKADVYSFGVVTLEIVSGKS 879
D +S GV+ E+++GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+G FG V D + A+K ++ + + R +NE ++ HP LV L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAYLHE 795
+ + LV + + G D Y L K K I L YLH
Sbjct: 68 SFQDEENMYLVVDLL---------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
I+HRDIK N+LLD+ + I+DF +A D ++T +GT GYMAPE R
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR 173
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
+ D +S GV E + GK
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 684 VGEGGFGSVYKG----ILSDGT---VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLV 735
+G G FG VY+G IL G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYL 793
KL G C+ ++ E M+ L + + L IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 847
++ +HRD+ N L+ D D KI DFGLA+ +Y+ D + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
MAPE + G T+++DV+SFGV+ EI++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 37/212 (17%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--------VNEIGMISA-QQHP 732
++G+G FGSVY G ++A+K++ ++F + E+ + +HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGL 790
N+VKL E ++L V+EYM+ N ++ KD + + + I I +GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKP-FSESVIRSIIYQILQGL 112
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH---ISTRIAGTIGY 847
A++H + HRD+K N+L+ KI+DFGLA+ + +STR Y
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164
Query: 848 MAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 878
APE +R +S D+++ G + E+ + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
E + +V E+M L + D +Y LKL P + IA G+AY+ R+ +
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKL--PQLVDMAAQIADGMAYIE---RMNYI 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD++ +N+L+ +L KI+DFGLA+L E+++ I + APE A+ G T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 863 DVYSFGVVTLEIVS 876
DV+SFG++ E+V+
Sbjct: 185 DVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L S + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + ++++ E+M+N L + D ++ ++L R GIA G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSE-- 124
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG--YMAPEYA 853
+ VHRD+ N+L++ +L K+SDFGL++ E+D + ++ + G I + APE
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 854 MRGYLTSKADVYSFGVVTLEIVS 876
TS +DV+S+G+V E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFV----NEIGMISAQQHP 732
+G+G +G VY + ++ G ++AVKQ+ + + ++ V +EI + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGL 790
N+V+ G L + EY+ + + +G+ E + + GL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHISTRIAGTIG 846
AYLH I+HRD+K N+L+D D KISDFG++K +Y+ D+ + G++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVF 175
Query: 847 YMAPEY---AMRGYLTSKADVYSFGVVTLEIVSGK 878
+MAPE +GY ++K D++S G V LE+ +G+
Sbjct: 176 WMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 683 KVGEGGFGSVY----KGIL-------------SDGTVIAVKQLSSKSRQGNR-EFVNEIG 724
K+GEG FG V+ +G+ + ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLK--LDWPT 778
++S + PN+++L C+ + L ++ EYM+ N LSR + E + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHI 837
+ IA G+ YL S + VHRD+ T N L+ K+ KI+DFG+++ LY D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
R I +M+ E + G T+ +DV++FGV EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-23
Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRDIK+ N+LL D + K++DFG +++ ST + GT +MAPE R K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 862 ADVYSFGVVTLEIVSGK 878
D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 679 DPANK------VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISA-QQ 730
DP +GEG +G VYK G ++A+K + + E E ++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 731 HPNLVKLYGC------CVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKIC 783
HPN+ YG +QL LV E ++ + G + RLK +W I
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--IL 119
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKL-YEEDKTHISTRI 841
RGLAYLHE+ K++HRDIK N+LL K+ K+ DFG+ A+L + +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174
Query: 842 AGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
GT +MAPE +++DV+S G+ +E+ GK
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 683 KVGEGGFGSVY----------------KGILSDGTV-IAVKQL----SSKSRQGNREFVN 721
K+GEG FG V+ + +D V +AVK L S +R+ +F+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDT--EYRLKLD 775
E+ ++S PN+ +L G C L ++ EYM+ N L + + L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDK 834
+ T + IA G+ YL + VHRD+ T N L+ K+ KI+DFG+++ LY D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ R I +MA E + G T+K+DV++FGV EI++
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-23
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY LS IA+K++ + + + EI + S +H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 743 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
E + E + LS R+ +G LK + T I GL YLH++
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 800 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 855
+IVHRDIK NVL++ KISDFG +K T GT+ YMAPE R
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
GY + AD++S G +E+ +GK
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-22
Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 27/245 (11%)
Query: 87 CSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE-LS 145
CSS ++ + L + +L G +P L R L+++ L N +G ++ L LV L
Sbjct: 377 CSSG--NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
+ N L G ++ +L+ LS+ N F G + PD L+ L LS N F+G +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPR 493
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+L L+ L L++S+N SG+IP+ + KK+ L + + L G IPAS S + L+ L
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL- 552
Query: 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
DL ++ + GEIP +G++ L +++S N+L G +P+T
Sbjct: 553 --DLSQNQ--------------------LSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
Query: 326 FEKLA 330
LA
Sbjct: 591 GAFLA 595
|
Length = 968 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-22
Identities = 67/202 (33%), Positives = 112/202 (55%), Gaps = 19/202 (9%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + +G + A+K L+ + + N EF++E ++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G C+ + LV + M + CL + + +L L+W C+ IA+G+ YL E
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 854
++VHRD+ NVL+ + KI+DFGLA+L E D+ + I +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
T ++DV+S+GV E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 58/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRDIK+ N+LL D + K++DFG +++ ST + GT +MAPE R K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 862 ADVYSFGVVTLEIVSGK 878
D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLV 735
+GEG FG V K + +AVK L + + + V+E+ M+ +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKI--------CI 784
L G C + L +V EY + L RA P + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 843
+ARG+ +L S+ K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T ++DV+SFGV+ EI +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 14/217 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNL 734
NF K+GEG + +VYKG + G ++A+K++ + +G + EI ++ +H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYL 793
V+L+ N+L+LV+EYM + L + + DT R LD T K + +G+A+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
HE+ +++HRD+K N+L++K K++DFGLA+ + S + T+ Y AP+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172
Query: 854 M--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888
+ R Y TS D++S G + E+++G+ NED
Sbjct: 173 LGSRTYSTS-IDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V G L +A+K L + + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + +++V EYM+N L + D ++ ++L R GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---S 123
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 855
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 856 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 899
TS +DV+S+G+V E++S G+ N+D + ++ Y L
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+V+KGI + +G I A+K + +S RQ +E + + + + H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C G L LV + L R RL L+W C+ IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-LNW------CVQIAKGMYYLE 126
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYA 853
E ++VHR++ N+LL D +I+DFG+A LY +DK + + I +MA E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 854 MRGYLTSKADVYSFGVVTLEIVS 876
+ G T ++DV+S+GV E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 683 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V + S G ++AVK++ + +Q NE+ ++ QH N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V E+++ L+ D +++ +C+ + + L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 860
+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195
Query: 861 KADVYSFGVVTLEIVSGK 878
+ D++S G++ +E+V G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGN--REFVNEIGMISAQQHPNLVK 736
+G G F S Y+ + GT++AVKQ++ + S Q EI +++ HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ G E + L E+M +S + +G E + + RGL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-------INYTEQLLRGLSYLH 120
Query: 795 EDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKT---HISTRIAGTIGYM 848
E+ +I+HRD+K +N+L+D + L +I+DFG A T ++ GTI +M
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 849 APEYAMRG--YLTSKADVYSFGVVTLEIVSGK 878
APE +RG Y S DV+S G V +E+ + K
Sbjct: 176 APE-VLRGEQYGRS-CDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 684 VGEGGFGSVYKGILS--DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FGSV +G LS DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 738 YGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIARG 789
G C E + L +++ +MK+ L + L P + K + IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALG 125
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED---KTHISTRIAGTI 845
+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D + I+ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PV 179
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
++A E TSK+DV++FGV EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL---SSKSRQGNREFVN---EIGMISAQQHPNLV 735
+G+G +G+VY G+ + G +IAVKQ+ +S +E+ E+ ++ + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ G C++ N + + E++ +S + FG E P K I G+AYL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-------PVFCKYTKQILDGVAYL 118
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-----EEDKTHISTRIAGTIGYM 848
H + +VHRDIK +NV+L + K+ DFG A+ +++ + GT +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
APE K+D++S G E+ +GK
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 79/253 (31%), Positives = 118/253 (46%), Gaps = 44/253 (17%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 725
++ A N+ + ++G G G VYK G V+AVKQ+ R GN+E I M
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64
Query: 726 -ISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRK 780
+ + H P +VK YG + + + + E M L + I G E L
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
K+ + I + L YL E ++HRD+K SN+LLD N K+ DFG++ + K TR
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 841 IAGTIGYMAPE----------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE-DF 889
AG YMAPE Y +R ADV+S G+ +E+ +G+ Y+ + +F
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQF--PYKNCKTEF 225
Query: 890 VYLLDWAYVLQEE 902
L +LQEE
Sbjct: 226 EVL---TKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 733
+++GEG GSV K L + G + A+K +++ ++ + E+ + + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+VK YG ++ + + + EY + L +I+ K + ++ KI + +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH KI+HRDIK SN+LL + K+ DFG++ E ++ GT YMAPE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPE 173
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ +DV+S G+ LE+ +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 23/204 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + DG + A+K L + S + N+E ++E +++ P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 793
G C+ + + LV + M CL + ++ + R+ L+W C+ IA+G++YL
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEY 852
E +++VHRD+ NVL+ + KI+DFGLA+L + D+T I +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
+ T ++DV+S+GV E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
++G G FG V G +A+K + S + EF+ E ++ H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + +V EYM N CL + E+ + ++C + G+AYL + +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD+ N L+D K+SDFGL++ +D+ S + + PE + +SK+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 863 DVYSFGVVTLEIVS-GK 878
DV++FGV+ E+ S GK
Sbjct: 183 DVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 61/220 (27%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE 718
++ L T+ I + K+G+G G+V+ I ++ G +A+KQ++ + +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQ 116
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+C + L +LH + +++HRDIK+ NVLL D + K++DFG +++ S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
T + GT +MAPE R K D++S G++ +E+V G+
Sbjct: 174 TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 677 NFDPANKVGEGGFGS--VYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
++ P +G+G FG +Y+ D +++ K+ L+ S + R+ +NEI ++S QHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARG 789
N++ Y ++ N LL+ EY L I + E + L + I
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSA 113
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
++Y+H+ I+HRDIKT N+ L K K+ DFG++K+ + + T + GT YM+
Sbjct: 114 VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMS 169
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
PE K+D+++ G V E+++ K
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 677 NFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQG-NREFVNEIGMISAQ 729
N +G G FG V+ KGI +G T++ VK L + EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLK-LDWPTRKKICIG 785
H N+V+L G C E ++ EY L RA KD + + L + +C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 844
IA G+ +L S + VHRD+ N L+ K+S L+K +Y + + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ ++APE ++K+DV+SFGV+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-21
Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY + ++ G +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 87 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRDIK+ N+LL D + K++DFG +++ S + GT +MAPE R K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPK 196
Query: 862 ADVYSFGVVTLEIVSGK 878
D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF-VNEIGM---ISAQQH 731
++ ++GEG +G+VYK L+ G +A+K++ S +G + EI + + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 732 PNLVKLYGCCV-----EGNQLLLVYEYMK-------NNCLSRAIFGKDTEYRLKLDWPTR 779
PN+V+L C +L LV+E++ + C L T
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-----------LPPETI 109
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS- 838
K + + RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++Y ++
Sbjct: 110 KDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMAL 163
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 874
T + T+ Y APE ++ + D++S G + E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 30/207 (14%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQH---PNLVKLY 738
+G G +G+VY+G + G V+A+K ++ + + + E+ ++S + PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 739 GCCVEGNQLLLVYEYMKNN---CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
G ++G +L ++ EY + L +A P +K I R L
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALK 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
Y+H+ ++HRDIK +N+L+ N K+ DFG+A L ++ + ST GT +MAPE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171
Query: 852 YAMRG-YLTSKADVYSFGVVTLEIVSG 877
G Y +KAD++S G+ E+ +G
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 23/216 (10%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F ++G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
K YG ++G +L ++ EY+ L RA G E+++ + I +GL Y
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 116
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
LH + +I HRDIK +NVLL + + K++DFG+A + + +T + GT +MAPE
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888
+ SKAD++S G+ +E+ G+ PN D
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEP-----PNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ ++ +AVK + + RE F+ E ++ HP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + +V E L + + LD + ++ LAYL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 857
+ VHRDI NVL+ K+ DFGL++ E++ + +++ I +MAPE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 858 LTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888
TS +DV+ FGV EI+ G N D
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+GEG FG+V +G + G +AVK + K + F+ E +++ H NLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
N L +V E M L + T R + + + +A G+ YL K+V
Sbjct: 70 H-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD+ N+L+ +D AK+SDFGLA++ ++++ + + APE +SK+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 863 DVYSFGVVTLEIVS 876
DV+S+GV+ E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 683 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V G +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G +L ++ E+++ L+ D + +L+ +C + + L YLH +
Sbjct: 88 LVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAMRGYLT 859
+HRDIK+ ++LL D K+SDFG +D + R + GT +MAPE R
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 860 SKADVYSFGVVTLEIVSGK 878
++ D++S G++ +E+V G+
Sbjct: 196 TEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 42/230 (18%)
Query: 683 KVGEGGFGSVY--------------------KGILSDGTVIAVKQLSSKSRQGNR-EFVN 721
K+GEG FG V+ KG ++AVK L + + R +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR---------- 771
E+ ++S + PN+++L G CV+ + L ++ EYM+N L++ + + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 772 ----LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ + + + + IA G+ YL S + VHRD+ T N L+ ++L KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 828 K-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ LY D I R I +MA E + G T+ +DV++FGV EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISAQQHPNL 734
N++G G G+VYK I G + A+K + GN R+ EI ++ HPN+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
VK + ++ ++ E+M L + L R+ I G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVARQ-----ILSGIAYLH 185
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-- 852
R IVHRDIK SN+L++ N KI+DFG++++ + ++ + GTI YM+PE
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN 241
Query: 853 ------AMRGYLTSKADVYSFGVVTLEIVSGK 878
A GY D++S GV LE G+
Sbjct: 242 TDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 9/222 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+ V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ ++ E+M L F K E K P IA G+A++ + + I
Sbjct: 71 TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 862
HRD++ +N+L+ L KI+DFGLA++ E+++ I + APE G T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 863 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 903
DV+SFG++ +EIV+ G+ N + + L+ Y + E
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V G +AVK++ + +Q NE+ ++ H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V E+++ L+ D +++ +C+ + R L+YLH +
Sbjct: 89 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 860
+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGT 197
Query: 861 KADVYSFGVVTLEIVSGK 878
+ D++S G++ +E++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQ 729
N+ +G+G FG VY D G +AVKQ S ++++ EI ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 787
QH +V+ YGC + L + EYM + + +G TE +K I
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE-------TVTRKYTRQIL 114
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTI 845
G+ YLH + IVHRDIK +N+L D N K+ DFG +K + + + + GT
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 846 GYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
+M+PE GY KADV+S G +E+++ K
Sbjct: 172 YWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G+G FG V G G +AVK + K+ + F+ E +++ +H NLV+L G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 744 GN-QLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L +V EYM L R++ G D + LD + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEA 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
++ VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALRE 173
Query: 856 GYLTSKADVYSFGVVTLEIVS 876
++K+DV+SFG++ EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 741 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C ++ E+M N L + ++ R +++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLD---YLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 856
HRD+ N L+ ++ K++DFGL++L D T AG I + APE
Sbjct: 127 ---HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+ K+DV++FGV+ EI +
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLY 738
++G G FG+VY V+A+K++S +Q N ++ + E+ + +HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
GC + + LV EY CL A + ++ L IC G +GLAYLH R
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAM-R 855
I HRDIK N+LL + K++DFG A L + + GT +MAPE AM
Sbjct: 137 I---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDE 188
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
G K DV+S G+ +E+ K
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVK 736
++GE FG +YKG L ++A+K L + Q EF E +++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIF------------GKDTEYRLKLDWPTRKKICI 784
L G + + +++EY+ L + +D + LD I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 843
IA G+ YL S VH+D+ N+L+ + L+ KISD GL++ +Y D + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
I +M PE M G +S +D++SFGVV EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G +A+K + +G +F+ E ++ HP LV+LYG
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
C + L +V E+M+N CL + KD +C + G+ YL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL----------SMCQDVCEGMEYL 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
+S I HRD+ N L+ K+SDFG+ + +D+ S+ + + PE
Sbjct: 117 ERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 854 MRGYLTSKADVYSFGVVTLEIVS-GK----SNTNY 883
+SK+DV+SFGV+ E+ + GK +NY
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 683 KVGEGGFGSVYKG--ILSDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKL 737
K+G+G FG V +G S G VI AVK L S +F+ E ++ + H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 738 YGCCVEGNQLLLV---------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
YG V + L++V + ++ + L + +Y + IA
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------------AVQIAN 108
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIST---RIAGT 844
G+ YL + +HRD+ N+LL D KI DFGL + L + + ++ ++
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-- 163
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ APE + +DV+ FGV E+ +
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L DG +A+K+ + +K+R + + EI ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGI 786
HPN++K Y +E N+L +V E LSR I + RL K W ++C
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC--- 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
L ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT
Sbjct: 117 -SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 171
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
YM+PE K+D++S G + E+ + +S
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 683 KVGEGGFGSVYKGILSD------GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++G+G FG VY+G D T +AVK ++ S S + EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI---CIGIARGL 790
+L G +G L+V E M + L + + E PT +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 849
AYL+ K VHRD+ N ++ D KI DFG+ + +YE D + + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVS 876
PE G T+ +D++SFGVV EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + +V E + + K E + K K + A G+AYL + +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESKN---CI 115
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMRGYLTSK 861
HRD+ N L+ ++ KISDFG+++ E+D + S+ + I + APE G +S+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 862 ADVYSFGVVTLEIVS 876
+DV+S+G++ E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 30/212 (14%)
Query: 684 VGEGGFGSVYKGILSDG--TVIAVKQLS---------SKSRQGN-REFVNEIGMISAQ-Q 730
+G G FG VYK + ++A+K+++ + R + + V+E+ +I Q +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF------GKDTEYRLKLDWPTRKKICI 784
HPN+V+ Y +E ++L +V + ++ L + TE R+ W I +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---W----NIFV 120
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ L YLH++ RI VHRD+ +N++L +D I+DFGLAK + + T + GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
I Y PE KADV++FG + ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 683 KVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 735
++G+G FG VY KG++ D T +A+K ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICI---GIARGL 790
+L G +G L++ E M L + + E P+ KK+ IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 849
AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D + + +M+
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVS 876
PE G T+ +DV+SFGVV EI +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 684 VGEGGFGSVYKGIL------SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNL 734
+GEG FG V L +DGT ++AVK L + Q N + EI ++ H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 735 VKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG------- 785
VK GCC E L L+ EY+ L D+ + K+ +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLLFAQ 114
Query: 786 -IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
I G+AYLH I HRD+ NVLLD D KI DFGLAK E + R G
Sbjct: 115 QICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 845 --IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 893
+ + A E + +DV+SFGV E+++ ++ P + F ++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPN 733
F+ N++GEG +G VY+ + G ++A+K++ R G + EI ++ +HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 734 LVKLYGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+V+L V G L LV EY + + L+ + T + K + + + RGL
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE----SQVKCLMLQLLRGL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
YLHE+ I+HRD+K SN+LL KI+DFGLA+ Y ++ ++ T+ Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 851 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
E Y T+ D+++ G + E+++ K
Sbjct: 178 ELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 61/204 (29%), Positives = 115/204 (56%), Gaps = 23/204 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKG+ + +G + A+K+L + S + N+E ++E ++++ +P++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 793
G C+ + + L+ + M CL + ++ + + L+W C+ IA+G+ YL
Sbjct: 75 LGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIGYMAPEY 852
E ++VHRD+ NVL+ + KI+DFGLAKL ++K + + I +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
+ T ++DV+S+GV E+++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ-LSSKSRQGNREF----VNEIGMIS 727
+++ K+GEG FG VYK + G V+A+K+ L + G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLD 775
+HPN+V L + + E + R T Y +KL
Sbjct: 63 KLKHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK- 834
K + + G+ YLHE+ I+HRDIK +N+L+D KI+DFGLA+ Y+
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 835 ---------THISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
T T + T Y PE + R Y T+ D++ G V E+ + +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAV-KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + V+A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
N L ++ E+ C A+ E L P + +C L YLHE+ KI
Sbjct: 72 YYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM----- 854
+HRD+K N+L D + K++DFG++ ++ I R GT +MAPE M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 855 -RGYLTSKADVYSFGVVTLEI 874
R Y KADV+S G+ +E+
Sbjct: 182 DRPY-DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 81/235 (34%), Positives = 117/235 (49%), Gaps = 28/235 (11%)
Query: 684 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 738
+G+G FG VY G L SDG I AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 739 GCCVEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG----IARGLAYL 793
G C+ L+V YMK+ L I R + PT K + IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDL-IGFGLQVAKGMEYL 114
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 850
K VHRD+ N +LD+ K++DFGLA+ +Y E H T + +MA
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 902
E T+K+DV+SFGV+ E+++ + Y + F VYLL +LQ E
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPE 225
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + G + A K+L K R+G + +NE ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ L LV M L I+ I GL +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
+IV+RD+K NVLLD N +ISD GLA +L K AGT GYMAPE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVY 171
Query: 859 TSKADVYSFGVVTLEIVSGKS 879
D ++ G E+++G+S
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F ++G+G FG VYKGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
+ YG ++G +L ++ EY+ G + L P + I R GL
Sbjct: 66 RYYGSYLKGTKLWIIMEYL----------GGGSALDLLKPGPLEETYIATILREILKGLD 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH + +I HRDIK +NVLL + + K++DFG+A + + +T + GT +MAPE
Sbjct: 116 YLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 889
+ KAD++S G+ +E+ G+ PN D
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEP-----PNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 730
N ++ VGEG +G V K G ++A+K+ K + + + + E+ ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H N+V L +L LV+EY++ L L + + + +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAI 113
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
AY H I+HRDIK N+L+ + K+ DFG A+ T T Y AP
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 851 E----YAMRGYLTSKADVYSFGVVTLEIVSG 877
E G DV++ G + E++ G
Sbjct: 171 ELLVGDTNYG---KPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
G+G FG VYK G A K + +S + +F+ EI ++S +HPN+V LY
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803
N+L ++ E+ C A+ E L P + +C + L +LH K++H
Sbjct: 74 ENKLWILIEF----CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 804 RDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM------RG 856
RD+K N+LL D + K++DFG+ AK + T I GT +MAPE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNP 184
Query: 857 YLTSKADVYSFGVVTLEI 874
Y KAD++S G+ +E+
Sbjct: 185 Y-DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + G + A K + +KS + +++ EI +++ HP +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+L ++ E+ C A+ E L P + IC + L YLH +KI
Sbjct: 79 YWDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLA----KLYEEDKTHISTRIAGTIGYMAPEYAMRGY 857
+HRD+K NVLL D + K++DFG++ K + + I GT +MAPE M
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 858 LTS-----KADVYSFGVVTLEI 874
+ KAD++S G+ +E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 28/208 (13%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QGNREFV-----NEIGMISAQQHPNLV 735
K+GEG +G VYK G ++A+K K R + E V EI ++ HPN+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L N+L LV+E++ + L + + D+ LD P K + +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLD-LKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCH- 116
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAPEY 852
S +++HRD+K N+L+D++ K++DFGLA+ + TH T+ Y APE
Sbjct: 117 -SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEI 170
Query: 853 AM--RGYLTSKADVYSFGVVTLEIVSGK 878
+ R Y T D++S G + E+V+ +
Sbjct: 171 LLGSRQYSTP-VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 47/219 (21%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE---FVNEIGMI-SAQQHPNLVKLY 738
+G G FG+V K + GT++AVK++ S +E + ++ ++ + P +VK Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 739 G-------C--CVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G C C+E VYE + + + I GK I
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK---------------IA 113
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ + L YL E+ +KI+HRD+K SN+LLD++ N K+ DFG++ + + TR AG
Sbjct: 114 VATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAG 169
Query: 844 TIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
YMAPE A GY ++DV+S G+ E+ +GK
Sbjct: 170 CRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F K+G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
K YG ++ +L ++ EY+ D LD I I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
+ +I HRDIK +NVLL + K++DFG+A + + GT +MAPE +
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
SKAD++S G+ +E+ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 683 KVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++GE FG VYKG L +A+K L K+ RE F +E M S QHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTEYRLKLDWPTRKKICI 784
L G + L +++ Y ++ L + + D + L+ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 843
IA G+ +L S +VH+D+ T NVL+ LN KISD GL + +Y D +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
I +M+PE M G + +D++S+GVV E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 677 NFDPANKVGEGGFGSVY--KG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG FG +Y K S+ VI L+ + E+ +++ +HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY------MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+V + E +L +V EY MK R + + + L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW------FVQIS 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
GL ++H+ KI+HRDIK+ N+ L K+ + AK+ DFG+A+ D ++ GT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPY 167
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y++PE +K D++S G V E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 677 NFDPANKVGEGGFGSVY--KGILSDGTVI----AVKQLSSKSRQGNREFVNEIGMISAQQ 730
++ VG G FG V+ + VI V+Q++ R + NE ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN+++ Y +E L++V EY L+ I + LD T + I L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL---LDEDTILHFFVQILLAL 114
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
++H I+HRD+KT N+LLDK KI DFG++K+ K+ T + GT Y++
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYIS 169
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
PE K+D+++ G V E+ S K
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+++G G FG V G G A VK+L +S + F+ E+ HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G C+E LLV E+ L + +++ +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYA--- 853
+ +H D+ N L DL+ KI D+GLA + Y ED A + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 854 ----MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 904
+ T K++++S GV E+ +P D V++E++I
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL----FTAADQPYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKL 737
+++G G FG+VY S V+AVK++S +Q N ++ + E+ + +HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
GC ++ + LV EY CL A + ++ L I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--- 854
I HRDIK N+LL + K++DFG A K+ + GT +MAPE +
Sbjct: 142 MI---HRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMD 193
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
G K DV+S G+ +E+ K
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF----VNEIGMISAQQ 730
++ N++ EG +G VY+ G ++A+K+L K ++G F + EI ++ Q
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 731 HPNLVKLYGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
HPN+V + V N ++ +V EY++++ L + + K + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLMETMKQPFLQ----SEVKCLMLQLLS 117
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
G+A+LH++ I+HRD+KTSN+LL+ KI DFGLA+ Y T++ T+ Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYR 173
Query: 849 APEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
APE + ++ D++S G + E+++ K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 678 FDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY CL A + ++ L I G +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYL 141
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H + ++HRDIK N+LL + K++DFG A + + + GT +MAPE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 854 M---RGYLTSKADVYSFGVVTLEIVSGK 878
+ G K DV+S G+ +E+ K
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 684 VGEGGFGSVYKGILS-DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+GEG FGSV +G L+ D ++ +AVK +++ +R +F++E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 739 GCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
G C++ + +++ +MK+ L S ++ + + L K IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAP 850
YL S +HRD+ N +L++++N ++DFGL+K + RIA + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVS 876
E T+K+DV+SFGV EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-18
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY CL A + ++ L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H + ++HRD+K N+LL + K+ DFG A + + GT +MAPE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 854 M---RGYLTSKADVYSFGVVTLEIVSGK 878
+ G K DV+S G+ +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L D +A+K+ + +K+RQ + V EI ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIA 787
HPN++K +E N+L +V E LS+ I + RL P R K + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL---IPERTVWKYFVQLC 116
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
+ ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT Y
Sbjct: 117 SAVEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
M+PE K+D++S G + E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 45/217 (20%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNE--IGMISAQQHPNLVKLYGC 740
G G +G V K + GT++AVK++ ++ + Q + + + I M S P V YG
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGA 68
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLH 794
+ + E M L D Y+ D KI + I + L YLH
Sbjct: 69 LFREGDVWICMEVMDT-SL-------DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFG--------LAKLYEEDKTHISTRIAGTIG 846
++ ++HRD+K SNVL++++ K+ DFG +AK T AG
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKP 168
Query: 847 YMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
YMAPE +GY K+DV+S G+ +E+ +G+
Sbjct: 169 YMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 41/223 (18%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILSDGTVI--AVKQLSSKSRQGNRE-FVNEIGMIS- 727
NN +G G FG V + G+ V+ AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK------ 781
H N+V L G C G +L++ EY C Y L++ RK+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEY----CC----------YGDLLNFLRRKRESFLTL 140
Query: 782 ---ICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ +A+G+A+L + +HRD+ NVLL KI DFGLA+ D +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 837 I---STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ + R+ + +MAPE T ++DV+S+G++ EI S
Sbjct: 198 VVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 684 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V + ++ DG + A+K L S +R+F E+ ++ HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L + EY L SR + F K+ L + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
G+ YL E + +HRD+ NVL+ ++L +KI+DFGL++ E R+ + +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
MA E T+K+DV+SFGV+ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 683 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
++G G FG V KG+ +A+K L +++ + R E + E ++ +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C E L+LV E L++ + GK E + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEGKN- 115
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 856
VHRD+ NVLL AKISDFGL+K D ++ R AG + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+S++DV+S+G+ E S
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 57/228 (25%), Positives = 110/228 (48%), Gaps = 33/228 (14%)
Query: 678 FDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQ 730
++ ++GEG +G V+K + + G +A+K++ ++ + + E+ ++ +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 731 HPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP-----TRK 780
HPN+V+L+ C +L LV+E++ + T Y K+ P T K
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPTETIK 113
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+ + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y T
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTS 168
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888
+ T+ Y APE ++ + D++S G + E+ + +R + D
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCC 741
+G G GSV K + GTV+A K + ++ R + + E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N + + E+M L R I+ K +++ KI + + GL YL+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHRI-- 125
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRDIK SN+L++ K+ DFG++ E I+ GT YM+PE G T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 862 ADVYSFGVVTLEIVSGK 878
+DV+S G+ +E+ GK
Sbjct: 183 SDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K+ L +++ + EI ++ HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKL N+L LV+E++ + L + + D + P K + +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAP 850
H +++HRD+K N+L++ + K++DFGLA+ + TH T+ Y AP
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 851 EYAM-RGYLTSKADVYSFGVVTLEIVSGKS 879
E + Y ++ D++S G + E+V+ ++
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 735
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 736 KLYGCCVEGN------QLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIAR 788
YG ++ N QL LV E+ ++ I K+T+ LK +W IC I R
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 122
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GL++LH+ K++HRDIK NVLL ++ K+ DFG++ + +T I GT +M
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178
Query: 849 APEYAM-----RGYLTSKADVYSFGVVTLEIVSG 877
APE K+D++S G+ +E+ G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 19/234 (8%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V G ++ G + VK+L S S Q +F+ E + QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C E LLV E+ L + + D T +++ IA GL +LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYA--MR 855
+H D+ N LL DL KI D+GL+ Y+ED ++ + ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 856 GYL-----TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 904
G L T +++V+S GV E+ + YR D L Y ++E+++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVL---TYTVREQQL 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 684 VGEGGFGSVY--KGILSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVK 736
+ +G FGSVY K + G A+K L +K++ N + I MI + P + K
Sbjct: 4 ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES-PYVAK 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK------LDWPTRKKICIGIARGL 790
LY + L LV EY+ G D +K DW K+ + G+
Sbjct: 62 LYYSFQSKDYLYLVMEYLN---------GGDCASLIKTLGGLPEDWA--KQYIAEVVLGV 110
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
LH+ I+HRDIK N+L+D+ + K++DFGL++ E+K + GT Y+AP
Sbjct: 111 EDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAP 162
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885
E + +D +S G V E + G Y P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFG-----YPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 50/223 (22%)
Query: 676 NNFDPANKVGEGGFGSV----YKG--------ILSDGTVIAVKQLSSKSRQGNREFVNEI 723
++F+ +G G FG V +KG ILS ++ +KQ+ +NE
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE--------HVLNEK 52
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
++ + +HP LV LYG + + L LV EY + G + L+ +
Sbjct: 53 RILQSIRHPFLVNLYGSFQDDSNLYLVMEY---------VPGGELFSHLR----KSGRFP 99
Query: 784 IGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+AR L YLH + IV+RD+K N+LLD D KI+DFG AK + +T
Sbjct: 100 EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRT 155
Query: 836 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 877
+ + GT Y+APE + +GY D ++ G++ E+++G
Sbjct: 156 YT---LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G GN +++V EYM N L F + E +L + G+A G+ YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAG--QLMGMLPGLASGMKYLSE--- 125
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAMRG 856
+ VH+ + VL++ DL KIS F +L E+ I T ++G + + APE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+ +S +DV+SFG+V E++S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G G+VYK L ++AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
N++ + E+M L ++ K E+ L +I + + +GL YL +KI
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKI 116
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRD+K SN+L++ K+ DFG++ + I+ GT YMAPE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 862 ADVYSFGVVTLEIVSGK 878
+DV+S G+ +E+ G+
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 683 KVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +D T +AVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK-----KICIGIARGLAYLHE 795
C + + +V E ++ G D L+ + P K ++ A G+ YL
Sbjct: 62 CTQKQPIYIVMELVQ---------GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPE 851
I HRD+ N L+ + KISDFG+++ EED + ST G + + APE
Sbjct: 113 KHCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPE 166
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVS 876
G +S++DV+SFG++ E S
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 678 FDPANKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQH 731
++ +G G +G VYK DG A+K+ Q ++ EI ++ +H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 732 PNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
N+V L +E + L+++Y +++ F + + R+ + K + I G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNG 120
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAK--------LYEEDKTHI 837
+ YLH + ++HRD+K +N+L+ + KI D GLA+ L + D +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 838 STRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVS 876
TI Y APE + R Y T D+++ G + E+++
Sbjct: 178 ------TIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 687 GGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVKLYGCCV 742
G +G V+ S G + A+K + + + E ++S Q P +VKLY
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 743 EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
L LV EY+ L+ + G LD + I L YLH
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGS-------LDEDVARIYIAEIVLALEYLH---SNG 113
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIST-----RIAGTIGYMAPEYA 853
I+HRD+K N+L+D + + K++DFGL+K L RI GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 854 MRGYLTSKADVYSFGVVTLEIVSG 877
+ + D +S G + E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 684 VGEGGFGSVY------KGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 736
+GEG FG V +G + G +AVK L +S + + EI ++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 737 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C E GN + L+ E++ + L + + LK + K + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGMDYL- 125
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEY 852
SR + VHRD+ NVL++ + KI DFGL K E DK + + + + + + APE
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 893
++ +DV+SFGV E+++ ++ P F+ ++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 684 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V K + DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L L EY + L SR + F L +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
RG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++ E R+ + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
MA E T+ +DV+S+GV+ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHPNLVKLYG 739
+G GGFG V + S A+K + + G +E + +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + ++ EY L + +D R D T + + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL--RD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAM-RGY 857
I++RD+K N+LLD + K+ DFG AK L KT GT Y+APE + +GY
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 858 LTSKADVYSFGVVTLEIVSGK 878
S D +S G++ E+++G+
Sbjct: 170 DFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQH 731
++P ++G G +G+VYK G +A+K + ++ + V E+ ++ A H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 732 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
PN+V+L C ++ LV+E++ + R K L + T K +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE--TIKDLMRQF 117
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGTI 845
RGL +LH + IVHRD+K N+L+ K++DFGLA++Y ++ T + T+
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTL 171
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE ++ + D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 735
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 736 KLYGCCVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIAR 788
YG ++ +QL LV E+ ++ + K+T+ LK DW IC I R
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY--ICREILR 132
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GLA+LH K++HRDIK NVLL ++ K+ DFG++ + +T I GT +M
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 188
Query: 849 APEY--------AMRGYLTSKADVYSFGVVTLEIVSG 877
APE A Y ++D++S G+ +E+ G
Sbjct: 189 APEVIACDENPDATYDY---RSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG +G+V+K ++A+K +L + EI ++ +H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V+LY +L LV+EY +K S +D K + +G
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS---------CNGDIDPEIVKSFMFQLLKG 111
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
LA+ H ++HRD+K N+L++K+ K++DFGLA+ + S + T+ Y
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRP 167
Query: 850 PEYAM--RGYLTSKADVYSFGVVTLEIVSG 877
P+ + Y TS D++S G + E+ +
Sbjct: 168 PDVLFGAKLYSTS-IDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 36/212 (16%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQQHPN 733
K+GEG FG K IL DG +K+ +S K R+ +R+ E+ ++S +HPN
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-------FGKDTEYRLKLDWPTRKKICIGI 786
+V+ E L +V +Y + L + I F +D LDW +IC+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDWFV--QICLA- 113
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
L ++H+ KI+HRDIK+ N+ L KD K+ DFG+A++ T I GT
Sbjct: 114 ---LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPY 166
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y++PE +K+D+++ G V E+ + K
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
A +HP L +L+ C ++L V EY+ G D + + + D P +
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVN---------GGDLMFHIQRSGRFDEPRARFYA 102
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 841
I GL +LHE I++RD+K NVLLD + + KI+DFG+ K + T +
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
GT Y+APE D ++ GV+ E+++G+S
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYKG G ++A+K+ L S+ + EI ++ QHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIGIARGLAYLHEDSR 798
++ ++L L++E++ + L + + D+ + + +D K I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI----AGTIGYMAPEYAM 854
+++HRD+K N+L+D K++DFGLA+ + I R+ T+ Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPEVLL 174
Query: 855 RGYLTS-KADVYSFGVVTLEIVSGK 878
S D++S G + E+ + K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKL 737
++G G FG+V KG+ +AVK L + + E + E ++ +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLH 794
G C E +LV E A G ++ K T K I ++ G+ YL
Sbjct: 62 IGIC-EAESWMLVMEL--------AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 852
E + VHRD+ NVLL AKISDFGL+K D+ + + G + + APE
Sbjct: 113 ETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
+SK+DV+SFGV+ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
L + T+ ++ +G+G +G VYK DG++ AVK L + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 727 -SAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
S HPN+VK YG + G QL LV E ++ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-LICGQRLDEAMIS 131
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
I G GL +LH + +I+HRD+K +N+LL + K+ DFG++ + +T
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 841 IAGTIGYMAPEYAM--RGYLTS---KADVYSFGVVTLEIVSG 877
+ GT +MAPE + Y S + DV+S G+ +E+ G
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 684 VGEGGFGSVY---KGILSD-GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G+G FG V+ K D G + A+K L + K R R E +++ HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 737 L-YGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
L Y EG +L L+ ++++ LS+ + + + + L +A L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 849
+LH + I++RD+K N+LLD++ + K++DFGL+K + E K + GT+ YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSG 877
PE R T AD +SFGV+ E+++G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
++ K+GEG +G VYK D IA+K+ L + + EI ++ QH
Sbjct: 4 YEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 733 NLVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
N+V+L +L LV+EY +K + S F K+ RL K I R
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN--PRLI------KTYLYQILR 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGY 847
G+AY H +++HRD+K N+L+D+ NA K++DFGLA+ + + + T+ Y
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWY 169
Query: 848 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
APE + R Y T D++S G + E+V+ K
Sbjct: 170 RAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 684 VGEGGFGSVYKG-ILSDGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V K I DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L L EY + L SR + F L +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
RG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++ E R+ + +
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 189
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
MA E T+ +DV+S+GV+ EIVS
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
VGEG +G V K + G ++A+K+ S + + + EI M+ +H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L LV+E++ + L D E Y LD +K I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKT-HISTRIAGTIGYMAPEYAM 854
I+HRDIK N+L+ + K+ DFG A+ E T +++TR Y APE +
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLV 173
Query: 855 RGYLTSKA-DVYSFGVVTLEIVSG 877
+A D+++ G + E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 72/233 (30%), Positives = 110/233 (47%), Gaps = 26/233 (11%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V GI D +AVK L + + + V+E+ M+ +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEY---RLKLDWPTRKKI--- 782
++ L G C + L ++ EY L +R G D + +L + T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 841
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 893
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 71/233 (30%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V GI D +AVK L + + + + V+E+ M+ +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL----DWPTRKKICIG- 785
++ L G C + L ++ EY L RA EY + D K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 786 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 841
+ARG+ YL K +HRD+ NVL+ ++ KI+DFGLA+ + D +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 893
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 41/235 (17%)
Query: 675 TNNFDPANK-VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGM--- 725
+ + +GEG +G V K G ++A+K++ S +R+ V G+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 726 -------ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ +H N++ L VEG+ + LV + M ++ L + + + +++L
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV-----DRKIRLTESQ 120
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-------- 830
K I + I GL LH+ +HRD+ +N+ ++ KI+DFGLA+ Y
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 831 -EEDKTHISTRIAG----TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
+D+T T+ Y APE M Y D++S G + E+++GK
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 684 VGEGGFGSV----YKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 737
VG+G +G V ++ +DG +K+L+ + SR+ + E ++S +HPN+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI--CIGIARGLAYLHE 795
Y EG LL Y M C ++ K E + KL P + + + IA L YLHE
Sbjct: 64 YRESWEGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHE 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
I+HRD+KT NV L + K+ D G+A++ E ST I GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 856 GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
K+DV++ G E+ + K N + VY
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 736
+G G FG VY +D G +AVKQ+ S++ ++E VN EI ++ +H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 737 LYGCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
YGC E +L + EYM + + +G TE ++ I +G++Y
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-------NVTRRYTRQILQGVSY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 849
LH + IVHRDIK +N+L D N K+ DFG +K + T I + + GT +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMS 177
Query: 850 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 878
PE + GY KADV+S +E+++ K
Sbjct: 178 PEVISGEGY-GRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 26/233 (11%)
Query: 684 VGEGGFGSVYK----GILSDG----TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V G+ + T +AVK L S + + + + ++E+ M+ +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG----- 785
++ L G C + L ++ EY L RA EY +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 786 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 841
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 893
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLS--SKSRQGNREFVN---EIGMISAQQHPNLVKL 737
+G+G FG VY D G +A KQ+ +S + ++E EI ++ QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 738 YGCCVE-GNQLLLVY-EYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
YGC + + L ++ EYM + + +G TE +K I G++YL
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-------SVTRKYTRQILEGMSYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMAP 850
H + IVHRDIK +N+L D N K+ DFG +K + T I + + GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSP 178
Query: 851 EY-AMRGYLTSKADVYSFGVVTLEIVSGK 878
E + GY KADV+S G +E+++ K
Sbjct: 179 EVISGEGY-GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA----QQHPNLVK 736
K+GEG F V K G A+K + K + E VN + I A HPN+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 737 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
L + +L LV+E M N L I G+ + L K + + L ++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMN-LYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL------YEEDKTHISTRIAGTIGYM 848
R I HRDIK N+L+ D+ K++DFG + Y E +ISTR Y
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR-----WYR 165
Query: 849 APEYAMR-GYLTSKADVYSFGVVTLEIVS 876
APE + GY K D+++ G V EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGK-DTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV M L I+ + + +IC G L LH++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
+IV+RD+K N+LLD + +ISD GLA E +T I R+ GT+GYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 859 TSKADVYSFGVVTLEIVSGKS 879
T D ++ G + E+++G+S
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 736
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAY 792
+ ++L + + M G D Y L + I GL +
Sbjct: 62 MSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
+H +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYMAPE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 853 AMRGY-LTSKADVYSFGVVTLEIVSGKS 879
+G S AD +S G + +++ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
N + G G+ YKG + V + + + ++G + QHPN+VKL G C
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL---QHPNIVKLIGLC 752
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
L++EY++ LS + L W R+KI IGIA+ L +LH +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 802 VHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 860
V ++ +++D KD L L D + Y+APE +T
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR--LSLPGLLCTDTKCFISS-----AYVAPETRETKDITE 857
Query: 861 KADVYSFGVVTLEIVSGKSNTN 882
K+D+Y FG++ +E+++GKS +
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 736
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAY 792
+ ++L + + M G D Y L +K I GL +
Sbjct: 62 MTYAFHTPDKLCFILDLMN---------GGDLHYHLSQHGVFSEKEMRFYATEIILGLEH 112
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
+H +R +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYMAPE
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 853 AMRGY-LTSKADVYSFGVVTLEIVSGKS 879
+G S AD +S G + +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I RGL YLH I+HRDIK N+L++ + KI DFGLA++ E D++ T+ T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 846 GYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
Y APE M R Y TS D++S G + E++ +
Sbjct: 169 YYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V + GI +AVK L + + + ++E+ ++ +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRL------KLDWPTRKKI 782
++ L G C + L ++ EY L +R G D + + +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 841
+ARG+ YL +SR + +HRD+ NVL+ +D KI+DFGLA+ +++ D ++
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 893
+ +MAPE T ++DV+SFG++ EI + G S P E+ LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-14
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 54/223 (24%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 733
+G G +G V + G +A+K++ + F + EI ++ +H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 734 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IG 785
++ L + N + +V E M+ + L + I + L T I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI-----KSPQPL---TDDHIQYFLYQ 111
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS------- 838
I RGL YLH ++HRD+K SN+L++ + + KI DFGLA+ + D+
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 839 TRIAGTIGYMAPE--YAMRGYLTSKA-DVYSFGVVTLEIVSGK 878
TR Y APE + Y +KA D++S G + E+++ K
Sbjct: 169 TRW-----YRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K + G + + E ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L LV M L I+ L+ I G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHS---M 114
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
IV+RD+K NVLLD N ++SD GLA ++ KT T+ AGT GYMAPE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172
Query: 860 SKADVYSFGVVTLEIVSGKS 879
D ++ G E+V+G++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 52/206 (25%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 676 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++F+ +++G G G V K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V YG ++ + E+M L + + E + ++ K+ I + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAK-RIPEEILGKVSIAVLRGLAYL 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEY 852
E + +I+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPER 173
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + ++D++S G+ +E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 26/205 (12%)
Query: 683 KVGEGGFGSVYKGILSDGTVIA------VKQLSSKSRQGNREFVN---EIGMISAQQHPN 733
++G+G FG+VY ++ D +A +K++ N E V E ++S HP
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPA 63
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGL 790
+VK + +E + ++ EY C R + K E + + ++C I + G+
Sbjct: 64 IVKFHASFLERDAFCIITEY----CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
Y+H+ +I+HRD+K N+ L +L KI DFG+++L ++T GT YM+P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174
Query: 851 E-YAMRGYLTSKADVYSFGVVTLEI 874
E +GY SK+D++S G + E+
Sbjct: 175 EALKHQGY-DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 43/215 (20%)
Query: 685 GEGGFGSV----YKG--------ILSDGTVIA---VKQLSSKSRQGNREFVNEIGMISAQ 729
G G FG V YK L G +IA V+ L + R + E +++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR------IFET--ANSE 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 788
+HP LV L+ C + + V EY G D + D + + A
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAA---------GGDLMMHIHTDVFSEPRAVFYAACV 110
Query: 789 --GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGT 844
GL YLHE+ KIV+RD+K N+LLD + KI+DFGL K + D+T ST GT
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGT 164
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
++APE T D + GV+ E++ G+S
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 684 VGEGGFGSVYKGIL--SDGTV--IAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 737
+G+G FGSV + L DG+ +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 738 YGCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
G + +++ +MK+ L + + + E L T + I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMA 849
YL S +HRD+ N +L++++ ++DFGL+ K+Y D + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVS 876
E T+ +DV++FGV EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 686 EGGFGSVYKGILSDGT--------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
EG FG ++ GIL D V VK +S+ Q + E ++ H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 738 YGCCVEGNQLLLV-YEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIG--IARGLA 791
C+E + V Y YM L +F + E T++ + + IA G++
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 850
YLH + ++H+DI N ++D++L KI+D L++ L+ D + + +MA
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVS 876
E + +S +DV+SFGV+ E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G V+K + G ++A+K+ S + + EI M+ +HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+L LV+EY + L+ + + KKI + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL-----EKNPRGVPEHLIKKIIWQTLQAVNFCHKH--- 119
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL---YEEDKT-HISTRIAGTIGYMAPE---- 851
+HRD+K N+L+ K K+ DFG A++ +D T +++TR Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174
Query: 852 ---YAMRGYLTSKADVYSFGVVTLEIVSG 877
Y DV++ G V E+++G
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+F+ ++G G +G VYK ++ G + A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+G + ++L + E+ L ++ + +R+ + +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMA 849
++ HRDIK +N+LL + + K++DFG++ I+ IA GT +MA
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174
Query: 850 PEYAM---RGYLTSKADVYSFGVVTLEI 874
PE A +G D+++ G+ +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
++++ +VG G +G VYK L G + AVK + + EI M+ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRA--IFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V +G + +L + EY L + G +E ++ +C +GLAY
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-------VCRETLQGLAY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIG 846
LH ++ HRDIK +N+LL + + K++DFG+A I+ IA GT
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPY 171
Query: 847 YMAPEYAM---RGYLTSKADVYSFGVVTLEI 874
+MAPE A G D+++ G+ +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 677 NFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--- 729
NF+ +G G +G V+ G G + A+K L K+ + E Q
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLE 59
Query: 730 ---QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG- 785
+ P LV L+ +L L+ +Y+ L ++ ++ ++ I
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTES---EVRVYIAE 113
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I L +LH+ + I++RDIK N+LLD + + ++DFGL+K + ++ + GTI
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 846 GYMAPEYAMRGYLT-SKA-DVYSFGVVTLEIVSGKS 879
YMAPE G KA D +S GV+T E+++G S
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L+ K R+G + E I A+ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVE-KRILAKVHSRFIVSLA 59
Query: 740 CCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV M L I+ D E P I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
+I++RD+K NVLLD D N +ISD GLA ++ ++ + AGT G+MAPE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 859 TSKADVYSFGVVTLEIVSGK 878
D ++ GV E+++ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 725 MISAQQHPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK 781
+ A +HP L L+ C + + L V EY+ L I G+ E R R
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR------ARFY 101
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
I GL +LH+ I++RD+K NVLLDKD + KI+DFG+ K + ST
Sbjct: 102 AA-EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-F 156
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
GT Y+APE D +SFGV+ E++ G+S
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS------AQQHPNLVK 736
+G+G FG V+ L A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAY 792
LY L V EY+ G D + + K D P I GL +
Sbjct: 61 LYCTFQTKENLFFVMEYLN---------GGDLMFHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAP 850
LH IV+RD+K N+LLD D + KI+DFG+ K + + KT GT Y+AP
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAP 165
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
E + + D +SFGV+ E++ G+S
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 42/175 (24%)
Query: 39 EEVKALKQIGRKLG---KKDWNFGVDPCS-QKGNWELSSDDKKGFESNVTC--DCSSATC 92
EEV AL+ + LG + WN DPC Q+ W S C D +
Sbjct: 372 EEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPW-----------SGADCQFDSTKGKW 418
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + L Q L G +P ++SKLR+L+ ++LS GN +
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLS-----------------------GNSIR 455
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL 207
G P L +IT+L+ L + N F GSIP + +L +L+ L L+ NS +G +PA L
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 54/210 (25%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++F+ +++G G G V+K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V YG ++ + E+M + L +A G+ E L K+ I + +G
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG-------KVSIAVIKG 115
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 848
L YL E + KI+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 169
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE + + ++D++S G+ +E+ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISA 728
+ ++ K+GEG +G VYK + G ++A+K+ + + RE ++ + M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLS- 58
Query: 729 QQHPNLVKLYGCCVEGN-------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
+ +V+L VE L LV+EY+ ++ L + + L T K
Sbjct: 59 -ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKS 114
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTR 840
+ +G+A+ H+ ++HRD+K N+L+DK KI+D GL + + +
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 841 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSG 877
I T+ Y APE + + ++ D++S G + E+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 740
K+GEG + +VYKGI +G ++A+K +S K+ +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
L V+EYM + I G Y ++L + RGLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH---G 121
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY- 857
I+HRD+K N+L+ K++DFGLA+ S+ + T+ Y P+ +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 858 LTSKADVYSFGVVTLEIVSGK 878
+S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE--F----VNEIGMISA 728
+ ++ K+G+G FG V+K ++A+K K N + F + EI ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67
Query: 729 QQHPNLVKLYGCC----VEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+H N+V L C N LV+E+ +++ L+ + K+ ++ L K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTL----SEIK 122
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTH 836
K+ + GL Y+H R KI+HRD+K +N+L+ KD K++DFGLA+ +
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 837 ISTRIAGTIGYMAPE 851
+ R+ T+ Y PE
Sbjct: 180 YTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 736
+G+G FG VY +D G +AVKQ+ +S + ++E VN EI ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
YGC + + L + E+M + + +G TE +K I G++Y
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-------NVTRKYTRQILEGVSY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 849
LH + IVHRDIK +N+L D N K+ DFG +K + T + + + GT +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMS 177
Query: 850 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 878
PE + GY KAD++S G +E+++ K
Sbjct: 178 PEVISGEGY-GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V + T +A VK+L ++ S + EF+ + QHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G CVE LLV+EY + L ++ ++ +R +++ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMR-- 855
+H D+ N L DL K+ D+G+ Y+ED + ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 856 -GYLTSK----ADVYSFGVVTLEI 874
G +T++ ++V++ GV E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 6e-13
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 39/221 (17%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVK------QLSSKSRQGNRE--FVNEIGMI 726
++ K+G+G +G V+K I D V+A+K + ++ +++ RE F+ E+G
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64
Query: 727 SAQQHPNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-IC 783
HPN+VKL N + LV+EYM+ + L I R + K+ I
Sbjct: 65 ---DHPNIVKLLNVIKAENDKDIYLVFEYMETD-LHAVI-------RANILEDVHKRYIM 113
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHIST 839
+ + L Y+H S ++HRD+K SN+LL+ D K++DFGLA+ L E + + T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 840 RIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
T Y APE Y T D++S G + E++ GK
Sbjct: 171 DYVATRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQL-----SSKSRQGNREFVNEIGMISAQQHPNLV 735
+++G+G +GSVYK + G +A+K++ SK Q + E+ ++ P +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
YG + + EYM L + G + ++I + +GL +L E
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKE 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEY- 852
+ I+HRD+K +NVL++ + K+ DFG++ KT+I G YMAPE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173
Query: 853 -----AMRGYLTSKADVYSFGVVTLEIVSGK 878
T ++DV+S G+ LE+ G+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 34/82 (41%), Positives = 52/82 (63%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
G IP DI KL +LQ + LS NS G +P L +T+L L +S N+F+G IPE +G+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 237 IQKLHIQGSSLEGPIPASISAL 258
++ L++ G+SL G +PA++
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 32/251 (12%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFT 176
L LDL+ N L + S L L + N ++ P ++ + LK L + N
Sbjct: 95 LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE 153
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+P +R L NL+ L LS N + +LP L+ L+NLN+L +S N S +P I
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
+++L + +S+ + +S+S L +L+ L +S+ K
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE------------------------ 245
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
++P+ IG+++ L+ +DLS N ++ ++ L + L+GN L+ +P
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 357 VDISLNNFTWE 367
+ T +
Sbjct: 304 ELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN-RE-----FVNEIGMISAQQ 730
FD ++GEG +G VYK D G ++A+K K R N +E + EI ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64
Query: 731 HPNLVKLYGCCVEGNQLL----------LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
H N+V L + L LV+EYM ++ + G + K
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+ GL Y H+ + +HRDIK SN+LL+ K++DFGLA+LY +++ T
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 841 IAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 878
T+ Y PE + A DV+S G + E+ + K
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHE 795
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCG----LEDLHR 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAM 854
++ V+RD+K N+LLD + +ISD GLA K+ E + I R+ GT+GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174
Query: 855 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 907
T D + G + E++ G+S R + +D VL+ EE+Y +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLETEEVYSA 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ----LSSKSRQGNREFVNEIGMISAQQ 730
+D +G+GG G VY D +A+K+ LS R F+ E + +
Sbjct: 4 YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLI 60
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDT---EYRLKLDWPTRKKICI 784
HP +V +Y C +G+ + Y++ L ++++ K++ E K I
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHIST-- 839
I + Y+H S+ ++HRD+K N+LL I D+G A L EED I
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 840 ------------RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+I GT YMAPE + + D+Y+ GV+ ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 65/204 (31%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIF----GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG----LEDLH- 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
R +IV+RD+K N+LLD + +ISD GLA E +T I R+ GT+GYMAPE
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175
Query: 856 GYLTSKADVYSFGVVTLEIVSGKS 879
T D + G + E++ GKS
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 684 VGEGGFGSVYKGILSDGT----VIAVKQLSS----KSRQGNREFVNEIGMISAQQHPNLV 735
+G+GG+G V++ G + A+K L ++++ E ++ A +HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI---GIA 787
L G +L L+ EY+ L IF +DT C I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-------------CFYLSEIS 110
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 845
L +LH+ I++RD+K N+LLD + K++DFGL K ++E TH GTI
Sbjct: 111 LALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTI 164
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
YMAPE MR D +S G + ++++G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREF---VNEIGMIS-AQQHPNLVKLY 738
+G+G FG V L G + AVK L + + + E ++S A+ HP L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
C ++L V E++ L I + + D + I L +LH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYAMRGY 857
I++RD+K NVLLD + + K++DFG+ K E +T GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 858 LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY 905
D ++ GV+ E++ G + NED ++ +L +E +Y
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLF----EAILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDW 776
++ HP+++++ V G +V Y Y+ SR +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR--SRPL------------- 154
Query: 777 PTRKKICI--GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
P + + I I GL YLH +I+HRD+KT N+ ++ I D G A+
Sbjct: 155 PIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +AGT+ APE R SKAD++S G+V E+++
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 682 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
K+GEG + +V+KG L++ ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 793
L LV+EY+ KD + + + K I RGLAY
Sbjct: 71 DIVHTDKSLTLVFEYLD----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H R K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVL 176
Query: 854 M-RGYLTSKADVYSFGVVTLEIVSGK 878
+ +++ D++ G + E+ SG+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 55/249 (22%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F +VG+GG+G V+ D G ++A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
LVKL + L L EY+ G D +R L G+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVP---------GGD--FRTLL-----------NNLGV- 97
Query: 792 YLHEDS----------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
L ED + +HRD+K N L+D + K++DFGL+K
Sbjct: 98 -LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIV 152
Query: 836 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVY 891
+ + G+ YMAPE +GY D +S G + E + G S + PNE +
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWEN 209
Query: 892 LLDWAYVLQ 900
L W LQ
Sbjct: 210 LKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIF-----GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ L LV M L I+ G D + + ++C G L
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG-------LE 116
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ R +IV+RD+K N+LLD + +ISD GLA E +T + R+ GT+GYMAPE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174
Query: 855 RGYLTSKADVYSFGVVTLEIVSGKS 879
T D + G + E++ G+S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 677 NFDPANKVGEGGFGSVY---------------KGILSDGTVIAVKQLSSKSRQGNREFVN 721
NF+ +G G +G V+ +L T++ + + +R R+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVLE 59
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTR 779
I +Q P LV L+ +L L+ +Y+ L + ++ E ++
Sbjct: 60 HI-----RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ------ 108
Query: 780 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
I G I L +LH ++ I++RDIK N+LLD + + ++DFGL+K + ED+ +
Sbjct: 109 --IYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 839 TRIAGTIGYMAPEYAMRGYL--TSKADVYSFGVVTLEIVSGKS 879
GTI YMAP+ G D +S GV+ E+++G S
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-12
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 700 GTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLL-VYEYMK 755
G +A+K L + + + + F E + + HPN+V L LL V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-- 813
L R + D L ++ + + LA H IVHRD+K N+++
Sbjct: 63 GRTL-REVLAADG----ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 814 -DKDLNAKISDFGLAKL----YEEDKTHIS--TRIAGTIGYMAPEYAMRGY-LTSKADVY 865
+AK+ DFG+ L + D ++ T + GT Y APE +RG +T +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 866 SFGVVTLEIVSGK 878
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 682 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+K+GEG + +VYKG L+D ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 793
L LV+EY+ KD + L ++ K + RGL Y
Sbjct: 71 DIIHTEKSLTLVFEYLD----------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H R K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDIL 176
Query: 854 MRGY-LTSKADVYSFGVVTLEIVSGK 878
+ +++ D++ G + E+ +G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY---- 738
+G G G V+ + SD +AVK++ Q + + EI +I H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 739 ----------GCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIA 787
G E N + +V EYM+ + L+ + G +E +L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
RGL Y+H + ++HRD+K +NV ++ +DL KI DFGLA++ + +H G +
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 847 --YMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
Y +P + Y T D+++ G + E+++GK
Sbjct: 182 KWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 684 VGEGGFGS--VYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
VGEG FG + + + SD A+K++ SS + + +R+ E +++ +HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAY 792
L +V EY L + I K +L L W ++C+G+ +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFV--QMCLGVQ----H 115
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
+HE +++HRDIK+ N+ L ++ K+ DFG A+L + T + GT Y+ PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEI 171
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
+K+D++S G + E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPN 733
+ + +GEG +G V G +A+K++S Q R + EI ++ +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 734 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---G 785
++ + N + +V E M+ + L + I + I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSN---------DHIQYFLYQ 114
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--EEDKTHISTRIAG 843
I RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA++ E D T T
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 844 TIGYMAPEYAM--RGYLTSKA-DVYSFGVVTLEIVSGK 878
T Y APE + +GY +KA D++S G + E++S +
Sbjct: 172 TRWYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 54/223 (24%)
Query: 685 GEGGFGSVYKGIL---SDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
G+G F ++YKG+L SD + +K L S R + F ++S H +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKH 62
Query: 734 LVKLYGCCV-EGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
LVKLYG CV + N +V EY+K + L R ++L + +A
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-------LNAKISDFG-----LAKLYEEDKTH 836
L YL + K+VH ++ N+L+ + K+SD G L++ ++
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-- 167
Query: 837 ISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSG 877
I ++APE G LT AD +SFG LEI S
Sbjct: 168 --------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 46/216 (21%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 733
VG G +G V + G +A+K+LS R F + E+ ++ H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 734 LVKLYGCCVEG------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI--- 784
++ L + LV M G D +K + I
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM----------GADLNNIVKCQKLSDDHIQFLVY 125
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAG 843
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR--- 179
Query: 844 TIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
Y APE + + D++S G + E+++GK
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARG 789
P +V YG ++ + E+M L + + G+ E L KI I + RG
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-------KISIAVLRG 111
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 848
L YL E + KI+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 165
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE + T ++D++S G+ +E+ G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC- 740
+G+G +G V+K + +G+ AVK L + E E ++ A HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 741 ----CVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G+QL LV E ++ + G K E +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPIIAYILHEALMGLQHLH 141
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY-A 853
+ K +HRD+K +N+LL + K+ DFG++ + +T + GT +MAPE A
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 854 MRGYLTS----KADVYSFGVVTLEIVSG 877
L S + DV+S G+ +E+ G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++++ K+GEG + +VYKG +G ++A+K + + +G + E ++ +H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V L+ L LV+EY+ + ++ L K + RGL+Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H+ I+HRD+K N+L+ K++DFGLA+ + +H + T+ Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVL 175
Query: 854 MRGYLTSKA-DVYSFGVVTLEIVSG 877
+ S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE----FVNEIGMISAQQHPNLVKLY 738
+G+G FG V L G AVK L + + V + + A ++P L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
L V E++ L I K + + + +C GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHSKG- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 856
I++RD+K NV+LD+D + KI+DFG+ K ++ +++ ++ GT Y+APE
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGL 171
Query: 857 YLTSKADVYSFGVVTLEIVSGKS 879
T D +SFGV+ E++ G+S
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNRE----FVNEIGMISA 728
+FD + VG G FG V ++ + G + A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICI 784
P + +L + + L LV EY + L+R Y + D +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR--------YEDQFDEDMAQFYLA 109
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ + +H+ + VHRDIK NVL+D+ + K++DFG A +K S GT
Sbjct: 110 ELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 845 IGYMAPEY--AMRGYLTSKADV----YSFGVVTLEIVSGKS 879
Y+APE M G V +S GV+ E++ G+S
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 723
T+ ++ N P VG G +GSV G +AVK+LS +S + E+
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 782
++ +H N++ L L E + L + G D +K T +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 783 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 839
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
Query: 840 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 879
R Y APE + + D++S G + E+++G++
Sbjct: 181 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 675 TNNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQ 730
TN + VG G FG V + L+ G +A+K++ + + E+ ++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 731 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
H N++ L + + + V E + + L R + + E + + I RG
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFI------QYFLYQILRG 120
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 848
L Y+H +VHRD+K SN+L++++ + KI DFGLA++ + T ++STR Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172
Query: 849 APEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
APE + + Y + D++S G + E++ GK
Sbjct: 173 APEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIG------MISAQQHPNLVK 736
+G+G FG VY+ D + A+K LS K +E + IG + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGLAYLHE 795
L + L LV +YM + E R D R K I + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHK 114
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYA 853
IV+RD+K N+LLD + + DFGL+K L + T+ GT Y+APE
Sbjct: 115 YD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVL 168
Query: 854 M--RGYLTSKADVYSFGVVTLEIVSGKS 879
+ +GY T D +S GV+ E+ G S
Sbjct: 169 LDEKGY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 48/238 (20%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS---RQGNREFVNEIGMISA 728
++F+ +G G FG V+ L G V A+K L KS ++ V I A
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILA 56
Query: 729 QQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
P +VKLY + L LV EYM L + KD + R IA
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-AR----FYIA 108
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT------------ 835
+ L ++ +HRDIK N+L+D D + K++DFGL K + K
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 836 ----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
+ GT Y+APE + D +S GV+ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN 733
+ P +G G +G V I G +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 734 LVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GI 786
++ + + + +V + M+++ L I L + I +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP---LTEE-----HIRYFLYQL 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTHISTRIA 842
RGL Y+H ++HRD+K SN+L+++D +I DFG+A+ E K ++ +A
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 843 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIV 875
T Y APE ++ Y T+ D++S G + E++
Sbjct: 174 -TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 730
N F+ VGEG +G V K + ++A+K+ K + N E + E+ M+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT---RKKICIGIA 787
N+V+L +L LV+EY++ N L L + P +K+ I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-----------ELLEEMPNGVPPEKVRSYIY 107
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
+ + +H + IVHRDIK N+L+ + K+ DFG A+ E T T Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE + D++S G + E+ G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
A HP LV L+ C ++L V EY+ L +F + +L + I +A
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA 108
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 845
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T + GT
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTP 160
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
Y+APE D ++ GV+ E+++G+S
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHP 732
+ + VG G FG V+ A+K ++ R + V NE ++ HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+++L+ + L ++ EY+ L + F T + + +C
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-----FYASEIVC---- 112
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
L YLH IV+RD+K N+LLDK+ + K++DFG AK D+T + GT Y
Sbjct: 113 -ALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEY 164
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+APE D ++ G++ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIG 785
A +P LV L+ C ++L LV EY+ L +F + +L + +ICI
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIA 108
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAG 843
L +LHE I++RD+K NVLLD D + K++D+G+ K L D T + G
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCG 158
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
T Y+APE D ++ GV+ E+++G+S
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYG 739
+K+GEG + +V+KG ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD-------WPTRKKICIGIARGLAY 792
L LV+EY+ D++ + LD K + RGL+Y
Sbjct: 71 IIHTERCLTLVFEYL------------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
H+ KI+HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174
Query: 853 AMRGY-LTSKADVYSFGVVTLEIVSGK 878
+ ++ D++ G + E+ +G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 21/153 (13%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y + K P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPHAVFYAAEIA 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 845
GL +LH I++RD+K NV+LD + + KI+DFG+ K ++ T GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTP 165
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE D ++FGV+ E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKL--- 737
VG G +GSV I G +A+K+LS +S + E+ ++ QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 738 YGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ V G++ LV YM+ + L + + +E K+ + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSED--KVQYLVYQMLC-----GLKYIH 134
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 853
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR Y APE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186
Query: 854 MRG-YLTSKADVYSFGVVTLEIVSGKS 879
+ + D++S G + E+++GK+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 42/109 (38%), Positives = 64/109 (58%), Gaps = 10/109 (9%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 842
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ S R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDF 889
+ +MAPE T+++DV+SFGV+ EI S G S + NE+F
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 684 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 738
VG G +GSV Y L +AVK+LS +S R E+ ++ +H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 739 GCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N++ LV M + + K ++ ++ + + RGL Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKY 133
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPE 851
+H I+HRD+K SNV +++D +I DFGLA+ +++ T +++TR Y APE
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185
Query: 852 YAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 890
+ + D++S G + E++ GK+ P D++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA---LFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLVKLY 738
+G+G FG V SDG+ AVK L K+ +E + + ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L V +Y+ L F E P + +A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL--EPRARFYAAEVASAIGYLHS--- 114
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
+ I++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPY 173
Query: 859 TSKADVYSFGVVTLEIVSG 877
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+A HP LV L+ C ++L V E++ L +F + +L + I +
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISL 107
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
A L +LHE I++RD+K NVLLD + + K++D+G+ K ST GT
Sbjct: 108 A--LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPN 161
Query: 847 YMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKS 879
Y+APE +RG Y S D ++ GV+ E+++G+S
Sbjct: 162 YIAPE-ILRGEDYGFS-VDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y + K P I+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 846
GL +LH I++RD+K NV+LD + + KI+DFG+ K E ++TR GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPD 166
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE D +++GV+ E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+R+++ ++D +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ P +V+L+ + L +V EYM L + + Y + W K
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--K 145
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 839
+ L +H + ++HRD+K N+LLDK + K++DFG K+ E T
Sbjct: 146 FYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 840 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 879
+ GT Y++PE GY + D +S GV E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+E+ ++A H +VK + ++LLL+ EY L++ I + RLK P ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168
Query: 781 K----ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT- 835
+ I L +H SR K++HRD+K++N+ L K+ DFG +K Y + +
Sbjct: 169 YEVGLLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885
+++ GT Y+APE R + KAD++S GV+ E++ T +RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-----TLHRP 270
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 4/95 (4%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I L +LH ++ IV+RDIK N+LLD + + ++DFGL+K + ++ + GTI
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 846 GYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKS 879
YMAPE KA D +S G++ E+++G S
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--------QHPNL 734
+G+G FG V +DG AVK L K+ E I A+ +HP L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNVLLKNVKHPFL 58
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V L+ ++L V +Y+ L F E P + IA L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP--EPRARFYAAEIASALGYLH 113
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ I++RD+K N+LLD + ++DFGL K E ST GT Y+APE
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169
Query: 855 RGYLTSKADVYSFGVVTLEIVSG 877
+ D + G V E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIG-MISAQQHPNLVKLY 738
+G+G FG V DG AVK L K +R+ + + E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L V +++ L F E P + IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRER--SFPEPRARFYAAEIASALGYLHS--- 114
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 856
I IV+RD+K N+LLD + ++DFGL K + + D T T GT Y+APE +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 857 YLTSKADVYSFGVVTLEIVSG 877
+ D + G V E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 842
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T+++DV+SFGV+ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV--IAVKQLSS----KSRQGNREFV 720
R+ K +F+ +G G FG V + +A+K+ K +Q + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+E +++ HP V LYG + + L LV E++ + F T R +P
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF---TFLRRNKRFPNDV 132
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
C A+ + + IV+RD+K N+LLDKD K++DFG AK+ + +T+
Sbjct: 133 G-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT--- 187
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
+ GT Y+APE + AD ++ G+ EI+ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
A +HP L L+ C ++L V EY+ G D +++ K D P +
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVN---------GGDLMFQIQRSRKFDEPRSRFYA 102
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIA 842
+ L +LH R +++RD+K N+LLD + + K++DFG+ K T +T
Sbjct: 103 AEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFC 157
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
GT Y+APE D ++ GV+ E+++G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLY 738
+G+G FG V ++ AVK L K+ ++ + ++E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW----PTRKKICIGIARGLAYLH 794
++L V +Y I G + Y L+ + P + IA L YLH
Sbjct: 63 FSFQTADKLYFVLDY---------INGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ IV+RD+K N+LLD + ++DFGL K E ST GT Y+APE
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLH 169
Query: 855 RGYLTSKADVYSFGVVTLEIVSG 877
+ D + G V E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 24/117 (20%)
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
GKW I L + L G IP IS L L + +S
Sbjct: 415 KGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS-------------------- 453
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I G IP +G +T L+ +DLS+N+ G IP + +L + L GN L+G VP
Sbjct: 454 ---IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I L YLH +V+RD+K N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE D + GVV E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y++ + P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYQIQQVGRFKEPHAVFYAAEIA 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 846
GL +LH I++RD+K NV+LD + + KI+DFG+ K E ++T+ GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPD 166
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
Y+APE D ++FGV+ E+++G++
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 39/212 (18%)
Query: 687 GGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744
+ K T++AVK+ L S S++ + EI QHPN++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 745 NQLLLVYEYM---------KNNCLSRAIFG-KDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++L +V M K + G + I + L Y+H
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF---------ILKDVLNALDYIH 118
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDK----THISTR-IAGTIGYM 848
+HR +K S++LL D +S + + + K H + + ++
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 849 APEY---AMRGYLTSKADVYSFGVVTLEIVSG 877
+PE ++GY K+D+YS G+ E+ +G
Sbjct: 176 SPEVLQQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 684 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVK 736
+G+G FG V IL + G A+K L + E + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 737 LYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLA 791
L ++L V EY+ LSR +F +D + I L
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE----------IVSALD 109
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH KIV+RD+K N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
D + GVV E++ G+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 2/90 (2%)
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 848
LA H S+ ++HRDIK++N+LL + K+ DFG +K+Y + + GT Y+
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
APE R + KAD++S GV+ E+++ K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I L YLH + +V+RD+K N++LDKD + KI+DFGL K +D + T GT
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE D + GVV E++ G+
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I L YLH +V+RDIK N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE D + GVV E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 684 VGEGGFGSVYKGI---LSDG-----TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G F ++KGI + D T + +K L R + F M+S H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LH 794
YG CV G++ ++V EY+K L + K + + + W + +A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWK------LEVAKQLAWALH 114
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE--DKTHISTRI-AGTIGYMAPE 851
+ H ++ NVLL ++ + K + KL + T + I I ++ PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 852 YAMRG-YLTSKADVYSFGVVTLEIVSG 877
L+ AD +SFG EI SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 677 NFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKS--RQGNREFVN-EIGMISAQ 729
+F+ +G G FG V +KG G A+K L + + + V E ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIGIA 787
HP +V + + N++ + E++ + +F T R +P K +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFV----VGGELF---THLRKAGRFPNDVAKFYHAELV 128
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
YLH I++RD+K N+LLD + K++DFG AK D+T + GT Y
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEY 181
Query: 848 MAPEYAM-RGYLTSKA-DVYSFGVVTLEIVSG 877
+APE +G+ KA D ++ GV+ E ++G
Sbjct: 182 LAPEVIQSKGH--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA+ +K T T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172
Query: 846 GYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 878
Y APE + Y T+ DV+S G + E++ K
Sbjct: 173 WYRAPELLLNCSEY-TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 24/155 (15%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 740
K+GEG + +VYKG G ++A+K++ + +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW------PTRKKICI-GIARGLAYL 793
L LV+EY+ DT+ + +D ++ + + RGLAY
Sbjct: 72 IHTKKTLTLVFEYL------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H + +++HRD+K N+L+ + K++DFGLA+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 43/177 (24%), Positives = 60/177 (33%), Gaps = 47/177 (26%)
Query: 451 WAFSSTGKFM--DDDT-------DLDNYIRTNTSTLSKVSAVD--------LELYRTARV 493
F + + DD + + ST V + +TA
Sbjct: 175 LNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVT 234
Query: 494 -----SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 548
+PL+ T+ L N Y V LHFAEI SL R FDIYI K V D
Sbjct: 235 PTNASAPLNFTW-DLVDPNFEYYVYLHFAEI--------QSLETREFDIYINGKTVYGDV 285
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR----GTYGPLISAI 601
+ G + +FP + +G G I L T PL++A+
Sbjct: 286 SP-KYLGTDTGALYLDFP-----------VNVSGGGLLNISLVPTSGSTLPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 844
+A+G+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ A
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T ++DV+SFGV+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 11/99 (11%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT----HISTRI 841
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ + E+ ++ +
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 842 AGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
A T Y APE + + Y T DV+S G + E++ K
Sbjct: 171 A-TRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 842
+A+G+ +L + I HRD+ NVLL AKI DFGLA+ D ++ + R+
Sbjct: 221 VAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKS 879
+ +MAPE T ++DV+S+G++ EI S GKS
Sbjct: 278 --VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 784 IGIARGL----AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIS 838
I I R L AYLH I+HRD+KT N+ LD+ NA + DFG A KL T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 839 TRIAGTIGYMAPEY-AMRGYLTSKADVYSFGVVTLEI 874
+GT+ +PE A+ Y K D++S G+V E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
VG G +G+V + G +A+K+L +S + E+ ++ +H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 741 CV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ LV +M + K +E R++ + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 853
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR Y APE
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 854 MRG-YLTSKADVYSFGVVTLEIVSGK 878
+ + T D++S G + E+++GK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 28/176 (15%)
Query: 713 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
R G E ++ A HP++++L G + Y K CL + D L
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCYL 173
Query: 773 KLDWPTRKKICI--------GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824
++ I I + R + YLHE+ I+HRDIK N+ ++ + + DF
Sbjct: 174 A----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226
Query: 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 880
G A + + AGTI APE R D++S G+V E+ + +
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK DG K+ + K +G + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 740 CCVEGN--QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ + ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 795 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 848
+ ++HRD+K +N+L+ + KI+D G A+L+ ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 849 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 878
APE + +KA D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 29/190 (15%)
Query: 700 GTVIAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQL 747
G +AVK+LS + +++ RE V ++ H N++ L E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807
LV E M N L + I ++LD + + G+ +LH I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVI-------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 808 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 867
SN+++ D KI DFGLA+ + T T Y APE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208
Query: 868 GVVTLEIVSG 877
G + E+V G
Sbjct: 209 GCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-08
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 36/237 (15%)
Query: 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 730
N P +G + Y +L +A+K+LS + +++ RE V ++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 74
Query: 731 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
H N++ L E + LV E M N L + I +++LD +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLY 126
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ G+ +LH I+HRD+K SN+++ D KI DFGLA+ + + T T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 181
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 901
Y APE + D++S G + E+V K P D Y+ W V+++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK DG A+KQ+ + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 740 CCVE--GNQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 795 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 848
+ ++HRD+K +N+L+ + KI+D G A+L+ ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 849 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 878
APE + +KA D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+ +++ +FD +G G FG V +K S V A+K LS R + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ +V+L+ + L +V EYM L + + Y + W
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFY 147
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 839
+ +A L +H + +HRD+K N+LLDK + K++DFG K+ T
Sbjct: 148 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202
Query: 840 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 877
+ GT Y++PE GY + D +S GV E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 844
+ARG+ +L + VHRD+ NVLL + KI DFGLA+ D ++S G+
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GST 299
Query: 845 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T+ +DV+S+G++ EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQ-------LSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G +G V I G +A+K+ +S +R + EI ++ +HP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62
Query: 736 KLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
++ + E + +V+E M+++ L + I D L + + R L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-----DLTPEHHQFFLYQLLRAL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYM 848
Y+H + + HRD+K N+L + D KI DFGLA++ D T T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 849 APEY--AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 894
APE + T D++S G + E+++GK P ++ V+ LD
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP---LFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-08
Identities = 43/121 (35%), Positives = 60/121 (49%), Gaps = 19/121 (15%)
Query: 487 LYRTARVS----PLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
LY++A VS P L+Y N NY+V LHFAEI D++ + GKR+FD+ I
Sbjct: 254 LYQSALVSTDTQP-DLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGD 308
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 602
KD +I +G +V N V+ TL I L P +GT+ +I+AI
Sbjct: 309 TAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINAIE 358
Query: 603 V 603
V
Sbjct: 359 V 359
|
Length = 623 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 56/247 (22%)
Query: 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 730
N P +G + Y IL +A+K+LS + +++ RE V ++
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 81
Query: 731 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
H N++ L E + +V E M N L + I +++LD +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLY 133
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ G+ +LH I+HRD+K SN+++ D KI DFGLA R AGT
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGT 178
Query: 845 IGYMAPEYAMRGY----------LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 894
M P R Y D++S G + E++ G P D ++
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV---LFPGTD--HIDQ 233
Query: 895 WAYVLQE 901
W V+++
Sbjct: 234 WNKVIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+R ++ +++ +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ P +V+L+ + L +V EYM L + + Y + W +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--R 145
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 839
+ L +H + +HRD+K N+LLDK + K++DFG K+ +E T
Sbjct: 146 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 840 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 879
+ GT Y++PE GY + D +S GV E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 721 NEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPT 778
NEI + H N++K+ E N ++ +Y + L ++ + +++ + L T
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFDWKDRPLLKQT 269
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
R I + + Y+H+ K++HRDIK N+ L+ D + DFG A +E+++
Sbjct: 270 RA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
GT+ +PE D++S G++ L+++S
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 52/232 (22%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQ 730
++ ++ N +G G FG VY+ I D + +A+K++ + NRE + ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 731 HPNLVKL----YGCCVEGNQ--LLL----------VYEYMK----NNCLSRAIFGKDTEY 770
H N++ L Y C + N+ + L V++YMK NN K Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 771 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKL 829
+L R LAY+H I HRD+K N+L+D + + K+ DFG AK
Sbjct: 178 QL--------------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 830 Y---EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSG 877
+ ++I +R Y APE + T+ D++S G + E++ G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 49/198 (24%)
Query: 703 IAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLV 750
+A+K+LS + +++ RE V ++ H N++ L E + LV
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810
E M N L + I ++ LD + + G+ +LH I+HRD+K SN
Sbjct: 100 MELMDAN-LCQVI-------QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148
Query: 811 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY----------LTS 860
+++ D KI DFGLA R AGT M P R Y
Sbjct: 149 IVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 861 KADVYSFGVVTLEIVSGK 878
D++S G + E++ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 55/266 (20%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL- 734
+F+ +G G FG V D G V A+K L R+ + ++G I A++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL----RKADMLEKEQVGHIRAERDILVE 57
Query: 735 ------VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
VK++ + L L+ E++ + + KDT T ++ IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--------TEEETQFYIAE 109
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL---------------------- 826
+ + ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 827 ------------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 874
A+ ++ ++ ++ GT Y+APE M+ D +S GV+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 875 VSGKSN-TNYRPNEDFVYLLDWAYVL 899
+ G + P E + +++W L
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 55/246 (22%)
Query: 676 NNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQ 729
++F+ +G G FG V + + G + A+K+L KS +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEA 58
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+P +VKLY + N L L+ EY+ + + KDT T ++ IA
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--------TEEETRFYIAET 110
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--------LYEEDKTHI---- 837
+ + ++ +HRDIK N+LLD + K+SDFGL + +H
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 838 ----------STRIA---------------GTIGYMAPEYAMR-GYLTSKADVYSFGVVT 871
S R A GT Y+APE ++ GY + D +S GV+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIM 229
Query: 872 LEIVSG 877
E++ G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 854
++ VHRDIK NVLLDK+ + +++DFG D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 855 --RGYLTSKADVYSFGVVTLEIVSGKS 879
+G + D +S GV E++ G++
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARG 789
+PN +KLY +L+ +Y+K+ L F D + KL KKI +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F--DLLKKEGKLSEAEVKKIIRQLVEA 121
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
L LH + I+H DIK NVL D+ + + D+GL K+ + GT+ Y
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 849 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE Y S D ++ GV+T E+++GK
Sbjct: 174 SPEKIKGHNYDVS-FDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 46/230 (20%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKS----RQGNREFVNEIGMISAQQ 730
+F+ + G +G+VY + A+K+++ ++ Q + FV E +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 731 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 788
+P +V ++ C E + L +V EY++ G D LK + + +AR
Sbjct: 60 NPFVVSMF-CSFETKRHLCMVMEYVE---------GGDCATLLKNIGA----LPVDMARM 105
Query: 789 -------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------LYE- 831
L YLH IVHRD+K N+L+ + K++DFGL+K LYE
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 832 ----EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
+ + + ++ GT Y+APE +R D ++ G++ E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 17/131 (12%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 844
+A G+ +L + VHRD+ NVL+ + KI DFGLA+ D +IS G+
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 845 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRPNEDFVYLLDWAYVL 899
+ +MAPE T+ +DV+SFG++ EI + G NE F + Y +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 900 QE-----EEIY 905
+ +EIY
Sbjct: 362 AKPAHASDEIY 372
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 842
+A+G+++L + I HRD+ N+LL KI DFGLA+ D ++ + R+
Sbjct: 223 VAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T ++DV+S+G++ EI S
Sbjct: 280 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
L LH+ +++RD+K N+LLD + + DFGL KL +D +T GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSG 877
PE + T D ++ GV+ E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 47/263 (17%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQH 731
++F+ +G G FG V D I ++ K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+VK++ + L L+ E++ + + KDT + + IA +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--------SEEATQFYIAETVL 112
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL------------------------- 826
+ ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 827 ---------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
A+ +++++ ++ GT Y+APE M+ D +S GV+ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 878 KSN-TNYRPNEDFVYLLDWAYVL 899
+ P E + +++W L
Sbjct: 233 YPPFCSETPQETYRKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
IA + +H ++ VHRDIK NVLLD + + +++DFG +D T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 846 GYMAPEY--AMR---GYLTSKADVYSFGVVTLEIVSGKS 879
Y++PE AM G + D +S GV E++ G++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQHPNLVKLY 738
+ G FG VY G ++ + AVK + K+ N+ V+++ ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSR--AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
N + LV EY+ + I+G D K +A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLH-- 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
R I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 700 GTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757
GT++ V+ L + + + + NE+ + +HPN++ + G+ L ++ +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817
+ + T + + I G RGL YLH++ I HR+IK S++L+ D
Sbjct: 85 SANSLL---KTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISGDG 138
Query: 818 NAKISDFGLAKLYEEDKTHISTRIA--------GTIGYMAPEYA---MRGYLTSKADVYS 866
+S GL+ LY + ++ + +++PE + GY K+D+YS
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYS 195
Query: 867 FGVVTLEIVSGK 878
G+ E+ +G+
Sbjct: 196 VGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 29/201 (14%)
Query: 691 SVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG----CCVEG 744
S+YKGI ++ VI K+ + NEI + N++K+YG +
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 804
+L L+ EY L + + L + T+ + I +GL L+ ++
Sbjct: 95 PRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYK 147
Query: 805 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL------ 858
++ + + L+ ++ KI GL K+ +S+ + +M Y L
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSE 198
Query: 859 -TSKADVYSFGVVTLEIVSGK 878
T K D+YS GVV EI +GK
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 854
++ VHRDIK N+L+D + + +++DFG ED T S+ GT Y++PE AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 855 --RGYLTSKADVYSFGVVTLEIVSGKS 879
+G + D +S GV E++ G++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 23/99 (23%)
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G IP I K + +Q +++ G+S+ G IP S+ ++TSL L DL +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---DLSYNS----------- 477
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
+G IP+ +G +T L+ ++L+ N+L+G +P
Sbjct: 478 ---------FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-06
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
NLK+L L+ + + LK +DLS NNLT P F L + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAP 850
Y+H + I+HRDIKT NVL++ + + DFG A T IAGT+ AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 851 EYAMRGYLTSKADVYSFGVVTLE 873
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 42/123 (34%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEEDKTH------------ 836
++ +HRDIK N+L+D+D + K++DFGL +K Y++ H
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 837 ---------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 875
++ + GT Y+APE +R T D +S GV+ E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 876 SGK 878
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 49/241 (20%)
Query: 676 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 731
N ++ K+G G FG V+ K A+ K R+ + + V E+ ++ +H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIEVNVMRELKH 71
Query: 732 PNLVKLYGCCV-EGNQ-LLLVYEYMKNNCLSRAI------FGKDTEYRLKLDWPTRKKIC 783
N+V+ + + NQ L ++ E+ LSR I FGK E+ + I
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV-------DIT 124
Query: 784 IGIARGLAYLHE----DSRIKIVHRDIKTSNVLLD-------------KDLN----AKIS 822
+ LAY H + +++HRD+K N+ L +LN AKI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 823 DFGLAK-LYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 878
DFGL+K + E H GT Y +PE + + Y K+D+++ G + E+ SGK
Sbjct: 185 DFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGK 240
Query: 879 S 879
+
Sbjct: 241 T 241
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 58/242 (23%)
Query: 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHP 732
F +G+G G V+ L G + A+K L K R V E +++ HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
L LY L LV +Y L R L K + +AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRL-----------LQRQPGKCLSEEVARFYAA 110
Query: 789 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------------- 828
L YLH + IV+RD+K N+LL + + +SDF L+K
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 829 ------------LYEEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIV 875
+ E+ + S GT Y+APE + G S D ++ G++ E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226
Query: 876 SG 877
G
Sbjct: 227 YG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 28/184 (15%)
Query: 703 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
+ +K L R F ++S H +L ++G CV G++ ++V E++++ L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-- 104
Query: 763 IFGKDTEYRLKLDWPTRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA- 819
+ + + R+ + W KI + +A L+YL + + +VH ++ N+LL + A
Sbjct: 105 VCLRKEKGRVPVAW----KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157
Query: 820 ------KISDFG--LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVV 870
K+SD G L E++ I ++APE G L++ AD +SFG
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTT 210
Query: 871 TLEI 874
LEI
Sbjct: 211 LLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 46/127 (36%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYE------EDKTHISTR-- 840
++ +HRDIK N+L+D+D + K++DFGL +K Y+ +D S
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 841 -----------------------------IAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
+ GT Y+APE +R T D +S GV+
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 872 LEIVSGK 878
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 47/150 (31%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEE---------------- 832
++ +HRDIK N+L+D D + K++DFGL +K Y++
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 833 ------------------DKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
K H ++ + GT Y+APE +R T D +S GV+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 872 LEIVSGKSN-TNYRPNEDFVYLLDWAYVLQ 900
E++ G+ P E + +++W L
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 676 NNFDPANKVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQ 730
+F +G+G FG V G + A+K L KS ++ + E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKI--C 783
P +V LY + L L+ E++ L F +D TR + C
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFYMAEC 110
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+ + +H ++ +HRDIK N+L+D+ + K+SDFGL+ + K H S
Sbjct: 111 V---LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH--KQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 684 VGEGGFGSVYKGIL-------SDGTV------IAVKQLSSKSRQGNREFVNEIGMISAQQ 730
+G G +Y GIL DG + +K L R + F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H ++V LYG CV + ++V E+++ L + K L P + K+ +A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASAL 118
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD-LNA------KISDFG--LAKLYEEDKTHISTRI 841
+YL ED +VH ++ T N+LL ++ ++ K+SD G + L ++
Sbjct: 119 SYL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170
Query: 842 AGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEI 874
I ++APE L+ AD +SFG EI
Sbjct: 171 --RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 27/150 (18%), Positives = 55/150 (36%), Gaps = 17/150 (11%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV-KLYGC 740
+ G VY + + +K S+ + +RE E+ ++ + V K+
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
L+ E+++ G+ + + + I +A LA LH+ +
Sbjct: 62 GESDGWSYLLMEWIE---------GETLDEVSEEEKE---DIAEQLAELLAKLHQLPLLV 109
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ H D+ N+L+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
KLR L+ C+ +F P+ LV+L + G++L + V ++T L+N+ + G
Sbjct: 589 PKLRLLRWDKYPLRCMPSNFRPE----NLVKLQMQGSKLEKLWDGV-HSLTGLRNIDLRG 643
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ IP D+ NL+ L LS S ELP+ + L L DL +S
Sbjct: 644 SKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 68/223 (30%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI---LSDGTVIAVKQLSSKS------------- 712
+ ++++F +K+G G FG ++G+ D V +L+++
Sbjct: 138 ANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD 197
Query: 713 RQGNR-EFVNEIGMISAQQHPNLVKLYGC------------CVE---------------- 743
RQG R +F+ + +V+ Y C C E
Sbjct: 198 RQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTK 257
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLDWPTRKK---ICIGIAR 788
G+Q L V+++ + L A+ GK + ++ + P K+ + G+ R
Sbjct: 258 GSQWL-VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316
Query: 789 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
GL LH RI IVHRDIK N+L+ D KI DFG A
Sbjct: 317 QVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 18/95 (18%)
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
V+ + L+V EY++ L A+ R + + R + LH + I
Sbjct: 69 VDPDNGLIVMEYIEGELLKDAL------------EEARPDLLREVGRLVGKLH---KAGI 113
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKL--YEEDK 834
VH D+ TSN++L DFGL + EDK
Sbjct: 114 VHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.003
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
++ + +A LH+ IVH D+ TSN ++ D I DFGL K + +
Sbjct: 430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKYSDLIEDK 483
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 907 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.88 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.98 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.43 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.41 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-67 Score=666.75 Aligned_cols=206 Identities=29% Similarity=0.500 Sum_probs=171.5
Q ss_pred HhcCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
....++..+.||+|+||.||+|+. .+++.||||+++..... ..+|++.+++++|||||+++|+|.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345678889999999999999997 47899999998654322 2346888999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 764 y~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 764 YIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999984 37899999999999999999997655679999999999999999988876 665543322
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV 898 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 898 (907)
. ....+++.|||||++.+..++.++|||||||++|||++|+.||+... .....+++|++.
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~ 894 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARY 894 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHH
Confidence 1 12357899999999999999999999999999999999999995432 234456677654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=413.75 Aligned_cols=238 Identities=56% Similarity=0.921 Sum_probs=210.3
Q ss_pred cCCcccHHHHHHHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEE
Q 002566 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741 (907)
Q Consensus 662 ~~~~~~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~ 741 (907)
....|++.+++.||++|...+.||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443256799999999999999999999999
Q ss_pred eeCc-eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEE
Q 002566 742 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (907)
Q Consensus 742 ~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 820 (907)
.+.+ +.+||||||++|+|.++|++.... +++|.+|++||.++|+||+|||+..+++||||||||+|||+|+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9988 599999999999999999987543 789999999999999999999999988999999999999999999999
Q ss_pred EeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 002566 821 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 900 (907)
Q Consensus 821 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 900 (907)
|+|||+|+..............||.+|+|||++..+..+.|+|||||||+|.||++|++|.+.......+.+++|+....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999997655411111111179999999999999999999999999999999999999998766666777999986665
Q ss_pred cc
Q 002566 901 EE 902 (907)
Q Consensus 901 ~~ 902 (907)
++
T Consensus 298 ~~ 299 (361)
T KOG1187|consen 298 EE 299 (361)
T ss_pred HC
Confidence 54
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=358.78 Aligned_cols=201 Identities=31% Similarity=0.557 Sum_probs=181.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
-.+|...++||+|+||+||+|+++ ++..||||.+... ..+..+-...|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356788888999999999999986 5789999999766 4555566789999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC------CcEEEeecC
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFG 825 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DFG 825 (907)
|||++|+|.++++..+ .+++..++.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998775 6899999999999999999999998 9999999999999764 468999999
Q ss_pred CcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
+|+.+.+... ....+|++.|||||++...+|+.|+|+||.|+++||+++|+.||....
T Consensus 161 fAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 161 FARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999875443 345789999999999999999999999999999999999999997443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.43 Aligned_cols=202 Identities=28% Similarity=0.442 Sum_probs=181.3
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
.++|++.++||+|+||+||.++.+ +++.+|+|++++.. ..+.+...+|..++.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999976 58899999998763 33456678899999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
+||+.||.|..+|..++ .+++..++-.+..|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999997654 6899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... ....++||+.|||||++.+..++..+|.||+|+++|||++|.+||....
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 44333 2344799999999999999999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.98 Aligned_cols=203 Identities=37% Similarity=0.609 Sum_probs=176.7
Q ss_pred CCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeCc-eeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~~ 754 (907)
+...+.||+|+||+||+|.++....||||++....... .++|.+|+.++.+++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999765569999998654322 568999999999999999999999999887 799999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCcccccCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEED 833 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 833 (907)
++|+|.++++.. ....+++..++++|.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 12379999999999999999999999973 99999999999999997 9999999999877653
Q ss_pred Cccccccccccccccchhhhc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
. ...+...||+.|||||++. ...++.|+|||||||++|||+||+.||....+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2 1223367999999999999 66999999999999999999999999976553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.14 Aligned_cols=208 Identities=30% Similarity=0.486 Sum_probs=181.2
Q ss_pred CcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-eeEEEeeecc
Q 002566 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMK 755 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~~~ 755 (907)
+..+.||+|..|+|||+.++ +++.+|+|++.... ....+++.+|+++++..+||+||+++|.|..++ +..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34689999999999999987 68889999996553 444678999999999999999999999999988 5999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|||++.+...+ ++++...-+|+.++++||.|||+.. +||||||||+|||++..|++||||||.+..+...
T Consensus 162 gGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999986543 6899999999999999999999742 4999999999999999999999999999987655
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CCcchhhHHHHH
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWA 896 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~--~~~~~~~l~~~~ 896 (907)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+... ...+...++.++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 334578999999999999999999999999999999999999998653 234455555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=352.94 Aligned_cols=202 Identities=29% Similarity=0.516 Sum_probs=183.2
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 78999999999774 2344567889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|+|++++|.+++...+ ++++.+++.++.||+.||.|||+++ |||||||-.|+|++++.++||+|||+|....
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999987443 7999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
.+... ...++|||.|+|||++.+...+..+||||+||+||.|+.|++||+.+.-
T Consensus 170 ~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 170 YDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred Ccccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 55332 3447999999999999999999999999999999999999999976543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=322.20 Aligned_cols=215 Identities=27% Similarity=0.422 Sum_probs=181.4
Q ss_pred CCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEe-EEeeCce-eEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYG-CCVEGNQ-LLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~LV~ 751 (907)
+|.+.++||+|.||+|||+.. .+|..||.|.++-. ..+..+....|+.+|++++|||||++++ .+.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 466788999999999999984 58999999988643 3455667899999999999999999998 4555555 89999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR-IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
||++.|+|.+++...+. ....+++..+++++.|+++||.++|..-+ .-|+||||||.||+++.+|.|||+|||+++++
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999965432 33478999999999999999999998421 13899999999999999999999999999998
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
...... ....+|||.||+||.+....|+.|+||||+||++|||..-++||..+ ....|-+.+
T Consensus 179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI 240 (375)
T KOG0591|consen 179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKI 240 (375)
T ss_pred cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHH
Confidence 766543 34578999999999999999999999999999999999999999654 344444433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.28 Aligned_cols=211 Identities=34% Similarity=0.542 Sum_probs=183.6
Q ss_pred CCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
++..+.||+|.||.||.|.+.....||+|.++.. ......|.+|+++|++++|++||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456899999999999999988889999999865 334578999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.++|.... ...+...+.+.++.|||+||+||++++ +|||||.++|||++++..|||+|||+|+...++....
T Consensus 287 sLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 287 SLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999997632 236889999999999999999999997 9999999999999999999999999999555444433
Q ss_pred cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 002566 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDW 895 (907)
Q Consensus 838 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 895 (907)
.....-+..|.|||.+..+.++.|+|||||||+||||+| |+.|+....+.+....++-
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~ 419 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER 419 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 333445789999999999999999999999999999999 9999877666555555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.41 Aligned_cols=201 Identities=29% Similarity=0.443 Sum_probs=173.4
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch-------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~-------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 745 (907)
..+.|-+.+.+|+|+||.|-+|..+ +|+.||||++++..-. ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566788899999999999999965 7999999999765211 1223469999999999999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CcEEEe
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKIS 822 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~ 822 (907)
..|+|||||+||.|.+.+-+++ .+.+..-.-++.|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999987764 5677788999999999999999998 9999999999999765 789999
Q ss_pred ecCCcccccCCCccccccccccccccchhhhccCC---CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 823 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 823 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|||+|+.... .......+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||...
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 9999998763 33455689999999999998653 344899999999999999999999543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=309.92 Aligned_cols=198 Identities=29% Similarity=0.430 Sum_probs=178.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|+..+.||.|+||.|..++.+ +|..+|+|++++..- ...+...+|.++|+++.||+++++.+.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999976 588999999977632 23445678999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|.|..+++..+ +++++.++-+|.||+.||+|||+.+ |++||+||+|||+|.+|.+||.|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999997654 6899999999999999999999998 9999999999999999999999999999775
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .-..+||+.|+|||.+....+...+|.|||||++|||+.|.+||....
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 54 234789999999999999999999999999999999999999996543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.10 Aligned_cols=212 Identities=26% Similarity=0.389 Sum_probs=182.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
+.|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-.++|+++|++++|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999987 599999999975432 234456899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|++..-|+++-+-. ..++...+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99986665543222 24788999999999999999999998 99999999999999999999999999998874
Q ss_pred CCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
. ....+..+.|.+|.|||.+.+ ..|++.+||||.||++.||++|.+-|..+++-|...++...
T Consensus 154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT 217 (396)
T ss_pred C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence 2 223455678999999999987 68999999999999999999999999888887777666653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.50 Aligned_cols=207 Identities=30% Similarity=0.480 Sum_probs=178.2
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV 750 (907)
+.|+..++||+|.||.||||+. .+|+.||+|++.... ...-.-..+||.+|++++||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678999999999999996 479999999987654 23344567899999999999999999998876 689999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
+|||++ +|.-++...+ ..++..++..++.|+++||+|||+++ |+|||||.+|||||.+|.+||+|||+|+++
T Consensus 197 FeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999986 5777775543 36899999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 890 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~ 890 (907)
........+..+-|.+|.|||++.+. .|+..+|+||.||||.||+.|++.|..+...++.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 87766555556779999999999875 7999999999999999999999988765543333
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.31 Aligned_cols=194 Identities=34% Similarity=0.531 Sum_probs=164.5
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeCc----eeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~L 749 (907)
+.....++||+|.||.||||.+. ++.||||++... ..+.|++|-++.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455788999999999999995 589999999644 45678888877764 79999999999987655 8899
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
|+||.+.|||.++|..+ .++|....+|+..|++||+|||+. .+|+|+|||||++|||+.+|+++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999776 689999999999999999999975 456799999999999999999999999
Q ss_pred cCCcccccCCCccc-cccccccccccchhhhccCC------CCchhHHHHHHHHHHHHHhCCC
Q 002566 824 FGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSGKS 879 (907)
Q Consensus 824 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~------~~~k~DvwSlGvvl~elltG~~ 879 (907)
||+|..+....... ....+||.+|||||++.+.. .-.+.||||+|.|||||++.-.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 99999887654322 12267999999999998653 2236899999999999998643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.49 Aligned_cols=212 Identities=33% Similarity=0.536 Sum_probs=182.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCcee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
+.+....+.||+|+||+||+|+.. +.+.||||.+++.... ...+|.+|++++..++|||||+++|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 455667889999999999999853 3568999999988665 678999999999999999999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCccc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEY---------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
++|+|||..|+|.++|....... ..+++..+.+.||.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997543221 334899999999999999999999887 999999999999999999
Q ss_pred EEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 002566 819 AKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDF 889 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~ 889 (907)
|||+|||+++..-..+.+ ...+..=.++||+||.+..++++.++|||||||+|||+++ |+.|+....+++.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 999999999865443332 2223334789999999999999999999999999999999 9999977666543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.46 Aligned_cols=198 Identities=29% Similarity=0.478 Sum_probs=179.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. .++.+...+|+++++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778899999999999999965 68899999997653 3345668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+.+ +|..++...+ .++++.+..|+.|++.||.|||+++ |+|||+||.|||++..+++|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9986 9999996653 6899999999999999999999997 99999999999999999999999999998876
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. .+-+.+.||+.|||||+..+..|+..+|+||+||++||+++|++||..
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 43 345668899999999999999999999999999999999999999953
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=324.35 Aligned_cols=220 Identities=25% Similarity=0.394 Sum_probs=188.8
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
..++|+..++||+|+||.||.|+-+ +|..+|+|++++.. ....+....|-.+|...++|+||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999976 69999999998763 3334567789999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||++||++..+|...+ .+++..++..+.+++-|++-+|+.| +|||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999997765 7899999999999999999999998 99999999999999999999999999853
Q ss_pred ccC-----------------------CCc----cc-------------------cccccccccccchhhhccCCCCchhH
Q 002566 830 YEE-----------------------DKT----HI-------------------STRIAGTIGYMAPEYAMRGYLTSKAD 863 (907)
Q Consensus 830 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~l~~~~~~~k~D 863 (907)
+.. +.. .. ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 311 000 00 01156999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCC-CCcchhhHHHHHHHhhc
Q 002566 864 VYSFGVVTLEIVSGKSNTNYR-PNEDFVYLLDWAYVLQE 901 (907)
Q Consensus 864 vwSlGvvl~elltG~~p~~~~-~~~~~~~l~~~~~~~~~ 901 (907)
.||+|||+|||+.|-+||... +.+....++.|...++.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f 409 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF 409 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC
Confidence 999999999999999999654 44566688888855543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=323.90 Aligned_cols=203 Identities=28% Similarity=0.441 Sum_probs=178.4
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCcee
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 747 (907)
...++|...+.||+|+|++|++|+.. .++.||||++.+.- ....+-...|-+.|.++ .||.||+|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999965 68999999986542 22234456778888888 899999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
|+|+||+++|.|.++|...+ .+++.-++.++.+|+.||+|||++| ||||||||+|||+|+|+++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999997764 6899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcc----------cc--ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKTH----------IS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+.+.+.... .+ ..++||..|.+||++.....++.+|+|+|||+||+|+.|++||..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 988653221 11 347899999999999999999999999999999999999999953
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.08 Aligned_cols=212 Identities=27% Similarity=0.422 Sum_probs=180.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|...+.+|+|.||.||+|+.. +|+.||+|+++.....+ .....+|+++|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35677889999999999999964 79999999998764433 4567899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
||+. +|+..++... ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9974 7998886653 37899999999999999999999998 99999999999999999999999999998876
Q ss_pred CCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYV 898 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 898 (907)
....... .+-|..|.|||.+.+. .|+..+||||.||++.||+-|.+-|....+ .+.+....+.
T Consensus 154 p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~ 217 (318)
T KOG0659|consen 154 PNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRA 217 (318)
T ss_pred CCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHH
Confidence 5543322 3679999999999865 699999999999999999999987755443 4444444333
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.86 Aligned_cols=207 Identities=30% Similarity=0.519 Sum_probs=180.1
Q ss_pred CCCcCCeeeccCceEEEEEEECC----CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
..++.++||.|.||.||+|.++- ...||||.++.... +..++|+.|+.+|.++.||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34678999999999999999862 45799999987744 45678999999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|||++|+|+.+|+.++. ++++.+...+.++||.||+||-+.+ +|||||.++|||++.+..+||+|||+++.++
T Consensus 710 EyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999988764 5889999999999999999999887 9999999999999999999999999999887
Q ss_pred CCCcccccccc--ccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 002566 832 EDKTHISTRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 890 (907)
Q Consensus 832 ~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 890 (907)
++.....+..- -+.+|.|||.+...+++..+|||||||+|||.++ |..|+=.-.++|..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 76533322222 2579999999999999999999999999999887 99997444444433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.23 Aligned_cols=221 Identities=27% Similarity=0.397 Sum_probs=184.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhh--HHHHHHHHHHHhcCCCceeeEEeEEee--CceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~--~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV 750 (907)
++|...+.|++|.||.||+|+.+ +++.||+|+++.+..... -.-++|+.+|.+.+|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677899999999999999976 688999999986643322 235789999999999999999998774 3579999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
||||+. +|..++..-. .++...++..++.|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999986 6888886543 37889999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccccc
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY 905 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 905 (907)
...... .+..+-|..|.|||.+.+. .|+..+|+||+|||+.||+++++-|...+.-++...+--.--...|.||
T Consensus 228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 876543 3456679999999999865 6999999999999999999999999877766665555444444555554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.18 Aligned_cols=198 Identities=30% Similarity=0.545 Sum_probs=180.4
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
..|+..++||+|+.|.||.|.- .+++.||||++........+-..+|+.+|+..+|+|||+++..+...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999985 468899999998776666677899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+.+... .+++.++..|++++++||+|||.++ |+|||||..|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999988544 5899999999999999999999998 9999999999999999999999999999887765
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... ...+||++|||||+.....|++|+||||||++++||+.|++||-+
T Consensus 424 ~KR-~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 424 SKR-STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred Ccc-ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 433 346899999999999999999999999999999999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=324.50 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=175.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L 749 (907)
-++|...++||+|.||+|+.+..+ +++.+|||.+++.. ..+.+..+.|-+++... +||.+++++.+|+..++++.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467899999999999999999986 57899999998874 34455677888887766 59999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+.||++..+.+.. .+++..+.-++..++.||+|||+++ ||+||||-+|||+|.+|++||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999965554432 6899999999999999999999998 99999999999999999999999999985
Q ss_pred ccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.-.... ....++||+.|||||++.+..|+..+|.|||||+||||+.|++||...
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 432222 345689999999999999999999999999999999999999999643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=318.82 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=176.1
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc----cc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK----SR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~----~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~ 745 (907)
...++|...+.||+|+||+|+.|... ++..||+|.+... .. ...+...+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999999865 6899999977553 11 22445668999999999 999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeec
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 824 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DF 824 (907)
..++||||+.+|.|.+++...+ ++.+..+.+++.|+++|++|||+++ |+||||||+|||++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999997643 6888999999999999999999998 9999999999999999 99999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCC-CC-chhHHHHHHHHHHHHHhCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY-LT-SKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus 166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 9999874 2222334578999999999999866 65 789999999999999999999976
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=318.47 Aligned_cols=204 Identities=29% Similarity=0.531 Sum_probs=175.3
Q ss_pred HHHHHHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 669 ~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
++++...+.+.+.+.||+|.||+||+|.|. ..||||++.... .+..+.|.+|+.++++-||.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 555666667778899999999999999994 358999997663 3456789999999999999999999999998876
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.+|+.++++.+|..++|..+. .++..+.+.||+|||+|+.|||.++ |||||||+.||++.++++|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 999999999999999987753 6899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCC-ccccccccccccccchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 827 AKLYEEDK-THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 827 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
+..-..-. ........|..-|||||++.. .+|+..+||||||+|+|||++|.-|+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 97543211 111112347889999999974 478999999999999999999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.08 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=176.7
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhH-HHHHHHHHHHhcC-CCceeeEEeEEeeCc-eeEE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQ-HPNLVKLYGCCVEGN-QLLL 749 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~-~f~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~L 749 (907)
..++|...++||.|.||.||+|+-. ++..||||+++..-...++ .-++|+..|++++ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888999999999999999954 6889999999876544332 3468999999999 999999999999988 9999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
|||||+. +|.+++..++ ..+++.+++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.
T Consensus 88 VfE~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999974 7999997653 37999999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCccccccccccccccchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
....... +..+.|.+|.|||++. .+.|+.++||||+||+++|+.+-++-|....
T Consensus 160 v~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 160 VRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred cccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 7765543 5567899999999876 5689999999999999999999999885544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.67 Aligned_cols=201 Identities=34% Similarity=0.554 Sum_probs=171.6
Q ss_pred cCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--eeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E 752 (907)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345667899999999999999864 8999999997664333566889999999999999999999855444 6899999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCccccc
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 831 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 831 (907)
|+++|+|.+++...+. .++++.+++.++||++||+|||+++ ||||||||+|||++. ++.+||+|||+++...
T Consensus 97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999976542 5899999999999999999999998 999999999999999 7999999999998776
Q ss_pred C--CCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 E--DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~--~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. ..........||+.|||||++..+ ...+++||||+||++.||+||++||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 4 111223346899999999999953 344599999999999999999999965
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.71 Aligned_cols=201 Identities=24% Similarity=0.366 Sum_probs=174.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999875 58899999997542 223356788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999986543 6899999999999999999999997 9999999999999999999999999987543
Q ss_pred CCCc----------------------------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhC
Q 002566 832 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877 (907)
Q Consensus 832 ~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG 877 (907)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001234799999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 002566 878 KSNTNYR 884 (907)
Q Consensus 878 ~~p~~~~ 884 (907)
+.||...
T Consensus 233 ~~Pf~~~ 239 (363)
T cd05628 233 YPPFCSE 239 (363)
T ss_pred CCCCCCC
Confidence 9999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.62 Aligned_cols=207 Identities=31% Similarity=0.510 Sum_probs=180.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhh-HHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~-~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.+...++++||+|-||+|..+....+..||||+++....... ++|..|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 455678899999999999999998889999999998866554 7899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
|++|+|.+++..+... .++.....+|+.|||+||+||.+.. +|||||.++|+|++.++++||+|||+++.+-.+
T Consensus 617 mEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999776432 2466778889999999999999986 999999999999999999999999999966554
Q ss_pred Ccc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCc
Q 002566 834 KTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRPNE 887 (907)
Q Consensus 834 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~~~ 887 (907)
+.+ ...+.+-+++|||||.+..++++.++|||+||+++||+++ .+.||..-.++
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 433 3334555789999999999999999999999999999876 67788655443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.03 Aligned_cols=216 Identities=26% Similarity=0.466 Sum_probs=188.2
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+|.+.+.||+|.||+|-+|.. ..|+.||||.+++..- ++.-.+.+|+++|+.++||||+.++.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577789999999999999985 5799999999977644 44445778999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||..+|.|.+++...+ .+++.+++++++||++|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999997664 6899999999999999999999997 9999999999999999999999999999886
Q ss_pred CCCccccccccccccccchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC------------------CcchhhH
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP------------------NEDFVYL 892 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~------------------~~~~~~l 892 (907)
... .-+.++|++-|.+||++.+.+| .+.+|-||+||+||.|+.|..||+.++ +.+.-.|
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gL 282 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGL 282 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHH
Confidence 643 3456899999999999998765 678999999999999999999996322 2355577
Q ss_pred HHHHHHhhc
Q 002566 893 LDWAYVLQE 901 (907)
Q Consensus 893 ~~~~~~~~~ 901 (907)
++|+-..-.
T Consensus 283 IRwmLmVNP 291 (668)
T KOG0611|consen 283 IRWMLMVNP 291 (668)
T ss_pred HHHHHhcCc
Confidence 888755443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.70 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=180.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.+.|+..++||.|..+.||+|+. +.+..||||++..+.-.. .+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788899999999999999995 467999999997664433 4788999999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
||.+||+.+.+...-.. .+++..+..|.+++++||.|||++| .||||||+.||||+++|.|||+|||.+-.+..
T Consensus 105 fMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999765433 5899999999999999999999998 99999999999999999999999998876655
Q ss_pred CCcccc---ccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 833 DKTHIS---TRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~~~~---~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
...... ...+||+.|||||++.. ..|+.|+|||||||+..||.+|..||..-++
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 432221 34689999999999653 4799999999999999999999999965554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.57 Aligned_cols=194 Identities=31% Similarity=0.473 Sum_probs=163.7
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHh--cCCCceeeEEeEEeeCc----e
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----Q 746 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~ 746 (907)
.........+.||+|.||.||+|.|+ |+.||||+|.. .+++.+.+|.++.+. +||+||+.+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 33467788899999999999999995 88899999953 345677788887775 79999999999876543 6
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-----DSRIKIVHRDIKTSNVLLDKDLNAKI 821 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiHrDlkp~NILl~~~~~~kl 821 (907)
++||.||.+.|||.|+|... .++....++++..+|.||+|||- +|+|.|.|||||++|||+..++.+.|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 89999999999999999764 68999999999999999999995 48889999999999999999999999
Q ss_pred eecCCcccccCCCccc---cccccccccccchhhhccC------CCCchhHHHHHHHHHHHHHh
Q 002566 822 SDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVS 876 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvvl~ellt 876 (907)
+|+|+|.......... ....+||-+|||||++... ..-..+||||||+|+||+.-
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999998876654322 2346899999999999643 12336999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=303.20 Aligned_cols=201 Identities=30% Similarity=0.405 Sum_probs=174.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999974 78999999986542 2233467899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888754321 25899999999999999999999997 99999999999999999999999999987543
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 322 223468999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=318.64 Aligned_cols=205 Identities=25% Similarity=0.369 Sum_probs=176.0
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
+....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999986 5789999998643 22334567899999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999998543 4788899999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 987654332222345799999999999754 3788999999999999999999999644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.25 Aligned_cols=197 Identities=25% Similarity=0.362 Sum_probs=174.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 68899999986532 223456888999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999986543 5789999999999999999999998 9999999999999999999999999998664
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2346899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=316.91 Aligned_cols=201 Identities=24% Similarity=0.370 Sum_probs=172.9
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999975 57899999997542 2334578899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 999999999986543 5788999999999999999999987 99999999999999999999999999764311
Q ss_pred CCc----------------------------------------------cccccccccccccchhhhccCCCCchhHHHH
Q 002566 833 DKT----------------------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYS 866 (907)
Q Consensus 833 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwS 866 (907)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012246999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 002566 867 FGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 867 lGvvl~elltG~~p~~~~~ 885 (907)
|||++|||++|+.||....
T Consensus 234 lG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred hhhHHHHHHhCCCCCcCCC
Confidence 9999999999999996543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.58 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=175.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999986 58899999997542 223456889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999996542 5789999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 3 1233568999999999998899999999999999999999999996544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.08 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=174.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 58899999997532 233456788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999986543 5899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCcc-------------------------------------ccccccccccccchhhhccCCCCchhHHHHHHHHHHHH
Q 002566 832 EDKTH-------------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 874 (907)
Q Consensus 832 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~el 874 (907)
..... .....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 00124689999999999998999999999999999999
Q ss_pred HhCCCCCCCC
Q 002566 875 VSGKSNTNYR 884 (907)
Q Consensus 875 ltG~~p~~~~ 884 (907)
++|+.||...
T Consensus 233 ~~G~~Pf~~~ 242 (364)
T cd05599 233 LVGYPPFCSD 242 (364)
T ss_pred hcCCCCCCCC
Confidence 9999999643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.58 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=174.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC--CcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~--g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
-++|.+.+.||+|+||.||+|.+.+ +..||+|++.... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998653 3689999986432 2334568899999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999986543 5889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 64322 2356899999999999888999999999999999999999999654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=315.27 Aligned_cols=208 Identities=24% Similarity=0.362 Sum_probs=178.4
Q ss_pred HHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002566 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (907)
Q Consensus 668 ~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 743 (907)
.+++....++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556789999999999999999999986 57899999986432 2334567889999999999999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
++..++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999988543 4788889999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999987654332223345799999999998753 3788999999999999999999999643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=316.81 Aligned_cols=202 Identities=23% Similarity=0.376 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 68899999986532 223456788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999986542 5788999999999999999999998 9999999999999999999999999996432
Q ss_pred CCCcc----------------------------------------------ccccccccccccchhhhccCCCCchhHHH
Q 002566 832 EDKTH----------------------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVY 865 (907)
Q Consensus 832 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~Dvw 865 (907)
..... .....+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00124699999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 002566 866 SFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 866 SlGvvl~elltG~~p~~~~~ 885 (907)
||||++|||++|+.||....
T Consensus 233 SlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred ecchhhhhhhcCCCCCCCCC
Confidence 99999999999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.01 Aligned_cols=194 Identities=27% Similarity=0.351 Sum_probs=169.4
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 68899999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 9998886543 6899999999999999999999998 99999999999999999999999999975432221 1
Q ss_pred cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 838 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 23356999999999999999999999999999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=296.07 Aligned_cols=201 Identities=32% Similarity=0.454 Sum_probs=166.8
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eeEEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLLV 750 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~LV 750 (907)
.|...+++|.|+||.||+|... +++.||||++-...+ .-.+|+++|++++|||||+++.++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999976 478999999865433 2236899999999999999999887532 23589
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL 829 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 829 (907)
||||+. +|.+.++.. ......++...+.-++.||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 101 leymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999985 788888642 122346788889999999999999999987 9999999999999977 9999999999999
Q ss_pred ccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 888 (907)
+..+....+ ...|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+..+
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d 233 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD 233 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH
Confidence 887766533 356889999999986 479999999999999999999999997655443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=309.74 Aligned_cols=197 Identities=23% Similarity=0.378 Sum_probs=174.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 58899999987542 223456889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999986543 5788999999999999999999997 9999999999999999999999999998664
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 432 2346899999999999988999999999999999999999999543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=316.84 Aligned_cols=201 Identities=23% Similarity=0.370 Sum_probs=172.4
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.|...++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|||||++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999975 58899999987542 2334568889999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 999999999986542 5788999999999999999999997 99999999999999999999999999753311
Q ss_pred CC----------------------------------------------ccccccccccccccchhhhccCCCCchhHHHH
Q 002566 833 DK----------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYS 866 (907)
Q Consensus 833 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwS 866 (907)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00011246899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 002566 867 FGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 867 lGvvl~elltG~~p~~~~~ 885 (907)
+||++|||++|+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred chHHHHHHHhCCCCCCCCC
Confidence 9999999999999996543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=306.48 Aligned_cols=194 Identities=28% Similarity=0.359 Sum_probs=169.0
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999975 68999999997542 233456778999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 9988886542 5899999999999999999999997 99999999999999999999999999875432222 1
Q ss_pred cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 838 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 22356899999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.47 Aligned_cols=208 Identities=27% Similarity=0.477 Sum_probs=183.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..|+..+.||+|.||.||||... .++.||+|++..+...+ ..+.++|+.++..++++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999975 68899999998765443 56788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+.+|++.+.+.... .+++..+.-|++++..|+.|||.++ .+|||||+.|||+.++|.+|++|||.+..+...
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999997653 4577888889999999999999997 999999999999999999999999999888766
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 892 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l 892 (907)
.... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+...++....++
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 5543 557899999999999988999999999999999999999999976665444333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=295.90 Aligned_cols=200 Identities=30% Similarity=0.468 Sum_probs=167.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--------------hhHHHHHHHHHHHhcCCCceeeEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--------------GNREFVNEIGMISAQQHPNLVKLYG 739 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--------------~~~~f~~E~~~l~~l~H~nIv~l~g 739 (907)
-+.|.+.+.||+|.||.|-+|+.. +++.||+|++.+.... ..+...+|+.++++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 478999999999999999999975 6899999999754211 1246788999999999999999999
Q ss_pred EEee--CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 002566 740 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (907)
Q Consensus 740 ~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 817 (907)
+..+ .+.+|||+|||..|.+...-- . ...++..++++++++++.||+|||.++ ||||||||+|+|++++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~-d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP-D----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC-C----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9875 568999999999987743211 1 113899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCcccccCCCc----cccccccccccccchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 818 NAKISDFGLAKLYEEDKT----HISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 818 ~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
++||+|||.+........ ..-...+||+.|+|||...++ ..+.+.||||+||+||-|+.|+-||.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 999999999987633321 112236899999999999863 34667899999999999999999995
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=278.88 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=180.7
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCcee
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
.++-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-+.++||||+++++++.++...
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 345578999999999999999999975 57789999986542 23356788999999999999999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
||++||.++|++...|.+... .++++.....++.|+|.|+.|+|..+ +|||||||+|+|++.++..|++|||.+
T Consensus 98 yLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred EEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence 999999999999999985443 26888899999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..-... .....+||..|.+||+..+...+..+|+|++|++.||++.|.+||....
T Consensus 172 V~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 172 VHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred eecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 765422 2244789999999999999999999999999999999999999997654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=308.85 Aligned_cols=208 Identities=28% Similarity=0.442 Sum_probs=171.9
Q ss_pred HhcCCCcCCeeeccCceEEEEEEE------CCCcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC-
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG- 744 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~- 744 (907)
..++|.+.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +|||||++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999974 2356899999975432 3346789999999999 899999999988764
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcc-------------------------------------------------------
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTE------------------------------------------------------- 769 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 769 (907)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999998653210
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc-ccccccccc
Q 002566 770 --YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIG 846 (907)
Q Consensus 770 --~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~ 846 (907)
...++++.++.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0135888999999999999999999987 9999999999999999999999999998654332211 122345688
Q ss_pred ccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 847 y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999899999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=307.05 Aligned_cols=194 Identities=28% Similarity=0.364 Sum_probs=169.7
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999997542 234467888999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.+++.... .+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 9988886542 5899999999999999999999997 99999999999999999999999999875433222 1
Q ss_pred cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 838 ~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 23356899999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=315.99 Aligned_cols=202 Identities=23% Similarity=0.369 Sum_probs=173.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 58899999986542 223456788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+.
T Consensus 81 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 9999999999996543 5788899999999999999999998 9999999999999999999999999975331
Q ss_pred CCC------------------------------------------ccccccccccccccchhhhccCCCCchhHHHHHHH
Q 002566 832 EDK------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGV 869 (907)
Q Consensus 832 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGv 869 (907)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 002566 870 VTLEIVSGKSNTNYRP 885 (907)
Q Consensus 870 vl~elltG~~p~~~~~ 885 (907)
++|||++|+.||....
T Consensus 233 ilyell~G~~Pf~~~~ 248 (376)
T cd05598 233 ILYEMLVGQPPFLADT 248 (376)
T ss_pred eeeehhhCCCCCCCCC
Confidence 9999999999996544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.43 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=174.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 57889999987542 2234567899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|++++++..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99988776554322 25889999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..........|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 33322234568999999999998889999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.75 Aligned_cols=211 Identities=26% Similarity=0.417 Sum_probs=173.9
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCc-eeeEEeEEeeCc------
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPN-LVKLYGCCVEGN------ 745 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~------ 745 (907)
..|...++||+|.||+||+|+.. +|+.||+|++....... -....+|+.+++.++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556778999999999999965 68999999997664421 234578999999999999 999999998877
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
.+++|+||++. +|.+++....... ..++...+..+++||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999974 7888886543211 24666889999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 892 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l 892 (907)
+|+...-.... .+..++|..|.|||++.+. .|+...||||+||+++||+++++-|....+.+....
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 99976633322 2345689999999999876 799999999999999999999988866554433333
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=313.66 Aligned_cols=202 Identities=25% Similarity=0.338 Sum_probs=173.8
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567899999999999999999976 58899999986432 2334457889999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|+|.+++... .++...+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999988643 4678889999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCccccccccccccccchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 654332222345799999999998653 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.67 Aligned_cols=202 Identities=34% Similarity=0.527 Sum_probs=172.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC--C--cE-EEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD--G--TV-IAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~--g--~~-vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
.++....++||+|+||.||+|.+.. + .. ||||..+.. ......+|.+|+++++.++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444556899999999999999753 2 23 899999863 35667899999999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
+++|||+|+||+|.++|..... .++..++.+++.++|+||+|||+.+ +|||||.++|+|++.++.+||+|||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999976642 5899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
++.......... ...-+.+|+|||.+..+.++.++|||||||++||+++ |..|+...
T Consensus 309 s~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 309 SRAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred ccCCcceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 886542111110 1124679999999999999999999999999999999 88888543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=302.92 Aligned_cols=201 Identities=24% Similarity=0.438 Sum_probs=176.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|++.+.||+|+||.||+++.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999986 578899999876532 334678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++.... .+++..+..++.|+++||.|||+.+ .|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999986542 5789999999999999999999864 399999999999999999999999999976543
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 223468999999999999899999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.41 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999976 5889999998642 2223456888999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999986432 25789999999999999999999998 9999999999999999999999999997665
Q ss_pred CCCccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...........||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 433322233468999999999863 4578899999999999999999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=297.26 Aligned_cols=201 Identities=23% Similarity=0.400 Sum_probs=171.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...++||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999976 688999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++ +|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 985 8888875442 25788999999999999999999997 999999999999999999999999999765432
Q ss_pred Cccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 123467899999998865 568999999999999999999999996544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.97 Aligned_cols=201 Identities=25% Similarity=0.329 Sum_probs=173.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++..++|++|+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 57889999986532 223445788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999996532 25789999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...........|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 443322233569999999999875 4678899999999999999999999954
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.83 Aligned_cols=191 Identities=25% Similarity=0.370 Sum_probs=167.9
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||.||+|... +++.||+|+++.. .......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 5789999998653 233446688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 99986542 5899999999999999999999997 99999999999999999999999999985433222 223
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 35699999999999999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.60 Aligned_cols=186 Identities=30% Similarity=0.501 Sum_probs=166.5
Q ss_pred cCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
..+-+|.|+.|.||.|+++ ++.||||+++.-. ..+|+-|++++||||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3578999999999999996 6679999885322 2467789999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
...|+... ++.......+..+||.|+.|||.+. |||||||+-||||..+..+||+|||-++........ .
T Consensus 200 ~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--M 269 (904)
T KOG4721|consen 200 YEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--M 269 (904)
T ss_pred HHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh--h
Confidence 99997654 6888899999999999999999985 999999999999999999999999999987665332 3
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.++||..|||||++...+.+.|+||||||||||||+||..|+..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 47899999999999999999999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=328.65 Aligned_cols=210 Identities=34% Similarity=0.527 Sum_probs=178.1
Q ss_pred cCCCcCCeeeccCceEEEEEEECC--Cc----EEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD--GT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~--g~----~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++.+..+.||+|+||.||+|...+ +. .||||.++.. +.+...+|++|..+|++++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455667899999999999999753 33 4899999776 4556778999999999999999999999999999999
Q ss_pred EEeeeccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 749 LVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
+++|||++|+|..+|+..+.. ....+...+.+.++.|||+|+.||++++ +|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999765211 1346899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcccc-ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 002566 827 AKLYEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888 (907)
Q Consensus 827 a~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~ 888 (907)
|+.+.....+.. ....=..+|||||.++.+.++.|+|||||||++||++| |..|+....+.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 995443332222 22123579999999999999999999999999999999 889997766543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.57 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=174.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 58899999997532 233456788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999986543 5889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCc----------------------------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhC
Q 002566 832 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877 (907)
Q Consensus 832 ~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG 877 (907)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 001134699999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 002566 878 KSNTNYRP 885 (907)
Q Consensus 878 ~~p~~~~~ 885 (907)
+.||....
T Consensus 233 ~~Pf~~~~ 240 (360)
T cd05627 233 YPPFCSET 240 (360)
T ss_pred CCCCCCCC
Confidence 99996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.24 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=171.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC----CCcEEEEEEecccc----chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCcee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 747 (907)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|++++..+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998853 57899999986532 22345677899999998 599999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999986543 5889999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 86544333333345799999999999865 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.35 Aligned_cols=207 Identities=29% Similarity=0.414 Sum_probs=181.8
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
-|+..+.||+|+-|.|-.|++. +|+.+|||++.+.. ......+.+|+-+|+-+.||||++++++++...++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3667889999999999999975 79999999997662 2223467789999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|-|.+++..++ ++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+.+||+|||+|....+
T Consensus 93 yv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999998765 7899999999999999999999998 99999999999999999999999999987665
Q ss_pred CCccccccccccccccchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
+.-- ..-+|++-|.|||++.+.+| +.++||||+|||||.|++|+.||+ ++....|...+
T Consensus 165 gklL--eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV 224 (786)
T KOG0588|consen 165 GKLL--ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKV 224 (786)
T ss_pred Cccc--cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHH
Confidence 5432 33589999999999998765 567999999999999999999997 45566666666
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.66 Aligned_cols=202 Identities=25% Similarity=0.339 Sum_probs=172.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.++||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999986 47789999986432 222345788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999996532 25789999999999999999999997 9999999999999999999999999997654
Q ss_pred CCCccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 43332233357999999999986 346788999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=301.72 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=170.5
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
+|.+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 57899999987542 22234566777777766 6899999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998886542 5789999999999999999999997 9999999999999999999999999997543
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 2221 1233568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.65 Aligned_cols=194 Identities=27% Similarity=0.358 Sum_probs=168.2
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.||+|+||.||++... +++.||+|+++... .....++.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 68899999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9998886542 58999999999999999999997 56 999999999999999999999999998754332221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 153 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred -cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 22356899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.68 Aligned_cols=211 Identities=26% Similarity=0.413 Sum_probs=178.4
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecc--ccchhhHHHHHHHHHHHhcCCCceeeEEeEEee-----Cc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-----GN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-----~~ 745 (907)
....|...+.||+|+||.|.+|..+ +|+.||+|++.. ......++-.+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999976 689999999973 355567788999999999999999999998865 24
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
..|+|+|+|+ .+|.+.++.+. .++.+.+..++.|+++||.|+|+.+ |+|||+||+|++++.+...||+|||
T Consensus 100 DvYiV~elMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 6899999995 68999997663 4899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCC-ccccccccccccccchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 002566 826 LAKLYEEDK-THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 893 (907)
Q Consensus 826 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~ 893 (907)
+|+...... ....+..+.|..|.|||++. ...|+..+||||.||++.||++|++-|...+.-++..++
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 999875431 22234567899999999876 568999999999999999999999999766554444443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=292.27 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC----CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999864 356899999986533 334678999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999986542 26899999999999999999999987 99999999999999999999999998765
Q ss_pred ccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 43322211112335678999999999999999999999999999875 999996443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=295.46 Aligned_cols=205 Identities=29% Similarity=0.491 Sum_probs=170.7
Q ss_pred cCCCcCCeeeccCceEEEEEEECC-----------------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKL 737 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~-----------------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l 737 (907)
++|.+.++||+|+||.||+|.+++ +..||+|.+..... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999998642 33699999876533 335679999999999999999999
Q ss_pred EeEEeeCceeEEEeeeccCCchhhhhhcCCc--------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 002566 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT--------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803 (907)
Q Consensus 738 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 803 (907)
++++.+.+..++||||+++|+|.+++..... .....+++..+.+++.||++||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854321 11135788999999999999999999997 999
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh--CCCC
Q 002566 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSN 880 (907)
Q Consensus 804 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt--G~~p 880 (907)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865443221 1222345789999999998889999999999999999997 4556
Q ss_pred CCC
Q 002566 881 TNY 883 (907)
Q Consensus 881 ~~~ 883 (907)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=300.58 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=170.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCC-ceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~LV~ 751 (907)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999976 47889999987542 23345678899999988765 5888999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999998886542 5789999999999999999999997 9999999999999999999999999987532
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 2221 123356899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=301.94 Aligned_cols=194 Identities=28% Similarity=0.434 Sum_probs=167.8
Q ss_pred CeeeccCceEEEEEEEC----CCcEEEEEEecccc----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 682 NKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.||+|+||.||++... +++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 57899999987532 22345677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++|+|.+++.... .+.+..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999886543 5788899999999999999999998 999999999999999999999999998754332
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 22 123356899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=299.59 Aligned_cols=194 Identities=29% Similarity=0.434 Sum_probs=165.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 57889999997542 2233445566666654 5899999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~- 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-
Confidence 99998886542 5889999999999999999999987 99999999999999999999999999976433222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=308.70 Aligned_cols=202 Identities=29% Similarity=0.410 Sum_probs=177.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 68999999997542 234567889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999999987552 6899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCC----------------------------ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDK----------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 0112235689999999999999999999999999999999999999965
Q ss_pred CC
Q 002566 884 RP 885 (907)
Q Consensus 884 ~~ 885 (907)
..
T Consensus 233 ~~ 234 (350)
T cd05573 233 DT 234 (350)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=295.07 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=170.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 688999999875432 223467889999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 56777665432 25788999999999999999999998 99999999999999999999999999975433
Q ss_pred CCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 222 1223467899999999865 45889999999999999999999999654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-34 Score=310.16 Aligned_cols=318 Identities=19% Similarity=0.230 Sum_probs=243.8
Q ss_pred CcceEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhccc-ccccEEEecCCcCCCCCchhcCCCCCCCEE
Q 002566 90 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-LQLVELSVMGNRLSGPFPKVLTNITTLKNL 168 (907)
Q Consensus 90 ~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 168 (907)
..+|++.|+|.+|.|+..-..+++.++.|++||||.|.|+.+..+.|.. .++++|+|++|+|+..-.+.|.++.+|..|
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 4578999999999999777788999999999999999999888888776 589999999999988888888888899999
Q ss_pred EeeCCcCCCCCChhhhcCcccceeeeccccccccCCcc------------------------ccCCCCCCeeecccCccc
Q 002566 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE------------------------LTKLTNLNDLRISDNNFS 224 (907)
Q Consensus 169 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------------~~~l~~L~~L~Ls~N~l~ 224 (907)
.|+.|+++...+..|.+|++|+.|+|..|+|.-..-.+ |..|.++++|+|+.|+++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 99999998666667777888888888888776221223 444555666666666666
Q ss_pred CCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCccccccc-ccceEEcccccccccCCcccc
Q 002566 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303 (907)
Q Consensus 225 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~ 303 (907)
..-..++.++++|+.|+|+.|.|....+++.+..++|+.|+|++|+++..+...+... .|++|+|++|.|...-...|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 5556667777777777777777777777777777777777777777777766666554 677788888887777677777
Q ss_pred CCCCccEEecCCCCCCCCCc---hhhhcCCCCCeEEecCCcCCCCCchhh---hccCCcceeecCCccCCCC--------
Q 002566 304 DMTKLKNIDLSFNNLTGGIP---TTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESS-------- 369 (907)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~L~~~~p~~~---~~~l~~l~ls~N~~~~~~~-------- 369 (907)
.+++|++|||++|.|+..+. ..|.+|++|+.|+|.+|+|. .||+.. ++.++.|||.+|-+....+
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L 441 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL 441 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchh
Confidence 88888888888888875554 35777888888888888887 666655 4567788888887764443
Q ss_pred -------CCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCCCCcccc
Q 002566 370 -------DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYT 415 (907)
Q Consensus 370 -------~p~~C~c~~~~l~~~~~~~~~~l~~~~~~~~~~~~C~~p~~~~~~~ 415 (907)
..+.|||++.|+..|+.... +.......|+.|+.+++++
T Consensus 442 k~Lv~nSssflCDCql~Wl~qWl~~~~-------lq~sv~a~CayPe~Lad~~ 487 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQLKWLAQWLYRRK-------LQSSVIAKCAYPEPLADQS 487 (873)
T ss_pred hhhhhcccceEEeccHHHHHHHHHhcc-------cccceeeeccCCcccccce
Confidence 44789999999999986432 1233467899999999887
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=301.15 Aligned_cols=197 Identities=29% Similarity=0.433 Sum_probs=168.0
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHH---HhcCCCceeeEEeEEeeCceeEEE
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999975 68899999997542 22234566666554 567899999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++|+|...+... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999998887542 5899999999999999999999997 999999999999999999999999998754
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 32222 123356899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=306.33 Aligned_cols=202 Identities=27% Similarity=0.367 Sum_probs=175.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 68899999997542 233456888999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999996542 26899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 44333333356899999999987 456788999999999999999999999543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=300.09 Aligned_cols=193 Identities=25% Similarity=0.379 Sum_probs=167.5
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999976 68899999997642 22345678899999888 799999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 99988885442 6899999999999999999999998 99999999999999999999999999875322211
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 12335789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=299.55 Aligned_cols=194 Identities=28% Similarity=0.445 Sum_probs=167.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 58899999987542 23345677888888765 799999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 99998886543 5889999999999999999999997 99999999999999999999999999875432222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 123356899999999999889999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=298.37 Aligned_cols=202 Identities=24% Similarity=0.443 Sum_probs=176.2
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|++.++||+|+||.||+|.+. ++..+|+|.++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999986 578899998876532 334578899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++.... .+++..+..++.|+++||.|||+.+ +|+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999986542 5788999999999999999999853 399999999999999999999999999976543
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 22 1234689999999999988899999999999999999999999975543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=313.45 Aligned_cols=204 Identities=23% Similarity=0.311 Sum_probs=176.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-C-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999864 3 5778888876555555567888999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++.... ....++++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999998886432 12236889999999999999999999987 9999999999999999999999999998765432
Q ss_pred c-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 T-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 1233456999999999999999999999999999999999999999643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=300.37 Aligned_cols=194 Identities=27% Similarity=0.421 Sum_probs=167.4
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57899999997542 23345677888888765 899999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|...+.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 99998886542 5789999999999999999999998 99999999999999999999999999875433222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 123356899999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=277.89 Aligned_cols=221 Identities=26% Similarity=0.386 Sum_probs=182.5
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
.++.|++.++||+|.|+.||+.... +|+.+|+|.+... +..+.+++.+|+++-+.++|||||++.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567888899999999999998865 6888888887543 344677889999999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CcEEEeecCCc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLA 827 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla 827 (907)
+|+|+|+.|..-+-.+ ...++..+-..++||++||.|+|.++ |||||+||+|+++-+. .-+|++|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999997766543 25688889999999999999999998 9999999999999533 45899999999
Q ss_pred ccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--HHhhccccc
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA--YVLQEEEIY 905 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~--~~~~~~~~~ 905 (907)
.....+ ......+|||+|||||++...+++..+|||+.||+||-|+.|..||-. ++...+.+-+ ........+
T Consensus 161 i~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 161 IEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred EEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCCcc
Confidence 988733 333456899999999999999999999999999999999999999953 2334444432 333444455
Q ss_pred CC
Q 002566 906 WS 907 (907)
Q Consensus 906 ~~ 907 (907)
|+
T Consensus 236 w~ 237 (355)
T KOG0033|consen 236 WD 237 (355)
T ss_pred cC
Confidence 64
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=296.61 Aligned_cols=195 Identities=31% Similarity=0.452 Sum_probs=166.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 47899999997642 2234456677777775 5999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||++........
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 99999886532 5789999999999999999999997 99999999999999999999999999875332221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 1223568999999999998899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=298.07 Aligned_cols=194 Identities=26% Similarity=0.377 Sum_probs=167.5
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 57899999997643 22345678899988887 699999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 99988885442 5899999999999999999999997 99999999999999999999999999875322211
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 123356899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=291.28 Aligned_cols=191 Identities=23% Similarity=0.333 Sum_probs=165.9
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccchh---hHHHHHHHHHHHhcCCCceeeEEeEEee----CceeEEEeee
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEY 753 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~---~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV~E~ 753 (907)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|++++.+++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 47899999999999998 68899999997653322 4678899999999999999999999876 3467999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
+++|+|.+++.... .+++....+++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 104 CTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999997542 578999999999999999999985 5 77999999999999999999999999986543
Q ss_pred CCccccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 22 12357899999999976 67899999999999999999999999754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=299.42 Aligned_cols=192 Identities=27% Similarity=0.392 Sum_probs=166.2
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 57899999997642 23345577888888766 899999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|..++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 99988875442 6899999999999999999999997 99999999999999999999999999875432221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 1233578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=286.68 Aligned_cols=201 Identities=28% Similarity=0.509 Sum_probs=173.7
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|++.+.||+|+||.||+|.+.++..+|+|.+... .....+|.+|++++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999988889999988643 2335678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999986542 25789999999999999999999997 99999999999999999999999999986543322
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22222345678999999988889999999999999999999 89998644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.96 Aligned_cols=199 Identities=27% Similarity=0.396 Sum_probs=170.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 751 (907)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999975 68899999987542 223456778888888775 577888999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999886543 5899999999999999999999997 9999999999999999999999999987543
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 3221 122356899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.00 Aligned_cols=194 Identities=30% Similarity=0.419 Sum_probs=166.1
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
++||+|+||.||+|+.. +++.||+|.++... ......+..|.+++.. .+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999986 58899999997542 2234456677777765 5899999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 99998886542 5789999999999999999999997 99999999999999999999999999875322221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=289.91 Aligned_cols=201 Identities=31% Similarity=0.416 Sum_probs=173.8
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 68899999986542 2223457889999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988864321 35899999999999999999999997 99999999999999999999999999987543
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 322 123468999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=299.29 Aligned_cols=194 Identities=29% Similarity=0.420 Sum_probs=165.4
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +|+.||+|++.... .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 68999999996542 223345555554 56779999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|..++.... .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 99988886442 6899999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 223456899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=300.39 Aligned_cols=196 Identities=31% Similarity=0.491 Sum_probs=165.2
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+|+..++||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456789999999999999975 689999999965433 33467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+.. ...+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999986432 3466788899999999999999997 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....||..|+|||++.. ...+.++|||||||++|||++|+.||....
T Consensus 223 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 223 DP-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred cc-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223468999999998743 334568999999999999999999997443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=288.74 Aligned_cols=196 Identities=30% Similarity=0.419 Sum_probs=168.6
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||+||++... +++.||+|++..... ...+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999975 688999999865422 2235677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++.... .....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 88875432 12236899999999999999999999997 999999999999999999999999999866543322 22
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.20 Aligned_cols=201 Identities=26% Similarity=0.467 Sum_probs=166.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC--CCcEEEEEEeccccch--hhHHHHHHHHHHHhc---CCCceeeEEeEEee-----
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVE----- 743 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~--~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~----- 743 (907)
++|.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 4678999998654322 234566677766654 79999999999853
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
....++||||++ ++|.+++..... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 346899999997 588888864322 25889999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
||+++...... ......|++.|+|||++....++.++|||||||++|||++|++||....
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99998665432 2233568999999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.84 Aligned_cols=194 Identities=28% Similarity=0.430 Sum_probs=165.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999986 68999999987542 222344555554 56789999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 99998886542 5789999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 223456899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=284.66 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=178.5
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
|+++++||+|+||.||||.++ .|+++|+|++... .+.+++..|+.++++.+.|++|++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667899999999999999986 5999999999754 4568899999999999999999999999988899999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
||..+.++.+. .++.+.++..+.+..++||+|||... -||||||+.|||++.+|.+|++|||.|-.+.+.-..
T Consensus 113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999997654 37999999999999999999999875 799999999999999999999999999877654333
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
. ..+.||+.|||||++..-.|..++||||+|+...||..|++|+...++
T Consensus 186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 2 346799999999999999999999999999999999999999865544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=302.47 Aligned_cols=192 Identities=23% Similarity=0.308 Sum_probs=167.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
++|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++|||||++++++...+..++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999975 68899999753 235678999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
. ++|..++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 166 ~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 K-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 6 67877775432 5789999999999999999999997 9999999999999999999999999997543322
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 222234579999999999999999999999999999999999998864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.59 Aligned_cols=199 Identities=26% Similarity=0.444 Sum_probs=167.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceeE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLL 748 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~ 748 (907)
+|++.+.||+|+||.||+|... +++.||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 6899999998753 223345788999999999999999999988643 2479
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||++ ++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 67888875442 5899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 829 LYEEDKT--HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 829 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 6533221 11233568999999999875 67899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=285.58 Aligned_cols=203 Identities=31% Similarity=0.516 Sum_probs=175.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888899999986543 33568899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++.... ...+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999986542 235788999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 222222345778999999998889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.99 Aligned_cols=194 Identities=28% Similarity=0.404 Sum_probs=164.1
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHH-HHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEI-GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999976 57789999987542 12233444444 456789999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 99999886542 5778899999999999999999998 99999999999999999999999999975432222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 223456999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=288.08 Aligned_cols=202 Identities=32% Similarity=0.439 Sum_probs=180.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
.+.|+.-++||+|+||.||-++.+ +|+.+|.|++.++ .++.+...++|-.|+.+++.+.||.+-..++..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456788899999999999999865 6999999988655 345566678899999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|..|.||+|.-+|+..+. ..+++..++-.+.+|+.||++||.+. ||.||+||+|||+|+.|+++|+|+|+|..+
T Consensus 264 LtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999977653 36899999999999999999999997 999999999999999999999999999988
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....... ..+||.+|||||++..+.|+...|.||+||++|||+.|+.||..+
T Consensus 338 ~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 338 PEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 7665432 238999999999999999999999999999999999999999543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=301.75 Aligned_cols=207 Identities=28% Similarity=0.433 Sum_probs=172.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEE------CCCcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCce
Q 002566 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 746 (907)
.++|++.++||+|+||.||+|.+ .++..||||+++... ....+.+.+|++++..+ +|||||+++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999974 235689999997543 33445788999999999 89999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcc---------------------------------------------------------
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 769 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 769 (907)
.++||||+++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998653210
Q ss_pred -------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 770 -------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 770 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0125789999999999999999999987 999999999999999999999999999866443221
Q ss_pred c-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 837 I-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 837 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1 112234678999999999999999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.34 Aligned_cols=194 Identities=27% Similarity=0.413 Sum_probs=164.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHH-HHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
++||+|+||.||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999986 58899999986542 122344555554 67889999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|...+.... .+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 99988885432 5788899999999999999999987 99999999999999999999999999875432221
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 223456899999999999888999999999999999999999999543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=297.24 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=183.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-eEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-LLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~LV~ 751 (907)
++|...+++|+|+||.++..+.+ +++.+++|.+.... ....+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999998875 57789999886553 2334467889999999999999999999999998 89999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
+|++||++.+.+...+ ...++++++..++.||+.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997665 246899999999999999999999886 9999999999999999999999999999998
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 895 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~ 895 (907)
..... ....+||+.||+||.+.+.+|..|+|||||||++|||.+=+++|... +...|+.-
T Consensus 158 ~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~k 217 (426)
T KOG0589|consen 158 PEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILK 217 (426)
T ss_pred Cchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHH
Confidence 77533 33468999999999999999999999999999999999999999543 34455444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=302.11 Aligned_cols=208 Identities=30% Similarity=0.455 Sum_probs=172.6
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
..++|++.+.||+|+||.||+|.+. ++..||||+++.... .....+.+|+++++++ +|+|||+++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999999852 245799999976533 3345688999999999 8999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCc---------------------------------------------------------
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDT--------------------------------------------------------- 768 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 768 (907)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998854311
Q ss_pred --------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc-ccc
Q 002566 769 --------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-IST 839 (907)
Q Consensus 769 --------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 839 (907)
....++++.++.+++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 01125788999999999999999999987 999999999999999999999999999865433221 111
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
...++..|||||++.+..++.++|||||||++|||++ |+.||...
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 2235678999999998899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=316.75 Aligned_cols=206 Identities=24% Similarity=0.397 Sum_probs=174.9
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.++||+|+||.||+|... +++.||+|++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999976 58899999997542 223467899999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCc------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 752 EYMKNNCLSRAIFGKDT------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
||+++|+|.+++..... ......++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 11234677889999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCc-----------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 826 LAKLYEEDKT-----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 826 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+++....... .......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9986621110 0111246999999999999999999999999999999999999999653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=293.47 Aligned_cols=194 Identities=29% Similarity=0.437 Sum_probs=167.3
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999986 57899999997542 23345677888888877 799999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99998886543 5899999999999999999999997 99999999999999999999999999875322222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 122346899999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=269.78 Aligned_cols=207 Identities=27% Similarity=0.320 Sum_probs=176.7
Q ss_pred hcCCCcCCeeeccCceEEEEEE-ECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eeE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 748 (907)
.++|.+.+++|+|||+.||.++ ..+++.+|+|++.-.+.++.+..++|++..++++||||++++++...+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 5689999999999999999999 5678999999998877778888999999999999999999999876533 489
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
|+++|...|+|.+.+...+.+ ...+++.++++|+.++++||++||+.. ++++||||||.|||+.+++.+++.|||.++
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999998765432 336899999999999999999999986 479999999999999999999999999987
Q ss_pred cccCCCccc--------cccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 829 LYEEDKTHI--------STRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 829 ~~~~~~~~~--------~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...-.-... ...-..|..|.|||.+. +...+.++|||||||+||+|+.|..||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 653221110 11123689999999886 45689999999999999999999999964
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=299.52 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=170.7
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eeE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 748 (907)
+|+..+.||+|+||.||+|... +++.||+|++... .....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 6899999998653 2234567889999999999999999999998776 789
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||+. ++|.+.+.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 56777765432 6899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
..............+++.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 7654433333334678999999998864 578999999999999999999999965543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.56 Aligned_cols=212 Identities=25% Similarity=0.320 Sum_probs=178.5
Q ss_pred CCCcCCeeeccCceEEEEEEECC-CcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
+|+..+.||+|.-|+||.+++++ +..+|+|++.+.. ++...+.+.|-++|+.++||.++.+|+.++.++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34556889999999999999875 5889999998764 3344567789999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
||+||+|..+.+.+... .+++..++-++..++-||+|||-.| ||+|||||+||||.++|++-|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999876543 7899999999999999999999998 99999999999999999999999998743211
Q ss_pred ---------------------------------CCc----------------------cccccccccccccchhhhccCC
Q 002566 833 ---------------------------------DKT----------------------HISTRIAGTIGYMAPEYAMRGY 857 (907)
Q Consensus 833 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~l~~~~ 857 (907)
... ..+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112267999999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 858 LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 858 ~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
.+.++|+|+|||++|||+.|+.||..... .+.+.+.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl~NIv 348 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN--KETLRNIV 348 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc--hhhHHHHh
Confidence 99999999999999999999999965433 34444443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=298.08 Aligned_cols=194 Identities=28% Similarity=0.396 Sum_probs=168.7
Q ss_pred CeeeccCceEEEEEEE----CCCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~----~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
+.||+|+||.||++.. .+|+.||+|+++.... .....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3578999999975432 233457789999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999886542 5899999999999999999999997 99999999999999999999999999986544322
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 122356899999999999888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=292.87 Aligned_cols=202 Identities=30% Similarity=0.555 Sum_probs=171.0
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCc----EEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~----~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999987543 34467889999999999999999999999865 5679
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
|+||+++|+|.+++.... ..+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999997643 25789999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcccc-ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 830 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 654332211 11234678999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=282.82 Aligned_cols=202 Identities=29% Similarity=0.502 Sum_probs=174.0
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999998877789999987543 334679999999999999999999999999889999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++..... .+++..+++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999865422 5799999999999999999999997 99999999999999999999999999886544332
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 21222335678999999998889999999999999999998 999986544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=318.64 Aligned_cols=208 Identities=28% Similarity=0.348 Sum_probs=187.0
Q ss_pred HHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002566 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (907)
Q Consensus 668 ~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 743 (907)
.++++...++|.++++||+|+||.|..++.+ .++.||+|++.+. .+....-|.+|-.+|.-.+.+-||+++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455666789999999999999999999986 5889999999763 34556678999999999999999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
++.+|+|||||+||+|-.++...+ +++++-++.++..|+-||.-||+.| +|||||||.|||+|..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 999999999999999999996653 6889999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhc----c-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAM----R-GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
||.+-.+..++.-.+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999988877766667788999999999996 2 5799999999999999999999999953
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=290.27 Aligned_cols=204 Identities=25% Similarity=0.412 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...++||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 578899999875432 2334678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++ +|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 985 7777775432 25788999999999999999999997 999999999999999999999999999765433
Q ss_pred Cccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 888 (907)
... .....+++.|+|||++.+ ..++.++||||+|+++|||++|+.||......+
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 221 122457899999998865 468899999999999999999999997654433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=285.23 Aligned_cols=199 Identities=38% Similarity=0.624 Sum_probs=167.0
Q ss_pred cCCeeeccCceEEEEEEEC-----CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 680 PANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~-----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 256899999966433 3478899999999999999999999999988889999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++|+|.+++.... ...+++.++.+|+.||++||+|||+++ ++||||+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999998762 126899999999999999999999987 999999999999999999999999999876322
Q ss_pred Cc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 834 KT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 834 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
.. ...........|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 21 12222346789999999999989999999999999999999 78888554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=281.65 Aligned_cols=203 Identities=31% Similarity=0.529 Sum_probs=175.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998888899999987543 33567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++.... ...+++..+.+++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999986543 236899999999999999999999997 9999999999999999999999999998765332
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 211111223468999999998899999999999999999999 99998543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.34 Aligned_cols=193 Identities=31% Similarity=0.435 Sum_probs=166.6
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||.||++... +|+.||+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 152 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--IT 152 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--ee
Confidence 988865432 25889999999999999999999987 99999999999999999999999999987654322 22
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=285.71 Aligned_cols=207 Identities=32% Similarity=0.526 Sum_probs=176.2
Q ss_pred cCCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998643 478999999766444 4578999999999999999999999999999999
Q ss_pred EEeeeccCCchhhhhhcCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 749 LVYEYMKNNCLSRAIFGKDT---------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
+||||+++++|.+++...+. .....+++.++..++.|++.|+.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999976432 12235889999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 820 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 820 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999976533221 11223346788999999999999999999999999999998 999985443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=280.70 Aligned_cols=201 Identities=30% Similarity=0.511 Sum_probs=172.3
Q ss_pred CCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+|++.+.||+|+||.||+|.++++..+|+|.+.... ....+|.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998877889999986433 2345788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
++|.+++..... .+++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.++........
T Consensus 84 ~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999875432 5799999999999999999999998 999999999999999999999999999865433222
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 1111224568999999998899999999999999999999 899986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=308.13 Aligned_cols=208 Identities=24% Similarity=0.336 Sum_probs=175.8
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc---
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 745 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--- 745 (907)
....++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++..++|+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999864 6899999998654 2344567889999999999999999988775432
Q ss_pred -----eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEE
Q 002566 746 -----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (907)
Q Consensus 746 -----~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 820 (907)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 36899999999999999865422 2246899999999999999999999987 99999999999999999999
Q ss_pred EeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 821 ISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 821 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987653321 122345799999999999999999999999999999999999999964
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=292.43 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=178.9
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccch---hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 748 (907)
....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... +.....+|+++|+++. |||||.+.+.+.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999999874 999999999776443 3457889999999998 999999999999999999
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CcEEEeec
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDF 824 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DF 824 (907)
+|||++.+|.|.+.+... .+++..+..++.|++.|++|||+.+ |+|||+||+|+|+... +.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999998655 2789999999999999999999988 9999999999999543 57999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
|++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 99998877 223455789999999999999999999999999999999999999996544
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=283.50 Aligned_cols=200 Identities=29% Similarity=0.389 Sum_probs=172.9
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999975 688999999865432 2234578899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999988865422 26899999999999999999999987 999999999999999999999999999765433
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....|+..|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 22 123468999999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.81 Aligned_cols=207 Identities=32% Similarity=0.539 Sum_probs=173.8
Q ss_pred cCCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++|++.+.||+|+||.||+|.... ...||+|.++.... ....+|.+|++++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999998643 25799999875433 33457899999999999999999999999989999
Q ss_pred EEeeeccCCchhhhhhcCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 817 (907)
++|||+++|+|.+++....... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999986542211 136889999999999999999999997 99999999999999999
Q ss_pred cEEEeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 818 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 818 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.+||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999986543321 12223456788999999998889999999999999999998 999986443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.62 Aligned_cols=201 Identities=27% Similarity=0.462 Sum_probs=173.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.+|.+.+.||+|+||.||+|.+. .++.||+|.+... .....++.+|++++.+++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999976 5888999998754 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999865432 25899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 222122234678999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=282.49 Aligned_cols=199 Identities=30% Similarity=0.411 Sum_probs=172.4
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|+..+.||+|+||.||++... +++.||||.+..... .....+.+|+.++++++|++++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999976 688999999865422 2234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999998864322 25889999999999999999999987 999999999999999999999999999765433
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 156 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 156 QTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ccc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 221 2246899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=282.47 Aligned_cols=205 Identities=29% Similarity=0.511 Sum_probs=179.6
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
...+|+..++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999988999999999877665667889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ..+++.++.+++.|+++|+.|||+.+ ++||||||+||++++++.+||+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999976432 25899999999999999999999997 999999999999999999999999999876443
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
... .....++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 221 112345778999999998889999999999999999998 899996543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=283.61 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=173.7
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
.+++|+..+.||+|+||.||+|.+. .+..||+|++.... .....+|.+|+.+++.++||||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999863 24679999986543 2345678999999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 821 (907)
.++||||+++|+|.+++...... .....++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 1234688899999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 822 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999997654332211 112345788999999998889999999999999999999 78888544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=296.31 Aligned_cols=207 Identities=27% Similarity=0.410 Sum_probs=172.7
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~ 745 (907)
..++|.+.++||+|+||.||+|.+.. +..||||+++.... ...+.+.+|+++++++. |||||++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678889999999999999998631 34799999975533 33457899999999996 999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (907)
..++||||+++|+|.++++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988653210
Q ss_pred -----------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 002566 770 -----------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (907)
Q Consensus 770 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 814 (907)
....+++.++.+++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124788899999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 815 KDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 815 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999999999998654332211 122346788999999998889999999999999999997 9899854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=282.67 Aligned_cols=205 Identities=30% Similarity=0.505 Sum_probs=171.9
Q ss_pred cCCCcCCeeeccCceEEEEEEE-----CCCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-----~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++|++.++||+|+||.||+|.+ ..++.||+|.+.... .....+|.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999985 246789999997543 3334678899999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 002566 750 VYEYMKNNCLSRAIFGKDT------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 817 (907)
||||+++++|.+++..... .....+++.+++.++.|++.||+|||+++ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999854321 11235789999999999999999999997 99999999999999999
Q ss_pred cEEEeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 818 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 818 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986543321 11222345778999999988889999999999999999998 9988854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=273.77 Aligned_cols=205 Identities=28% Similarity=0.352 Sum_probs=180.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch---hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
-++|+..++||+|.||+|-.++-+ .++.+|+|+++++.-- ....-+.|-++|+..+||.+..+...++..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468899999999999999999865 6899999999887432 234456789999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+.||.|.-+|.... .++++..+..-..|+.||.|||+++ ||.||+|.+|.|+|.||++||+|||+++..
T Consensus 247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999998886543 6788899999999999999999987 999999999999999999999999999865
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 888 (907)
-.... ....++||+.|.|||++....|...+|.|.+||++|||++|+.||...+.+.
T Consensus 319 I~~g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 319 IKYGD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred ccccc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 44333 3345899999999999999999999999999999999999999997665443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.44 Aligned_cols=206 Identities=33% Similarity=0.539 Sum_probs=175.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999852 345689999977665566789999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002566 750 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 821 (907)
||||+++++|.+++..... .....+++.+++.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999999865431 11235899999999999999999999997 999999999999999999999
Q ss_pred eecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 822 SDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 822 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986543322 11222345778999999998889999999999999999998 89998544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.48 Aligned_cols=202 Identities=30% Similarity=0.521 Sum_probs=172.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999988888899999976433 3467899999999999999999999875 45688999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++.++++++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999975432 25799999999999999999999997 9999999999999999999999999998765433
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 222222335678999999988889999999999999999999 88888543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=279.59 Aligned_cols=202 Identities=30% Similarity=0.498 Sum_probs=173.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC----CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.++|++.+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++++++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999999753 4579999987653 3345678999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++++|.+++..... .+++..+.+++.|++.|++|||+++ |+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999865432 6899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 830 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 830 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 75222211 112235678999999998889999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=297.65 Aligned_cols=202 Identities=29% Similarity=0.479 Sum_probs=172.6
Q ss_pred CcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ceeEEE
Q 002566 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLLV 750 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~LV 750 (907)
...+.||+||||.||+|+++ .|+.||||.+..... ...+...+|++++++++|+|||++.+.-.+. +...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34678999999999999965 699999999987643 3345667899999999999999999876543 357899
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCc--EEEeecCC
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLN--AKISDFGL 826 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~--~kl~DFGl 826 (907)
||||.+|||...+..... ...+++.+.+.+..+++.||.|||+++ |+||||||.||++- ++|. -||+|||.
T Consensus 96 mEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999966533 347999999999999999999999998 99999999999983 4443 59999999
Q ss_pred cccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 887 (907)
|+...++. ....++||..|.+||++.. +.|+..+|.|||||++||.+||..||......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99887765 3355789999999999995 88999999999999999999999999665544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=304.24 Aligned_cols=205 Identities=24% Similarity=0.292 Sum_probs=173.1
Q ss_pred cCCCcCCeeeccCceEEEEEEECCC-cEEEEEEeccccchhhHHHHHHHHHHHhcC-CCceeeEEeEE-ee------Cce
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCC-VE------GNQ 746 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g-~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~-~~------~~~ 746 (907)
.++++.+.|.+|||+.||.|....+ ..||+|++-.......+...+|+++|+.++ |+|||.+++.. .. .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456789999999999999998766 999999998888888889999999999997 99999999932 21 236
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.+|.||||.+|+|-+++..+.. ..|++.++++|+.|+++|+.+||... +||||||||-+||||+.++..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 7999999999999999975432 25999999999999999999999985 6799999999999999999999999999
Q ss_pred cccccCCCc-cc-------cccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 827 AKLYEEDKT-HI-------STRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~-~~-------~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|.-...... .. ......|+.|+|||++. +..+++|+|||||||+||-|+....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 974332221 10 01123689999999884 678999999999999999999999999654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=278.44 Aligned_cols=198 Identities=27% Similarity=0.440 Sum_probs=172.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57889999999999999999974 68899999997665555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++.... ++++..+..++.|+++|++|||+.+ |+||||+|+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999886432 5789999999999999999999987 9999999999999999999999999998664332
Q ss_pred ccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
.. .....|+..|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 21 12245889999999884 3457889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=300.40 Aligned_cols=217 Identities=33% Similarity=0.506 Sum_probs=187.7
Q ss_pred CCcCCeeeccCceEEEEEEEC-CC----cEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g----~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+..++||+|+||+||||.|- .| -+||+|++... ..+...++++|+.+|.+++|||+++++|+|..+. +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345689999999999999973 33 36899988655 4556789999999999999999999999999876 88999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
+||+.|+|.++++.++ ..+.....+.+..|||+||.|||++. ++||||.++|||+.+-..+||.|||+|+...
T Consensus 777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999997754 36888999999999999999999886 9999999999999999999999999999888
Q ss_pred CCCcccccc-ccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhcc
Q 002566 832 EDKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEE 902 (907)
Q Consensus 832 ~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 902 (907)
.+....... ..-.+.|||-|.+....++.++|||||||++||++| |..|+...+.+++..+.+--..+-+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP 922 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence 776554432 334678999999999999999999999999999999 99999998888888887765444443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=276.79 Aligned_cols=201 Identities=30% Similarity=0.442 Sum_probs=173.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-----hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-----~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++|...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999975 688999999864421 223568889999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++++|.+++.... .+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999886542 5788999999999999999999997 99999999999999999999999999976
Q ss_pred ccCCCcccc--ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 543222111 2345788999999999888999999999999999999999998543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=278.63 Aligned_cols=202 Identities=30% Similarity=0.507 Sum_probs=171.7
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.++||+|+||.||+|.+.++..||+|+++.... ...+|.+|++++++++||||+++++.+. ++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356888999999999999999987777899999975432 3457899999999999999999999875 45679999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999965321 25789999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||+..+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 222222346778999999988889999999999999999999 88888543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=294.87 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=171.0
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcC-C-----CceeeEEeEEeeCce
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-H-----PNLVKLYGCCVEGNQ 746 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~ 746 (907)
..-+|.+.+.||+|.||.|.||... +++.||||+++... .-.++-..|+.+|..++ | -|+|++++++...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3347899999999999999999965 68999999998653 33456678999999987 4 379999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CcEEEeec
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDF 824 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DF 824 (907)
+|||+|.++ -+|.+++..+... .++...++.|+.||+.||..||+.+ |||+||||+||||.+- ..+||+||
T Consensus 263 lciVfELL~-~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 999999996 5899999876543 5899999999999999999999998 9999999999999654 47999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|.|....+... ...-+..|.|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus 336 GSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 336 GSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 99997665433 34568899999999999999999999999999999999776743
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=282.38 Aligned_cols=206 Identities=31% Similarity=0.525 Sum_probs=175.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.+|...+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999853 345789999877666666789999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 750 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
||||+++++|.+++..... .....+++..++.++.|++.|++|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975432 11235899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999986544322 11223456789999999998899999999999999999999 99998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=282.76 Aligned_cols=199 Identities=26% Similarity=0.527 Sum_probs=176.0
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.+|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999964 68899999998766666677889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999988543 4788999999999999999999997 9999999999999999999999999988654432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 12346889999999999888899999999999999999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=280.12 Aligned_cols=202 Identities=30% Similarity=0.461 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCc----EEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++|++.+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999974 344 477888754432 234567788889999999999999998764 45788
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
++||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997543 25899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 830 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 6443221 1223456789999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=298.60 Aligned_cols=200 Identities=24% Similarity=0.349 Sum_probs=162.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--------c
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--------N 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------~ 745 (907)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999975 58899999885432 2345799999999999999999876432 2
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEeec
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDF 824 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DF 824 (907)
.+++||||+++ ++.+++.... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 46789999985 6666654321 11236899999999999999999999998 99999999999999665 7999999
Q ss_pred CCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
|+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 216 Gla~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876543322 23468999999999875 468999999999999999999999996544
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=283.26 Aligned_cols=199 Identities=26% Similarity=0.451 Sum_probs=172.9
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|++.+.||+|+||.||++... ++..+|+|.++.... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999976 578899998875432 3345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... .+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999996542 5789999999999999999999842 3999999999999999999999999998765332
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 12346889999999998888999999999999999999999998543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=275.47 Aligned_cols=202 Identities=32% Similarity=0.490 Sum_probs=176.4
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|...+.||+|++|.||+|... +++.|++|.+... ......++.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677899999999999999976 6889999998643 334567789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999997642 236889999999999999999999987 999999999999999999999999999876544
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....|++.|+|||+..+..++.++|+||||++++||++|+.||....
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 322 223468899999999998889999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=273.53 Aligned_cols=196 Identities=30% Similarity=0.456 Sum_probs=168.4
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchh
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 760 (907)
++||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888999999998765433 3456889999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccccc
Q 002566 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840 (907)
Q Consensus 761 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 840 (907)
+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9886543 25789999999999999999999987 9999999999999999999999999997644332211112
Q ss_pred ccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 841 ~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
..++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 234678999999998889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=279.25 Aligned_cols=193 Identities=25% Similarity=0.425 Sum_probs=169.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...++||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 68899999986543 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999986542 4678899999999999999999997 999999999999999999999999999865433
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2 1234689999999999988899999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=276.39 Aligned_cols=202 Identities=31% Similarity=0.533 Sum_probs=173.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.++||+|+||.||+|..++++.||+|.+..... ...++.+|++++++++|+||+++++++. ++..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467888999999999999999998899999999875433 3467899999999999999999999864 55789999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999998865432 36899999999999999999999987 9999999999999999999999999998765332
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 222222345778999999998889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=264.88 Aligned_cols=199 Identities=28% Similarity=0.442 Sum_probs=172.3
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc----hh----hHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR----QG----NREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~----~~----~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 744 (907)
-++|...+.+|+|..+.|-+...+ +|+.+|+|++..... .. .+.-..|+.+|+++ -||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456788899999999999988865 688899998854321 11 12345688999885 699999999999999
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
..+++|+|.|+.|.|.++|... ..+++++.++|++|+.+|++|||.+. ||||||||+|||+|++.++||+||
T Consensus 96 sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999654 36899999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhcc------CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|+|..+.++..- ...+||++|.|||.+.. ..|+..+|+||+||+||.|+.|-+||-.
T Consensus 168 GFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 168 GFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred ceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 999988776542 45799999999999864 3588899999999999999999999843
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=277.36 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=165.7
Q ss_pred CeeeccCceEEEEEEECC---CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~---g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 45799998876543 33457889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.+++...........++..+.+++.|+++|++|||+.+ ++||||||+||++++++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997643322335678888999999999999999997 9999999999999999999999999997544332211
Q ss_pred -cccccccccccchhhhccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 838 -STRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 838 -~~~~~gt~~y~aPE~l~~~-------~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.....++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1234578889999998642 35789999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.47 Aligned_cols=200 Identities=25% Similarity=0.376 Sum_probs=163.2
Q ss_pred CeeeccCceEEEEEEECC---CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~---g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
++||+|+||.||+|...+ ...+|+|.+..... .....|.+|++.++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999998543 35788888765433 33567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.+++...........++..+.+++.||++|++|||+.+ |+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997654332234578889999999999999999997 9999999999999999999999999987543322111
Q ss_pred -cccccccccccchhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 838 -STRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 838 -~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122345778999998753 356889999999999999999 77887543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=274.90 Aligned_cols=203 Identities=33% Similarity=0.547 Sum_probs=175.7
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.++||+|+||.||+|...+++.||||.+.... ....++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788999999999999999998888899999987543 33567899999999999999999999999888999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++..+..++.|++.|++|||+++ ++||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999976432 25899999999999999999999997 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211122234568999999998889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=290.52 Aligned_cols=198 Identities=26% Similarity=0.368 Sum_probs=168.1
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----- 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----- 745 (907)
..++|...+.||+|+||.||++... +++.||+|++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999975 5889999998654 2334567889999999999999999999986543
Q ss_pred -eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 746 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
..++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 47999999976 45555532 4688899999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9997643322 123356899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=292.02 Aligned_cols=192 Identities=28% Similarity=0.386 Sum_probs=161.2
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhc---CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
||+|+||.||+|... +++.||||++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 588999999865322 2233455666666654 799999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 99998886542 5889999999999999999999998 99999999999999999999999999975433222
Q ss_pred ccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 12335699999999998754 4789999999999999999999998543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=273.70 Aligned_cols=197 Identities=27% Similarity=0.445 Sum_probs=166.9
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 68899999886543 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccc-
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS- 838 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 838 (907)
.+++.... ..+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99986542 25789999999999999999999997 99999999999999999999999999986543221111
Q ss_pred ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 839 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 11123567999999998889999999999999999998 888886443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=280.27 Aligned_cols=199 Identities=28% Similarity=0.529 Sum_probs=176.4
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367889999999999999999974 6899999999776555567788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999988543 4788999999999999999999987 999999999999999999999999999865443
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 321 1234578899999999988899999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=288.09 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=171.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEee-Cc
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-GN 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~-~~ 745 (907)
.++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457889999999999999999742 247899999975432 2345678899999999 89999999998865 45
Q ss_pred eeEEEeeeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (907)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988643210
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc-ccccccccccc
Q 002566 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYM 848 (907)
Q Consensus 770 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 848 (907)
...++++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0126899999999999999999999987 9999999999999999999999999998764433221 12234577899
Q ss_pred chhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 849 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 849 aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=274.73 Aligned_cols=198 Identities=33% Similarity=0.521 Sum_probs=171.8
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhH--HHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~--~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
|+..+.||+|+||+||++... +++.||+|.+......... ...+|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 4668999999876543322 3456999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... ..+++..+..++.|+++||++||+.+ |+||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999722 26799999999999999999999997 9999999999999999999999999998652222
Q ss_pred ccccccccccccccchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. ......++..|+|||++. +..++.++||||+|+++++|++|+.||...
T Consensus 153 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 E-NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp S-EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred c-ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2 223456899999999998 888999999999999999999999999755
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=273.24 Aligned_cols=195 Identities=28% Similarity=0.467 Sum_probs=163.6
Q ss_pred eeeccCceEEEEEEEC---CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCc
Q 002566 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~---~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 758 (907)
.||+|+||.||+|.+. ++..||+|++..... ...++|.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999874 355799999876543 33467899999999999999999999885 457899999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccc
Q 002566 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838 (907)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 838 (907)
|.+++.... ..+++..+++++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999986532 26899999999999999999999997 99999999999999999999999999986544332111
Q ss_pred --ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 839 --TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 839 --~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
....++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11223578999999988889999999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=273.81 Aligned_cols=200 Identities=31% Similarity=0.506 Sum_probs=170.4
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|.+.+.||+|++|.||+|.+.++..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998877789999886543 23467889999999999999999998875 456889999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999975432 25789999999999999999999987 99999999999999999999999999987644332
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22222345678999999998889999999999999999999 8989854
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=277.13 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999975 58899999987665555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++.... .+++.+++.++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999886543 5889999999999999999999997 9999999999999999999999999987654332
Q ss_pred ccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 2 122346899999999874 45688899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=300.40 Aligned_cols=203 Identities=23% Similarity=0.313 Sum_probs=165.2
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCC------CceeeEEeEEee
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH------PNLVKLYGCCVE 743 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H------~nIv~l~g~~~~ 743 (907)
+...+++|.+.++||+|+||+||+|... .++.||||+++... ...+++..|+++++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445788999999999999999999975 57889999996432 223455667777766654 458999998876
Q ss_pred C-ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCC----
Q 002566 744 G-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL---- 817 (907)
Q Consensus 744 ~-~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~---- 817 (907)
+ +..++|||++ +++|.+++.... .+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 4 5788999988 667888776442 689999999999999999999974 6 99999999999998765
Q ss_pred ------------cEEEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 818 ------------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 818 ------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4999999988643221 234579999999999999999999999999999999999999997654
Q ss_pred Cc
Q 002566 886 NE 887 (907)
Q Consensus 886 ~~ 887 (907)
..
T Consensus 350 ~~ 351 (467)
T PTZ00284 350 NL 351 (467)
T ss_pred hH
Confidence 43
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=278.77 Aligned_cols=205 Identities=32% Similarity=0.481 Sum_probs=170.9
Q ss_pred CCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+|.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999863 235789998875543 335678899999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 002566 750 VYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 810 (907)
||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998864211 11235889999999999999999999987 9999999999
Q ss_pred EEEcCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 811 VLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 811 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998654332211 122345678999999988889999999999999999998 99998544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=280.10 Aligned_cols=200 Identities=28% Similarity=0.530 Sum_probs=176.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999864 68899999997665555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... .+++.++..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999988543 5789999999999999999999997 9999999999999999999999999988665433
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 123458889999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=291.41 Aligned_cols=193 Identities=33% Similarity=0.465 Sum_probs=171.4
Q ss_pred CeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchh
Q 002566 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 760 (907)
-++|+|.||+||.|++.+ ...+|||.+........+.+.+|+...+.++|.|||+++|.|.+++.+-+.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999765 5579999998887777889999999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCcccccCCCccc
Q 002566 761 RAIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 761 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
++++...+ ++ .+..+-....||++||.|||++. |||||||-.|||++ ..|.+||+|||-++.+..-.. .
T Consensus 661 sLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~ 732 (1226)
T KOG4279|consen 661 SLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-C 732 (1226)
T ss_pred HHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-c
Confidence 99987754 44 67788889999999999999997 99999999999996 579999999999987754332 3
Q ss_pred cccccccccccchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 838 STRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 838 ~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
...+.||..|||||++..+ .|++.+|||||||++.||.|||+||.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 3446799999999999865 58999999999999999999999994
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=277.15 Aligned_cols=209 Identities=31% Similarity=0.429 Sum_probs=173.3
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
.+++|.+.+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999999753 5678999886543 3334578999999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---cEEE
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKI 821 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl 821 (907)
.++||||+++++|.+++..... .....+++..+++++.||++|++|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 11235899999999999999999999997 99999999999998754 5999
Q ss_pred eecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 822 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998763322111 112234568999999998899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=292.34 Aligned_cols=194 Identities=27% Similarity=0.508 Sum_probs=166.3
Q ss_pred CcCCeeeccCceEEEEEEEC-CCcEEEEEEec--c--ccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce--eEEEe
Q 002566 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLS--S--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVY 751 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~--~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~LV~ 751 (907)
+...+||+|+|-+||||.+. +|..||=-.++ . .+....++|.+|+++|+.++|||||+++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44678999999999999975 46667632222 1 134445789999999999999999999999987654 78899
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCcccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 830 (907)
|.+..|+|..|+...+ .++.+.+.++++||++||.|||++. |||||||||-.||+|+.+ |.|||+|+|+|..+
T Consensus 123 EL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999997664 6788899999999999999999986 689999999999999865 89999999999988
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
..... ..+.|||.|||||++. ..|+..+||||||++++||+|+..|+.
T Consensus 197 r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 197 RKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred hcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 76543 2368999999999997 788999999999999999999999984
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=282.51 Aligned_cols=198 Identities=26% Similarity=0.422 Sum_probs=160.5
Q ss_pred CCeeeccCceEEEEEEEC---CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceeEEEeeecc
Q 002566 681 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~ 755 (907)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 46789999986542 23457789999999999999999998854 456899999986
Q ss_pred CCchhhhhhcCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCcEEEeecCCc
Q 002566 756 NNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (907)
Q Consensus 756 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla 827 (907)
+ +|.+++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 67766643211 11235889999999999999999999998 9999999999999 45678999999999
Q ss_pred ccccCCCcc--ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 1223568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=276.93 Aligned_cols=202 Identities=31% Similarity=0.540 Sum_probs=169.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCc----EEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~----~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
.++|+..++||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888899999999999999864 444 48999987543 33456788999999999999999999998754 567
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
++|||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999987543 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 829 LYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 829 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
......... .....++..|+|||...+..++.++||||||+++|||++ |+.||+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 765433211 111234678999999998889999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=290.90 Aligned_cols=197 Identities=22% Similarity=0.273 Sum_probs=169.2
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC---CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
..+|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++|||||++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457899999999999999999854 3578999988643 24567999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|++. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9996 5777777332 26899999999999999999999997 9999999999999999999999999998665
Q ss_pred CCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43321 1223579999999999999999999999999999999999999985543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=289.06 Aligned_cols=198 Identities=24% Similarity=0.325 Sum_probs=168.3
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 744 (907)
..++|...+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999975 58889999987542 33356788999999999999999999987643
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
...++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 56666532 4688899999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCccccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99986543321 23346899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=276.82 Aligned_cols=203 Identities=30% Similarity=0.483 Sum_probs=171.2
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC------
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG------ 744 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~------ 744 (907)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999975 57889999986543 3345788899999988 799999999998753
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
+..++||||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 468999999999999999865321 25889999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99986543322 223356899999999986 34578899999999999999999999854
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=277.45 Aligned_cols=206 Identities=32% Similarity=0.521 Sum_probs=174.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+++...++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 356899999887766667789999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 750 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
||||+++++|.+++...... ....+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 99999999999998754321 1135889999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 820 KISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 99999999765432211 1122345788999999998899999999999999999998 89998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=278.51 Aligned_cols=198 Identities=29% Similarity=0.443 Sum_probs=174.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|...+.||+|+||.||++... +++.||+|+++... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999976 58899999986542 233466889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999986542 6889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||....
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 43 223468899999999988888999999999999999999999986433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=280.01 Aligned_cols=201 Identities=23% Similarity=0.406 Sum_probs=169.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...++||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999976 578999999875432 2334677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 58888875432 25789999999999999999999997 999999999999999999999999999765432
Q ss_pred Cccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 122356889999998865 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=271.58 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=176.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|+..+.||+|+||.||+|.+.+ ++.||+|.+..... ..++.+|++++++++||||+++++++.+++..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999875 78999999875433 67899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... ..+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999986432 36899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 32 122345788999999999889999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=276.52 Aligned_cols=201 Identities=31% Similarity=0.483 Sum_probs=170.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-----CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEee--Ccee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-----~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 747 (907)
.++|++.+.||+|+||.||++..+ +++.||+|+++.......+.|.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357888999999999999999853 578999999987666666789999999999999999999998754 3468
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 99999999999999986542 25899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCccc--cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 828 KLYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 828 ~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
+......... .....++..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 8765433211 111223456999999998889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=272.04 Aligned_cols=202 Identities=30% Similarity=0.586 Sum_probs=173.4
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.+|+..+.||+|+||.||+|.+.+++.+|+|.++... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999987543 234578999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++..... .++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999865432 5789999999999999999999997 99999999999999999999999999876543322
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.......++.+|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11222235678999999998889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=276.87 Aligned_cols=199 Identities=29% Similarity=0.498 Sum_probs=171.6
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 466788999999999999986 4778899998766656667889999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
++|..++.... .++++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99988876532 26899999999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 122346889999999984 345778999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=277.47 Aligned_cols=200 Identities=28% Similarity=0.480 Sum_probs=165.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--hhHHHHHHHHHHHhc---CCCceeeEEeEEee-----Cc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----GN 745 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~-----~~ 745 (907)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999976 6889999998754322 223456677766654 79999999998864 34
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 57999999984 78777754322 25899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
+++....... .....|+..|+|||++.+..++.++||||+||++|||++|++||....
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 154 LARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 9987653322 123467899999999998899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=273.55 Aligned_cols=191 Identities=27% Similarity=0.417 Sum_probs=161.7
Q ss_pred CeeeccCceEEEEEEECC-------------CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 682 NKVGEGGFGSVYKGILSD-------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~-------------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
+.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998632 2358899887665555668899999999999999999999999998999
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc-------EEE
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-------AKI 821 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl 821 (907)
+||||+++|+|..++.... ..+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998886542 25899999999999999999999987 999999999999987664 899
Q ss_pred eecCCcccccCCCccccccccccccccchhhhc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCC
Q 002566 822 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV-SGKSNTNYR 884 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvvl~ell-tG~~p~~~~ 884 (907)
+|||++....... ...++..|+|||.+. +..++.++|||||||++|||+ .|+.|+...
T Consensus 154 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 154 SDPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999987554322 235788899999887 467899999999999999998 588887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=278.99 Aligned_cols=206 Identities=29% Similarity=0.469 Sum_probs=169.9
Q ss_pred cCCCcCCeeeccCceEEEEEEECC---------------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD---------------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYG 739 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~---------------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g 739 (907)
++|.+.+.||+|+||.||++...+ ...||+|.++.... .....|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987642 23589999876533 33457899999999999999999999
Q ss_pred EEeeCceeEEEeeeccCCchhhhhhcCCcc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 002566 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 740 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 812 (907)
++..++..++||||+++++|.+++...... ....+++..+++++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 999999999999999999999998643211 1124789999999999999999999997 999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCC
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYR 884 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~ 884 (907)
+++++.+||+|||++......... ......++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999865433221 1122345778999999998889999999999999999998 55666543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=279.51 Aligned_cols=204 Identities=30% Similarity=0.455 Sum_probs=169.3
Q ss_pred cCCCcCCeeeccCceEEEEEEECC-C--cEEEEEEeccc-cchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-G--TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~-g--~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999754 3 34788888753 334456789999999998 799999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 751 YEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
|||+++++|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999653211 1125889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 820 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999864322111 111123567999999998889999999999999999997 99998544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=281.07 Aligned_cols=208 Identities=29% Similarity=0.439 Sum_probs=172.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC--------CCcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 744 (907)
.++|.+.+.||+|+||.||+|... +...+|+|.++... .....++.+|++++.++ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467889999999999999999853 23579999997653 33455788899999998 799999999999999
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 813 (907)
+..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999764321 1135899999999999999999999987 9999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 814 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
++++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999997654322111 111224568999999998889999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=276.83 Aligned_cols=207 Identities=28% Similarity=0.432 Sum_probs=174.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCcee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998743 3689999987553 23456788999999999999999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 822 (907)
++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998654321 1224789999999999999999999987 9999999999999999999999
Q ss_pred ecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 823 DFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 823 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|||+++........ ......++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999865443221 1223346789999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=274.16 Aligned_cols=205 Identities=29% Similarity=0.386 Sum_probs=175.3
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456777878889999999999999965 577899999887766667789999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeecCC
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGL 826 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGl 826 (907)
||||+++++|.+++..... .+ ++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.++|+|||.
T Consensus 83 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999875421 34 78889999999999999999987 999999999999986 67999999999
Q ss_pred cccccCCCccccccccccccccchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+........ ......|+..|+|||++... .++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 876543222 12224578999999998654 378899999999999999999999853
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=274.20 Aligned_cols=202 Identities=30% Similarity=0.490 Sum_probs=171.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC----CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
.+|++.+.||+|+||.||+|.+. .+..+|+|.++.... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788999999999999999864 234799999875432 3356789999999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++++|.+++.... ..+++.++.+++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999996543 25799999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCccccc--cccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 831 EEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 831 ~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
......... ...++..|+|||++.+..++.++|+||||+++||+++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 543322111 1223568999999998889999999999999999887 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=271.94 Aligned_cols=193 Identities=30% Similarity=0.462 Sum_probs=163.6
Q ss_pred eeeccCceEEEEEEEC---CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~---~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999763 57889999986543 233567899999999999999999999885 45678999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 837 (907)
+|.+++.... .+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999986432 5889999999999999999999997 9999999999999999999999999998765443221
Q ss_pred c--ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 838 S--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 838 ~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
. ....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12234678999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=288.24 Aligned_cols=200 Identities=26% Similarity=0.328 Sum_probs=168.9
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----- 744 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~----- 744 (907)
...++|...+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999875 58899999987542 23346778899999999999999999988643
Q ss_pred -ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 745 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 745 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEee
Confidence 357999999975 56555532 4788899999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 fg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 163 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CcccccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986543321 233568999999999999899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=288.92 Aligned_cols=191 Identities=30% Similarity=0.513 Sum_probs=168.7
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|...+.||.|+||.||-|+.. +..+||||++.-... ....+++.|++.|.+++|||.|.+.|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555788999999999999964 688999999865433 3356789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
|- ||-.+++.-.+ .++.+.++..|+.+.++||+|||+.+ .||||||+.|||+++.|.||++|||.|....+.
T Consensus 108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 95 67888885443 37899999999999999999999997 899999999999999999999999999987664
Q ss_pred Cccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
. .++|||.|||||++. .+.|+-|+||||+||+..||...++|.
T Consensus 180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred h-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 3 358999999999986 468999999999999999999999984
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=277.53 Aligned_cols=202 Identities=27% Similarity=0.490 Sum_probs=175.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.|.+|++++++++||||+++++.+..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999975 6889999999876666667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999986532 25899999999999999999999998 999999999999999999999999998765433
Q ss_pred Cccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... .....++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 157 LQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 221 22346889999999985 345678999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=273.26 Aligned_cols=200 Identities=29% Similarity=0.410 Sum_probs=169.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--cee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 747 (907)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999975 58899999875321 12345688899999999999999999988763 467
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++.... .+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 89999999999999886442 5788899999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 865432111 11224588899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=273.05 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=173.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|... +++.||||.++.. .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 6889999987643 2233457889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++..... ....++...+..++.|+++||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988853221 1235788999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred chhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 43221 1224578899999999888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=281.51 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=169.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCc--EEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~--~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999975 344 46788776543 33456788999999999 899999999999999999999
Q ss_pred eeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 751 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
|||+++|+|.++++.... .....+++.+++.++.|+++|++|||+++ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975431 11235889999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 820 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
||+|||++........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999864321111 111234678999999988889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=273.09 Aligned_cols=202 Identities=29% Similarity=0.480 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|...++||+|+||.||+|...++..+|+|.++... .....|.+|++++++++|+||+++++.+.+ +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998788889999887542 234678899999999999999999999887 7789999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999976432 35789999999999999999999987 9999999999999999999999999997664432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........++..|+|||++....++.++|+||||+++||+++ |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 222222345678999999998889999999999999999998 89998643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=278.26 Aligned_cols=208 Identities=29% Similarity=0.436 Sum_probs=172.2
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
.+++|++.++||+|+||.||+|..++ +..||+|.+..... ....++.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997542 45799998865432 334568899999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 821 (907)
.++||||+++|+|.+++...... .....++..+.+++.|++.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999653211 1234677889999999999999999997 999999999999999999999
Q ss_pred eecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 822 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998654322211 122235678999999998889999999999999999999 78888543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=286.30 Aligned_cols=207 Identities=26% Similarity=0.448 Sum_probs=181.3
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
+++...-+....++||-|.||.||.|+|+. .-.||||.++.. .....+|+.|+.+|+.++|||+|+++|+|..+..+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344444566778999999999999999975 567999999864 445789999999999999999999999999999999
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
||+|||..|+|.++|+..+.. .++.-..+.+|.||++|++||..++ +|||||.++|+|+.++..|||+|||+++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999877543 5677788999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
++..+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |-.|+..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 998776543333345789999999999999999999999999999998 8888743
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=327.48 Aligned_cols=276 Identities=32% Similarity=0.444 Sum_probs=237.7
Q ss_pred ceEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccc-cccEEEecCCcCCCCCchhcCCCCCCCEEEe
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 170 (907)
.+++.|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..+..+ +|++|+|++|++.+.+|..++++++|++|+|
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219 (968)
T ss_pred CCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence 467899999999999999999999999999999999999999888887 8999999999999999999999999999999
Q ss_pred eCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCC
Q 002566 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (907)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 250 (907)
++|++++.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.++++|++|+|++|.+.+.
T Consensus 220 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 299 (968)
T PLN00113 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299 (968)
T ss_pred cCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC
Confidence 99999999999999999999999999999989999999999999999999999988999999999999999999999988
Q ss_pred chhhhhcCCCCCEEEcCCCCCCCCCcccccc-cccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcC
Q 002566 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (907)
Q Consensus 251 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (907)
+|..+.++++|+.|++++|.+....+..+.. .+|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..+
T Consensus 300 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~ 379 (968)
T PLN00113 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379 (968)
T ss_pred CChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc
Confidence 9999999999999999988887655544433 378888888888888888888888888888888888887777777777
Q ss_pred CCCCeEEecCCcCCCCCchhh--hccCCcceeecCCccCC
Q 002566 330 AKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE 367 (907)
Q Consensus 330 ~~L~~L~Ls~N~L~~~~p~~~--~~~l~~l~ls~N~~~~~ 367 (907)
++|+.|++++|++++.+|..+ ...++.|++++|++++.
T Consensus 380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 777777777777777777665 34666777777776644
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=288.72 Aligned_cols=208 Identities=27% Similarity=0.431 Sum_probs=172.8
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccch-hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~ 745 (907)
..++|.+.++||+|+||.||+|.+. .++.||+|+++..... ..+.+..|++++.++. |||||++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999864 2467999999765332 2457889999999997 999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (907)
..++||||+++|+|.++++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 999999999999999999754210
Q ss_pred -------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 002566 770 -------------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 770 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 812 (907)
....+++..+.+++.|++.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124778889999999999999999987 999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999865432211 1122356789999999998889999999999999999998 88898653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=274.55 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=172.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 58899999986542 2234568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++++|..++.... .+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999998887764432 5899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....+
T Consensus 153 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 153 PGDD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred Cccc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 3321 122457889999999875 5578899999999999999999999965443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=293.33 Aligned_cols=193 Identities=24% Similarity=0.295 Sum_probs=166.7
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999986 478899996432 3467899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+. ++|.+++.... ..+++.++++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 67887775432 26899999999999999999999997 999999999999999999999999999865433
Q ss_pred Ccc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 834 KTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 834 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 221 122356999999999999999999999999999999999988764
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=276.66 Aligned_cols=200 Identities=29% Similarity=0.483 Sum_probs=173.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
++|++.++||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999986 48899999998776666778999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|..++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999988775432 25899999999999999999999987 9999999999999999999999999987543322
Q ss_pred ccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. ......++..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 1 112345788999999884 34568899999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=275.20 Aligned_cols=198 Identities=31% Similarity=0.469 Sum_probs=167.5
Q ss_pred CCcCCeeeccCceEEEEEEE-----CCCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEE
Q 002566 678 FDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~-----~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~L 749 (907)
|+..+.||+|+||.||++.. .+++.||+|.++.... .....|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 3577899999976532 3456788999999999999999999988753 45789
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++++|.+++... .+++.++..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999998643 5899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCccc--cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
........ .....++..|+|||.+....++.++||||||+++|||++|+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 65432211 11223566799999998888999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=272.87 Aligned_cols=203 Identities=28% Similarity=0.455 Sum_probs=166.1
Q ss_pred CCcCCeeeccCceEEEEEEECC-Cc--EEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------ce
Q 002566 678 FDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ 746 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~-g~--~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 746 (907)
|.+.++||+|+||.||+|.+.+ ++ .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999764 32 6899988754 234456788999999999999999999987532 24
Q ss_pred eEEEeeeccCCchhhhhhcCC-cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
.++||||+++|+|.+++.... ......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 112235899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 826 LAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 826 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
+++.+....... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998765433211 122345778999999998899999999999999999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=279.42 Aligned_cols=210 Identities=27% Similarity=0.438 Sum_probs=174.5
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC--------CCcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEe
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCV 742 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~ 742 (907)
...++|.+.+.||+|+||.||+|... ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999742 24579999987543 34456789999999999 8999999999999
Q ss_pred eCceeEEEeeeccCCchhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 002566 743 EGNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 811 (907)
Q Consensus 743 ~~~~~~LV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 811 (907)
..+..++||||+++|+|.+++...... ....+++.++..++.||++||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 999999999999999999999754211 1235789999999999999999999997 99999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 812 LLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 812 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999998765432211 122345678999999998889999999999999999998 788885443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=271.37 Aligned_cols=199 Identities=29% Similarity=0.493 Sum_probs=172.2
Q ss_pred CCCcCCeeeccCceEEEEEEECCCcEEEEEEecccc------chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
+|+..+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999998889999999886432 12234688899999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++++|.+++.... ++++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999986542 5789999999999999999999987 999999999999999999999999998765
Q ss_pred cCCC-----ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 831 EEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 831 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.... ........|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 3211 1111234588999999999988899999999999999999999999954
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=271.01 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=174.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 6889999998643 3334567888999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..++...+.+++.|+++||.|||+++ |+|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999988864322 25789999999999999999999997 9999999999999999999999999998664432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 2 222356889999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=276.18 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=175.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.-|+..+.||+|.|..|-.|++- .|..||||++.+.. ......+.+|+++|+.++|||||++|++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44677789999999999988853 79999999997763 3334578899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCcEEEeecCCccccc
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYE 831 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 831 (907)
.=++|+|.++|...+. .+.++.+.+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-|||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999976643 5889999999999999999999998 99999999998875 55899999999999887
Q ss_pred CCCccccccccccccccchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
++..- ...+|+..|-|||++.+..| .+++||||+||+||-|+.|+.||...-
T Consensus 171 PG~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 171 PGKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred Ccchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 76543 34689999999999998765 567999999999999999999996543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=285.23 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=168.9
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC----
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG---- 744 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~---- 744 (907)
....++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999975 67899999987542 22345678899999999999999999887543
Q ss_pred --ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002566 745 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (907)
Q Consensus 745 --~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 822 (907)
...+++||++ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence 3568999988 67888777432 5899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 823 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 823 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999998654322 23468999999999876 56899999999999999999999999543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=272.42 Aligned_cols=203 Identities=30% Similarity=0.516 Sum_probs=171.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CC---cEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+++..|++++.+++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999975 23 379999987553 3345678999999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986542 26899999999999999999999997 99999999999999999999999999986
Q ss_pred ccCCCccccc--cccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 830 YEEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
.......... ....+..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 6443221111 1223467999999998889999999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=276.52 Aligned_cols=207 Identities=28% Similarity=0.466 Sum_probs=171.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-----------------CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-----------------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l 737 (907)
++|++.++||+|+||.||++... ++..||+|++.... .....+|.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998643 23468999997553 3345678999999999999999999
Q ss_pred EeEEeeCceeEEEeeeccCCchhhhhhcCCcc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 002566 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 811 (907)
Q Consensus 738 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 811 (907)
++++..++..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998754321 1124788899999999999999999997 99999999999
Q ss_pred EEcCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 002566 812 LLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRP 885 (907)
Q Consensus 812 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~ 885 (907)
++++++.++|+|||+++.+....... .....++..|+|||+..++.++.++|||||||++|||++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999998654432211 112234678999999888889999999999999999998 667775443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=277.26 Aligned_cols=205 Identities=31% Similarity=0.438 Sum_probs=170.1
Q ss_pred CCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+|.+.++||+|+||.||+|...+ ++.||+|+++..... ....|.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667899999999999998642 478999999765433 24568899999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 750 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
++||+++++|.+++..... .....+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 9999999999999853211 11235888999999999999999999997 999999999999999999
Q ss_pred EEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999998865433221 1122345788999999988889999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=279.07 Aligned_cols=210 Identities=28% Similarity=0.427 Sum_probs=175.2
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEee
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 743 (907)
....++|+..+.||+|+||.||++...+ ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4445678889999999999999998642 3679999987643 33445688999999999 89999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 812 (907)
++..++||||+++|+|..++..... .....+++..+++++.|++.||+|||+.+ |+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 9999999999999999999865321 12346899999999999999999999987 999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999998765432211 112234678999999988889999999999999999998 99888544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=274.80 Aligned_cols=191 Identities=25% Similarity=0.381 Sum_probs=160.3
Q ss_pred eeeccCceEEEEEEECC-------------------------CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeE
Q 002566 683 KVGEGGFGSVYKGILSD-------------------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~~-------------------------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l 737 (907)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 13589999876655556788999999999999999999
Q ss_pred EeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 002566 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (907)
Q Consensus 738 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 817 (907)
++++.+++..++||||+++|+|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999886532 25789999999999999999999987 99999999999997643
Q ss_pred -------cEEEeecCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCC
Q 002566 818 -------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIV-SGKSNTNYRP 885 (907)
Q Consensus 818 -------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~ell-tG~~p~~~~~ 885 (907)
.+|++|||.+....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 38999999886543221 1246788999998875 56899999999999999984 7999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=270.70 Aligned_cols=202 Identities=27% Similarity=0.461 Sum_probs=176.7
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999975 5788999999876555667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999886542 26889999999999999999999987 999999999999999999999999999865443
Q ss_pred CccccccccccccccchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... .....++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 155 IAK-RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred hhc-cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 211 1234678899999999776 7899999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=272.66 Aligned_cols=205 Identities=29% Similarity=0.444 Sum_probs=169.2
Q ss_pred CCcCCeeeccCceEEEEEEECC----CcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce-----
Q 002566 678 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 746 (907)
|++.+.||+|+||.||+|.... +..||+|+++... ......+.+|+++++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998742 3679999987542 2334678999999999999999999998876554
Q ss_pred -eEEEeeeccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 747 -LLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 747 -~~LV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
.++||||+++|+|..++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7999999999999988854321 12236899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 825 GLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 825 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998765433221 111234678999999988889999999999999999999 888885443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=269.43 Aligned_cols=198 Identities=32% Similarity=0.544 Sum_probs=173.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999875 78899999986654 5678999999999999999999999999889999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999865432 25899999999999999999999997 9999999999999999999999999998764322
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
. ....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 2 1234678999999988889999999999999999997 99998544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=272.81 Aligned_cols=199 Identities=29% Similarity=0.487 Sum_probs=175.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999976 58899999987553 34456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++... ++++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998643 6899999999999999999999987 999999999999999999999999999877644
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 152 MSK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ccc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 221 22346788999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=270.20 Aligned_cols=201 Identities=29% Similarity=0.429 Sum_probs=170.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-----chhhHHHHHHHHHHHhcCCCceeeEEeEEee--Ccee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 747 (907)
.+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999975 58899999886432 1234568889999999999999999998875 3567
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
+++|||+++++|.+++.... .+++.....++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999986542 5788999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCc--cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 76543211 1112245789999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=278.59 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=160.2
Q ss_pred CCeeeccCceEEEEEEEC---CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceeEEEeeecc
Q 002566 681 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~ 755 (907)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999975 35789999986543 23467889999999999999999998854 567899999987
Q ss_pred CCchhhhhhcCC----cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCcEEEeecCCc
Q 002566 756 NNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (907)
Q Consensus 756 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla 827 (907)
+ +|.+++.... ......+++..+.+++.|+++||+|||+.+ |+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6666654221 111235889999999999999999999997 9999999999999 56679999999999
Q ss_pred ccccCCCcc--ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1223568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=273.06 Aligned_cols=201 Identities=30% Similarity=0.531 Sum_probs=169.9
Q ss_pred CCCcCCeeeccCceEEEEEEECC-C---cEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~-g---~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
+|++.+.||+|+||.||+|.+.. + ..||+|.++.. ......+|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46788999999999999999753 3 36999998765 3334568999999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... ..+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999986543 25799999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCccc--ccccc--ccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 832 EDKTHI--STRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~--~~~~~--gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
...... ..... .+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 432211 11111 2457999999998899999999999999999886 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=270.25 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=175.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 7899999988643 2233567889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .....+++.++..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999886432 12235899999999999999999999997 9999999999999999999999999988654
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 43221 1224578899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=270.71 Aligned_cols=199 Identities=31% Similarity=0.527 Sum_probs=171.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch---------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCce
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~---------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 746 (907)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999875 5789999988654322 12467889999999999999999999999999
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 999999999999999996542 5788999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcc-----ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 827 AKLYEEDKTH-----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 827 a~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
++........ ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 9876532111 11124578899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=272.54 Aligned_cols=203 Identities=28% Similarity=0.444 Sum_probs=174.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|... +++.+|||.+.... .....++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778899999999999999964 78999999886432 233467889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... .....+++..+.+++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999886422 12236899999999999999999999997 9999999999999999999999999988765
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 43321 1234588999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=272.72 Aligned_cols=201 Identities=27% Similarity=0.450 Sum_probs=169.2
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|++.+.||+|++|.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68899999986542 22345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++ ++|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 678877754321 236899999999999999999999987 999999999999999999999999999765433
Q ss_pred CccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 11223568899999988654 5788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=278.63 Aligned_cols=195 Identities=28% Similarity=0.501 Sum_probs=170.5
Q ss_pred cCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCc
Q 002566 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 758 (907)
....||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999975 688999999876555556678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccc
Q 002566 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838 (907)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 838 (907)
|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 105 L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 174 (297)
T cd06659 105 LTDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-R 174 (297)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-c
Confidence 99877432 5789999999999999999999997 999999999999999999999999998765433221 1
Q ss_pred ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 839 ~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2346889999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=275.51 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=173.3
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-----------------CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVK 736 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-----------------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~ 736 (907)
..+|++.++||+|+||.||+|...+ +..||+|.+..... ....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998642 24689999876543 34567889999999999999999
Q ss_pred EEeEEeeCceeEEEeeeccCCchhhhhhcCCccc------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 002566 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (907)
Q Consensus 737 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 810 (907)
+++++..++..++||||+++++|.+++....... ...+++..++.++.|+++||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999987654211 226899999999999999999999987 9999999999
Q ss_pred EEEcCCCcEEEeecCCcccccCCCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCC
Q 002566 811 VLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY 883 (907)
Q Consensus 811 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~ 883 (907)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543322 11223446788999999998889999999999999999998 6677754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.35 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=173.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++|+..+.||+|+||.||+|..+ +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999964 2467999988765443 3567999999999999999999999999989999
Q ss_pred EEeeeccCCchhhhhhcCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
+||||+++|+|.+++....... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543211 125899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|++...............++..|+|||.+.+...+.++||||||+++|||++ |..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9987543332222223356778999999988888999999999999999999 78888543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=272.81 Aligned_cols=202 Identities=32% Similarity=0.578 Sum_probs=171.3
Q ss_pred cCCCcCCeeeccCceEEEEEEECC-Cc----EEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-GT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~-g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.+|...+.||+|+||.||+|.+.+ ++ .||+|....... ....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999999753 32 589998876543 345678899999999999999999999987 78899
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|+|.+++..... .+++..+.+++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.
T Consensus 86 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999976432 5899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCcccc-ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 830 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 654332211 11223568999999988889999999999999999998 999996544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=268.03 Aligned_cols=199 Identities=32% Similarity=0.502 Sum_probs=173.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-----chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999987 78999999986543 23456788999999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++++|.+++.... ++++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999986542 5789999999999999999999997 999999999999999999999999998865
Q ss_pred cCCCccccccccccccccchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.... ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 4433 122346889999999987766 8999999999999999999999985543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=274.08 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=169.2
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++++|.+.+.||+|+||.||+|... +++.||+|.+....... ...+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999875 68899999987553322 346788999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||++ +++.+.+.... ..+.+..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 56666654332 24678889999999999999999997 9999999999999999999999999997643
Q ss_pred CCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 32211 122357889999999875 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=277.78 Aligned_cols=198 Identities=27% Similarity=0.523 Sum_probs=172.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.|+....||+|+||.||++... +++.||+|++........+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444577999999999999975 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 103 ~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 103 GGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999987432 4789999999999999999999997 99999999999999999999999999876543322
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. .....|+..|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 174 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 174 K-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred c-CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 12345889999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=260.64 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=172.8
Q ss_pred HHHHHHHhcCCCcCCeeeccCceEEEEEE-ECCCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002566 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 668 ~~~i~~~~~~~~~~~~IG~G~fG~Vyka~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
++++-..| .+.||+|+++.|-.++ +.+|..+|||++.+.......+..+|++++... .|+||++++++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 55555555 4689999999999887 568999999999988777788899999999876 5999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---cEEEe
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKIS 822 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 822 (907)
.+|||||-|.||+|..+|+.+. .+++.++.++..+|+.||.+||.+| |.|||+||+|||-..-. -+|||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 9999999999999999997664 6899999999999999999999998 99999999999986443 47999
Q ss_pred ecCCcccccCCCc--cc----cccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 823 DFGLAKLYEEDKT--HI----STRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 823 DFGla~~~~~~~~--~~----~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
||.+..-+..... .. -...+|+..|||||+.. ...|+.++|.||+||++|-|++|.+||..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 9998865433211 11 12357899999999874 34789999999999999999999999953
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=276.65 Aligned_cols=204 Identities=28% Similarity=0.434 Sum_probs=172.8
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
..++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457889999999999999999742 345799999876533 3345788999999999 7999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+++ |+|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999975432 23799999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 826 LAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 826 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
+++........ ......++..|+|||++....++.++||||+||++|||++ |+.||..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 99865443221 1112345778999999998889999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=275.63 Aligned_cols=201 Identities=23% Similarity=0.374 Sum_probs=171.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|+..+.||+|+||.||++... .++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 57899999987553 233457889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999996542 5889999999999999999999987 9999999999999999999999999987421
Q ss_pred CCCc--------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKT--------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~--------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... .......++..|+|||++....++.++|+||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 0011235788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=277.57 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=174.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch---hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|+..+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999976 4899999999765322 4457889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999986432 236899999999999999999999997 9999999999999999999999999987653
Q ss_pred CCCcc----------------------------ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTH----------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 32110 01124578899999999988899999999999999999999999854
Q ss_pred C
Q 002566 884 R 884 (907)
Q Consensus 884 ~ 884 (907)
.
T Consensus 235 ~ 235 (316)
T cd05574 235 S 235 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=271.70 Aligned_cols=202 Identities=29% Similarity=0.421 Sum_probs=170.5
Q ss_pred cCCCcCCeeeccCceEEEEEEECC----CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999887655 3455689999999999999999999998875 457899
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999996542 25799999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 5443222222334578999999988889999999999999999996 999986443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=303.25 Aligned_cols=208 Identities=25% Similarity=0.395 Sum_probs=171.1
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEee--Ccee
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 747 (907)
...++|.+.+.||+|+||.||+|... .+..||+|.+... .......|..|+.++++++|||||++++++.. .+.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999976 4678999988654 23345678899999999999999999998864 4568
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEcCCCCCCEEEcCC-------
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR----IKIVHRDIKTSNVLLDKD------- 816 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlkp~NILl~~~------- 816 (907)
++||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999865321 12368999999999999999999998542 249999999999999642
Q ss_pred ----------CcEEEeecCCcccccCCCccccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 817 ----------LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 817 ----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3489999999986644322 233568999999999864 4588999999999999999999999964
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=273.65 Aligned_cols=207 Identities=25% Similarity=0.413 Sum_probs=174.1
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC-----CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEee-Cce
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~-----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 746 (907)
..++|.+.+.||+|+||.||+|.+.+ +..|++|++.... ......+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999865 6889999987543 3335668899999999999999999998876 467
Q ss_pred eEEEeeeccCCchhhhhhcCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTE---YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
.++++||+++++|.+++...... ....+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654221 1136899999999999999999999987 99999999999999999999999
Q ss_pred cCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 824 FGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 824 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 9999866443321 1122345778999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.28 Aligned_cols=200 Identities=28% Similarity=0.456 Sum_probs=174.8
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999865 5888999988654 234456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... ...+++.++..++.|+++|+.|||+.+ ++||||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999987542 236899999999999999999999987 999999999999999999999999999876544
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. ......+++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 32 22335689999999999888889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=267.40 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=172.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E 752 (907)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999975 57889999986542 2345578899999999999999999998764 446789999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++++|.+++..... ..+++.++..++.|++.|+++||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999865321 25899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ......+++.|+|||++.+..++.++||||+|++++||++|+.||...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 322 223346889999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=268.75 Aligned_cols=195 Identities=29% Similarity=0.470 Sum_probs=169.1
Q ss_pred CeeeccCceEEEEEEECC--C--cEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILSD--G--TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~--g--~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+++.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 3 3689999987765 556789999999999999999999999988 889999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999976532 36899999999999999999999997 999999999999999999999999999876543221
Q ss_pred c--cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 837 I--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 837 ~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 112456789999999998889999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=277.96 Aligned_cols=208 Identities=26% Similarity=0.438 Sum_probs=171.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC--------CCcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 744 (907)
.++|.+.+.||+|+||.||+|... ....||+|.++... .....++..|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999752 24578999987543 33456788999999998 699999999999999
Q ss_pred ceeEEEeeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 813 (907)
+..++||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999965321 01235899999999999999999999987 9999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 814 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
++++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999998664322211 111224567999999998889999999999999999999 888885443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=282.26 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=164.9
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++.+.+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 33568999999999999999999986 4678999975432 2346899999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|++. ++|.+++.... ..+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 57877775432 26899999999999999999999997 9999999999999999999999999997543
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
.... .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAPA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCcc--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3221 22356899999999999999999999999999999999866554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=272.95 Aligned_cols=201 Identities=24% Similarity=0.417 Sum_probs=169.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 6889999998754322 234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 985 8988886543 25789999999999999999999997 999999999999999999999999998754322
Q ss_pred Cccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
... .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 111 122346789999999875 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=278.35 Aligned_cols=199 Identities=19% Similarity=0.267 Sum_probs=165.1
Q ss_pred cCCeeecc--CceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 680 PANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 680 ~~~~IG~G--~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+.++||+| +|++||++..+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78899999875 689999999975532 23446778999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999865322 25889999999999999999999987 9999999999999999999999998765432211
Q ss_pred cc------ccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 TH------ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~------~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 10 0112346778999999976 45889999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=267.45 Aligned_cols=200 Identities=38% Similarity=0.569 Sum_probs=172.5
Q ss_pred CeeeccCceEEEEEEECC----CcEEEEEEeccccchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++++..++|+||+++++++..++..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999864 7889999998664433 67889999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 757 NCLSRAIFGKDTE----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 757 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
++|.+++...... ....+++.++.+++.|+++||+|||+++ ++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 1246899999999999999999999987 99999999999999999999999999987765
Q ss_pred CCc-cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 833 DKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 833 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 431 11223457889999999988889999999999999999999 69998655
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=273.07 Aligned_cols=200 Identities=28% Similarity=0.461 Sum_probs=173.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777899999999999999975 58899999886543 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++...+ .+++..+..++.++++||.|||+.. .++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999998886532 5899999999999999999999742 3999999999999999999999999998754322
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 IA---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred cc---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 21 23468999999999988889999999999999999999999996433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=273.96 Aligned_cols=202 Identities=26% Similarity=0.481 Sum_probs=171.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36778899999999999999986 6899999988754 233346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|..++..... ...+++..+.+++.|+++||.|||+.. +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999988865321 236899999999999999999999742 3999999999999999999999999999765432
Q ss_pred CccccccccccccccchhhhccC------CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~------~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ....++..|+|||++.+. .++.++|+|||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 LA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred cc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 22 223578899999998654 3578999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=266.58 Aligned_cols=211 Identities=29% Similarity=0.471 Sum_probs=181.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|.+.+.||+|++|.||+|... +++.||+|++..... ...+++.+|++++.+++|+|++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999987 489999999876644 4467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999654 268999999999999999999999 87 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 895 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~ 895 (907)
..... ....++..|+|||.+....++.++|+||||+++|||++|+.||......+...+.++
T Consensus 153 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 153 TLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred CCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 43321 234578899999999988999999999999999999999999966542233333333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=265.60 Aligned_cols=197 Identities=32% Similarity=0.509 Sum_probs=168.8
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchh
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 760 (907)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccc-c
Q 002566 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-T 839 (907)
Q Consensus 761 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 839 (907)
+++..... .+++..+..++.+++.|++|||+++ ++||||||+||+++.++.+||+|||.+........... .
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99865432 5789999999999999999999997 99999999999999999999999999986543221111 1
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
...++..|+|||++.+..++.++|+||||+++|||++ |+.||....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 1223567999999988889999999999999999999 888885443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=268.29 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=170.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc-----cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--cee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 747 (907)
.+|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999975 5889999987532 123345788999999999999999999998764 467
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++.... .+++..+.+++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999886542 5788999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCc--cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+....... .......++..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 86543211 111234588999999999988889999999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=269.43 Aligned_cols=197 Identities=29% Similarity=0.473 Sum_probs=163.3
Q ss_pred CeeeccCceEEEEEEECC-Cc--EEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILSD-GT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~-g~--~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|.+.+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999864 33 57888887543 34456788999999999 899999999999999999999999999
Q ss_pred CchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 757 NCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 757 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
|+|.+++..... .....+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865421 11124789999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
++........ ......+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9863321111 111223567999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=274.10 Aligned_cols=197 Identities=29% Similarity=0.523 Sum_probs=171.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999875 57889999987543 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... .+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++++|||++.......
T Consensus 85 ~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999988542 5789999999999999999999987 9999999999999999999999999998665432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. .....++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 IK-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred hh-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 21 2224578899999999988899999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=266.69 Aligned_cols=195 Identities=32% Similarity=0.508 Sum_probs=165.1
Q ss_pred CeeeccCceEEEEEEECC----CcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998642 26899999976543 34567899999999999999999999876 4568999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999997543 5799999999999999999999987 999999999999999999999999999876544332
Q ss_pred cccc--ccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 837 ISTR--IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 837 ~~~~--~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
.... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 2111 123568999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=279.21 Aligned_cols=211 Identities=32% Similarity=0.504 Sum_probs=180.6
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEECC---C--cEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILSD---G--TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~---g--~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 743 (907)
+.+...+.....++||+|-||.||+|...+ | -.||||.-+.. ...+.+.|+.|+.+++.++|||||+++|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 333444455667899999999999999643 2 35889988875 34556779999999999999999999999986
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
. ..++|||.++-|.|..+|..+.. .++......++.||+.||.|||+.. +|||||..+|||+.+..-||++|
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence 5 68999999999999999977643 6888899999999999999999986 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~ 888 (907)
||+++.+..+..+..+...-++.|||||.+...+++.++|||.|||++||+++ |..||..-.+.|
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 99999988876655555555789999999999999999999999999999887 999996554444
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=270.13 Aligned_cols=197 Identities=29% Similarity=0.526 Sum_probs=172.5
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.|+..+.||+|+||.||+|.+. +++.||+|.++... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999975 58899999987543 344567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++... ++++.++..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999988543 5788999999999999999999987 9999999999999999999999999997664432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. .....++..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus 156 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 IK-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cc-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 2234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=262.06 Aligned_cols=205 Identities=25% Similarity=0.420 Sum_probs=171.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-----CcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEee-Cce
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-----g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 746 (907)
-..|+....||+|.||.||||.-.+ .+.+|+|+++.+.... .....+|+..++.++|||||.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999997432 2368999998764322 3457789999999999999999998877 788
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CcEEEe
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKIS 822 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~ 822 (907)
+++++||.+. +|...|+-........++...+..|..||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999986 5767776544444457899999999999999999999998 9999999999999877 999999
Q ss_pred ecCCcccccCCCccc--cccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 823 DFGLAKLYEEDKTHI--STRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 823 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|||+++.+...-... ...++-|+.|.|||.+.+. .|++++||||.||++.||++-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999887654332 2346679999999999875 699999999999999999999887743
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=268.21 Aligned_cols=189 Identities=30% Similarity=0.477 Sum_probs=161.4
Q ss_pred CeeeccCceEEEEEEECCCc-----------EEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 682 NKVGEGGFGSVYKGILSDGT-----------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~-----------~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986433 5788877654433 6789999999999999999999999988 778999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-------cEEEee
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-------NAKISD 823 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~D 823 (907)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999875432 5789999999999999999999987 99999999999999888 799999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
||++...... ....++..|+|||++... .++.++||||||+++|||++ |..|+...
T Consensus 152 fg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9999865442 123467789999999876 78999999999999999999 57777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=274.38 Aligned_cols=200 Identities=27% Similarity=0.424 Sum_probs=171.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|+..++||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 588999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++++|.++..... .+++.+++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999999988765432 4799999999999999999999987 99999999999999999999999999986544
Q ss_pred CCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ......++..|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 332 2223457889999999875 45788999999999999999999988543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=266.90 Aligned_cols=195 Identities=30% Similarity=0.480 Sum_probs=167.4
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEe-eCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E~~ 754 (907)
++|.+.+.||+|+||.||++... ++.||+|.++... ..+.|.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999875 7789999986443 3467899999999999999999999765 456789999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++..... ..+++..+.+++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999865432 25789999999999999999999987 9999999999999999999999999988654322
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
. ...++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 157 ~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 D----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred C----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 2234678999999998889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=267.47 Aligned_cols=200 Identities=34% Similarity=0.559 Sum_probs=174.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 688999999876544 3567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999986542 4788999999999999999999998 999999999999999999999999999876544
Q ss_pred Cccccc---cccccccccchhhhccCC---CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHIST---RIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~---~~~gt~~y~aPE~l~~~~---~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...... ...++..|+|||++.... .+.++||||||++++||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 332211 245788999999998765 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=272.70 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=173.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|+..+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999986 57899999987543 2334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|++++.+..+.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987776655432 25789999999999999999999997 99999999999999999999999999987665
Q ss_pred CCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 443222335678899999999887 88999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=272.92 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=172.3
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC------CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCcee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
.++|+..+.||+|+||.||+|... ++..||+|+++... ....++|.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999864 46789999987653 33456789999999999999999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCc-----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 002566 748 LLVYEYMKNNCLSRAIFGKDT-----------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 810 (907)
++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864321 11135789999999999999999999997 9999999999
Q ss_pred EEEcCCCcEEEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002566 811 VLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTN 882 (907)
Q Consensus 811 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~ 882 (907)
|++++++.++|+|||.+......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999998765433211 1112234678999999998899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=268.24 Aligned_cols=201 Identities=28% Similarity=0.470 Sum_probs=172.6
Q ss_pred CCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccc------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 4688999999865431 124578899999999999999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCcc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 828 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 828 (907)
||||+++++|.+++.... ++++..+.+++.|++.||.|||+.+ ++||||+|+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999986542 6789999999999999999999997 99999999999998776 58999999998
Q ss_pred cccCCCcc---ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 829 LYEEDKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 829 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.+...... ......++..|+|||++.+..++.++||||+|++++||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 76543211 1123467889999999988889999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=280.68 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=169.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEE------CCCcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC-c
Q 002566 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~-~ 745 (907)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999974 3467899999976432 3345688999999999 689999999988654 4
Q ss_pred eeEEEeeeccCCchhhhhhcCCcc--------------------------------------------------------
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (907)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998653210
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccc-ccccc
Q 002566 770 ------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIA 842 (907)
Q Consensus 770 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 842 (907)
....+++.++.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788999999999999999999997 9999999999999999999999999998654332211 11223
Q ss_pred ccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 843 gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999988889999999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=294.62 Aligned_cols=203 Identities=19% Similarity=0.319 Sum_probs=162.7
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC--CcEEEEE------------------EeccccchhhHHHHHHHHHHHhcCCCc
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD--GTVIAVK------------------QLSSKSRQGNREFVNEIGMISAQQHPN 733 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~--g~~vAVK------------------~~~~~~~~~~~~f~~E~~~l~~l~H~n 733 (907)
..++|.+.++||+|+||+||++..+. +..+++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987642 2222222 111 11223456889999999999999
Q ss_pred eeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 002566 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 734 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 813 (907)
||++++++...+..++|+|++. +++.+++..............++..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 46666665443222223446678899999999999999997 9999999999999
Q ss_pred cCCCcEEEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 814 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999877654433333467999999999999999999999999999999999998643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=269.10 Aligned_cols=193 Identities=30% Similarity=0.414 Sum_probs=160.1
Q ss_pred eeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHH---hcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMIS---AQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865421 22233445544433 4579999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 999998886542 6899999999999999999999998 99999999999999999999999999875543221
Q ss_pred cccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
....|+..|+|||.+.. ..++.++||||+||++|||++|+.||.....
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 22468999999999864 5688999999999999999999999965443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=273.28 Aligned_cols=212 Identities=26% Similarity=0.436 Sum_probs=174.7
Q ss_pred cHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEe--
Q 002566 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV-- 742 (907)
Q Consensus 667 ~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~-- 742 (907)
.+..+..+.++|.+.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455667889999999999999999999975 57899999886432 2235678899999998 6999999999874
Q ss_pred ---eCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 743 ---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 743 ---~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
.++..++||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 3456899999999999998876431 12236889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCCccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 820 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
||+|||++......... .....|++.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999866443221 223468999999998853 45788999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=279.19 Aligned_cols=208 Identities=28% Similarity=0.423 Sum_probs=172.0
Q ss_pred HhcCCCcCCeeeccCceEEEEEEECC--------CcEEEEEEecccc-chhhHHHHHHHHHHHhc-CCCceeeEEeEEee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~~--------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 743 (907)
...+|.+.+.||+|+||.||+|.... +..||+|.++... ....+++.+|++++.++ +||||+++++++.+
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34568889999999999999997521 2368999887543 33456789999999999 89999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 812 (907)
++..++||||+++|+|.+++..... .....+++.++++++.|+++||+|||+++ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 9999999999999999999865321 11235889999999999999999999997 999999999999
Q ss_pred EcCCCcEEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998664432211 111234567999999999999999999999999999998 88888544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=271.29 Aligned_cols=200 Identities=29% Similarity=0.467 Sum_probs=172.4
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 68899999987654 23356789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886543 36899999999999999999999997 999999999999999999999999999876554
Q ss_pred CccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.........|+..|+|||++.+. .++.++||||+|++++||++|++||...
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 32222334688999999988654 4689999999999999999998777543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=280.88 Aligned_cols=198 Identities=26% Similarity=0.444 Sum_probs=177.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
...|.+.+.||+|.|+.|..|++. .+..||+|.+++..- ...+.+.+|++++..++|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999975 689999999987632 33455889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+.+|.+.+++...+ ......+..++.|+.+|++|||+++ |+|||||++||||+.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999998765 3455889999999999999999998 9999999999999999999999999999887
Q ss_pred CCCccccccccccccccchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
... .....+|++.|.|||+..+.. ..+++|+||+|+++|-|+.|..||+
T Consensus 207 ~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 207 YGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred ccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 543 334578999999999998764 5779999999999999999999996
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.96 Aligned_cols=200 Identities=26% Similarity=0.360 Sum_probs=166.6
Q ss_pred HHHHHHHhcCCCcCCee--eccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHh-cCCCceeeEEeEEee
Q 002566 668 LRQIKAATNNFDPANKV--GEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 743 (907)
Q Consensus 668 ~~~i~~~~~~~~~~~~I--G~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~ 743 (907)
..++....++|++.+.+ |+|+||.||++... ++..+|+|.+........ |+..... .+||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556778887777 99999999999975 678899999865422111 2222221 279999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEe
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKIS 822 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~ 822 (907)
.+..++||||+++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999999999986542 6899999999999999999999998 99999999999999998 99999
Q ss_pred ecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 823 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 823 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
|||.+....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 153 dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 153 DYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred cCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999987654322 2357899999999998889999999999999999999999997443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=272.84 Aligned_cols=199 Identities=28% Similarity=0.539 Sum_probs=175.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999864 67899999987655555677899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... .+++.++..++.|+++|+.|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998643 4688899999999999999999997 9999999999999999999999999987654433
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. .....|++.|+|||.+....++.++||||||+++||+++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 12245888999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=272.37 Aligned_cols=199 Identities=29% Similarity=0.483 Sum_probs=168.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-----CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--cee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-----~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 747 (907)
+.|.+.+.||+|+||.||.+... ++..||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34678899999999999999842 47789999987553 33356789999999999999999999998875 568
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 99999999999999986442 25799999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 828 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 828 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
+........ ......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 876543221 112244677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=265.84 Aligned_cols=204 Identities=29% Similarity=0.487 Sum_probs=176.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999975 57889999986543 33567889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999865422 125899999999999999999999987 999999999999999999999999999876544
Q ss_pred Ccc---ccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~---~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... ......|+..|+|||++... ..+.++|+||||++++||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 322 12234688999999998876 7899999999999999999999999644
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=273.84 Aligned_cols=201 Identities=32% Similarity=0.567 Sum_probs=167.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCc----EEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999874 343 578898875433 3345788999999999999999999998754 4678
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
++||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 999999999999986543 25789999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 830 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432211 112345678999999998899999999999999999997 89998543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=270.89 Aligned_cols=201 Identities=27% Similarity=0.463 Sum_probs=166.1
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHH-HHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|++.+.||+|+||.||+|... +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 68999999987653 2334455566654 666799999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|++ |+|.+++..... ....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 678777754321 124689999999999999999999987 5 9999999999999999999999999998654
Q ss_pred CCCccccccccccccccchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.... .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||..
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 3221 122457889999998864 4568899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=271.57 Aligned_cols=213 Identities=29% Similarity=0.457 Sum_probs=175.8
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEee
Q 002566 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (907)
Q Consensus 666 ~~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 743 (907)
+.++++..++++|.+.+.||+|+||.||+|... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566677899999999999999999999975 68899999986542 2245677889999888 89999999999875
Q ss_pred C-----ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 744 G-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 744 ~-----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
. +..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 4 358999999999999998864211 1236899999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCCccccccccccccccchhhhccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999865443221 1234688999999998643 3688999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=270.99 Aligned_cols=197 Identities=24% Similarity=0.430 Sum_probs=166.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999986 688999999865422 2235678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++ ++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 46777765432 25899999999999999999999997 999999999999999999999999999865443
Q ss_pred CccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
... .....++..|+|||++.+. .++.++|||||||++|||++|+.|+.
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 221 1223578899999998764 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.75 Aligned_cols=200 Identities=37% Similarity=0.580 Sum_probs=172.2
Q ss_pred CCcCCeeeccCceEEEEEEECC-----CcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 678 FDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~-----g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
|.+.+.||+|+||.||++.+.+ +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999864 378999999765443 5678899999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++...... .+++.++..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||.+....
T Consensus 81 e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999998764321 2899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
...........+++.|+|||.+....++.++||||+|++++||++ |+.||..
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 543222212236789999999988889999999999999999998 7888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=270.07 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=169.9
Q ss_pred CCCcCCeeeccCceEEEEEEE----CCCcEEEEEEeccccc----hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCcee
Q 002566 677 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~----~~g~~vAVK~~~~~~~----~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 747 (907)
+|++.+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|++++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3688999999875422 2345678899999999 599999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 99999999999999986542 5788999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...............|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 87644332222235688999999998753 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=270.89 Aligned_cols=200 Identities=29% Similarity=0.442 Sum_probs=170.4
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch-----hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6889999999765432 244577899999999999999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+ +|+|.+++.... ..+++..+.+++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999986543 25899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
....... ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||....
T Consensus 153 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 153 GSPNRKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred cCCCccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 5433221 22346788999998864 467899999999999999999987775433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=284.58 Aligned_cols=200 Identities=26% Similarity=0.471 Sum_probs=172.9
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCc-EEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~-~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+.+.++..||.|+||.||||+.++.. ..|.|++...+.....+|+-|+++|...+||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34556778999999999999987644 45678887777778889999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
.||-.+..+..-+ ..+.++++.-+++|++.||.|||++. |||||||+.|||++-||.++|+|||.+.......
T Consensus 112 ~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred CCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 9999988875543 37999999999999999999999997 9999999999999999999999999986543322
Q ss_pred ccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. ....+.||++|||||+... .+|+.++|||||||+|.||..+.+|...
T Consensus 185 q-kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 185 Q-KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred h-hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 1 1234689999999998863 4799999999999999999999999743
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=267.43 Aligned_cols=198 Identities=27% Similarity=0.534 Sum_probs=171.5
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcC---CCceeeEEeEEeeCceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... .....++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999974 68899999987543 334567888999999886 999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++... .+++..+..++.|+++||.|||+.+ |+||||+|+||++++++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988543 5889999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
..... .....|+..|+|||++.++ .++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 54322 2234688999999988754 5688999999999999999999999543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=267.78 Aligned_cols=198 Identities=23% Similarity=0.401 Sum_probs=159.2
Q ss_pred CeeeccCceEEEEEEECCC---cEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 682 NKVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
++||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986443 346677765443 334568999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC-cc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-TH 836 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 836 (907)
+|.+++...... ....++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999764321 234677788899999999999999987 9999999999999999999999999986432211 11
Q ss_pred ccccccccccccchhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNY 883 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~-------~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 883 (907)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 1123457889999998753 245789999999999999997 5667743
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=273.04 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=169.7
Q ss_pred CCCcCCeeeccCceEEEEEEECC---CcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeE
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~---g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 748 (907)
+|++.++||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999998643 33345678899999999999999999999987 7899
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC----CCcEEEeec
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKISDF 824 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 824 (907)
+||||+++ ++.+++..........++...+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5656554332222236889999999999999999999997 999999999999999 999999999
Q ss_pred CCcccccCCCcc--ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 825 GLAKLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 825 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
|++......... ......++..|+|||++.+ ..++.++||||||++++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999876443221 1223467899999998876 4578999999999999999999999965433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=267.99 Aligned_cols=200 Identities=30% Similarity=0.434 Sum_probs=176.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 58899999997543 2345678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998654 26889999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
... .....|+..|+|||++....++.++|+||||+++|+|++|+.||.....
T Consensus 153 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 153 DTL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred Ccc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 321 2234688899999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=266.42 Aligned_cols=199 Identities=27% Similarity=0.447 Sum_probs=168.9
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch----------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ----------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~----------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 745 (907)
+|...+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999865 6889999988542111 1245778999999999999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 9999999999999999986542 6889999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcc-ccccccccccccchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 826 LAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 826 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
++......... ......|+..|+|||++.... ++.++|+||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 99765432211 122345789999999987654 78899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.16 Aligned_cols=201 Identities=26% Similarity=0.421 Sum_probs=173.7
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999975 6889999998653 233446788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ..+++.++++++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998865321 25789999999999999999999987 999999999999999999999999999866443
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. ......|++.|+|||++.+...+.++|+||||++++||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 22 122345788999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=265.67 Aligned_cols=197 Identities=30% Similarity=0.519 Sum_probs=171.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999875 68899999986543 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999988543 5789999999999999999999987 9999999999999999999999999987654432
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. .....++..|+|||++.....+.++|+||||+++|||++|+.||..
T Consensus 156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 156 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hh-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 21 2234578899999999888889999999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=269.56 Aligned_cols=190 Identities=27% Similarity=0.438 Sum_probs=161.4
Q ss_pred CeeeccCceEEEEEEECC--------CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~--------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888766555567889999999999999999999999998999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc--------EEEeecC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFG 825 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFG 825 (907)
+++|+|.+++..... .+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999976532 5789999999999999999999987 999999999999987765 6999999
Q ss_pred CcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCC-CCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK-SNTNY 883 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~-~p~~~ 883 (907)
.+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 98755432 12357889999999986 45789999999999999999995 55543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=273.58 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=170.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccc--cchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 751 (907)
...|++.++||+||.+.||++...+.+.+|+|++... ..+....|.+|+..|.+++ |.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4567888999999999999999988899999887543 3455678999999999985 999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||= ..+|..+|..+... ..+| .++.+..||+.|+.++|++| |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 985 56899999766432 3344 78899999999999999998 99999999999986 5789999999999888
Q ss_pred CCCcccc-ccccccccccchhhhccC-----------CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHIS-TRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~-~~~~gt~~y~aPE~l~~~-----------~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.+..... ...+||+.||+||.+... +.++++||||+||+||+|+.|+.||..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 7765442 236899999999998632 367789999999999999999999953
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=269.00 Aligned_cols=210 Identities=29% Similarity=0.475 Sum_probs=173.9
Q ss_pred cHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEee-
Q 002566 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE- 743 (907)
Q Consensus 667 ~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~- 743 (907)
++.++....+.|++.+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566788999999999999999999975 58899999986543 2345678899999888 79999999999853
Q ss_pred -----CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 744 -----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 744 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
.+..++||||+++|+|.+++..... ..+++..+..++.|+++|+.|||+.+ |+||||+|+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 4578999999999999998865332 25788889999999999999999997 999999999999999999
Q ss_pred EEEeecCCcccccCCCccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999876543221 122346889999999886 346788999999999999999999999543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.47 Aligned_cols=194 Identities=30% Similarity=0.465 Sum_probs=159.4
Q ss_pred CeeeccCceEEEEEEECC----CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEee-CceeEEEeeecc
Q 002566 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYMK 755 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~~~ 755 (907)
+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 4579999986432 3345678899999999999999999998764 556789999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++..... ..++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999965422 4577888999999999999999987 99999999999999999999999999976543221
Q ss_pred c---ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhC-CCCCC
Q 002566 836 H---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTN 882 (907)
Q Consensus 836 ~---~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG-~~p~~ 882 (907)
. ......++..|+|||++.+..++.++||||||+++|||++| .+||.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 11123457789999999888899999999999999999995 45554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=267.14 Aligned_cols=197 Identities=28% Similarity=0.533 Sum_probs=172.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.|+..+.||+|++|.||+|... +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555689999999999999974 688999999876555556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++... ++++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 100 GGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999988652 5789999999999999999999997 99999999999999999999999998876543322
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 R-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred c-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 1 1224588999999999888899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=264.21 Aligned_cols=196 Identities=29% Similarity=0.479 Sum_probs=167.3
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67789999986542 345788999999999999999999998764 4799999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++..... ..+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 9999999975432 25789999999999999999999987 99999999999999999999999999876433211
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~ 885 (907)
....+..|+|||++.+..++.++|+||||+++|||++ |+.||....
T Consensus 156 ----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 156 ----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 1234568999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=266.35 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=171.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 751 (907)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|+++++.++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999985 578999999875433 3456789999999999999999999998653 4689999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++..... ....++...+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999888753211 2235788999999999999999999987 9999999999999999999999999987554
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 3221 2345788999999999889999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=268.56 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=169.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|++|.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 688999999875432 2235788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+. ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 578888765322 36899999999999999999999987 999999999999999999999999998865443
Q ss_pred CccccccccccccccchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred ccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 221 12234688999999887644 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=265.80 Aligned_cols=193 Identities=32% Similarity=0.418 Sum_probs=166.9
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||+||++... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999986542 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++..... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||.+........ ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 152 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IK 152 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cc
Confidence 999875532 25899999999999999999999997 99999999999999999999999999986543221 12
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...++..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 245788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=280.60 Aligned_cols=208 Identities=26% Similarity=0.404 Sum_probs=176.8
Q ss_pred cCCeeeccCceEEEEEEECC--Cc--EEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 680 PANKVGEGGFGSVYKGILSD--GT--VIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~~--g~--~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
..++||+|.||.|++|.|.. |+ .||||.++..... ...+|++|+.+|.+++|||+|++||.+.+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35889999999999999863 43 6899999877554 56789999999999999999999999987 6788999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
+.|||.+.|+.. ....+-......++.|||.||.||..++ +|||||..+|+|+-....+||+|||+.+-+....
T Consensus 193 plGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999872 2346788899999999999999999987 9999999999999999999999999999887654
Q ss_pred cccc--ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 002566 835 THIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLD 894 (907)
Q Consensus 835 ~~~~--~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~l~~ 894 (907)
.... ....-.+.|+|||.+....++.++|||+|||++|||++ |+.||-....-.+...++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 4321 12334678999999999999999999999999999999 888997665544444444
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=261.73 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=172.6
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 68889999986542 33456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 832 (907)
+++++|.+++.... ...+++..+.+++.|+++|++|||+++ ++||||+|+||+++++ +.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999996543 225799999999999999999999987 9999999999999865 4679999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
... .....++..|+|||.+.+...+.++||||||+++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 322 12346889999999999888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=265.00 Aligned_cols=191 Identities=30% Similarity=0.430 Sum_probs=159.4
Q ss_pred eeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHH---HHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIG---MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865422 22223444443 3445689999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++.... .+++..+..++.|+++|++|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 999998885432 6899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....|+..|+|||++.++ .++.++||||+|+++|||++|+.||...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 224689999999998754 6889999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=265.36 Aligned_cols=202 Identities=29% Similarity=0.500 Sum_probs=170.8
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+|+..++||+|++|.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999986 5889999998765432 3456778999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++ +|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 85 78887755432 236899999999999999999999987 9999999999999999999999999997654332
Q ss_pred ccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....++..|++||++.+. .++.++||||||+++|||++|+.||....
T Consensus 155 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 NT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred cc-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223568899999988654 57889999999999999999999996544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=262.15 Aligned_cols=192 Identities=25% Similarity=0.396 Sum_probs=168.8
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|++|.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++.+.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 488999999875432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--~~ 150 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TW 150 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--cc
Confidence 99996543 4789999999999999999999987 99999999999999999999999999987654321 12
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
...++..|+|||++....++.++|+||+|+++|||++|+.||....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3467889999999988889999999999999999999999996554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=266.61 Aligned_cols=202 Identities=29% Similarity=0.470 Sum_probs=172.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-----CCcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEee--Ccee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-----~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 747 (907)
+.|...+.||+|+||.||+|.+. .++.||||.++..... ..++|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999864 3678999999866543 46789999999999999999999999887 5578
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++..... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 999999999999999976532 5899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCccc--cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.......... .....++..|+|||.+....++.++||||||++++||++|+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 8775332211 11223456799999998888999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.00 Aligned_cols=196 Identities=28% Similarity=0.436 Sum_probs=172.3
Q ss_pred CCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCC
Q 002566 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
.++||.|.||+||-|.++ +|+.||||++.+. .++.+..+.+|+.+|+.++||.||.+---|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 579999999999999976 7999999999765 3455677889999999999999999999999999999999999877
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CcEEEeecCCcccccCCC
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 834 (907)
-|+-.|..... ++++..-..+..||+.||.|||.++ |+|+||||+|||+.+. -.+||||||.|+...+..
T Consensus 649 MLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 77776655433 6888888889999999999999998 9999999999999643 579999999999987643
Q ss_pred ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
....++||+.|.|||++....|...-|+||.||++|-=++|.-||+..+
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 3345789999999999999999999999999999999999999997543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=266.49 Aligned_cols=202 Identities=28% Similarity=0.434 Sum_probs=167.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999976 688999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCccccc
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 831 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 831 (907)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 577777644321 24678889999999999999999987 999999999999985 5679999999997654
Q ss_pred CCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... .....+++.|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 155 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 155 IPVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred CCccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33221 122357889999998865 457899999999999999999999996543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=264.24 Aligned_cols=202 Identities=27% Similarity=0.486 Sum_probs=169.5
Q ss_pred CCCcCCeeeccCceEEEEEEECC--CcEEEEEEecccc----------chhhHHHHHHHHHHHh-cCCCceeeEEeEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS----------RQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 743 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~--g~~vAVK~~~~~~----------~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~ 743 (907)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 6789999875332 2223457788888765 799999999999999
Q ss_pred CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
++..++||||+++++|.+++.... .....+++..+++++.|++.||.|||+.. .++||||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998875321 11236889999999999999999999632 399999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998765443 22334688999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=266.53 Aligned_cols=202 Identities=31% Similarity=0.580 Sum_probs=177.4
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++.|...+.||+|++|.||+|.+. +++.||+|++..... ....+.+|+++++.++|+|++++++++..++..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999987 688999999976554 56678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999997653 26899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 169 EKSK-RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred chhh-hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 3221 12235788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=266.62 Aligned_cols=200 Identities=32% Similarity=0.508 Sum_probs=166.3
Q ss_pred CeeeccCceEEEEEEECC-------CcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 682 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~-------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.||+|+||.||+|...+ ++.+|+|.+.... .....++.+|+++++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998643 2578999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-----cEEEeecCC
Q 002566 754 MKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-----NAKISDFGL 826 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGl 826 (907)
+++++|.+++...... ....+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999653221 1234789999999999999999999987 99999999999999887 899999999
Q ss_pred cccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 827 AKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9765432211 1112345678999999999999999999999999999998 99998543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=269.70 Aligned_cols=195 Identities=31% Similarity=0.511 Sum_probs=166.6
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
+.|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 68899999986432 233457889999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||++ |++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 56766664332 25899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... ...++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 332 235788999999874 35688899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=267.46 Aligned_cols=204 Identities=25% Similarity=0.358 Sum_probs=168.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCce-----
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ----- 746 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~----- 746 (907)
++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 6889999998654322 2457888999999995 6999999999887665
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeecC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFG 825 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 825 (907)
.++||||+++ +|.+++..........+++..+..++.||++||+|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888876543222346899999999999999999999997 999999999999998 8999999999
Q ss_pred CcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99865433221 122346888999998865 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=257.58 Aligned_cols=199 Identities=33% Similarity=0.588 Sum_probs=177.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999986 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++.... ..+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999986643 36899999999999999999999987 99999999999999999999999999987665432
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.....++..|+|||++.....+.++||||||++++||++|+.||...
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23346889999999999888999999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.21 Aligned_cols=199 Identities=26% Similarity=0.478 Sum_probs=174.7
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999986 58899999987653 34456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
+++++|.+++.... ..++...+.+++.|+++|++|||+ .+ ++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999986542 368899999999999999999999 76 99999999999999999999999999876643
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 154 SLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 3221 156888999999999889999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=268.04 Aligned_cols=194 Identities=27% Similarity=0.519 Sum_probs=169.9
Q ss_pred CCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
..+||+|+||.||+|... +++.||+|++..........+.+|+.+++.++|+|++++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++... .+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||.+........ ...
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9887432 4789999999999999999999997 99999999999999999999999999876543321 122
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
...|++.|+|||++.+..++.++|+||+|+++|||++|+.||...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 346889999999998888899999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=266.90 Aligned_cols=202 Identities=28% Similarity=0.444 Sum_probs=170.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV 750 (907)
++|...+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 5889999998754322 233567899999999999999999998877 889999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||++ ++|.+++..... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.+...
T Consensus 85 ~e~~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 488888765432 5899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
....... ....++..|+|||.+.+. ..+.++|+||+|+++|||++|+.||.....
T Consensus 157 ~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 157 GSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred cCCcccc-ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5542211 223578899999988754 468899999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=261.41 Aligned_cols=206 Identities=27% Similarity=0.456 Sum_probs=172.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEee--CceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~LV~ 751 (907)
+|++.+.||.|+||.||+|... +++.||+|.+... .....+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 6789999998654 23345678899999999999999999998764 45679999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||+++++|.+++.... ....++++..++.++.|+++||+|||..+ ..+++||||+|+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999986532 12246899999999999999999999332 22499999999999999999999999999987
Q ss_pred ccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....... .....++..|+|||++....++.++|+||||+++++|++|+.||...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 6554321 22346899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=262.98 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=166.5
Q ss_pred CCcCCeeeccCceEEEEEEEC----CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002566 678 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 745 (907)
|.+.+.||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 36789999987542 334567889999999999999999999886532
Q ss_pred eeEEEeeeccCCchhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
..++++||+++|+|.+++..... .....+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999888753321 11225788999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 002566 825 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 884 (907)
Q Consensus 825 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 884 (907)
|.++........ ......++..|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999866433211 1122345678999999998889999999999999999999 88888543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=273.12 Aligned_cols=216 Identities=24% Similarity=0.405 Sum_probs=180.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
-|...+.||-|+||+|..+.-- +...+|+|.+.+.. +........|-.+|...+.+-||+|+..|++++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4667789999999999999854 46679999997653 3334456789999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc-
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE- 831 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~- 831 (907)
|++||++-.+|-..+ .+.+..++..+..++.|+++.|..| +|||||||.|||||.||++||.|||++.-+.
T Consensus 710 YIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 999999988886553 5788888999999999999999988 9999999999999999999999999985431
Q ss_pred --------CCCcc--------------------------------ccccccccccccchhhhccCCCCchhHHHHHHHHH
Q 002566 832 --------EDKTH--------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871 (907)
Q Consensus 832 --------~~~~~--------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl 871 (907)
.+... .....+||+.|+|||++....++.-+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 10000 00115699999999999999999999999999999
Q ss_pred HHHHhCCCCCCC-CCCcchhhHHHHHHHhh
Q 002566 872 LEIVSGKSNTNY-RPNEDFVYLLDWAYVLQ 900 (907)
Q Consensus 872 ~elltG~~p~~~-~~~~~~~~l~~~~~~~~ 900 (907)
|||+.|+.||-. .+.+....+++|...++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~ 891 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLH 891 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccc
Confidence 999999999954 45566667888875543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=267.06 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=170.0
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc---
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 745 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--- 745 (907)
+...++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999986 588999999875432 22356778999999999999999999987654
Q ss_pred -------eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 746 -------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 746 -------~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
..++||||+++ ++.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 78999999986 5666665432 26899999999999999999999997 999999999999999999
Q ss_pred EEEeecCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+||+|||.+...............++..|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998765443222222346788999998864 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=264.58 Aligned_cols=200 Identities=29% Similarity=0.471 Sum_probs=170.0
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEEEee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVYE 752 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E 752 (907)
|++.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999986 48899999998663 33345688999999999999999999999887 88999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9975 7888875542 26899999999999999999999987 99999999999999999999999999987755
Q ss_pred CCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43222233456888999997764 467899999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=234.35 Aligned_cols=218 Identities=23% Similarity=0.392 Sum_probs=176.7
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..++||+|.||+||||+.. .++.||+|++......+ -...++|+.+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999965 57889999987553322 34578999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++. .|..+...-. ..++.+.++.++.|+++||.++|+++ +.|||+||.|.|++.+|+.|++|||+++.++-.
T Consensus 83 cdq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 964 5666654332 36899999999999999999999997 999999999999999999999999999987665
Q ss_pred CccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccc
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 903 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 903 (907)
....+. .+-|..|.+|.++.+. -|+...|+||.||++.|+.. |++-|...+.+++...+-|+--...|+
T Consensus 155 vrcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 155 VRCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred eEeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 433333 3468999999999875 58889999999999999998 555565555555555555654434443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=264.44 Aligned_cols=205 Identities=30% Similarity=0.500 Sum_probs=172.1
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc-----
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN----- 745 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~----- 745 (907)
..+++|++.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999985 578899999875543 346789999999998 7999999999997644
Q ss_pred -eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 746 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
..++||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999998886432 11236899999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
|.+......... .....|+..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 158 GVSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ccceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 999765433221 223458899999998853 3467889999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=250.05 Aligned_cols=198 Identities=28% Similarity=0.514 Sum_probs=167.7
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.+....||.|..|.|+++..+ .|..+|||.+... ..+..++++..+.++.+- .+|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445678999999999999976 5899999999765 445567778888876665 489999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
|.. .+++++..-. .++++.-+-++...+++||.||.+++ .|||||+||+|||+|+.|.+|+||||++-++.+.
T Consensus 173 Ms~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 173 MST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 963 5666665432 36888888899999999999998876 5999999999999999999999999999888765
Q ss_pred Cccccccccccccccchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..+ ++-+|-+.|||||.+.- ..|+.++|||||||.++||.||+.||..
T Consensus 246 kAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 246 KAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 543 44579999999999963 4789999999999999999999999965
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=268.13 Aligned_cols=202 Identities=30% Similarity=0.476 Sum_probs=168.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~L 749 (907)
.++|++.+.||+|+||.||+|... +|+.||+|+++...... ...+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 58999999987543221 23567899999999999999999998754 56899
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.+..
T Consensus 86 v~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999974 7877775432 36899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
....... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6543221 122345788999999865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=260.12 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=164.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHH-HhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMI-SAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.+....||.|+||+|+|..++ .|+.+|||++..... .+.++++.|.+.. +.-+.||||+++|.+..++.-|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444678999999999999976 689999999987654 5567788888754 456899999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
|+ .|++.+-..-..-....+++.-.-.|+...++||.||.+.- +|||||+||+|||+|..|.+||||||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 96 45644322111122336888888899999999999998765 6999999999999999999999999999876553
Q ss_pred Cccccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
-. .+..+|-..|||||.+.. ..|+.++||||+|++|||+.||+.|+.
T Consensus 222 iA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 222 IA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred HH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 32 345678999999999963 358999999999999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=302.43 Aligned_cols=203 Identities=32% Similarity=0.475 Sum_probs=172.2
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
-++.....||.|.||.||.|.. .+|...|||.++... ....+...+|+.++..++|||+|+++|+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3566678999999999999995 468889999886543 3334567889999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
||++|+|.+.+...+ ..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|.....
T Consensus 1315 yC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999985442 4567777888899999999999998 99999999999999999999999999987765
Q ss_pred CCccc---cccccccccccchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 833 DKTHI---STRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~~~---~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
..... -...+||+.|||||++.+. ....++||||+|||+.||+||+.||...+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 43111 1236799999999999754 356689999999999999999999965544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=272.63 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=167.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----cee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~ 747 (907)
+++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999865 68899999986532 23456688899999999999999999987654 357
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++ ++.+.+... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 999999974 777776443 5899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCccc--cccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKTHI--STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.......... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8654332211 123468899999998754 5688999999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=264.03 Aligned_cols=199 Identities=28% Similarity=0.481 Sum_probs=168.4
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
|+..+.||+|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999975 68999999987543 222356889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
+ ++|.+++..... ..+++..+.+++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689888865432 35899999999999999999999987 9999999999999999999999999997654332
Q ss_pred ccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.. .....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1223468899999988654 5788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=261.77 Aligned_cols=194 Identities=28% Similarity=0.445 Sum_probs=168.4
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999876533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc----
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---- 835 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 835 (907)
.+++.... .+++..+.+++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99986543 6899999999999999999999997 99999999999999999999999999876543321
Q ss_pred ---cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 836 ---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 836 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.......++..|+|||.......+.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 01223457889999999988888999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.54 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=169.4
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch---hhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV 750 (907)
.+|....+||+|+||+|..|.-+ +.+.+|||++++..-- +.+--+.|-++|... +-|.+++++.+++.-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999876 4678999999876321 122223455566543 678999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+.+|+|--++..-+ .+.++.+.-.|..||-||-+||+++ ||.||||..|||+|.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999988886543 5778889999999999999999998 999999999999999999999999999854
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
-.+.. ....++||+.|+|||++...+|+..+|.|||||+||||+.|++||+..
T Consensus 501 i~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 IFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 33322 234589999999999999999999999999999999999999999754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=266.34 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=166.2
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-------
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 745 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------- 745 (907)
++|+..++||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999976 688999998865432 22345678999999999999999999987644
Q ss_pred -eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 746 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
..++||||+++ +|.+.+.... ..+++.++..++.|+++||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 35999999974 7777775432 25899999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcc---ccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 825 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 825 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
|++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999866443221 11224578899999988764 46889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=266.02 Aligned_cols=193 Identities=30% Similarity=0.501 Sum_probs=164.9
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999975 68899999986432 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++ |++.+.+.... .++++.++..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 97 57777664432 26899999999999999999999997 999999999999999999999999998754432
Q ss_pred Cccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
....|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2235788999999974 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=270.34 Aligned_cols=205 Identities=27% Similarity=0.410 Sum_probs=172.1
Q ss_pred cHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEee
Q 002566 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (907)
Q Consensus 667 ~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 743 (907)
..+++..++++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566778899999999999999999999864 68899999987542 2234568889999999999999999998864
Q ss_pred C------ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 002566 744 G------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (907)
Q Consensus 744 ~------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 817 (907)
. ...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3 3467888887 67888877532 5789999999999999999999997 99999999999999999
Q ss_pred cEEEeecCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 818 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 818 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 158 ELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred CEEEecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999988653321 23457889999998866 568889999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=258.55 Aligned_cols=190 Identities=28% Similarity=0.392 Sum_probs=161.1
Q ss_pred CeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHH-HHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999975 588999999875432 222334445444 4456899999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
++|.+++.... .+++..+.+++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 150 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence 99999986542 5789999999999999999999987 999999999999999999999999998754331
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred --ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 2345788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=260.14 Aligned_cols=200 Identities=26% Similarity=0.451 Sum_probs=172.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999986 57889999986542 23345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 832 (907)
+++++|.+++..... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999865422 25799999999999999999999987 99999999999999885 469999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... ......|++.|+|||+..+..++.++|+||||++++||++|+.||..
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 12234588999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=255.22 Aligned_cols=198 Identities=30% Similarity=0.522 Sum_probs=175.1
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++.+++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 578999999977644 4556789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988654 26899999999999999999999997 999999999999999999999999999877654
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... .....++..|+|||...+...+.++||||+|++++||++|+.||..
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 332 2234678999999999888889999999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=271.34 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=169.0
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----- 744 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~----- 744 (907)
...++|+..+.||+|+||.||+|... +++.||+|.+... ......++.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999975 6889999998643 233345677899999999999999999988643
Q ss_pred -ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 745 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 745 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
...++||||++ ++|.+.+.. .++...+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 34699999996 477777642 2688899999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
||+++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 999987644322 22345788999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=262.45 Aligned_cols=201 Identities=21% Similarity=0.241 Sum_probs=153.6
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC----CcEEEEEEeccccchhh-----------HHHHHHHHHHHhcCCCceeeEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-----------REFVNEIGMISAQQHPNLVKLYG 739 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~~~~~-----------~~f~~E~~~l~~l~H~nIv~l~g 739 (907)
.++|.+.++||+|+||.||+|.+.+ +..+|+|+......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999764 34566665433221111 11223344556678999999999
Q ss_pred EEeeCc----eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 002566 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (907)
Q Consensus 740 ~~~~~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 815 (907)
++.... ..++++|++.. ++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 876543 34677887643 455554322 13577889999999999999999987 999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcc------ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 816 DLNAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 816 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
++.++|+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999876432211 112246999999999999999999999999999999999999999655
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=255.39 Aligned_cols=201 Identities=34% Similarity=0.507 Sum_probs=176.7
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeC--ceeEEEe
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 751 (907)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999987 688999999876543 4567889999999999999999999999988 8899999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999986543 6899999999999999999999987 9999999999999999999999999998776
Q ss_pred CCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 832 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... ......++..|+|||.+.....+.++||||||++++||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 1223468899999999988889999999999999999999999996554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=271.24 Aligned_cols=203 Identities=29% Similarity=0.470 Sum_probs=169.3
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC--cee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG--NQL 747 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~ 747 (907)
..++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999976 5789999988643 223345677899999999 999999999998653 367
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 5888887543 5788999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcc----ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 828 KLYEEDKTH----ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 828 ~~~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
......... ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 866443221 2223568899999998764 5678899999999999999999999965443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=264.83 Aligned_cols=202 Identities=29% Similarity=0.466 Sum_probs=164.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999975 58899999987543 334567889999999986 99999999999998899999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
++. ++.++...........+++..+..++.|+++||+|||+.. .++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 4544321100011236899999999999999999999752 3999999999999999999999999999765433
Q ss_pred CccccccccccccccchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
... ....|+..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 221 223578899999999765 689999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=262.79 Aligned_cols=199 Identities=28% Similarity=0.421 Sum_probs=169.2
Q ss_pred CCCcCCeeeccCceEEEEEEEC----CCcEEEEEEecccc----chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCcee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~----~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 747 (907)
+|++.+.||+|++|.||++... +++.||||.++... ....+.+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999999853 56889999987532 22345688899999999 599999999999999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 99999999999999886532 5789999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCccccccccccccccchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 865443322222346889999999987654 78899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=259.88 Aligned_cols=196 Identities=28% Similarity=0.381 Sum_probs=163.2
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeC--ceeEEEee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVYE 752 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~E 752 (907)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999975 68899999987642 222334567888888885 99999999999987 88999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|++ +++.+.+.... ..+++.++..++.|+++||+|||+.+ ++||||+|+||+++. +.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 57777775432 26899999999999999999999997 999999999999999 9999999999986644
Q ss_pred CCccccccccccccccchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
.... ....++..|+|||++. ...++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 152 KPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 3221 2245788999999765 456788999999999999999999999653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=238.60 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=165.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHH-hcCCCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+.......||+|++|.|=+.++. +|+..|||.+.... .+..++.+.|+.+.. ...+|.+|.++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344445678999999999888864 79999999997653 344566778887654 468999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|.|+ .||+.+-.. --.....+++..+-+||..+.+||.|||++- .+||||+||+|||++.+|++|+||||.+-.+.
T Consensus 125 E~M~-tSldkfy~~-v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRK-VLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhh-hhHHHHHHH-HHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9996 466544321 1122346899999999999999999999975 69999999999999999999999999998776
Q ss_pred CCCccccccccccccccchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
+.-.. +..+|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.|++.
T Consensus 201 dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 201 DSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 54332 22468889999999863 3689999999999999999999999854
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=257.23 Aligned_cols=202 Identities=32% Similarity=0.489 Sum_probs=175.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 67899999987543 33456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++.... .....+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999886532 12236899999999999999999999997 999999999999999999999999999876554
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
. .....++..|+|||.+.+..++.++|+||+|++++||++|+.||....
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 122457889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=254.06 Aligned_cols=203 Identities=26% Similarity=0.450 Sum_probs=177.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999986 588999999976533 4566788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++++|.+++..... ....+++.++..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998876421 1237899999999999999999999997 999999999999999999999999999876544
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. .......|++.|+|||......++.++||||+|+++++|++|+.||...
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 3 1223346888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=261.26 Aligned_cols=202 Identities=28% Similarity=0.445 Sum_probs=175.5
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV 750 (907)
++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 6899999998753 2233467888999999998 99999999999999999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999986543 6899999999999999999999997 999999999999999999999999999866
Q ss_pred cCCCc-------------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 831 EEDKT-------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~-------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
..... .......++..|+|||.......+.++||||||++++|+++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 54321 11123457899999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=263.12 Aligned_cols=204 Identities=27% Similarity=0.419 Sum_probs=171.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-c------hhhHHHHHHHHHHHhcCCCceeeEEeEEe-eCc
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-R------QGNREFVNEIGMISAQQHPNLVKLYGCCV-EGN 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~-~~~ 745 (907)
.++|-..++||+|||+.||||.+- ..+.||||+-.... . .-.+...+|.++.+.++||-||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456777889999999999999854 56788999865331 1 11344678999999999999999999987 457
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCcEEEe
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKIS 822 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~ 822 (907)
.++-|+||++|.+|+-+|.... -+++++++.|+.||+.||.||.+.. +||||-||||.|||+. .-|.+||.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 7899999999999999997764 5899999999999999999999885 6799999999999995 34789999
Q ss_pred ecCCcccccCCCcc------ccccccccccccchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 823 DFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 823 DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~----~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
|||+++.+..+... .....+||.+|++||.+.- ..++.|+||||.||++|..+.|+.||...
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 99999998765432 3445789999999997753 35888999999999999999999999643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=266.82 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=169.0
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc--
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-- 745 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-- 745 (907)
+....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445788999999999999999999865 68899999986432 223456889999999999999999999987643
Q ss_pred ----eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEE
Q 002566 746 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (907)
Q Consensus 746 ----~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 821 (907)
..++||||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 458999998 67888877532 5789999999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 822 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+|||++....... ....+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 160 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 160 LDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred eecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998654322 22357889999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=268.25 Aligned_cols=201 Identities=23% Similarity=0.413 Sum_probs=169.0
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEee----Ccee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~ 747 (907)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478899999999999999999975 68999999987543 2334567789999999999999999988763 3468
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+. ++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 68888886542 5899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcc---ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 828 KLYEEDKTH---ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 828 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 765433221 1123468899999999865 46889999999999999999999999543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=267.56 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=168.4
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ce
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 746 (907)
.++|.+.+.||+|+||.||+|... +++.||||.++.. ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467899999999999999999975 6889999998754 233345678899999999999999999988654 34
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+. ++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999996 67888775432 6899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 155 ARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 986644321 2223457889999998865 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=258.71 Aligned_cols=200 Identities=28% Similarity=0.449 Sum_probs=171.0
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
|+..+.||+|++|.||+|... +++.+++|+++..... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999975 6889999998765332 3567888999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++ ++.+.+.... .++++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 7877775532 26899999999999999999999997 9999999999999999999999999998775543
Q ss_pred ccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
. ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.....
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 12224578899999998876 789999999999999999999999965443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=267.21 Aligned_cols=200 Identities=27% Similarity=0.424 Sum_probs=172.4
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc-----eeE
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 748 (907)
+|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999976 48899999987654 344567899999999999999999999988765 789
Q ss_pred EEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||++ ++|.+++.... ++++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 47888886542 6899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCc--cccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 829 LYEEDKT--HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 829 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
....... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 7655431 112234578899999999877 88999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=271.19 Aligned_cols=275 Identities=22% Similarity=0.234 Sum_probs=194.3
Q ss_pred ceEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEee
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 171 (907)
..+..|++++|.+...-+..|.++++|++++|.+|.++.++...-..-+|+.|+|.+|.|+.+-...++.++.|+.||||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 35678999999999777888999999999999999998654322222268888888888888877888888888888888
Q ss_pred CCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCc
Q 002566 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (907)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 251 (907)
.|.|+...-..|..-.+|++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-..
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 88888555566777778888888888888777778888888888888888888667777878888888888888887554
Q ss_pred hhhhhcCCCCCEEEcCCCCCCCCCcccc-------------------------cccccceEEcccccccccCCccccCCC
Q 002566 252 PASISALTSLTDLRISDLKGSESAFPKL-------------------------DKMNLKTLILTKCLIHGEIPDYIGDMT 306 (907)
Q Consensus 252 ~~~l~~l~~L~~L~L~~n~~~~~~~~~~-------------------------~~~~L~~L~Ls~N~i~~~~p~~~~~l~ 306 (907)
-..|..|++|+.|.|..|.+.......+ +...|+.|+||+|.|..+.++.....+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 5566666666666666666554433322 122455556666666555555555556
Q ss_pred CccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhh---hccCCcceeecCCccCC
Q 002566 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWE 367 (907)
Q Consensus 307 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~---~~~l~~l~ls~N~~~~~ 367 (907)
+|+.|+||+|+|+...+.+|..|..|+.|+|++|+++ .+.+.. ..+++.|||+.|.++|.
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 6666666666666555666666666666666666655 333322 33566777777777753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=266.17 Aligned_cols=196 Identities=27% Similarity=0.429 Sum_probs=164.4
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------c
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~ 745 (907)
.++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999975 68999999987542 22245688999999999999999999998754 2
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
..++|+||+.. +|.+... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 46899999964 5655541 15789999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 163 LARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 997653321 22457889999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=256.98 Aligned_cols=198 Identities=29% Similarity=0.474 Sum_probs=165.4
Q ss_pred CCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccch--hhHHHHHHHHHHHhc---CCCceeeEEeEEeeCce-----
Q 002566 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQ----- 746 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~----- 746 (907)
|++.+.||+|+||.||+|+.+. ++.||+|+++..... ....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999874 899999999754322 234566777776655 69999999999988776
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.+++|||+++ +|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999974 78888765322 25899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+......... ....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 154 ARIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ceeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 9876543221 2235788999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=260.63 Aligned_cols=200 Identities=30% Similarity=0.528 Sum_probs=164.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
-++|++.+.||+|+||.||+|.+.+ ++.||||.++.... ....++..|+.++.+. .||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999999875 89999999975432 3345667777766666 4999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||++ +++.+++.... ..+++..+.+++.|+++|++|||+.. +|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 46666654422 26899999999999999999999742 39999999999999999999999999997664
Q ss_pred CCCccccccccccccccchhhhccCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGY----LTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 33222 2235788999999987553 78899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=264.01 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=169.4
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEee-Cce
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 746 (907)
+..++++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456889999999999999999999865 78999999886432 2334678899999999999999999999875 557
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+. ++|.+++... ++++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||.
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred EEEEeehhc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 899999984 6888887543 4688889999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+....... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 155 ARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 97553321 22356889999998765 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=262.98 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=165.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch--hhHHHHHHHHHHHhcCCCceeeEEeEEeeC-------
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEG------- 744 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------- 744 (907)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 5889999998654322 234577899999999999999999987543
Q ss_pred -ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 745 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 745 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
...++||||++. ++...+.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 346999999975 5666664432 26899999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCccc----------cccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHI----------STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 824 FGla~~~~~~~~~~----------~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
||+++......... .+...+++.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99998654332111 122356888999998865 457899999999999999999999996433
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=258.58 Aligned_cols=193 Identities=31% Similarity=0.507 Sum_probs=163.8
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|...++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 688999999865422 2345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+. |++.+.+.... .++++.++..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 96 56766664432 26899999999999999999999997 999999999999999999999999998643322
Q ss_pred Cccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
....|+..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2346888999999984 45688899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=285.22 Aligned_cols=197 Identities=32% Similarity=0.506 Sum_probs=159.4
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc-chhhHHHHHHHHHHHhcCCCceeeEEeEEeeC------
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 744 (907)
+-..+|.+.+.||+||||.|||++.+ ||+.||||++.... ........+|+.++++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999987 89999999997663 33355688999999999999999987543210
Q ss_pred --------------------------------------------------------------------------------
Q 002566 745 -------------------------------------------------------------------------------- 744 (907)
Q Consensus 745 -------------------------------------------------------------------------------- 744 (907)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHH
Q 002566 745 ---------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791 (907)
Q Consensus 745 ---------------------------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 791 (907)
-.+||-||||+..++.++++.+... -.....++++++|++||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHH
Confidence 0147788888887777777655321 146788999999999999
Q ss_pred HHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc------C-----------CCccccccccccccccchhhhc
Q 002566 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE------E-----------DKTHISTRIAGTIGYMAPEYAM 854 (907)
Q Consensus 792 yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~l~ 854 (907)
|+|+.| ||||||||.||++|++..|||+|||+|.... . ......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999998 9999999999999999999999999998721 0 0011234468999999999997
Q ss_pred cC---CCCchhHHHHHHHHHHHHHh
Q 002566 855 RG---YLTSKADVYSFGVVTLEIVS 876 (907)
Q Consensus 855 ~~---~~~~k~DvwSlGvvl~ellt 876 (907)
+. .|+.|+|+||+|||++||+.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc
Confidence 64 59999999999999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=263.04 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=166.2
Q ss_pred hcCCCc-CCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--------------hHHHHHHHHHHHhcCCCceeeEE
Q 002566 675 TNNFDP-ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--------------NREFVNEIGMISAQQHPNLVKLY 738 (907)
Q Consensus 675 ~~~~~~-~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--------------~~~f~~E~~~l~~l~H~nIv~l~ 738 (907)
.++|.. .+.||+|+||.||+|... +++.||+|++....... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345543 567999999999999975 68899999986543221 12577899999999999999999
Q ss_pred eEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 739 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
+++..++..++||||++ |+|.+++... ..+++.....++.|+++||+|||+.+ ++||||+|+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 99999999999999997 6888887543 25789999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCC-------------ccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDK-------------THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+||+|||++....... ........++..|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998665111 0011123467889999998764 4689999999999999999999999654
Q ss_pred C
Q 002566 885 P 885 (907)
Q Consensus 885 ~ 885 (907)
.
T Consensus 238 ~ 238 (335)
T PTZ00024 238 N 238 (335)
T ss_pred C
Confidence 3
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=261.33 Aligned_cols=196 Identities=19% Similarity=0.236 Sum_probs=161.0
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344455555555544 6899999998754 344556899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc---
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--- 836 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 836 (907)
.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999875422 25788999999999999999999997 999999999999999999999999998765432211
Q ss_pred ---ccccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ---ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ---~~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122456788999999876 35788999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=262.49 Aligned_cols=197 Identities=21% Similarity=0.342 Sum_probs=161.9
Q ss_pred Ceeecc--CceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccC
Q 002566 682 NKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G--~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
..||+| +||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999975 78999999987543 22346788899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
+++.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998865432 25889999999999999999999987 999999999999999999999999865433221111
Q ss_pred c------cccccccccccchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 I------STRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~------~~~~~gt~~y~aPE~l~~~--~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0 0112346679999999764 4789999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=259.49 Aligned_cols=194 Identities=29% Similarity=0.498 Sum_probs=165.0
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEee
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++..++..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666789999999999999975 5788999998643 22334568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+. |++.+.+.... .++++.++..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 57777765432 25789999999999999999999987 99999999999999999999999999876543
Q ss_pred CCccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 833 DKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.. ...++..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 168 AN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred cc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 22 235788999999975 34678899999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=257.14 Aligned_cols=199 Identities=28% Similarity=0.425 Sum_probs=168.4
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
|.+.+.||+|++|.||+|... +++.||+|++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 478899999875533 23334567899999999 999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
+|+|.+.+.... ...+++..+..++.|++++|.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 788988886553 136799999999999999999999997 9999999999999999999999999998665432
Q ss_pred ccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
. .....++..|+|||++.+ ..++.++|+||||++++||++|+.||....
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 2 123457889999998754 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=265.26 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=166.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC---------
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--------- 744 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------- 744 (907)
..+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999975 5889999998776666667788999999999999999999776543
Q ss_pred -----ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCc
Q 002566 745 -----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLN 818 (907)
Q Consensus 745 -----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~ 818 (907)
...++||||++ ++|.+++... .+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 35789999997 5887777432 5789999999999999999999998 999999999999974 567
Q ss_pred EEEeecCCcccccCCCcc--ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 819 AKISDFGLAKLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
+|++|||.++........ ......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999865432111 1122357889999998754 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=261.76 Aligned_cols=200 Identities=26% Similarity=0.396 Sum_probs=164.2
Q ss_pred CCCcCCeeeccCceEEEEEEEC-C--CcEEEEEEecccc--chhhHHHHHHHHHHHhc-CCCceeeEEeEEeeC----ce
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-D--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG----NQ 746 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~--g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~----~~ 746 (907)
+|++.+.||+|+||.||++... . ++.||+|++.... ....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999975 3 6789999986532 22345678899999998 599999999875432 45
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCC
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 826 (907)
.++++||++ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999986 67888875432 6899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCcc---ccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 827 AKLYEEDKTH---ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 827 a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
++........ ......|+..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9865432211 1123468999999998765 468999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=244.85 Aligned_cols=199 Identities=26% Similarity=0.378 Sum_probs=172.8
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~L 749 (907)
-++|+..++||+|+|++|..+++. +.+.+|+|+++++.- ++..-.+.|-.+..+ -+||.+|-+..+++.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367899999999999999999975 578899999987632 333445566666654 589999999999999999999
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
|.||+++|+|--++..+. .++++.++.....|.-||.|||++| ||.||+|..|+|+|.+|++|+.|+|+.+.
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 999999999977765543 6899999999999999999999998 99999999999999999999999999985
Q ss_pred ccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
--.. ......++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 4332 223456899999999999999999999999999999999999999994
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=248.34 Aligned_cols=201 Identities=29% Similarity=0.418 Sum_probs=170.2
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeC-----ceeEE
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLL 749 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~L 749 (907)
....+.||-|+||.||.+.+. +|+.||.|++... +-...+.+.+|+.+++.++|.|++..++..+.. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344689999999999999875 7999999998654 233467889999999999999999988876543 25788
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
++|.|. .+|.+.+-... .++.+.+.-+..||++||+|||+.+ |.||||||.|.|++++...||||||+|+.
T Consensus 135 ~TELmQ-SDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 999986 46777775542 6888899999999999999999997 99999999999999999999999999998
Q ss_pred ccCCCccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 887 (907)
.+.+.....+..+-|..|.|||.+++. .|+..+||||.||++.||+..+.-|....+-
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 877665555555678999999999975 6899999999999999999999988765543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=248.47 Aligned_cols=193 Identities=30% Similarity=0.413 Sum_probs=168.6
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccccc---hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCch
Q 002566 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 684 IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
||+|+||.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 588999999876532 2355788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 839 (907)
.+++.... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 99986542 5799999999999999999999987 99999999999999999999999999987654321 123
Q ss_pred cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 840 ~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
...++..|+|||...+...+.++|+||||+++|||++|+.||...+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3467889999999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=270.05 Aligned_cols=207 Identities=23% Similarity=0.275 Sum_probs=157.6
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEE-----------------CCCcEEEEEEeccccchhhHH--------------HHH
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGIL-----------------SDGTVIAVKQLSSKSRQGNRE--------------FVN 721 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~-----------------~~g~~vAVK~~~~~~~~~~~~--------------f~~ 721 (907)
+..++|++.++||+|+||.||+|.. ..++.||||++........++ +..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4578999999999999999999974 235679999987543332233 334
Q ss_pred HHHHHHhcCCCce-----eeEEeEEee--------CceeEEEeeeccCCchhhhhhcCCcc-------------------
Q 002566 722 EIGMISAQQHPNL-----VKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTE------------------- 769 (907)
Q Consensus 722 E~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~l~~~~~~------------------- 769 (907)
|+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677887753 35689999999999999999753211
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccccccccccccc
Q 002566 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849 (907)
Q Consensus 770 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 849 (907)
....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++..+............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1123578889999999999999999987 9999999999999999999999999997654432211122235789999
Q ss_pred hhhhccCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCC
Q 002566 850 PEYAMRGYL----------------------TSKADVYSFGVVTLEIVSGKS-NTN 882 (907)
Q Consensus 850 PE~l~~~~~----------------------~~k~DvwSlGvvl~elltG~~-p~~ 882 (907)
||.+..... ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998864321 234799999999999999985 553
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=254.06 Aligned_cols=199 Identities=30% Similarity=0.473 Sum_probs=170.2
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc--chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999986 48999999998653 233457788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCC
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+++ |+||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 58999986542 26899999999999999999999997 9999999999999999999999999998765433
Q ss_pred ccccccccccccccchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 835 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.. .....++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 153 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 153 RT-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred cc-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 21 1223457789999998766 78999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=261.91 Aligned_cols=201 Identities=22% Similarity=0.340 Sum_probs=175.8
Q ss_pred cCCCcCCeeeccCceEEEEEEECCCc-EEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~g~-~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+++....||-|+||.|=.+...... .+|+|.+++.. +...+....|-.+|...+.|.||++|..+.+++..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556778999999999998875433 47888887653 344455778999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|-|-||.+...++.++ .++...+..++..+++|++|||.++ ||.|||||+|.++|.+|.+||.|||+|+...
T Consensus 500 EaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999997664 5788899999999999999999998 9999999999999999999999999999987
Q ss_pred CCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
.+... -.++||+.|.|||++.....+..+|.||+|+++|||++|++||...++
T Consensus 572 ~g~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 572 SGRKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred cCCce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 76543 247999999999999999999999999999999999999999976554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=244.19 Aligned_cols=200 Identities=25% Similarity=0.311 Sum_probs=165.7
Q ss_pred HhcCCCcC-CeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHH-hcCCCceeeEEeEEee----Cce
Q 002566 674 ATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE----GNQ 746 (907)
Q Consensus 674 ~~~~~~~~-~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~----~~~ 746 (907)
.+++|.+. ++||-|-.|.|..+..+ +++.+|+|++... ....+|++..- .-.|||||.+++++.. .+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666653 67999999999999876 6889999998643 23456777643 3479999999998763 467
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCcEEEee
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISD 823 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~D 823 (907)
+.+|||.|+||.|...+..++. ..+++.++.+|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence 8899999999999999876653 36899999999999999999999987 999999999999964 56789999
Q ss_pred cCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
||+|+....... -...+-|+.|.|||++...+|+..+|+||+||++|-|+.|-+||.....
T Consensus 208 fGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 208 FGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 999997654322 1234679999999999999999999999999999999999999965544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=278.49 Aligned_cols=222 Identities=30% Similarity=0.455 Sum_probs=179.7
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEEC----C----CcEEEEEEeccccc-hhhHHHHHHHHHHHhc-CCCceeeEEeE
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILS----D----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGC 740 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~----~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~ 740 (907)
++...++..+.+.+|+|+||.|++|... . ...||||.++.... .+.+.+..|+++++.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444556667779999999999999853 1 45799999986643 4567899999999886 69999999999
Q ss_pred EeeCceeEEEeeeccCCchhhhhhcCC---------cccc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 002566 741 CVEGNQLLLVYEYMKNNCLSRAIFGKD---------TEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 809 (907)
Q Consensus 741 ~~~~~~~~LV~E~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~ 809 (907)
|..++..++|+||+..|+|.++++..+ .... ..++..+.+.++.|||.|++||++.. +|||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998765 1111 13899999999999999999999986 999999999
Q ss_pred CEEEcCCCcEEEeecCCcccccCCCccccccccc--cccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 002566 810 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 886 (907)
Q Consensus 810 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~ 886 (907)
|||+.++..+||+|||+|+............-.| ...|||||.+....++.|+|||||||+|||++| |..|+..-.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 9999999999999999999655544332222222 457999999999999999999999999999999 788885422
Q ss_pred cchhhHHHHHH
Q 002566 887 EDFVYLLDWAY 897 (907)
Q Consensus 887 ~~~~~l~~~~~ 897 (907)
..+.+.++++
T Consensus 527 -~~~~l~~~l~ 536 (609)
T KOG0200|consen 527 -PTEELLEFLK 536 (609)
T ss_pred -cHHHHHHHHh
Confidence 1334455553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=263.64 Aligned_cols=198 Identities=27% Similarity=0.438 Sum_probs=168.6
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCce---
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--- 746 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--- 746 (907)
...++|.+.+.||+|++|.||+|... +++.||+|++... .......+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999986 5789999998653 22334567789999999999999999988776554
Q ss_pred ---eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEee
Q 002566 747 ---LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 747 ---~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 823 (907)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 56898888542 5899999999999999999999987 99999999999999999999999
Q ss_pred cCCcccccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 162 FGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccccccc----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998664331 22457889999998865 46788999999999999999999999644
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=279.03 Aligned_cols=145 Identities=28% Similarity=0.439 Sum_probs=130.3
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.++||+|+||.||+|... +++.||+|+++... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 68899999997543 222456888999999999999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 828 (907)
||+++++|.+++.... .+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986542 5788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=249.73 Aligned_cols=201 Identities=24% Similarity=0.352 Sum_probs=165.5
Q ss_pred CCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccc-----cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998753 444555555432 122334577889999999999999999999998999999
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++++|.+++.... .....+++..++.++.|+++|+.|||+.+ ++|+||+|+||+++. +.+||+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999998886432 12236899999999999999999999987 999999999999975 56999999998766
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
..... ......|+..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43322 12234578899999999888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=266.18 Aligned_cols=207 Identities=28% Similarity=0.471 Sum_probs=176.7
Q ss_pred HHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEee-----C
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-----G 744 (907)
Q Consensus 672 ~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~-----~ 744 (907)
...++-|.+.++||+|.+|.||+++.. +++.+|+|+....... ..+...|.++++.. +|||++.++|++.. +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 334677889999999999999999964 6889999998765443 34566788888875 79999999999864 5
Q ss_pred ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeec
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 824 (907)
+++|||||||.+||..+++.+.. ...+.|+.+..|++.+++|+.+||.+. ++|||||-.|||++.++.||+.||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 78999999999999999997765 347999999999999999999999986 999999999999999999999999
Q ss_pred CCcccccCCCccccccccccccccchhhhccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
|.+........... ...||+.|||||++... .|+.++|+||+|++..||--|.+|+...++
T Consensus 168 GvSaQldsT~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred eeeeeeeccccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 99987766544332 35799999999999743 478899999999999999999999865544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=243.90 Aligned_cols=179 Identities=24% Similarity=0.248 Sum_probs=153.6
Q ss_pred cCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchhhhhhc
Q 002566 687 GGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (907)
Q Consensus 687 G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 765 (907)
|.+|.||++... +++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 68899999997643 233455555666899999999999999999999999999999998865
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccccccccc
Q 002566 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845 (907)
Q Consensus 766 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 845 (907)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 146 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN 146 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence 42 5899999999999999999999987 9999999999999999999999999887654321 1234567
Q ss_pred cccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 846 ~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
.|+|||++.+..++.++||||+|+++|||++|+.|+.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 8999999988888999999999999999999998764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=235.01 Aligned_cols=199 Identities=34% Similarity=0.513 Sum_probs=173.2
Q ss_pred CCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeecc
Q 002566 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999876554 56788999999999999999999999999899999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+++|.+++..... .+++..+..++.++++++.+||+.+ ++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999865431 1789999999999999999999997 99999999999999999999999999987755431
Q ss_pred cccccccccccccchhhh-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l-~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122234578899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=239.28 Aligned_cols=212 Identities=25% Similarity=0.457 Sum_probs=168.3
Q ss_pred CCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchh--hHHHHHHHHHHHhcCCCceeeEEeEEee--------Cc
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVE--------GN 745 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~--------~~ 745 (907)
.|....+||+|.||.||+|+.+ +|+.||+|++--+.... -...++|++++..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445678999999999999976 47788988754332221 3456789999999999999999988863 23
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
.+++||++++. +|.-++... ..+++..++.+++.++..||.|+|... |+|||+||.|+|++.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 58999999985 576666433 246899999999999999999999886 9999999999999999999999999
Q ss_pred CcccccCCCccc---cccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 826 LAKLYEEDKTHI---STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 826 la~~~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
+++.+....... .+..+-|..|.+||.+.+ ..++++.|||..||++.||.+|.+-+..........++.-.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 998765443221 233456999999998886 46999999999999999999999887665544444444433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=255.45 Aligned_cols=323 Identities=21% Similarity=0.242 Sum_probs=215.7
Q ss_pred ceeccCCCCcceEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccc-cccEEEecCCcCCCCCchhcC
Q 002566 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160 (907)
Q Consensus 82 ~v~C~~~~~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~ 160 (907)
+..|.|++.. -..+++++.+++ .+|..+. +.-.+++|..|+|+.+++.+|+.+ +|+.||||+|.|+.+-|++|.
T Consensus 38 P~pC~Cs~~~--g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~ 112 (498)
T KOG4237|consen 38 PAPCTCSDVE--GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFK 112 (498)
T ss_pred CCCcccCCCC--CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhh
Confidence 3445554422 234455566665 4554443 244567777777777777777776 677777777777777777777
Q ss_pred CCCCCCEEEeeC-CcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccce
Q 002566 161 NITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (907)
Q Consensus 161 ~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 239 (907)
+|.+|..|-+.+ |+|+......|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+..+--..|..+..++.
T Consensus 113 GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~t 192 (498)
T KOG4237|consen 113 GLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKT 192 (498)
T ss_pred hhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccch
Confidence 777766665555 6777555556777777777777777777666667777777777777777776333346777777777
Q ss_pred eecccccC------------------------------------CCCchhhhhcC-CCCC-EEEcCCCCCCCCCcccccc
Q 002566 240 LHIQGSSL------------------------------------EGPIPASISAL-TSLT-DLRISDLKGSESAFPKLDK 281 (907)
Q Consensus 240 L~L~~N~l------------------------------------~~~~~~~l~~l-~~L~-~L~L~~n~~~~~~~~~~~~ 281 (907)
+++..|.+ ..+.+..|... .++. .+...++....-+...+..
T Consensus 193 lhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~ 272 (498)
T KOG4237|consen 193 LHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKK 272 (498)
T ss_pred HhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhh
Confidence 77776662 11111111111 1111 1111222222222223333
Q ss_pred -cccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhh--hccCCcce
Q 002566 282 -MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 358 (907)
Q Consensus 282 -~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~--~~~l~~l~ 358 (907)
.+|+.|+|++|+|+.+-+.+|.++..|++|.|..|+|..+....|.++..|+.|+|.+|+|+..-|..| ..++..|.
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 389999999999999999999999999999999999998888999999999999999999997777766 44677888
Q ss_pred eecCCccCCCCCCCCCCCCCccceeccCCCCCCCCCCcCccCCCCCCCCCCCCcccc------cccccCCCccc
Q 002566 359 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYT------LHINCGGAKIN 426 (907)
Q Consensus 359 ls~N~~~~~~~~p~~C~c~~~~l~~~~~~~~~~l~~~~~~~~~~~~C~~p~~~~~~~------~~~~C~~~~~~ 426 (907)
|-.| ||.|+|.+.|+.+|++..+ ..+. .+|.+|...++.. -...|++|+..
T Consensus 353 l~~N--------p~~CnC~l~wl~~Wlr~~~--~~~~-------~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~ 409 (498)
T KOG4237|consen 353 LLSN--------PFNCNCRLAWLGEWLRKKS--VVGN-------PRCQSPGFVRQIPISDVAFGDFRCGGPEEL 409 (498)
T ss_pred hccC--------cccCccchHHHHHHHhhCC--CCCC-------CCCCCCchhccccchhccccccccCCcccc
Confidence 8888 9999999999999999876 2233 4566555444322 12467766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=256.99 Aligned_cols=197 Identities=28% Similarity=0.398 Sum_probs=165.6
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHh-cCCCceeeEEeEEeeCceeEEEe
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.++.|.....+|.|+|+.|-.+... +++..+||++.+.. .+-.+|+.++.. -+||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3566777788999999999998865 57889999997652 223356655444 57999999999999999999999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cCCCcEEEeecCCcccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~ 830 (907)
|.+.++-+.+.+.... ....++..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++..
T Consensus 396 e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999998888776553 222678889999999999999998 9999999999999 58999999999999877
Q ss_pred cCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 887 (907)
+.. ....+-|..|.|||++....+++++|+||||++||||++|+.||...+.+
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 655 11224588999999999999999999999999999999999999876654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=233.21 Aligned_cols=224 Identities=21% Similarity=0.333 Sum_probs=182.4
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEECC------CcEEEEEEeccc-cchhhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~------g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~ 742 (907)
++.....+++....+-+|.||.||.|.|.+ .+.|-||.++.. ++-....++.|.-++..+.|||+.++.+.+.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 444445677888889999999999998754 345778888655 3344567888988888999999999999987
Q ss_pred eC-ceeEEEeeeccCCchhhhhh---cCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCc
Q 002566 743 EG-NQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (907)
Q Consensus 743 ~~-~~~~LV~E~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 818 (907)
++ +..+.+|.++.-|+|..++. +.+......++..+...++.|++.|++|||.++ +||.||..+|+++|+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 64 56688999999999999986 223333446778889999999999999999998 999999999999999999
Q ss_pred EEEeecCCcccccCCCccc-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 002566 819 AKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 819 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 896 (907)
+||+|=.+++.+-+.+.+. ...--.+..||+||.+....++..+|||||||+||||+| |+.|+...++.+++..++--
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 9999999999876654331 122234678999999999999999999999999999999 99999887777766655443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=252.07 Aligned_cols=196 Identities=26% Similarity=0.361 Sum_probs=165.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccch---hhH-----HHHHHHHHHHhcC---CCceeeEEeEEee
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNR-----EFVNEIGMISAQQ---HPNLVKLYGCCVE 743 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~---~~~-----~f~~E~~~l~~l~---H~nIv~l~g~~~~ 743 (907)
.+|...+.+|+|+||.|+.|.++ +...|++|.+.++.-- +.+ ..-.|+++|..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999987 4567889988765211 111 1335899999987 9999999999999
Q ss_pred CceeEEEeeecc-CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEe
Q 002566 744 GNQLLLVYEYMK-NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (907)
Q Consensus 744 ~~~~~LV~E~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 822 (907)
++.+||+||-.. +-+|.+++..+ ..+++.++.-|+.|++.|+++||+.+ |||||||-+||.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999875 44778888554 36899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCccccccccccccccchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCC
Q 002566 823 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 823 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
|||.|.....+.- ..++||..|.|||++.+..| ...-||||+|++||.++....||.
T Consensus 713 dfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999986655432 34689999999999998766 445899999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=224.88 Aligned_cols=213 Identities=23% Similarity=0.402 Sum_probs=176.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchhhHHHHHHHHHHHhcC-CCceeeEEeEEeeC--ceeEEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLV 750 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~LV 750 (907)
.++|.+.+++|+|-++.||.|.. .+.+.++||++++.. .+.+.+|+.+|..++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788899999999999999984 467889999997654 357788999999997 99999999998764 456899
Q ss_pred eeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCccc
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL 829 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 829 (907)
+||+.+.+...+- ..++...++..+.+++.||.|+|+.| |+|||+||+|+++|.. ...+|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 9999987664432 24677789999999999999999998 9999999999999865 5789999999999
Q ss_pred ccCCCccccccccccccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcccc
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 904 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 904 (907)
+.++... ...+.+..|.-||.+-. ..++..-|+|||||++.+|+..+.||-..+ +....|++.+..+..+|.
T Consensus 183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHH
Confidence 9876543 22356788999998864 568888999999999999999999995433 346678888887776664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=243.34 Aligned_cols=220 Identities=21% Similarity=0.332 Sum_probs=177.7
Q ss_pred CCcccHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCC--Cc----ee
Q 002566 663 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PN----LV 735 (907)
Q Consensus 663 ~~~~~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H--~n----Iv 735 (907)
.+.+-++.-...+++|.+...+|+|.||.|-++... .+..||||+++.... -.+...-|+++++++.+ |+ +|
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 343334444455889999999999999999999865 468899999975433 23345678999999842 22 78
Q ss_pred eEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 002566 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (907)
Q Consensus 736 ~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 815 (907)
++.+++...++.++|+|.+ |-|+.+++..+. ..+++...++.|+.|+++++++||+.. ++|-||||+|||+.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvs 227 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVS 227 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEec
Confidence 8899999999999999998 458999997653 247899999999999999999999997 999999999999942
Q ss_pred --------------------CCcEEEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHH
Q 002566 816 --------------------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 875 (907)
Q Consensus 816 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ell 875 (907)
+..+||+|||.|+...+.. ..++.|.-|.|||++.+-.++.++||||+||+|+|+.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 2358999999999876654 3356799999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhhHHH
Q 002566 876 SGKSNTNYRPNEDFVYLLD 894 (907)
Q Consensus 876 tG~~p~~~~~~~~~~~l~~ 894 (907)
+|..-|..-++-++..+++
T Consensus 304 tG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMME 322 (415)
T ss_pred ccceecccCCcHHHHHHHH
Confidence 9999997655444433333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=261.62 Aligned_cols=201 Identities=24% Similarity=0.330 Sum_probs=144.2
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-C----CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeE------Ee
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-D----GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC------CV 742 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~----g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~------~~ 742 (907)
..++|...++||+|+||.||+|++. + +..||+|++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999986 4 689999987643221 111111 1112222222222211 24
Q ss_pred eCceeEEEeeeccCCchhhhhhcCCccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 002566 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEY---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807 (907)
Q Consensus 743 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 807 (907)
.++..++||||+++++|.+++....... ........+..++.|+++||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5678899999999999999886543110 001223446689999999999999987 9999999
Q ss_pred CCCEEEcC-CCcEEEeecCCcccccCCCccccccccccccccchhhhccC----------------------CCCchhHH
Q 002566 808 TSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----------------------YLTSKADV 864 (907)
Q Consensus 808 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~k~Dv 864 (907)
|+|||+++ ++.+||+|||+|+.+............+++.|||||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999987655444344456789999999976422 23456799
Q ss_pred HHHHHHHHHHHhCCCCC
Q 002566 865 YSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 865 wSlGvvl~elltG~~p~ 881 (907)
|||||++|||+++..|+
T Consensus 363 wSlGviL~el~~~~~~~ 379 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHHHhCcCCC
Confidence 99999999999977654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=228.02 Aligned_cols=186 Identities=32% Similarity=0.532 Sum_probs=165.2
Q ss_pred CceEEEEEEEC-CCcEEEEEEeccccchh-hHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchhhhhhc
Q 002566 688 GFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (907)
Q Consensus 688 ~fG~Vyka~~~-~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 765 (907)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999998765544 67899999999999999999999999999999999999999999998865
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccccccccc
Q 002566 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845 (907)
Q Consensus 766 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 845 (907)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 42 3789999999999999999999997 9999999999999999999999999998776542 122346788
Q ss_pred cccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 846 ~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.|++||......++.++||||+|++++||++|+.||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999988889999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-27 Score=257.04 Aligned_cols=277 Identities=25% Similarity=0.332 Sum_probs=175.0
Q ss_pred eEEEEeccCCCcc-ccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEee
Q 002566 93 HVVTIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (907)
Q Consensus 93 ~v~~L~L~~~~l~-g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 171 (907)
++.++.+..|++. .-||+.+..|..|+.||||+|+++..+...-..-++..|+||+|+|..+....|-+|+.|-+||||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccc
Confidence 4556666666664 356777777777777777777777655443333367777777777775555556777777777777
Q ss_pred CCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCccc-CCCcccccCccccceeecccccCCCC
Q 002566 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGP 250 (907)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~ 250 (907)
+|++. .+|+.+..|.+|++|+|++|.+...--..+..+++|+.|++++.+=+ ..+|.++..+.+|..++|+.|.+. .
T Consensus 159 ~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~ 236 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-I 236 (1255)
T ss_pred cchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-c
Confidence 77777 66777777777777777777665222223333445555555544332 345555555555555555555555 4
Q ss_pred chhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEccccccc-----------------------cc-CCccccCCC
Q 002566 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIH-----------------------GE-IPDYIGDMT 306 (907)
Q Consensus 251 ~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~-----------------------~~-~p~~~~~l~ 306 (907)
+|+.+-++.+|+.|+||+|++++.....-.-.+|++|+||+|+++ -. +|..++.+.
T Consensus 237 vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~ 316 (1255)
T KOG0444|consen 237 VPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLI 316 (1255)
T ss_pred chHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhh
Confidence 555555555555555555555544332222224555555555554 21 444455555
Q ss_pred CccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhh--hccCCcceeecCCccCCCCCCCC
Q 002566 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIE 373 (907)
Q Consensus 307 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~ 373 (907)
+|+.+..++|.|. ..|+.++.+.+|+.|.|++|+|. .+|+.+ .+.++.||+..|.....++-|-.
T Consensus 317 ~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~d 383 (1255)
T KOG0444|consen 317 QLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPND 383 (1255)
T ss_pred hhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcch
Confidence 5555555555555 67788888888888888888887 677766 67788999999988777776644
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=250.53 Aligned_cols=197 Identities=31% Similarity=0.444 Sum_probs=161.1
Q ss_pred CCcCCeeeccCce-EEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeeecc
Q 002566 678 FDPANKVGEGGFG-SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 678 ~~~~~~IG~G~fG-~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
|...+.+|.|+-| .||+|.. +|+.||||++-.+. ..-..+|+..++.- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4455788999998 6999998 58899999985432 33457899998876 69999999999899999999999996
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---C--CcEEEeecCCcccc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---D--LNAKISDFGLAKLY 830 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~DFGla~~~ 830 (907)
-+|.+++.....+. ........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 587 -~sL~dlie~~~~d~-~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDV-EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhHHHHHhccccch-hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 58999997741111 11122456788999999999999987 999999999999975 3 46899999999998
Q ss_pred cCCCccccc--cccccccccchhhhccCCCCchhHHHHHHHHHHHHHhC-CCCCCC
Q 002566 831 EEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTNY 883 (907)
Q Consensus 831 ~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG-~~p~~~ 883 (907)
..+...... ...||-+|+|||++....-+..+||||+||++|+.++| +.||..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 776654433 36799999999999988888899999999999998885 899953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=222.74 Aligned_cols=194 Identities=27% Similarity=0.391 Sum_probs=164.2
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCc------
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 745 (907)
..+|...+.+|.|+- .|..|.+. .+++||+|++... .....++..+|..++..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666788899988 66666543 5889999987544 2344567889999999999999999999987543
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
+.|+|||+|+ .+|...++- .++-+++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 5799999996 578877762 4677899999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
+|+..... ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 99866544 34556788999999999998889999999999999999999999886
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-26 Score=247.28 Aligned_cols=271 Identities=25% Similarity=0.358 Sum_probs=153.4
Q ss_pred eEEEEeccCCCcc-ccCChhccCCCCCCEEEeecCcCCCCCchhcccc-cccEEEecCCcCCCCCchhcCCCCCCCEEEe
Q 002566 93 HVVTIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (907)
Q Consensus 93 ~v~~L~L~~~~l~-g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 170 (907)
-|..+|+++|.++ +..|.....++.++.|.|...++..+ |..++.+ +|++|.+++|++. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~v-PeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQV-PEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhC-hHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3556666666666 35566666666666666666655533 3333333 5666666666665 33445566666666666
Q ss_pred eCCcCC-CCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCC
Q 002566 171 EGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (907)
Q Consensus 171 s~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 249 (907)
..|++. .-+|..+..+..|+.||||+|+++ +.|..+..-+++-.|+||+|+|..+....|-+++.|-.|+|++|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 666654 235555666666666666666666 56666655566666666666665333344556666666666666665
Q ss_pred CchhhhhcCCCCCEEEcCCCCCCCCCccccccc-ccceEEccccccc-ccCCccccCCCCccEEecCCCCCCCCCchhhh
Q 002566 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (907)
Q Consensus 250 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (907)
.+|..+..+..|+.|+|++|.+.......+..+ +|+.|.+++.+=+ ..+|.++.++.+|..+|||.|.|. ..|+++-
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 344555666666666666666554444333333 4555555554322 235555555666666666666665 5566666
Q ss_pred cCCCCCeEEecCCcCCCCC-chhhhccCCcceeecCCccCCC
Q 002566 328 KLAKTNFMYLTGNKLTGPV-PKYIFNSNKNVDISLNNFTWES 368 (907)
Q Consensus 328 ~l~~L~~L~Ls~N~L~~~~-p~~~~~~l~~l~ls~N~~~~~~ 368 (907)
++++|+.|+||+|+|+..- -...+..+++|++|.|+++.++
T Consensus 243 ~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP 284 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLP 284 (1255)
T ss_pred hhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccch
Confidence 6666666666666655211 1222445555566666555443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=217.92 Aligned_cols=213 Identities=20% Similarity=0.359 Sum_probs=169.5
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeE-EeeCceeEEEe
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGC-CVEGNQLLLVY 751 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~LV~ 751 (907)
.+.|++.+.+|+|.||.+-.++++. .+.+++|-++.. ....++|.+|...--.+ .|.||+.-++. |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678899999999999999999874 567888888654 33467899998754333 69999987764 66778889999
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cC-CCcEEEeecCCccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DK-DLNAKISDFGLAKL 829 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~-~~~~kl~DFGla~~ 829 (907)
||++.|+|..-+... .+.+....+++.|+++|++|||+.. +||||||.+|||+ +. ..++||||||+.+.
T Consensus 102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999998877543 4677888999999999999999997 9999999999999 33 45799999999886
Q ss_pred ccCCCccccccccccccccchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 902 (907)
.+..... ..-+..|.+||.... -...+.+|+|.|||+++..++|+.||. ....+.....+|....+..
T Consensus 173 ~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 173 VGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred cCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhccc
Confidence 5443222 123556899998753 246778999999999999999999997 4555667788887665543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-24 Score=224.46 Aligned_cols=217 Identities=30% Similarity=0.454 Sum_probs=177.0
Q ss_pred HHHHhcCCCcCCeeeccCceEEEEEEECC----CcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCc
Q 002566 671 IKAATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 671 i~~~~~~~~~~~~IG~G~fG~Vyka~~~~----g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
+....+.|..+++||+|.|++||+|.+.. .+.||+|.+...+.. .+..+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 45556789999999999999999998643 578999999765443 5688999999987 5999999999999999
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeec
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDF 824 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DF 824 (907)
...+|+||++.....++.. .++..++...+..+..||.++|.+| ||||||||+|+|.+. .+.-.|.||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 9999999999988777764 3567899999999999999999998 999999999999975 477899999
Q ss_pred CCcccccCCC--------------c-----------------------------cccccccccccccchhhhcc-CCCCc
Q 002566 825 GLAKLYEEDK--------------T-----------------------------HISTRIAGTIGYMAPEYAMR-GYLTS 860 (907)
Q Consensus 825 Gla~~~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~ 860 (907)
|+|....... . ......+||++|.|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997321100 0 00112569999999999875 56788
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 002566 861 KADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 901 (907)
Q Consensus 861 k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 901 (907)
++||||.||+++-+++++.||-. ..++...+++.+-.+..
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~-a~dd~~al~ei~tifG~ 297 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFK-AKDDADALAEIATIFGS 297 (418)
T ss_pred ccceeeccceeehhhcccccccc-CccccchHHHHHHHhCh
Confidence 99999999999999999999944 45567777777655443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-24 Score=240.80 Aligned_cols=203 Identities=27% Similarity=0.460 Sum_probs=177.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|.....+|.|.+|.||||+.. .++..|||+++.+...+..-.+.|+-+++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888899999999999999975 6889999999988877778888999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+.+|+|.+.-+..+ ++++.++..+++...+|++|||+.+ =+|||||-.||++++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999988776553 7899999999999999999999998 689999999999999999999999998776543
Q ss_pred Cccccccccccccccchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
-.+ ...+.||+.|||||+.. .+.|..++|||+.|+...|+-.-++|-..-.+
T Consensus 166 i~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 166 IAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred hhh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence 322 23367999999999874 56789999999999999999888887544333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-22 Score=203.77 Aligned_cols=183 Identities=39% Similarity=0.668 Sum_probs=159.7
Q ss_pred eeccCceEEEEEEECC-CcEEEEEEeccccch-hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchhh
Q 002566 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761 (907)
Q Consensus 684 IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 761 (907)
||+|++|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999999866443 35678999999999999999999999999999999999999999999
Q ss_pred hhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCcEEEeecCCcccccCCCcccccc
Q 002566 762 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTR 840 (907)
Q Consensus 762 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 840 (907)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 986542 25789999999999999999999997 999999999999999 89999999999987655431 1122
Q ss_pred ccccccccchhhhccC-CCCchhHHHHHHHHHHHH
Q 002566 841 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEI 874 (907)
Q Consensus 841 ~~gt~~y~aPE~l~~~-~~~~k~DvwSlGvvl~el 874 (907)
..+...|++||..... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4578899999999877 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-24 Score=227.35 Aligned_cols=225 Identities=21% Similarity=0.294 Sum_probs=187.7
Q ss_pred ccccCCcccHHHHHHHhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcC------C
Q 002566 659 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ------H 731 (907)
Q Consensus 659 ~~~~~~~~~~~~i~~~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~------H 731 (907)
.+...+.|.+...+....+|.+....|+|-|++|..|... .|+.||||++...... .+.=+.|+++|++++ -
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhh
Confidence 4556778888888889999999999999999999999975 4789999999765322 233457899999985 3
Q ss_pred CceeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 002566 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 811 (907)
Q Consensus 732 ~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 811 (907)
-|+++++..|....++|||+|-+. -+|.+.|...+.. ..+....+..++.|+.-||..|...+ |+|.||||.||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi 567 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI 567 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence 478999999999999999999885 4788888765433 35777889999999999999999887 99999999999
Q ss_pred EEcCC-CcEEEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 002566 812 LLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 890 (907)
Q Consensus 812 Ll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~ 890 (907)
|+++. ..+||||||.|........ +.+.-+..|.|||++.+..|+...|+||.||+||||.||+.-|....+..+.
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred EeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 99876 4579999999987765432 3334567899999999999999999999999999999999999888777766
Q ss_pred hHH
Q 002566 891 YLL 893 (907)
Q Consensus 891 ~l~ 893 (907)
.+.
T Consensus 645 rl~ 647 (752)
T KOG0670|consen 645 RLF 647 (752)
T ss_pred HHH
Confidence 543
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=208.54 Aligned_cols=170 Identities=41% Similarity=0.661 Sum_probs=112.4
Q ss_pred ccccccCCCcc-ccCCcccccccccccccceeeccceeEEeeecccccCCCccccccccccccccccccchhhhhhhccc
Q 002566 415 TLHINCGGAKI-NTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARV 493 (907)
Q Consensus 415 ~~~~~C~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~w~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 493 (907)
.+.++||++.. ......|..|....+.+. .+..+ ++.. .+ ..........+.|..||+|+|.
T Consensus 2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~--------~y~~~-----~~~~--~~--~~~~~~~i~~t~d~~Lyqt~R~ 64 (174)
T PF11721_consen 2 VLRINAGGPAYTDSSGIVWEADQYYTGGSW--------GYYVS-----SDNN--GS--TSSTNSSIPGTTDDPLYQTERY 64 (174)
T ss_dssp EEEEEETSSSEEETTTEEE-SSSSSTTSS--------------------------S--STTS--TTS-HHHHHTTT----
T ss_pred EEEEECCCCcccCCCCCEEcCCCCCCCCCc--------ccccc-----cccc--cc--cccccccccCCCchhhhHhhcC
Confidence 45789999998 556677777765544432 11100 0000 00 0112223346889999999999
Q ss_pred ccccceEeeeeccCeeEEEEEeeeEEEecCCcccccccceeEEEEecceecccccchhhhcCCCCcceEEec-ccccccc
Q 002566 494 SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSH 572 (907)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~l~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~v~~~ 572 (907)
.|.+++|..+|+.+|.|+|+|||||+.+..+..++..|+|||||+|+|++++++|||.+++|+.++++.+.| ++.|++.
T Consensus 65 g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg 144 (174)
T PF11721_consen 65 GPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG 144 (174)
T ss_dssp -SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT
T ss_pred CCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC
Confidence 999999999999999999999999999999999999999999999999999999999999999998898888 8999999
Q ss_pred eEEEEEeecCCCCcccCCCCCCC-Cccccc
Q 002566 573 TLKIHLYWAGRGTTGIPLRGTYG-PLISAI 601 (907)
Q Consensus 573 ~~~~~~~~~g~g~~~ip~~~~~~-pl~s~~ 601 (907)
.|.|++.|+++|+++||..+.++ |++++|
T Consensus 145 ~L~i~f~~~~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 145 TLNIQFVWAGKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEETTEEEE--SEEEEEEESSSSSSSEEEE
T ss_pred cEEEEEEecCCCcEEeeccccCCCcEEeeC
Confidence 99999999999999999988887 888875
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=220.56 Aligned_cols=169 Identities=21% Similarity=0.202 Sum_probs=131.6
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEEC--CCcEEEEEEecccc-----chhhHHHHHHHHHHHhcCCCceeeEEeEEe
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~--~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~ 742 (907)
.+....++|...+.||+|+||+||+|.+. +++.||||++.... ....+.|.+|++++++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34556788999999999999999999875 57788999875331 2234568999999999999999853322
Q ss_pred eCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCcEEE
Q 002566 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKI 821 (907)
Q Consensus 743 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl 821 (907)
.+..++||||+++++|.. ... .. ...++.|+++||+|||+.+ |+|||| ||+|||++.++.+||
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 246799999999999963 211 01 1467889999999999997 999999 999999999999999
Q ss_pred eecCCcccccCCCcccc-------ccccccccccchhhhccC
Q 002566 822 SDFGLAKLYEEDKTHIS-------TRIAGTIGYMAPEYAMRG 856 (907)
Q Consensus 822 ~DFGla~~~~~~~~~~~-------~~~~gt~~y~aPE~l~~~ 856 (907)
+|||+|+.+........ ....+++.|+|||++...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999997755431111 235688899999998643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-25 Score=234.31 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=205.2
Q ss_pred EEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCC
Q 002566 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (907)
Q Consensus 94 v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 173 (907)
...+.+++|.++ .+.+.+.++..|++|++++|++...+|.......++.|+.++|+++ .+|..+..+.+|..|+.++|
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence 456778888887 5667788888888888888888877766665568888888888888 77888888888888888888
Q ss_pred cCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchh
Q 002566 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (907)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 253 (907)
.+. ++|+.++.+..|+.|+..+|+++ ..|+.+..+.+|..|++.+|+++...|+.+. ++.|++|+...|.++ .+|.
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~ 200 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPP 200 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCCh
Confidence 888 77788888888888888888888 7788888888888888888888855555554 888888888888887 6788
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCcc-ccCCCCccEEecCCCCCCCCCchhhhcCCCC
Q 002566 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (907)
Q Consensus 254 ~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 332 (907)
.++.+.+|+.|+|..|++...+ ..-+...|++|+++.|+|+ .+|.. ..++++|..|||..|+++ ..|+.+..+.+|
T Consensus 201 ~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL 277 (565)
T KOG0472|consen 201 ELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSL 277 (565)
T ss_pred hhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhh
Confidence 8888888888888888887765 2223336888888888888 44444 458888888888888888 788888888888
Q ss_pred CeEEecCCcCCCCCchhhhc-cCCcceeecCCc
Q 002566 333 NFMYLTGNKLTGPVPKYIFN-SNKNVDISLNNF 364 (907)
Q Consensus 333 ~~L~Ls~N~L~~~~p~~~~~-~l~~l~ls~N~~ 364 (907)
++||||+|.|+ .+|..+.+ .++.|-+-+|.+
T Consensus 278 ~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 278 ERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred hhhcccCCccc-cCCcccccceeeehhhcCCch
Confidence 88888888888 45555533 566677777743
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=211.36 Aligned_cols=132 Identities=25% Similarity=0.404 Sum_probs=108.8
Q ss_pred cCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcC-----C---CceeeEEeEEeeC--
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----H---PNLVKLYGCCVEG-- 744 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-----H---~nIv~l~g~~~~~-- 744 (907)
.+|.+.++||-|.|++||.+.+. +.+.||+|+.+... .-.+..+.||++|++++ | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999875 56789999997543 23445678999998874 3 4699999999863
Q ss_pred --ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 002566 745 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (907)
Q Consensus 745 --~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 814 (907)
.++++|+|++ |.+|..+|....- ..++...+.+|++||+.||.|||.++ .|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999998 4567777755432 25889999999999999999999987 699999999999994
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-24 Score=225.08 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=223.7
Q ss_pred eEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeC
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 172 (907)
-++.+++.+|+++ .+|++++.+..++.|+.++|++...++......+|+.|+.+.|.+. .+|+.++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 3788999999999 8999999999999999999999988888878889999999999999 6777899999999999999
Q ss_pred CcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCch
Q 002566 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (907)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 252 (907)
|+++ ..|..++++.+|..|++.+|++. ..|+..-+++.|++||+-.|-++ .+|..++.+.+|..|+|.+|+|. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 9999 78999999999999999999999 45555545999999999999998 89999999999999999999999 556
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCcccccc-cccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCC
Q 002566 253 ASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (907)
Q Consensus 253 ~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (907)
+|..+..|++|+++.|.+...+...... .+|..|||..|+++ ..|+.+.-+.+|.+||||+|.|+ ..|.+++++ +
T Consensus 223 -ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-e
Confidence 8999999999999999999888777644 38999999999999 78999999999999999999999 788899999 9
Q ss_pred CCeEEecCCcCCCCCchhh
Q 002566 332 TNFMYLTGNKLTGPVPKYI 350 (907)
Q Consensus 332 L~~L~Ls~N~L~~~~p~~~ 350 (907)
|+.|-|.||+|. .+-.++
T Consensus 299 L~~L~leGNPlr-TiRr~i 316 (565)
T KOG0472|consen 299 LKFLALEGNPLR-TIRREI 316 (565)
T ss_pred eeehhhcCCchH-HHHHHH
Confidence 999999999997 344443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-20 Score=203.71 Aligned_cols=202 Identities=22% Similarity=0.253 Sum_probs=165.3
Q ss_pred CCCcCCeeeccCceEEEEEEECCC--cEEEEEEeccccchhhHHHHHHHHHHHhcCC----CceeeEEeEE-eeCceeEE
Q 002566 677 NFDPANKVGEGGFGSVYKGILSDG--TVIAVKQLSSKSRQGNREFVNEIGMISAQQH----PNLVKLYGCC-VEGNQLLL 749 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~g--~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~L 749 (907)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++.++++.. ..++..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788888876544433367788888888763 6888998888 47778899
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-----CcEEEeec
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-----LNAKISDF 824 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DF 824 (907)
||+.+ +.+|.++..... ...++..++.+|+.|++.+|++||+.| ++||||||.|+++... ..++|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99987 678988775443 237899999999999999999999998 9999999999999754 46899999
Q ss_pred CCcc--cccCCCc-----c-c-cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 825 GLAK--LYEEDKT-----H-I-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 825 Gla~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
|+++ .+..... . . .....||.+|+++....+...+.+.|+||++.++.|++.|..||....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9999 3322211 1 1 123569999999999999999999999999999999999999995543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=181.61 Aligned_cols=202 Identities=23% Similarity=0.313 Sum_probs=167.1
Q ss_pred hcCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchhhHHHHHHHHHHHhcCC-CceeeEEeEEeeCceeEEEee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E 752 (907)
..+|..+++||.|+||.+|.|.. .+|..||+|+-..... ...+..|..+...++| ..|..+..+..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999984 5799999999865433 3456778888888876 456677777788888899999
Q ss_pred eccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CcEEEeecCCccc
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKL 829 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~ 829 (907)
.. +-||+++..-.. ..++.++.+-++.||+.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.
T Consensus 92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 98 568988875443 36788999999999999999999998 9999999999998643 4689999999998
Q ss_pred ccCCCccc------cccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 002566 830 YEEDKTHI------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 830 ~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 886 (907)
+.+..... .....||.+|.+-....+...+.+.|+-|+|.+|...--|+.||..-..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 86543321 2346799999999888888889999999999999999999999965443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-22 Score=208.48 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=194.9
Q ss_pred EEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeecc-ccc
Q 002566 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS-NSF 199 (907)
Q Consensus 121 L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l 199 (907)
+|-++-.++.++... ......|+|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++++|.+|.+.+ |+|
T Consensus 51 VdCr~~GL~eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred EEccCCCcccCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 455555555443211 11567899999999999999999999999999999999999999999999988887776 999
Q ss_pred cccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCC-----
Q 002566 200 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES----- 274 (907)
Q Consensus 200 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~----- 274 (907)
+......|.+|.+|+-|.+.-|++.-...+.|..+++|..|.+.+|.+...--.+|..+.+++.+++..|.+...
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 965567899999999999999999988899999999999999999999965556899999999999988773211
Q ss_pred ----------Ccccccc--------------------cccceE---EcccccccccCC-ccccCCCCccEEecCCCCCCC
Q 002566 275 ----------AFPKLDK--------------------MNLKTL---ILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTG 320 (907)
Q Consensus 275 ----------~~~~~~~--------------------~~L~~L---~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 320 (907)
.+..+.. ..++.+ -.+.+...++.| ..|..+++|++|+|++|+|++
T Consensus 209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 1111100 012222 122333444444 459999999999999999999
Q ss_pred CCchhhhcCCCCCeEEecCCcCCCCCchhhhc---cCCcceeecCCccCCCCC
Q 002566 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SNKNVDISLNNFTWESSD 370 (907)
Q Consensus 321 ~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~---~l~~l~ls~N~~~~~~~~ 370 (907)
+-+.+|.++.+|++|+|..|+|. .+....|. .++.|+|.+|+++-..+-
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~ 340 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPG 340 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecc
Confidence 99999999999999999999998 55555544 678899999999865543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=219.27 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=171.8
Q ss_pred eEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeC
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 172 (907)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+.++...+ .+|+.|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 3567888888887 4676554 478888888888886654433 27888888888888 4565443 4688888888
Q ss_pred CcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCch
Q 002566 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (907)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 252 (907)
|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|+++. +|
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP 320 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LP 320 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CC
Confidence 8888 6676664 47888888888888 5676554 478888888888884 454443 468888888888884 44
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCC
Q 002566 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (907)
Q Consensus 253 ~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 332 (907)
..+ .++|+.|++++|.++..+.... .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|
T Consensus 321 ~~l--~~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL 390 (754)
T PRK15370 321 ETL--PPGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AAL 390 (754)
T ss_pred ccc--cccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHH
Confidence 433 2578888888888776543221 37888888888887 4555543 57888888888888 4565554 368
Q ss_pred CeEEecCCcCCCCCchhhh------ccCCcceeecCCcc
Q 002566 333 NFMYLTGNKLTGPVPKYIF------NSNKNVDISLNNFT 365 (907)
Q Consensus 333 ~~L~Ls~N~L~~~~p~~~~------~~l~~l~ls~N~~~ 365 (907)
+.|++++|+|+ .+|..+. +.+..+++.+|+++
T Consensus 391 ~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 391 QIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 88888888887 5665541 34566788888554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-19 Score=193.18 Aligned_cols=201 Identities=34% Similarity=0.552 Sum_probs=170.5
Q ss_pred CCcCCeeeccCceEEEEEEECCCcEEEEEEeccccch---hhHHHHHHHHHHHhcCCC-ceeeEEeEEeeCceeEEEeee
Q 002566 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~LV~E~ 753 (907)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+..+..+.|+ +++++.+.+...+..++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 78899998766433 367899999999999988 799999999777778999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 832 (907)
+.++++.+.+...... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666543211 25788999999999999999999998 99999999999999988 799999999986554
Q ss_pred CCcc-----ccccccccccccchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002566 833 DKTH-----ISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~-----~~~~~~gt~~y~aPE~l~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 885 (907)
.... ......|+..|+|||.+.+ .......|+||+|++++++++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 2345679999999999987 578899999999999999999999975543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=232.50 Aligned_cols=146 Identities=18% Similarity=0.200 Sum_probs=113.3
Q ss_pred cCC-CceeeEEeEE-------eeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 002566 729 QQH-PNLVKLYGCC-------VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800 (907)
Q Consensus 729 l~H-~nIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 800 (907)
++| +||+++++++ .+.+.++.+|||+ +++|.+++.... ..+++.+++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 355 5788888877 2334678889987 569999996432 25899999999999999999999998
Q ss_pred eEEcCCCCCCEEEcC-------------------CCcEEEeecCCcccccCCCc---------------ccccccccccc
Q 002566 801 IVHRDIKTSNVLLDK-------------------DLNAKISDFGLAKLYEEDKT---------------HISTRIAGTIG 846 (907)
Q Consensus 801 iiHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~ 846 (907)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566666776654221000 00111357889
Q ss_pred ccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 847 y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 999999999999999999999999999999998864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=213.94 Aligned_cols=236 Identities=26% Similarity=0.337 Sum_probs=159.1
Q ss_pred EEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCc
Q 002566 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (907)
Q Consensus 95 ~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 174 (907)
..|+|++++|+ .+|+.+. ++|+.|+|++|+|+.++. . ..+|++|+|++|+|+. +|.. .++|+.|+|++|.
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~-l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA-L--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNP 273 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC-C--CCCCcEEEecCCccCc-ccCc---ccccceeeccCCc
Confidence 36788889888 6888776 478999999999887543 1 2378999999999884 4542 4678888888888
Q ss_pred CCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchhh
Q 002566 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254 (907)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 254 (907)
|+ .+|.. ..+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|..
T Consensus 274 L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l 340 (788)
T PRK15387 274 LT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL 340 (788)
T ss_pred hh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc
Confidence 87 44542 246778888888887 45542 4678888888888874 44322 356677777887774 3321
Q ss_pred hhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCCCe
Q 002566 255 ISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334 (907)
Q Consensus 255 l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 334 (907)
..+|+.|+|++|+++..+.. ..+|+.|++++|+|+. +|.. .++|+.|+|++|+|++ +|.. .++|+.
T Consensus 341 ---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~ 406 (788)
T PRK15387 341 ---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKE 406 (788)
T ss_pred ---ccccceEecCCCccCCCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCE
Confidence 24677888888777764421 1267777777777774 4433 2467777777777773 4432 256777
Q ss_pred EEecCCcCCCCCchhhhccCCcceeecCCccCCCC
Q 002566 335 MYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (907)
Q Consensus 335 L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~~~~~~ 369 (907)
|+|++|+|++ +|.. ...++.|++++|+++.++.
T Consensus 407 LdLS~N~Lss-IP~l-~~~L~~L~Ls~NqLt~LP~ 439 (788)
T PRK15387 407 LMVSGNRLTS-LPML-PSGLLSLSVYRNQLTRLPE 439 (788)
T ss_pred EEccCCcCCC-CCcc-hhhhhhhhhccCcccccCh
Confidence 7777777763 5543 3456667777777775543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=183.82 Aligned_cols=198 Identities=23% Similarity=0.337 Sum_probs=165.4
Q ss_pred cCCCcCCeeeccCceEEEEEEE-CCCcEEEEEEeccccchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCceeEEEeee
Q 002566 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
-+|++.++||+|.||.++.|+. -+++.||||.-...+. ..++..|.+..+.+ ..+.|...+.+-.++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4788999999999999999994 4799999998765433 24566677777765 578899988888888888999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCcEEEeecCCcc
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAK 828 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~ 828 (907)
+ |-||+|+..-.+ ..++.+++..||.||+.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+
T Consensus 106 L-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred h-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 8 568888775443 36899999999999999999999998 999999999999953 3458999999999
Q ss_pred cccCCCcccc------ccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 829 LYEEDKTHIS------TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 829 ~~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
.+.+...... ....||.+||+-....+.+.+.+.|+-|+|-++...+-|..||..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 9876554321 235699999999999999999999999999999999999999954
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=182.76 Aligned_cols=139 Identities=15% Similarity=0.185 Sum_probs=107.7
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccch--h-------hHHH-----------------HHHHHHHHhcCCCce
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--G-------NREF-----------------VNEIGMISAQQHPNL 734 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~nI 734 (907)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754221 1 1122 348999999988776
Q ss_pred eeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEE
Q 002566 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 735 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl 813 (907)
.....+.. ...++||||++++++....... .+++..++.+++.|++++|.|+ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 44332222 2348999999988775443222 2578899999999999999999 6777 9999999999999
Q ss_pred cCCCcEEEeecCCcccc
Q 002566 814 DKDLNAKISDFGLAKLY 830 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~ 830 (907)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=186.16 Aligned_cols=171 Identities=15% Similarity=0.142 Sum_probs=132.7
Q ss_pred HHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHH---------HHHHHHHHHhcCCCceeeEEeEEee
Q 002566 673 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---------FVNEIGMISAQQHPNLVKLYGCCVE 743 (907)
Q Consensus 673 ~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~---------f~~E~~~l~~l~H~nIv~l~g~~~~ 743 (907)
...++|+..+++|.|+||.||.+.. +++.+|+|.+.+......+. +.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3478999999999999999999766 57789999997654333222 6789999999999999999888653
Q ss_pred C--------ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 002566 744 G--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (907)
Q Consensus 744 ~--------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 815 (907)
. +..++||||++|.+|.++. .++. ....+++.++..+|+.+ ++|||+||+||++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 3 3578999999999997763 1222 24568999999999998 999999999999999
Q ss_pred CCcEEEeecCCcccccCCCccccccccccccccchhhhccCCCCchhHHHHHHHHHHHH
Q 002566 816 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 874 (907)
Q Consensus 816 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~el 874 (907)
++ ++|+|||........... ..+.....+..++|+||||+.+.-.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 98 999999988765332211 1133334456789999999986554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=212.67 Aligned_cols=235 Identities=28% Similarity=0.355 Sum_probs=173.5
Q ss_pred eEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeC
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 172 (907)
+++.|++.+|+++. +|.. .++|++|+|++|+|+.+++ . ..+|+.|+|++|.++. +|.. .++|+.|+|++
T Consensus 223 ~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsLP~-l--p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~ 291 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSLPV-L--PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFG 291 (788)
T ss_pred CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcccC-c--ccccceeeccCCchhh-hhhc---hhhcCEEECcC
Confidence 68899999999994 6653 5899999999999997642 2 1378999999999884 4443 35788899999
Q ss_pred CcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCch
Q 002566 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (907)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 252 (907)
|+|+ .+|. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|
T Consensus 292 N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP 358 (788)
T PRK15387 292 NQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LP 358 (788)
T ss_pred Cccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CC
Confidence 9998 4554 24689999999999984 55422 457788889998874 5542 2478889999999885 44
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCC
Q 002566 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (907)
Q Consensus 253 ~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 332 (907)
.. ..+|+.|++++|++...+.. ..+|+.|+|++|+|++ +|.. .++|+.|+|++|+|++ +|..+ .+|
T Consensus 359 ~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L 424 (788)
T PRK15387 359 TL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGL 424 (788)
T ss_pred CC---CcccceehhhccccccCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhh
Confidence 32 34677888888888764421 1368888888888885 4433 3578888888888884 56433 467
Q ss_pred CeEEecCCcCCCCCchhh--hccCCcceeecCCccC
Q 002566 333 NFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTW 366 (907)
Q Consensus 333 ~~L~Ls~N~L~~~~p~~~--~~~l~~l~ls~N~~~~ 366 (907)
+.|+|++|+|+ .+|..+ ...++.|+|++|+|++
T Consensus 425 ~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 425 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred hhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 78888888887 678776 4467788888887764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=176.38 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=110.8
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccchh--------------------------hHHHHHHHHHHHhcCCCce
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--------------------------NREFVNEIGMISAQQHPNL 734 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~--------------------------~~~f~~E~~~l~~l~H~nI 734 (907)
...||+|++|.||+|...+|+.||||++....... ...+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998889999999987642110 1123578899999999987
Q ss_pred eeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEE
Q 002566 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 735 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl 813 (907)
.....+... ..++||||++++++....... .+++..+..+++.|+++++.++|+ .+ |+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 544443332 248999999988554332111 256788999999999999999999 87 9999999999999
Q ss_pred cCCCcEEEeecCCcccccC
Q 002566 814 DKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~~~ 832 (907)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 89999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-19 Score=210.21 Aligned_cols=228 Identities=25% Similarity=0.319 Sum_probs=185.6
Q ss_pred CCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeec
Q 002566 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (907)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 195 (907)
.+.+.|+|+++.++.++.. +. .+|+.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~-Ip-~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLTTIPAC-IP-EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcCcCCcc-cc-cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 5678999999999975432 21 379999999999994 565443 58999999999999 5677664 479999999
Q ss_pred cccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCC
Q 002566 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (907)
Q Consensus 196 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 275 (907)
+|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|.++..+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP 320 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALP 320 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCC
Confidence 99999 7787764 58999999999999 5677664 589999999999995 454432 47899999999998754
Q ss_pred cccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhhhccCC
Q 002566 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355 (907)
Q Consensus 276 ~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~ 355 (907)
.... .+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+...++
T Consensus 321 ~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~ 391 (754)
T PRK15370 321 ETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQ 391 (754)
T ss_pred cccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHH
Confidence 3322 489999999999986 666554 79999999999998 5777664 68999999999999 67888888899
Q ss_pred cceeecCCccCCCC
Q 002566 356 NVDISLNNFTWESS 369 (907)
Q Consensus 356 ~l~ls~N~~~~~~~ 369 (907)
.|++++|+++.++.
T Consensus 392 ~LdLs~N~L~~LP~ 405 (754)
T PRK15370 392 IMQASRNNLVRLPE 405 (754)
T ss_pred HHhhccCCcccCch
Confidence 99999999986654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.3e-18 Score=168.61 Aligned_cols=183 Identities=14% Similarity=0.062 Sum_probs=139.2
Q ss_pred CcCCeeeccCceEEEEEEECCCcEEEEEEeccccch----hhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEeee
Q 002566 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~----~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.+...|++|+||+||.+.- ++.+++.+.+.....- ....|.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997665 6777887777654331 1235789999999995 5789999886 346899999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCcEEEeecCCcccccC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
+.+.+|.+.+.. ....++.|++++++++|++| |+|||| ||.|||+++++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888654311 12357789999999999998 999999 79999999999999999999986554
Q ss_pred CCcc----c--------cccccccccccchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002566 833 DKTH----I--------STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNT 881 (907)
Q Consensus 833 ~~~~----~--------~~~~~gt~~y~aPE~l~~--~~~~~k~DvwSlGvvl~elltG~~p~ 881 (907)
.... . ......++.|++|+...- ..--.+.+.++-|.-+|.++|++.|+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 3311 0 011235778888886542 23336789999999999999999876
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-19 Score=201.24 Aligned_cols=267 Identities=19% Similarity=0.217 Sum_probs=182.7
Q ss_pred EEeccCCCcc-ccCChhccCCCCCCEEEeecCcCCCCC----chhcccc-cccEEEecCCcCCC------CCchhcCCCC
Q 002566 96 TIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSF----SPQWASL-QLVELSVMGNRLSG------PFPKVLTNIT 163 (907)
Q Consensus 96 ~L~L~~~~l~-g~ip~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l-~L~~L~Ls~N~l~~------~~p~~l~~l~ 163 (907)
.|+|..++++ ......+..++.|+.|+|+++.++... +..+... ++++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566677776 344555677777888888888876532 2222222 48888888887762 2345677788
Q ss_pred CCCEEEeeCCcCCCCCChhhhcCcc---cceeeeccccccc----cCCccccCC-CCCCeeecccCcccCC----Ccccc
Q 002566 164 TLKNLSIEGNLFTGSIPPDIRKLIN---LQKLILSSNSFTG----ELPAELTKL-TNLNDLRISDNNFSGK----IPEFI 231 (907)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~l 231 (907)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888888666666666665 8888888888873 233445566 7888888888888743 33456
Q ss_pred cCccccceeecccccCCCC----chhhhhcCCCCCEEEcCCCCCCCCCcccc-----cccccceEEcccccccccCCccc
Q 002566 232 GKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL-----DKMNLKTLILTKCLIHGEIPDYI 302 (907)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~-----~~~~L~~L~Ls~N~i~~~~p~~~ 302 (907)
..+++|++|++++|.+++. ++..+..+++|+.|++++|.+.......+ ...+|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6667888888888888742 34455666788888888888765433222 12368888888888876333332
Q ss_pred c-----CCCCccEEecCCCCCCC----CCchhhhcCCCCCeEEecCCcCCCCCch----hh--h-ccCCcceeecC
Q 002566 303 G-----DMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGPVPK----YI--F-NSNKNVDISLN 362 (907)
Q Consensus 303 ~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~L~~~~p~----~~--~-~~l~~l~ls~N 362 (907)
. ..++|++|++++|.++. .+...+..+++|+++++++|+++..-.. .+ + ..++.+++.+|
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD 317 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCC
Confidence 2 24789999999998872 3445667778899999999999855332 22 2 45677887777
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-20 Score=210.50 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=191.3
Q ss_pred CCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeec
Q 002566 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (907)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 195 (907)
++|+.|+.++|.++ .....+...+|++++++.|++++ +|+.++.+.+|+.|+..+|+|+ .+|..+....+|+.|.+.
T Consensus 219 ~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 219 PSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred cchheeeeccCcce-eeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 44555555555555 22333444478888888888884 4588888888888888888886 778888888888888888
Q ss_pred cccccccCCccccCCCCCCeeecccCcccCCCcccc--------------------------cCccccceeecccccCCC
Q 002566 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI--------------------------GKWKKIQKLHIQGSSLEG 249 (907)
Q Consensus 196 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l--------------------------~~l~~L~~L~L~~N~l~~ 249 (907)
.|.+. .+|....++++|++|+|..|+|.. .|+.+ ..++.|+.|++.+|.++.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 88888 677777778888888888888873 33211 123568889999999998
Q ss_pred CchhhhhcCCCCCEEEcCCCCCCCCCccccccc-ccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhc
Q 002566 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (907)
Q Consensus 250 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (907)
..-..+.+.+.|+.|+|++|++...+...+.+. .|++|+||+|+++ .+|+.+.++..|+.|...+|+|. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 888889999999999999999998887777665 7999999999998 67788999999999999999998 677 8899
Q ss_pred CCCCCeEEecCCcCCC-CCchhhh-ccCCcceeecCC
Q 002566 329 LAKTNFMYLTGNKLTG-PVPKYIF-NSNKNVDISLNN 363 (907)
Q Consensus 329 l~~L~~L~Ls~N~L~~-~~p~~~~-~~l~~l~ls~N~ 363 (907)
++.|+.+||+.|+|+- .+|.... +.|+.||+++|-
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999999999999974 4555554 789999999995
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=171.23 Aligned_cols=107 Identities=25% Similarity=0.270 Sum_probs=93.8
Q ss_pred CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcc
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++...+ ..+++.++..++.|+++||+|||+++ ||+|||++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 68888886532 26899999999999999999999875 999999999999999 99998765432
Q ss_pred ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002566 837 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 837 ~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 884 (907)
..|++.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999998543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-17 Score=209.76 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=119.6
Q ss_pred EEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccc-cccEEEecCCcCCCCCchhcCCCCCCCEEEeeC
Q 002566 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 94 v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 172 (907)
++.|+|.++.+. .++..+..+++|+.|+|++|.....+|. +..+ +|+.|+|++|.....+|..+.++++|+.|+|++
T Consensus 613 L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~ 690 (1153)
T PLN03210 613 LVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690 (1153)
T ss_pred CcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence 334444444443 3344444444445555444332222222 2222 445555544443334444445555555555554
Q ss_pred CcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccc---------------------
Q 002566 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI--------------------- 231 (907)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l--------------------- 231 (907)
|...+.+|..+ ++++|+.|+|++|...+.+|.. .++|++|+|++|.++ .+|..+
T Consensus 691 c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~ 765 (1153)
T PLN03210 691 CENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWER 765 (1153)
T ss_pred CCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhcccc
Confidence 43222344333 4444555555544433333321 234555555555554 233221
Q ss_pred ---------cCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccc
Q 002566 232 ---------GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI 302 (907)
Q Consensus 232 ---------~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~ 302 (907)
...++|+.|+|++|...+.+|..++++++|+.|+|++|......+......+|+.|+|++|..-..+|..
T Consensus 766 ~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~- 844 (1153)
T PLN03210 766 VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI- 844 (1153)
T ss_pred ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc-
Confidence 0113455555555555555666666666666666665543222222223335666666665443333332
Q ss_pred cCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecC-CcCCCCCchhh--hccCCcceeec
Q 002566 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYI--FNSNKNVDISL 361 (907)
Q Consensus 303 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~L~~~~p~~~--~~~l~~l~ls~ 361 (907)
.++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |+|+ .+|..+ ...++.+++++
T Consensus 845 --~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~ 902 (1153)
T PLN03210 845 --STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSD 902 (1153)
T ss_pred --ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCC
Confidence 245666666666666 4566666666666666666 3333 344333 22344444443
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.9e-19 Score=175.17 Aligned_cols=198 Identities=24% Similarity=0.391 Sum_probs=155.8
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccc--cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCc
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 758 (907)
..+|.+...|..|+|+|+ |..+++|++... .....++|.+|.-.++-+.||||..++|.|.....+.++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 456888999999999996 555666766433 33345789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCcccc
Q 002566 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838 (907)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 838 (907)
|...+|+... ...+-.++.+++.+||+|++|||+..+ .|----+.++.+++|++.+++|+ .+-+++--+...
T Consensus 274 lynvlhe~t~---vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsfqe~g--- 345 (448)
T KOG0195|consen 274 LYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG--- 345 (448)
T ss_pred HHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeeeeccc---
Confidence 9999998643 367888999999999999999999863 23344688999999999998886 111221111111
Q ss_pred ccccccccccchhhhccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCCcch
Q 002566 839 TRIAGTIGYMAPEYAMRGYLT---SKADVYSFGVVTLEIVSGKSNTNYRPNEDF 889 (907)
Q Consensus 839 ~~~~gt~~y~aPE~l~~~~~~---~k~DvwSlGvvl~elltG~~p~~~~~~~~~ 889 (907)
..-.+.||+||.++..+.+ ..+|+|||++++|||.|.+.||..-++.+.
T Consensus 346 --r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 346 --RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred --cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 1236789999999876533 368999999999999999999977665443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-19 Score=169.60 Aligned_cols=155 Identities=23% Similarity=0.414 Sum_probs=81.4
Q ss_pred EEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCc
Q 002566 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222 (907)
Q Consensus 143 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (907)
.|.||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||+.|+
T Consensus 37 rLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynn 113 (264)
T KOG0617|consen 37 RLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNN 113 (264)
T ss_pred hhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccc
Confidence 3333444443 33334445555555555555555 44445555555555555555554 445555555555555555555
Q ss_pred cc-CCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCcc
Q 002566 223 FS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY 301 (907)
Q Consensus 223 l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~ 301 (907)
+. ..+|..|..++.|+.|+|++|.+. .+|..
T Consensus 114 l~e~~lpgnff~m~tlralyl~dndfe------------------------------------------------~lp~d 145 (264)
T KOG0617|consen 114 LNENSLPGNFFYMTTLRALYLGDNDFE------------------------------------------------ILPPD 145 (264)
T ss_pred cccccCCcchhHHHHHHHHHhcCCCcc------------------------------------------------cCChh
Confidence 43 234444444444444444444444 44555
Q ss_pred ccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhh
Q 002566 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (907)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~ 350 (907)
++++++|+.|.+..|.+- ..|..++.+..|++|.+.+|+|+ .+|..+
T Consensus 146 vg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel 192 (264)
T KOG0617|consen 146 VGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPEL 192 (264)
T ss_pred hhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhh
Confidence 566666666666666655 56666666666666666666666 445444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-17 Score=207.62 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=119.4
Q ss_pred CCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccc
Q 002566 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (907)
Q Consensus 118 L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 197 (907)
|+.|++.+|.+... |..|...+|+.|+|++|++. .++..+..+++|+.|+|++|...+.+| .+..+++|++|+|++|
T Consensus 591 Lr~L~~~~~~l~~l-P~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c 667 (1153)
T PLN03210 591 LRLLRWDKYPLRCM-PSNFRPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDC 667 (1153)
T ss_pred cEEEEecCCCCCCC-CCcCCccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCC
Confidence 44444444443322 22333334555555555554 344445555555555555544333444 2455555555555555
Q ss_pred cccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcc
Q 002566 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277 (907)
Q Consensus 198 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~ 277 (907)
.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.+...+..
T Consensus 668 ~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~ 743 (1153)
T PLN03210 668 SSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSN 743 (1153)
T ss_pred CCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccccc
Confidence 4444555555555555555555543333444433 4555555555555433333321 23444555554444332210
Q ss_pred c------------------------------ccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhh
Q 002566 278 K------------------------------LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (907)
Q Consensus 278 ~------------------------------~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (907)
. ....+|+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+
T Consensus 744 ~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~- 822 (1153)
T PLN03210 744 LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI- 822 (1153)
T ss_pred ccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-
Confidence 0 001246666666665555566666666666666666654333455444
Q ss_pred cCCCCCeEEecCCcCCCCCchhhhccCCcceeecCCccCC
Q 002566 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE 367 (907)
Q Consensus 328 ~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~~~~ 367 (907)
++++|+.|+|++|.....+|.. ..+++.|+|++|.++.+
T Consensus 823 ~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~~i 861 (1153)
T PLN03210 823 NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIEEV 861 (1153)
T ss_pred CccccCEEECCCCCcccccccc-ccccCEeECCCCCCccC
Confidence 5666666666665544444432 24566666666666543
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-19 Score=204.86 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=188.9
Q ss_pred eEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEeeC
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 172 (907)
.++.++++.++++ .+|..++.+.+|+.|+..+|+|+..+...+...+|+.|++..|.++ .+|.....++.|++|||..
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence 4556666666666 3456666677777777777766555555555556677777777766 5555666677777777777
Q ss_pred CcCCCCCChhh-hcCcc-cceeeeccccccccCCc-cccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCC
Q 002566 173 NLFTGSIPPDI-RKLIN-LQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (907)
Q Consensus 173 N~l~~~~p~~~-~~l~~-L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 249 (907)
|+|. ..|+.+ .-+.. |+.|+.+.|++. ..|. .=..++.|+.|+|.+|+|+...-..|.+..+|+.|+|++|+|..
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 7776 334333 22322 666666666666 3331 11235678999999999998888889999999999999999997
Q ss_pred CchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCC-Cchhhhc
Q 002566 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG-IPTTFEK 328 (907)
Q Consensus 250 ~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~ 328 (907)
.....+.++..|++|+||+|+++..+........|++|...+|+|. ..| .+..++.|+.+|||.|+|+.. +|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p- 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP- 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-
Confidence 7778899999999999999999998866666668999999999998 566 889999999999999999843 343333
Q ss_pred CCCCCeEEecCCcCCCCCchhh---hccCCcceeecCC
Q 002566 329 LAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNN 363 (907)
Q Consensus 329 l~~L~~L~Ls~N~L~~~~p~~~---~~~l~~l~ls~N~ 363 (907)
-++|++|||++|.-. .....- +..+...+++-|+
T Consensus 475 ~p~LkyLdlSGN~~l-~~d~~~l~~l~~l~~~~i~~~~ 511 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTRL-VFDHKTLKVLKSLSQMDITLNN 511 (1081)
T ss_pred CcccceeeccCCccc-ccchhhhHHhhhhhheecccCC
Confidence 389999999999743 222222 3445556666663
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=165.87 Aligned_cols=139 Identities=14% Similarity=0.272 Sum_probs=107.3
Q ss_pred CCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhc-----CCCceeeEEeEEeeCc---ee-E
Q 002566 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLYGCCVEGN---QL-L 748 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~-~ 748 (907)
++..+.||+|+||.||. +++....+||++........+.+.+|++++..+ .||||++++|++.++. .. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 443333478988765455567899999999999 6799999999998863 33 3
Q ss_pred EEeee--ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCEEEcC----CCcEEE
Q 002566 749 LVYEY--MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKI 821 (907)
Q Consensus 749 LV~E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl 821 (907)
+|||| +++|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5579999999543 24444 35677888777 9999998 999999999999974 347999
Q ss_pred ee-cCCccc
Q 002566 822 SD-FGLAKL 829 (907)
Q Consensus 822 ~D-FGla~~ 829 (907)
+| ||....
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 554443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-18 Score=192.15 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=193.8
Q ss_pred eEEEEeccCCCccc----cCChhccCCCCCCEEEeecCcCCC------CCchhcccc-cccEEEecCCcCCCCCchhcCC
Q 002566 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTG------SFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161 (907)
Q Consensus 93 ~v~~L~L~~~~l~g----~ip~~l~~l~~L~~L~Ls~N~l~~------~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~ 161 (907)
.++.+++.++.++. .++..+...+.|++|+++++.+.+ .++..+..+ +|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 38899999999854 366778889999999999998873 122334444 7999999999998777777766
Q ss_pred CCC---CCEEEeeCCcCCC----CCChhhhcC-cccceeeecccccccc----CCccccCCCCCCeeecccCcccCC---
Q 002566 162 ITT---LKNLSIEGNLFTG----SIPPDIRKL-INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK--- 226 (907)
Q Consensus 162 l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~--- 226 (907)
+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 665 9999999999984 233455667 8999999999999843 344567788999999999999843
Q ss_pred -CcccccCccccceeecccccCCCC----chhhhhcCCCCCEEEcCCCCCCCCCccccc------ccccceEEccccccc
Q 002566 227 -IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKLD------KMNLKTLILTKCLIH 295 (907)
Q Consensus 227 -~p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~------~~~L~~L~Ls~N~i~ 295 (907)
++..+..+++|+.|+|++|.+++. +...+..+++|+.|++++|.+.......+. ..+|+.|++++|.|+
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 344556667999999999999854 344567788999999999998763322221 248999999999997
Q ss_pred c----cCCccccCCCCccEEecCCCCCCCC----CchhhhcC-CCCCeEEecCCcC
Q 002566 296 G----EIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKL-AKTNFMYLTGNKL 342 (907)
Q Consensus 296 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~L 342 (907)
. .+...+..+++|+.|++++|.++.. ....+... ++|++|++.+|.+
T Consensus 264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 2445667779999999999999955 44455555 7899999999864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-18 Score=199.56 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=159.4
Q ss_pred CcCCeeeccCceEEEEEEEC-CCcEEEEEEec----cc-cc-hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLS----SK-SR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~----~~-~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
...+.+|.|++|.|+.+... ..+..+.|.+. .. .. .....+..|+.+-..++|+|++..+..+.+.+...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877643 33334444332 11 11 11122556777778899999998888877776666669
Q ss_pred eeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++ +|...+.... .+...++..++.|+.+|+.|+|+.| |.|||+|++|++++.++.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 9988886642 5788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc---cccccccccccccchhhhccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCcch
Q 002566 832 EDKT---HISTRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGKSNTNYRPNEDF 889 (907)
Q Consensus 832 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k-~DvwSlGvvl~elltG~~p~~~~~~~~~ 889 (907)
.... .....++|+..|+|||.+.+..|.++ .||||.|+++..|++|+.||.....++.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 5433 23445789999999999999888886 7999999999999999999966555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.5e-18 Score=191.12 Aligned_cols=186 Identities=28% Similarity=0.333 Sum_probs=154.6
Q ss_pred eeeccCceEEEEEE----ECCCcEEEEEEeccccchh--hHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEEeeecc
Q 002566 683 KVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 683 ~IG~G~fG~Vyka~----~~~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
.+|+|+||.|+.+. .+.|..+|+|+.++..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999755 3357789999887653221 124456777888877 9999999999999999999999999
Q ss_pred CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCc
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|.+...+.... .++..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.......
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999987775443 3566667777778899999999998 99999999999999999999999999987665443
Q ss_pred cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
. +||..|||||++. .....+|.||||++++||++|-.||..
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2 7999999999998 557789999999999999999999964
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.2e-19 Score=165.28 Aligned_cols=162 Identities=30% Similarity=0.481 Sum_probs=129.3
Q ss_pred ceEEEEeccCCCccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCCCEEEee
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 171 (907)
.+++.|.|++|.++ .+|+.+++|.+|+.|++++|+|+..++..-...+|+.|++.-|++. ..|..|+.++.|+.|||+
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 46888888999888 7888899999999999999988866554444447888888888887 778888888888888888
Q ss_pred CCcCC-CCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCC
Q 002566 172 GNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (907)
Q Consensus 172 ~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 250 (907)
.|++. ..+|..|..+..|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|++.+|+++ .
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-v 187 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-V 187 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-e
Confidence 88876 357778888888888888888887 77888888888888888888887 67888888888888888888887 5
Q ss_pred chhhhhcC
Q 002566 251 IPASISAL 258 (907)
Q Consensus 251 ~~~~l~~l 258 (907)
+|..++++
T Consensus 188 lppel~~l 195 (264)
T KOG0617|consen 188 LPPELANL 195 (264)
T ss_pred cChhhhhh
Confidence 55555544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.1e-17 Score=194.28 Aligned_cols=200 Identities=22% Similarity=0.229 Sum_probs=160.0
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcC---CCceeeEEeEEeeCce
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQ 746 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~ 746 (907)
+.+.-.+.|.+.+.||+|+||.||+|...+|+.||+|+-++... -+|.--.+++.+++ -+.|..+..+..-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44445678899999999999999999998999999999876543 23333334455555 2344455555556777
Q ss_pred eEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-------CCCcE
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-------KDLNA 819 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-------~~~~~ 819 (907)
-+||+||.+.|+|.+++... ..++|.-.+.++.||++.+++||..+ ||||||||.|.||. ...-+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 78999999999999999633 36899999999999999999999998 99999999999994 23458
Q ss_pred EEeecCCcccccCCCcc-ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCC
Q 002566 820 KISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 880 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p 880 (907)
+|+|||.+..+..-... .-...++|-.+-.+|+..+..++.++|.|.++-+++-|+.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999999866433222 22345789999999999999999999999999999999999863
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.3e-16 Score=183.42 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=113.4
Q ss_pred hcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccc-------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCcee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~-------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
...|...+.||+|+||.||+|.+.+...++.++..+... ....++.+|++++..++|++++....++...+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445567899999999999999986554333333322111 1234688999999999999999888888777788
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCc
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 827 (907)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++|||+||+||++ +++.++|+|||++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 99999999999988773 35678999999999999997 9999999999999 6789999999999
Q ss_pred cccc
Q 002566 828 KLYE 831 (907)
Q Consensus 828 ~~~~ 831 (907)
+...
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 8653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=163.88 Aligned_cols=144 Identities=16% Similarity=0.150 Sum_probs=111.3
Q ss_pred CCCcCCeeeccCceEEEEEE--ECCCcEEEEEEeccccch------------------------hhHHHHHHHHHHHhcC
Q 002566 677 NFDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 730 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~--~~~g~~vAVK~~~~~~~~------------------------~~~~f~~E~~~l~~l~ 730 (907)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 468999999998754210 0123567999999987
Q ss_pred CCc--eeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 002566 731 HPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 808 (907)
Q Consensus 731 H~n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp 808 (907)
+.. +.+++++ ...++||||++++++........ .....+...++.|++.++++||+.+ .++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 633 3444443 23589999999988866542221 3456667899999999999999986 499999999
Q ss_pred CCEEEcCCCcEEEeecCCcccccC
Q 002566 809 SNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 809 ~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
+||+++ ++.++|+|||.+.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-16 Score=160.83 Aligned_cols=135 Identities=22% Similarity=0.305 Sum_probs=113.9
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEeccccch--------hhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
+.||+|++|.||+|.+ ++..|++|+....... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 6777899986543211 123577899999999999988777777777788999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
+++++|.+.+... .+ .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999888532 12 78899999999999999997 99999999999999 789999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=158.85 Aligned_cols=145 Identities=19% Similarity=0.193 Sum_probs=112.3
Q ss_pred HHHHHhcCCCcCCeeeccCceEEEEEEECCCcEEEEEEeccccch----------------------hhHHHHHHHHHHH
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----------------------GNREFVNEIGMIS 727 (907)
Q Consensus 670 ~i~~~~~~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~----------------------~~~~f~~E~~~l~ 727 (907)
++......|...+.||+|+||.||++..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333334447778999999999999999888999999987643210 1123567888888
Q ss_pred hcCCCc--eeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 002566 728 AQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (907)
Q Consensus 728 ~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 805 (907)
++.|++ +.+.++. ...++||||+++++|.+.... ....+++.++++++.++|+.+ |+|||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 888874 4444442 356899999999988765321 245678899999999999987 99999
Q ss_pred CCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 806 IKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 806 lkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|||+||++++++.++|+|||.+.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=157.26 Aligned_cols=132 Identities=25% Similarity=0.328 Sum_probs=107.3
Q ss_pred eeeccCceEEEEEEECCCcEEEEEEeccccc--------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeec
Q 002566 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 683 ~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 577899998654321 11245778999999999987665555556667779999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
++++|.+.+.... . .++.+++++|.+||+.+ ++|||++|+||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~~-----------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH-----------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988774321 0 78999999999999997 99999999999999 8899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=159.20 Aligned_cols=199 Identities=19% Similarity=0.236 Sum_probs=129.3
Q ss_pred CCcCCeeeccCceEEEEEEEC-CCcEEEEEEecccc---chhhHHHHHHHHHHHhcCC----------CceeeEEeEEe-
Q 002566 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH----------PNLVKLYGCCV- 742 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H----------~nIv~l~g~~~- 742 (907)
+...+.||.|+++.||.+++. +++.+|||++.... ....+.+.+|.-....+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999987 48999999985433 2334556666654444322 11221122111
Q ss_pred --------eC---c-----eeEEEeeeccCCchhhhhh---cCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 002566 743 --------EG---N-----QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803 (907)
Q Consensus 743 --------~~---~-----~~~LV~E~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 803 (907)
.. . ..+++|+-+ .++|.+++. ..... ...+....++.+..|+++.+++||..| ++|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236677777 467876653 22111 123445566778899999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCcccccCCCccccccccccccccchhhhccC--------CCCchhHHHHHHHHHHHHH
Q 002566 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--------YLTSKADVYSFGVVTLEIV 875 (907)
Q Consensus 804 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~k~DvwSlGvvl~ell 875 (907)
+||+|+|++++++|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999887765442221 2345789999977542 5788999999999999999
Q ss_pred hCCCCCCCCC
Q 002566 876 SGKSNTNYRP 885 (907)
Q Consensus 876 tG~~p~~~~~ 885 (907)
+|+.||+...
T Consensus 245 C~~lPf~~~~ 254 (288)
T PF14531_consen 245 CGRLPFGLSS 254 (288)
T ss_dssp HSS-STCCCG
T ss_pred HccCCCCCCC
Confidence 9999997543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.5e-16 Score=179.29 Aligned_cols=196 Identities=22% Similarity=0.284 Sum_probs=150.3
Q ss_pred CCCcCCeeeccCceEEEEEEECCCcEEEEEEecccc-chhhHHHHHHHHH--HHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGM--ISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 677 ~~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~-~~~~~~f~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++...+.+|.+.|=+|.+|+.++|. |+||++-+.. .-..++|.++++- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667889999999999999998887 8899886554 4445555554443 4557999999988887777778999999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc--c
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--E 831 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~--~ 831 (907)
+.+ +|.|.+..+. -+...+.+-|+.|++.|+..+|..+ |+|||||.+|||+++-.=+.|+||..-+.. .
T Consensus 103 vkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 864 7888875542 4677788899999999999999998 999999999999999988999999765421 1
Q ss_pred CCCcc-c---cccccccccccchhhhccC-----------CCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002566 832 EDKTH-I---STRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVVTLEIVS-GKSNTN 882 (907)
Q Consensus 832 ~~~~~-~---~~~~~gt~~y~aPE~l~~~-----------~~~~k~DvwSlGvvl~ellt-G~~p~~ 882 (907)
.+... . -..-.....|.|||.+-.. ..+++-||||+||++.||++ |++||+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11111 0 0011123469999987531 16778999999999999998 788884
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-14 Score=138.35 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=114.8
Q ss_pred cCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCC--CceeeEEeEEeeCceeEEEeeeccCC
Q 002566 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNN 757 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~g 757 (907)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+..+..++| .++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999866543 4678899999999977 58999999888888899999999987
Q ss_pred chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
.+..+ +......++.+++++++++|......++|||++|+||++++.+.++++|||.+...
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 66433 45577888999999999999865445999999999999999999999999988743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.7e-14 Score=144.19 Aligned_cols=138 Identities=20% Similarity=0.266 Sum_probs=98.6
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccch--hhHHH----------------------HHHHHHHHhcCCCc--e
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNREF----------------------VNEIGMISAQQHPN--L 734 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--I 734 (907)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998754221 11111 24555555554433 3
Q ss_pred eeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEE
Q 002566 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 735 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl 813 (907)
.+.+++ ...++||||++++.+........ ... .++..++.+++.++.++|. .+ |+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 444443 24589999999865432111110 011 5678999999999999999 76 9999999999999
Q ss_pred cCCCcEEEeecCCcccccC
Q 002566 814 DKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 814 ~~~~~~kl~DFGla~~~~~ 832 (907)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 99999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=168.74 Aligned_cols=152 Identities=31% Similarity=0.590 Sum_probs=100.4
Q ss_pred cCCCHHHHHHHHHHHHHhCCC---CCCCCCCCCCCC-CCccccCCCCCCCccceeccCCCC--cceEEEEeccCCCcccc
Q 002566 34 NKLHAEEVKALKQIGRKLGKK---DWNFGVDPCSQK-GNWELSSDDKKGFESNVTCDCSSA--TCHVVTIALKAQNLTGT 107 (907)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~~~---~w~~~~d~C~~~-g~w~~~~~~~~~~~~~v~C~~~~~--~~~v~~L~L~~~~l~g~ 107 (907)
..+.+.|.+||+++|++++.. +|+ .|+|... ..| .||.|..... ..+|+.|+|.+++++|.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w-----------~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ 433 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPW-----------SGADCQFDSTKGKWFIDGLGLDNQGLRGF 433 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCC--CCCCCCccccc-----------ccceeeccCCCCceEEEEEECCCCCcccc
Confidence 356778999999999998752 675 4677421 124 5899964322 24699999999999999
Q ss_pred CChhccCCCCCCEEEeecCcCCCCCchhcccc-cccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcC
Q 002566 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (907)
Q Consensus 108 ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 186 (907)
+|..++.+++|+.|+|++|.|++.+|..+..+ +|+.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..+
T Consensus 434 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513 (623)
T ss_pred CCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence 99999999999999999888776665555554 45555555555555555555555555555555555555555554432
Q ss_pred -cccceeeecccc
Q 002566 187 -INLQKLILSSNS 198 (907)
Q Consensus 187 -~~L~~L~Ls~N~ 198 (907)
.++..+++.+|.
T Consensus 514 ~~~~~~l~~~~N~ 526 (623)
T PLN03150 514 LLHRASFNFTDNA 526 (623)
T ss_pred cccCceEEecCCc
Confidence 233444444443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.9e-15 Score=163.91 Aligned_cols=123 Identities=27% Similarity=0.429 Sum_probs=107.5
Q ss_pred eeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecC
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 825 (907)
.+++.|+++...+|.+++.+... ....++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 57899999999999999976543 3356888999999999999999 55 8999999999999999999999999
Q ss_pred CcccccCCC-----ccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHh
Q 002566 826 LAKLYEEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876 (907)
Q Consensus 826 la~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ellt 876 (907)
+........ ....+..+||..||+||.+.+..|+.|+||||+|++|+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998776554 222344679999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.7e-14 Score=169.05 Aligned_cols=168 Identities=23% Similarity=0.358 Sum_probs=119.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..+|+.++.|..|++|.||..+++. .+.+|+|+=+ +.- ..+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee------------------
Confidence 3578889999999999999999874 5677774322 110 0000 22223333333
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
|+-...+..-+ +++. +++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+.++....
T Consensus 136 ---gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---chhhhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 22233332221 2221 2378999999998 999999999999999999999999998764221
Q ss_pred Cc--------------cccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 002566 834 KT--------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 834 ~~--------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 887 (907)
.. .....++||+.|.|||++....|...+|+|++|+++||.+-|..||...-+|
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 10 0122368999999999999999999999999999999999999999665333
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.7e-13 Score=142.91 Aligned_cols=137 Identities=18% Similarity=0.214 Sum_probs=105.8
Q ss_pred CCeee-ccCceEEEEEEECCCcEEEEEEecccc-------------chhhHHHHHHHHHHHhcCCCce--eeEEeEEeeC
Q 002566 681 ANKVG-EGGFGSVYKGILSDGTVIAVKQLSSKS-------------RQGNREFVNEIGMISAQQHPNL--VKLYGCCVEG 744 (907)
Q Consensus 681 ~~~IG-~G~fG~Vyka~~~~g~~vAVK~~~~~~-------------~~~~~~f~~E~~~l~~l~H~nI--v~l~g~~~~~ 744 (907)
...|| .|+.|+||++... +..++||.+.... ......+.+|++++..++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999885 6778888875321 1223467889999999999885 6777765443
Q ss_pred c----eeEEEeeeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 745 N----QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 745 ~----~~~LV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
. ..++|||++++ .+|.+++... +++.. .+.++++++.+||+.| |+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 6888887432 23433 3578999999999998 9999999999999999999
Q ss_pred EEeecCCccccc
Q 002566 820 KISDFGLAKLYE 831 (907)
Q Consensus 820 kl~DFGla~~~~ 831 (907)
+|+|||.+....
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999987643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.2e-14 Score=157.73 Aligned_cols=164 Identities=32% Similarity=0.491 Sum_probs=131.2
Q ss_pred HhcCCCceeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 002566 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806 (907)
Q Consensus 727 ~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 806 (907)
+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+.... ..++|.....+.++++.||+|+|+.. . ..|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence 46789999999999999999999999999999999997643 37899999999999999999999864 2 289999
Q ss_pred CCCCEEEcCCCcEEEeecCCcccccCCC-ccccccccccccccchhhhccC-------CCCchhHHHHHHHHHHHHHhCC
Q 002566 807 KTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVSGK 878 (907)
Q Consensus 807 kp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-------~~~~k~DvwSlGvvl~elltG~ 878 (907)
+++|+++|....+|++|||+........ ........-..-|.|||.+... ..++++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998774310 0111112234579999999753 1477899999999999999999
Q ss_pred CCCCCCCC-cchhhHHHHH
Q 002566 879 SNTNYRPN-EDFVYLLDWA 896 (907)
Q Consensus 879 ~p~~~~~~-~~~~~l~~~~ 896 (907)
.||..... ++...++.++
T Consensus 156 ~~~~~~~~~~~~~eii~~~ 174 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRV 174 (484)
T ss_pred CccccccccCChHHHHHHH
Confidence 99965322 2223444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.3e-15 Score=161.86 Aligned_cols=170 Identities=29% Similarity=0.452 Sum_probs=109.3
Q ss_pred cEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccC
Q 002566 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (907)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (907)
...||+.|+++ .+|..+..+-.|+.|.|..|.|. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34566666666 56666667777777777777777 67777777777777777777777 6666676666 777777777
Q ss_pred cccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCcc
Q 002566 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY 301 (907)
Q Consensus 222 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~ 301 (907)
+++ .+|+.++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++... |..
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l------------------------p~E 207 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL------------------------PEE 207 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC------------------------CHH
Confidence 776 66777777777777777777776 4566666666666555554444333 333
Q ss_pred ccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCC
Q 002566 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (907)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~ 343 (907)
+..| .|..||+|+|+++ .+|-.|.+|+.|++|-|.+|.|+
T Consensus 208 l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 208 LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 3322 3555555555555 55555555555555555555555
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-13 Score=141.03 Aligned_cols=144 Identities=25% Similarity=0.403 Sum_probs=109.1
Q ss_pred CCCceeeEEeEEee---------------------------CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHH
Q 002566 730 QHPNLVKLYGCCVE---------------------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782 (907)
Q Consensus 730 ~H~nIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 782 (907)
+|||||++.++|.+ ...+|+||..++ .+|..++..+. .+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 69999998887643 235799999886 47888887653 355567778
Q ss_pred HHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCCC--cEEEeecCCcccccCCCc---cc--cccccccccccchhhh
Q 002566 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDL--NAKISDFGLAKLYEEDKT---HI--STRIAGTIGYMAPEYA 853 (907)
Q Consensus 783 ~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~---~~--~~~~~gt~~y~aPE~l 853 (907)
..|+++|+.|||+++ |.|||+|+.|||+ |+|+ ...|+|||.+--.....- .. .-..-|...-||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999998 9999999999998 4444 468899998754332111 00 1113467788999998
Q ss_pred ccCC------CCchhHHHHHHHHHHHHHhCCCCCCC
Q 002566 854 MRGY------LTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 854 ~~~~------~~~k~DvwSlGvvl~elltG~~p~~~ 883 (907)
...+ --.|+|.|+.|.+.||+++...||..
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 6432 23489999999999999999999965
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-14 Score=158.83 Aligned_cols=194 Identities=22% Similarity=0.391 Sum_probs=162.3
Q ss_pred CCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccce
Q 002566 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (907)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 239 (907)
-.|+.-...||+.|++. ++|..+..+..|+.|.|+.|.|. .+|..+.++..|++|+|+.|+++ ..|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34566677899999999 89999999999999999999998 89999999999999999999998 7788888776 888
Q ss_pred eecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCC
Q 002566 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (907)
Q Consensus 240 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (907)
|.+++|+++ .+|..++.+..| ..||.+.|+|. .+|..++++.+|+.|.+..|++.
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl-----------------------~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTL-----------------------AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EEEecCccc-cCCcccccchhH-----------------------HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 899999988 567666655544 44556666666 57778899999999999999999
Q ss_pred CCCchhhhcCCCCCeEEecCCcCCCCCchhh--hccCCcceeecCCccCCCCCCCCCCCCCccceeccCC
Q 002566 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSS 387 (907)
Q Consensus 320 ~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~--~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~l~~~~~~ 387 (907)
..|+.+..| .|..||+|.|+++ .+|..| +..|++|.|.+|.++..+. -.|--+.+-...|++.
T Consensus 203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA--qIC~kGkVHIFKyL~~ 267 (722)
T KOG0532|consen 203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA--QICEKGKVHIFKYLST 267 (722)
T ss_pred -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH--HHHhccceeeeeeecc
Confidence 678888855 5999999999999 899988 6689999999999986543 3688788888888764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.4e-13 Score=151.26 Aligned_cols=200 Identities=30% Similarity=0.462 Sum_probs=123.1
Q ss_pred EEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCc-ccceeeeccccccccCCccccCCCCCCeeecccC
Q 002566 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-NLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (907)
Q Consensus 143 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (907)
.|++..|.+... ...+..++.++.|++.+|.++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 355555554322 222344455666666666666 4454555553 6666666666665 44455556666666666666
Q ss_pred cccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCcc
Q 002566 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY 301 (907)
Q Consensus 222 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~ 301 (907)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+.......-...++..|.+.+|++.. .+..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~~ 250 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPES 250 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccch
Confidence 665 44444445566666666666666 34444444445666666666433333333333356666677777763 3677
Q ss_pred ccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCchhh
Q 002566 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (907)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~ 350 (907)
++.+++|+.|++++|+++...+ +..+.+|+.|++++|.++...|...
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 8888889999999999984444 8899999999999999987777655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2e-12 Score=147.97 Aligned_cols=142 Identities=22% Similarity=0.248 Sum_probs=102.4
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccchh----------------------------------------hHHHH
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG----------------------------------------NREFV 720 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~----------------------------------------~~~f~ 720 (907)
.+.||.|++|.||+|++++|+.||||+.++..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999987642111 01245
Q ss_pred HHHHHHHhc----CCCceeeEEeEE-eeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHH-HHHHHH
Q 002566 721 NEIGMISAQ----QHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR-GLAYLH 794 (907)
Q Consensus 721 ~E~~~l~~l----~H~nIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH 794 (907)
+|++.+.++ +|.+-+.+-..+ ......+|||||++|++|.+....... .. .+.+++.++++ .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 566655554 233333332332 224457999999999999887643211 11 24567777766 478889
Q ss_pred hCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccC
Q 002566 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 795 ~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
..| ++|+|+||.||++++++.++++|||++..+.+
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 887 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.9e-14 Score=163.56 Aligned_cols=213 Identities=26% Similarity=0.386 Sum_probs=165.5
Q ss_pred cCCCcCCeeeccCceEEEEEEECC--CcEEEEEEecccc--chhhHHHHHHHHHHHhcC-CCceeeEEeEEeeCceeEEE
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~--g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV 750 (907)
..|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-.... |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677889999999998877643 4456677665443 112223334666666666 99999999999999999999
Q ss_pred eeeccCCchhhhh-hcCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCEEEcCCC-cEEEeecCCc
Q 002566 751 YEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLA 827 (907)
Q Consensus 751 ~E~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla 827 (907)
+||.+++++.+-+ +... ...+...+-....|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|
T Consensus 100 ~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 9999999998877 3321 13566678889999999999999 777 99999999999999999 9999999999
Q ss_pred ccccC-C-Cccccccccc-cccccchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002566 828 KLYEE-D-KTHISTRIAG-TIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 828 ~~~~~-~-~~~~~~~~~g-t~~y~aPE~l~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 896 (907)
..+.. . ........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+......+ .....|.
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~ 244 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWK 244 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeec
Confidence 98766 2 2333334678 999999999887 467788999999999999999999997655443 3334443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=147.73 Aligned_cols=201 Identities=30% Similarity=0.431 Sum_probs=162.6
Q ss_pred EEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCC-CCCEEEeeCCcCCCCCChhhhcCcccceeeecccc
Q 002566 120 QLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (907)
Q Consensus 120 ~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (907)
.|+++.|.+...+......-.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 688888887655555544457899999999998 5666677774 9999999999999 666788999999999999999
Q ss_pred ccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCccc
Q 002566 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278 (907)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~ 278 (907)
++ .+|.....+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+.++.++..|.+.+|++.......
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~ 251 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI 251 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchh
Confidence 99 67776668899999999999998 67777667778999999999644 46778889999999999999887743333
Q ss_pred ccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhh
Q 002566 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (907)
Q Consensus 279 ~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (907)
-...+|+.|++++|.++...+ ++.+.+|+.|++++|.+....|....
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 333369999999999996555 88999999999999999976665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.8e-11 Score=119.12 Aligned_cols=131 Identities=19% Similarity=0.154 Sum_probs=97.2
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCcee-eEEeEEeeCceeEEEeeeccCCch
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVYEYMKNNCL 759 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~gsL 759 (907)
.+.++.|.++.||++... ++.|++|....... ....+..|++++..+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 77899999865432 223467888888888665554 454443 2345799999999877
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
... . .....++.+++++++.||+.+ +..++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~---~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE---D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 532 0 012345678999999999886 23369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-12 Score=137.07 Aligned_cols=234 Identities=16% Similarity=0.238 Sum_probs=127.9
Q ss_pred eEEEEeccCCCccc----cCChhccCCCCCCEEEeecC---cCCCCCchhcccccccEEEecCCcCCCCCchhcCCCCCC
Q 002566 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRN---CLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTL 165 (907)
Q Consensus 93 ~v~~L~L~~~~l~g----~ip~~l~~l~~L~~L~Ls~N---~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~~L 165 (907)
.++.|+|++|.+.. .+.+.+.+.++|+..++|+- ++...+|..+.. +.+.+...++|
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~----------------l~~aL~~~~~L 94 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM----------------LSKALLGCPKL 94 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH----------------HHHHHhcCCce
Confidence 46677777776643 34455666677777777642 111122222111 11223333455
Q ss_pred CEEEeeCCcCCCCCChh----hhcCcccceeeeccccccccC-------------CccccCCCCCCeeecccCcccCC--
Q 002566 166 KNLSIEGNLFTGSIPPD----IRKLINLQKLILSSNSFTGEL-------------PAELTKLTNLNDLRISDNNFSGK-- 226 (907)
Q Consensus 166 ~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~Ls~N~l~~~-- 226 (907)
+.||||.|-|...-+.. +..+..|++|.|.+|.+.-.- ..-...-++|+.+..++|++...
T Consensus 95 ~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga 174 (382)
T KOG1909|consen 95 QKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGA 174 (382)
T ss_pred eEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccH
Confidence 55555555555333332 233455555555555544110 01122335677777777777532
Q ss_pred --CcccccCccccceeecccccCCC----CchhhhhcCCCCCEEEcCCCCCCCCCcccccc-----cccceEEccccccc
Q 002566 227 --IPEFIGKWKKIQKLHIQGSSLEG----PIPASISALTSLTDLRISDLKGSESAFPKLDK-----MNLKTLILTKCLIH 295 (907)
Q Consensus 227 --~p~~l~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~-----~~L~~L~Ls~N~i~ 295 (907)
+...|...+.|+.+.+..|.|.. .+...|..+++|+.|||.+|.++......+.. .+|+.|++++|.++
T Consensus 175 ~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 175 TALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 22345556677777777777653 23345666777777777777766533222211 14677777777776
Q ss_pred ccCCccc-----cCCCCccEEecCCCCCCC----CCchhhhcCCCCCeEEecCCcC
Q 002566 296 GEIPDYI-----GDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKL 342 (907)
Q Consensus 296 ~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~L 342 (907)
.....+| ...++|+.|.|.+|.++. .+..++...+.|+.|+|++|++
T Consensus 255 ~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 255 NEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 5444333 235778888888888762 2334556677788888888877
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-11 Score=138.62 Aligned_cols=147 Identities=17% Similarity=0.209 Sum_probs=95.7
Q ss_pred cCCCcCCeeeccCceEEEEEEECC-CcEEEEEEeccccchh---------------------------------------
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQG--------------------------------------- 715 (907)
Q Consensus 676 ~~~~~~~~IG~G~fG~Vyka~~~~-g~~vAVK~~~~~~~~~--------------------------------------- 715 (907)
..|+. +.||.|++|.||+|++++ |+.||||+.++.....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35776 789999999999999987 9999999997542110
Q ss_pred -hHHHHHHHHHHHhcC----CCceeeEEeEEee-CceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHH-
Q 002566 716 -NREFVNEIGMISAQQ----HPNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 788 (907)
Q Consensus 716 -~~~f~~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~- 788 (907)
+-+|.+|+..+.+++ +...+.+-..+.+ ....+|||||++|+.+.+.-.-... ..+ +..++...++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~----g~d---~~~la~~~v~~ 271 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA----GTD---MKLLAERGVEV 271 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc----CCC---HHHHHHHHHHH
Confidence 012444555444442 4443443333332 4567899999999999764211100 111 1122222222
Q ss_pred HHHHHHhCCCCCeEEcCCCCCCEEEcCCC----cEEEeecCCcccccCC
Q 002566 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDFGLAKLYEED 833 (907)
Q Consensus 789 ~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~~ 833 (907)
-+..++..| ++|+|+||.||+++.++ .++++|||++..+.+.
T Consensus 272 ~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 233344566 99999999999999988 9999999999877543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.8e-12 Score=126.84 Aligned_cols=223 Identities=23% Similarity=0.231 Sum_probs=107.8
Q ss_pred ceEEEEeccCC--------CccccCChhccCCCCCCEEEeecCcCCCCCchhcccccccEEEecCCcCCCCCchhcCCCC
Q 002566 92 CHVVTIALKAQ--------NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163 (907)
Q Consensus 92 ~~v~~L~L~~~--------~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~l~ 163 (907)
|+++.|..++. -+...+|-.+.-+++|+.+.+|.+.-..+..-......|+.+...+..++. .|. +--..
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~ 259 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQD-VPS-LLPET 259 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccc-ccc-ccchh
Confidence 46666666542 123345566777888888888887543332222233357777766655441 111 11111
Q ss_pred CCCEEEeeCC-cCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeec
Q 002566 164 TLKNLSIEGN-LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (907)
Q Consensus 164 ~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 242 (907)
.+..+.-+.- -.+|..-..+....-|++||||+|.|+ .+.++..-+|.++.|++|+|.|... +.+..+++|+.|||
T Consensus 260 ~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDL 336 (490)
T KOG1259|consen 260 ILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDL 336 (490)
T ss_pred hhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeec
Confidence 1111111110 111222222233345666666666665 4455555556666666666666522 22555666666666
Q ss_pred ccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCCCCccEEecCCCCCCCCC
Q 002566 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (907)
Q Consensus 243 ~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (907)
++|.++.. ...-.++- |++.|.|++|.|+. -..++.+-+|..||+++|+|....
T Consensus 337 S~N~Ls~~-~Gwh~KLG-----------------------NIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ld 390 (490)
T KOG1259|consen 337 SGNLLAEC-VGWHLKLG-----------------------NIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELD 390 (490)
T ss_pred ccchhHhh-hhhHhhhc-----------------------CEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHH
Confidence 66665521 11111222 23344444444431 122444555666666666665321
Q ss_pred -chhhhcCCCCCeEEecCCcCCCC
Q 002566 323 -PTTFEKLAKTNFMYLTGNKLTGP 345 (907)
Q Consensus 323 -p~~~~~l~~L~~L~Ls~N~L~~~ 345 (907)
-..+++||-|+.|.|.+|+|.+.
T Consensus 391 eV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 391 EVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred HhcccccccHHHHHhhcCCCcccc
Confidence 23456666667777777766643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.2e-11 Score=141.45 Aligned_cols=110 Identities=34% Similarity=0.570 Sum_probs=100.7
Q ss_pred CCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeecc
Q 002566 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (907)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 243 (907)
.++.|+|++|.+.|.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCchhhhhcC-CCCCEEEcCCCCCCC
Q 002566 244 GSSLEGPIPASISAL-TSLTDLRISDLKGSE 273 (907)
Q Consensus 244 ~N~l~~~~~~~l~~l-~~L~~L~L~~n~~~~ 273 (907)
+|+++|.+|..+..+ .++..+++.+|....
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999998875 467888998887543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-12 Score=132.70 Aligned_cols=216 Identities=19% Similarity=0.247 Sum_probs=110.2
Q ss_pred ceEEEEeccCCCccc----cCC-------hhccCCCCCCEEEeecCcCCCCCchhcccc-----cccEEEecCCcCCCCC
Q 002566 92 CHVVTIALKAQNLTG----TLP-------TELSKLRYLKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLSGPF 155 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g----~ip-------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~L~~L~Ls~N~l~~~~ 155 (907)
..++.+++++. ++| .+| +++-..++|++||||.|-|....+..|..+ .|++|.|.+|.+.-.-
T Consensus 58 ~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~a 136 (382)
T KOG1909|consen 58 KELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEA 136 (382)
T ss_pred ccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhH
Confidence 36677777653 333 333 445667799999999998886666555443 5777777777766221
Q ss_pred chhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeecccccccc----CCccccCCCCCCeeecccCcccC----CC
Q 002566 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSG----KI 227 (907)
Q Consensus 156 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~ 227 (907)
-..++. .|..|. .| ...+.-++|+.+..++|++... +...|...+.|+.+.++.|.|.. .+
T Consensus 137 g~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al 205 (382)
T KOG1909|consen 137 GGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTAL 205 (382)
T ss_pred HHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHH
Confidence 111111 000000 00 0011223444444444444311 11223333444444444444431 11
Q ss_pred cccccCccccceeecccccCCCC----chhhhhcCCCCCEEEcCCCCCCCCCcccc----c--ccccceEEccccccccc
Q 002566 228 PEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL----D--KMNLKTLILTKCLIHGE 297 (907)
Q Consensus 228 p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~~~~~~~~~~----~--~~~L~~L~Ls~N~i~~~ 297 (907)
...|..+++|+.|+|.+|-++.. +...+..+++|+.|+++++.+.......+ . .++|+.|.|.+|.|+..
T Consensus 206 ~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~d 285 (382)
T KOG1909|consen 206 AEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRD 285 (382)
T ss_pred HHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHH
Confidence 22344445555555555544421 23334444555555555544443322111 1 22678888888888743
Q ss_pred ----CCccccCCCCccEEecCCCCCC
Q 002566 298 ----IPDYIGDMTKLKNIDLSFNNLT 319 (907)
Q Consensus 298 ----~p~~~~~l~~L~~L~Ls~N~l~ 319 (907)
+...+...+.|..|+|++|++.
T Consensus 286 a~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 286 AALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHHHHhcchhhHHhcCCccccc
Confidence 2334566899999999999994
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=130.89 Aligned_cols=204 Identities=20% Similarity=0.209 Sum_probs=97.4
Q ss_pred cccEEEecCCcCCCCCc-hhcCCCCCCCEEEeeCCcCCCC--CChhhhcCcccceeeeccccccccCCccc-cCCCCCCe
Q 002566 140 QLVELSVMGNRLSGPFP-KVLTNITTLKNLSIEGNLFTGS--IPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 215 (907)
+|+.+.|.+..+.-... .....|++++.||||.|-|..- +-.....||+|+.|+|+.|++.-...... ..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 46666666666552211 3455667777777777766621 11233456777777777777663222211 23556666
Q ss_pred eecccCcccCC-CcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcc--cccccccceEEcccc
Q 002566 216 LRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP--KLDKMNLKTLILTKC 292 (907)
Q Consensus 216 L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~--~~~~~~L~~L~Ls~N 292 (907)
|.|+.+.|+-. +-..+..+++|+.|+|..|............+..|+.|+|++|.+...+.. ......|+.|+++.|
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 66666666522 112233456666666666643323333333444555555555554433311 111123444444444
Q ss_pred ccccc-CCcc-----ccCCCCccEEecCCCCCCC-CCchhhhcCCCCCeEEecCCcCC
Q 002566 293 LIHGE-IPDY-----IGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLT 343 (907)
Q Consensus 293 ~i~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~L~ 343 (907)
.|+.+ .|+. ...+++|++|+++.|++.. ..-..+..+++|+.|....|.|+
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 44432 1221 2334555555555555531 11122333444444444444443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.7e-10 Score=125.37 Aligned_cols=166 Identities=16% Similarity=0.200 Sum_probs=126.0
Q ss_pred ECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCH
Q 002566 697 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 776 (907)
Q Consensus 697 ~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~ 776 (907)
..++.+|.|+..+...........+-++.++.+|||||++++.....++..|||+|.+.. |..++... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l--------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL--------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh--------HH
Confidence 346888999988766553344566778889999999999999999999999999999864 56555432 34
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCCCccccccccccccccchhhhccC
Q 002566 777 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856 (907)
Q Consensus 777 ~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 856 (907)
....-.+.||+.||.+||+.+ .++|++|.-..|++++.|+.||++|..+......... .....--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCcc
Confidence 566778889999999999876 5999999999999999999999999888654332210 0001112346667655433
Q ss_pred CCCchhHHHHHHHHHHHHHhC
Q 002566 857 YLTSKADVYSFGVVTLEIVSG 877 (907)
Q Consensus 857 ~~~~k~DvwSlGvvl~elltG 877 (907)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 236999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-09 Score=108.54 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=96.9
Q ss_pred CeeeccCceEEEEEEECC-------CcEEEEEEeccccc----------------------hhhHHHH----HHHHHHHh
Q 002566 682 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKSR----------------------QGNREFV----NEIGMISA 728 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~-------g~~vAVK~~~~~~~----------------------~~~~~f~----~E~~~l~~ 728 (907)
..||.|--+.||.|...+ +..+|||+++.... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998653 47899998753210 0011223 68888888
Q ss_pred cCCC--ceeeEEeEEeeCceeEEEeeeccCCchhh-hhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEc
Q 002566 729 QQHP--NLVKLYGCCVEGNQLLLVYEYMKNNCLSR-AIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHR 804 (907)
Q Consensus 729 l~H~--nIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHr 804 (907)
++.. ++.+.+++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|..| |+.+ +|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 7543 45555554 45689999998654421 1211 1344556778889999999999 7777 9999
Q ss_pred CCCCCCEEEcCCCcEEEeecCCccccc
Q 002566 805 DIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 805 Dlkp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
|+++.||+++ ++.++|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-11 Score=123.91 Aligned_cols=137 Identities=16% Similarity=0.183 Sum_probs=90.3
Q ss_pred CCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCCccccCC
Q 002566 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM 305 (907)
Q Consensus 226 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l 305 (907)
..-..+..++.|++|||++|.|+ .+..+..-++.++.|+++.|.+..... .-...+|+.||||+|.++ .+-++=..+
T Consensus 275 ~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KL 351 (490)
T KOG1259|consen 275 SALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKL 351 (490)
T ss_pred ceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhh
Confidence 33334445566666666666666 455555566666666666666655433 112226777788888776 334444567
Q ss_pred CCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCCCch-hh--hccCCcceeecCCccCC
Q 002566 306 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK-YI--FNSNKNVDISLNNFTWE 367 (907)
Q Consensus 306 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~-~~--~~~l~~l~ls~N~~~~~ 367 (907)
-|++.|.|++|.|. .-..+.+|-+|..||+++|+|...-.. .+ .+.++.+.|.+|.+..+
T Consensus 352 GNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 352 GNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred cCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 88999999999987 334577788899999999999732111 12 55778899999977654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-09 Score=112.30 Aligned_cols=143 Identities=20% Similarity=0.280 Sum_probs=110.8
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccc-hhhHHHHHHHHHHHhcCCCc--eeeEEeEEeeC---ceeEEEeeec
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPN--LVKLYGCCVEG---NQLLLVYEYM 754 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~---~~~~LV~E~~ 754 (907)
.+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++.+ +.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987778899999765432 23457889999999987644 56677776654 2568999999
Q ss_pred cCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------------- 797 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 797 (907)
++.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765431 14677788888899999999998531
Q ss_pred ----------------CCCeEEcCCCCCCEEEcC--CCcEEEeecCCccc
Q 002566 798 ----------------RIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKL 829 (907)
Q Consensus 798 ----------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~ 829 (907)
+..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.6e-10 Score=112.78 Aligned_cols=123 Identities=28% Similarity=0.336 Sum_probs=42.6
Q ss_pred cccEEEecCCcCCCCCchhcC-CCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccc-cCCCCCCeee
Q 002566 140 QLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLR 217 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 217 (907)
++++|+|++|.|+.+ . .++ .+.+|+.|||++|.|+. ++ .+..+++|++|++++|+|+ .+.+.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc-c-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 455556666665532 2 244 45667777777777773 22 4666677777777777776 344333 3467777777
Q ss_pred cccCcccCCC-cccccCccccceeecccccCCCCc---hhhhhcCCCCCEEEcC
Q 002566 218 ISDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLRIS 267 (907)
Q Consensus 218 Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L~L~ 267 (907)
|++|+|.... -..+..+++|+.|+|.+|.++... ...+..+|+|+.||-.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 7777775321 134566777777777777776431 2356778888888643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.8e-10 Score=126.55 Aligned_cols=198 Identities=24% Similarity=0.268 Sum_probs=156.4
Q ss_pred cCCCcCCeeec--cCceEEEEEEE--C-CCcEEEEEEeccc--cchhhHHHHHHHHHHHhc-CCCceeeEEeEEeeCcee
Q 002566 676 NNFDPANKVGE--GGFGSVYKGIL--S-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 676 ~~~~~~~~IG~--G~fG~Vyka~~--~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 747 (907)
..|.+.+.+|. |.+|.||++.. + ++..+|+|+-+.. .......=.+|+....++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999987 3 5788999984433 223334445666666666 499999988889999999
Q ss_pred EEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEe
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKIS 822 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~ 822 (907)
++-+|++. .+|..+.+.... .++......+..+..+ |+.++|... ++|-|+||.||+..++ ..++++
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 99999986 678777765432 3677788888888888 999999987 9999999999999999 889999
Q ss_pred ecCCcccccCCCcc----ccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002566 823 DFGLAKLYEEDKTH----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 823 DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p~~ 882 (907)
|||+...+....-. ...+..|...|++||...+ -++...|+|++|.+..|...|..++.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 99999988765421 1122357889999998864 45888999999999999999887653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.1e-11 Score=126.54 Aligned_cols=212 Identities=19% Similarity=0.216 Sum_probs=149.3
Q ss_pred hhccCCCCCCEEEeecCcCCCCCc-hhcccc-cccEEEecCCcCCCCCc--hhcCCCCCCCEEEeeCCcCCCCCChhh-h
Q 002566 110 TELSKLRYLKQLDLSRNCLTGSFS-PQWASL-QLVELSVMGNRLSGPFP--KVLTNITTLKNLSIEGNLFTGSIPPDI-R 184 (907)
Q Consensus 110 ~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l-~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~ 184 (907)
..=+++++|+.+.|.+..+..... .....+ +++.|||+.|-+....+ .....|++|+.|+|+.|.+.-...... .
T Consensus 115 akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~ 194 (505)
T KOG3207|consen 115 AKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL 194 (505)
T ss_pred HHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh
Confidence 345667888888888877665443 223333 78889999888875433 445678999999999998873332222 2
Q ss_pred cCcccceeeeccccccccC-CccccCCCCCCeeecccCcccCCCcccccCccccceeecccccCCCCc-hhhhhcCCCCC
Q 002566 185 KLINLQKLILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLT 262 (907)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~ 262 (907)
.+++|+.|.|+.|.|+-.- -..+..+|+|+.|+|..|..-..-.....-+..|++|+|++|++-... -...+.++.|+
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence 5778999999999888322 222356788999999988533344444556788999999998876422 25677888999
Q ss_pred EEEcCCCCCCCCCcccc-------cccccceEEcccccccccC-CccccCCCCccEEecCCCCCCCC
Q 002566 263 DLRISDLKGSESAFPKL-------DKMNLKTLILTKCLIHGEI-PDYIGDMTKLKNIDLSFNNLTGG 321 (907)
Q Consensus 263 ~L~L~~n~~~~~~~~~~-------~~~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ 321 (907)
.|.++.+.+.+...+.. ...+|+.|+++.|+|.... -..+..+++|+.|....|.|+..
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 99999988887665554 1238999999999986321 23466678899999999999843
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-11 Score=136.31 Aligned_cols=194 Identities=25% Similarity=0.261 Sum_probs=96.5
Q ss_pred ccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeeccc
Q 002566 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (907)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (907)
++.++++.|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+... .+..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 4444444444442 2223455555555555555555 22222455555555555555555322 233444455555555
Q ss_pred CcccCCCcccccCccccceeecccccCCCCch-hhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEcccccccccCC
Q 002566 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (907)
Q Consensus 221 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p 299 (907)
|.|+. ...+..+..|+.+++++|++....+ . ...+.+|+.+++++|.+.......... .+..+++..|.++..-+
T Consensus 150 N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~-~l~~~~l~~n~i~~~~~ 225 (414)
T KOG0531|consen 150 NLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLK-KLVLLSLLDNKISKLEG 225 (414)
T ss_pred Ccchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHH-HHHHhhcccccceeccC
Confidence 55541 1223345555555566665553333 1 345555555555555554433211111 23334556666553222
Q ss_pred ccccCCC--CccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCCCC
Q 002566 300 DYIGDMT--KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (907)
Q Consensus 300 ~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~~~ 345 (907)
+..+. .|+.+++++|++. ..+..+..+..+..|++.+|++...
T Consensus 226 --l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 226 --LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred --cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc
Confidence 11122 2667777777776 3335556666677777777766543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.2e-09 Score=101.77 Aligned_cols=132 Identities=23% Similarity=0.295 Sum_probs=98.1
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEecccc-c-------hhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEeee
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-R-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~-~-------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
..+++|+-+.+|.+.+.+.. +++|.=.++. . -...+-.+|++++.+++--.|.-.+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999885444 5555432221 1 1123456799999888766665555566777888899999
Q ss_pred ccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccc
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 830 (907)
+++..|.+.+... ...++..+=+-+.-||..+ |+|+|+.++||.+..+. +.++|||++..-
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9998888887443 2445666667778899998 99999999999998765 999999999854
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.7e-09 Score=99.54 Aligned_cols=144 Identities=18% Similarity=0.277 Sum_probs=102.2
Q ss_pred cCCeeeccCceEEEEEEECCCcEEEEE-Eecccc-------chhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEEEe
Q 002566 680 PANKVGEGGFGSVYKGILSDGTVIAVK-QLSSKS-------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~~g~~vAVK-~~~~~~-------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
....|-||+-+.|+++.++ |+...|| ++.+.- +-..++-.+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999986 5554454 443321 122456778999988876545443333455555667899
Q ss_pred eeccC-CchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---cEEEeecCCc
Q 002566 752 EYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLA 827 (907)
Q Consensus 752 E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla 827 (907)
||+++ .++.+++...... +...+....++..|=+.+.-||.++ ||||||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99986 3677777554322 2223333788889999999999998 99999999999997654 4689999998
Q ss_pred ccc
Q 002566 828 KLY 830 (907)
Q Consensus 828 ~~~ 830 (907)
..-
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.5e-10 Score=109.97 Aligned_cols=127 Identities=25% Similarity=0.288 Sum_probs=49.2
Q ss_pred ccCCCCCCEEEeecCcCCCCCchhcc-cc-cccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhh-hcCcc
Q 002566 112 LSKLRYLKQLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLIN 188 (907)
Q Consensus 112 l~~l~~L~~L~Ls~N~l~~~~~~~~~-~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 188 (907)
+.+...+++|+|++|.|+.+. .++ .+ +|+.|+|++|.|+.. . .+..+++|++|+|++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 444556788888888887653 232 33 788888888888843 2 47788999999999999994 54445 46899
Q ss_pred cceeeeccccccccC-CccccCCCCCCeeecccCcccCCC---cccccCccccceeecc
Q 002566 189 LQKLILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKI---PEFIGKWKKIQKLHIQ 243 (907)
Q Consensus 189 L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~L~ 243 (907)
|++|+|++|+|...- -..+..+++|+.|+|.+|.++... ...+..+|+|+.||-.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 999999999998432 245678899999999999987431 1245678888888754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-11 Score=134.50 Aligned_cols=219 Identities=24% Similarity=0.302 Sum_probs=159.6
Q ss_pred cCCCCCCEEEeecCcCCCCCchhccc-ccccEEEecCCcCCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCcccce
Q 002566 113 SKLRYLKQLDLSRNCLTGSFSPQWAS-LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (907)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (907)
..+..++.+++..|.|.... ..+.. .+|..|++.+|+|..+ ...+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~-~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKIL-NHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhhhh-cccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhh
Confidence 45677777778888887622 22333 3788999999998844 333778899999999999999554 3677888999
Q ss_pred eeeccccccccCCccccCCCCCCeeecccCcccCCCc-ccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCC
Q 002566 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (907)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~ 270 (907)
|++++|.|+. + ..+..+++|+.+++++|+++..-+ . ...+.+|+.+++.+|.+... ..+..+..+..+++.+|.
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 9999999983 3 345668899999999999985544 2 57888999999999998743 233344455555777777
Q ss_pred CCCCCcccccc-cccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcCC
Q 002566 271 GSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (907)
Q Consensus 271 ~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L~ 343 (907)
+.......... ..|+.+++++|.+.. .+..+..+.++..|++++|++...- .+...+.+..+.+..|++.
T Consensus 220 i~~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 220 ISKLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ceeccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 76654322211 138899999999983 3366778899999999999998432 3566677788888888876
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.4e-08 Score=97.38 Aligned_cols=126 Identities=27% Similarity=0.291 Sum_probs=83.3
Q ss_pred EEEEEEECCCcEEEEEEecccc--------------c-------h-----hhHHHHHHHHHHHhcCCCc--eeeEEeEEe
Q 002566 691 SVYKGILSDGTVIAVKQLSSKS--------------R-------Q-----GNREFVNEIGMISAQQHPN--LVKLYGCCV 742 (907)
Q Consensus 691 ~Vyka~~~~g~~vAVK~~~~~~--------------~-------~-----~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~ 742 (907)
.||.|...+|..+|||..+... . . ......+|.+.|.++...+ +.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999975321 0 0 0124567999999988764 55565442
Q ss_pred eCceeEEEeeecc--CCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEcCCCCCCEEEcCCCcE
Q 002566 743 EGNQLLLVYEYMK--NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 743 ~~~~~~LV~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiHrDlkp~NILl~~~~~~ 819 (907)
...+||||++ +..+.++.... ++.+....++.++++.+.. +|..| |+|||+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999999 65554443221 1134566778888886666 46776 9999999999999988 99
Q ss_pred EEeecCCccccc
Q 002566 820 KISDFGLAKLYE 831 (907)
Q Consensus 820 kl~DFGla~~~~ 831 (907)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.4e-09 Score=119.77 Aligned_cols=193 Identities=22% Similarity=0.237 Sum_probs=146.9
Q ss_pred hcCCCcCCeeeccCceEEEEEEEC--CCcEEEEEEeccccchhhHH--HHHHHHHHHhc-CCCceeeEEeEEeeCceeEE
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNRE--FVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 ~~~~~~~~~IG~G~fG~Vyka~~~--~g~~vAVK~~~~~~~~~~~~--f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~L 749 (907)
+.+|..+..||.|.|+.|++...+ ++..+++|.+.........+ -..|+.+...+ -|.++++....+...+..++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999998754 57789999886654332222 23455555544 58899988888888888889
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CcEEEeecCCcc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAK 828 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 828 (907)
--||++++++...+.. ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+.
T Consensus 344 p~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred chhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999988766521 124778889999999999999999887 9999999999999876 888999999987
Q ss_pred cccCCCcccccccccccccc--chhhhccCCCCchhHHHHHHHHHHHHHhCCC
Q 002566 829 LYEEDKTHISTRIAGTIGYM--APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~k~DvwSlGvvl~elltG~~ 879 (907)
.+..... .....-+++ +|+......+..+.|++|||.-+.|.++|..
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 4322111 112233444 5555667788999999999999999999876
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.8e-09 Score=84.88 Aligned_cols=60 Identities=33% Similarity=0.505 Sum_probs=56.5
Q ss_pred ccceEEcccccccccCCccccCCCCccEEecCCCCCCCCCchhhhcCCCCCeEEecCCcC
Q 002566 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342 (907)
Q Consensus 283 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~L 342 (907)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 688999999999988889999999999999999999988889999999999999999976
|
... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-08 Score=106.80 Aligned_cols=153 Identities=22% Similarity=0.325 Sum_probs=114.6
Q ss_pred HHHhcCCCceeeEEeEEeeC-----ceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 002566 725 MISAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799 (907)
Q Consensus 725 ~l~~l~H~nIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 799 (907)
-+-.+.|.|||+++.|+.+. .+..++.|||+.|++..+|+... .....+....-.+++.||..||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 34456799999999998653 34688999999999999997643 22335677778899999999999999985 6
Q ss_pred CeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC----CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHH
Q 002566 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED----KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 875 (907)
Q Consensus 800 ~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~ell 875 (907)
+|+|+++.-+-|++..++-+|+.--- -...... .......-.+-++|.|||+=....-+..+|||+||....||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999988885211 0000000 000111123568999999877777778899999999999999
Q ss_pred hCCCC
Q 002566 876 SGKSN 880 (907)
Q Consensus 876 tG~~p 880 (907)
.|..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 88753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=104.58 Aligned_cols=170 Identities=19% Similarity=0.291 Sum_probs=129.5
Q ss_pred eEEEEEEEC-CCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCceeeEEeEEee----CceeEEEeeeccC-Cchhhhh
Q 002566 690 GSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEYMKN-NCLSRAI 763 (907)
Q Consensus 690 G~Vyka~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV~E~~~~-gsL~~~l 763 (907)
.+.||+... ||..|+.|+++....+.......-+++++++.|+|||++.+++.. +..+++||+|+++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999854 899999999965544333333456788999999999999998873 4578999999985 3565544
Q ss_pred hcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCcccccCC
Q 002566 764 FGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 764 ~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+..... .....++..++.++.|+..||.++|+.| +..+-|.+++|+++.+.+++|+..|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 432221 1235778999999999999999999998 888999999999999999999887776655544
Q ss_pred CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCCC
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 880 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~p 880 (907)
... -+ ..-++-|.-.||.+++.|.+|...
T Consensus 447 ~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 311 01 123467999999999999999765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.2e-07 Score=99.21 Aligned_cols=141 Identities=16% Similarity=0.055 Sum_probs=99.8
Q ss_pred CeeeccCceEEEEEEECCCcEEEEEEeccccchh-----------hHHHHHHHHHHHhcCCCce--eeEEeEEee-----
Q 002566 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNL--VKLYGCCVE----- 743 (907)
Q Consensus 682 ~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~nI--v~l~g~~~~----- 743 (907)
+.+-+-....|++..+ +|+.|.||......... ...+.+|.+.+.++...+| .+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777776 57789999875433110 1137788888877754333 344555433
Q ss_pred CceeEEEeeeccCC-chhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-------
Q 002566 744 GNQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK------- 815 (907)
Q Consensus 744 ~~~~~LV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------- 815 (907)
...-+||||++++- +|.+++..... .+.+......++.++++.+.-||+.| |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23468999999876 78888742111 13456678899999999999999998 999999999999975
Q ss_pred CCcEEEeecCCccc
Q 002566 816 DLNAKISDFGLAKL 829 (907)
Q Consensus 816 ~~~~kl~DFGla~~ 829 (907)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 47899999998864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.5e-08 Score=122.21 Aligned_cols=150 Identities=21% Similarity=0.286 Sum_probs=90.4
Q ss_pred CCCCCEEEeecCcCCCCCchhcccccccEEEecCCc--CCCCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcCccccee
Q 002566 115 LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR--LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (907)
Q Consensus 115 l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 192 (907)
....+.+.+.+|.+... +......+|+.|-+..|. +....+..|..++.|+.|||++|.=.+.+|..+++|.+|++|
T Consensus 522 ~~~~rr~s~~~~~~~~~-~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIEHI-AGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hhheeEEEEeccchhhc-cCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 35556666666655432 222222356666666665 443444456667777777777765555677777777777777
Q ss_pred eeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeeccccc--CCCCchhhhhcCCCCCEEEc
Q 002566 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS--LEGPIPASISALTSLTDLRI 266 (907)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~~~~l~~l~~L~~L~L 266 (907)
+|++..++ .+|..+.+|..|.+|++..+.-...+|..+..+++|++|.+.... .....-..+.++.+|+.|..
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 77777776 677777777777777777666555556666667777777665443 22233334444555554444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-08 Score=82.87 Aligned_cols=58 Identities=36% Similarity=0.497 Sum_probs=23.2
Q ss_pred CCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCc
Q 002566 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222 (907)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 222 (907)
|++|+|++|+|+...+..|.++++|++|++++|+|+...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444443323333444444444444444443333334444444444444443
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.6e-09 Score=123.56 Aligned_cols=206 Identities=19% Similarity=0.262 Sum_probs=147.0
Q ss_pred HhcCCCcCCeeeccCceEEEEEEEC-CCcEEEEEEeccc---cchhhHHHHHHHHHHHhcCCCceeeEEeEEeeCceeEE
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 674 ~~~~~~~~~~IG~G~fG~Vyka~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
..+.+.+.+-+-.|.++.++.+.-. .|...+.|..... .+.+.+....+-.++-..+||.+++....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777788889999999877643 2433344433222 11122222223333333456777766655666778899
Q ss_pred EeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
|++|..+++|...++... ..+.+-++.....+..+.+|||... +.|||++|.|++...++..+++|||....
T Consensus 882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 999999999998887654 3455556666777889999999875 89999999999999999999999984332
Q ss_pred ccCC------------------------------CccccccccccccccchhhhccCCCCchhHHHHHHHHHHHHHhCCC
Q 002566 830 YEED------------------------------KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879 (907)
Q Consensus 830 ~~~~------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DvwSlGvvl~elltG~~ 879 (907)
.... .........||+.|.+||...+......+|.|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1100 0001123568999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 002566 880 NTNYRPNE 887 (907)
Q Consensus 880 p~~~~~~~ 887 (907)
||+....+
T Consensus 1034 p~na~tpq 1041 (1205)
T KOG0606|consen 1034 PFNAETPQ 1041 (1205)
T ss_pred CCCCcchh
Confidence 99765443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.6e-08 Score=119.26 Aligned_cols=148 Identities=20% Similarity=0.280 Sum_probs=108.2
Q ss_pred eEEEEeccCCCccccCChhccCCCCCCEEEeecCc--CCCCCchhcccc-cccEEEecCCcCCCCCchhcCCCCCCCEEE
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC--LTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~--l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 169 (907)
.+..+.+-++.+. .++.... .+.|++|-+..|. +.......|..+ .|+.|||++|.--+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4556666666554 2333222 3378899998886 666666667777 689999999887778999999999999999
Q ss_pred eeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcc--cCCCcccccCccccceeecc
Q 002566 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF--SGKIPEFIGKWKKIQKLHIQ 243 (907)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~l~~l~~L~~L~L~ 243 (907)
|++..+. .+|..+.+|.+|.+|++..+.-...+|.....|++|++|.+..-.. +...-..+.++.+|+.|...
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 9999999 8899999999999999998887656677777799999999865542 22233344455555555543
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1e-07 Score=106.04 Aligned_cols=85 Identities=31% Similarity=0.415 Sum_probs=68.6
Q ss_pred ccchhhhhhhccccc-----ccceEeeeeccCeeEEEEEeeeEEEecCCcccccccceeEEEEecceecccccchhh-hc
Q 002566 481 SAVDLELYRTARVSP-----LSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIED-EA 554 (907)
Q Consensus 481 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 554 (907)
..+|..+|+|||.+. ++++|-. ...+..|.|+||||||+ ......+.|+|||||+|+.+.+ +|.. +.
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~-~~~~~~y~v~lHFaEi~----~~~~~~~~R~F~IyiN~~~~~~--~~~~~~~ 302 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSF-VDPGFSYYVRLHFAEIQ----SLSPNNNQREFDIYINGQTAYS--DVSPPYL 302 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEecc-CCCCccEEEEEEEeecc----cccCCCCeEEEEEEECCeEccC--ccCcccc
Confidence 578999999999876 6888865 55566999999999996 3334556899999999999987 5555 56
Q ss_pred CCCCcceEEecccccccc
Q 002566 555 GGTGIPIVKNFPAEVTSH 572 (907)
Q Consensus 555 ~~~~~~~~~~~~~~v~~~ 572 (907)
++...+++++|.+.++..
T Consensus 303 ~~~~~~~~~d~~~~~~~~ 320 (347)
T PF12819_consen 303 GADTVPYYSDYVVNVPDS 320 (347)
T ss_pred cCcceEeecceEEEecCC
Confidence 677788899998887754
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.2e-07 Score=93.85 Aligned_cols=134 Identities=23% Similarity=0.209 Sum_probs=95.4
Q ss_pred CCcCCeeeccCceEEEEEEECCCcEEEEEEeccccc----------------------hhhHHHHHHHHHHHhcCCC--c
Q 002566 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------------------QGNREFVNEIGMISAQQHP--N 733 (907)
Q Consensus 678 ~~~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~----------------------~~~~~f~~E~~~l~~l~H~--n 733 (907)
..+.++||.|--+.||.|..+.|.++|||.-....+ .......+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999997542210 0122356788888888655 5
Q ss_pred eeeEEeEEeeCceeEEEeeeccCCchhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 002566 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (907)
Q Consensus 734 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 813 (907)
|.+.+++ +...+||||+++--|.+.- ++.+....|+..|++-+.-.-..| |||||+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 5555554 4568999999986664332 123334444555555544444556 9999999999999
Q ss_pred cCCCcEEEeecCCcc
Q 002566 814 DKDLNAKISDFGLAK 828 (907)
Q Consensus 814 ~~~~~~kl~DFGla~ 828 (907)
++||.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.7e-09 Score=120.83 Aligned_cols=127 Identities=19% Similarity=0.184 Sum_probs=95.7
Q ss_pred CCCeeecccCcccCCCcccccCccccceeecccccCCCCchhhhhcCCCCCEEEcCCCCCCCCCcccccccccceEEccc
Q 002566 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291 (907)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~ 291 (907)
.|...+.+.|.|. .+-.++.-++.|+.|+|++|+++... .+..++.|+.|||+.|.+...+--......|..|.|++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrn 241 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRN 241 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeecc
Confidence 4667777777776 55666777777888888888877443 67777888888888888777665555555789999999
Q ss_pred ccccccCCccccCCCCccEEecCCCCCCCCC-chhhhcCCCCCeEEecCCcCC
Q 002566 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMYLTGNKLT 343 (907)
Q Consensus 292 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~L~ 343 (907)
|.++.. ..+.++.+|+.|||++|-|.+.- -.-+..|..|+.|+|.||+|.
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 988732 34678899999999999987532 234667788999999999987
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.3e-06 Score=92.44 Aligned_cols=193 Identities=15% Similarity=0.201 Sum_probs=125.9
Q ss_pred cCCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHh-cCCCceeeEEeEE-------eeCceeEEEe
Q 002566 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCC-------VEGNQLLLVY 751 (907)
Q Consensus 680 ~~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~-------~~~~~~~LV~ 751 (907)
..+.||+|+-+.+|-.--- +.. +.|+++........+. +++|.+ -.||-+-.-+.+= ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999964311 222 4466554433322222 223333 3566443311111 1122366778
Q ss_pred eeccCCchhhhhhcC--CcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 752 EYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 752 E~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
..+++--=-..+... ..+.....+|+..+++++.+|.+.+.||+.| .+-||+.++|+|+.+++.+.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 777654222222221 1223345899999999999999999999998 88899999999999999999997554333
Q ss_pred ccCCCccccccccccccccchhhhc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCC
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSG-KSNTN 882 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DvwSlGvvl~elltG-~~p~~ 882 (907)
-..+.. ..-.+|...|.+||... +...+...|-|.+|+++++++.| +.||.
T Consensus 167 ~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 167 NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 222222 12246889999999875 33567789999999999999886 99985
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4e-08 Score=101.02 Aligned_cols=211 Identities=20% Similarity=0.259 Sum_probs=111.6
Q ss_pred ccCCCCCCEEEeecCcCCCCCc-hhcccc--cccEEEecCCcCC--CCCchhcCCCCCCCEEEeeCCcCCCCCChhhhcC
Q 002566 112 LSKLRYLKQLDLSRNCLTGSFS-PQWASL--QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (907)
Q Consensus 112 l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l--~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 186 (907)
++.+..++.|.|.++.|..... ..|+.. .++.|||.+|.|+ ..+...+.+|+.|+.|+|+.|++...|...-..+
T Consensus 41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~ 120 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL 120 (418)
T ss_pred eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence 3344455566676666654432 123332 5777888888877 2455556778888888888888774433222355
Q ss_pred cccceeeecccccccc-CCccccCCCCCCeeecccCcccCC--CcccccCc-cccceeecccccCCCCchhhhhcCCCCC
Q 002566 187 INLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGK--IPEFIGKW-KKIQKLHIQGSSLEGPIPASISALTSLT 262 (907)
Q Consensus 187 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 262 (907)
.+|+.|.|.+..+.-. ....+..+|.++.|++|.|.+.-. ..+..... +.+.+|++..|..
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~--------------- 185 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLE--------------- 185 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHH---------------
Confidence 6777887777766522 223345677777777777744311 11111111 1222222222211
Q ss_pred EEEcCCCCCCCCCcccccccccceEEcccccccccCC-ccccCCCCccEEecCCCCCCCC-CchhhhcCCCCCeEEecCC
Q 002566 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGG-IPTTFEKLAKTNFMYLTGN 340 (907)
Q Consensus 263 ~L~L~~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N 340 (907)
.+.++-|++.... .++..+-+..|.|..... ..+..++.+.-|+|+.|+|..- --+.+.+++.|..|.+++|
T Consensus 186 ~~w~~~~~l~r~F------pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~ 259 (418)
T KOG2982|consen 186 QLWLNKNKLSRIF------PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSEN 259 (418)
T ss_pred HHHHHHHhHHhhc------ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCC
Confidence 1111111111110 144445555555543322 2345566666777777777632 2245667777777777777
Q ss_pred cCC
Q 002566 341 KLT 343 (907)
Q Consensus 341 ~L~ 343 (907)
+|.
T Consensus 260 Pl~ 262 (418)
T KOG2982|consen 260 PLS 262 (418)
T ss_pred ccc
Confidence 765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-08 Score=115.68 Aligned_cols=124 Identities=27% Similarity=0.278 Sum_probs=54.3
Q ss_pred CCEEEeeCCcCCCCCChhhhcCcccceeeeccccccccCCccccCCCCCCeeecccCcccCCCcccccCccccceeeccc
Q 002566 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG 244 (907)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 244 (907)
|...+.+.|.+. .+..++.-++.|+.|+|++|+++. . ..+..|++|++|||++|+|+ .+|..=..-.+|+.|.+++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-V-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-h-HHHHhcccccccccccchhc-cccccchhhhhheeeeecc
Confidence 444445555544 333444444555555555555542 1 13444555555555555554 2232111112255555555
Q ss_pred ccCCCCchhhhhcCCCCCEEEcCCCCCCCCC--cccccccccceEEcccccc
Q 002566 245 SSLEGPIPASISALTSLTDLRISDLKGSESA--FPKLDKMNLKTLILTKCLI 294 (907)
Q Consensus 245 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~--~~~~~~~~L~~L~Ls~N~i 294 (907)
|.++. -..+.+|.+|+.||+++|-+.+.. .+.+....|+.|+|.+|.+
T Consensus 242 N~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 242 NALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred cHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 55442 123444455555555555444321 1122223455555555544
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.2e-08 Score=100.40 Aligned_cols=161 Identities=16% Similarity=0.188 Sum_probs=77.8
Q ss_pred cCCCCCCEEEeecCcCCCCCchhcccc-----cccEEEecCCcCC---CC-------CchhcCCCCCCCEEEeeCCcCCC
Q 002566 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS---GP-------FPKVLTNITTLKNLSIEGNLFTG 177 (907)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~L~~L~Ls~N~l~---~~-------~p~~l~~l~~L~~L~Ls~N~l~~ 177 (907)
..+..++.+|||+|.|.......+++. +|+..+++.-... .. +.+++-.+++|+..+||.|.|..
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 335556666666666654433333322 3444444432111 11 22345556677777777777665
Q ss_pred CCChhh----hcCcccceeeecccccccc----CCcc---------ccCCCCCCeeecccCcccCCCcc----cccCccc
Q 002566 178 SIPPDI----RKLINLQKLILSSNSFTGE----LPAE---------LTKLTNLNDLRISDNNFSGKIPE----FIGKWKK 236 (907)
Q Consensus 178 ~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p~~---------~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~ 236 (907)
..|..+ +.-+.|++|.|++|.+--. +..+ ..+-|.|+...+..|++...... .|..-..
T Consensus 107 ~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~ 186 (388)
T COG5238 107 EFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHEN 186 (388)
T ss_pred ccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcC
Confidence 555433 3445667777776665411 1111 12235666666666666522111 1222245
Q ss_pred cceeecccccCCCC-----chhhhhcCCCCCEEEcCCCCCCC
Q 002566 237 IQKLHIQGSSLEGP-----IPASISALTSLTDLRISDLKGSE 273 (907)
Q Consensus 237 L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~L~~n~~~~ 273 (907)
|+++.+..|.|... +-..+..+.+|+.|||.+|.++.
T Consensus 187 lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 187 LKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred ceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhh
Confidence 66666666666522 11122334455555555555443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.2e-06 Score=86.25 Aligned_cols=140 Identities=18% Similarity=0.228 Sum_probs=85.3
Q ss_pred CCeeeccCceEEEEEEECCCcEEEEEEeccccchhhHHHHHHHHHHHhcCCCc--eeeEEeEEeeCceeEEEeeeccCCc
Q 002566 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNC 758 (907)
Q Consensus 681 ~~~IG~G~fG~Vyka~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gs 758 (907)
-.+||+|..+.||+. .+..+++|....... .....+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 367999999999984 245678888865432 234578998888876443 3567777777777889999999863
Q ss_pred -hhhh---------------------hhcCCcccccCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCCeEE
Q 002566 759 -LSRA---------------------IFGKDTEYRLKLDWPTRK-KICI----------GIAR-GLAYLHE-DSRIKIVH 803 (907)
Q Consensus 759 -L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~iiH 803 (907)
+... +|.-... ........ ++.. .+.+ ..++|.. ..++.++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 2111 1211000 00100000 0000 0111 1222221 12334789
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCccc
Q 002566 804 RDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 804 rDlkp~NILl~~~~~~kl~DFGla~~ 829 (907)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4e-08 Score=90.08 Aligned_cols=105 Identities=21% Similarity=0.309 Sum_probs=67.1
Q ss_pred cccEEEecCCcCCCCCchhc---CCCCCCCEEEeeCCcCCCCCChhhh-cCcccceeeeccccccccCCccccCCCCCCe
Q 002566 140 QLVELSVMGNRLSGPFPKVL---TNITTLKNLSIEGNLFTGSIPPDIR-KLINLQKLILSSNSFTGELPAELTKLTNLND 215 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 215 (907)
.+..++|+++.|- .+++.. .....|+..+|++|.+. ..|..|. ..+.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3556777777665 344443 33445555677777777 4455544 3446777777777777 66766777777777
Q ss_pred eecccCcccCCCcccccCccccceeecccccCC
Q 002566 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (907)
Q Consensus 216 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 248 (907)
|++++|.|. ..|..+..+.+|..|+..+|.+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 777777776 55666666666666666666665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 907 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-156
Identities = 109/255 (42%), Positives = 163/255 (63%), Gaps = 5/255 (1%)
Query: 652 ADKELRGLDL-QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS 710
+E + L Q ++LR+++ A++NF N +G GGFG VYKG L+DGT++AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 711 KSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE 769
+ QG +F E+ MIS H NL++L G C+ + LLVY YM N ++ + + E
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-E 123
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ LDWP R++I +G ARGLAYLH+ KI+HRD+K +N+LLD++ A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNE 887
+ TH++T + GTIG++APEY G + K DV+ +GV+ LE+++G+ + N+
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 888 DFVYLLDWAYVLQEE 902
D V LLDW L +E
Sbjct: 244 DDVMLLDWVKGLLKE 258
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-140
Identities = 105/238 (44%), Positives = 151/238 (63%), Gaps = 5/238 (2%)
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
L ++ ATNNFD +G G FG VYKG+L DG +A+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+S +HP+LV L G C E N+++L+Y+YM+N L R ++G D + + W R +ICIG
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIG 147
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGT 844
ARGL YLH + I+HRD+K+ N+LLD++ KI+DFG++K E D+TH+ST + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 902
+GY+ PEY ++G LT K+DVYSFGVV E++ +S + V L +WA
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-139
Identities = 106/262 (40%), Positives = 153/262 (58%), Gaps = 20/262 (7%)
Query: 653 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 706
+K L D + ++ ++K TNNFD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 707 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
+L++ + + ++F EI +++ QH NLV+L G +G+ L LVY YM N L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 763 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822
+ D L W R KI G A G+ +LHE+ I HRDIK++N+LLD+ AKIS
Sbjct: 121 LSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 823 DFGLAKLY-EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 881
DFGLA+ + +T +++RI GT YMAPE +RG +T K+D+YSFGVV LEI++G
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 882 NYRPNEDFVYLLDWAYVLQEEE 903
+ LLD +++EE
Sbjct: 235 DEHREPQ--LLLDIKEEIEDEE 254
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 9e-76
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 25/246 (10%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
+ + G FG V+K L +AVK + +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 727 SAQQHPNLVKLYGCCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+H N+++ G G L L+ + + LS + + W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126
Query: 783 CIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+ARGLAYLHED + I HRDIK+ NVLL +L A I+DFGLA +E K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 836 HI-STRIAGTIGYMAPEYAMRGYLTS-----KADVYSFGVVTLEIVSGKSNTNYRPNEDF 889
+ GT YMAPE + D+Y+ G+V E+ S + + +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 890 VYLLDW 895
+ +
Sbjct: 247 LPFEEE 252
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-63
Identities = 68/242 (28%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQH 731
+N +G G +G+VYKG L D +AVK S +RQ F+NE I + +H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 732 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
N+ + + LLV EY N L + + DW + ++ +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSV 120
Query: 787 ARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK------ 834
RGLAYLH + + I HRD+ + NVL+ D ISDFGL+ ++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 835 -THISTRIAGTIGYMAPEYAM-------RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886
+ + GTI YMAPE + D+Y+ G++ EI T+ P
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPG 238
Query: 887 ED 888
E
Sbjct: 239 ES 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-60
Identities = 76/321 (23%), Positives = 121/321 (37%), Gaps = 47/321 (14%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTW-----------LGVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTGT--LPTELSKLRYLKQLDLS-RNCLTGSFSPQWASLQ-LVELSVMG 148
V + L NL +P+ L+ L YL L + N L G P A L L L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267
+ L + IS N +GKIP + + + + LEG + +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ----- 224
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ L K + ++ +G L +DL N + G +P
Sbjct: 225 ------------------KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 328 KLAKTNFMYLTGNKLTGPVPK 348
+L + + ++ N L G +P+
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
G L ++ + LDLS L P P L N+
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKP---------------------YPIPSSLANL 75
Query: 163 TTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L L I G N G IPP I KL L L ++ + +G +P L+++ L L S N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISD--LKGSESAFPK 278
SG +P I + + G+ + G IP S + + L T + IS L G P
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK---IPP 192
Query: 279 -LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+NL + L++ ++ G+ G + I L+ N+L + N + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 338 TGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
N++ G +P+ + ++++S NN
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
N++G +P LS+++ L LD S N L+G+ P +SL LV ++ GNR+SG P +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 162 ITTL-KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L +++I N TG IPP L NL + LS N G+ N + ++
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N+ + + + +G K + L ++ + + G +P ++ L L L +S
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF------------ 277
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
N + GEIP G++ + + N G P
Sbjct: 278 --NN---------LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-58
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+V++ G+ +AVK L + EF+ E+ ++ +HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ L +V EY+ L R + + R +LD R + +A+G+ YLH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 858
IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS- 216
Query: 859 TSKADVYSFGVVTLEIVSGK 878
K+DVYSFGV+ E+ + +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-57
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
VG G FG V K +A+KQ+ S+S + + F+ E+ +S HPN+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N + LV EY + L + G + C+ ++G+AYLH +
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 802 VHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 860
+HRD+K N+LL KI DFG A D T G+ +MAPE +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 861 KADVYSFGVVTLEIVSGK 878
K DV+S+G++ E+++ +
Sbjct: 183 KCDVFSWGIILWEVITRR 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-57
Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 103 NLTGTLPTEL---SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 159
+++G LK L +S N ++G + L L V N S P L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIP-FL 219
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + L++L I GN +G I L+ L +SSN F G +P L +L L ++
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277
Query: 220 DNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ES 274
+N F+G+IP+F+ G + L + G+ G +P + + L L +S G
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTN 333
K+ LK L L+ GE+P+ + +++ L +DLS NN +G I + K
Sbjct: 338 TLLKMR--GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 334 --FMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 365
+YL N TG +P + N S ++ +S N +
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 7e-56
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSVMGNRLSGPFPK 157
L KL L+ LDLS N ++G+ W +L L++ GN++SG
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
++ L+ L + N F+ IP + LQ L +S N +G+ ++ T L L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA-LTSLTDLRISD--LKGSES 274
IS N F G IP K +Q L + + G IP +S +LT L +S G+
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA-- 309
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P L++L L+ GE+P D + M LK +DLSFN +G +P + L+
Sbjct: 310 -VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 332 T-NFMYLTGNKLTGPVPKYIFNSNKN----VDISLNNFT 365
+ + L+ N +GP+ + + KN + + N FT
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-54
Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 14/272 (5%)
Query: 103 NLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
N +G + L + L++L L N TG P ++ +LV L + N LSG P L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+++ L++L + N+ G IP ++ + L+ LIL N TGE+P+ L+ TNLN + +S
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+N +G+IP++IG+ + + L + +S G IPA + SL L ++ G+ P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT---IP 555
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEKLAKTNFM 335
M ++ + I G+ YI + K + N G +L+ N
Sbjct: 556 A--AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 336 YLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
+T G N+ +D+S N +
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-53
Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 12/270 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L G +P EL ++ L+ L L N LTG ++ L +S+ NRL+G PK +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L L + N F+G+IP ++ +L L L++N F G +PA + K + I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGS--SLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+GK +I ++ H G+ +G ++ L++ I+ G S
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+ ++ L ++ ++ G IP IG M L ++L N+++G IP L N + L
Sbjct: 629 DNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 338 TGNKLTGPVPKYI--FNSNKNVDISLNNFT 365
+ NKL G +P+ + +D+S NN +
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-53
Identities = 78/323 (24%), Positives = 127/323 (39%), Gaps = 59/323 (18%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLT---GTLPTE 111
DW+ +PC+ ++ G VTC V +I L ++ L + +
Sbjct: 32 DWSSNKNPCT----FD-------G----VTCR----DDKVTSIDLSSKPLNVGFSAVSSS 72
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV--LTNITTLKNLS 169
L L L+ L LS + + GS S S L L + N LSGP + L + + LK L+
Sbjct: 73 LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 170 IEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELT---KLTNLNDLRISDNNFSG 225
+ N KL +L+ L LS+NS +G L L IS N SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK 285
+ + + ++ L + ++ IP + ++L L IS
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG----------------- 232
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345
+ G+ I T+LK +++S N G IP L ++ L NK TG
Sbjct: 233 ------NKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 346 VPKYIFNSNKN---VDISLNNFT 365
+P ++ + +D+S N+F
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-45
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 30/248 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
LTG +P + +L L L LS N +G+ + L+ L + N +G P +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRIS 219
+ I N G I+ ++ + N F G +L +L+ N I+
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L G IP I ++ L L +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG------------ 664
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
N I G IPD +GD+ L +DLS N L G IP L + L+
Sbjct: 665 --HND---------ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 340 NKLTGPVP 347
N L+GP+P
Sbjct: 714 NNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-42
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 28/225 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ +G +P EL R L LDL+ N G+ + N ++G + N
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG---KIAANFIAGKRYVYIKND 581
Query: 163 TTLKNLSIEGNL--FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
K GNL F G + +L ++S + G ++ L +S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N SG IP+ IG + L++ + + G IP + L L L +S
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS------------ 689
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
N L G IP + +T L IDLS NNL+G IP
Sbjct: 690 --NK----LD-----GRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-------REFVNEIGMISAQQHPN 733
++G+GGFG V+KG + D +V+A+K L +G +EF E+ ++S HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKLYG N +V E++ L + K + W + ++ + IA G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYM 138
Query: 794 HEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
+ IVHRD+++ N+ L + AK++DFGL++ H + + G +M
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193
Query: 849 APE-YAMRGYL-TSKADVYSFGVVTLEIVSGK 878
APE T KAD YSF ++ I++G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+G+G FG K G V+ +K+L + R F+ E+ ++ +HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
+ +L + EY+K L I D+ + W R IA G+AYLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-------------ISTRIAGTIGY 847
I+HRD+ + N L+ ++ N ++DFGLA+L ++KT + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
MAPE K DV+SFG+V EI+
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-56
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G GGFG VY+ G +AVK Q E + + +HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G C++ L LV E+ + L+R + GK ++ + IARG+ YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 798 RIKIVHRDIKTSNVLLDKDL--------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
+ I+HRD+K+SN+L+ + + KI+DFGLA+ E +T + AG +MA
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMA 182
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
PE + +DV+S+GV+ E+++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-54
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+ E G ++KG G I VK L + R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 740 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
C L+ +M L + +D K + +ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG- 856
I + + +V++D+D+ A+IS + ++ S ++APE A++
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKK 183
Query: 857 ---YLTSKADVYSFGVVTLEIVSGK 878
AD++SF V+ E+V+ +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-54
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++G G FG+VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L +V ++ + + L + +T K + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH---AK 139
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
I+HRD+K++N+ L +D KI DFGLA +H +++G+I +MAPE +R
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQD 198
Query: 859 ----TSKADVYSFGVVTLEIVSGK 878
+ ++DVY+FG+V E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-53
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
VG+G +G V++G G +AVK SS + + + E + +H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ QL L+ Y + L + LD + +I + IA GLA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 847
+ + I HRD+K+ N+L+ K+ I+D GLA ++ + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 848 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSG 877
MAPE + D+++FG+V E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-53
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 30/230 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
++G+G +G V+ G G +AVK + + E I +H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++G QL L+ +Y +N L + LD + K+ GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 847
+ + I HRD+K+ N+L+ K+ I+D GLA + D + GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 848 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
M PE AD+YSFG++ E+ + Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
+G+G FG VY G G V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C+ L ++ K L + LD ++I I +G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL----YEEDKTHISTRIAGTIGYMAPE---- 851
I+H+D+K+ NV D I+DFGL + + G + ++APE
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 852 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + +DV++ G + E+ + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
+G+G FG V++G G +AVK SS + R + E I +H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ N QL LV +Y ++ L + R + K+ + A GLA+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 847
+ + I HRD+K+ N+L+ K+ I+D GLA ++ I GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 848 MAPEYAMRGYL-------TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
MAPE + + +AD+Y+ G+V EI S + Y
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ + ++AVK L S ++F E +++ QH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL----------SRAIFGKDTEYRLKLDWPTRKKICIG 785
+ +G C EG LL+V+EYM++ L ++ + G + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 844
+A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 880
I +M PE + T+++DV+SFGVV EI + SN
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ D ++AVK L + ++F E +++ QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKICI 784
K YG C +G+ L++V+EYMK+ L + G+ + + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 843
IA G+ YL + VHRD+ T N L+ +L KI DFG+++ +Y D +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSNT 881
I +M PE M T+++DV+SFGV+ EI + SNT
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-45
Identities = 51/342 (14%), Positives = 108/342 (31%), Gaps = 51/342 (14%)
Query: 43 ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKA 101
ALK+I L K+W+ NW + + D G + V+ + + V ++L+
Sbjct: 34 ALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG---RVTGLSLEG 90
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----LQLVELSVMGNRLSGPFP 156
+G +P + +L L+ L L + + + + M F
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 157 KVLT--NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ + L I + SI R + ++ SN+ T + + +LT L
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
+ ++ F + + + + L LTD+ + +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYN------ 258
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG--------IPTTF 326
C ++P ++ + +++ I+++ N G
Sbjct: 259 -----------------CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 327 EKLAKTNFMYLTGNKL-TGPVPKYIFN-SN-KNVDISLNNFT 365
K +Y+ N L T PV + ++ N
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-40
Identities = 40/285 (14%), Positives = 83/285 (29%), Gaps = 31/285 (10%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVL 159
L G LP L L+L+ N +T + Q+ LS N+L P
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398
Query: 160 TNITTLKNLSIEGNLFTG-------SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+++ + + N + P K IN+ + LS+N + + +
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 213 LNDLRISDNNFSG-------KIPEFIGKWKKIQKLHIQGSSLEGPIPASISA--LTSLTD 263
L+ + + N + E + + ++ + L + A L L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517
Query: 264 LRISD--LKG-SESAF--PKLDKMNLKT-LILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
+ +S L ++ E P+ I L + + N+
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
+ + + + + N Y+ + L
Sbjct: 578 IRKVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-35
Identities = 42/290 (14%), Positives = 95/290 (32%), Gaps = 32/290 (11%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
+ + ++ Q+ N +T S L L + + +
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENIC 224
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ + L +L + + + +LP L L + +
Sbjct: 225 EAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 218 ISDNNF--------SGKIPEFIGKWKKIQKLHIQGSSL-EGPIPASISALTSLTDLRISD 268
++ N + +KIQ ++I ++L P+ S+ + L L
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 269 --LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326
L+G AF + L +L L I ++ G +++N+ + N L IP F
Sbjct: 340 NQLEGKLPAFGSE--IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396
Query: 327 E--KLAKTNFMYLTGNKLTG-------PVPKYIFNSNK--NVDISLNNFT 365
+ ++ + + + N++ P+ F ++++S N +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-44
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +AVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
C + + +V E ++ F + RL++ T ++ A G+ YL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRV--KTLLQMVGDAAAGMEYLES---KC 233
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPEYAMRG 856
+HRD+ N L+ + KISDFG+++ + + G + + APE G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYG 290
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+S++DV+SFG++ E S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 792
G C + L L+ EY+ L +D +++ ++D + I +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 850
L + +HRD+ T N+L++ + KI DFGL K+ +DK + G I + AP
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVS 876
E + +DV+SFGVV E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V + G +AVK L + EI ++ H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
K G C E GN + L+ E++ + L + + ++ L + K + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINL--KQQLKYAVQICKGMDYL 142
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 851
+ VHRD+ NVL++ + KI DFGL K E DK + + + + + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVS 876
M+ +DV+SFGV E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNL 734
++G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK---KICIGIAR 788
V+L G +G L++ E M L R++ L P+ ++ IA
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 847
G+AYL+ K VHRD+ N ++ +D KI DFG+ +YE D + + +
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
M+PE G T+ +DV+SFGVV EI +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C + L L+ EY+ L + + + R+ + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDH--IKLLQYTSQICKGMEYLG 162
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 852
+ +HRD+ T N+L++ + KI DFGL K+ +DK + + G I + APE
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
+ +DV+SFGVV E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
++GE FG VYKG L +A+K L K EF +E + + QHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKIC 783
V L G + L +++ Y + L D + L+ P +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTR 840
IA G+ YL S +VH+D+ T NVL+ LN KISD GL ++Y D K ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ I +MAPE M G + +D++S+GVV E+ S
Sbjct: 192 LP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V G +A+K + S S EF+ E ++ H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C + + ++ EYM N CL + ++ +R + ++C + + YL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLN--YLREMRHRFQT--QQLLEMCKDVCEAMEYL---ESK 139
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 856
+ +HRD+ N L++ K+SDFGL++ +D T G+ + + PE M
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYS 196
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+SK+D+++FGV+ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTV-IAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ ++ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRG 856
+HRD+ N L+ ++ K++DFGL++L D H + I + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN 187
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+ K+DV++FGV+ EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V G ++AVK L + Q + EI ++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLA 791
K GCC + L LV EY+ L +Y R + I G+A
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLR--------DYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMA 849
YLH +HRD+ NVLLD D KI DFGLAK E + R G + + A
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVS 876
PE +DV+SFGV E+++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + + S + +F+ E ++ HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C+E + LV E+M++ CLS + + T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAA--ETLLGMCLDVCEGMAYL---EEA 123
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRGY 857
++HRD+ N L+ ++ K+SDFG+ + +D + T+ + + +PE
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSR 181
Query: 858 LTSKADVYSFGVVTLEIVS 876
+SK+DV+SFGV+ E+ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
+++G+G FGSV + G ++AVKQL R+F EI ++ A +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 792
G + L LV EY+ + CL +D +R +LD I +G+ Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 850
L + VHRD+ N+L++ + + KI+DFGLAKL DK + R G I + AP
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVS 876
E + ++DV+SFGVV E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPNLVK 736
+ +GEG FG V K + A+K++ S+ +R+F E+ + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------KICIG 785
L G C L L EY + L R +T+ + T
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ARG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++ E R+ +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE- 901
+MA E T+ +DV+S+GV+ EIVS G T Y + L Y L++
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQGYRLEKP 263
Query: 902 ----EEIY 905
+E+Y
Sbjct: 264 LNCDDEVY 271
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V G +AVK + S S EF E + HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHED 796
C + + +V EY+ N CL Y L+ ++C + G+A+L
Sbjct: 72 CSKEYPIYIVTEYISNGCLL--------NYLRSHGKGLEPSQLLEMCYDVCEGMAFL--- 120
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYA 853
+ +HRD+ N L+D+DL K+SDFG+ + +D+ GT + + APE
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVF 177
Query: 854 MRGYLTSKADVYSFGVVTLEIVS 876
+SK+DV++FG++ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 854
++VHRD+ NVL+ + KI+DFGLAKL ++ I +MA E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
T ++DV+S+GV E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 28/249 (11%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L S+ ++E+ M QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK---KICI 784
+V L G C G +L++ EY L + D + + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAG 843
+A+G+A+L + +HRD+ NVLL AKI DFGLA + + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDFVYLLDWAYVLQE 901
+ +MAPE T ++DV+S+G++ EI S G + N F L+ Y + +
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 902 -----EEIY 905
+ IY
Sbjct: 289 PAFAPKNIY 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY G LS+ IA+K++ + + ++ EI + +H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 743 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
E + + E + LS R+ +G LK + T I GL YLH++
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 800 KIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 855
+IVHRDIK NVL++ KISDFG +K T GT+ YMAPE R
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
GY AD++S G +E+ +GK
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGK 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTV-----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VYKG+L + +A+K L + + + +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G + ++++ EYM+N L + F ++ + + + GIA G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV--LQLVGMLRGIAAGMKYL--- 163
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 854
+ + VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
TS +DV+SFG+V E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-41
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 336
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 858
+HR++ N L+ ++ K++DFGL++L D I + APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 859 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 899
+ K+DV++FGV+ EI + G S LL+ Y +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G+G FG VY G D A+K L Q F+ E ++ HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 737 LYGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L G + ++ YM + L + F + + + + +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTV--KDLISFGLQVARGMEYL-- 140
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYMAPEY 852
+ K VHRD+ N +LD+ K++DFGLA+ + + + + + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
T+K+DV+SFGV+ E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 44/261 (16%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V K T +AVK L + S R+ ++E ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK-------- 780
+KLYG C + LLL+ EY K L SR + + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 833
I++G+ YL + +K+VHRD+ N+L+ + KISDFGL+ +YEED
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 834 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDF 889
RI + +MA E T+++DV+SFGV+ EIV+ G Y P E
Sbjct: 206 YVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPERL 261
Query: 890 VYLLDWAYVLQE-----EEIY 905
LL + ++ EE+Y
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G F +VYKG+ +A + ++ + F E M+ QHPN+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 740 CCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++LV E M + L + ++ + + C I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFK-VMKIKVLRSWCRQILKGLQFLHT 147
Query: 796 DSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYE 203
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
Y DVY+FG+ LE+ + +
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSE 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + T +AVK L S S F+ E ++ QH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + ++ EYM+N L F K +KL + IA G+A++
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVD--FLKTPS-GIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 856
+HRD++ +N+L+ L+ KI+DFGLA+L E++ T G I + APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 185
Query: 857 YLTSKADVYSFGVVTLEIVS 876
T K+DV+SFG++ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 791
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 848
YL K VHRD+ N +LD+ K++DFGLA+ +Y+++ + + + +M
Sbjct: 143 YLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 902
A E T+K+DV+SFGV+ E+++ G D L L + +
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259
Query: 903 EIY 905
+Y
Sbjct: 260 PLY 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 742 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
VE L +V EYM L + + R L K + + + YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVD--YLRSRG-RSVLGGDCLLKFSLDVCEAMEYL---EGNN 137
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 860
VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFST 193
Query: 861 KADVYSFGVVTLEIVS 876
K+DV+SFG++ EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G G V G L +A+K L + + + R+F++E ++ HPN+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G G ++V EYM+N L F + + + + + G+ G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTI--MQLVGMLRGVGAGMRYL--- 167
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 854
S + VHRD+ NVL+D +L K+SDFGL+++ E+D T G I + APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
+S +DV+SFGVV E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-41
Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V++ T++AVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRK--- 780
VKL G C G + L++EYM L ++ D R ++ P
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 833
I +A G+AYL S K VHRD+ T N L+ +++ KI+DFGL+ +Y D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 834 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
K + I I +M PE T+++DV+++GVV EI S
Sbjct: 230 YKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------K 781
+V L G C G L+++ E+ K LS R+ + Y++ + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHIS 838
+A+G+ +L + K +HRD+ N+LL + KI DFGLA +Y++
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
R+ + +MAPE T ++DV+SFGV+ EI S
Sbjct: 210 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 780
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 837
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ R+ + +MAPE T ++DV+SFGV+ EI +
Sbjct: 218 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 35/250 (14%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FGSV + L +AVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 736 KLYGCCVEG------NQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGI 786
KL G + +++ +MK+ L A + + L L T + + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVRFMVDI 146
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTRIAG 843
A G+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D + ++++
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP- 202
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQ 900
+ ++A E T +DV++FGV EI++ G+ T Y N + L L+
Sbjct: 203 -VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAEIYNYLIGGNRLK 259
Query: 901 E-----EEIY 905
+ EE+Y
Sbjct: 260 QPPECMEEVY 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 66/220 (30%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
V+ G ++ ++ E M L R + ++ L + IA G
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQ 154
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 847
YL +HRDI N LL AKI DFG+A+ +Y + +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 880
M PE M G TSK D +SFGV+ EI S KSN
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ +A+K L + E + E ++ +P +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C + L+LV E L + + GK ++ ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYL---EE 128
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 856
VHRD+ NVLL AKISDFGL+K D ++ + R AG + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+S++DV+S+GV E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 68/249 (27%), Positives = 116/249 (46%), Gaps = 34/249 (13%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FGSV +G L +AVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 736 KLYGCCVEGN-----QLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIA 787
+L G C+E + + +++ +MK L + + L T K + IA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIA 157
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGT 844
G+ YL S +HRD+ N +L D+ ++DFGL+K +Y D + ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-- 212
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE 901
+ ++A E TSK+DV++FGV EI + G T Y N + L + L++
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 902 -----EEIY 905
+E+Y
Sbjct: 271 PEDCLDELY 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 9/219 (4%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
E + +V EYM L + G+ L P + IA G+AY+ R+
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 862 ADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 899
+DV+SFG++ E+ + G+ N + + ++ Y +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+V+KG+ + +K + RQ + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C G+ L LV +Y+ L + L + IA+G+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLD--HVRQHRGALGP--QLLLNWGVQIAKGMYYL-- 131
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 854
+VHR++ NVLL +++DFG+A L D + A T I +MA E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
G T ++DV+S+GV E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
VG G FG V G L +A+K L + + R+F+ E ++ HPN+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G + +++V EYM+N L F + + + + + GIA G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTV--IQLVGMLRGIASGMKYL--- 163
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 854
S + VHRD+ N+L++ +L K+SDFGL ++ E+D T G I + +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
TS +DV+S+G+V E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 25/217 (11%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L + R ++E+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 780
+V L G C G L++ EY L R F ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 839
+A+G+A+L + +HRD+ N+LL KI DFGLA + + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ +MAPE T ++DV+S+G+ E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-40
Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 742 VEGN-QLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
VE L +V EYM L D + R L K + + + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 857
VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362
Query: 858 LTSKADVYSFGVVTLEIVS 876
++K+DV+SFG++ EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 39/256 (15%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 780
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 837
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D K
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLD 894
+ R+ + +MAPE T ++DV+SFGV+ EI + G + Y P E+ LL
Sbjct: 264 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEELFKLLK 319
Query: 895 WAYVLQE-----EEIY 905
+ + + E+Y
Sbjct: 320 EGHRMDKPANCTNELY 335
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 854
++VHRD+ NVL+ + KI+DFGLAKL ++ I +MA E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
T ++DV+S+GV E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + ++ E L F + +Y L L + ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDL--ASLILYAYQLSTALAYL---E 133
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 857
+ VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAPE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 858 LTSKADVYSFGVVTLEIVS 876
TS +DV+ FGV EI+
Sbjct: 194 FTSASDVWMFGVCMWEILM 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 6e-40
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 19/224 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+G+G FG V+ G + T +A+K L + S + F+ E ++ +H LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHED 796
E + +V EYM L D E L P + IA G+AY+
Sbjct: 330 VVSE-EPIYIVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYV--- 379
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
R+ VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 857 YLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 899
T K+DV+SFG++ E+ + G+ N + + ++ Y +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-40
Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 9/270 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L ++ L LD+ N ++ L L L++ N LS K
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
T L L + N K NL L LS N + +L NL +L +S+N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 222 NFSGKIPEFIG--KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---- 275
E + ++KL + + ++ P A+ L L +++++ S
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
+L +++ L L+ + + T L +DLS+NNL +F L +
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ +L N + + ++L
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-38
Identities = 53/293 (18%), Positives = 90/293 (30%), Gaps = 25/293 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQLVELSVMGNRLSGPFPKV 158
+ P + L L L+ L S + A+ + LS+ ++LS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 159 LTN--ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
T L L + N L L+ L N+ L L N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 217 R---------ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL--- 264
IS + K ++ L+++ + + G + L +L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 265 --RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S + F L L L LTK I D + L+ +DL N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFTWESSDP 371
+ L +YL+ NK + + F + + + S P
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSP 473
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-37
Identities = 50/283 (17%), Positives = 94/283 (33%), Gaps = 20/283 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-----QWASLQLVELSVMGNRLSGPFPK 157
++ G + L LK L LS + + A L L++ N++S
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
+ + L+ L + N + R L N+ ++ LS N + + +L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 217 RISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
+ P + + L + +++ + L L L ++ L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 270 KGSESAFPKLDKM----NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
+ + + +L L L + D+ +LK IDL NNL +
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F + L N +T K + +N +D+ N F
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-34
Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 25/289 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
+ +L L+ L+ L++ N + G S + L L LS+ + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 158 VLT----NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTN 212
T + L L++ N + L +L+ L L N EL E L N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--PIPASISALTSLTDLRISD-- 268
+ ++ +S N + +Q+L ++ +L+ P+ L +LT L +S+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 269 LKG-SESAFPKLDKMNLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLT 319
+ ++ L+ L+ L L + G ++ ++ L ++L N
Sbjct: 492 IANINDDMLEGLE--KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F+ L + + L N L +P +FN+ + +++ N T
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLIT 597
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 50/262 (19%), Positives = 85/262 (32%), Gaps = 18/262 (6%)
Query: 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176
+ D S LT P + L++ N+L T + L +L + N +
Sbjct: 5 SHEVADCSHLKLTQV--PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
P +KL L+ L L N + TNL +L + N+ K K
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
+ L + + L + L +L +L +I L +LK L L+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL--KSEELDIFANSSLKKLELSS 180
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I P + +L + L+ L + + L+ ++L+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239
Query: 349 YIFNSNKNV-----DISLNNFT 365
F K D+S NN
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-17
Identities = 38/207 (18%), Positives = 71/207 (34%), Gaps = 18/207 (8%)
Query: 103 NLTG--TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS------- 152
L + P+ LR L LDLS N + L +L L + N L+
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524
Query: 153 -GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
G L ++ L L++E N F + L L+ + L N+ +
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584
Query: 212 NLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTS---LTDLRIS 267
+L L + N + + F ++ + +L ++ + + SI+ + T I
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE-SIAWFVNWINETHTNIP 643
Query: 268 DLKGS-ESAFP-KLDKMNLKTLILTKC 292
+L P ++ + C
Sbjct: 644 ELSSHYLCNTPPHYHGFPVRLFDTSSC 670
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ + +AVK + +F++E ++ HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E ++ E L + + + LK+ T + I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGH--YLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAM 854
I VHRDI N+L+ K+ DFGL++ E++ + + T I +M+PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESIN 187
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
T+ +DV+ F V EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-40
Identities = 66/236 (27%), Positives = 94/236 (39%), Gaps = 23/236 (9%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
V+ G ++ ++ E M L R L + IA G
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 847
YL +HRDI N LL AKI DFG+A+ +Y + +
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQ 900
M PE M G TSK D +SFGV+ EI S G Y + N++ + + +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY--MPYPSKSNQEVLEFVTSGGRMD 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 30/243 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 791
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLR--------NFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 848
+L + K VHRD+ N +LD+ K++DFGLA+ +Y+++ + + + +M
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 902
A E T+K+DV+SFGV+ E+++ G D L L + +
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323
Query: 903 EIY 905
+Y
Sbjct: 324 PLY 326
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 29/211 (13%)
Query: 683 KVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+G+G F ++KG+ T + +K L R + F M+S H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V YG CV G++ +LV E++K L + K + + + + ++ +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINI--LWKLEVAKQLAAAMHFL- 129
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFGLAKLYEEDKTHISTRIAGTIG 846
++H ++ N+LL ++ + K+SD G++ + I
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IP 182
Query: 847 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVS 876
++ PE L D +SFG EI S
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFVNEIGMISA 728
NF K+G G F VY+ L DG +A+K++ +K+R + + EI ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 786
HPN++K Y +E N+L +V E LSR I F K + T K + +
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQL 145
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
L ++H +++HRDIK +NV + K+ D GL + + T + + GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 847 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 878
YM+PE GY K+D++S G + E+ + +
Sbjct: 202 YMSPERIHENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 23/211 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-QH 731
+F +++G G +G V+K DG + AVK+ S +G ++ + E+G QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
P V+L EG L L E C L + + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL----CGPSLQQHC----EAWGASLPEAQVWGYLRDTLL 168
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
LA+LH +VH D+K +N+ L K+ DFGL G YM
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYM 223
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
APE Y + ADV+S G+ LE+
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACNME 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 34/224 (15%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V +AVK L ++E+ M H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 780
+V L G C + L++EY L R F +D +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 833
+A+G+ +L VHRD+ NVL+ KI DFGLA + +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 834 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ R+ + +MAPE G T K+DV+S+G++ EI S
Sbjct: 228 YVVRGNARLP--VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 683 KVGEGGFGSVYKGIL---SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
++G G FG+V KG +AVK L + E + E ++ +P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RLKLDWPTRKKICIGIARGLAYLH 794
G C E +LV E + L+ +Y + ++ ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLN--------KYLQQNRHVKDKNIIELVHQVSMGMKYL- 133
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 852
VHRD+ NVLL AKISDFGL+K D+ + + G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 853 AMRGYLTSKADVYSFGVVTLEIVS 876
+SK+DV+SFGV+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-39
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 682 NKVGEGGFGSVYKGIL--------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQH 731
+GEG FG V + T +AVK L S + + + ++E+ M +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG--- 785
N++ L G C + L ++ EY L +A EY +++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 786 -----IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 837
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA ++ D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 838 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ R+ + +MAPE T ++DV+SFGV+ EI +
Sbjct: 252 NGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-39
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ + ++ E+M L F K E K P IA G+A++ +
Sbjct: 253 TK-EPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 861
+HRD++ +N+L+ L KI+DFGLA++ E+++ I + APE G T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 862 ADVYSFGVVTLEIVS 876
+DV+SFG++ +EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLV 735
K+G+G FG V +G +AVK L + +F+ E+ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG + + +V E L + + L T + + +A G+ YL
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLL--GTLSRYAVQVAEGMGYL-- 137
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYA 853
+ +HRD+ N+LL KI DFGL + ++ H + + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 854 MRGYLTSKADVYSFGVVTLEIVS 876
+ +D + FGV E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+ K+GEG FG DG +K+ +S S + E E+ +++ +HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N+V+ E L +V +Y + L + I + + I L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKH 140
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 851
+H+ KI+HRDIK+ N+ L KD ++ DFG+A++ I GT Y++PE
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ Y +K+D+++ G V E+ + K
Sbjct: 197 CENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-39
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 683 KVGEGGFGSVYKGIL--SDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ + +A+K L + E + E ++ +P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C + L+LV E L + + R ++ ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 856
VHR++ NVLL AKISDFGL+K D ++ + R AG + + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 857 YLTSKADVYSFGVVTLEIVS 876
+S++DV+S+GV E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 40/207 (19%)
Query: 409 ADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLD 467
AD+ + +N GG Y D + G+ + + + +
Sbjct: 3 ADKVIW--AVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRSNPE-- 52
Query: 468 NYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF 527
D LY+T R + S Y G Y + L FAE F
Sbjct: 53 ----------------DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAE------VYF 90
Query: 528 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL---YWAGRG 584
+++FD+ + V KD +I D G + P + L + + G+
Sbjct: 91 AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKL 149
Query: 585 TTGIPLRGTYGPLISAISVKSNFKPPV 611
+ P + A+ + K
Sbjct: 150 SVEFVKGYYDNPKVCALFI---MKGTA 173
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 17/218 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIA 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+C + L +LH + I HRDIK+ N+LL D + K++DFG +++ ST
Sbjct: 120 AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ GT +MAPE R K D++S G++ +E++ G+
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+VG G FG V++ G AVK++ + + V E+ + P +V LYG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 741 CVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
EG + + E ++ + + G E GL YLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPE-------DRALYYLGQALEGLEYLHTR 169
Query: 797 SRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTR----IAGTIGYMAPE 851
+I+H D+K NVLL D A + DFG A + D S I GT +MAPE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 852 YAM-RGYLTSKADVYSFGVVTLEIVSGK 878
M + +K D++S + L +++G
Sbjct: 227 VVMGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 17/218 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
++ + DP K+GEG G V G +AVK + + +Q
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NE+ ++ QH N+V++Y + G +L ++ E+++ L+ D +++L+
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIA 144
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+C + + LAYLH I HRDIK+ ++LL D K+SDFG +D +
Sbjct: 145 TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ GT +MAPE R ++ D++S G++ +E+V G+
Sbjct: 202 V-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + ++ E L F + ++ L L + ++ LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRS--FLQVRKFSLDL--ASLILYAYQLSTALAYL---E 508
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 857
+ VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 858 LTSKADVYSFGVVTLEIVS 876
TS +DV+ FGV EI+
Sbjct: 569 FTSASDVWMFGVCMWEILM 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-37
Identities = 47/272 (17%), Positives = 95/272 (34%), Gaps = 17/272 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV-LTN 161
+ S + L+L P L L+ N+ F +V L +
Sbjct: 293 TIERVKD--FSYNFGWQHLELVNCKFGQF--PTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L +LS G F G +L+ L LS N + + L L L +
Sbjct: 349 LEFL-DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 222 NFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ESAF 276
N + + L I + + L+SL L+++ + + F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
+L NL L L++C + P ++ L+ +++S NN ++ L +
Sbjct: 467 TELR--NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 337 LTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
+ N + + + + + ++++ N+F
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 46/270 (17%), Positives = 95/270 (35%), Gaps = 15/270 (5%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT--GSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
+ G L L+ LDLSRN L+ G S L L + N +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L++L + + + L NL L +S L++L L++
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SES 274
+ N+F P+ + + + L + LE P + ++L+SL L +S
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTT--FEKLAK 331
+ L+ +L+ L + I + + L ++L+ N+ + +
Sbjct: 513 PYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDIS 360
+ + ++ P +++I+
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 52/308 (16%), Positives = 89/308 (28%), Gaps = 43/308 (13%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW----ASLQLVELSVMGNRLSGPFPKV 158
+ P ++R L +L L N + + A L++ L + R G K
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 159 -LTNITTLKNLSIEGN------LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ + L NL+IE + I L N+ L S + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS---------------------SLEGP 250
L + + F + K++ +G S +G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 251 IPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTK 307
S TSL L +S + S F L L+ L + +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGL--EQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L +D+S + F L+ + + GN IF +N+ D+S
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 365 TWESSDPI 372
S
Sbjct: 483 EQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 14/214 (6%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ KNL + N LQ L LS L++L+ L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSE--SAFPK 278
+QKL ++L I L +L +L ++ ++ + F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN----IDLSFNNLTGGIPTTFEKLAKTNF 334
L NL+ L L+ I + + ++ +DLS N + P F+++ + +
Sbjct: 148 LT--NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204
Query: 335 MYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
+ L N + V K + L F
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 52/296 (17%), Positives = 91/296 (30%), Gaps = 51/296 (17%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQL 141
N+T C N +P L K LDLS
Sbjct: 9 NITYQCME------------LNFY-KIPDNLP--FSTKNLDLS----------------- 36
Query: 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG 201
N L + L+ L + + L +L LIL+ N
Sbjct: 37 ------FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 202 ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTS 260
+ L++L L + N + IG K +++L++ + ++ +P S LT+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 261 LTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
L L +S ++ + L +M L +L L+ ++ I +L + L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 316 NNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFT 365
N + + T + LA L + K N+ I
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+++ +G G +G K SDG ++ K+ S + + V+E+ ++ +HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 733 NLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
N+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 791 AYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
H D ++HRD+K +NV LD N K+ DFGLA++ D + T + GT YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 849 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE Y K+D++S G + E+ +
Sbjct: 184 SPEQMNRMSY-NEKSDIWSLGCLLYELCALM 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 35/229 (15%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ-Q 730
T F K+G G FGSV+K + DG + A+K+ + + E+ + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H ++V+ + E + +L+ EY L+ AI K + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGL 128
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD-------------------LNAKISDFGLAKLYE 831
Y+H +VH DIK SN+ + + + KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 832 EDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
+ G ++A E +L KAD+++ + + +
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+F +G GGFG V+K DG +K++ + N + E+ ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 735 VKLYGCCVE----------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
V GC L + E+ L + I + E LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVL 123
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
++ I +G+ Y+H K+++RD+K SN+ L KI DFGL + D
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 839 TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
TR GT+ YM+PE + + Y + D+Y+ G++ E++
Sbjct: 179 TRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L+++ + P K+GEG +GSVYK I G ++A+KQ+ +S +E +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
EI ++ P++VK YG + L +V EY +S I + L D
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT- 129
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
I +GL YLH +I HRDIK N+LL+ + +AK++DFG+A + +T
Sbjct: 130 -ILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
I GT +MAPE AD++S G+ +E+ GK
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-36
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 27/235 (11%)
Query: 654 KELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR 713
E D +T + + +I F P + +G G G++ + D +AVK++ +
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 714 QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
E+ + + +HPN+++ + + + E L + KD +
Sbjct: 62 SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLG 117
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLA 827
+ GLA+LH + IVHRD+K N+L+ + A ISDFGL
Sbjct: 118 LE----PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 828 KLYEEDKTHISTR--IAGTIGYMAPEY---AMRGYLTSKADVYSFGVVTLEIVSG 877
K + S R + GT G++APE + T D++S G V ++S
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 36/231 (15%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++F+ +G+G FG V K D A+K++ + + ++E+ ++++ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 734 LVKLYGCCVEGNQ-------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+V+ Y +E L + EY +N L I L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-- 838
++ I L+Y+H I+HRD+K N+ +D+ N KI DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 839 -----------TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 877
T GT Y+A E G+ K D+YS G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
R+ + + DP ++G+G FG VYK G + A K + +KS + +++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
EI +++ HP +VKL G +L ++ E+ + + E L P +
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQ 120
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+C + L +LH I HRD+K NVL+ + + +++DFG++ + +
Sbjct: 121 VVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177
Query: 841 IAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGK 878
I GT +MAPE M Y KAD++S G+ +E+ +
Sbjct: 178 I-GTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIE 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHP 732
+ ++G G +GSV K + G ++AVK++ S+ + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
+V+ YG + E M + + + + KI + + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 851
L E+ KI+HRDIK SN+LLD+ N K+ DFG++ + + TR AG YMAPE
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPER 196
Query: 852 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ +GY ++DV+S G+ E+ +G+
Sbjct: 197 IDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQ-QHP 732
++ +P ++G G +G V K + G ++AVK++ ++ + Q + + ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V YG + + E M + L + + + + + KI + I + L +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 851
LH S++ ++HRD+K SNVL++ K+ DFG++ AG YMAPE
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180
Query: 852 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+GY + K+D++S G+ +E+ +
Sbjct: 181 INPELNQKGY-SVKSDIWSLGITMIELAILR 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++++ +G G V +A+K+++ + Q + + + EI +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+V Y V ++L LV + + + + I K LD T I + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHISTR--IAGTIG 846
YLH++ +I HRD+K N+LL +D + +I+DFG+ A L D T R GT
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 847 YMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 878
+MAPE + GY KAD++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
F K+G+G FG V+KGI V+A+K + + + E EI ++S P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
K YG ++ +L ++ EY+ + G E ++ I I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLH 136
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ +I HRDIK +NVLL + K++DFG+A + + +T + GT +MAPE
Sbjct: 137 SEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
+ SKAD++S G+ +E+ G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGE 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 20/227 (8%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
+ ++ K+GEGGF V L DG A+K++ +Q E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 728 AQQHPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
HPN+++L C+ ++ L+ + K L I + + L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLL 140
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA- 842
+GI RGL +H HRD+K +N+LL + + D G +
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 843 -------GTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
TI Y APE + + DV+S G V ++ G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 26/237 (10%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQG 715
G+DL T + + + ++G GG V++ + + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 716 NREFVNEIGMISAQQHPNL--VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 773
+ NEI ++ Q + ++LY + + +V E N L+ + + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKS 123
Query: 774 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+D RK + + +H+ IVH D+K +N L+ K+ DFG+A + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179
Query: 834 KTHISTR-IAGTIGYMAPE-----------YAMRGYLTSKADVYSFGVVTLEIVSGK 878
T + GT+ YM PE + ++ K+DV+S G + + GK
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 32/233 (13%)
Query: 662 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ 714
+ G + DP ++G G FG+VY + + V+A+K++S +Q
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 715 GNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTE 769
N ++ + E+ + +HPN ++ GC + + LV EY + L E
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ + G +GLAYLH + I HRD+K N+LL + K+ DFG A +
Sbjct: 154 VEIAA-------VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 830 YEEDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGK 878
+ + GT +MAPE + Y K DV+S G+ +E+ K
Sbjct: 204 MAPANSFV-----GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE + E+ ++ +HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 734 LVKLYGCCVEGNQ------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
+V+ + +E N L + + + L + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
I + IA + +LH ++HRD+K SN+ D K+ DFGL ++D+ +
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 842 A-----------GTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEI 874
GT YM+PE Y + K D++S G++ E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 733
++F+ +++G G G V+K G V+A K + + + + + E+ ++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 791
+V YG ++ + E+M L + + G+ E L K+ I + +GL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 145
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMA 849
YL E KI+HRD+K SN+L++ K+ DFG++ + + + GT YM+
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMS 198
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
PE + + ++D++S G+ +E+ G+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 851
IVH D+K +N L+ K+ DFG+A + D T + GT+ YM PE
Sbjct: 128 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 852 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ ++ K+DV+S G + + GK
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 851
IVH D+K +N L+ K+ DFG+A + D T + G + YM PE
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 852 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ ++ K+DV+S G + + GK
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-33
Identities = 52/352 (14%), Positives = 104/352 (29%), Gaps = 57/352 (16%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNF---GVDPCSQKGNWELSSD-DKKGFESNVT 84
I + ++ KALK I L K+W + ++ NW + + D G + V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG--------SFSPQW 136
D + V ++L G +P + +L LK L + T +P
Sbjct: 319 LDNNG---RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 137 ASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG------------------- 177
+ + + + ++ + + L L++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 178 ---SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW 234
I I++L LQ + +++ FT + A + N
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNL 490
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLI 294
K + + + +P + L L L I+ N
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC--------------NRGISAAQLKAD 536
Query: 295 HGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGP 345
+ D K++ + +NNL + +K+ K + NK+
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-30
Identities = 55/304 (18%), Positives = 97/304 (31%), Gaps = 47/304 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ L+ L+ + SL+ ++ + NR++ K + +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 163 TTLKNLSIEGNLFTG-------------------SIPPDIRKLINLQKLILSSNSFTGEL 203
T L+ + + FT + L +L + L + +L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 204 PAELTKLTNLNDLRISDNNFSG---------KIPEFIGKWKKIQKLHIQGSSLEG-PIPA 253
P L L L L I+ N ++ + KIQ ++ ++LE P A
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 254 SISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIG-DMTKLKNI 311
S+ + L L K AF L L L I EIP+ +++ +
Sbjct: 568 SLQKMVKLGLLDCVHNKVRHLEAFGTNV--KLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 312 DLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIFNSNKN--------VDISL 361
S N L IP F + + + NK+ + I S + V +S
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSY 682
Query: 362 NNFT 365
N
Sbjct: 683 NEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-29
Identities = 37/293 (12%), Positives = 78/293 (26%), Gaps = 38/293 (12%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVLTNIT 163
L L L N + + + Q+ L N+L P ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644
Query: 164 TLKNLSIEGNLFTG-----SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ ++ N S D K IN + LS N + ++ + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 219 SDNNFS-------GKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDL----- 264
S+N + + + ++ + L + + L L+++
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 265 RISDLKGSESAFPKLDKMNL-KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
S +L + I + P I L + + N++
Sbjct: 764 CFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE 823
Query: 324 TTFEKLAKTNFMYLTGNKLT-GPVP---------KYIFNSNKNVDISLNNFTW 366
+L + + N V Y+ +K DI +
Sbjct: 824 KLTPQL---YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-21
Identities = 43/267 (16%), Positives = 85/267 (31%), Gaps = 45/267 (16%)
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD----------------- 182
++ LS+ G G P + +T LK LS + T S
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 183 --------IRKLINLQKLILSSNSFTGEL---PAELTKLTNLNDLRISD-NNFSGKIPEF 230
+ L L ++ P + +L D +I + N I +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
I + K+Q ++ S A + + + E ++ L +L + L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ--YENEELSWSNLK--DLTDVELY 499
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTG---------GIPTTFEKLAKTNFMYLTGNK 341
C ++PD++ D+ +L++++++ N + + K Y+ N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 342 LTG-PVPKYIFNSNK--NVDISLNNFT 365
L P + K +D N
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 35/145 (24%), Positives = 49/145 (33%), Gaps = 15/145 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVM---GNRLSGPFPKV 158
+N L +DL N LT S S + + L LS M N S FP
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 159 LTNITTLKNLSIEGNL------FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
N + LK I P I +L +L + SN ++ +L
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQ 828
Query: 213 LNDLRISDN-NFSGKIPEFIGKWKK 236
L L I+DN N S + +
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 29/227 (12%), Positives = 69/227 (30%), Gaps = 29/227 (12%)
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
N + E +++ D+ + L L+ G +P + +LT L L ++ +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSE----SAFPKLDK 281
F + + + + L + + K +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 282 MNLKTLILTKC--LIHGEIPDYIGDMTKLKNIDLSFNNLTG------------------- 320
++LK + I I I +TKL+ I + + T
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
++ L + L +P ++++ + +++I+ N
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 675 TNNFDPANKVGEG--GFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 729
++ +G+G +V G + V++ L + S + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
HPN+V + N+L +V +M I T + ++ I G+ +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKA 140
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG-LAKLYEEDK-----THISTRIAG 843
L Y+H + HR +K S++L+ D +S + +
Sbjct: 141 LDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 844 TIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ +++PE ++GY +K+D+YS G+ E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 29/243 (11%)
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK 706
G + + G G ++ +A N+ + ++G G G V+K G VIAVK
Sbjct: 1 GSSGSSGKQTGYLTIGG----QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 707 QL-SSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---R 761
Q+ S +++ N+ + ++ ++ P +V+ +G + + + E M C +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115
Query: 762 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821
+ G E L K+ + I + L YL E ++HRD+K SN+LLD+ K+
Sbjct: 116 RMQGPIPERILG-------KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKL 166
Query: 822 SDFGLAKLYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIV 875
DFG++ R AG YMAPE Y +ADV+S G+ +E+
Sbjct: 167 CDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELA 223
Query: 876 SGK 878
+G+
Sbjct: 224 TGQ 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 46/272 (16%), Positives = 96/272 (35%), Gaps = 12/272 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L L L+ N L + + L L + +S L N
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS-D 220
TL++L + N + P L+ L +N+ +++ L +L ++ +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISDLKG---SESA 275
N I Q L+ G+ I + + SL D+ S +
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
F L +M+++++ L K + + L+ +DL+ +L+ +P+ L+ +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 336 YLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L+ NK + + ++ ++ I N
Sbjct: 307 VLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 16/272 (5%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITT 164
LP+ L L LK+L LS N ++ L LS+ GN L N+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 165 LKNLSIEGNLFTGS--IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L+ L + + S +R L +LQ L LS N + L L ++
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 223 FSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD------LKGSESA 275
K + ++ L++ S L+ L +L L + ++
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L L+ L+L+ C + + + ++DLS N LT L ++
Sbjct: 472 LQTLG--RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528
Query: 336 YLTGNKLTGPVPK--YIFNSNKNVDISLNNFT 365
L N ++ +P I + + +++ N
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 40/279 (14%), Positives = 93/279 (33%), Gaps = 15/279 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
G + + L D+ ++ + + + +++ +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L+ L + + +P + L L+KL+LS+N F + +L L I
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD--LKGSE 273
N ++ + + +++L + +E + L+ L L +S +
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 274 S-AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ AF + L+ L L + + ++ LK ++LS + L F+ L
Sbjct: 393 TEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 332 TNFMYLTGNKLTG--PVPKYIFNSNKNV---DISLNNFT 365
+ L GN + + +S + +
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 43/229 (18%), Positives = 77/229 (33%), Gaps = 14/229 (6%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGS--FSPQWASL-QLVELSVMGNRLSGPFPKV 158
L T L L L++LDLS + + S + Q +L L L++ N +
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L+ L + + L L+ L LS + L L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 218 ISDNNFSGKI---PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG- 271
+ N+F + +++ L + L + ++L + + +S L
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
S A L L L I +P + +++ + I+L N L
Sbjct: 516 SIEALSHL---KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 39/297 (13%), Positives = 80/297 (26%), Gaps = 43/297 (14%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 139
S+ C T + L +P L + L+ S
Sbjct: 3 SSDQKCIEKEVN---KTYNCENLGLN-EIPGTLP--NSTECLEFS--------------- 41
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 199
N L + + L L + + L L+L++N
Sbjct: 42 --------FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 200 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 259
L+ L L S + K ++ L++ + +
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 260 SLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
L L I L S+ L + +L L I I D ++++
Sbjct: 154 KLKVLDFQNNAIHYL--SKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFG 210
Query: 315 FNNLTGGIP-----TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFT 365
I +T + L F + ++ V + + + +++++ + F
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 4/122 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+L+ + L+ + +DLS N LT S + L+ + L++ N +S P +L +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ + +++ N + + + L +R+SD
Sbjct: 547 SQQRTINLRQNPLDCT--CSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 223 FS 224
S
Sbjct: 603 LS 604
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
K+G GG +VY IL +A+K + + E + E+ S H N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ E + LV EY++ LS I E L T I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
++IVHRDIK N+L+D + KI DFG+AK E + + GT+ Y +PE A
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
D+YS G+V E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNL 734
N +G G G+V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
++ Y L + E N L + E + IA G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 793 LHEDSRIKIVHRDIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHIST 839
LH +KI+HRD+K N+L+ ++L ISDFGL K + ++ T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 840 R---IAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVTLEIVSG 877
+GT G+ APE + LT D++S G V I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L+ E+ L + ++ L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE--- 130
Query: 799 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 851
IVHR+IK N++ D K++DFG A+ E+D + GT Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 852 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + D++S GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLV 735
F+ VG G +G VYKG + G + A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 736 KLYGC------CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
YG +QL LV E+ ++ I K+T+ L IC I RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGN-TLKEEWIAYICREILRG 141
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
L++LH+ K++HRDIK NVLL ++ K+ DFG++ + +T I GT +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 197
Query: 850 PEYAMR------GYLTSKADVYSFGVVTLEIVSGK 878
PE Y K+D++S G+ +E+ G
Sbjct: 198 PEVIACDENPDATY-DFKSDLWSLGITAIEMAEGA 231
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/264 (23%), Positives = 96/264 (36%), Gaps = 37/264 (14%)
Query: 640 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 697
M G LGG D+ + G ++ G LR + + EGGF VY+ +
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDV 50
Query: 698 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV-------EGNQLLL 749
G A+K+L S + NR + E+ M HPN+V+ G L
Sbjct: 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 809
+ + L + K E R L T KI R + ++H + I+HRD+K
Sbjct: 111 LLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167
Query: 810 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----------GTIGYMAPE---YAMR 855
N+LL K+ DFG A + + T Y PE
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 856 GYLTSKADVYSFGVVTLEIVSGKS 879
+ K D+++ G + + +
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQH 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 49/244 (20%), Positives = 87/244 (35%), Gaps = 23/244 (9%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
L++ L P + +L +L+ + + L L L++ N L P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI---------RKLINLQKLILSSNSFTGELPAELT 208
+ ++ L+ LSI +P + + L+NLQ L L LPA +
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L NL L+I ++ S + I K+++L ++G + P L L + D
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 269 LKGSES---AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN---NLTGGI 322
+ +L L+ L L C+ +P I + I + + L
Sbjct: 263 CSNLLTLPLDIHRLT--QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
Query: 323 PTTF 326
P
Sbjct: 321 PVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 20/251 (7%)
Query: 107 TLPTELSKLRY--LKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNIT 163
L L+L L F Q L L +++ L P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFA 127
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL---------TKLTNLN 214
L+ L++ N ++P I L L++L + + ELP L L NL
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
LR+ +P I + ++ L I+ S L + +I L L +L + +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+P LK LIL C +P I +T+L+ +DL +P+ +L
Sbjct: 245 -YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 333 NFMYLTGNKLT 343
+ + +
Sbjct: 304 CIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 38/244 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG-------------------SIPP 181
L G+ P+ VL+ N +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 182 DIRKL--INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L L S + P + +L++L + I ++P+ + ++ ++
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLET 131
Query: 240 LHIQGSSLEGPIPASISALTSLTDLRISDLK---------GSESAFPKLDKM-NLKTLIL 289
L + + L +PASI++L L +L I S A + + NL++L L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPK 348
I +P I ++ LK++ + + L+ + L K + L G L P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPP 247
Query: 349 YIFN 352
Sbjct: 248 IFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 32/156 (20%), Positives = 55/156 (35%), Gaps = 3/156 (1%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTL 165
E L L+ L L + S A+LQ L L + + LS + ++ L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ L + G + PP L++LIL S LP ++ +LT L L +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL 261
++P I + + + A +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 19/167 (11%), Positives = 44/167 (26%), Gaps = 28/167 (16%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
GS + L ++ L++ + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN------- 54
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
S + LK + + L L +
Sbjct: 55 -------------------SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP- 94
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ PD ++ L+++ + L +P T ++ A + L N L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 23/212 (10%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L+ E+ L + Y L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRE--- 130
Query: 799 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 851
IVHR+IK N++ D K++DFG A+ E+D + GT Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 852 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + D++S GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
+G GG V+ +AVK L + + F E +A HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 736 KLY--GCCVEGNQLLLVY---EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+Y G E L Y EY+ L + + ++ + L
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQAL 129
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGTIGYM 848
+ H + I+HRD+K +N+++ K+ DFG+A+ + + + + GT Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE A + +++DVYS G V E+++G+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-29
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLY---- 738
G GGFG V + I G +A+KQ + NRE EI ++ HPN+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 739 --GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ LL EY + L + + + LK + + I+ L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYLHE- 139
Query: 797 SRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-Y 852
+I+HRD+K N++L + L KI D G AK ++ + T GT+ Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPELL 195
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
+ Y T D +SFG + E ++G
Sbjct: 196 EQKKY-TVTVDYWSFGTLAFECITGF 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 20/204 (9%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
VG GG G VY+ + ++A+K +S + + F E Q P++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++ QL + + L+ + + L I I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVA--IVRQIGSALDAAHA 152
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAM 854
HRD+K N+L+ D A + DFG+A ++K T + + GT+ YMAPE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFS 208
Query: 855 RGYLTSKADVYSFGVVTLEIVSGK 878
+ T +AD+Y+ V E ++G
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ 730
+F+ +G+G FG+VY ++A+K L K+ ++ E+ + S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN+++LYG + ++ L+ EY + + + + K D +A L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLS-KFDEQRTATYITELANAL 122
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
+Y H +++HRDIK N+LL KI+DFG + + + GT+ Y+ P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPP 176
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGK 878
E K D++S GV+ E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 36/293 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL----------------QLV 142
N + L + + L+ + +W SL L
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK 331
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFT 200
L++ N+ S F + +L L + N + G +L+ L LS N
Sbjct: 332 SLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 201 GELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALT 259
+ A L L L + +K+ L I ++ + LT
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 260 SLTDLRISD--LKGS--ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
SL L+++ K + + F NL L L+KC + + +L+ +++S
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTT--NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 316 NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
NNL + + +L + + + N++ + + K+ +++ N+
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 48/303 (15%), Positives = 91/303 (30%), Gaps = 39/303 (12%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C +T Q L+ +P ++ K +DLS N L S +++ +L
Sbjct: 7 CIEV---VPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
L + + K + L NL + GN P L +L+ L+
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 204 PAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
+ +L L L ++ N K+P + + + + + ++ + L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
+ +L ++ I I D KL + L N + I
Sbjct: 181 QV-------------------NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSDP 371
T + LA + L + IF + ++ N +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 372 IEC 374
C
Sbjct: 281 FHC 283
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 17/279 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
L S L+ LDLSR + W L L L + GN + P +
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISD 220
+T+L+NL I +LI L+KL ++ N +LPA + LTNL + +S
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 221 NNFSGKIPEFIGKWKK----IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
N + ++ L + + ++ I L +L + S +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 277 PKLDKM--NLKTLILTKCLIHGEI------PDYIGDMTKL--KNIDLSFNNLTGGIPTTF 326
+ L L E P + + + L++ N F
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
LA + M L G + +++ I
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK 320
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 46/286 (16%), Positives = 83/286 (29%), Gaps = 26/286 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ---------WASLQLVELSVMGNRLS 152
N + + T L L L L + + + + E +
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+ + +S+ G D+ K Q L + + P L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPF 329
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD-- 268
L L ++ N S + + + L + ++L G S SL L +S
Sbjct: 330 LKSLTLTMNKGSI-SFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ F L+ L+ L + + KL +D+S+ N F
Sbjct: 388 AIIMSANFMGLE--ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFTWESSD 370
L N + + GN +F + N+ D+S S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 45/257 (17%), Positives = 86/257 (33%), Gaps = 32/257 (12%)
Query: 130 GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI-TTLKNLSIEGNLFTGSIPPDIRKLIN 188
GS +P + + M +LS KV +I ++ KN+ + N
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS----KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
LQ L LS L +L++L ++ N P ++ L + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL 308
I L +L L ++ N + ++P Y ++T L
Sbjct: 118 SLESFPIGQLITLKKLNVAH--------------NF--------IHSCKLPAYFSNLTNL 155
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFM----YLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
++DLS+N + + L + + ++ N + + F K +++L
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN 214
Query: 365 TWESSDPIECPRGSVNL 381
S+ C + L
Sbjct: 215 FNSSNIMKTCLQNLAGL 231
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-16
Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 5/170 (2%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKVLT 160
N L L L ++ N + + L L + +L V
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L+ L++ N +L +L L S N +L +++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL--TSLTDLRISD 268
N+ + I E + +++ ++E A+ + + + D S
Sbjct: 555 NSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 23/248 (9%)
Query: 640 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LS 698
M L G++ + + + K+G G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 699 DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
A+K + K+ + E+ ++ HPN++KLY + LV E K
Sbjct: 61 THVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 756 NNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
L I + E I + G+ YLH+ IVHRD+K N+LL
Sbjct: 120 GGELFDEIIHRMKFNEV-------DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169
Query: 814 ---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVV 870
+KD KI DFGL+ ++E K GT Y+APE + Y K DV+S GV+
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVI 226
Query: 871 TLEIVSGK 878
+++G
Sbjct: 227 LFILLAGY 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + + +V E + L + R L P + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
+++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 860 SKADVYSFGVVTLEIVSGK 878
+ DV+S G + ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 61/284 (21%), Positives = 99/284 (34%), Gaps = 40/284 (14%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
LT +LP L L L S L +L + GN+L+ P +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLTS-LPVLPPG- 142
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L+ LS+ N S+P L KL +N T LP + L L+ +SDN
Sbjct: 143 --LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQ 192
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLD 280
+ +P + K+ + + +SL PA S L L R++ L S
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLTSL----PALPSGLKELIVSGNRLTSLPVLPS------ 241
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
LK L+++ + +P L ++ + N LT +P + L+ + L GN
Sbjct: 242 --ELKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 341 KLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
L+ + PR + L +
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 26/181 (14%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L++ + T ++P + ++ L++ N+ T LPA +L L +S N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +P ++ + L PA S L L + + L P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-WIFGNQLTSLPVLPP----- 141
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L+ L ++ + +P ++ KL N LT +P L + + ++ N+L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPMLPSGLQE---LSVSDNQL 193
Query: 343 T 343
Sbjct: 194 A 194
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 29/237 (12%), Positives = 65/237 (27%), Gaps = 51/237 (21%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------- 718
G+ + + G V R +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 719 ---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RL 772
F+ ++ Q ++++ + L + Y + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 833 DKTHISTRIAGTIGYMAPEY-----------AMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + G+ PE R +T D ++ G+V I
Sbjct: 259 RVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + + +V E + L + R L P + I G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 160
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
+++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 860 SKADVYSFGVVTLEIVSGK 878
+ DV+S G + ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 659 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR 717
L G++ ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 718 EFV----NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYR 771
E+ ++ HPN++KLY + LV E L I + +E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 828
+I + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL+
Sbjct: 128 A-------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 829 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 877
+E K GT Y+APE Y K DV+S GV+ ++SG
Sbjct: 178 HFEASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSG 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 21/227 (9%), Positives = 46/227 (20%), Gaps = 40/227 (17%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGC 740
G V+ + A+K + + E + + +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 741 C--------------------------VEGNQLLLVYEYMK-NNCLSRAIFGKDTEYRLK 773
LL+ + L + +R
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 774 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ + R A L +VH N+ + D + D
Sbjct: 191 EGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246
Query: 834 KTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 878
+ + Y E+ T + + G+ +
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
K + + + + + L K +DP + +G G V + + + G AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 708 LSSKSRQGNREFV--------NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758
+ + + + E + E + HP+++ L + + LV++ M+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 759 LSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814
L + +E ++ I + +++LH IVHRD+K N+LLD
Sbjct: 187 LFDYLTEKVALSE---------KETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 815 KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSF 867
++ ++SDFG + E + + GT GY+APE GY + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWAC 291
Query: 868 GVVT 871
GV+
Sbjct: 292 GVIL 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 31/247 (12%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNREFVNE 722
+ + + + +GEG F VY+ D +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 723 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+ + +K Y + N +LV E L AI +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----------DKDLNAKISDFGLAKLYE 831
+ + + +H+ +I+H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 832 --EDKTHISTRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK------SNTN 882
T + + T G+ E + + + + D + ++ G
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 883 YRPNEDF 889
+P F
Sbjct: 293 CKPEGLF 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV--------------- 720
N++ + +G F + D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 721 --NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLD 775
NE+ +I+ ++ + G +++ ++YEYM+N+ + F D Y +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
K I + +Y+H + I HRD+K SN+L+DK+ K+SDFG ++ + K
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 836 HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 878
S GT +M PE+ Y +K D++S G+ +
Sbjct: 208 KGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++ +G+G FG V K AVK ++ K+ N++ + E+ ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIAR 788
HPN++KL+ + + +V E L I + +E+ +I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS 132
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ ++++ GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVT 871
Y+APE Y K DV+S GV+
Sbjct: 188 YYIAPEVLRGTY-DEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKL 737
+G+G FG V K AVK ++ K+ N++ + E+ ++ HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ + + +V E L I + +E+ +I + G+ Y+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK 139
Query: 796 DSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
IVHRD+K N+LL +KD + KI DFGL+ ++++ GT Y+APE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEV 194
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSG 877
Y K DV+S GV+ ++SG
Sbjct: 195 LRGTY-DEKCDVWSAGVILYILLSG 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
K+G G FG V+ S G +K ++ Q E + EI ++ + HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 741 CVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ + + +V E + L ++A +E + ++ + LAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-------ELMKQMMNALAYFH 141
Query: 795 EDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
+VH+D+K N+L KI DFGLA+L++ D+ T AGT YMAPE
Sbjct: 142 S---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196
Query: 852 YAMRGYLTSKADVYSFGVVT 871
R T K D++S GVV
Sbjct: 197 VFKRDV-TFKCDIWSAGVVM 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 26/234 (11%), Positives = 62/234 (26%), Gaps = 42/234 (17%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------ 718
+G+ + + G V R +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 719 ----FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC----LSRAIFGKDTEY 770
F+ ++ Q ++++ + L + Y + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 771 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 206 K-SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 831 EEDKTHISTRIAGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
R A +T D ++ G+ I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 32/248 (12%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
+ +G+ + G+Y ++ ++ K+G G +G V + + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 708 LS------------SKSRQGNREFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
+ +K+ + E + NEI ++ + HPN++KL+ + LV E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 755 KNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812
+ L I K E I I G+ YLH+ IVHRDIK N+L
Sbjct: 129 EGGELFEQIINRHKFDECDA-------ANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 813 L---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGV 869
L + LN KI DFGL+ + +D GT Y+APE + Y K DV+S GV
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKY-NEKCDVWSCGV 235
Query: 870 VTLEIVSG 877
+ ++ G
Sbjct: 236 IMYILLCG 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNRE--FVNEIGMISAQQH 731
++FD +G+G FG+VY + ++A+K L S+ + E EI + S +H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
PN++++Y + ++ L+ E+ L + + ++ + D +A L
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHG-RFDEQRSATFMEELADALH 128
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
Y H K++HRDIK N+L+ KI+DFG + + T + GT+ Y+ PE
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE 182
Query: 852 YAM-RGYLTSKADVYSFGVVTLEIVSGK 878
+ + K D++ GV+ E + G
Sbjct: 183 MIEGKTH-DEKVDLWCAGVLCYEFLVGM 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--------QLSSKSRQGNREF 719
N++P +G G V + I AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 720 V-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLD 775
E+ + HPN+++L LV++ MK L + +E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------ 123
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+KI + + LH+ + IVHRD+K N+LLD D+N K++DFG + + +
Sbjct: 124 -KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 836 HISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVT 871
+ GT Y+APE GY + D++S GV+
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIM 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 27/205 (13%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 738
+ GG G +Y ++ V +K L + + E ++ HP++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 739 GCCVEGNQLL-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ +V EY+ L R+ K L + I L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H I +V+ D+K N++L ++ K+ D G + GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGY-LYGTPGFQAPEIV 249
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
R T D+Y+ G +
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 44/279 (15%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N ++ +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLT-GPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
L GN G + + + + ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 22/289 (7%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ K ++ + L + + S + EL + GN LS L T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ N+ D+ L L+ L L++N EL ++ L ++NN S +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NL 284
+ + + + +++ + + + + L + + F +L L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
+ L L I+ ++ + KLK +DLS N L + F+ A ++ L NKL
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 345 PVPKYIFNSN--KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391
+ K + S ++ D+ N F + V++ + K
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGF---HCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+G F VY+ + G +A+K + K+ R NE+ + +HP++++LY
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYN 78
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ N + LV E N ++R + K+ + R + I G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFS-ENEARHFM-HQIITGMLYLH---SH 131
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
I+HRD+ SN+LL +++N KI+DFGLA + T + GT Y++PE A R
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190
Query: 860 SKADVYSFGVVTLEIVSGK 878
++DV+S G + ++ G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G +G V + A K++ + F EI ++ + HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 742 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + LV E L + E +I + +AY H+ +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHK---L 125
Query: 800 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
+ HRD+K N L D K+ DFGLA ++ K GT Y++P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGL 183
Query: 857 YLTSKADVYSFGVVT 871
Y + D +S GV+
Sbjct: 184 Y-GPECDEWSAGVMM 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
T+ ++ +G G + + I + AVK + R E EI ++ QHPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPN 77
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARG 789
++ L +G + +V E MK L I + +E R+ + I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---------REASAVLFTITKT 128
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRIAGTI 845
+ YLH +VHRD+K SN+L D+ N +I DFG AK + + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTA 184
Query: 846 GYMAPE-YAMRGYLTSKADVYSFGVVT 871
++APE +GY + D++S GV+
Sbjct: 185 NFVAPEVLERQGY-DAACDIWSLGVLL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 53/253 (20%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISA 728
+ +G+G +G V I + A+K ++ + + E+ ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTR------- 779
HPN+ +LY + + LV E L + F D+ + +D
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 780 --------------------------KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
I I L YLH I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 814 DKDLNA--KISDFGLAKLYEEDKTHISTR---IAGTIGYMAPE---YAMRGYLTSKADVY 865
+ + K+ DFGL+K + + AGT ++APE Y K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAW 260
Query: 866 SFGVVTLEIVSGK 878
S GV+ ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 23/243 (9%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T + L L L++L L+ + ++ SP ++ L++ N L+N+T L
Sbjct: 101 TDISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ + P I L +L L L+ N P L LT+L+ N +
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDK 281
P + ++ L I + + P ++ L+ LT L +ISD+ +A L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI----NAVKDLT- 265
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
LK L + I + ++++L ++ L+ N L L ++L+ N
Sbjct: 266 -KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 342 LTG 344
+T
Sbjct: 323 ITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 23/238 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170
L+ L + L+L N SP L L+V +++ P + N+T L +LS+
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230
N P + L +L N T P + +T LN L+I +N + P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLK 285
+ ++ L I + + + LT L L +ISD+ S L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDI----SVLNNLS--QLN 290
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L L + E + IG +T L + LS N++T P L+K + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 52/281 (18%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L+ ++T + +L + +L ++ + S L L++ GN+++
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQIT 79
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L+N+ L NL I N T ++ L NL++L L+ ++ + + L LT
Sbjct: 80 DISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTK 133
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RIS 267
+ L + N+ + + L + S ++ P I+ LT L L +I
Sbjct: 134 MYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
D+ S L +L I P + +MT+L ++ + N +T P
Sbjct: 191 DI----SPLASLT--SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA 240
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
L++ ++ + N+++ +++ N +
Sbjct: 241 NLSQLTWLEIGTNQISDINA---VKDLTKLKMLNVGSNQIS 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 49/236 (20%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L + L + +T + + + +L V G +++ + + +T L+ L+
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELE-SITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ GN T P + L+ L L + +N T + L LTNL +L ++++N S P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLI 288
+ K+ L++ + + +S +T L L +++ K + + L +L +L
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLT--DLYSLS 183
Query: 289 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
L I P + +T L N +T P + + N + + NK+T
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 44/250 (17%), Positives = 88/250 (35%), Gaps = 19/250 (7%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
L + P + + + ++ + ++ L + G
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
SI I L NL+ L L+ N T P L+ L L +L I N + + +
Sbjct: 58 SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIH 295
++L++ ++ P ++ LT + L + S + L L +T+ +
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT--GLNYLTVTESKVK 168
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
P I ++T L ++ L++N + P L ++ N++T P
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLN 224
Query: 356 NVDISLNNFT 365
++ I N T
Sbjct: 225 SLKIGNNKIT 234
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L+ L L N +T +P +L L + N+++ P L N++ L L
Sbjct: 193 SPLASLTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
I N + I ++ L L+ L + SN + + L L+ LN L +++N + E
Sbjct: 250 IGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IG + L + + + P +++L+ + ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG V+K + G +A K + ++ + E NEI +++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
+LY N ++LV EY+ L I + T I + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL-------TELD-TILFMKQICEGIR 201
Query: 792 YLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
++H+ + I+H D+K N+L ++D KI DFGLA+ Y+ + GT ++A
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 850 PEYAMRGYLTSKADVYSFGVVT 871
PE +++ D++S GV+
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
+G G F V+ G + A+K + KS + NEI ++ +H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHED 796
LV + + L I G TE + + + + YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTE---------KDASLVIQQVLSAVKYLHE- 124
Query: 797 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
IVHRD+K N+L +++ I+DFGL+K+ + + GT GY+APE
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179
Query: 854 MRGYLTSKADVYSFGVVT 871
+ + D +S GV+T
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 46/279 (16%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N + +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLTGPVPKYIFNSNKNV-DISLNNFTWESSDPIE 373
L GN + F+ N+ V ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 52/259 (20%), Positives = 102/259 (39%), Gaps = 19/259 (7%)
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
K ++ + L + + S + EL + GN LS L T L+ L++ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ D+ L L+ L L++N EL ++ L ++NN S ++ +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SR 118
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTK 291
+ + +++ + + + + L + + F +L L+ L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
I+ ++ + KLK +DLS N L + F+ A ++ L NKL + K +
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALR 234
Query: 352 NSN--KNVDISLNNFTWES 368
S ++ D+ N F +
Sbjct: 235 FSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 35/270 (12%), Positives = 76/270 (28%), Gaps = 17/270 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKV 158
+T + ++ LDL N + + +L+ L++ N +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE--HLNLQYNFIYD-VKG- 186
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
LK L + N + P+ + + + L +N + L NL +
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244
Query: 219 SDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
N F G + +F K +++Q + Q + +L + + F
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 278 ----KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
L + L + + + + ID I +
Sbjct: 305 DRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ L ++ +D +L
Sbjct: 364 TLEQKKKALD-EQVSNGRRAHAELDGTLQQ 392
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 22/216 (10%)
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N K + + ++ + N+++L LS N + A+L T L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGS 272
+S N + ++ L + + ++ + S+ L IS + S
Sbjct: 65 LSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV--S 115
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAK 331
S K + L I G ++++ +DL N +
Sbjct: 116 CSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFTW 366
+ L N + V + + K +D+S N +
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF 205
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 27/218 (12%), Positives = 59/218 (27%), Gaps = 5/218 (2%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L + L+ DL N + S +V + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILS----SNSFTGELPAELTKLTNLNDLRISDNN 222
P +LI L++ + S T L E ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ I + + + L + +L+ + A L + E ++
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 283 NLKTLI-LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L+ L + K + +++ D+ + T
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 28/205 (13%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGMISAQQHPN 733
+G G G V +A++ +S ++ EI ++ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++K+ + +V E M+ L + G +L T K + + YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYL 255
Query: 794 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
HE I+HRD+K NVLL ++D KI+DFG +K+ E + + GT Y+AP
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAP 310
Query: 851 E----YAMRGYLTSKADVYSFGVVT 871
E GY D +S GV+
Sbjct: 311 EVLVSVGTAGY-NRAVDCWSLGVIL 334
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGM 725
+ + KVGEG +G VYK S G ++A+K + R E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ HPN+V L L LV+E+M+ + L + + E + L K
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQ 127
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+ + + + T+
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183
Query: 846 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y AP+ + Y TS D++S G + E+++GK
Sbjct: 184 WYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ F G+G FG+V G G +A+K++ R NRE + + ++ HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 734 LVKLYGCCVEGNQ-------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICI 784
+V+L + L +V EY+ + L R YR ++ P K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKVFLF 136
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHIS--- 838
+ R + LH S + HRDIK NVL+++ L K+ DFG AK + +++
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 839 TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+R Y APE + + Y T+ D++S G + E++ G+
Sbjct: 194 SRY-----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMI 726
++++ F K+G G + +VYKG+ + G +A+K + + + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIG 785
+H N+V+LY N+L LV+E+M N+ L + + + + L+ K
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ +GLA+ HE+ KI+HRD+K N+L++K K+ DFGLA+ + S+ + T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 846 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y AP+ R Y TS D++S G + E+++GK
Sbjct: 173 WYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-26
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 20/262 (7%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ + L+KL L+ L + N ++ +P L ELS+ GN+L L ++T L
Sbjct: 190 SDISVLAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLT 246
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
+L + N + P + L L +L L +N + P L LT L +L +++N
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKM-N 283
P I K + L + +++ P +S+LT L L + + L + N
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD----VSSLANLTN 354
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ L I P + ++T++ + L+ T ++ N + L
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
Query: 344 GPVPKYIFNSNKNVDISLNNFT 365
P S DI+ N +
Sbjct: 413 APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 42/254 (16%), Positives = 93/254 (36%), Gaps = 17/254 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ L + L + +T + Q Q+ L + + + L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N T P ++ L L +++++N L LTNL L + +N + P +
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+ +L + +++ +S LTSL L + L L+ L ++
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPLANLT--TLERLDISS 186
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ + +T L+++ + N ++ P L + + L GN+L
Sbjct: 187 NKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242
Query: 352 NSNKNVDISLNNFT 365
+ ++D++ N +
Sbjct: 243 TNLTDLDLANNQIS 256
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-24
Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 21/274 (7%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L N+T T+ + L + L R + S L +++ N+L+
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLT 81
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T L ++ + N P + L NL L L +N T P L LTN
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
LN L +S N S + +Q+L G+ + P ++ LT+L L IS K S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 273 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ L K+ NL++LI T I P +G +T L + L+ N L T L
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 244
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+++ P + + N +
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 34/186 (18%), Positives = 67/186 (36%), Gaps = 17/186 (9%)
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L + +I + I D L K +L + T + T L + L+
Sbjct: 2 PLGSATITQDTPINQIFTDT-ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
+ + + +++ + L P + LT L D+ +++ + + L
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TPLANLT- 112
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
NL L L I P + ++T L ++LS N ++ + L + GN+
Sbjct: 113 -NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQ 166
Query: 342 LTGPVP 347
+T P
Sbjct: 167 VTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 27/141 (19%), Positives = 51/141 (36%), Gaps = 7/141 (4%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L+ L L L N ++ SP + +L L N++S L N+T + LS
Sbjct: 303 SPISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLS 359
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N + P + L + +L L+ ++T ++ N ++ P
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415
Query: 230 FIGKWKKIQKLHIQGSSLEGP 250
I + I +
Sbjct: 416 TISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 25/154 (16%), Positives = 56/154 (36%), Gaps = 10/154 (6%)
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L I+ + +I + K + +++ + + L +T L+ L
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 273 E-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ NL + + + P + ++TKL +I ++ N + P L
Sbjct: 60 SIDGVEYLN--NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N++T P + +++S N +
Sbjct: 114 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 28/142 (19%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L L++L N ++ S + LS N++S P L N+T + L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-------- 221
+ +T + P + + +++ + + PA ++ + + I+ N
Sbjct: 382 LNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEV 439
Query: 222 ---------------NFSGKIP 228
FSG +
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 33/211 (15%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----------SAQQHP 732
G+GGFG+V+ G L+D +A+K + ++R +++ + HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIAR 788
+++L +LV E +D + L + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLP--------AQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
+ + H +VHRDIK N+L+D AK+ DFG L ++ GT Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204
Query: 848 MAPEY-AMRGYLTSKADVYSFGVVTLEIVSG 877
PE+ + Y A V+S G++ ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 671 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG 724
+K+ ++ + +GEG F +VYK + ++A+K++ R ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
++ HPN++ L + + LV+++M+ + L I KD L L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII--KDN--SLVLTPSHIKAYML 119
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+GL YLH+ I+HRD+K +N+LLD++ K++DFGLAK + + ++ T
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-T 175
Query: 845 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE + R Y D+++ G + E++
Sbjct: 176 RWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
++N+D ++G+G F V + + + G A K ++ K + + + E + QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARG 789
PN+V+L+ E + LV++ + L I +E I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILES 117
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
+AY H IVHR++K N+LL K K++DFGLA + + AGT G
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPG 172
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVT 871
Y++PE + + D+++ GV+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----G 789
L+ L+ + +++L+ E++ L I +D + + + I R G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-------SEAE-VINYMRQACEG 161
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 847
L ++HE IVH DIK N++ K + KI DFGLA D+ T +
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEF 216
Query: 848 MAPEYAMRGYLTSKADVYSFGVVT 871
APE R + D+++ GV+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 5e-26
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISAQ 729
+ K+GEG +G VYK + G A+K K R E + EI ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+H N+VKLY +L+LV+E++ + L + + L+ T K + + G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
+AY H+ +++HRD+K N+L++++ KI+DFGLA+ + + I T+ Y A
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRA 168
Query: 850 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
P+ + Y T+ D++S G + E+V+G
Sbjct: 169 PDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGM 725
+ + + +G G G V +A+K +S ++ EI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ HP ++K+ + +V E M+ L + G +L T K
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQ 122
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIA 842
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ E + T +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT-LC 177
Query: 843 GTIGYMAPE----YAMRGYLTSKADVYSFGVVT 871
GT Y+APE GY D +S GV+
Sbjct: 178 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVIL 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 14/203 (6%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQH 731
++ +G+G F V + I G AVK + +S + E + +H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P++V+L L +V+E+M L I + I L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALR 144
Query: 792 YLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
Y H+ I+HRD+K VLL + K+ FG+A E R+ GT +M
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 849 APEYAMRGYLTSKADVYSFGVVT 871
APE R DV+ GV+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 62/228 (27%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ--------- 730
G+G +G V +D T A+K LS + R +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 731 -------------HPNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 773
HPN+VKL V + L +V+E + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV-------------- 125
Query: 774 LDWPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
++ PT K + AR G+ YLH KI+HRDIK SN+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 826 LAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVV 870
++ ++ +S GT +MAPE + + DV++ GV
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGC 740
+GEG F K + AVK +S + + EI + + HPN+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHED 796
+ LV E + L I K +E + I + ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---------TEASYIMRKLVSAVSHMHD- 124
Query: 797 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
+ +VHRD+K N+L + +L KI DFG A+L D + T T+ Y APE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181
Query: 854 MRGYLTSKADVYSFGVVT 871
+ D++S GV+
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
++++ ++G G F V K G A K +LSS R +RE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+HPN++ L+ ++L+ E + + + TE +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TE-------DEATQF 113
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS 838
I G+ YLH +I H D+K N++L + K+ DFG+A E
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
I GT ++APE L +AD++S GV+T
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G V+K G ++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+HPNLV L +L LV+EY + + + Y+ + K I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL----DRYQRGVPEHLVKSITWQTLQ 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
+ + H+ +HRD+K N+L+ K K+ DFG A+L + +A T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 849 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+PE Y DV++ G V E++SG
Sbjct: 170 SPELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKV-GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQ 714
G+DL T + ++ N + +K G G F V + I S G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 715 GNREFV-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKD 767
R + +EI + A+ P ++ L+ ++++L+ EY + CL
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMV 128
Query: 768 TEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAK 820
+E I + + G+ YLH+ IVH D+K N+LL + K
Sbjct: 129 SE-----------NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 821 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
I DFG+++ I GT Y+APE +T+ D+++ G++
Sbjct: 175 IVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 39/205 (19%), Positives = 81/205 (39%), Gaps = 23/205 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+ A +G G FG V++ + S K + K ++ V EI +++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
N++ L+ +L++++E++ + I E ++ +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-------NERE-IVSYVHQVCE 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
L +LH + I H DI+ N++ + KI +FG A+ + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVT 871
Y APE +++ D++S G +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+++D ++G G FG V++ + G A K + + ++E V EI +S +HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
LV L+ + N+++++YE+M L + + + + + + R
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDE-AVEYMRQVCK 266
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIG 846
GL ++HE VH D+K N++ K N K+ DFGL + ++ GT
Sbjct: 267 GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAE 321
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
+ APE A + D++S GV++ ++SG S
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNR 717
G+ T +Q + + +D ++G G F V K S G A K Q + R R
Sbjct: 1 GMETFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 718 EFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKL 774
E + E+ ++ HPN++ L+ ++L+ E + L + K+ +E
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-- 117
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 830
I G+ YLH KI H D+K N++L + K+ DFGLA
Sbjct: 118 -----TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
E+ I GT ++APE L +AD++S GV+T
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ VGEG +G V K G ++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+H NLV L C + + LV+E++ + + + + LD+ +K I
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQIIN 135
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
G+ + H I+HRDIK N+L+ + K+ DFG A+ +A T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 849 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
APE Y + DV++ G + E+ G+
Sbjct: 192 APELLVGDVKYGKA-VDVWAIGCLVTEMFMGE 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
+ +D ++G G F V K S G A K Q + R +RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIG 785
H N++ L+ ++L+ E + L + K+ +E
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQ 123
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRI 841
I G+ YLH KI H D+K N++L DK++ K+ DFGLA E+ I
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
GT ++APE L +AD++S GV+T
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQ 729
+ +K+GEG + +VYKG ++A+K + R + E E+ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+H N+V L+ L LV+EY+ + L + + + ++ K + RG
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL----DDCGNIINMHNVKLFLFQLLRG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
LAY H K++HRD+K N+L+++ K++DFGLA+ + T+ Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 850 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
P+ Y T D++ G + E+ +G+
Sbjct: 169 PDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPNL 734
G G FG V+ + + VK + K + ++ EI ++S +H N+
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGL 790
+K+ LV E + G D + +LD P I + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS--------GLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
YL I+HRDIK N+++ +D K+ DFG A E K T GTI Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAP 198
Query: 851 E-YAMRGYLTSKADVYSFGVVTLEIVSG 877
E Y + +++S GV +V
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/276 (18%), Positives = 92/276 (33%), Gaps = 65/276 (23%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE V E+ ++ +HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI----------- 782
+V+ + +E E + + + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 783 -----------------CIG------IARGLAYLHEDSRI------------------KI 801
C + R + + + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-----------KTHISTRIAGTIGYMAP 850
+HRD+K SN+ D K+ DFGL ++D T GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886
E + K D++S G++ E++ S R
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
T + ++G+G F V + + + G A ++ K + + + E + +H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIA 787
PN+V+L+ E L+++ + L I +E I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQIL 120
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ + H+ + +VHR++K N+LL K K++DFGLA E ++ AGT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGT 176
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVT 871
GY++PE + D+++ GV+
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 48/208 (23%), Positives = 76/208 (36%), Gaps = 34/208 (16%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV 742
GEG V I L AVK + + E+ + Q H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHEDSR 798
E ++ LV+E M+ + I + E + + +A L +LH
Sbjct: 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQDVASALDFLHN--- 129
Query: 799 IKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTR------IAGTIGYMA 849
I HRD+K N+L ++ KI DF L + + G+ YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 850 PE------YAMRGYLTSKADVYSFGVVT 871
PE Y + D++S GV+
Sbjct: 190 PEVVEAFSEEASIY-DKRCDLWSLGVIL 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG--- 724
AT+ ++P ++G G +G+VYK G +A+K + + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 725 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+ A +HPN+V+L C ++ LV+E++ + L + D L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
K + RGL +LH + IVHRD+K N+L+ K++DFGLA++Y T
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--T 177
Query: 840 RIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
+ T+ Y APE + Y T D++S G + E+ K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV 720
T+ + + + +D ++G G F V K S G A K + S R +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 721 -NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKL 774
E+ ++ QHPN++ L+ ++L+ E + + + TE
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TE----- 113
Query: 775 DWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGL 826
+ + G+ YLH ++I H D+K N++L KI DFGL
Sbjct: 114 ------EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 871
A + I GT ++APE L +AD++S GV+T
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +G G FG V++ L + +A+K++ R NR E+ ++ +HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 735 VKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIGI 786
V L L LV EY+ + RA +LK P K +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRAS---RHYAKLKQTMPMLLIKLYMYQL 150
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRIA 842
R LAY+H I I HRDIK N+LLD K+ DFG AK+ + I +R
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY- 206
Query: 843 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE + Y T+ D++S G V E++ G+
Sbjct: 207 ----YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-------EIGMISAQQH--PNL 734
G GGFGSVY GI +SD +A+K + K R + + E+ ++ +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++L + +L+ E + + +F TE R L + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 166
Query: 795 EDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 852
++HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
Y A V+S G++ ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G+V+K ++A+K + R + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+H N+V+L+ +L LV+E+ + L + LD K + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF----DSCNGDLDPEIVKSFLFQLLK 112
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GL + H ++HRD+K N+L++++ K+++FGLA+ + S + T+ Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYR 168
Query: 849 APE--YAMRGYLTSKADVYSFGVVTLEIVS 876
P+ + + Y TS D++S G + E+ +
Sbjct: 169 PPDVLFGAKLYSTS-IDMWSAGCIFAELAN 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G G VY+ A+K L + EIG++ HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 742 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDS 797
++ LV E + L I G +E R I +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE---------RDAADAVKQILEAVAYLHE-- 166
Query: 798 RIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
IVHRD+K N+L D KI+DFGL+K+ E + GT GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILR 223
Query: 855 RGYLTSKADVYSFGVVT 871
+ D++S G++T
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++N+D ++G+G F V + + + G A K ++ + R+ E + Q
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGI 786
HPN+V+L+ E + LV++ + L I +E I
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQI 137
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+AY H IVHR++K N+LL K K++DFGLA + + AG
Sbjct: 138 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 192
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVT 871
T GY++PE + + D+++ GV+
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVN-EIGMISAQQHPNLVKLYGCC 741
G+G F V + G +A+K + ++ + + + E+ ++ HPN+VKL+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
L L+ EY + + ++ + I + Y H + +I
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLTS 860
VHRD+K N+LLD D+N KI+DFG + + + G Y APE + + Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAPPYAAPELFQGKKYDGP 193
Query: 861 KADVYSFGVVTLEIVSGK 878
+ DV+S GV+ +VSG
Sbjct: 194 EVDVWSLGVILYTLVSGS 211
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 63/312 (20%), Positives = 120/312 (38%), Gaps = 40/312 (12%)
Query: 85 CDCSSATCHV------------------VTIALKAQNLTGTLPTELSKLRYLKQLDLSRN 126
C+CS+ V + L + E + +L++L+L+ N
Sbjct: 7 CECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 127 CLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
++ G+F+ +L+ + L NRL V T ++ L L I N +
Sbjct: 67 IVSAVEPGAFNNL-FNLRTLGLR--SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY 122
Query: 183 I-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQ 238
+ + L NL+ L + N + + L +L L + N + IP +
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH-LHGLI 179
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGE 297
L ++ ++ S L L L IS ++ P L +NL +L +T C +
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238
Query: 298 IPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
+P + + L+ ++LS+N ++ + +L + + L G +L V Y F
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNY 297
Query: 357 V---DISLNNFT 365
+ ++S N T
Sbjct: 298 LRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 21/248 (8%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+P + L L +LD+S N + F L L V N L + +
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL---YNLKSLEVGDNDLVYISHRAFSG 150
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ +L+ L++E T SIP + L L L L + +L L L IS
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESA 275
+ + + L I +L ++ L L L IS + S
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGSM 267
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
+L L+ + L + + Y + L+ +++S N LT + F +
Sbjct: 268 LHELL--RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 335 MYLTGNKL 342
+ L N L
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 11/135 (8%)
Query: 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRL 151
+ + T+ L L ++ LT + L+ + LS N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-VYLRFLNLS--YNPI 260
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
S +L + L+ + + G + P R L L+ L +S N T L +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 210 LTNLNDLRISDNNFS 224
+ NL L + N +
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 798
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 856
I I HRDIK N+LLD+ N KISDFGLA ++ ++ + ++ GT+ Y+APE R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 857 YLTSKADVYSFGVV 870
+ DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNE-- 722
I N+F +G GGFG VY +D G + A+K L K +QG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 723 -IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWP 777
+ ++S P +V + ++L + + M G D Y L
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEA 292
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
+ I GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H
Sbjct: 293 DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 348
Query: 838 STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKS 879
GT GYMAPE + Y S AD +S G + +++ G S
Sbjct: 349 -AS-VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHS 389
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ + K+GEG +G VYK I +A+K + R + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
QH N+++L ++L L++EY +N+ L + + + + K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM-----DKNPDVSMRVIKSFLYQLIN 143
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-----KISDFGLAKLYEEDKTHISTRIAG 843
G+ + H + +HRD+K N+LL + KI DFGLA+ + + I
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 844 TIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
T+ Y PE R Y TS D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ +G G FG VY+ L D G ++A+K++ R NRE + ++ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 734 LVKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIG 785
+V+L + L LV +Y+ + R R K P K
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVA---RHYSRAKQTLPVIYVKLYMYQ 164
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRI 841
+ R LAY+H I HRDIK N+LLD D K+ DFG AK + I +R
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 842 AGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE + Y TS DV+S G V E++ G+
Sbjct: 222 -----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 35/202 (17%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + G A+K L S + +E + A P++V +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYEN 93
Query: 742 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL++ E M+ L I + TE R+ +I I + +L
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---------REAAEIMRDIGTAIQFL 144
Query: 794 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
H I HRD+K N+L +KD K++DFG AK ++ + T T Y+AP
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAP 198
Query: 851 E-YAMRGYLTSKADVYSFGVVT 871
E Y D++S GV+
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVIM 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGN----------REFVNEI 723
++ ++GEG +G V+K + + G +A+K + R RE V +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE-VAVL 65
Query: 724 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+ +HPN+V+L+ C +L LV+E++ + L+ + D + T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
K + + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 839 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
T + T+ Y APE + Y T D++S G + E+ K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 798
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 856
I I HRDIK N+LLD+ N KISDFGLA ++ ++ + ++ GT+ Y+APE R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 857 YLTSKADVYSFGVV 870
+ DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 45/240 (18%), Positives = 81/240 (33%), Gaps = 39/240 (16%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTL 165
LP L ++ N L P+ +L L + N L P + + L
Sbjct: 167 KLPDLPPSLEFI---AAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLS---L 217
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+++ N+ P+++ L L + +N LP L LN + DN +
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT- 270
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMN 283
+PE + S L L L I L +
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLPP--------S 318
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L+ L ++ + E+P +L+ + SFN+L +P + L + +++ N L
Sbjct: 319 LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-22
Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 39/251 (15%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
EL L +L + N L + SL+ L+V N L+ P++ ++T L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--ALNVRDNYLTD-LPELPQSLTFLD 283
Query: 167 NLSIEGNLFTGSIPPDIRKLI--------------NLQKLILSSNSFTGELPAELTKLTN 212
+ + +PP++ L +L++L +S+N ELPA +L
Sbjct: 284 VSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L S N+ + ++PE +++LH++ + L P S+ DLR++
Sbjct: 342 LI---ASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPE---SVEDLRMNSHLAE 390
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
P+ NLK L + + E PD ++++ ++ + E K
Sbjct: 391 VPELPQ----NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKL 442
Query: 333 NFMYLTGNKLT 343
+
Sbjct: 443 EDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-22
Identities = 47/273 (17%), Positives = 98/273 (35%), Gaps = 56/273 (20%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--------------QLVELSVMG 148
NLT +P E ++ + + + + P Q EL +
Sbjct: 22 NLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNN 80
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
LS P++ + L++L N T +P + L +L + + + +LP L
Sbjct: 81 LGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLE 134
Query: 209 KL----------------TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252
L + L + + +N+ K+P+ ++ + + LE +P
Sbjct: 135 YLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LP 189
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGEIPDYIGDMTKLKN 310
+ L LT + + KL + +L++++ ++ E+P+ + ++ L
Sbjct: 190 -ELQNLPFLTAIYADNNS-----LKKLPDLPLSLESIVAGNNILE-ELPE-LQNLPFLTT 241
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
I N L +P L + + N LT
Sbjct: 242 IYADNNLLK-TLPDLPPSLEA---LNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 32/196 (16%), Positives = 71/196 (36%), Gaps = 35/196 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL------------ 210
T L+ + T +P + + + + + + + P +
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 211 -TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRIS 267
++L +++ S +PE ++ L +SL +P +L SL + +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
L S P L+ L ++ + ++P+ + + + LK ID+ N+L +P
Sbjct: 125 AL----SDLPP----LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 328 KLAKTNFMYLTGNKLT 343
L + N+L
Sbjct: 174 SLEF---IAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 6/78 (7%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L+ + +P LKQL + N L F S++ +L + R+ P+
Sbjct: 382 LRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVE--DLRMNSERVVDPYEFA 435
Query: 159 LTNITTLKNLSIEGNLFT 176
L++ E +
Sbjct: 436 HETTDKLEDDVFEHHHHH 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-23
Identities = 55/299 (18%), Positives = 99/299 (33%), Gaps = 34/299 (11%)
Query: 99 LKAQNLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQW-ASLQ-LVELSVMGNRLSGPF 155
L +Q T+ E L L+ LDL + + P L L EL + LS
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 156 --PKVLTNITTLKNLSIEGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT- 211
N+ L L + N + P KL +L+ + SSN EL L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 212 -NLNDLRISDNNFSGKIPEFIGKWKK------IQKLHIQGSSLEGPIPA---------SI 255
L+ ++ N+ ++ GK ++ L + G+ I
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 256 SALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
+L + + ++ F L + +++ L L+ + + LK
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
++L++N + F L + L+ N L + F V D+ N+
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-22
Identities = 47/275 (17%), Positives = 96/275 (34%), Gaps = 24/275 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L+ LK L+L+ N + + L L L++ N L +
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ + + ++ N I + L LQ L L N+ T + + ++ D+ +S
Sbjct: 337 LPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSG 390
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLK----GSESA 275
N +H+ + LE I + + L L ++ + +
Sbjct: 391 NKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
+ +L+ L L + ++ + ++ L+ + L+ N L P F L
Sbjct: 447 PSENP--SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+LT + + + +DIS N
Sbjct: 505 ALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-20
Identities = 41/276 (14%), Positives = 89/276 (32%), Gaps = 20/276 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLT 160
+ + L L+ L+L + + +L L L + +++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 161 NITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLR 217
+ L L + + ++ D R L L +L LS N L KL +L +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 218 ISDNNFSGKIPE-FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSES 274
S N + K + + +SL + + ++ + L S +
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN- 333
+ N I + + F+N+ TF LA+++
Sbjct: 215 GWTVDITGNFSN------AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 334 -FMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
+ L+ + + +F + K++ +++ N
Sbjct: 269 RHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-18
Identities = 47/272 (17%), Positives = 91/272 (33%), Gaps = 45/272 (16%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+ L L+ L+LS N L +S + L ++ + + N ++ +
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE--------------- 206
+ L+ L + N T I + ++ + LS N LP
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLE 414
Query: 207 -------LTKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI--S 256
L ++ +L L ++ N FS + +++L + + L+ +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 257 ALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 310
L+ L++ L F L L+ L L + + L+
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLT--ALRGLSLNSNRLT-VLSHND-LPANLEI 530
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+D+S N L P F L + + +T NK
Sbjct: 531 LDISRNQLLAPNPDVFVSL---SVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 51/297 (17%), Positives = 89/297 (29%), Gaps = 51/297 (17%)
Query: 84 TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE 143
+C + NLT +P L+ L LS N +
Sbjct: 1 SCSFDGRIAF-----YRFCNLT-QVPQVLNTTERL---LLSFN-------------YIRT 38
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
++ + L+ L + +I + R L NL+ L L S+
Sbjct: 39 VT----------ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-F 87
Query: 203 LPAE-LTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLEG-PIPASISAL 258
L + L +L +LR+ S + + K + +L + + + + S L
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 259 TSLTDLRISDLK---GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK------LK 309
SL + S + E L L L ++ + G L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 310 NIDLSFNNLTGGIPTTFEK-LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+D+S N T I F ++K+ L F + D N F
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA---GFGFHNIKDPDQNTFA 261
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 9e-16
Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 22/210 (10%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKK 236
+P + ++L+LS N + L L L + I E
Sbjct: 18 QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
++ L + S + P + L L +L +SD + F L L L L+K
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK--ALTRLDLSK 132
Query: 292 CLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTGNKLTGPVPK 348
I + G + LK+ID S N + E L F L N L V
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 349 YIFNSNKN--------VDISLNNFTWESSD 370
+D+S N +T + +
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITG 222
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 43/298 (14%), Positives = 98/298 (32%), Gaps = 44/298 (14%)
Query: 111 ELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ---------LVELSVMGNRLSGPFPK 157
+ L+ LD+S N T G+FS + Q ++ + + P
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 158 VLTNI--TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ +++++L + S+ + L +L+ L L+ N L NL
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L +S N K+ + +Q + + + L L L ++ +
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
Query: 270 KGSES------------AFPKLDKMNLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFN 316
S PK++ + + L++ + +I ++ + L+ + L+ N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKIN-LTANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 317 NLTGGIPT-TFEKLAKTNFMYLTGNKLTGP----VPKYIFNSNKNV---DISLNNFTW 366
+ T + ++L N L + +F ++ ++ N
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 17/197 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPK 157
L+ +L T + + + + LS N L + + L+ LS NRL
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLS--ENRLENLDILY 420
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTK-----L 210
L + L+ L + N F+ S D + +L++L L N EL L
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
++L L ++ N + P ++ L + + L + + +L L IS
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN-DLPANLEILDISRNQ 537
Query: 269 -LKGSESAFPKLDKMNL 284
L + F L +++
Sbjct: 538 LLAPNPDVFVSLSVLDI 554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 7/125 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ T L +L+ L L+ N L ++ L L LS+ NRL+
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDL 216
L L+ L I N + PD+ ++L L ++ N F E + N ++
Sbjct: 523 DLP--ANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNV 577
Query: 217 RISDN 221
I+
Sbjct: 578 TIAGP 582
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 51/298 (17%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C CS+ V+ +NL +P +S + L+L N + SF
Sbjct: 39 CSCSNQFSKVI---CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLR---H 89
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N + + L L + N T +IP L L++L L +N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 200 TGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+P+ ++ +L L + + ++ +I + EG L
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELK-------------RLS--YISEGAFEG--------L 184
Query: 259 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L L ++ E L L L L+ + P + L+ + + +
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLI--KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
+ F+ L + L N LT +P +F + I L++ +P C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHH------NPWNC 293
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 683 KVGEGGFGSVYKGI---LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK D A+KQ+ + EI ++ +HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 740 CCVE--GNQLLLVYEYMKN---NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ ++ L+++Y ++ + + K + ++L K + I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAKLY---EEDKTHISTRIAGTIGY 847
+ ++HRD+K +N+L+ + KI+D G A+L+ + + + T Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 848 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
APE + R Y T D+++ G + E+++ +
Sbjct: 202 RAPELLLGARHY-TKAIDIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 31/211 (14%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----------QHP 732
GEG +G V + + AVK L ++ + I A +H
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 733 NLVKLYG--CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
N+++L E ++ +V EY + E R C + GL
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFP-VCQAHGYFC-QLIDGL 122
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMA 849
YLH IVH+DIK N+LL KIS G+A+ G+ +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 850 PEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
PE A + K D++S GV I +G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+V EY+ L I +++ +++ I + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RH 130
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 858
+VHRD+K NVLLD +NAKI+DFGL+ + + + + T G+ Y APE + R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 188
Query: 859 TSKADVYSFGVV 870
+ D++S GV+
Sbjct: 189 GPEVDIWSCGVI 200
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 53/298 (17%), Positives = 105/298 (35%), Gaps = 51/298 (17%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C CS+ VV + L+ +P + + L+L N + +F
Sbjct: 50 CSCSNQFSKVV---CTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLH---H 100
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N + + +L L + N T IP L L++L L +N
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI 159
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+P+ ++ +L L + + K++ +I + EG L
Sbjct: 160 E-SIPSYAFNRVPSLMRLDLGELK-------------KLE--YISEGAFEG--------L 195
Query: 259 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
+L L + + L L+ L ++ P ++ LK + + +
Sbjct: 196 FNLKYLNLGMCNIKDMPNLTPLV--GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
++ F+ LA + L N L+ +P +F + V++ L++ +P C
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHH------NPWNC 304
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 55/201 (27%), Positives = 78/201 (38%), Gaps = 32/201 (15%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG---- 739
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 126
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL+V E + L I + TE R+ +I I + YL
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 177
Query: 794 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
H I I HRD+K N+L K NA K++DFG AK + T T Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 232
Query: 851 EYAMRGYLTSKADVYSFGVVT 871
E D++S GV+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ ++ K+G+G FG V+K G +A+K K N +E EI ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72
Query: 729 QQHPNLVKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+H N+V L C + LV+++ +++ L+ + + +K K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL----SNVLVKFTLSEIK 127
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
++ + GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ + K R
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 841 IAG---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
T+ Y PE + R Y D++ G + E+ +
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+ F +G GGFG V+ + G + A K+L+ K R+G + + E +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR--- 788
+V L L LV M G D Y + A
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMN---------GGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 789 -----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
GL +LH+ I++RD+K NVLLD D N +ISD GLA + +T AG
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AG 351
Query: 844 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
T G+MAPE + D ++ GV E+++ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 53/268 (19%), Positives = 85/268 (31%), Gaps = 50/268 (18%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C C + + Q L +P + +++ L N ++ SF
Sbjct: 6 CVCYNEPKVTTS--CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRAC---RN 57
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N L+ T + L+ L + N S+ P L L L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
EL L L L + DN + + L
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ----------------ALPDDTFRD--------L 152
Query: 259 TSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNID 312
+LT L RIS + E AF L +L L+L + + + + D+ +L +
Sbjct: 153 GNLTHLFLHGNRISSV--PERAFRGLH--SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L NNL+ L ++ L N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 23/220 (10%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLT 211
L + + + + GN + +P R NL L L SN + A T L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80
Query: 212 NLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 268
L L +SDN + F G ++ LH+ L+ + + L +L L + D
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHG-LGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD 138
Query: 269 --LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPT 324
L+ + F L NL L L I +P+ + L + L N + P
Sbjct: 139 NALQALPDDTFRDL--GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNN 363
F L + +YL N L+ +P + + + LN+
Sbjct: 196 AFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 13/119 (10%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
L L+ L L N L +F L L L + GNR+S + + +L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFR----DLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
L + N + P R L L L L +N+ + LP E L L L LR++DN +
Sbjct: 181 RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 45/244 (18%), Positives = 98/244 (40%), Gaps = 24/244 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 115
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 173
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 174 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV--VRGP 223
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 224 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 340 NKLT 343
N+L
Sbjct: 282 NRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 50/281 (17%), Positives = 94/281 (33%), Gaps = 39/281 (13%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP + L L L RN L+ G F +L LS+ N L
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTLSMSNNNLERIEDDTFQA 163
Query: 162 ITTLKNLSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELP 204
T+L+NL + N T + + I +++L S NS +
Sbjct: 164 TTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR 221
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
+ L L++ NN + + + + ++ + + LE + + L L
Sbjct: 222 GPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277
Query: 265 RISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
IS+ L + LK L L+ + + +L+N+ L N++
Sbjct: 278 YISNNRLVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 334
Query: 323 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+T L + L+ N + +F + + +
Sbjct: 335 LSTHHTLKN---LTLSHNDWDCNSLRALFRNVARPAVDDAD 372
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 14 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 69 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 181
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 182 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 273
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 33/171 (19%), Positives = 71/171 (41%), Gaps = 11/171 (6%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L N++ L + L+ +++LD S N + +++L L + N L+
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGP-VNVELTILKLQHNNLTD--TAW 243
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L N L + + N I K+ L++L +S+N L + L L
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+S N+ + ++ +++ L++ +S+ + +S +L +L +S
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 41/236 (17%), Positives = 78/236 (33%), Gaps = 36/236 (15%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 215 DLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDL-----RIS 267
L ++D +I + IQKL++ +++ +P + + LT L +S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIP--- 323
L F L TL ++ + I D T L+N+ LS N LT +
Sbjct: 131 SL--PRGIFHNTP--KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 324 --------------TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+T + + N + V + + + NN T
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + +V EY+ L I +LD +++ I G+ Y H R
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH---RH 135
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 858
+VHRD+K NVLLD +NAKI+DFGL+ + + + + T G+ Y APE + R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 193
Query: 859 TSKADVYSFGVV 870
+ D++S GV+
Sbjct: 194 GPEVDIWSSGVI 205
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 4e-21
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 43/271 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
NL+ +LP L + L++++N L S ASL+ L NRLS P++ +
Sbjct: 70 NLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE--YLDACDNRLST-LPELPAS- 121
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
LK+L ++ N T +P L+ + +N T LP T L L+ + +N
Sbjct: 122 --LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQ 171
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +PE ++ L + + LE +PA + I
Sbjct: 172 LT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF--------------- 211
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ I IP+ I + I L N L+ I + + +
Sbjct: 212 ----FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 343 TGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
+ + D F +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 7e-15
Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 43/278 (15%)
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAE 206
N +SG + + + ++ G S+ + + +L L+ + + LP
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDN 77
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL----- 261
L + L I+ N +PE ++ L + L +P ++L L
Sbjct: 78 L--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPASLKHLDVDNN 130
Query: 262 ---------TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311
L + ++ + P+L +L+ L + + +P+ + L
Sbjct: 131 QLTMLPELPALLEYINADNNQLTMLPELPT-SLEVLSVRNNQL-TFLPELPESLEAL--- 185
Query: 312 DLSFNNLTGGIPTTFEKLAK----TNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFT 365
D+S N L +P + F N++T +P+ I + + + N
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL- 242
Query: 366 WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 403
S I Y PR
Sbjct: 243 ---SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 36/246 (14%), Positives = 69/246 (28%), Gaps = 18/246 (7%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
N LP + L L + N LT SL+ L V N L P V
Sbjct: 149 NNQLTMLPELPTSLEVL---SVRNNQLT-FLPELPESLE--ALDVSTNLLES-LPAVPVR 201
Query: 162 ITTLKN----LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N T IP +I L +IL N + + L++ T D
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
FS + + + + + +S + + + +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWH----AFEHEEHANTFSA 314
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
LD+++ ++ ++ ++ + + + E + L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
Query: 338 TGNKLT 343
L
Sbjct: 375 RKTLLV 380
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
N F +G+GGFG V + G + A K+L K R+G +NE ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT-----RKKICIG- 785
+V L + L LV M G D ++ + R
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMN---------GGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
I GL LH + +IV+RD+K N+LLD + +ISD GLA E +T I R GT+
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR-VGTV 349
Query: 846 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
GYMAPE Y T D ++ G + E+++G+S
Sbjct: 350 GYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQS 383
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-21
Identities = 50/269 (18%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 121
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS--INVVRGP 229
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 230 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 340 NKLTGPVPKYIFNSN--KNVDISLNNFTW 366
N+L + Y K +D+S N+
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 7e-19
Identities = 53/313 (16%), Positives = 104/313 (33%), Gaps = 45/313 (14%)
Query: 107 TLPTEL-SKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP + + L L L RN L+ G F +L LS+ N L
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP---KLTTLSMSNNNLERIEDDTFQA 169
Query: 162 ITTLKNLSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELP 204
T+L+NL + N T + + I +++L S NS +
Sbjct: 170 TTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR 227
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
+ L L++ NN + + + + ++ + + LE + + L L
Sbjct: 228 GPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283
Query: 265 RISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
IS+ L + LK L L+ + + +L+N+ L N++
Sbjct: 284 YISNNRLVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 340
Query: 323 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLV 382
+T L + L+ N + +F + + + + + +
Sbjct: 341 LSTHHTLKN---LTLSHNDWDCNSLRALFRNVARPAVDDADQH------CKIDYQLEHGL 391
Query: 383 ESYSSPRNKLDKV 395
S + LD++
Sbjct: 392 CCKESDKPYLDRL 404
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 9e-19
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 20 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 75 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 130
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 187
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 188 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 238
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-14
Identities = 36/217 (16%), Positives = 74/217 (34%), Gaps = 38/217 (17%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L ++D +I+++ + + ++ L I L
Sbjct: 79 LLNLNDL--------------QIEEID----------TYAFAYAHTIQKLYMGFNAIRYL 114
Query: 270 KGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEK 328
F + L L+L + + +P I + KL + +S NNL TF+
Sbjct: 115 --PPHVFQNVP--LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L+ N+LT V + S + ++S N +
Sbjct: 170 TTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLS 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-21
Identities = 54/271 (19%), Positives = 93/271 (34%), Gaps = 28/271 (10%)
Query: 108 LPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163
+ + L + L + S++ W L+LV + K L +T
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLT 331
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
N L +L+ L LS N + G T+L L +S N
Sbjct: 332 FTSNKGGNAFSEVD--------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGS---ESAFP 277
+ ++++ L Q S+L+ S+ +L +L L IS F
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L+ L + I ++ L +DLS L PT F L+ +
Sbjct: 443 GL--SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 337 LTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
+ N+L VP IF+ + + + N +
Sbjct: 501 MASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 61/352 (17%), Positives = 108/352 (30%), Gaps = 68/352 (19%)
Query: 61 DPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQ 120
+PC + N+T C N +P L K
Sbjct: 1 EPCVEVVP-------------NITYQCME------------LNFY-KIPDNLP--FSTKN 32
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDLS N L L + L+ L + +I
Sbjct: 33 LDLSFN-------------PLRHLG----------SYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 181 PD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L +L LIL+ N + L++L L + N + IG K +++
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 240 LHIQGSSL-EGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCL 293
L++ + + +P S LT+L L +S ++ + L +M L +L L+
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVP 347
++ I +L + L N + + T + LA L +
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 348 KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL--VESYSSPRNKLDKVHP 397
K N+ I + + L V S+S +++V
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 46/283 (16%), Positives = 85/283 (30%), Gaps = 29/283 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNC---------LTGSFSPQWASLQLVELSVMGNRLS 152
+ + T + L L+ L S +L + E +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 153 G-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ +T + + S+ D Q L L + F + P KL
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL--KLK 325
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD- 268
+L L + N + ++ L + + L G S TSL L +S
Sbjct: 326 SLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 269 -LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTT 325
+ S F L L+ L + ++ ++ + L +D+S +
Sbjct: 384 GVITMSSNFLGL--EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
F L+ + + GN IF +N+ D+S
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK-VLTNITTLKNLS 169
LR L LD+S +F+ + L L L + GN F + T + L L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 170 IEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKI 227
+ + P L +LQ L ++SN +P +LT+L + + N +
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 534
Query: 228 P--EFIGKWKKIQKLHIQGS 245
P +++ +W QGS
Sbjct: 535 PRIDYLSRWLNKNSQKEQGS 554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160
+ + ++LR L LDLS+ L + SL L L++ N+L +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+T+L+ + + N + S P I L
Sbjct: 516 RLTSLQKIWLHTNPWDCS-CPRIDYLSR 542
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 52/194 (26%), Positives = 76/194 (39%), Gaps = 23/194 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
G G FG ++AVK + + + EI + +HPN+V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSRI 799
L ++ EY L I R D R + G++Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNAG---RFSED-EARFFFQQLLS-----GVSYCH---SM 135
Query: 800 KIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRG 856
+I HRD+K N LLD KI DFG +K + + GT Y+APE +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQE 193
Query: 857 YLTSKADVYSFGVV 870
Y ADV+S GV
Sbjct: 194 YDGKIADVWSCGVT 207
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 36/276 (13%)
Query: 109 PTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT 164
+ L++L L L N ++ +FSP +L +L + N L P + ++
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLPSS--- 124
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNN 222
L L I N +P + L N+ + + N LN LRIS+
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA-SISALTSLTDL-----RISDLKGSESAF 276
+ IP+ + + +LH+ + ++ I + + L L +I + +
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMI--ENGSL 237
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT---- 332
L L+ L L + +P + D+ L+ + L NN+T F +
Sbjct: 238 SFLP--TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294
Query: 333 --NFMYLTGNKLT-GPVPKYIFNSNKN-VDISLNNF 364
N + L N + V F + + I N+
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 58/273 (21%), Positives = 96/273 (35%), Gaps = 32/273 (11%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P E+S LDL N ++ F L L L
Sbjct: 32 HCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFK----GLQHLYALV 84
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S K + + L+ L I N IPP++ +L +L + N
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKG 141
Query: 206 ELTKLTNLNDLRISDNNF-SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
+ L N+N + + N + K+ L I + L G IP +L +L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNEL 198
Query: 265 -----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNL 318
+I + + L L L I I + + L+ + L N L
Sbjct: 199 HLDHNKIQAI--ELEDLLRYS--KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P L +YL N +T V F
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDF 284
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 25/188 (13%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 234
++P +I + L L +N + EL + L +L L + +N S KI E F
Sbjct: 47 AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSP-L 101
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLR-----ISDLKGSESAFPKLDKMNLKTLIL 289
+K+QKL+I + L IP + +SL +LR I + + F L N+ + +
Sbjct: 102 RKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKV--PKGVFSGLR--NMNCIEM 154
Query: 290 TK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348
L + D KL + +S LTG E L N ++L NK+ +
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLDHNKIQA-IEL 210
Query: 349 YIFNSNKN 356
Sbjct: 211 EDLLRYSK 218
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 51/291 (17%), Positives = 101/291 (34%), Gaps = 36/291 (12%)
Query: 81 SNVTCDCSSA---------TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-- 129
N C SS T V ++ L +T ++L + L+ L L+ N +
Sbjct: 32 RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91
Query: 130 --GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI--RK 185
SFS L L + N LS +++L L++ GN + ++
Sbjct: 92 EEDSFSSLG---SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 186 LINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHI 242
L LQ L + + ++ + LT L +L I ++ + L +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ-NVSHLIL 205
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL---------DKMNLKTLILTKCL 293
+ + +S+ L + D F +L K + + +T
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLT 343
+ ++ + ++ L ++ S N L +P F++L ++L N
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 39/211 (18%), Positives = 77/211 (36%), Gaps = 41/211 (19%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLT 211
L +I +K+L + N T I ++ +NLQ L+L+SN + + + L
Sbjct: 43 LNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--L 269
+L L +S N + L + L+SLT L +
Sbjct: 101 SLEHLDLSYN--------------YLSNLS----------SSWFKPLSSLTFLNLLGNPY 136
Query: 270 K--GSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF 326
K G S F L L+ L + +I +T L+ +++ ++L P +
Sbjct: 137 KTLGETSLFSHL--TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
+ + + + L + + + + +V
Sbjct: 195 KSIQNVSHLILHMKQHIL-LLEIFVDVTSSV 224
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 56/281 (19%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS ++ LT ++PT + +L+L N L G F L
Sbjct: 5 CSCSGTEIR-----CNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFD----KLT 52
Query: 140 QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197
QL +LS+ N LS G + T+LK L + N ++ + L L+ L +
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 198 SFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255
+ ++ L NL L IS + G
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG------ 148
Query: 256 SALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKN 310
L+SL L+++ E+ F +L NL L L++C + ++ ++ L+
Sbjct: 149 --LSSLEVLKMAGNSFQENFLPDIFTELR--NLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+++S NN ++ L + + N + K
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQEL 243
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 8/168 (4%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLTNITT 164
T+ + L L+ LD + L SL L+ L + F + +++
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNN 222
L+ L + GN F + PDI +L NL L LS +L L++L L +S NN
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDLRISD 268
F +Q L + + +SL L ++
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQ 257
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 676 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMIS 727
++F+ +G+G FG V + A+K ++ K + R V E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQ 70
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKIC 783
+HP LV L+ + + +V + + L + E +KL + IC
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKL-F-----IC 122
Query: 784 -IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 842
+ +A L YL +I+HRD+K N+LLD+ + I+DF +A + + + +A
Sbjct: 123 ELVMA--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 843 GTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
GT YMAPE GY + D +S GV E++ G+
Sbjct: 176 GTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
GEG FG V +A+K +S + + EI + +HP+++KLY
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+++V EY +F E + ++ ++ I + Y H R
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 858
KIVHRD+K N+LLD +LN KI+DFGL+ + + + T G+ Y APE + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-CGSPNYAAPEVINGKLYA 185
Query: 859 TSKADVYSFGVVTLEIVSGK 878
+ DV+S G+V ++ G+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 49/249 (19%), Positives = 80/249 (32%), Gaps = 41/249 (16%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL---QLVELSVMGNRLSGPFPKVLTNI----- 162
+ + L++L L +TG+ P L L++ + L +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT----KLTNLNDLRI 218
LK LSI +R L L LS N GE K L L +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGSESAF 276
+ + G A +A L L +S L+ + A
Sbjct: 209 RNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L L+ + ++P + KL +DLS+N L P + ++L + +
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLS 302
Query: 337 LTGNKLTGP 345
L GN
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 49/296 (16%), Positives = 84/296 (28%), Gaps = 57/296 (19%)
Query: 86 DCSSATCHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLTGSFSPQWA--SLQLV 142
CS A N G EL R L+ L + SL L
Sbjct: 12 SCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK 71
Query: 143 ELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDIRKLI--NLQKLILSSN 197
L+V R+ + I+ L+ L++E TG+ PP + + +L L L +
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 198 SFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252
S+ A L +L L L I+ + E + + + L + + G
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+ FP L + L+ + G +L+ +D
Sbjct: 191 LISALC--------------PLKFPTLQVLALRNAGMET--PSGVCSALAAARVQLQGLD 234
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
LS N+L + + ++S
Sbjct: 235 LSHNSL------------------------RDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 27/246 (10%), Positives = 63/246 (25%), Gaps = 51/246 (20%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL---TNLNDLRISDNNFS 224
L DI K ++L++L + + + ++ + L +L + + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G P + + L L + ++
Sbjct: 109 GTAPPPLLEAT----------------------GPDLNILNLRNVS-------------- 132
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
T+ E+ ++ LK + ++ + + + L+ N G
Sbjct: 133 ---WATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 345 PVP------KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398
F + + + + S V L S N L
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS-HNSLRDAAGA 246
Query: 399 LRQNFP 404
++P
Sbjct: 247 PSCDWP 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 4e-20
Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 79/301 (26%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCLS--------------------------RAIFGK 766
+V L G C G L+++ E+ K LS
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 767 DTEYRLKLDWPTRKKICIGI--ARGLAYLHEDSRIKIVHRDIKTSNVLLD---------- 814
D + RL ++ G + L+ + E+ + +++D T L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 815 ---------KDLNA-----------KISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYA 853
+DL A KI DFGLA+ +D ++ A + +MAPE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267
Query: 854 MRGYLTSKADVYSFGVVTLEIVS-GKSNTNY---RPNEDFVYLLDWAYVLQE-----EEI 904
T ++DV+SFGV+ EI S G + Y + +E+F L ++ E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
Query: 905 Y 905
Y
Sbjct: 326 Y 326
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 27/230 (11%)
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQ 714
LQ + K +F +GEG F +V + A+K L + ++
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKE 71
Query: 715 GNREFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTE 769
+V E ++S HP VKLY + +L Y KN + + G E
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDE 129
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ I L YLH I+HRD+K N+LL++D++ +I+DFG AK+
Sbjct: 130 TCTRF-------YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 830 YEEDKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ GT Y++PE +D+++ G + ++V+G
Sbjct: 180 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 29/276 (10%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS---------LQLVELSVMGNRLSGPFPK 157
L + +L ++ D + N L + + + L + L
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGEL---PAELTKLTNL 213
V + + +K +++E + +P + L +L+ L LS N E A +L
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 214 NDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +S N+ K E + K + L I ++ P+P S + L +S
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ L ++ + + +L+ + +S N L +
Sbjct: 423 RV--VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLKTLPDASL--FPV 474
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
M ++ N+L VP IF+ + + + N +
Sbjct: 475 LLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-19
Identities = 41/261 (15%), Positives = 91/261 (34%), Gaps = 25/261 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+L + L LK L+L N S P +LQ + + + S
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRIDFAG 146
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+T+L L I+ ++ + ++ L L + L L+++ L + D
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 222 N---FSGKIPEFIGKWKKIQKLHIQGSSLE----GPIPASISALTSLTDLRISDLKGSE- 273
N F ++KL +GS L + + + L+++ D +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 274 -----------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S K++ + ++ L + + + ++ + K+K I + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 323 PTTFEKLAKTNFMYLTGNKLT 343
+ + L F+ L+ N +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-18
Identities = 50/299 (16%), Positives = 112/299 (37%), Gaps = 29/299 (9%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRL 151
+ + +KA +L L +R + L L + L + L + L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 152 SGPFP---KVLTNITTLKNLSIEGNLFT----GSIPPDIRKLINLQKLILSSNSFTG--- 201
+ V + +K L+ G++ T + +R ++ L ++ + G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 202 ------ELPAELTKL--TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253
++ +EL K+ + L I + +K++++ ++ S + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 254 SISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH--GEIPDYIGDMT 306
L SL L + + SA K +L+TL+L++ + + + + +
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSAC-KGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++D+S N +P + + K F+ L+ + V I + + +D+S NN
Sbjct: 388 NLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 53/341 (15%), Positives = 107/341 (31%), Gaps = 77/341 (22%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 139
+++ CD S ++ T ++P+ L+ +K LDLS N +T +
Sbjct: 5 DASGVCDGRS------------RSFT-SIPSGLT--AAMKSLDLSFNKIT--------YI 41
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNS 198
L L+ L ++ + +I D L +L+ L LS N
Sbjct: 42 G---------------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L++L L + N + + + L
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQ-----------------------TLGVTSLFPNL 122
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
T+L LRI +++ F L +L L + + + + + ++ L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLT--SLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFTWESS 369
+ + + L+ ++ L L + + K + + T ES
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 370 DPI-ECPRGSVNL--VESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + + R + L VE N L +P
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 9e-14
Identities = 30/173 (17%), Positives = 55/173 (31%), Gaps = 19/173 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT------GSFSPQWASLQLVELSVMGNRLSGPF 155
L+ L LS+N L +L +++S N P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL-TLKNLTSLDIS--RNTFH-PM 402
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P ++ L++ + I L+ L +S+N+ L +L L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY- 457
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IS N +P+ + + + I + L+ LTSL + +
Sbjct: 458 --ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 10/146 (6%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+N +P ++ L+LS + + +L+++++S N L F L
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS--NNNLDS-FSLFLPR 452
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L+ L I N ++P L + +S N +LT+L + + N
Sbjct: 453 ---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 222 NFSG--KIPEFIGKWKKIQKLHIQGS 245
+ +++ +W QGS
Sbjct: 508 PWDCSCPRIDYLSRWLNKNSQKEQGS 533
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 54/251 (21%), Positives = 92/251 (36%), Gaps = 64/251 (25%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ + +G G FG V + + G A+K++ R NRE + ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 734 LVKLYGC--------------------------------------CVEGNQLLLVYEYMK 755
++KL + L ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTR--KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
+ L + + + R P + R + ++H + I HRDIK N+L+
Sbjct: 122 DT-LHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 814 D-KDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAPE--YAMRGYLTSKADVYSF 867
+ KD K+ DFG AK + ++ +R Y APE Y T D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSI 228
Query: 868 GVVTLEIVSGK 878
G V E++ GK
Sbjct: 229 GCVFGELILGK 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 48/237 (20%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFVN 721
++Q++ +F+ +G G FG V K V A+K L+ ++
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122
Query: 722 -EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDW 776
E ++ + L+ + N L LV +Y LS+ E RL +
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEM 176
Query: 777 PTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
AR + +H+ + VHRDIK N+L+D + + +++DFG
Sbjct: 177 ----------ARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 829 LYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
ED T S+ GT Y++PE Y + D +S GV E++ G++
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 46/266 (17%), Positives = 86/266 (32%), Gaps = 23/266 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L +++ L LD S N +T Q L L+ N ++
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN--RLNCDTNNITKL---D 207
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
L L L N T I D+ L L S N T EL ++ L+ L L
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278
+ +I + ++ +G + ++ T L L +E +
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQ 316
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 338
L L L + E+ + TKLK++ ++ + K+ N +
Sbjct: 317 N--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369
Query: 339 GNKLTGPVPKYIFNSNKNVDISLNNF 364
+ + + N++ + +S +
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 47/263 (17%), Positives = 91/263 (34%), Gaps = 24/263 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +L L LD + +T + L +L N ++ L+
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT-LD--LSQN 84
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
T L L+ + N T ++ + L L L +N T +L +++ L L + N
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNT 138
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +I + ++ +L + + ++ T LT L S K +E +
Sbjct: 139 LT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNK-- 191
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L L I ++ + +L +D S N LT I L + + + N L
Sbjct: 192 LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL 245
Query: 343 TGPVPKYIFNSNKNVDISLNNFT 365
T + + + +
Sbjct: 246 T-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 26/261 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
++S+ + L +L+ N +T QL L N+L+ +T +T L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N T + + L L L E+ LT T L + ++
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTL 287
+ ++ L Q + + + +S L L +++ L + LK+L
Sbjct: 293 -VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL----TELDVSHNTKLKSL 344
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I + +G + L N + T + T + G
Sbjct: 345 SCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 348 KYIFNSNKNVDISLNNFTWES 368
D + N TWE+
Sbjct: 403 NIEPGDGGVYDQATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 31/179 (17%), Positives = 62/179 (34%), Gaps = 15/179 (8%)
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224
+ + +L L L ++S T ++ + KLT L L + NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
+ + + + L + L + ++ LT LT L K ++ + L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNP--LL 129
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L + + EI + T+L +D N + + + + NK+T
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 27/178 (15%), Positives = 55/178 (30%), Gaps = 13/178 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
N + ++ +L L L +++ + + I K + KL +++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
+ +S T+LT L K + L L L + ++ +
Sbjct: 77 TT-LD--LSQNTNLTYLACDSNKLTNLDVTPLT--KLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ + N LT + + NK + +D S N T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ VG G +GSV I G +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ QH N++ L LV +M+ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM-------GLKFSEEK 127
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-I 837
+ + + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184
Query: 838 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
TR Y APE + Y D++S G + E+++GK
Sbjct: 185 VTRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 25/280 (8%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + IA N+T T+ + L + L +T + L+ L + N+++
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT 76
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T + L + GN ++ I L +++ L L+S T P L L+N
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + N + I + +Q L I + + ++ L +L+ L +
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADDN 183
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
+ S L + NL + L I P + + + L + L+ +T L
Sbjct: 184 KISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
N + P I + N + N TW +
Sbjct: 242 VPNVVKGPSGAPI--APATISD---NGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 16/167 (9%)
Query: 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238
I PD L N K+ ++ T + L + L + I E + +
Sbjct: 12 IFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLI 66
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHG 296
L ++ + + ++ L +LT + +L G+ + + ++KTL LT I
Sbjct: 67 GLELKDNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
P + ++ L+ + L N +T P L ++ + +++
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 42/261 (16%), Positives = 91/261 (34%), Gaps = 19/261 (7%)
Query: 117 YLKQLDLSRNCLTGSFSPQWAS----LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
L ++ + N W + + + + G F T++ L +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232
++F N+ + + +K++ L S+N + + E G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 233 KWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD----LKGSESAFPKLDKMNLKT 286
+++ L +Q + L+ I + + SL L IS + +L +
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK--SLLS 403
Query: 287 LILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346
L ++ ++ I + ++K +DL N + IP KL + + N+L V
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-V 459
Query: 347 PKYIFNSNKN---VDISLNNF 364
P IF+ + + + N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 7/170 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--GPFPKVL 159
SK+ LD S N LT + L +L L + N+L ++
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
T + +L+ L I N + +L L +SSN T + L + L +
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
N IP+ + K + +Q+L++ + L+ LTSL + +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 44/304 (14%), Positives = 90/304 (29%), Gaps = 34/304 (11%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSG-PFPK 157
++ +++ L L+ L +S N + F +L L + N+L
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQ---ELEYLDLSHNKLVKISCHP 88
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
N LK+L + N F ++P + L+ L LS+ + L
Sbjct: 89 -TVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L + + K + + LHI + + ++ ++ +L +S++K
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 276 ----------FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI-DLSFNNLT----- 319
L L L I + + S +N+
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 320 --GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG 377
+ L + + + P YI+ N++I + + CP
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322
Query: 378 SVNL 381
Sbjct: 323 ISPF 326
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 7/209 (3%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDN 221
L+I N + DI L L+ LI+S N L L L +S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLD 280
KI ++ L + ++ + PI ++ L L +S +S+ +
Sbjct: 80 KLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+N+ ++L +GE D + L T ++ L +
Sbjct: 137 HLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 341 KLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+ + + ++ L S+
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 39/245 (15%), Positives = 72/245 (29%), Gaps = 31/245 (12%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ L +S N + +++ L+ L L IS N +I
Sbjct: 14 HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHN--------------RI 57
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
Q L + L L +S K + + +NLK L L+
Sbjct: 58 QYLD----------ISVFKFNQELEYLDLSHNKLVKISCHPT--VNLKHLDLSFNAFD-A 104
Query: 298 IPD--YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
+P G+M++LK + LS +L L + + + G
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164
Query: 356 NVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYT 415
+ + T + I S+ + L+ + +
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
Query: 416 LHINC 420
L +N
Sbjct: 225 LTLNN 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ +G G G V + +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ H N++ L E + +V E M N L + I +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHER 128
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+ + G+ +LH I+HRD+K SN+++ D KI DFGLA+ +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
T T Y APE + D++S G + E++ G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 50/286 (17%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P +L LDL N +T G F +L L L
Sbjct: 30 QCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFK----NLKNLHTLI 82
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S P + L+ L + N +P + LQ+L + N T +
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKS 139
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
L + + + N ++ I+ + +G + L+ +R
Sbjct: 140 VFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSYIR 177
Query: 266 ISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGG 321
I+D + + P +L L L I ++ + L + LSFN+++
Sbjct: 178 IADTNITTIPQGLPP-----SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
+ ++L NKL VP + + + V + NN +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 43/249 (17%), Positives = 84/249 (33%), Gaps = 33/249 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L++L LS+N L L EL V N ++ V + +
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPK------TLQELRVHENEITKVRKSVFNGLNQMIV 149
Query: 168 LSIEGN-LFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ + N L + I + + L + ++ + T +P L +L +L + N +
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205
Query: 226 KIPE--FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
K+ G + KL + +S+ S++ L +L +++ L
Sbjct: 206 KVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH-- 262
Query: 282 MNLKTLILTKCLIHGEIPD-------YIGDMTKLKNIDLSFNNLTGGI--PTTFEKLAKT 332
++ + L I I Y + L N + P+TF +
Sbjct: 263 KYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 333 NFMYLTGNK 341
+ L K
Sbjct: 322 AAVQLGNYK 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 647 GGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY---KGILSD-GTV 702
GG +L+T T K NF+ +G G +G V+ K D G +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 703 IAVKQLSSKSRQGNREFV------NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756
A+K L + + ++ + +Q P LV L+ +L L+ +Y+
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYIN- 142
Query: 757 NCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IARGLAYLHEDSRIKIVHRDIKTS 809
G + R +I +G I L +LH+ + I++RDIK
Sbjct: 143 --------GGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHK---LGIIYRDIKLE 188
Query: 810 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYS 866
N+LLD + + ++DFGL+K + D+T + GTI YMAP+ G+ + D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWS 247
Query: 867 FGVVTLEIVSGKS 879
GV+ E+++G S
Sbjct: 248 LGVLMYELLTGAS 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 85.3 bits (210), Expect = 6e-18
Identities = 45/236 (19%), Positives = 71/236 (30%), Gaps = 48/236 (20%)
Query: 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--------SSKSR 713
Q G T K+GEG FG V++ I D T +A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 714 QGNREFVNEIGM---------ISAQQHPNLVKLYGC-CVEGN---QLLLVYEYMKNNCLS 760
+ E + EI + + + L CV+G+ LL +++ + S
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 761 ----RAIFGKDTEYRL----------------KLDWPTRKKICIGIARGLAYLHEDSRIK 800
F D + + T K I + LA ++
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
HRD+ NVLL K K+ K I Y G
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERDG 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKSRQGNREFVN---------EI 723
+ + + G +G+V G+ S+G +A+K++ + + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 724 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+++ HPN++ L V ++L LV E M+ + L++ I D +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI--HDQRIVISPQ--- 134
Query: 779 RKKICI-GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-- 835
+ + I GL LHE +VHRD+ N+LL + + I DF LA+ D
Sbjct: 135 HIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 836 -HISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+++ R Y APE +G+ T D++S G V E+ + K
Sbjct: 192 HYVTHRW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 55/274 (20%), Positives = 84/274 (30%), Gaps = 60/274 (21%)
Query: 84 TCDCSSAT--CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWA 137
+ T C N +P L K LDLS N L SF
Sbjct: 4 VEVVPNITYQCM-------ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFF---- 49
Query: 138 SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILS 195
S +L L + + +++ L L + GN S+ L +LQKL+
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108
Query: 196 SNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
+ L L L +L ++ N IQ +P
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHN--------------LIQSF---------KLPEY 144
Query: 255 ISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH---GEIPDYIGDMT 306
S LT+L L +I + + L + L L+ L I
Sbjct: 145 FSNLTNLEHLDLSSNKIQSI--YCTDLRVLH--QMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+LK + L N L F++L ++L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 36/218 (16%), Positives = 70/218 (32%), Gaps = 63/218 (28%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
N+ + KNL + N + LQ L LS + L++L+ L
Sbjct: 24 DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
++ N + SL + AF
Sbjct: 82 ILTGNP-----------------------------------IQSL----------ALGAF 96
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNF 334
L +L+ L+ + + + ++ G + LK ++++ N + +P F L
Sbjct: 97 SGL--SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 335 MYLTGNKLTGPVPKYIFNS-------NKNVDISLNNFT 365
+ L+ NK+ + N ++D+SLN
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 672 KAATNNFDPANKVGEGGFGSVY---KGILSD-GTVIAVKQLSSKSRQGNREFV----NEI 723
K F+ +G+GG+G V+ K ++ G + A+K L N + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWP 777
++ +HP +V L G +L L+ EY+ G + E D
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLS---------GGELFMQLEREGIFMED-- 121
Query: 778 TRKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDK 834
+ I+ L +LH+ I++RD+K N++L+ + K++DFGL K +++
Sbjct: 122 -TACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 835 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
TH T GTI YMAPE MR G+ D +S G + ++++G
Sbjct: 178 TH--T-FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAP 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 19/202 (9%), Positives = 48/202 (23%), Gaps = 46/202 (22%)
Query: 683 KVGEGGFGSVYKGILSD---GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 736
G ++ + D +A+ + +E ++ +S P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ L+V E+++ L + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAH-- 146
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 856
R + S V + D + ++ M
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA----- 179
Query: 857 YLTSKADVYSFGVVTLEIVSGK 878
+ D+ G ++ +
Sbjct: 180 --NPQDDIRGIGASLYALLVNR 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREF---VNEIG 724
+ N F+ +G+G FG V K G A+K L + E + E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 780
++ +HP L L ++L V EY G + + L +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYAN---------GGELFFHLSRERVFSEDRAR 251
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
I L YLH S +V+RD+K N++LDKD + KI+DFGL K +D + T
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
GT Y+APE D + GVV E++ G+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVN---EIG 724
KA + F+ +G+G FG V+ + A+K L K+ R+ V E
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERD 78
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPT 778
++ HP +VKL+ +L L+ ++++ G D E +
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLR---------GGDLFTRLSKEVMFTEE--- 126
Query: 779 RKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKT 835
K + +A L +LH + I++RD+K N+LLD++ + K++DFGL+K + E K
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 836 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
+ + GT+ YMAPE R G+ T AD +SFGV+ E+++G
Sbjct: 184 Y--S-FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTL 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ +G G G V +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ H N++ L E + LV E M N L + I +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHER 165
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+ + G+ +LH S I+HRD+K SN+++ D KI DFGLA+ +
Sbjct: 166 MSYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 220
Query: 839 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
T T Y APE + D++S G + E+V K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ VG G +G+V + G +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ +H N++ L + LV +M + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM------KHEKLGEDR 129
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HI 837
+ + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 838 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
TR Y APE Y T D++S G + E+++GK
Sbjct: 187 VTRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEI 723
A + FD +G G FG V K G A+K L K + + + NE
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILD-KQKVVKLKQIEHTLNEK 92
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTR 779
++ A P LVKL + + L +V EY+ + L R G+ +E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPH-------- 142
Query: 780 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+ I YLH + +++RD+K N+L+D+ +++DFG AK + +T
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW-- 196
Query: 839 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKS 879
T + GT +APE + +GY + D ++ GV+ E+ +G
Sbjct: 197 T-LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYP 236
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 27/166 (16%), Positives = 64/166 (38%), Gaps = 6/166 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +++ L + L+ +T + + + +L++ + P ++ +
Sbjct: 31 GQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNYNP--ISGL 87
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ L+ L I G T P++ L +L L +S ++ + ++ L +N + +S N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
I + +++ L+IQ + I L L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 20/168 (11%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +L +++ T + I N++ L +++ T P ++ L+NL LRI
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL------RISDLKGSE 273
+ + + + L I S+ + I I+ L + + I+D+
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-- 154
Query: 274 SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
L + LK+L + +H I D KL + + G
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 33/163 (20%)
Query: 181 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240
PD +L +S A++ LT + +++ N +
Sbjct: 18 PD-STFKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT---------------- 57
Query: 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIP 299
L G I ++ DL I+++ + + L NL+ L + + +
Sbjct: 58 -----DLTG-----IEYAHNIKDLTINNIHATNYNPISGLS--NLERLRIMGKDVTSDKI 105
Query: 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ +T L +D+S + I T L K N + L+ N
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 18/257 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 17 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 73
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 74 GNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 127
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 128 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 182
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I + + L ++L L N + T L P
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 350 IFNSNKNVDISLNNFTW 366
+ ++ + +
Sbjct: 241 DDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 47/300 (15%), Positives = 103/300 (34%), Gaps = 19/300 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ LK +++T + ++L + Q+ + + + S + +L + GN+L+
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P LTN+ L L ++ N + ++ L L+ L L N + ++ L L
Sbjct: 79 DIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + +N + + + K+ L ++ + + I L LT L+ L +
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKN 185
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
S L + NL L L + ++ ++ + + +L +
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGD 244
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+IF + + F + P++ V+
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 44/275 (16%), Positives = 83/275 (30%), Gaps = 17/275 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
L L L+ L L N +T + +L LS+ N++S P L +T L+NL +
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 183
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N + + + L NL L L S + + L N ++ +D + PE I
Sbjct: 184 KNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 239
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+K +++ E S + I K + T+
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVS---FIFYQPVTIGKAKARFHGRVTQPLKEVYTVS--- 293
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
++ + ++ F+ N T + F
Sbjct: 294 ----YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDF 349
Query: 352 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYS 386
T + ++ RG+ + +
Sbjct: 350 TLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPR 384
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 44/224 (19%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ + VG G +GSV + G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWP 777
++ +H N++ L E N + LV M + L+ + + T+ ++
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF--- 136
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-H 836
+ I RGL Y+H S I+HRD+K SN+ +++D KI DFGLA+ ++ T +
Sbjct: 137 ----LIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 837 ISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
++TR Y APE Y D++S G + E+++G+
Sbjct: 190 VATRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 672 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 725
+ +F+ +G+G FG V KG + AVK L K + V +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILK-KDVVIQDDDVECTMVEK 392
Query: 726 ---ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPT 778
+ P L +L+ C ++L V EY+ G D Y + + P
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPH 443
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
IA GL +L I++RD+K NV+LD + + KI+DFG+ K +++ T
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499
Query: 837 ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
T GT Y+APE Y D ++FGV+ E+++G++
Sbjct: 500 -KT-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 540
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFV-NEIG 724
K + +F +G G FG V+ + +G A+K L + R E +E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRK 780
M+S HP +++++G + Q+ ++ +Y++ + L ++ + K
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKF------ 110
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+ L YLH I++RD+K N+LLDK+ + KI+DFG AK Y D T+ T
Sbjct: 111 -YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY--T- 162
Query: 841 IAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSG 877
+ GT Y+APE Y S D +SFG++ E+++G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAG 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 50/239 (20%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 719
L++++ ++F+ +G G F V K G V A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLD 775
E ++ + +L+ + N L LV EY LS+ R+ +
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF------GERIPAE 162
Query: 776 WPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
AR + +H + VHRDIK N+LLD+ + +++DFG
Sbjct: 163 M----------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVY-------SFGVVTLEIVSGKS 879
D T S GT Y++PE Y + GV E+ G++
Sbjct: 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 41/232 (17%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 719
+R ++ +++ +G G FG V K V A+K LS K R F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFF 116
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
E +++ P +V+L+ + L +V EYM G D +
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMS-----N 162
Query: 780 KKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
+ AR L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 832 EDKTHISTRIAGTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
++ GT Y++PE GY + D +S GV E++ G +
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 50/219 (22%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 735
+G+G FG V K + AVK L K+ +E + + ++ +HP LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 736 KLYGCCVEGNQLLLVYEYM----------KNNCLS--RAIFGKDTEYRLKLDWPTRKKIC 783
L+ ++L V +Y+ + C RA F Y
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----Y------------A 145
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 841
IA L YLH + IV+RD+K N+LLD + ++DFGL K + T ST
Sbjct: 146 AEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-F 199
Query: 842 AGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
GT Y+APE + Y D + G V E++ G
Sbjct: 200 CGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 68/227 (29%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 724
QIK +F +G+G FG V +K A+K L K + V
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALK-KDVVLMDDDVECTM 65
Query: 725 M-----ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLD 775
+ A +HP L ++ L V EY+ G D Y + K D
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFD 116
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEED 833
I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K + +
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
KT +T GT Y+APE + Y D +SFGV+ E++ G+S
Sbjct: 174 KT--NT-FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQS 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 63/223 (28%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 672 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVN----EI 723
K N+FD +G+G FG V K G A+K L K ++ V E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILR-KEVIIAKDEVAHTVTES 56
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTR 779
++ +HP L L ++L V EY G + + L
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN---------GGELFFHLSRERVFTEERA 107
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHI 837
+ I L YLH +V+RDIK N++LDKD + KI+DFGL K + +
Sbjct: 108 RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-- 162
Query: 838 STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
T GT Y+APE Y D + GVV E++ G+
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 50/201 (24%), Positives = 71/201 (35%), Gaps = 53/201 (26%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 82
Query: 742 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL+V E + L I + TE R+ +I I + YL
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 133
Query: 794 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
H I I HRD+K N+L K NA K++DFG A
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AK 168
Query: 851 EYAMRGYLTSKADVYSFGVVT 871
E Y D++S GV+
Sbjct: 169 ETTGEKY-DKSCDMWSLGVIM 188
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+ + +GEG +G V + +A+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 732 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 785
N++ + + + +V + M+ + L + + + + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICY-------FLYQ 136
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAG 843
I RGL Y+H + ++HRD+K SN+LL+ + KI DFGLA++ + D H T
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 844 TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 878
T Y APE + +GY T D++S G + E++S +
Sbjct: 194 TRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 50/235 (21%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 734
+G G + V K + A+K + K + E ++ + A HP L
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 787
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 73 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 120
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 845
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T T GT
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTP 174
Query: 846 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 891
Y+APE Y D ++ GV+ E+++G+S + + ED+++
Sbjct: 175 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 734
+G G + V K + A++ + K + E ++ + A HP L
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 787
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 116 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 845
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T GT
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTP 217
Query: 846 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 891
Y+APE Y D ++ GV+ E+++G+S + + ED+++
Sbjct: 218 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-----ISAQQHPNL 734
+G+G FG V K G + AVK L K + V A+ HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGL 790
+L+ C ++L V E++ G D + + + D + I L
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVN---------GGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 848
+LH+ I++RD+K NVLLD + + K++DFG+ K + T +T GT Y+
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYI 191
Query: 849 APEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
APE Y D ++ GV+ E++ G +
Sbjct: 192 APEILQEMLY-GPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 684 VGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 735
+G+G FG V KG + AVK L + + + + + P L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLA 791
+L+ C ++L V EY+ G D Y + + P IA GL
Sbjct: 85 QLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 849
+L I++RD+K NV+LD + + KI+DFG+ K +++ T T GT Y+A
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIA 189
Query: 850 PEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
PE Y D ++FGV+ E+++G++
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS-KSRQGNREFVNEIGMISA---- 728
+++ K+G G + V++ I +++ + VK L K ++ RE I
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 729 QQHPNLVKLYGCCV---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ PN++ L V LV+E++ NN + ++ T+Y ++
Sbjct: 88 RGGPNIITLA-DIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIR-------FYMYE 138
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGT 844
I + L Y H S I+HRD+K NV++D + ++ D+GLA+ Y + + + R+A +
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-S 193
Query: 845 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ PE + Y S D++S G + ++ K
Sbjct: 194 RYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRK 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 44/254 (17%), Positives = 88/254 (34%), Gaps = 18/254 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 20 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 77 GNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 131 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I ++ + + L ++L L N + T L P
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
Query: 350 IFNSNKNVDISLNN 363
+ ++ +
Sbjct: 244 DDGDYEKPNVKWHL 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 64/272 (23%), Positives = 99/272 (36%), Gaps = 38/272 (13%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS+ + +T +P++L R +L L G+FS
Sbjct: 7 CHCSNRVFL-----CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFS----GFG 54
Query: 140 QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIE-GNLFTGSIPPDI-RKLINLQKLILSS 196
L ++ + N L V +N+ L + IE N I P+ + L NLQ L++S+
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN 113
Query: 197 NSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA 253
LP L I DN I F+G + L + + ++ I
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHN 171
Query: 254 SISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKL 308
S T L +L +SD F L +++ IH +P Y ++ KL
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGAS--GPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+ S NL +P T EKL LT
Sbjct: 229 RA--RSTYNLK-KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 32/213 (15%), Positives = 62/213 (29%), Gaps = 37/213 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISD 220
L I +L+K+ +S N + A+ + L L+++RI
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFP 277
N + ++ P + L +L L IS+ +K +
Sbjct: 89 AN-------------NLLYIN----------PEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
+ L + + I G + + L+ N + + F
Sbjct: 126 HS--LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183
Query: 336 YLTGNKLTGPVPKYIF---NSNKNVDISLNNFT 365
N L +P +F + +DIS
Sbjct: 184 LSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ + +G GG G V+ + +D +A+K++ Q + + EI +I H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 734 LVKLY--------------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPT 778
+VK++ G E N + +V EYM+ + L+ + E +L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL---- 124
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHI 837
+ RGL Y+H + ++HRD+K +N+ ++ +DL KI DFGLA++ + +H
Sbjct: 125 ---FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 838 S--TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ T Y +P + Y T D+++ G + E+++GK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+++F + +GEG +G V G ++A+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 732 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 785
N++ ++ N++ ++ E M+ + L R I + ++ ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQY-------FIYQ 120
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
R + LH + ++HRD+K SN+L++ + + K+ DFGLA++ +E S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 846 G---------YMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 878
G Y APE Y + DV+S G + E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 9/173 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L L L L QL+L R LT L L + N+L P +
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLL 95
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+ L L + N T S+P R L LQ+L L N LP L T L L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 217 RISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+++NN + ++P + + + L +Q +SL IP L +
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 17/195 (8%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++PPD+ + L LS N A L T L L + + K+ G +
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKC 292
L + + L+ +P L +LT L R++ L A L L+ L L
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSL--PLGALRGLG--ELQELYLKGN 134
Query: 293 LIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P + KL+ + L+ NNLT L + + L N L +PK F
Sbjct: 135 ELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192
Query: 352 NSNKNVDISLNNFTW 366
S+ L+ W
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 35/249 (14%), Positives = 75/249 (30%), Gaps = 29/249 (11%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
+ + + N ++ + + L+ L +E I + R L +L L L N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 200 TGELPAE-LTKLTNLNDLRISDNNF-SGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI- 255
+L L NL L ++ N + ++ L ++ ++++ PAS
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 256 SALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 310
+ L ++ + E + L L + +
Sbjct: 151 LNMRRFHVLDLTFNKVKSIC--EEDLLNFQGKHFTLLRL----------------SSITL 192
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
D++ L K + L+GN + K F++ I + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 371 PIECPRGSV 379
+
Sbjct: 253 GSSFGHTNF 261
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 54/293 (18%)
Query: 114 KLRYLKQLDLSRNCLT-----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTL--- 165
L L+ L L N + F +++L+ N++ + L N
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLN-MRRFHVLDLT--FNKVKSICEEDLLNFQGKHFT 183
Query: 166 -------KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR- 217
+ + K ++ L LS N F + ++
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 218 ------------ISDNNFSGKIPE--FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSL 261
NF F G + ++ + S + + S+ S T L
Sbjct: 244 LILSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDL 301
Query: 262 TDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSF 315
L I+ + ++AF L +L L L++ + G I + + + KL+ +DLS+
Sbjct: 302 EQLTLAQNEINKI--DDNAFWGLT--HLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSY 356
Query: 316 NNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
N++ + +F L + L N+L VP IF+ + + + N +
Sbjct: 357 NHIRA-LGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 40/280 (14%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLTGSFSPQ--WASL-QLVELSVMGNRLSGPFPK-VLTN 161
L T + L L+ L L++ L G+ + L L L + N + P N
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-----------RKLINLQKLILSSNSFTGELPAELTKL 210
+ L + N SI + +L ++ ++ E K
Sbjct: 153 MRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKL--------HIQGSSLEGPIPASISALT--- 259
T++ L +S N F + + K+ + GSS T
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 260 -SLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNI 311
+ ++ DL +S F +L+ L L + I+ +I D +T L +
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFT--DLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+LS N L FE L K + L+ N + + F
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 35/258 (13%), Positives = 78/258 (30%), Gaps = 46/258 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISD 220
+ + + N + +L +LQ L + + + L++L L++
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS---ESA 275
N + +L + + L +L L ++ L G+ +
Sbjct: 89 N--------------QFLQLE----------TGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
F L +L+ L+L I P M + +DL+FN + +F
Sbjct: 125 FKPLT--SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182
Query: 335 --MYLTGNKLT-------GPVPKYIFNSNKNVDI-SLNNFTWESSDPIECPRGSVNLVES 384
+ L+ L G N ++ L+ ++ S + ++ +
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES-MAKRFFDAIAGTKI 241
Query: 385 YSSPRNKLDKVHPCLRQN 402
S + +
Sbjct: 242 QSLILSNSYNMGSSFGHT 259
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 43/260 (16%), Positives = 80/260 (30%), Gaps = 37/260 (14%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-----------NRLSGPFPKVLTN 161
+R LDL+ N + + Q +++ L
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI-------------LSSNSFTGELPAELT 208
T++ L + GN F S+ I K+ +F
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 209 KL--TNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI-SALTSLTDL 264
L + + +S + + + + +++L + + + I + LT L L
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 265 RISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTG 320
+S L F LD L+ L L+ I + D + LK + L N L
Sbjct: 329 NLSQNFLGSIDSRMFENLD--KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS 385
Query: 321 GIPTTFEKLAKTNFMYLTGN 340
F++L ++L N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 16/129 (12%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFP 156
L ++ + + L L L++N + +F L L++L++ N L
Sbjct: 288 FALLKSVFSHFTDLEQL---TLAQNEINKIDDNAF----WGLTHLLKLNLSQNFLGSIDS 340
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
++ N+ L+ L + N ++ L NL++L L +N +P +LT+L
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398
Query: 215 DLRISDNNF 223
+ + N +
Sbjct: 399 KIWLHTNPW 407
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 38/181 (20%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ ++ + +G G +G V + + V+A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 725 MISAQQHPNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+++ H ++VK+ + ++L +V E ++ + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF---RTPVYLTEL--HI 158
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
K + + G+ Y+H I+HRD+K +N L+++D + K+ DFGLA+ + + S
Sbjct: 159 KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 840 R 840
Sbjct: 216 L 216
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 48/302 (15%), Positives = 97/302 (32%), Gaps = 22/302 (7%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
N V+ + +D+ + ++ + L+ T +L +
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271
Query: 115 L---RYLKQLDLSRNCLTGSF---SPQWASLQLVELSVM---GNRLSGPFPKVLTNITTL 165
R ++ L++ +T ++ L L + + + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 166 K--NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
LSI F + P + L + N FT + + L L L + N
Sbjct: 332 NIKMLSISDTPFIHMVCPPS--PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSL----EGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ K + L SL + + S+ L +S + S F L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLT 338
+K L L I IP + + L+ ++++ N L +P F++L +++L
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 339 GN 340
N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 41/257 (15%), Positives = 95/257 (36%), Gaps = 17/257 (6%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-----FPKVLTNITTLKNLSIEG 172
L+ ++ + C F W + L++ ++ F T + +L ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232
+F S + +LS + ++ L + N F+ + +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 233 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG---SESAFPKL--DKMNLKTL 287
K++Q L +Q + L+ +++ L D+ + A+ + ++ L
Sbjct: 375 TLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
L+ ++ G + + K+K +DL N + IP L + + N+L VP
Sbjct: 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VP 489
Query: 348 KYIFNSNKNV-DISLNN 363
+F+ ++ I L++
Sbjct: 490 DGVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 35/191 (18%), Positives = 64/191 (33%), Gaps = 10/191 (5%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLN 214
V ++ K LS+ N + + DI L L+ L LS N L + +L
Sbjct: 46 VPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSE 273
L +S N I ++ L + + + P+ LT LT L +S K +
Sbjct: 104 YLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 274 SAFPKLDKMNLKTLIL-TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+ ++L ++L + + L F+ + +
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 333 NFMYLTGNKLT 343
+ L+ KL
Sbjct: 221 GHLQLSNIKLN 231
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 52/333 (15%), Positives = 107/333 (32%), Gaps = 39/333 (11%)
Query: 80 ESNVTCDCSSATCHVV--TIALKAQNL-------TGTLPTELSKLRYLKQLDLSRNCLT- 129
E D S+ V + + + L + ++S L L+ L LS N +
Sbjct: 31 ELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 130 ---GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP--DIR 184
F L L V NRL + + L++L + N F +P +
Sbjct: 91 LDFHVFLFNQ---DLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFD-VLPVCKEFG 143
Query: 185 KLINLQKLILSSNSFTGELPAELTKL-TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
L L L LS+ F + L + L + + G E + LH+
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLV 202
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM------NLKTLILTKCLIHGE 297
++ +L L++S++K ++ +L L +T I
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 298 IPDYIGDM-----TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV----PK 348
+ ++ +++ +T I ++T L + V +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 349 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
+++ ++I + + + + CP +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 112 LSKLRYLKQLDLSRNCLT-GSFSP--QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+ L+ LD+S N L ++ WA ++ L++ N L+G + L +K L
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAE-SILVLNLSSNMLTGSVFRCLP--PKVKVL 455
Query: 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
+ N SIP D+ L LQ+L ++SN +P +LT+L + + DN +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 35/233 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L ++ L +N+ + + + ++ + L + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L +L L L I + ++ P + +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNT--------------GLKMF---------PDLTKVYST 129
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
L I+D +AF L TL L + Y + TKL + L+
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 315 FNNLTGGIPT-TFEKLAKT-NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
N I F + + + ++ +T +P K + I+ N +T
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKEL-IARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 43/195 (22%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+PP + Q L L +P+ + L N++ + +S +
Sbjct: 28 SLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV-------------T 67
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKC 292
+Q+L S L+ +T + I + + A +L LK L +
Sbjct: 68 LQQLE----------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP--LLKFLGIFNT 115
Query: 293 LIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPT-TFEKLAK-TNFMYLTGNKLTGPVPK 348
+ PD + ++++ N IP F+ L T + L N T V
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQG 173
Query: 349 YIFNSNKNVDISLNN 363
Y FN K + LN
Sbjct: 174 YAFNGTKLDAVYLNK 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+N+ + +G G +G VY + +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 725 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWP 777
+++ + +++LY + + ++L +V E ++ L + TE +K
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKT--- 133
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTH 836
I + G ++HE I+HRD+K +N LL++D + K+ DFGLA + E T+
Sbjct: 134 ----ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 837 ISTRIAGTIGYMAPEYAMRGYLT 859
I + ++ LT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLT 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 32/199 (16%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
++ K+G+G +G V+K I G V+AVK++ F N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 725 MISA-QQHPNLVKLYGCCV--EGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK 780
+++ H N+V L + LV++YM+ + L I +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQY------ 113
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+ + + + YLH S ++HRD+K SN+LL+ + + K++DFGL++ + + +
Sbjct: 114 -VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 841 IAGTIGYMAPEYAMRGYLT 859
+ LT
Sbjct: 170 PLSINENTENFDDDQPILT 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNRE-----FVNEIGMI--SAQQH 731
K+G G F +V+ + + T +A+K + E VN+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 732 PNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+++KL G +++V+E + N L+ K E+R + K+I +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLL 141
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLD------KDLNAKISDFGLAKLYEEDKT-HISTR 840
GL Y+H R I+H DIK NVL++ + KI+D G A Y+E T I TR
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y +PE + AD++S + E+++G
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+NI K L ++ N + S+P +L L+ L L+ N LPA + +L NL L
Sbjct: 33 SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG-S 272
++DN K+Q L P + L +L +LR+ LK
Sbjct: 91 WVTDN--------------KLQAL-----------PIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAK 331
F L L L L + +P + D +T LK + L N L F+KL +
Sbjct: 126 PRVFDSL--TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFTW 366
+ L N+L VP+ F+S + + + L W
Sbjct: 183 LKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPW 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ +L L+ L L+ N L G F L L L V N+L
Sbjct: 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK----ELKNLETLWVTDNKLQALPIG 103
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + L L ++ N S+PP + L L L L N LP + KLT+L +
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 216 LRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 268
LR+ +N ++PE K +++ L + + L+ +P +L L L++ +
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQE 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 48/192 (25%), Positives = 70/192 (36%), Gaps = 35/192 (18%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
NF K+G G FG + G L +A+K KSR +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA---- 787
++Y G +V E + G E D R K + IA
Sbjct: 68 PQVYYFGPCGKYNAMVLELL----------GPSLED--LFDLCDRTFSLKTVLMIAIQLI 115
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR 840
+ Y+H + +++RD+K N L+ + N I DF LAK Y + +T HI R
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 841 ----IAGTIGYM 848
+ GT YM
Sbjct: 173 EHKSLTGTARYM 184
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 31/182 (17%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 740
K+G G FG +Y G ++ G +A+K K++ E + Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 795
EG+ ++V E + G E K T + + + Y+H
Sbjct: 74 GAEGDYNVMVMELL----------GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 846
+ +HRD+K N L+ I DFGLAK Y + +T HI R + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 847 YM 848
Y
Sbjct: 181 YA 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 27/203 (13%), Positives = 63/203 (31%), Gaps = 39/203 (19%)
Query: 676 NNFDPANKVGEGGFGSVYKGI---------LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
+ + G +Y+ ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI----FGKDTEYRLKLDWPTRKK- 781
Q KLY + + + + R + G+ + LD +
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHVL 156
Query: 782 -----ICIG---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYE 831
+ + + L +LHE+ VH ++ N+ +D + +++ + +G A Y
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 832 EDKTHISTR------IAGTIGYM 848
H++ G + ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 35/185 (18%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++GEG FG +++G L + +A+K +S + +Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFG 75
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA----RGLAYLH 794
EG +LV + + G E LD RK K A + +H
Sbjct: 76 QEGLHNVLVIDLL----------GPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR----IAG 843
E S +V+RDIK N L+ + + + DFG+ K Y + T HI R ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 844 TIGYM 848
T YM
Sbjct: 181 TARYM 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 740
K+G G FG +Y G + +A+K + K++ + + + E + Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 795
VEG+ +LV + + G E KL T + + + ++H
Sbjct: 72 GVEGDYNVLVMDLL----------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 846
S +HRDIK N L+ A I DFGLAK Y + T HI R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 847 YMAPEYAMRGYLTS-KADVYSFGVVTLEIVSGK 878
Y A G S + D+ S G V + + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/259 (15%), Positives = 83/259 (32%), Gaps = 20/259 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
L + +L + +T Q + + + + + T LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ N + + P ++ L L++L ++ N L+ L + +N +
Sbjct: 70 LSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TD 122
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTL 287
+ K ++ L I+ + L+ SI L L+ L + DL G+E + L ++ + +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWI 177
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PV 346
LT E Y ++ + P +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDE 235
Query: 347 PKYIFNSNKNVDISLNNFT 365
Y F+ NV + F
Sbjct: 236 VSYKFSEYINVGETEAIFD 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 37/198 (18%), Positives = 68/198 (34%), Gaps = 43/198 (21%)
Query: 683 KVGEGGFGSVYKGILSDGTVI------AVKQLSSKSRQ-----------GNREFVNEIGM 725
+G+GGFG +Y ++ + VK S + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK----- 780
++ + K +G + + FG D + + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQK--IYEANAKRFSRKT 153
Query: 781 --KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKT- 835
++ + I L Y+HE VH DIK SN+LL+ ++ D+GLA Y +
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 836 -HISTR----IAGTIGYM 848
+ GTI +
Sbjct: 211 KAYAADPKRCHDGTIEFT 228
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 32/142 (22%), Positives = 50/142 (35%), Gaps = 16/142 (11%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
++L L L LS N L +F + L L + N L + +++ L+
Sbjct: 60 PTRLTNLHSLLLSHNHLNFISSEAFV----PVPNLRYLDLSSNHLHTLDEFLFSDLQALE 115
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE----LTKLTNLNDLRISDN 221
L + N + + + LQKL LS N + P E KL L L +S N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173
Query: 222 NFSGKIPEFIGKWKKIQKLHIQ 243
+ K K +
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 43/198 (21%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWK 235
++P + L LS N+ + L AE T+LTNL+ L +S N
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN-------------- 74
Query: 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKC 292
+ + + + +L L +S L E F L L+ L+L
Sbjct: 75 HLNFIS----------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL--QALEVLLLYNN 122
Query: 293 LIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I + DM +L+ + LS N ++ KL K + L+ NKL +P
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPL 180
Query: 349 YIFN---SNKNVDISLNN 363
+ + L+N
Sbjct: 181 TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 16/123 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L+ LDLS N L FS L L L + N + ++ L+
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEFLFS----DLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139
Query: 167 NLSIEGNLFTGSIPPDI----RKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISD 220
L + N + P ++ KL L L LSSN +L KL N L + +
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 221 NNF 223
N
Sbjct: 199 NPL 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHP---NLVK 736
+G+G FG V K +A+K + ++ R Q E + + + Q N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTMNVIH 163
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ N + + +E + N K +++ P +K I + L LH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYE---LIKKNKFQ-GFSLPLVRKFAHSILQCLDALH-- 217
Query: 797 SRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEY 852
+ +I+H D+K N+LL K+ DFG + YE + T+I +R Y APE
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQRVYTYIQSRF-----YRAPEV 270
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
+ D++S G + E+++G
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 75/260 (28%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----SAQQHPN--- 733
K+G G F +V+ + +A+K + S ++EI ++ S PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 734 LVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V+L V G + +V+E + ++ L + + Y+ L P KKI + +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQG-LPLPCVKKIIQQVLQG 158
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL------------------------------------ 813
L YLH ++ +I+H DIK N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 814 -------------DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLT 859
+ L KI+D G A + T I TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 860 SKADVYSFGVVTLEIVSGKS 879
+ AD++S + E+ +G
Sbjct: 272 TPADIWSTACMAFELATGDY 291
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 25/160 (15%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C CS+ C + I L+ + P S + L+++DLS N +
Sbjct: 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68
Query: 129 T----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI- 183
+ +F L L + GN+++ + + +L+ L + N + D
Sbjct: 69 SELAPDAFQGL---RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ L NL L L N + L + + ++ N F
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 62/247 (25%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ + ++ L N+ P + L + +S+N +I
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QI 68
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+L + AF L +L +L+L I E
Sbjct: 69 SEL-------------------------------APDAFQGL--RSLNSLVLYGNKIT-E 94
Query: 298 IPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
+P + + + L+ + L+ N + + F+ L N + L NKL + K F+ +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLR 152
Query: 356 NV-DISLNNFTWES-------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + L + +D + + S R ++ + F CSA
Sbjct: 153 AIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKFRCSA 212
Query: 408 PADQYHY 414
A +H+
Sbjct: 213 AAHHHHH 219
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 41/193 (21%), Positives = 60/193 (31%), Gaps = 60/193 (31%)
Query: 157 KVLTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
K LT I T+ + +E N IPP L+++ LS+N + EL +
Sbjct: 21 KGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78
Query: 210 LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 268
L +LN L + N KI +L P S+ L SL L
Sbjct: 79 LRSLNSLVLYGN--------------KITEL-----------PKSLFEGLFSLQLL---- 109
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFE 327
L+ + + + L + L N L TF
Sbjct: 110 ---------LLNANKINC-----------LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 328 KLAKTNFMYLTGN 340
L M+L N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/193 (18%), Positives = 65/193 (33%), Gaps = 36/193 (18%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--------------GNREFVNEIGMIS 727
K+G GGFG +Y + A + + ++ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
+ + YG G Y + G D + T ++
Sbjct: 104 QLDYLGIPLFYGS---GLTEFKGRSY---RFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKTHI---- 837
I + L Y+HE+ VH DIK +N+LL ++ +D+GL+ Y + H
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 838 --STRIAGTIGYM 848
GTI +
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 84/565 (14%), Positives = 171/565 (30%), Gaps = 170/565 (30%)
Query: 35 KLH---AEEVKALKQIGRKLGKKDWNF--GVDPCSQKGNWELSSD---DKK---GFESNV 83
K + + L+Q +L GV G ++ D K + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKI 184
Query: 84 ------TCDCSSAT-------CHVVTIALKAQ-NLTGTLPTEL----SKLRYLKQLDLSR 125
C+ + + ++ + + + + ++LR L +
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFP---KVLTNITTLKNLSIEGNLFTGSIPPD 182
NCL LV L+V + F K+L +TT + + T +
Sbjct: 245 NCL------------LVLLNVQNAKAWNAFNLSCKIL--LTT-RFKQV-----TDFLSAA 284
Query: 183 IRKLINLQKL-----------ILSS--NSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
I+L +L + +LP E+ N R+S + I +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT---NPRRLS--IIAESIRD 339
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR--ISDLKGSESAFPKLDKMNLKTL 287
+ W + H+ L I +S++ L + R L S FP + L
Sbjct: 340 GLATWDNWK--HVNCDKLTTIIESSLNVLEP-AEYRKMFDRL----SVFPPSAHIPTILL 392
Query: 288 -ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346
++ +I ++ + + K ++ T IP+ +YL +L +
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS----------IYL---ELKVKL 439
Query: 347 PKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 406
+ +L+ ++V+ Y+ P+ +
Sbjct: 440 EN---------EYALHR----------------SIVDHYNIPK--------TFDSDDLIP 466
Query: 407 APADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF---Y-----------SSGQYWA 452
DQY Y+ HI GH + R ++F + W
Sbjct: 467 PYLDQYFYS-HI---------GHHLKNIEHPER-MTLFRMVFLDFRFLEQKIRHDSTAW- 514
Query: 453 FSSTGKFMDDDTDLDNY---IRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGN 509
+++G ++ L Y I N ++ + + L L
Sbjct: 515 -NASGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDF---------LPKIEENLICSK 563
Query: 510 YTVRLHFAEIIFKNDSTFNSLGKRI 534
YT L A ++ ++++ F K++
Sbjct: 564 YTDLLRIA-LMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 57/341 (16%), Positives = 98/341 (28%), Gaps = 103/341 (30%)
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS-----HTLKI--------HL 578
K I ++ +F+ +D V++ P + S H + L
Sbjct: 19 KDILSVFEDA--FVDNFDCKD---------VQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 579 YWA--GRGTTGI------PLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASV 630
+W + + LR Y L+S I + +P S + I +
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QP----SMMTRMYIEQRDRLYND 122
Query: 631 LLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV---GEG 687
V + R + L L+ L LR PA V G
Sbjct: 123 NQVFAKYNVSRLQ-----PY--------LKLRQALLELR----------PAKNVLIDGVL 159
Query: 688 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747
G G K T +A+ S Q + +I ++ C +
Sbjct: 160 GSG---K------TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETV 198
Query: 748 L-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
L L+Y+ N SR+ + + R+ R L +V
Sbjct: 199 LEMLQKLLYQIDPNWT-SRSDHSSNIKLRIH-SIQAEL-------RRLLKSKPYENCLLV 249
Query: 803 HRDIKTSNVLLDKDLNAKI----SDFGLA-KLYEEDKTHIS 838
+++ + +L+ KI + L THIS
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 26/161 (16%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPT-ELSKLRYLKQLDLSRNC 127
C C T C + L T T KL L++++ S N
Sbjct: 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 128 LT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+T G+F + E+ + NRL K+ + +LK L + N T + D
Sbjct: 69 ITDIEEGAFEGA---SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124
Query: 184 -RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L +++ L L N T P L +L+ L + N F
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
IP I +L L++N FT E KL L + S+N K
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN--------------K 68
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKCL 293
I + + + + ++ ++ L+ F L+ +LKTL+L
Sbjct: 69 ITDIE----------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE--SLKTLMLRSNR 116
Query: 294 IHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
I + + ++ ++ + L N +T P F+ L + + L N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 27/159 (16%), Positives = 57/159 (35%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +R DL L + + + L + L+ L + + +L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIP 228
+ N ++PP + L L+ L S N+ + + L L +L + +N
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 229 EFIGKWKKIQKLHIQG---SSLEGPIPASISALTSLTDL 264
+ + ++ L++QG EG L S++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 8e-08
Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 31/310 (10%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
++ + S+ G L D+ T D + HV L A +L LP +
Sbjct: 260 CFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFR 319
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP----FPKVLTNITTLKNLSI 170
+ + L W + + LS L + L+ L
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEP 379
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-----NNFSG 225
E +I +R L L E + L ++ +R + + F
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMN 283
+ ++ ++ LH+ L + + L +T L +S L+ A L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALR--C 487
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN---FMYLTGN 340
L+ L + + + + ++ +L+ + L N L + L + L GN
Sbjct: 488 LEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGN 543
Query: 341 KLTGPVPKYI 350
L
Sbjct: 544 SLCQE-EGIQ 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPKVLTNITTL 165
LP L+ LR L+ L S N L + +L EL + NRL + L + L
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 166 KNLSIEGNLFTGSIPPDIRKLINL 189
L+++GN +L +
Sbjct: 536 VLLNLQGNSLC-QEEGIQERLAEM 558
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--- 713
G D Y ++ + + ++ + +G+G FG V K + +A+K + +K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 714 QGNRE--FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
Q E + + + +V L + N L LV+E + N L + ++T +R
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFR 152
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKL 829
+ +K + L +L + I+H D+K N+LL K KI DFG +
Sbjct: 153 -GVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-C 209
Query: 830 YEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 878
+ +I +R Y +PE + Y D++S G + +E+ +G+
Sbjct: 210 QLGQRIYQYIQSRF-----YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 56/306 (18%), Positives = 106/306 (34%), Gaps = 53/306 (17%)
Query: 88 SSATCHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL---- 139
+ +C + ++L+ LTG L + L L L++L LS N L +
Sbjct: 81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140
Query: 140 --QLVELSVMGNRLS----GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL------- 186
+L +L + LS P VL K L++ N + +R L
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQGLKDS 197
Query: 187 -INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-----KK 236
L+ L L S T + L + +L +L + N + +
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 237 IQKLHIQGSSL--EG--PIPASISALTSLTDLRISDLK-GSESA---FPKLDKMN--LKT 286
++ L I + +G + + A SL +L ++ + G E A L + L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 287 LILTKCLIHGEIPDYIGDM----TKLKNIDLSFNNLT-GGIPTTFEKLAKTN----FMYL 337
L + C + + L + +S N L G+ + L + ++L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 338 TGNKLT 343
++
Sbjct: 378 ADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 55/281 (19%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWA------SLQLVELSVMGNRLS----GPFPKVLTN 161
L L +L+L N L S ++ +LS+ L+ G L
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLI--------NLQKLILSSNSFTGE----LPAELTK 209
+ TL+ L + NL + ++ L L+KL L S + L + L
Sbjct: 112 LPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 210 LTNLNDLRISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSLEGPIPASISAL------ 258
+ +L +S+N+ + + + +++ L ++ + + L
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVAS 225
Query: 259 -TSLTDLRISD----LKGSESAFPKLDKMN--LKTLILTKCLIHGEIPDYIGDM----TK 307
SL +L + G P L + L+TL + +C I + + +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 308 LKNIDLSFNNLTG-GIPTTFEKLAKTNFM----YLTGNKLT 343
LK + L+ N L G E L + ++ T
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 46/242 (19%)
Query: 118 LKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS----GPFPKVLTNITTLKNL 168
++ LD+ L+ +WA L Q + + L+ L L L
Sbjct: 5 IQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 169 SIEGNLFTGSIPPDIRKL--------INLQKLILSSNSFTGE----LPAELTKLTNLNDL 216
++ N + + +QKL L + TG L + L L L +L
Sbjct: 62 NLRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 217 RISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSL--EG--PIPASISALTSLTDLRIS 267
+SDN + + + +++KL ++ SL P+ + + A +L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 268 DLKGSESAFPKLDKM------NLKTLILTKCLIHGEIPDYIGDM----TKLKNIDLSFNN 317
+ +E+ L + L+ L L C + + + + L+ + L N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 318 LT 319
L
Sbjct: 239 LG 240
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
++LDL L + L +L L++ N+L V ++T L L + N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGK 233
S+P + L L KL L N LP+ + +LT L +LR++ N IP F K
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DK 153
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+Q L + + L+ + L L +
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 45/190 (23%), Positives = 65/190 (34%), Gaps = 36/190 (18%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + I + L ++ R L L L L N L A + LT L
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG- 271
L +++N ++ L P + LT L L + LK
Sbjct: 88 LGLANN--------------QLASL-----------PLGVFDHLTQLDKLYLGGNQLKSL 122
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLA 330
F +L LK L L + IP D +T L+ + LS N L F++L
Sbjct: 123 PSGVFDRL--TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179
Query: 331 KTNFMYLTGN 340
K + L GN
Sbjct: 180 KLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 37/116 (31%), Positives = 47/116 (40%), Gaps = 11/116 (9%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
L L L L+ N L G F L QL +L + GN+L V +T LK L
Sbjct: 81 DLTELGTLGLANNQLASLPLGVFD----HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ N SIP KL NLQ L LS+N +L L + + N F
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 7/114 (6%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSV 146
H + ++ L L +L + + L +L L++
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHL--ELRDLRGLGELRNLTI 63
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT 200
+ + L P L L++ N S+ + ++LQ+L+LS N
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 251 IPASISALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDM 305
+ +LT+L I + + + L L+ L + K + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLG--ELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 306 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L ++LSFN L T + L+ + L+GN L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 234
+ NL +L + + L L L L +L I + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT- 79
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
++ +L++ ++LE + SL +L +S
Sbjct: 80 PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
+ L L N +T + SL L EL + N+L V ++T L L + N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+P + +L++L++L + N T ELP + +LT+L L + N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 42/192 (21%), Positives = 61/192 (31%), Gaps = 56/192 (29%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
S+P I N Q L L N T P L NL +L + N ++
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN--------------QL 76
Query: 238 QKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
L P + +LT LT L L L L
Sbjct: 77 GAL-----------PVGVFDSLTQLTVLD-------------LGTNQLTVL--------- 103
Query: 297 EIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
P + D + LK + + N LT +P E+L + L N+L +P F+
Sbjct: 104 --PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159
Query: 356 NV-DISLNNFTW 366
++ L W
Sbjct: 160 SLTHAYLFGNPW 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 39/282 (13%), Positives = 85/282 (30%), Gaps = 71/282 (25%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-----------LVELSVMGNRLSG----PFP 156
++ + L+ + S +L+ L + + N P
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 157 KVLTNITTLKNLSIEGN-------------LFTGSIPPDIRKLINLQKLILSSNSFTGE- 202
L+ T L++L + N L ++ + L+ +I N
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 203 ---LPAELTKLTNLNDLRISDNNFSGK-----IPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
L+ +++ N + + E + ++++ L +Q ++ + +S
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSS 234
Query: 255 I--SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM------T 306
AL S NL+ L L CL+ + D
Sbjct: 235 ALAIALKSWP--------------------NLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTN-----FMYLTGNKLT 343
L+ + L +N + T + + F+ L GN+ +
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 36/235 (15%), Positives = 76/235 (32%), Gaps = 43/235 (18%)
Query: 141 LVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKL 192
+ S+ + ++ VL ++K + + GN + +I +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 193 ILSSNSFTGELPAE-----------LTKLTNLNDLRISDNNFSGK----IPEFIGKWKKI 237
S FTG + E L K L+ +R+SDN F + +F+ K +
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+ L++ + L P + + + L+ + L+++I + +
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARA-------LQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 298 IPDYIGDM----TKLKNIDLSFNNLTG-GIPTTFEKLAKTN----FMYLTGNKLT 343
L + + N + GI + + L N T
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 39/115 (33%), Positives = 52/115 (45%), Gaps = 13/115 (11%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+L L L L+ N L G F L L EL ++ N+L V +T L L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVF----DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDN 221
++ N S+P + KL NL +L LS N LP + KLT L DLR+ N
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 34/192 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+++ T +L ++ ++I +++ + + L N+ L + N
Sbjct: 19 AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDK 281
I + + L + G+ L+ +P + LT+L +L L +
Sbjct: 75 LH-DISAL-KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV-------------LVE 118
Query: 282 MNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L++L PD + D +T L ++L+ N L F+KL + L+ N
Sbjct: 119 NQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
Query: 341 KLTGPVPKYIFN 352
+L +P+ +F+
Sbjct: 168 QLQS-LPEGVFD 178
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 13/140 (9%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C CS T + + + +P + LDL N L + + L L +
Sbjct: 5 CSCSGTTVECYSQGRTS--VPTGIPAQT------TYLDLETNSLKSLPNGVFDELTSLTQ 56
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
L + GN+L V +T+L L++ N S+P + KL L++L L++N
Sbjct: 57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-S 114
Query: 203 LPAEL-TKLTNLNDLRISDN 221
LP + KLT L DLR+ N
Sbjct: 115 LPDGVFDKLTQLKDLRLYQN 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTG 201
EL + GN+ + PK L+N L + + N + ++ + L LILS N
Sbjct: 35 ELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 202 ELPAELT-KLTNLNDLRISDNNFSGKIPE 229
+P L +L L + N+ S +PE
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 7/116 (6%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ LS L+ K L LS N + S L LS+ N + + TL+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEE 97
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
L I N S+ I KL+NL+ L +S+N T GE+ +L L L DL ++ N
Sbjct: 98 LWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 42/233 (18%), Positives = 80/233 (34%), Gaps = 59/233 (25%)
Query: 683 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNRE--FVNEIGMISAQQHPNLV 735
+GEG FG V + + + +A+K + + + E + +I + V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 736 KLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+ + + +E++K N Y L + + +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--------YPLPH----VRHMAYQLC 133
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDFGLAK 828
L +LHE ++ H D+K N+L +++DFG A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 829 LYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 878
++ + T ++TR Y PE + G+ DV+S G + E G
Sbjct: 190 TFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFEYYRGF 236
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 30/129 (23%), Positives = 54/129 (41%), Gaps = 12/129 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTG-SFSPQWASLQLVELSVMGNRLSGPFPKVLT 160
++ G + ++ L+ L L L S P+ L+ +ELS NR+ G +
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELS--ENRIFGGLDMLAE 92
Query: 161 NITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFTGE------LPAELTKLTN 212
+ L +L++ GN ++ P ++KL L+ L L + T + L +LT
Sbjct: 93 KLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151
Query: 213 LNDLRISDN 221
L+ D
Sbjct: 152 LDGYDREDQ 160
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 31/235 (13%), Positives = 76/235 (32%), Gaps = 30/235 (12%)
Query: 112 LSKLRYLKQLDLSRNCLT-------GSFSPQWASLQLVELSVMGNRLSGP--FPKVLTNI 162
++ R +K L + + + + SL+++ + P + N
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219
Query: 163 TTLKNLSIEG--NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+L ++ + L L L+ + E L L L +S
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG--SESAFPK 278
+ +P +I+KL + + LE + + +L + + + +
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETE--DHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 279 LDKM--NLKTLILTKCLIHGEIPDYIGDMT------------KLKNIDLSFNNLT 319
L + LK L + + + D G ++ +L+ + + +++T
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 39/261 (14%), Positives = 99/261 (37%), Gaps = 18/261 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-NLFTG 177
+ LDL+ L + + S ++ + + P + + ++++ + +
Sbjct: 50 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 108
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGK-WK 235
++ + + LQ L L + + L K +NL L +S + FS + +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168
Query: 236 KIQKLHIQGSSL---EGPIPASISALTSLTDLRISDLKG--SESAFPKLDKM--NLKTLI 288
++ +L++ + A ++T L +S + +S L + NL L
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 289 LTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAK-TNFMYLT-GNKLTG 344
L+ ++ + + L+++ LS ++ P T +L + L +
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII---PETLLELGEIPTLKTLQVFGIVPD 285
Query: 345 PVPKYIFNSNKNVDISLNNFT 365
+ + + ++ I+ ++FT
Sbjct: 286 GTLQLLKEALPHLQINCSHFT 306
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 13/166 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMG------NRLSGPFPKVLTNITT 164
+++ LK L L+R + QL EL G + L+
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNF 223
L+ LS + +P L L LS + L L + L L + D
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269
+ K +++L + S P + +LT+ + +
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSE-----PFVMEPNVALTEQGLVSV 367
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 11/117 (9%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ + ++LDL + + Q + N + + L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK 67
Query: 170 ---IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
+ N + L +L +LIL++NS G+L L L +L L I N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 140 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
+ EL + +R + G + L+ LS T SI ++ KL L+KL LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 199 FTGELPAELTKLTNLNDLRISDNNFS 224
+G L K NL L +S N
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 161 NITTLKNLSIEGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +K L ++ + G + + L+ L + T + A L KL L L +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
DN SG + K + L++ G+ ++ ++I L L +L+ DL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 28/122 (22%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
++ G L + L+ L LT ++ L
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLT--------------------SIAN-----LPK 62
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRIS 219
+ LK L + N +G + K NL L LS N + L KL NL L +
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLF 121
Query: 220 DN 221
+
Sbjct: 122 NC 123
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 143 ELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT 200
EL + N L + + L L ++ N T I P+ ++Q+L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 201 GELPAEL-TKLTNLNDLRISDN 221
E+ ++ L L L + DN
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDN 112
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 67/237 (28%)
Query: 683 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNREFVNEIGMIS--AQQHP--- 732
+GEG FG V + I + G +AVK + + R +EI ++ P
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 733 -NLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
V++ + +V Y+++K N +RL +K+
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--------FRLDH----IRKMA 124
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDF 824
I + + +LH K+ H D+K N+L + K+ DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 825 GLAKLYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 878
G A Y+++ T +STR Y APE + G+ + DV+S G + +E G
Sbjct: 182 GSA-TYDDEHHSTLVSTRH-----YRAPEVILALGW-SQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMIS--AQQHP---N 733
K+G+G FG V + + AVK + + + E ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 734 LVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+VK +G + + + L+ YE + N + + ++ K CI
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG--------FHIED----IKLYCIE 145
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------------K 820
I + L YL + + + H D+K N+LLD K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 821 ISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 877
+ DFG A ++ D + I+TR Y APE + G+ +D++SFG V E+ +G
Sbjct: 203 LIDFGCA-TFKSDYHGSIINTRQ-----YRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255
Query: 878 K 878
Sbjct: 256 S 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 907 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-62
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQH 731
++F+ +++G G G V+K G V+A K + + + R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P +V YG ++ + E+M L + + ++ K+ I + +GL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLT 118
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YL + KI+HRD+K SN+L++ K+ DFG++ + GT YM+PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + ++D++S G+ +E+ G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-62
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG+VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G QL +V ++ + + L + +T K + I A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM 854
I+HRD+K++N+ L +DL KI DFGLA + +H +++G+I +MAPE
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 855 ---RGYLTSKADVYSFGVVTLEIVSGK 878
+ + ++DVY+FG+V E+++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-60
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 9/229 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG V+ G + T +AVK L + F+ E ++ QH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LY + + ++ EYM+N L + +KL + IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
+HRD++ +N+L+ L+ KI+DFGLA+L E+++ I + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 856 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 903
G T K+DV+SFG++ EIV+ G+ N + + L+ Y + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 9/231 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V+ G + +A+K + + +F+ E ++ HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG C+E + LV+E+M++ CLS + + + T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
++HRD+ N L+ ++ K+SDFG+ + +D+ ST + + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 856 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 905
+SK+DV+SFGV+ E+ S GK R N + V + + L + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 9/231 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V G +A+K + + EF+ E ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG C + + ++ EYM N CL + R + ++C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
+ +HRD+ N L++ K+SDFGL++ +D+ S + + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 856 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 905
+SK+D+++FGV+ EI S GK N + + L +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-57
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ K+G+G FG V+ G + T +A+K L F+ E ++ +H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LY + +V EYM L + G+ +Y P + IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVE- 130
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
R+ VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
G T K+DV+SFG++ E+ +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKG 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 12/221 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++D +GEG +G V + +AVK + K E EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VK YG EGN L EY L I + + P ++ + G+ YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYL 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEY 852
H I I HRDIK N+LLD+ N KISDFGLA ++ + + + ++ GT+ Y+APE
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 853 AMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 892
R + DV+S G+V +++G+ + + Y
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+++ +G G +G K SDG ++ K+L S + + V+E+ ++ +HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 792 YLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 849
H D ++HRD+K +NV LD N K+ DFGLA++ D T + GT YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 850 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
PE R K+D++S G + E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-55
Identities = 58/219 (26%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 667 TLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF 719
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQI 118
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+C + L +LH + +++HRDIK+ N+LL D + K++DFG +++ ST
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ GT +MAPE R K D++S G++ +E++ G+
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 8e-55
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 20/237 (8%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY + K L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYL 131
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H ++HRD+K N+LL + K+ DFG A + + + GT +MAPE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 854 M---RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 907
+ G K DV+S G+ +E+ K +Y + + +WS
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 2e-54
Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 26/257 (10%)
Query: 666 YTLRQIKAATNNFDPA---------NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSK 711
+T A F +G G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
+ + R+F++E ++ HPN++ L G + ++++ E+M+N L + D ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
+ GIA G+ YL + VHRD+ N+L++ +L K+SDFGL++ E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 832 EDKTHISTR----IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 886
+D + + I + APE TS +DV+S+G+V E++S G+ N
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 887 EDFVYLLDWAYVLQEEE 903
+D + ++ Y L
Sbjct: 240 QDVINAIEQDYRLPPPM 256
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G+G FG VYK + A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
N L ++ E+ + + E L + +C L YLH+ K
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----R 855
I+HRD+K N+L D + K++DFG++ + I GT +MAPE M
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 189
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
KADV+S G+ +E+ +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIE 212
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 1e-53
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V+L G C ++ E+M L + + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE 132
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ +HRD+ N L+ ++ K++DFGL++L D I + APE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 855 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
+ K+DV++FGV+ EI + + + VY
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 15/230 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FG V G G +AVK + + + + F+ E +++ +H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 736 KLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+L G VE L +V EYM L + + R L K + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 854
+ VHRD+ NVL+ +D AK+SDFGL K + + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALR 173
Query: 855 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 903
++K+DV+SFG++ EI S G+ P +D V ++ Y + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 16/240 (6%)
Query: 669 RQIKAATNNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNRE-FVNEI 723
+++ +N A+ ++G G FGSV +G+ +A+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
++ +P +V+L G C + L+LV E L + + GK R ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--I 841
++ G+ YL E VHRD+ NVLL AKISDFGL+K D ++ + R
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 842 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQ 900
+ + APE +S++DV+S+GV E +S G+ + + ++ ++
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-53
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G F +VYKG+ ++ +A +L + ++ + F E M+ QHPN+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 739 GCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++LV E M + L + + + C I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 795 EDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
Y DVY+FG+ LE+ + +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSE 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 9e-53
Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 30/251 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNR-EFV 720
L ++ NN + +GEG FG V++ T++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------------- 767
E +++ +PN+VKL G C G + L++EYM L+ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 768 ------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821
+ L + I +A G+AYL E K VHRD+ T N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 822 SDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 880
+DFGL++ +Y D A I +M PE T+++DV+++GVV EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 881 TNYRPNEDFVY 891
Y + V
Sbjct: 242 PYYGMAHEEVI 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 26/241 (10%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V++G G +AVK SS+ + + EI +H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 743 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 796
+ N QL LV +Y ++ L + R + K+ + A GLA+LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 797 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 850
+ I HRD+K+ N+L+ K+ I+D GLA ++ I GT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 851 EY------AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 904
E +AD+Y+ G+V EI S + Y EE+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 905 Y 905
Sbjct: 242 R 242
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F+ +G+G FG+VY ++A+K L + E+ + S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
PN+++LYG + ++ L+ EY + R + K D +A L+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
Y H +++HRDIK N+LL KI+DFG + + + GT+ Y+ PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
K D++S GV+ E + GK
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-52
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVK 736
++G G FG+V KG +AVK L +++ E + E ++ +P +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ G C E +LV E + L++ + + ++ ++ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM 854
VHRD+ NVLL AKISDFGL+K D+ + + + + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 855 RGYLTSKADVYSFGVVTLEIVS 876
+SK+DV+SFGV+ E S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 30/230 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N + +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK------------------DTE 769
H N+V L G C + L++EY L + K + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 828
L + +A+G+ +L VHRD+ NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 829 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ + + + +MAPE G T K+DV+S+G++ EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 25/235 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N +G G FG V + +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-------------DTEYRLKL 774
H N+V L G C G L++ EY L + K + L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
D +A+G+A+L +HRD+ N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888
+ + +MAPE T ++DV+S+G+ E+ S S+ D
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-51
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 15/224 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQ 729
+ +G G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
H N+++L G + ++++ EYM+N L + + KD + + GIA G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGY 847
+ YL + VHRD+ N+L++ +L K+SDFGL+++ E+D T+ ++ I +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
APE TS +DV+SFG+V E+++ + + V
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 3e-50
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+++D ++G G FG V++ + G A K + + EI +S +HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V L+ + N+++++YE+M L + + K+ + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
E VH D+K N++ + K+ DFGL + ++ T GT + APE
Sbjct: 142 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEV 196
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
A + D++S GV++ ++SG
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISAQQH 731
+F+ +G G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 732 PNLVKLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
PN++ L G C+ L+V YMK+ L I + + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGM 143
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHISTRIAGTIGY 847
+L K VHRD+ N +LD+ K++DFGLA+ E D H T + +
Sbjct: 144 KFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 848 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS--NTNYRPNEDFVYLLDWAYVLQEEEI 904
MA E T+K+DV+SFGV+ E+++ + + + VYLL +LQ E
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 18/246 (7%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTV----IAVKQLS-SKSRQGNREFVN 721
LR +K F +G G FG+VYKG+ + +G +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
E ++++ +P++ +L G C+ + L+ + M CL +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI----GSQYLLN 115
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 840
C+ IA+G+ YL ++VHRD+ NVL+ + KI+DFGLAK L E+K + +
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 841 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 899
I +MA E + T ++DV+S+GV E+++ G + P + +L+ L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 900 QEEEIY 905
+ I
Sbjct: 233 PQPPIC 238
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQLS-SKSRQGNREFVNEIGMISA-QQ 730
N+ + +GEG FG V K + A+K++ S+ +R+F E+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKLDWPTR 779
HPN++ L G C L L EY + L + F L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+ARG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 840 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ +MA E T+ +DV+S+GV+ EIVS
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 3e-49
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ L+ + +++L+ E++ L I +D K+ GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH 144
Query: 795 EDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
E IVH DIK N++ + K + KI DFGLA D+ T T + APE
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEI 199
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGK 878
R + D+++ GV+ ++SG
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 13/221 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQ 730
+ +GEG FG V++GI +A+K + + RE F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HP++VKL G E N + ++ E L + + LD + ++ L
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTAL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
AYL + VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
E TS +DV+ FGV EI+ + V
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 13/212 (6%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMIS 727
K +F +GEG F +V L+ A+K L + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
HP VKLY + +L Y KN L + I D + I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 846
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E K + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y++PE +D+++ G + ++V+G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-48
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK---SRQGNREFVNEIGMISA 728
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NL++LYG + + +V E L + +++ T + + +A
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG 846
G+ YL + +HRD+ N+LL KI DFGL + ++ H +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 876
+ APE + +D + FGV E+ +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (434), Expect = 2e-47
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 19/230 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ- 730
N+F +G GGFG VY +D G + A+K L K +QG +NE M+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 731 --HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
P +V + ++L + + M L + + I
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYM
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 172
Query: 849 APEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 897
APE +G S AD +S G + +++ G S +D +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-46
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 16/229 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLS-SKSRQGNREFVNEIGMISA 728
+ ++G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----FGKDTEYRLKLDWPTRKKIC 783
++V+L G +G L++ E M L + + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIA 842
IA G+AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 891
+ +M+PE G T+ +DV+SFGVV EI + + + V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQG-NREFVNEIGMISA 728
+ +G G FG V + + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 729 QQH-PNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLD 775
H N+V L G C + G L+++ E+ K LS + K E Y+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+A+G+ +L K +HRD+ N+LL + KI DFGLA+ +D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 836 HI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 892
++ + +MAPE T ++DV+SFGV+ EI S ++ D +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 2e-44
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F +G G FG V+ +G A+K L + + +E M+S H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P +++++G + Q+ ++ +Y++ L + + P K + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH I++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPE 171
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGKS 879
D +SFG++ E+++G +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 2e-44
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 9/212 (4%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMI 726
+Q + + +D + +G G F V ++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+HPN+V L G L L+ + + L I K ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
+ YLH+ + + LD+D ISDFGL+K+ ED + + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE + + D +S GV+ ++ G
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-44
Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 26/251 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGN-REFVNEIGMI 726
+ +GEG FG V + T +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKL 774
+H N++ L G C + L ++ EY L + + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 835 THIST-RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYL 892
+ T + +MAPE T ++DV+SFGV+ EI + G S P E+ L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 893 LDWAYVLQEEE 903
L + + +
Sbjct: 250 LKEGHRMDKPS 260
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 1e-43
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+ K+GEG +G VYK + G A+K++ + + EI ++ +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKLY +L+LV+E++ + + L+ T K + + G+AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H+ +++HRD+K N+L++++ KI+DFGLA+ + + I
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
++ D++S G + E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-43
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 10/209 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHP 732
+ + +GEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N++ + + Y+ + + ++ L I RGL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAP 850
+H ++HRD+K SN+LL+ + KI DFGLA++ + D H T T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 851 EYAMRG-YLTSKADVYSFGVVTLEIVSGK 878
E + T D++S G + E++S +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K++ +++ + EI ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKL N+L LV+E++ + D + P K + +GLA+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 853
H +++HRD+K N+L++ + K++DFGLA+ + + +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 854 MRGYLTSKADVYSFGVVTLEIVSGK 878
Y ++ D++S G + E+V+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (395), Expect = 3e-43
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---------SKSRQGNREFVNEIGMI 726
N++P +G G V + I AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
HPN+++L LV++ MK L + K L +KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ + LH+ + IVHRD+K N+LLD D+N K++DFG + + + + GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 846 GYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGK 878
Y+APE + D++S GV+ +++G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-43
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-Q 730
+F +G+G FG V+ A+K L + + + E ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HP L ++ L V EY+ L I K D I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
+LH IV+RD+K N+LLDKD + KI+DFG+ K +T GT Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 172
Query: 851 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 879
E + D +SFGV+ E++ G+S
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-43
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 674 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNRE-----FVNEIGMI 726
A ++ ++GEG +G V+K + + G +A+K++ ++ + V + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKICIG 785
+HPN+V+L+ C + + + + D + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 845
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++Y T + T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 846 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE ++ + D++S G + E+ K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-43
Identities = 39/199 (19%), Positives = 79/199 (39%), Gaps = 13/199 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G FG V++ + S K + K EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+L++++E++ + I +L+ + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 802 VHRDIKTSNVLLDKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 859
H DI+ N++ ++ KI +FG A+ + Y APE ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVS 181
Query: 860 SKADVYSFGVVTLEIVSGK 878
+ D++S G + ++SG
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (386), Expect = 4e-42
Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQ 730
++ ++ +G GG V+ L +AVK L ++ F E +A
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 731 HPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
HP +V +Y G +V EY+ L + + + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 120
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGT 844
+ L + H+ I+HRD+K +N+++ K+ DFG+A+ + + + + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y++PE A + +++DVYS G V E+++G+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLV 735
+ +GEG F +VYK + ++A+K++ R NR + EI ++ HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L + + LV+++M+ + + L L K + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
I+HRD+K +N+LLD++ K++DFGLAK + T T Y APE
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174
Query: 856 -GYLTSKADVYSFGVVTLEIVSGK 878
D+++ G + E++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-40
Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 21/231 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
N + K+G G FG +Y G ++ G +A+K K++ + E + Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 735 VKLYG-CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ C EG+ ++V E + + F K T + + + Y+
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYI 119
Query: 794 HEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHI------STRIAGT 844
H +HRD+K N L K I DFGLAK Y + +TH + + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 895
Y + + + + D+ S G V + G +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 6e-40
Identities = 41/226 (18%), Positives = 81/226 (35%), Gaps = 23/226 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPN 733
++ ++GEG FG +++G L + +A+K +S + +E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ +Y EG +LV + + + K T + + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLAKLYEEDKTHI------STRIA 842
HE +V+RDIK N L+ + + + DFG+ K Y + T ++
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 843 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888
GT YM+ + + + D+ + G V + + G
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR------EFVNEIGMISA 728
+ +D ++G G F V K S G A K + + + +R + E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
QHPN++ L+ ++L+ E + L + K+ L + I
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILN 124
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYEEDKTHISTRIAGT 844
G+ YLH +I H D+K N++L KI DFGLA + I GT
Sbjct: 125 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGT 179
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
++APE L +AD++S GV+T ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-39
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++ +G G FG VY+ L G ++A+K++ R NRE + ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 736 KLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+L + L LV +Y+ A + L K + R
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL--PVIYVKLYMYQLFRS 134
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 848
LAY+H I HRDIK N+LLD D K+ DFG AK + ++ + I
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRA 190
Query: 849 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
TS DV+S G V E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------FVNEIGMISA--QQHPN 733
+G GGFGSVY GI +SD +A+K + E E+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+++L + +L+ E + + R L + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126
Query: 794 HEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
H ++HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180
Query: 853 AM-RGYLTSKADVYSFGVVTLEIVSGKS 879
Y A V+S G++ ++V G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHP 732
+ ++ K+G+G FG V+K G +A+K++ ++ + + EI ++ +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 733 NLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
N+V L C + LV+++ +++ G + +K K++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---HISTRI 841
+ GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ + K + T
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 842 AGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGK 878
T+ Y PE + D++ G + E+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 13/207 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
N+FD +G+G FG V + G A+K L + ++ V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P L L ++L V EY L + + + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH +V+RDIK N++LDKD + KI+DFGL K D GT Y+APE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPE 175
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
D + GVV E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 39/207 (18%), Positives = 85/207 (41%), Gaps = 11/207 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 732
++ K+GEG +G+V+K ++A+K++ + EI ++ +H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N+V+L+ +L LV+E+ + K + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 852
H ++HRD+K N+L++++ K+++FGLA+ + S +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 853 AMRGYLTSKADVYSFGVVTLEIVSGKS 879
++ D++S G + E+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-37
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQH 731
+ FD +G G FG V G A+K L + ++ +NE ++ A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P LVKL + + L +V EY+ + + + P + I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
YLH + +++RD+K N+L+D+ +++DFG AK + + GT +APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPE 208
Query: 852 YAMRGYLTSKADVYSFGVVTLEIVSGK 878
+ D ++ GV+ E+ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 20/203 (9%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC- 741
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 742 ---VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
LL+V E + L I + + +I I + YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS--- 129
Query: 799 IKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 855
I I HRD+K N+L + K++DFG AK + + T Y+APE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 856 GYLTSKADVYSFGVVTLEIVSGK 878
D++S GV+ ++ G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 666 YTLRQIKAAT----NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNRE 718
+ +++ + VG G +G+V + G +A+K+L +S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRL 772
E+ ++ +H N++ L L LV +M +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------- 116
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
KL + + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ +
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 833 DKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 878
+ T T Y APE + T D++S G + E+++GK
Sbjct: 174 EMTG----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-33
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 22/212 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHP 732
+ +G G G V +A+K+LS +++ + E+ ++ H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 733 NLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
N++ L E + LV E M N +++LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV--------IQMELDHERMSYLLYQM 128
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 846
G+ +LH I HRD+K SN+++ D KI DFGLA+ T T
Sbjct: 129 LCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 183
Query: 847 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 878
Y APE + D++S G + E+V K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-33
Identities = 41/210 (19%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPN 733
+++ K+G G + V++ I +++ + VK L ++ + EI + + + PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
++ L + LV+E++ N + L + I + L
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFK--------QLYQTLTDYDIRFYMYEILKALD 143
Query: 792 YLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 850
Y H + I+HRD+K NV++D + ++ D+GLA+ Y + + + + P
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 851 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 879
E + D++S G + ++ K
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-33
Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 24/240 (10%)
Query: 650 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAV 705
++ ELR +L T K NF+ +G G +G V+ G + A+
Sbjct: 3 LTVKHELRTANL-----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 706 KQLS----SKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760
K L + + E ++ + P LV L+ +L L+ +Y+ L
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820
+ ++ T ++ I + + L ++ I++RDIK N+LLD + +
Sbjct: 118 THLSQRE--------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 821 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 878
++DFGL+K + D+T + GTI YMAP+ G D +S GV+ E+++G
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+ + VG G +GSV G +AVK+LS +S + E+ ++ +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
N++ L L + L A + + KL + + I RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 851
Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T T Y APE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188
Query: 852 YAMR-GYLTSKADVYSFGVVTLEIVSGK 878
+ + D++S G + E+++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 8e-27
Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 27/240 (11%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G F +V+ + + T +A+K + + +EI ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 742 VEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----------RLKLDWPTRKKICIGIARGL 790
+LL + + N + + + + K+I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFGLAKLYEEDKTHISTRIAGT 844
Y+H I+H DIK NVL++ + KI+D G A Y+E T+ T
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192
Query: 845 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 904
Y +PE + AD++S + E+++G + P+E Y D ++ Q E+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--LFEPDEGHSYTKDDDHIAQIIEL 250
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 101 bits (251), Expect = 6e-24
Identities = 73/318 (22%), Positives = 116/318 (36%), Gaps = 23/318 (7%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTG--TLPTELSKLRYLKQLDLS--RNCLTGSFSPQWASLQLVELSVMG 148
V + L NL +P+ L+ L YL L + N + QL L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+ L N + + + + LEG + + + ++
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ NL L L I+G +P + + L ++++SFNNL G IP
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 329 LAKTNFMYLTGNK-LTGP 345
L + + NK L G
Sbjct: 290 LQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 194 LSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPI 251
L +N G LP LT+L L+ L +S NN G+IP+ G ++ + P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 252 PA 253
PA
Sbjct: 310 PA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 19/58 (32%), Positives = 29/58 (50%), Gaps = 4/58 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL--SGPFPK 157
+ GTLP L++L++L L++S N L G PQ +LQ + N+ P P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 7e-22
Identities = 28/161 (17%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQH 731
+GEG +V+ VK G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 732 PNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
L KL G V ++ E + L R ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+A + IVH D+ NVL+ + I DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 39/189 (20%), Positives = 69/189 (36%), Gaps = 5/189 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ + L L +N T + L NL+ L + +N S P K+
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
++L++ + L+ L L K +S F L++M + L G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
M KL I ++ N+T L + ++L GNK+T + N
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLA 198
Query: 358 DISLNNFTW 366
+ L+ +
Sbjct: 199 KLGLSFNSI 207
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.0 bits (188), Expect = 9e-16
Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 28/293 (9%)
Query: 85 CDCSSATCH----------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C C + L+ +T + L+ L L L N +
Sbjct: 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 129 TGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187
+ +A L +L L + N+L K+ + L+ E S+ + ++I
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
++ L + +G + L+ +RI+D N + IP+ G + +LH+ G+ +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
AS+ L +L L +S S L + ++P + D
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 308 LKNIDLSFNNLTGGIPTTF------EKLAKTNFMYLTGNKLT-GPVPKYIFNS 353
++ + L NN++ F K A + + L N + + F
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.7 bits (182), Expect = 5e-15
Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 15/247 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
++ T+ L ++ P + L L++L LS+N L P+ L EL V N ++
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL--PEKMPKTLQELRVHENEIT 113
Query: 153 GPFPKVLTNIT--TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
V + + L +G + + L + ++ + T +P L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
+L +L + N + + + KL + +S+ S++ L +L +++ K
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHG------EIPDYIGDMTKLKNIDLSFNNLTGG--I 322
+ D ++ + L I P Y + L N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 323 PTTFEKL 329
P+TF +
Sbjct: 291 PSTFRCV 297
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 1e-15
Identities = 39/195 (20%), Positives = 73/195 (37%), Gaps = 13/195 (6%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI 227
L N + P I NL +L L+ N L LTNL DL +++N S
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 228 PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 287
P + K+ +L + + + P + + +L + E P + NL L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ---LEDISPISNLKNLTYL 312
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
L I P + +TKL+ + + N ++ ++ L N++ N+++ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 348 KYIFNSNKNVDISLN 362
+ ++
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 2e-14
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL 151
++ ++L L L+ L L LDL+ N ++ +P +L EL + N++
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 275
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
S P L +T L NL + N I L NL L L N+ + P ++ LT
Sbjct: 276 SNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L L ++N S + I L + + P ++ LT +T L ++D
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 5e-14
Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 15/198 (7%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
L N++S P +T L LS+ GN + L NL L L++N +
Sbjct: 201 SLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L+ LT L +L++ N S I G + + +++ LT L
Sbjct: 257 AP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYL- 312
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
L +++ S L L+ L + + ++T + + N ++
Sbjct: 313 TLYFNNISDI-SPVSSLT--KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 323 PTTFEKLAKTNFMYLTGN 340
P L + + L
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 9e-06
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
S ++ + L N++ P +S L L++L + N ++ A+L +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
LS N++S P L N+T + L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 3e-05
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
KLTNL L ++N S P I + +L + G+ L+ ++++LT+LTDL +++
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ S A P L L L I P + +T L N++L+ N L +
Sbjct: 251 NQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISN 305
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ L N ++ P + + + N +
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVS 342
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (152), Expect = 2e-11
Identities = 30/177 (16%), Positives = 58/177 (32%), Gaps = 4/177 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++P I Q++ L N + A NL L + N + +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 238 QKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSESAFP-KLDKMNLKTLILTKCLIH 295
++L + ++ + PA+ L L L + E L+ L L +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
D D+ L ++ L N ++ F L + + L N++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 36/287 (12%), Positives = 83/287 (28%), Gaps = 16/287 (5%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVEL 144
C C + VT + Q L +P + +++ L N ++ + + + + + +
Sbjct: 6 CVCYNEP--KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 145 SV--MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
+ + P L L L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L L L + DN + + L + G+ + + L SL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 263 DLRI---SDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L + AF L ++ L + + + L+ + L+ N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL--PTEALAPLRALQYLRLNDNPWV 238
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFT 365
A + +++ +P+ + + +++ ++ N+
Sbjct: 239 CDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL--AGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (144), Expect = 3e-10
Identities = 42/254 (16%), Positives = 66/254 (25%), Gaps = 28/254 (11%)
Query: 68 NWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC 127
N + + L P L L L L R
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 128 LTGSF-SPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186
L L L + N L ++ L +L + GN + R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS 246
+L +L+L N P L L L + NN S E + + +Q L + +
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 247 LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT 306
D R L L+ + + +P +
Sbjct: 237 WVC-------------DCRARPLWA-----------WLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 307 KLKNIDLSFNNLTG 320
L+ N+L G
Sbjct: 273 LK---RLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 30/257 (11%), Positives = 83/257 (32%), Gaps = 14/257 (5%)
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDL+ L + + S ++ + + P + + ++++ + ++ S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTL 63
Query: 181 PDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE---------- 229
I + LQ L L + + L K +NL L +S + +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL 289
+ + + +L+ R + K S + + +
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348
++ + + L+++ LS ++ ++ + + G G +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 349 YIFNSNKNVDISLNNFT 365
+ + ++ I+ ++FT
Sbjct: 244 -LKEALPHLQINCSHFT 259
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 38/258 (14%), Positives = 72/258 (27%), Gaps = 24/258 (9%)
Query: 101 AQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKV 158
++ E ++ +DLS + + S S +L LS+ G RLS P
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 159 LTNITTLKNLSIE--GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
L + L L++ ++ + L + L+ D
Sbjct: 91 LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE----------------LNLSWCFDF 134
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
+ + + DL S + ++
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 277 PKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L+ L L++C I E +G++ LK + + G + E L
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252
Query: 336 YLTGNKLTGPVPKYIFNS 353
+ + T I N
Sbjct: 253 -INCSHFTTIARPTIGNK 269
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 6/207 (2%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + + ++ + T ++PPD+ K + L LS N A L T L L +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L+ + + S
Sbjct: 64 --RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
L+ L L + P + KL+ + L+ NNLT L + + L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 340 NKLTGPVPKYIFNSNKNVDISLNNFTW 366
N L +PK F S+ L+ W
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 48/240 (20%), Positives = 73/240 (30%), Gaps = 36/240 (15%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q 140
+ C+ S H+ + +NLT LP +L K L LS N L +
Sbjct: 1 HPICEVSKVASHL-EVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTR 56
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSI--EGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +L L L TL L + S+P + L L L +S N
Sbjct: 57 LTQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR 111
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
T L L L +L + N P + K++KL + ++L ++ L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 259 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318
+L L + + IP L L N
Sbjct: 172 ENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 4/113 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T+ L +L + LDLS N L A L L N L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE--LPAELTK-LTNLNDL 216
L L + + L L L NS E + L + L +++ +
Sbjct: 71 LLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 22/118 (18%), Positives = 37/118 (31%), Gaps = 10/118 (8%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GNLFT 176
+ L L+ LT L + L + NRL P + L+ L + +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 177 GSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ L LQ+L+L +N L L L + N+ +
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 5e-04
Identities = 20/143 (13%), Positives = 40/143 (27%), Gaps = 28/143 (19%)
Query: 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
+ L L+ T L +L + L +S N P ++
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALR------CLEVLQASD 52
Query: 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
++ + +L L+ L + L + +L
Sbjct: 53 NALENVDGVANLPRLQELLLCNN-------------------RLQQSAAIQPLVSCPRLV 93
Query: 310 NIDLSFNNLTGGIPTTFEKLAKT 332
++L N+L E+LA+
Sbjct: 94 LLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 161 NITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAELTK-----LT 211
+ L+ L + + S+ + +L++L LS+N +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKK 236
L L + D +S ++ + + +K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRIS 219
+++L I+ + + ++ L Q + L T + + L L +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
N + + + IQ SL+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)
Query: 140 QLVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-----NLQ 190
L L + +S L +L+ L + N + + + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 191 KLILSSNSFTGELPAELTKL-TNLNDLRI 218
+L+L ++ E+ L L + LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 12/92 (13%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 187 INLQKLILSSNSFTGELPAELTK-LTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLH 241
+++Q L + + AEL L +R+ D + I + + +L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 242 IQGSSLEGPIPASISAL-----TSLTDLRISD 268
++ + L + + L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 7e-05
Identities = 17/167 (10%), Positives = 40/167 (23%), Gaps = 6/167 (3%)
Query: 260 SLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGE----IPDYIGDMTKLKNIDL 313
+ L I + S++ + +L + + + L C + I + L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 314 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
N L + +T + L + + E
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 374 CPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINC 420
+ + + L +A + L
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 169
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 12/96 (12%)
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
N S + +L+ L++ N +P L++LI S N E+P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
L L+ + N + P+ ++ L +
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPE---SVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 8/135 (5%)
Query: 56 WNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL 115
+ +L + +V+ + S + + + +
Sbjct: 224 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 283
Query: 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175
L++L++S N L L+ + S N L+ P++ N LK L +E N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIAS--FNHLAE-VPELPQN---LKQLHVEYNPL 336
Query: 176 TGSIPPDIRKLINLQ 190
P + +L+
Sbjct: 337 R-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
+L L++ + LP L +L S N+ + ++PE K + + +L
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 248 EGPIP 252
P
Sbjct: 94 SDLPP 98
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 7e-04
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 5/152 (3%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
L +SK Q L L P + + + + ++ + NI L +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLS 69
Query: 168 LSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
L++ N + ++K NL+ L LS N E + K L +L + N+ S
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEG-PIPASIS 256
+ I++ + L+G +P I+
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.004
Identities = 28/190 (14%), Positives = 57/190 (30%), Gaps = 35/190 (18%)
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ LK +E + + K + + L +L L +
Sbjct: 1 LNELKPEQVE------QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-S 51
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK 281
+ + + ++ L+ L++ R+ L S K
Sbjct: 52 SMAATLRIIEENIPELLSLN-------------------LSNNRLYRLDDMSSIVQKAP- 91
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT-----NFMY 336
NLK L L+ + E KL+ + L N+L+ ++ +
Sbjct: 92 -NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
Query: 337 LTGNKLTGPV 346
L G++L P+
Sbjct: 151 LDGHELPPPI 160
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 164 TLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 215
+++ S++ + T S+ + + ++++++LS N+ E L + +L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
SD E + + + ++ L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 6/69 (8%)
Query: 185 KLINLQKLILSSNSFTGELPAEL-----TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ I LQ L L N + L K+ +L L ++ N F + + + + +++
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFS 329
Query: 240 LHIQGSSLE 248
+G E
Sbjct: 330 TRGRGELDE 338
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 23/203 (11%)
Query: 156 PKVLTNITTLKNLS--IEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
P + I + + I+ NL S+ +L ++ ++I +++ + L
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLP 68
Query: 212 NLNDLRISDNNFSGKIP---------------EFIGKWKKIQKLHIQGSSLEGPIPASIS 256
N+ L ++ N + P + ++ SLE + I+
Sbjct: 69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 257 ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L L L L ++ + K L+ + +TKL+N+ LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 317 NLTGGIPTTFEKLAKTNFMYLTG 339
+++ L + + L
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 30/224 (13%), Positives = 68/224 (30%), Gaps = 25/224 (11%)
Query: 155 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 214
FP + ++ + T ++ L + L T + + L NL
Sbjct: 13 FP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 215 DLRISDNNFSGK---------------IPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 259
L + DN + I+ L ++ L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 260 SLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L++L++ L ++ L+ + +++KL + N ++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
P L ++L N+++ P + N++ ++L N
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 907 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.98 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.97 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.82 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.75 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.75 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.68 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.57 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.56 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.8 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.63 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.53 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 92.89 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.27 Aligned_cols=201 Identities=26% Similarity=0.521 Sum_probs=180.4
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 349886782411396599999987-9939999990466610258899999999715999623487587408646888641
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|...+.||+|+||.||+|... +++.||+|+++.......+.+.+|+++++.++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779889998999970
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 36894245551587422458998999999999999999998479998387088999978749993999634885001478
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 ~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 3798089886415------9999999999999999999999879---722677688868878996864251564132136
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8521124345665344221114989954679999999999991999999999
Q 002566 834 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 170 ~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp TCC-BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCC-CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC
T ss_conf 664-444444777368266447998801203137299999804889989979
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.22 Aligned_cols=202 Identities=24% Similarity=0.434 Sum_probs=179.4
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 8349886782411396599999987-99399999904666-102588999999997159996234875874086468886
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 413689424555158742245899899999999999999999847-9998387088999978749993999634885001
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 830 (907)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred ECCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 7679986899874249-----99999999999999999999998599---971445779946878998999548776256
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 47885211243456653442211149899546799999999999919999999999
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
.... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 156 ~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 156 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CCCC---CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 7886---2111377141194687589989488899899999999988899899887
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.82 Aligned_cols=205 Identities=31% Similarity=0.476 Sum_probs=179.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 349886782411396599999987-99399999904666-1025889999999971599962348758740864688864
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 13689424555158742245899899999999999999999847999838708899997874999399963488500147
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 458980899975379-----9999999999999999999999759---83575468997887899879832314224046
Q ss_pred CCC-CCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 885-21124345665344221114989-95467999999999999199999999996
Q 002566 833 DKT-HISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 833 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGiil~eLltG~~p~~~~~~~ 887 (907)
... ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 886531113255747428728618999997101617379999998299788889859
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=322.94 Aligned_cols=202 Identities=25% Similarity=0.408 Sum_probs=180.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 349886782411396599999987-9939999990466610258899999999715999623487587408646888641
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
-++|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCC
Q ss_conf 36894245551587422458998999999999999999998479998387088999978749--9939996348850014
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 831 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~ 831 (907)
+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 105 ~~gg~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECC
T ss_conf 799889999976237----8999999999999999999997569---760001546736416889869995452104425
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
..... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 178 ~~~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 178 PKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp TTSCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC--CEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 65432--00068624218899758998726765546599999985989989979
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.62 Aligned_cols=203 Identities=27% Similarity=0.458 Sum_probs=178.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 49886782411396599999987-99399999904666102588999999997159996234875874086468886413
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
+.|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++.... ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|.......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC
T ss_conf 9981889998628----99999999999999999999999889---8871407003148789998997161230357786
Q ss_pred CCCCCCCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 52112434566534422111-----49899546799999999999919999999999
Q 002566 835 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred C-CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 4-1001025626479999832025788888066578789999998208899999899
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=320.65 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=179.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 349886782411396599999987-9939999990466610258899999999715999623487587408646888641
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
-++|++.+.||+|+||.||+|... +++.||||+++.........+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCC
Q ss_conf 3689424555158742245899899999999999999999847999838708899997874--99939996348850014
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYE 831 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~--~~~~~kl~DFGla~~~~ 831 (907)
+++|+|.+.+.... ..+++.++..|+.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|....
T Consensus 108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf 89980888898638----99899999999999999999999779---265131445531134678848995256303437
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
..... ....|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 181 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 181 PDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp TTSCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCCE--EECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 88720--10047645348999747998976333898999999996889989979
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.35 Aligned_cols=202 Identities=30% Similarity=0.545 Sum_probs=178.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 49886782411396599999987993999999046661025889999999971599962348758740864688864136
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|...+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 89424555158742245899899999999999999999847999838708899997874999399963488500147885
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|+|.+++..... .+++..+..++.|+|+||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 9918997520134----7889999999999999877653164---31044315326666887768655321002368873
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 211243456653442211149899546799999999999919-99999999
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTNYRP 885 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG-~~p~~~~~ 885 (907)
.......||+.|+|||++.+..++.++||||||+++|||+++ ++|+....
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 350430017666785786079998403321059999999878988877899
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.55 Aligned_cols=199 Identities=28% Similarity=0.478 Sum_probs=177.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|.+.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|....
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECC
T ss_conf 5047985898875048-----9999999999999999999999889---4652202344146689987115556335448
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 158 ~~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 158 SSRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CCCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCC---CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 8852---35578876349999758998931440467599999832999988899
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=323.17 Aligned_cols=204 Identities=30% Similarity=0.508 Sum_probs=175.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC-C---CEEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 498867824113965999999879-9---39999990466-610258899999999715999623487587408646888
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~-g---~~VAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|++.+.||+|+||.||+|.++. + ..||||.+... .....++|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 64136894245551587422458998999999999999999998479998387088999978749993999634885001
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++|+|.+++..... .+++.++..++.|+|+||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCEEEECCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 972279853002104567----9999999999999999889885279---835761504489889991998884431575
Q ss_pred CCCCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 4788521----124345665344221114989954679999999999991-9999999999
Q 002566 831 EEDKTHI----STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 886 (907)
Q Consensus 831 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~ 886 (907)
....... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 6777765365025666883003878883699786121445357899998679999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=326.37 Aligned_cols=207 Identities=25% Similarity=0.433 Sum_probs=181.3
Q ss_pred HHHHHHCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 99998349886782411396599999987-99399999904666102588999999997159996234875874086468
Q 002566 670 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 670 ~i~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
+++...++|...+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+++++.++|||||+++|++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEE
T ss_conf 51745799398659820888089999999999699999977761-03999999999998679998826775274578547
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 88641368942455515874224589989999999999999999984799983870889999787499939996348850
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||+++|+|.+++..... ..+++..+..|+.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 90 iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEECCCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 87631467606777530355---41579999999999999788898789---3057604576899899928983244546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 0147885211243456653442211149899546799999999999919999999
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~ 883 (907)
..............|++.|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 5378872210355665466692787279998104302178999999867998877
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.25 Aligned_cols=201 Identities=29% Similarity=0.368 Sum_probs=178.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|..++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 0357986055553256-----7759999999999965211343159---6224647778476589988882056520035
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCC-CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 6786-2055100889966665048988833310223067889987899999969
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.19 Aligned_cols=201 Identities=26% Similarity=0.416 Sum_probs=178.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECC
T ss_conf 7048987777653159-----9999999999999999997621650---8847677412366888538860321024225
Q ss_pred CCCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 7885-2112434566534422111498995467999999999999199999999
Q 002566 832 EDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~ 884 (907)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC
T ss_conf 677643335556775525844002689896662304569999980388998995
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.81 Aligned_cols=202 Identities=32% Similarity=0.538 Sum_probs=173.6
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 3498867824113965999999879939999990466--61025889999999971599962348758740864688864
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|.+.+.||+|+||.||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 13689424555158742245899899999999999999999847999838708899997874999399963488500147
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+++|+|.+++...+. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred CCCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 5899888999852357----8999999999999999988875099---95161478997981899788750022133355
Q ss_pred CCC-CCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 885-21124345665344221114---9899546799999999999919999999999
Q 002566 833 DKT-HISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 833 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
... .......||+.|||||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 6776312566557431799999505689999531516359999999978899899896
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.96 Aligned_cols=200 Identities=31% Similarity=0.525 Sum_probs=175.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 34988678241139659999998799399999904666102588999999997159996234875874086468886413
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++..... ..+++..+++|+.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf 89828888751478---98878899999999999999997489---5467564225156202440423410147735886
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 521124345665344221114989954679999999999991999999
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 882 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~ 882 (907)
........|++.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 442035677444458289837999824564525799999996898888
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.90 Aligned_cols=209 Identities=27% Similarity=0.441 Sum_probs=178.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf 349886782411396599999987-99399999904666--1025889999999971599962348758740--864688
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 749 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~L 749 (907)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+.+|++++++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 8641368942455515874224589989999999999999999984799--98387088999978749993999634885
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR--IKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~--~~iiH~Dikp~NILl~~~~~~kl~DFGla 827 (907)
||||+++|+|.+++.... .....+++..++.++.|++.||.|||+++. .+|+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEECCCCCCHHHHHHHCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 995689993899998515-4578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 0014788521124345665344221114989954679999999999991999999999
Q 002566 828 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 162 RILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EECCCCCCC-CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC
T ss_conf 322457775-566778823279999839999938988752789999801889989989
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=316.67 Aligned_cols=198 Identities=27% Similarity=0.441 Sum_probs=176.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|++..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EECCCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEEC
T ss_conf 5037863223432222-----1110079999999987655412476---7705568105038689988983175216712
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCC----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC
T ss_conf 456----43457634359999838999804304653336899975989999969
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.46 Aligned_cols=205 Identities=27% Similarity=0.488 Sum_probs=182.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 49886782411396599999987993999999046661025889999999971599962348758740864688864136
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 755 (907)
++|+..++||+|+||.||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 89424555158742245899899999999999999999847999838708899997874999399963488500147885
Q 002566 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (907)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 835 (907)
+|++..++..... .+++..+++++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 9938886410246----7768999999999999999875468---43466541358876998479886144202357872
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 21124345665344221114989954679999999999991-999999999965
Q 002566 836 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888 (907)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~ 888 (907)
.......||+.|+|||++....++.++||||||+++|||++ |+.||.....++
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH
T ss_conf 252465788775780786379988521033643246739755999988999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.28 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=179.0
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEECC-C-----CEEEEEEECCC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 83498867824113965999999879-9-----39999990466-610258899999999715-9996234875874086
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD-G-----TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~~-g-----~~VAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
..++|.+.++||+|+||.||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 468886413689424555158742------------------24589989999999999999999984799983870889
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dik 807 (907)
..++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf 5899997279995999998625777510221000012220012577899999999999999999997399---0505270
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 99978749993999634885001478852-1124345665344221114989954679999999999991-999999999
Q 002566 808 TSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 808 p~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~ 885 (907)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CC
Q ss_conf 96
Q 002566 886 NE 887 (907)
Q Consensus 886 ~~ 887 (907)
.+
T Consensus 272 ~~ 273 (325)
T d1rjba_ 272 VD 273 (325)
T ss_dssp CS
T ss_pred HH
T ss_conf 89
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.90 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=174.3
Q ss_pred HCCCCCCC-EEECCCCEEEEEEEEC---CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 34988678-2411396599999987---99399999904666-1025889999999971599962348758740864688
Q 002566 675 TNNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 t~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.++|...+ +||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 86413689424555158742245899899999999999999999847999838708899997874999399963488500
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHC
T ss_conf 998078996899752125----69999999999999999878998688---10576764660454688542033134211
Q ss_pred CCCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 14788521--124345665344221114989954679999999999991-999999999965
Q 002566 830 YEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888 (907)
Q Consensus 830 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~ 888 (907)
........ .....||+.|+|||++....++.++|||||||++|||++ |+.||......+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~ 220 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 55434321135621137433586887279999541232201789999938999999979999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=313.61 Aligned_cols=208 Identities=28% Similarity=0.407 Sum_probs=174.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHH---HHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999---999997159996234875874086468
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVN---EIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~---E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+ ++.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 88641368942455515874224589989999999999999999984799983870889999787499939996348850
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf 9999148983899987325-----5327899999999999999999779---6220444221678588967982201023
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 014788521124345665344221114-989954679999999999991999999999965566999
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 894 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~~~~~~l~~ 894 (907)
....... ....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...+.+
T Consensus 156 ~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~ 219 (364)
T d1omwa3 156 DFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219 (364)
T ss_dssp ECSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH
T ss_pred ECCCCCC---CCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 3378864---331134554216876038999844104677899999985999888899899999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.87 Aligned_cols=196 Identities=29% Similarity=0.494 Sum_probs=171.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-993999999046661---02588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
+.|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+++|++..++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCC
T ss_conf 8069994578997379-----9999999999999999999998689---7666788421798799978984436533467
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 788521124345665344221114---98995467999999999999199999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGiil~eLltG~~p~~~~ 884 (907)
.. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CC-----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 78-----7313476636889983467888672145455899999998788999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.24 Aligned_cols=202 Identities=26% Similarity=0.404 Sum_probs=177.4
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 8349886782411396599999987-993999999046661-02588999999997159996234875874086468886
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
..+.|++.+.||+|+||.||+|..+ +++.||||++..... .....+.+|+.+++.++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCC
Q ss_conf 413689424555158742245899899999999999999999847999838708899997874---99939996348850
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK 828 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~ 828 (907)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf 5268984888653036-----7887899999999999987524130---5568704630011046888249983154358
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 014788521124345665344221114989954679999999999991999999999
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
....... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 ~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 159 MEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ECCCCCE--EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 7258970--440032842259188737999807873451599999985979999989
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=314.64 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=176.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997159996234875874086468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 751 (907)
++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+++++.++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 41368942455515874224589989999999999999999984799983870889999787499939996348850014
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 831 (907)
||+.+|+|..++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECC
T ss_conf 2334662266675158-----9899999999999999899998599---8617679999360778978861010333225
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 78852112434566534422111498995467999999999999199999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~ 884 (907)
... ....||+.|||||++.+..++.++||||+||++|||++|+.||...
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 666----4336763567889971799885331145007899997588998995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.04 Aligned_cols=201 Identities=27% Similarity=0.371 Sum_probs=177.2
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf 349886782411396599999987-993999999046661------0258899999999715999623487587408646
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 747 (907)
.++|++.+.||+|+||.||+|+.+ +++.||||+++.... ...+.+.+|+.+++.++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEE
Q ss_conf 8886413689424555158742245899899999999999999999847999838708899997874999----399963
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 823 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~D 823 (907)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEECCCCCCCCCHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 99998677864310010356-----4215578999999999987666254---221133301279825898666469643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 48850014788521124345665344221114989954679999999999991999999999
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
||+|........ .....|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf 344210577763--122477774309999818999976652214099999970889988999
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=312.38 Aligned_cols=291 Identities=27% Similarity=0.441 Sum_probs=241.7
Q ss_pred CCCHHHHHHHHHHHHHHCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCEEEEEECCCCCCCC--CC
Q ss_conf 8999999999999998199----99999899999999952259999998664110589992169998235997542--28
Q 002566 35 KLHAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TL 108 (907)
Q Consensus 35 ~~~~~d~~al~~~~~~~~~----~~w~~~~d~c~~~g~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~L~~~~l~g--~i 108 (907)
-|+|+|++||++||+++.+ ++|..++|||. ..|. ||+|+......||+.|+|.+++++| .+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~--~~w~-----------gv~C~~~~~~~~v~~L~L~~~~l~g~~~l 68 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCST-----------TEEECCSSSCCCEEEEEEECCCCSSCEEC
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--CCCC-----------CEEEECCCCCEEEEEEECCCCCCCCCCCC
T ss_conf 9898999999999997799986778899999988--9488-----------96974899947988998989988888879
Q ss_pred CHHCCCCCCCCEEEEEC-CCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCC
Q ss_conf 82002999888998006-86899870000246-52399903876888784101899998999730885899998001067
Q 002566 109 PTELSKLRYLKQLDLSR-NCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (907)
Q Consensus 109 p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l 186 (907)
|++++++++|++|+|++ |++++.+|..++.+ +|++|+|++|++.+..+..+..+.+|+.++++.|.+.+.+|..+.++
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCC
T ss_conf 84784675335202026543330024311454200110203564344332222201110011112245555685122067
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEE
Q ss_conf 554500301331453479000199999-9053335745677730016743345345016657777526431699998898
Q 002566 187 INLQKLILSSNSFTGELPAELTKLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265 (907)
Q Consensus 187 ~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 265 (907)
+.|+.+++++|.+.+.+|..+..+.++ +.++++.|++++..+..+..+..+ .+++..+...+.+|..+..+++++.++
T Consensus 149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4000000235533562031214431123231022464353324332222222-333333433222222222222211122
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCC
Q ss_conf 68987998876511224554698345426556781336989725894579989999914441599879699128857899
Q 002566 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (907)
Q Consensus 266 Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~ 345 (907)
+++|.+.+.++ .+..+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+|+|.
T Consensus 228 -----------------------~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~ 283 (313)
T d1ogqa_ 228 -----------------------LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp -----------------------CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred -----------------------CCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCC
T ss_conf -----------------------22222222222-222455444444765706660876884799999897958835166
Q ss_pred CCHHH-HCCCCCCEEECCC
Q ss_conf 73444-4069841121277
Q 002566 346 VPKYI-FNSNKNVDISLNN 363 (907)
Q Consensus 346 ~p~~~-~~~l~~l~ls~N~ 363 (907)
+|... ...++.+++++|+
T Consensus 284 iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 284 IPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSS
T ss_pred CCCCCCCCCCCHHHHCCCC
T ss_conf 8986667998978868895
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.93 Aligned_cols=197 Identities=28% Similarity=0.469 Sum_probs=167.9
Q ss_pred CCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCEEEEEE
Q ss_conf 86782411396599999987-9939999990466--61025889999999971599962348758740----86468886
Q 002566 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 751 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 751 (907)
+..++||+|+||.||+|.+. +++.||+|.+... .....+.+.+|++++++++|||||++++++.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCC
Q ss_conf 413689424555158742245899899999999999999999847999838708899997874-9993999634885001
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~ 830 (907)
||+++|+|.+++.... .+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 5789894899975135-----5469999999999999999999789-979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4788521124345665344221114989954679999999999991999999999
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCCC---CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 6876---677553813008988478-99986711007999999987889998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.09 Aligned_cols=196 Identities=30% Similarity=0.437 Sum_probs=169.3
Q ss_pred CEEECCCCEEEEEEEECC---CCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 824113965999999879---9399999904666--10258899999999715999623487587408646888641368
Q 002566 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (907)
Q Consensus 682 ~~IG~G~fG~Vyk~~~~~---g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 756 (907)
++||+|+||.||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 94245551587422458998999999999999999998479998387088999978749993999634885001478852
Q 002566 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (907)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 836 (907)
|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|++|||+++........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 96899975225-----7899999999999999976687479---556777611310235675123413453313432344
Q ss_pred C--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 1--124345665344221114989954679999999999991-9999999999
Q 002566 837 I--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 886 (907)
Q Consensus 837 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~ 886 (907)
. .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 32244567784203916653799984344303403132896589999999899
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.36 Aligned_cols=201 Identities=30% Similarity=0.520 Sum_probs=173.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCC-----CEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 4988678241139659999998799-----3999999046661-025889999999971599962348758740864688
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDG-----TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g-----~~VAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
+.|+..++||+|+||.||+|.++.. ..||||++..... ....+|.+|+++++.++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 86413689424555158742245899899999999999999999847999838708899997874999399963488500
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||++++++.+.+..... .+++.++..++.|+++|++|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEECCCCCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 9972135740222102345----4208999999999998541212123---42576564427888998499845510300
Q ss_pred CCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 1478852--11243456653442211149899546799999999999919999999
Q 002566 830 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 830 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~ 883 (907)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 35787652674267777343488887049999735563448989999967988655
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.09 Aligned_cols=201 Identities=30% Similarity=0.507 Sum_probs=175.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 34988678241139659999998799399999904666102588999999997159996234875874086468886413
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++|.+.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|+|||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|..++..... ..++|.+++.|+.|++.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 94 ~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 79943542000035---53059999999999999999875411---4335312307999899929984425554256887
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5211243456653442211149899546799999999999919999999
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~ 883 (907)
........|++.|+|||++..+.++.++||||||+++|||++|..|+..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC
T ss_conf 3352454556654580898379989177413235899999868999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.17 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=174.5
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC---CHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 49886782411396599999987-99399999904666---102588999999997-15999623487587408646888
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~---~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|.+.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 64136894245551587422458998999999999999999998479998387088999978749993999634885001
Q 002566 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 830 (907)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEECCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHC
T ss_conf 75037980899864047-----8999999999999999999998689---340347654044448996301555302323
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4788521124345665344221114989954679999999999991999999999
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 154 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 154 MLGDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CCTTCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 566533-454578777689999827998832320112278989873889999989
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.14 Aligned_cols=210 Identities=29% Similarity=0.544 Sum_probs=177.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCC----EEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 49886782411396599999987-993----9999990466-61025889999999971599962348758740864688
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~VAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.+|++.++||+|+||.||+|.+. +++ .||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 86413689424555158742245899899999999999999999847999838708899997874999399963488500
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
++|++.+|+|.+.+.... ..+++..+++++.|+|+||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEECCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf 998426874010111334----57999999999999999999998769---50476212031167998758602552223
Q ss_pred CCCCCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHH
Q ss_conf 14788521-124345665344221114989954679999999999991-99999999996556699
Q 002566 830 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 893 (907)
Q Consensus 830 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~~~~l~ 893 (907)
........ .....||+.|+|||++.++.++.++||||||+++|||+| |+.||......+....+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 354445322365105864467088746999835654407999999997799999999989999999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.74 Aligned_cols=201 Identities=19% Similarity=0.316 Sum_probs=176.6
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 349886782411396599999987-9939999990466610258899999999715999623487587408646888641
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
.++|.+.+.||+|+||.||+|.+. +++.||+|.++... .....+.+|+++++.++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCC
Q ss_conf 368942455515874224589989999999999999999984799983870889999787499--939996348850014
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE 831 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~--~~~kl~DFGla~~~~ 831 (907)
+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ ..+|++|||+++...
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC
T ss_conf 89980889987538----99999999999999999999998769---975135544434437885189976441110034
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 788521124345665344221114989954679999999999991999999999
Q 002566 832 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.... .....+++.|+|||...+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCC--CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 6775--321223322234021048777840113027999999982899999989
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=307.79 Aligned_cols=215 Identities=30% Similarity=0.444 Sum_probs=181.7
Q ss_pred HHHHHHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCH-HHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 8899998349886782411396599999987------9939999990466610-25889999999971599962348758
Q 002566 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGC 740 (907)
Q Consensus 668 ~~~i~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~ 740 (907)
+.+++..+++|++.+.||+|+||.||+|+++ +++.||||+++..... ..++|.+|+++++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 7408646888641368942455515874-------------------224589989999999999999999984799983
Q 002566 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801 (907)
Q Consensus 741 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 801 (907)
+...+..++|||++++|+|.++++.... .....+++..++.|+.|++.||+|||+.+ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred EECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC-
Q ss_conf 87088999978749993999634885001478852-1124345665344221114989954679999999999991999-
Q 002566 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS- 879 (907)
Q Consensus 802 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~- 879 (907)
+||||||+|||++.++.+||+|||+|+........ ......|++.|+|||++.+..++.++||||||+++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCC
Q ss_conf 999999
Q 002566 880 NTNYRP 885 (907)
Q Consensus 880 p~~~~~ 885 (907)
||....
T Consensus 242 p~~~~~ 247 (301)
T d1lufa_ 242 PYYGMA 247 (301)
T ss_dssp TTTTSC
T ss_pred CCCCCC
T ss_conf 999989
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=301.66 Aligned_cols=203 Identities=23% Similarity=0.375 Sum_probs=175.8
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----E
Q ss_conf 349886782411396599999987-993999999046661---02588999999997159996234875874086----4
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 746 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 746 (907)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 68886413689424555158742245899899999999999999999847999838708899997874999399963488
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+++++|.+++.... .+++.+++.++.|+++||+|||+++ |+||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEEHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHH
T ss_conf 999997788987101120358-----9999999999999999999998579---52763467556657543201003444
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 500147885--21124345665344221114989954679999999999991999999999
Q 002566 827 AKLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 827 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
+........ .......||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC
T ss_conf 3221235443333464257624369999839999966320265289999976979989969
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.29 Aligned_cols=206 Identities=28% Similarity=0.409 Sum_probs=177.0
Q ss_pred HCCCCCCCEEECCCCEEEEEEEECC----CCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 3498867824113965999999879----93999999046661-025889999999971599962348758740864688
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~VAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~L 749 (907)
.++|...+.||+|+||.||+|++.. +..||||.++.... .....|.+|+.++++++|||||+++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 86413689424555158742245899899999999999999999847999838708899997874999399963488500
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
||||+++|++.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 998406980776542247----89999999999999987752302267---44141026553206789678765034213
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 14788521124345665344221114989954679999999999991-999999999965
Q 002566 830 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 888 (907)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~ 888 (907)
.............||+.|+|||++.+..++.++|||||||++|||++ |++||......+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 367762330540058310326675169988745244424789999826999988899999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.78 Aligned_cols=198 Identities=23% Similarity=0.301 Sum_probs=168.3
Q ss_pred HCCCCCCC-EEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEE----CCEE
Q ss_conf 34988678-2411396599999987-993999999046661025889999999971-599962348758740----8646
Q 002566 675 TNNFDPAN-KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE----GNQL 747 (907)
Q Consensus 675 t~~f~~~~-~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~ 747 (907)
-++|.+.. .||+|+||.||+|+.. +++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEC
Q ss_conf 88864136894245551587422458998999999999999999998479998387088999978749---993999634
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDF 824 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DF 824 (907)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 999977899849999986278---77579999999999999999999769---864441002201135555663113545
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8850014788521124345665344221114989954679999999999991999999999
Q 002566 825 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 825 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
|+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 G~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 159 GFAKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp TTCEECCCCCCC--CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred CEEEECCCCCCC--CCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC
T ss_conf 512333688864--32267756379277748988888888764516778865889988988
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=297.40 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=175.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCH---------HHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 349886782411396599999987-9939999990466610---------2588999999997159-9962348758740
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQ-HPNLVKLYGCCVE 743 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~---------~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~ 743 (907)
-++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 86468886413689424555158742245899899999999999999999847999838708899997874999399963
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 823 (907)
++..++||||+++|+|.+++..+. .+++.+++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECC
T ss_conf 760599997689866899998659-----9999999999999999999998759---94323462548986899838712
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 48850014788521124345665344221114------989954679999999999991999999999
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 154 FG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 154 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHEEECCCCCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC
T ss_conf 403167268872--134524678889888605344567889923318565602310322888988999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=300.15 Aligned_cols=197 Identities=27% Similarity=0.398 Sum_probs=168.3
Q ss_pred CCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 782411396599999987-9939999990466610-----2588999999997159996234875874086468886413
Q 002566 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (907)
Q Consensus 681 ~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 754 (907)
.++||+|+||.||+|+.+ +++.||||+++..... ..+.+.+|+.+++.++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
+++++..+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CCHHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 450776554126-----67789999999999999998863163---5503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 521124345665344221114-9899546799999999999919999999999
Q 002566 835 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
.. ....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC-CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCH
T ss_conf 54-33020473336399972677888056436304289999859699999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=297.28 Aligned_cols=202 Identities=28% Similarity=0.458 Sum_probs=172.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 49886782411396599999987-99399999904666--1025889999999971599962348758740864688864
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|++.++||+|+||.||+|++. +++.||+|+++... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 13689424555158742245899899999999999999999847999838708899997874999399963488500147
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
|+.++.+........ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEEHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ECCCCHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCC
T ss_conf 237744555442025----68888999999999999999865288---99213571140113467621035786134368
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8852112434566534422111498-9954679999999999991999999999
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.... .....|++.|+|||++.... ++.++||||+||++|||++|+.||....
T Consensus 155 ~~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 155 PVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp CSBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCC-CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC
T ss_conf 8641-0010365215411221366577742210333313427966879989889
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.92 Aligned_cols=214 Identities=27% Similarity=0.392 Sum_probs=174.7
Q ss_pred HHHHHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHC-CCCCEEEEEEE
Q ss_conf 899998349886782411396599999987------99399999904666-10258899999999715-99962348758
Q 002566 669 RQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGC 740 (907)
Q Consensus 669 ~~i~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~ 740 (907)
.+++...++|.+.++||+|+||.||+|.+. +++.||||+++... ....+.+.+|...+.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 25261679979844984167839999998677755578399999986001717899999999998861499849974115
Q ss_pred EEEC-CEEEEEEEECCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 7408-6468886413689424555158742-----------245899899999999999999999847999838708899
Q 002566 741 CVEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 808 (907)
Q Consensus 741 ~~~~-~~~~LV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp 808 (907)
+.+. ...++||||+++|+|.+++...... ....+++.++..++.|+++||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCC
T ss_conf 404797579999845899299999853666665322202332146899999999999999999887379---71786773
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 9978749993999634885001478852-112434566534422111498995467999999999999199-9999999
Q 002566 809 SNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTNYRP 885 (907)
Q Consensus 809 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~-~p~~~~~ 885 (907)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf 1065779982898457520011356652224751667210203686468899663221367899999868899998999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=293.97 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=177.7
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 8349886782411396599999987------993999999046661-0258899999999715-9996234875874086
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 745 (907)
..++|...++||+|+||.||+|++. +++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred EEEEEEEECCCCCHHHHHHCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 46888641368942455515874-------------22458998999999999999999998479998387088999978
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDT-------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 812 (907)
..++||||+++|+|.++++.... .....+++..+.+++.||++|++|||+++ ++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579---266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 74999399963488500147885-21124345665344221114989954679999999999991-9999999999
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 886 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~ 886 (907)
++.++.+|++|||.++....... .......||+.|+|||++....++.++||||||+++|||++ |++|+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 0025752102340102336788615862013596876778861799997400102589999998589988778998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.89 Aligned_cols=197 Identities=29% Similarity=0.449 Sum_probs=169.1
Q ss_pred CCEEECCCCEEEEEEEECCC----CEEEEEEECCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEEC
Q ss_conf 78241139659999998799----39999990466-61025889999999971599962348758740-86468886413
Q 002566 681 ANKVGEGGFGSVYKGILSDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 754 (907)
Q Consensus 681 ~~~IG~G~fG~Vyk~~~~~g----~~VAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~~ 754 (907)
.++||+|+||+||+|.+.+. ..||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++..... .+++..+++++.|+++||.|+|+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ECCCHHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 06741442101345----4048999999999887652003367---6257766875767799988991065232255665
Q ss_pred CC---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52---112434566534422111498995467999999999999199999999
Q 002566 835 TH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 835 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~ 884 (907)
.. ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 55310025655564556768874379997457466199999999789999888
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=297.23 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=174.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEEC
Q ss_conf 49886782411396599999987993999999046661025889999999971599962348758740-86468886413
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 754 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~~ 754 (907)
++|+..+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|++++++++||||++++|++.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-9099999988577--79999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 68942455515874224589989999999999999999984799983870889999787499939996348850014788
Q 002566 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (907)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 834 (907)
++|+|.+++..... ..+++..+++|+.|++.|+.|||+.+ ++||||||+|||++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 99989999874578---88899999999999985232113376---5536665676014689977632456003447877
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHH
Q ss_conf 521124345665344221114989954679999999999991-999999999965566999888
Q 002566 835 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAY 897 (907)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~~~~l~~~~~ 897 (907)
....++..|+|||++.+..+++++||||||+++|||++ |+.||..... ..+++++.
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~ 214 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE 214 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT
T ss_pred ----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH
T ss_conf ----6556664677817872798885887775799999999789999999999---99999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.39 Aligned_cols=198 Identities=30% Similarity=0.423 Sum_probs=162.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHH--HHHHHCCCCCEEEEEEEEEECC----EEEE
Q ss_conf 498867824113965999999879939999990466610258899999--9997159996234875874086----4688
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI--GMISAQQHPNLVKLYGCCVEGN----QLLL 749 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~--~~l~~l~H~nIv~l~g~~~~~~----~~~L 749 (907)
++|...+.||+|+||.||+|++ +++.||||+++... .+.+..|. ..+..++|||||++++++.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-99899999987200---4679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 86413689424555158742245899899999999999999999847-----9998387088999978749993999634
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~iiH~Dikp~NILl~~~~~~kl~DF 824 (907)
||||+++|+|.+++... .++|..+++++.|+|.|+.|+|+. +.++|+||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEECCCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEEC
T ss_conf 99646698989998658------999899999999999999998876652046898661531731357868877688763
Q ss_pred CCCCCCCCCCCCC---CCCCCCCCCCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 8850014788521---12434566534422111498------99546799999999999919999999
Q 002566 825 GLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 825 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGiil~eLltG~~p~~~ 883 (907)
|+++......... .....||+.|+|||++.... ++.++||||||+++|||++|..|+..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 86623467776200135525035476782210565454677767501220159999999628998876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.28 Aligned_cols=213 Identities=28% Similarity=0.422 Sum_probs=176.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC-CC--EEEEEEECCC-CCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf 498867824113965999999879-93--9999990466-610258899999999715-999623487587408646888
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~--~VAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~LV 750 (907)
++|+..++||+|+||.||+|++++ +. .||||++... .....+.|.+|+++++++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 641368942455515874-----------224589989999999999999999984799983870889999787499939
Q 002566 751 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 751 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 819 (907)
|||+++|+|.++++.... .....+++..+.+++.|+|+|+.|+|+.+ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCCCCHHHHHHHH
Q ss_conf 996348850014788521124345665344221114989954679999999999991999-99999996556699988
Q 002566 820 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS-NTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~-p~~~~~~~~~~~l~~~~ 896 (907)
||+|||+++........ ....||..|+|||.+....++.++||||||+++|||++|.. ||... ....+.+.+
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHG
T ss_pred EECCCCCCCCCCCCCCC--CCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC---CHHHHHHHH
T ss_conf 87434432244422345--53013775555387526999962215313889999983689999999---999999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=294.04 Aligned_cols=209 Identities=29% Similarity=0.435 Sum_probs=177.4
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCC-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE
Q ss_conf 83498867824113965999999879--------93999999046661-0258899999999715-99962348758740
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 743 (907)
..++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 86468886413689424555158742-----------2458998999999999999999998479998387088999978
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 812 (907)
++..++||||+++|+|.+++...... ....+++..+++++.|+++||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379---786302210224
Q ss_pred ECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 74999399963488500147885-21124345665344221114989954679999999999991-999999999
Q 002566 813 LDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 885 (907)
Q Consensus 813 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~ 885 (907)
++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 547897676221110113555554314667888466326675179888255547758888874017989899999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.63 Aligned_cols=211 Identities=26% Similarity=0.412 Sum_probs=177.5
Q ss_pred HHHHCCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
Q ss_conf 998349886782411396599999987------99399999904666-10258899999999715999623487587408
Q 002566 672 KAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (907)
Q Consensus 672 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 744 (907)
+...++|...+.||+|+||.||+|.+. +++.||||+++... ......|.+|+.++++++||||++++|++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 42689918835982078818999998786447789689999987012868999999999999976999884125478428
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 646888641368942455515874-----224589989999999999999999984799983870889999787499939
Q 002566 745 NQLLLVYEYMKNNCLSRAIFGKDT-----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (907)
Q Consensus 745 ~~~~LV~E~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 819 (907)
+..++||||+++|+|.+++..... .....+++..+.+++.|+|+||.|||+++ |+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEE
T ss_conf 8106777604899889998750332113444688799999999999999999876479---6543286775403599649
Q ss_pred EEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 99634885001478852-112434566534422111498995467999999999999199-9999999
Q 002566 820 KISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTNYRP 885 (907)
Q Consensus 820 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~-~p~~~~~ 885 (907)
||+|||+|+........ ......|++.|+|||.+.+..++.++||||||+++|||++|+ .||....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 99424542023577630313402316323788887369988333444378999999968999999989
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=292.32 Aligned_cols=203 Identities=26% Similarity=0.458 Sum_probs=167.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-C-CCEEEEEEECCCCC--HHHHHHHHHHHHHHH---CCCCCEEEEEEEEEE----
Q ss_conf 349886782411396599999987-9-93999999046661--025889999999971---599962348758740----
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSR--QGNREFVNEIGMISA---QQHPNLVKLYGCCVE---- 743 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~-g~~VAVK~~~~~~~--~~~~~f~~E~~~l~~---l~H~nIv~l~g~~~~---- 743 (907)
.++|++.++||+|+||.||+|++. + ++.||||+++.... .....+.+|+.+++. .+||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf -8646888641368942455515874224589989999999999999999984799983870889999787499939996
Q 002566 744 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (907)
Q Consensus 744 -~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 822 (907)
....+++||+++++.+........ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEEC
T ss_conf 6746999997405871444443037----89998999999999999999997588---9835798627898589975421
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 3488500147885211243456653442211149899546799999999999919999999999
Q 002566 823 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 823 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
|||.+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 159 dfg~~~~~~~~~~--~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 159 DFGLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp SCCSCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CHHHHHHHCCCCC--CCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH
T ss_conf 0001011002345--7776548511483100179888111000328999999878799899898
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=297.42 Aligned_cols=210 Identities=24% Similarity=0.405 Sum_probs=175.3
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC--C--CEEEEEEECCC---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 498867824113965999999879--9--39999990466---6102588999999997159996234875874086468
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSD--G--TVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~--g--~~VAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 748 (907)
++|++.+.||+|+||.||+|++.. + ..||||+++.. ..+..++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 88641368942455515874224589989999999999999999984799983870889999787499939996348850
Q 002566 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (907)
Q Consensus 749 LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 828 (907)
+||||+++|++.+.+.... ..+++..+++++.|+|+||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEECCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf 1465423861254442126----89999999999999999998752178---7520566888156556543325611555
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHH
Q ss_conf 01478852--1124345665344221114989954679999999999991-99999999996556699988
Q 002566 829 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWA 896 (907)
Q Consensus 829 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLlt-G~~p~~~~~~~~~~~l~~~~ 896 (907)
........ ......|+..|+|||++.+..++.++||||||+++|||++ |+.||.... ....+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i 227 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKI 227 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH
T ss_conf 303588752654763257310799998379999421566148999999968999999969---99999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=291.31 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=174.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 4988678241139659999998799399999904666--10258899999999715999623487587408646888641
Q 002566 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 753 (907)
++|...++||+|+||.||+|++++++.||||+++... ......+.+|+.++++++|||||++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 36894245551587422458998999999999999999998479998387088999978749993999634885001478
Q 002566 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (907)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 833 (907)
+.++.+....... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EHHHHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 0045678998604-----77514456899999999999860574---882678775056868997873236643011467
Q ss_pred CCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8521124345665344221114-989954679999999999991999999999
Q 002566 834 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
... .....|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 154 VRK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCC-CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCC
T ss_conf 654-1010243110137887178888841002111758999977979989889
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=289.30 Aligned_cols=204 Identities=24% Similarity=0.360 Sum_probs=171.4
Q ss_pred HHCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EE
Q ss_conf 8349886782411396599999987-99399999904666-102588999999997159996234875874086----46
Q 002566 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QL 747 (907)
Q Consensus 674 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~ 747 (907)
.+.+|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88864136894245551587422458998999999999999999998479998387088999978749993999634885
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 827 (907)
+++++++.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 9999962598656644058------9999999999999999999999789---867778764378879997787545705
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 001478852--112434566534422111-49899546799999999999919999999999
Q 002566 828 KLYEEDKTH--ISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 828 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
......... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCH
T ss_conf 65047776410101102652000387860478887410100467013377669799788888
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=286.68 Aligned_cols=207 Identities=24% Similarity=0.393 Sum_probs=171.6
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
Q ss_conf 349886782411396599999987-99399999904666--1025889999999971599962348758740--------
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-------- 743 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-------- 743 (907)
-++|++.++||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 86468886413689424555158742245899899999999999999999847999838708899997874999399963
Q 002566 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (907)
Q Consensus 744 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 823 (907)
.+..++|||+++++.+....... ..++...+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEECCCCCCCCHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEE
T ss_conf 76389998535787410122203-----44330899999999999998852299---88567672220366899687631
Q ss_pred CCCCCCCCCCCCC---CCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 4885001478852---11243456653442211149-899546799999999999919999999999655
Q 002566 824 FGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 889 (907)
Q Consensus 824 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGiil~eLltG~~p~~~~~~~~~ 889 (907)
||++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred CCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH
T ss_conf 3500223554443211356602497874289970799989178700678646617448799899899999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=286.20 Aligned_cols=199 Identities=29% Similarity=0.377 Sum_probs=163.4
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CEEEE
Q ss_conf 9886782411396599999987-9939999990466610258899999999715999623487587408------64688
Q 002566 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 749 (907)
Q Consensus 677 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~L 749 (907)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|++++++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCC
Q ss_conf 86413689424555158742245899899999999999999999847999838708899997874999-39996348850
Q 002566 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 828 (907)
Q Consensus 750 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~ 828 (907)
||||++++.+....... .....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 98416886078888631--03689999999999999999999998668---76457886037873589711673366054
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 014788521124345665344221114-9899546799999999999919999999999
Q 002566 829 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
........ ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 172 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 172 QLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp ECCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred HCCCCCCC--CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCH
T ss_conf 40477653--2002555556827764046888210002465277855028799898799
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=287.43 Aligned_cols=197 Identities=26% Similarity=0.423 Sum_probs=169.5
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCC--CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf 349886782411396599999987-9939999990466--6102588999999997159996234875874086------
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 745 (907)
.++|.+.++||+|+||.||+|... +++.||||+++.. .....+.+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 46888641368942455515874224589989999999999999999984799983870889999787499939996348
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 825 (907)
..++||||+ +.+|....... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEECC-CCCHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 599998405-52189998740------2269999999999999999987378---7645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 850014788521124345665344221114-989954679999999999991999999999
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
+|+...... ....|++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CEECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 022068763----102455333588998178789965010300389999997869988897
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=289.59 Aligned_cols=198 Identities=23% Similarity=0.366 Sum_probs=167.1
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 349886782411396599999987-993999999046661------02588999999997159--996234875874086
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGN 745 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~------~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~ 745 (907)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEE
Q ss_conf 46888641368-942455515874224589989999999999999999984799983870889999787499-9399963
Q 002566 746 QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISD 823 (907)
Q Consensus 746 ~~~LV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~D 823 (907)
..++|||++.+ +++.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEEEECCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECC
T ss_conf 6899998336862289998615-----89999999999999999999998779---755667611147744788489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 48850014788521124345665344221114989-9546799999999999919999999
Q 002566 824 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 883 (907)
Q Consensus 824 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGiil~eLltG~~p~~~ 883 (907)
||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||..
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCCEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCC
T ss_conf 46535324445---56656587747999984899788653325540345367568899887
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=279.70 Aligned_cols=206 Identities=20% Similarity=0.289 Sum_probs=173.5
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf 349886782411396599999987-993999999046661025889999999971599-962348758740864688864
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E 752 (907)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCC
Q ss_conf 136894245551587422458998999999999999999998479998387088999978749-----993999634885
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLA 827 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-----~~~~kl~DFGla 827 (907)
++ +++|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EC-CCCHHHHHHHHCC----CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEE
T ss_conf 64-8887999975203----1106899999999999999999779---66266771315234754344795687236605
Q ss_pred CCCCCCCCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 001478852------112434566534422111498995467999999999999199999999996556
Q 002566 828 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 890 (907)
Q Consensus 828 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~~~~~ 890 (907)
+........ ......||+.|||||++.+..++.++||||||+++|||++|+.||.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~ 222 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred EECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 771467665411102467627751026798964888886999898319999998698767885302199
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=284.70 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=176.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC----CCCEEEEEEECCCC----CHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCE
Q ss_conf 49886782411396599999987----99399999904666----1025889999999971599-962348758740864
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQ 746 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~VAVK~~~~~~----~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 746 (907)
++|++.+.||+|+||.||+|+.. +|+.||+|.++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 68886413689424555158742245899899999999999999999847999838708899997874999399963488
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 826 (907)
.++||||+.+|+|.+++.... .++...+..++.|++.|++|+|+++ ++||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCC
T ss_conf 001231234117999987304-----5437888888999999998851499---89654773201246999888741320
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 500147885211243456653442211149--89954679999999999991999999999965
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 888 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGiil~eLltG~~p~~~~~~~~ 888 (907)
++.+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 2220344443221222333331068760577688713251777799999976899988887777
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=274.54 Aligned_cols=200 Identities=22% Similarity=0.375 Sum_probs=173.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 49886782411396599999987-99399999904666--1025889999999971599962348758740864688864
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 752 (907)
++|++.++||+|+||+||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 13689424555158742245899899999999999999999847999838708899997874999399963488500147
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 832 (907)
++.++++..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||.+.....
T Consensus 82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCC
T ss_conf 023322211212356-----5403678999999999987743399---86001467612113378266520460110468
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 8852112434566534422111498-995467999999999999199999999
Q 002566 833 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 884 (907)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGiil~eLltG~~p~~~~ 884 (907)
.... .....++..|+|||++.... ++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred CCCC-CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf 8751-001034431014667506988880444026541889985189999889
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-45 Score=275.14 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=165.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCEEE-EEEEEEECCEEEEEEE
Q ss_conf 349886782411396599999987-99399999904666102588999999997159996234-8758740864688864
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK-LYGCCVEGNQLLLVYE 752 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~LV~E 752 (907)
.++|.+.+.||+|+||.||+|++. +++.||||++..... ..++..|+++++.++|++++. +.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCCC
Q ss_conf 136894245551587422458998999999999999999998479998387088999978749---99399963488500
Q 002566 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKL 829 (907)
Q Consensus 753 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~ 829 (907)
|+++ ++...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+|++|||+|+.
T Consensus 84 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCCC-BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred ECCC-CHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 7387-1333244306----88768999999999999999999799---44266787660643357776156504675134
Q ss_pred CCCCCCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 1478852------112434566534422111498995467999999999999199999999996
Q 002566 830 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 887 (907)
Q Consensus 830 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~~~ 887 (907)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHH
T ss_conf 2554455410001357767873532999991899898321886177899998498766553057
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-45 Score=274.03 Aligned_cols=195 Identities=21% Similarity=0.357 Sum_probs=167.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE--CCEEEEEE
Q ss_conf 49886782411396599999987-99399999904666102588999999997159-9962348758740--86468886
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY 751 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~ 751 (907)
++|.+.++||+|+||.||+|+.. +++.||+|+++... .+.+.+|+++++.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 413689424555158742245899899999999999999999847999838708899997874999-3999634885001
Q 002566 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY 830 (907)
Q Consensus 752 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~ 830 (907)
||+++++|..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+|++|||+|+..
T Consensus 112 e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EECCCCCHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 6317985899746--------8999999999999999998876433---4434564412377489983664156542664
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 47885211243456653442211149-899546799999999999919999999999
Q 002566 831 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 886 (907)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGiil~eLltG~~p~~~~~~ 886 (907)
..... .....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||.....
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 68874--44322486424761026888888452323354555876048899988760
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=276.43 Aligned_cols=198 Identities=26% Similarity=0.318 Sum_probs=169.9
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE------CC
Q ss_conf 349886782411396599999987-99399999904666--1025889999999971599962348758740------86
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GN 745 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~------~~ 745 (907)
.++|++.++||+|+||+||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 46888641368942455515874224589989999999999999999984799983870889999787499939996348
Q 002566 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (907)
Q Consensus 746 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 825 (907)
..++||||+.++.+. .+.. .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHHH-HHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEECCCHHHHH-HHHC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 269998414467787-6503-------8999999999999999998865221---1245677632113654431320102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 850014788521124345665344221114989954679999999999991999999999
Q 002566 826 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 826 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
+++....... .....+|+.|+|||++.+..+++++||||+||+++||++|+.||....
T Consensus 165 ~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 165 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHCCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC
T ss_conf 3211466655--332214655558133147777877433356625789865989988897
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=277.23 Aligned_cols=198 Identities=26% Similarity=0.389 Sum_probs=169.3
Q ss_pred HCCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----CE
Q ss_conf 349886782411396599999987-99399999904666--10258899999999715999623487587408-----64
Q 002566 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (907)
Q Consensus 675 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 746 (907)
.++|.+.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++++.++|+|+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 68886413689424555158742245899899999999999999999847999838708899997874999399963488
Q 002566 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (907)
Q Consensus 747 ~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 826 (907)
.+++++++.+|+|.+++..+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEEEEECCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 49999962588623200224------5309999999999999999997388---76516677633455432200132100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 500147885211243456653442211149-89954679999999999991999999999
Q 002566 827 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 827 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
+...... .....|+..|+|||...+. .++.++||||+||++|||++|+.||....
T Consensus 168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HCCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 0125754----4443454355583553377567855124320589999976889978898
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-39 Score=240.52 Aligned_cols=200 Identities=24% Similarity=0.270 Sum_probs=157.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf 49886782411396599999987-99399999904666102588999999997159-----------9962348758740
Q 002566 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE 743 (907)
Q Consensus 676 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~g~~~~ 743 (907)
.+|.+.++||+|+||.||+|+.. +++.||||+++.... ....+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC---
Q ss_conf 8--646888641368942455515874224589989999999999999999984-7999838708899997874999---
Q 002566 744 G--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDL--- 817 (907)
Q Consensus 744 ~--~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~--- 817 (907)
. ...+++++++..+......... .....+++..+..++.|++.|+.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCC
T ss_conf 2565202343200035420000012--234678689999999999999888764058---64656770570563057656
Q ss_pred ---CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf ---39996348850014788521124345665344221114989954679999999999991999999999
Q 002566 818 ---NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 885 (907)
Q Consensus 818 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGiil~eLltG~~p~~~~~ 885 (907)
.++++|||.+....... ....|++.|+|||++....++.++||||+|++++||++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCCEEEEEECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 44305675314421234454----22366521057132146677764320123789999987889989875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=236.15 Aligned_cols=267 Identities=19% Similarity=0.253 Sum_probs=194.0
Q ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCC
Q ss_conf 110589992169998235997542288200299988899800686899870000246-5239990387688878410189
Q 002566 83 VTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161 (907)
Q Consensus 83 v~C~~~~~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~ 161 (907)
..|.|..... ..+++++.+++ .+|..+. +.+++|+|++|+|+.+.+..|..+ +|+.|++++|.+..+.+..+..
T Consensus 4 ~~C~C~~~~~--~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~ 78 (284)
T d1ozna_ 4 GACVCYNEPK--VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78 (284)
T ss_dssp TTCEEECSSS--CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CCCEECCCCC--EEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9889869999--69984799989-4497889--99888977488179879778641421300001344543321112122
Q ss_pred CCCCCEEEEE-CCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 9998999730-885899998001067554500301331453479000199999905333574567773001674334534
Q 002566 162 ITTLKNLSIE-GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (907)
Q Consensus 162 L~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 240 (907)
+..++.++.. .|.++...+..|.++++|+.|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|
T Consensus 79 ~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L 158 (284)
T d1ozna_ 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (284)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHC
T ss_conf 22222222221022354462010101027787568854432013533200012110200143144580574043405022
Q ss_pred ECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 50166577775264316999988986898799887651122455469834542655678133698972589457998999
Q 002566 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (907)
Q Consensus 241 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~ 320 (907)
++++|+++...+..|.++++| +.+++++|++++..|..|..+++|+.|++++|++.+
T Consensus 159 ~l~~N~l~~l~~~~f~~l~~L-----------------------~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~ 215 (284)
T d1ozna_ 159 FLHGNRISSVPERAFRGLHSL-----------------------DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTC-----------------------CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCCCCCCCCHHHHCCCCCC-----------------------CHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 314176566256665465634-----------------------131421143466281676653200023333352210
Q ss_pred CCCHHHHCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCC
Q ss_conf 99144415998796991288578997344440698411212776479999888899983320024788887887768667
Q 002566 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLR 400 (907)
Q Consensus 321 ~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~l~~~~~~~~~~~~~~~~~~~ 400 (907)
..+..|..+++|+.|+|++| ||.|||.+.|+..|++..... .
T Consensus 216 ~~~~~~~~~~~L~~L~l~~N------------------------------~l~C~C~~~~l~~~l~~~~~~--------~ 257 (284)
T d1ozna_ 216 LPTEALAPLRALQYLRLNDN------------------------------PWVCDCRARPLWAWLQKFRGS--------S 257 (284)
T ss_dssp CCHHHHTTCTTCCEEECCSS------------------------------CEECSGGGHHHHHHHHHCCSE--------E
T ss_pred CCCCCCCCCCCCCEEEECCC------------------------------CCCCCCCCHHHHHHHHHCCCC--------C
T ss_conf 00002355465688981199------------------------------887875646999999867388--------8
Q ss_pred CCCCCCCCCCCCCCC
Q ss_conf 787899997876433
Q 002566 401 QNFPCSAPADQYHYT 415 (907)
Q Consensus 401 ~~~~C~~p~~~~~~~ 415 (907)
....|+.|....|+.
T Consensus 258 ~~~~C~~p~~l~g~~ 272 (284)
T d1ozna_ 258 SEVPCSLPQRLAGRD 272 (284)
T ss_dssp CCCBEEESGGGTTCB
T ss_pred CCEEECCCHHHCCCC
T ss_conf 866747966984985
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.6e-38 Score=232.92 Aligned_cols=228 Identities=27% Similarity=0.440 Sum_probs=163.0
Q ss_pred CCCEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEEEC-CCCCCCCCHHHHCCCCCCEEEEC
Q ss_conf 88899800686899870000246523999038768887841018999989997308-85899998001067554500301
Q 002566 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILS 195 (907)
Q Consensus 117 ~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~ 195 (907)
+++.|+|++|++++.. .+|..+++|++|++|+|++ |+++|.+|..|+++++|++|+|+
T Consensus 51 ~v~~L~L~~~~l~g~~---------------------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls 109 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPY---------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109 (313)
T ss_dssp CEEEEEEECCCCSSCE---------------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEE
T ss_pred EEEEEECCCCCCCCCC---------------------CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 9889989899888888---------------------7984784675335202026543330024311454200110203
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCC-CEEECCCCCCCCC
Q ss_conf 331453479000199999905333574567773001674334534501665777752643169999-8898689879988
Q 002566 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISDLKGSES 274 (907)
Q Consensus 196 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~n~~~~~ 274 (907)
+|++.+..+..+..+.+|+.++++.|.+.+.+|..+.+++.++.+++++|.+.+.+|..+..+..+ +.++++.|++...
T Consensus 110 ~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~ 189 (313)
T d1ogqa_ 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189 (313)
T ss_dssp EECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEE
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 56434433222220111001111224555568512206740000002355335620312144311232310224643533
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHH--HC
Q ss_conf 7651122455469834542655678133698972589457998999991444159987969912885789973444--40
Q 002566 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FN 352 (907)
Q Consensus 275 ~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~--~~ 352 (907)
....+....+..++++.|.+.+.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..+ ..
T Consensus 190 ~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~ 268 (313)
T d1ogqa_ 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268 (313)
T ss_dssp CCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCC
T ss_conf 2433222222233333343322222222222221112222222222222-222455444444765706660876884799
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 69841121277647
Q 002566 353 SNKNVDISLNNFTW 366 (907)
Q Consensus 353 ~l~~l~ls~N~~~~ 366 (907)
.++.+++++|+++.
T Consensus 269 ~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 269 FLHSLNVSFNNLCG 282 (313)
T ss_dssp TCCEEECCSSEEEE
T ss_pred CCCEEECCCCCCCC
T ss_conf 99989795883516
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=219.11 Aligned_cols=220 Identities=24% Similarity=0.275 Sum_probs=113.4
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCCCCHHCCCCCC
Q ss_conf 05899921699982359975422882002999888998006868998700002465239990387688878410189999
Q 002566 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT 164 (907)
Q Consensus 85 C~~~~~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~L~~ 164 (907)
|.|..... ...+++++++++ .+|+.+. ++|+.|+|++|.|+++. +..|.++++
T Consensus 4 C~~~~~~~-~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~-----------------------~~~f~~l~~ 56 (266)
T d1p9ag_ 4 CEVSKVAS-HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFS-----------------------LATLMPYTR 56 (266)
T ss_dssp SEEECSTT-CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEE-----------------------GGGGTTCTT
T ss_pred CEECCCCC-CEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCC-----------------------HHHHHCCCC
T ss_conf 67742689-869980699988-6196757--68898988499289859-----------------------778634565
Q ss_pred CCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 89997308858999980010675545003013314534790001999999053335745677730016743345345016
Q 002566 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG 244 (907)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 244 (907)
|++|+|++|+|+. ++ .+..+++|+.|+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.+++.|++++
T Consensus 57 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 57 LTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp CCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 5221356654444-31-1111223211111222221-1111212222222222222311011001122221111221243
Q ss_pred CCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH
Q ss_conf 65777752643169999889868987998876511224554698345426556781336989725894579989999914
Q 002566 245 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT 324 (907)
Q Consensus 245 N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~ 324 (907)
|.++...+..+..++ +|+.+++++|+|++..+..|..+++|++|+|++|+|+ .+|.
T Consensus 134 n~l~~l~~~~~~~l~-----------------------~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~ 189 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTP-----------------------KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (266)
T ss_dssp SCCCCCCTTTTTTCT-----------------------TCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred CCCCEECCCCCCCCC-----------------------CCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCH
T ss_conf 421022123332211-----------------------1000000015652237200134212423430139785-5686
Q ss_pred HHHCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf 4415998796991288578997344440698411212776479999888899983320024788
Q 002566 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (907)
Q Consensus 325 ~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~~~~~~~p~~C~c~~~~l~~~~~~~ 388 (907)
.+..+++|+.|+|++| ||.|||.+.||..|++..
T Consensus 190 ~~~~~~~L~~L~L~~N------------------------------p~~CdC~~~~l~~wl~~~ 223 (266)
T d1p9ag_ 190 GFFGSHLLPFAFLHGN------------------------------PWLCNCEILYFRRWLQDN 223 (266)
T ss_dssp TTTTTCCCSEEECCSC------------------------------CBCCSGGGHHHHHHHHHT
T ss_pred HHCCCCCCCEEEECCC------------------------------CCCCCCCHHHHHHHHHHC
T ss_conf 6777888999983699------------------------------987886437999999866
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-33 Score=208.58 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=218.8
Q ss_pred CEECCCCCCCCEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCC
Q ss_conf 4110589992169998235997542288200299988899800686899870000246-523999038768887841018
Q 002566 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160 (907)
Q Consensus 82 ~v~C~~~~~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~ 160 (907)
+-.|.| ....+++++.+++ .+|..+. +.+++|+|++|+|+.+.+..|..+ +|++|++++|.+....|..|.
T Consensus 5 p~~c~c-----~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~ 76 (305)
T d1xkua_ 5 PFRCQC-----HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76 (305)
T ss_dssp CTTCEE-----ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred CCCCEE-----CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHH
T ss_conf 998895-----5999985599988-5198889--9979897849918986965760465652311234434452356652
Q ss_pred CCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCC
Q ss_conf 9999899973088589999800106755450030133145347900019999990533357456--77730016743345
Q 002566 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQ 238 (907)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~ 238 (907)
++++|+.|++++|+++. +|..+ ...|+.|++.+|.+....+..+.....+..++...|... ...+..+..+++|+
T Consensus 77 ~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~ 153 (305)
T d1xkua_ 77 PLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153 (305)
T ss_dssp TCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred CCCCCCEECCCCCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 79855783156875676-76400--1113232102461023444454013311000012333334677764223456567
Q ss_pred EEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 34501665777752643169999889868987998876511224-55469834542655678133698972589457998
Q 002566 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317 (907)
Q Consensus 239 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~ 317 (907)
.+.+++|.+.. ++.. ..++|+.|++++|.........+... .++.|++++|.+++..+..|.++++|++|+|++|+
T Consensus 154 ~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~ 230 (305)
T d1xkua_ 154 YIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230 (305)
T ss_dssp EEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred CCCCCCCCCCC-CCCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 12034677451-6710--17766789897886778882676413413301544553322234543344332243025540
Q ss_pred CCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHH--------HCCCCCCEEECCC
Q ss_conf 999991444159987969912885789973444--------4069841121277
Q 002566 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--------FNSNKNVDISLNN 363 (907)
Q Consensus 318 L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~--------~~~l~~l~ls~N~ 363 (907)
|+ .+|..+..+++|+.|+|++|+|+......+ ...++.+++++|.
T Consensus 231 L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~ 283 (305)
T d1xkua_ 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283 (305)
T ss_dssp CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred CC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCC
T ss_conf 02-463110334678989898986576381002672100215888978898995
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.98 E-value=2e-30 Score=189.85 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=160.9
Q ss_pred EEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEE
Q ss_conf 69998235997542288200299988899800686899870000246-52399903876888784101899998999730
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls 171 (907)
.++.|++.+++++. + +.+..+++|++|+|++|+|+++.+ ++.+ +|++|++++|++.+..+ ++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 87899899989877-6-242458999989681881798863--3477110103013433322221--1123343334433
Q ss_pred CCCCCCCCC---------------------------------------------------------------HHHHCCCC
Q ss_conf 885899998---------------------------------------------------------------00106755
Q 002566 172 GNLFTGSIP---------------------------------------------------------------PDIRKLIN 188 (907)
Q Consensus 172 ~N~l~~~~p---------------------------------------------------------------~~l~~l~~ 188 (907)
+|.+++..+ ..+..+++
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 198 (384)
T d2omza2 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 22222222222222221121346631310023222211222221232201111245421101122243332110022353
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCC
Q ss_conf 45003013314534790001999999053335745677730016743345345016657777526431699998898689
Q 002566 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268 (907)
Q Consensus 189 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 268 (907)
++.+++++|.+++..| +...++|+.|++++|+++.. +.+..+++|+.|++++|++++..+ +..+++|+.|+++.
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 272 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCC
T ss_conf 2333035774478786--44457787888877777896--134325653410044674478775--35546687754567
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCH
Q ss_conf 87998876511224554698345426556781336989725894579989999914441599879699128857899734
Q 002566 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348 (907)
Q Consensus 269 n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~ 348 (907)
+.+..... ......++.+.++.|++++. ..+..+++++.|++++|++++.. .+..+++|+.|++++|+|++ ++
T Consensus 273 ~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~- 345 (384)
T d2omza2 273 NQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS- 345 (384)
T ss_dssp SCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-
T ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-
T ss_conf 44578773-23565222233232333332--21000024676777788778984--53668988989898998999-74-
Q ss_pred HH--HCCCCCCEEECCCCCCC
Q ss_conf 44--40698411212776479
Q 002566 349 YI--FNSNKNVDISLNNFTWE 367 (907)
Q Consensus 349 ~~--~~~l~~l~ls~N~~~~~ 367 (907)
.+ .+.++.+++++|+++.+
T Consensus 346 ~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 346 SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCBC
T ss_pred HHCCCCCCCEEECCCCCCCCC
T ss_conf 670899999898979958998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=9e-30 Score=186.13 Aligned_cols=255 Identities=22% Similarity=0.244 Sum_probs=190.1
Q ss_pred CEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEE
Q ss_conf 169998235997542288200299988899800686899870000246-5239990387688878410189999899973
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~L 170 (907)
..++.|+|++|+++...+.+|.++++|+.|++++|.+..+.+..|..+ +|+.|++++|+++.. |.. ....|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l-~~~--~~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEK--MPKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSS--CCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCCC-CCC--HHHHHHHHHC
T ss_conf 9979897849918986965760465652311234434452356652798557831568756767-640--0111323210
Q ss_pred ECCCCCCCCCHHHHCCCCCCEEEECCCCCC--CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 088589999800106755450030133145--347900019999990533357456777300167433453450166577
Q 002566 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (907)
Q Consensus 171 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 248 (907)
.+|.+.+..+..+.....+..+....|... ...+..+..+++|+.+++++|.++. ++..+ .++|+.|++++|.+.
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCC
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCC--CCCCCEEECCCCCCC
T ss_conf 246102344445401331100001233333467776422345656712034677451-67101--776678989788677
Q ss_pred CCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCC-CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHH-
Q ss_conf 775264316999988986898799887651122-455469834542655678133698972589457998999991444-
Q 002566 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF- 326 (907)
Q Consensus 249 ~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~- 326 (907)
...+..|..++.++.|++++|.+...+...+.. .+|+.|+|++|+|+. +|..|..+++|++|+|++|+|+.+....|
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCHHHCC
T ss_conf 8882676413413301544553322234543344332243025540024-631103346789898989865763810026
Q ss_pred -----HCCCCCCEEEECCCCCC-CCCCHHHHCC
Q ss_conf -----15998796991288578-9973444406
Q 002566 327 -----EKLAKTNFMYLTGNKLT-GPVPKYIFNS 353 (907)
Q Consensus 327 -----~~l~~L~~L~Ls~N~L~-~~~p~~~~~~ 353 (907)
..+.+|+.|+|++|+++ ..++...|..
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCHHCCCCCCCEEECCCCCCCCCCCCHHHHCC
T ss_conf 721002158889788989957667689768300
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-31 Score=192.61 Aligned_cols=248 Identities=17% Similarity=0.170 Sum_probs=198.2
Q ss_pred CEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEEC-CCCCCCCCCHHCCCCCCCCEEE
Q ss_conf 169998235997542288200299988899800686899870000246-52399903-8768887841018999989997
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVM-GNRLSGPFPKVLTNITTLKNLS 169 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls-~N~l~~~~p~~l~~L~~L~~L~ 169 (907)
..++.|+|++|+++...+.+|.++++|+.|++++|.+..+.+..+... .+..+... .|.++...+..|.++++|+.|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 99888977488179879778641421300001344543321112122222222222210223544620101010277875
Q ss_pred EECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 30885899998001067554500301331453479000199999905333574567773001674334534501665777
Q 002566 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (907)
Q Consensus 170 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 249 (907)
+++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|+++...+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCC
T ss_conf 68854432013533200012110200143144580574043405022314176566256665465634131421143466
Q ss_pred CCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCC
Q ss_conf 75264316999988986898799887651122455469834542655678133698972589457998999991444159
Q 002566 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (907)
Q Consensus 250 ~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l 329 (907)
..|..|..+++|+.| ++++|++.+..+..|.++++|+.|+|++|.+...-+.. .-.
T Consensus 192 i~~~~f~~l~~L~~L-----------------------~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~ 247 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTL-----------------------YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW 247 (284)
T ss_dssp ECTTTTTTCTTCCEE-----------------------ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred CCHHHHHHHHHCCCC-----------------------CCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCH-HHH
T ss_conf 281676653200023-----------------------33335221000002355465688981199887875646-999
Q ss_pred CCCCEEEECCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf 98796991288578997344440698411212776
Q 002566 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF 364 (907)
Q Consensus 330 ~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~ 364 (907)
..++.+....+.++...|..+. .....+++.+++
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~l~-g~~l~~l~~~~l 281 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDL 281 (284)
T ss_dssp HHHHHCCSEECCCBEEESGGGT-TCBGGGSCGGGS
T ss_pred HHHHHCCCCCCCEEECCCHHHC-CCCCCCCCHHHC
T ss_conf 9998673888866747966984-985341898887
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-29 Score=182.88 Aligned_cols=160 Identities=21% Similarity=0.226 Sum_probs=68.3
Q ss_pred CCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 98999730885899998001067554500301331453479000199999905333574567773001674334534501
Q 002566 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (907)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 243 (907)
+|+.|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .+..+++|++|+|++|+++. .+..+.++++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf 88989884992898597786345655221356654444-31-11112232111112222211-11121222222222222
Q ss_pred CCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 66577775264316999988986898799887651122455469834542655678133698972589457998999991
Q 002566 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (907)
Q Consensus 244 ~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p 323 (907)
+|.+....+..+..+. +++.|++++|.++...+..+..+++|+.|++++|+|++..+
T Consensus 109 ~~~~~~~~~~~~~~l~-----------------------~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLG-----------------------ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SSCCCCCCSSTTTTCT-----------------------TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CCCCCEEECCCCCCCC-----------------------CCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCC
T ss_conf 2311011001122221-----------------------11122124342102212333221110000000156522372
Q ss_pred HHHHCCCCCCEEEECCCCCCCCCCHHH
Q ss_conf 444159987969912885789973444
Q 002566 324 TTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (907)
Q Consensus 324 ~~~~~l~~L~~L~Ls~N~L~~~~p~~~ 350 (907)
..|..+++|+.|+|++|+|+ .+|..+
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~ 191 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLY-TIPKGF 191 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred CCCCCCCCCCEEECCCCCCC-CCCHHH
T ss_conf 00134212423430139785-568667
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.7e-28 Score=174.92 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=201.6
Q ss_pred CEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCC----------------
Q ss_conf 169998235997542288200299988899800686899870000246-523999038768887----------------
Q 002566 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP---------------- 154 (907)
Q Consensus 92 ~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~---------------- 154 (907)
.+++.|+|++|++++ ++ .+.++++|++|++++|.+.++.+ ++.+ +|+.|++++|.+++.
T Consensus 66 ~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (384)
T d2omza2 66 NNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141 (384)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEE
T ss_pred CCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 999989681881798-86-33477110103013433322221--112334333443322222222222222221121346
Q ss_pred -----------------------------------------------CCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCC
Q ss_conf -----------------------------------------------841018999989997308858999980010675
Q 002566 155 -----------------------------------------------FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (907)
Q Consensus 155 -----------------------------------------------~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~ 187 (907)
....+..+++++.+++++|.+++..+ +...+
T Consensus 142 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~ 219 (384)
T d2omza2 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILT 219 (384)
T ss_dssp EEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCC
T ss_conf 6313100232222112222212322011112454211011222433321100223532333035774478786--44457
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECC
Q ss_conf 54500301331453479000199999905333574567773001674334534501665777752643169999889868
Q 002566 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267 (907)
Q Consensus 188 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 267 (907)
+|+.|++++|+++. + ..+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..++.++.++++
T Consensus 220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 78788887777789-6-134325653410044674478775--355466877545674457877--32356522223323
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCC
Q ss_conf 98799887651122455469834542655678133698972589457998999991444159987969912885789973
Q 002566 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347 (907)
Q Consensus 268 ~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p 347 (907)
.|.+..... .....+++.|++++|+|++..+ +..+++|++|++++|+|++ ++ .+.++++|+.|++++|+|++..|
T Consensus 294 ~n~l~~~~~-~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 294 ENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCCCC-CCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH
T ss_conf 233333221-0000246767777887789845--3668988989898998999-74-67089999989897995899800
Q ss_pred HHHHCCCCCCEEECC
Q ss_conf 444406984112127
Q 002566 348 KYIFNSNKNVDISLN 362 (907)
Q Consensus 348 ~~~~~~l~~l~ls~N 362 (907)
-.-+..++.+++++|
T Consensus 369 l~~l~~L~~L~L~~N 383 (384)
T d2omza2 369 LANLTRITQLGLNDQ 383 (384)
T ss_dssp GTTCTTCSEEECCCE
T ss_pred HCCCCCCCEEECCCC
T ss_conf 003999999639789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9e-26 Score=162.94 Aligned_cols=162 Identities=19% Similarity=0.142 Sum_probs=118.0
Q ss_pred CCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCC------------------HHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 86782411396599999987993999999046661------------------025889999999971599962348758
Q 002566 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPNLVKLYGC 740 (907)
Q Consensus 679 ~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~------------------~~~~~f~~E~~~l~~l~H~nIv~l~g~ 740 (907)
.+.++||+|+||.||+|...+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 74086468886413689424555158742245899899999999999999999847999838708899997874999399
Q 002566 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (907)
Q Consensus 741 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~k 820 (907)
. ..+++||+++++.+.+ ++......++.|++++++|||+.+ |+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred C----CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEE
T ss_conf 2----8889999504565420------------015789999999999999982688---8983689036114289-899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHCCCCCCCHHHHHHHHHH
Q ss_conf 963488500147885211243456653442------21114989954679999999
Q 002566 821 ISDFGLAKLYEEDKTHISTRIAGTIGYMAP------EYAMRGYLTSKADVYSFGVV 870 (907)
Q Consensus 821 l~DFGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~SlGii 870 (907)
++|||.|......... .|... +.. ...+..++|+||..--
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCCCCCCCCCCH---------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
T ss_conf 9877884308998709---------99987799999997-5789984468999998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.6e-24 Score=152.52 Aligned_cols=225 Identities=16% Similarity=0.157 Sum_probs=117.4
Q ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCC-CHHCC
Q ss_conf 110589992169998235997542288200299988899800686899870000246-5239990387688878-41018
Q 002566 83 VTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF-PKVLT 160 (907)
Q Consensus 83 v~C~~~~~~~~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~-p~~l~ 160 (907)
..|+|.+ ..+++++.+++ .+|..+. ++++.|+|++|.|+.+.+..|..+ +|++|+|++|.+...+ +..|.
T Consensus 4 ~~C~C~~-----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~ 75 (242)
T d1xwdc1 4 RICHCSN-----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75 (242)
T ss_dssp SSEEECS-----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEE
T ss_pred CCCCCCC-----CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCC
T ss_conf 8288739-----99998189988-7688889--98899987699189649668614643232110221124201001122
Q ss_pred CCCCCCEEEEEC-CCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CC
Q ss_conf 999989997308-858999980010675545003013314534790-001999999053335745677730016743-34
Q 002566 161 NITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KI 237 (907)
Q Consensus 161 ~L~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L 237 (907)
+++.++.|.+.. |++....+..|.++++|+.|++++|++....+. .+..+..+..+..+++.+....+..|.+++ .+
T Consensus 76 ~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l 155 (242)
T d1xwdc1 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 155 (242)
T ss_dssp SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 22222221111123432222221222222222234211112554333222111122222221211122222222223310
Q ss_pred CEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 53450166577775264316999988986898799887651122455469-83454265567813369897258945799
Q 002566 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL-ILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (907)
Q Consensus 238 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L-~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N 316 (907)
+.|++++|+++ ......+...++..+ .+++|+|+.+.+..|.++++|++|+|++|
T Consensus 156 ~~L~l~~n~l~------------------------~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 156 VILWLNKNGIQ------------------------EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEEECCSSCCC------------------------EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred EEEECCCCCCC------------------------CCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCC
T ss_conf 01220012333------------------------322222220111012123543246424788668999998989799
Q ss_pred CCCCCCCHHHHCCCCCCEEEECC
Q ss_conf 89999914441599879699128
Q 002566 317 NLTGGIPTTFEKLAKTNFMYLTG 339 (907)
Q Consensus 317 ~L~~~~p~~~~~l~~L~~L~Ls~ 339 (907)
+|+...+..|.++++|+.+++.+
T Consensus 212 ~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 212 RIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCCSSSCTTCCEEESSSEES
T ss_pred CCCCCCHHHHCCCCCCCCCCCCC
T ss_conf 28945977973771341476788
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.3e-24 Score=152.25 Aligned_cols=214 Identities=16% Similarity=0.078 Sum_probs=132.3
Q ss_pred CEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCC-CHHHHCCCCCCEEEECC-
Q ss_conf 8998006868998700002465239990387688878410189999899973088589999-80010675545003013-
Q 002566 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSI-PPDIRKLINLQKLILSS- 196 (907)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~- 196 (907)
+.++.++++++.+++..+ .++++|+|++|+|+.+.+..|.++++|++|+|++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEECCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf 999981899887688889--988999876991896496686146432321102211242010011222222222111112
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCC
Q ss_conf 314534790001999999053335745677730-0167433453450166577775264316999988986898799887
Q 002566 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (907)
Q Consensus 197 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~ 275 (907)
|++....+..|.++++|+.|++++|++....+. .+..+..+..+...++.+....+..|.+++
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~---------------- 152 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS---------------- 152 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB----------------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----------------
T ss_conf 3432222221222222222234211112554333222111122222221211122222222223----------------
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHHCCCC
Q ss_conf 65112245546983454265567813369897258945799899999144415998796991288578997344440698
Q 002566 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355 (907)
Q Consensus 276 ~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~ 355 (907)
..+..|++++|+++...+..|.....++.+++++|+|+.+.+..|.++++|+.|+|++|+|+ .+|...+..+.
T Consensus 153 ------~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~ 225 (242)
T d1xwdc1 153 ------FESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLK 225 (242)
T ss_dssp ------SSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCC
T ss_pred ------CCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC-CCCHHHHCCCC
T ss_conf ------31001220012333322222220111012123543246424788668999998989799289-45977973771
Q ss_pred CC
Q ss_conf 41
Q 002566 356 NV 357 (907)
Q Consensus 356 ~l 357 (907)
.+
T Consensus 226 ~L 227 (242)
T d1xwdc1 226 KL 227 (242)
T ss_dssp EE
T ss_pred CC
T ss_conf 34
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.90 E-value=6.4e-21 Score=134.81 Aligned_cols=251 Identities=20% Similarity=0.195 Sum_probs=141.4
Q ss_pred EEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEEEC
Q ss_conf 69998235997542288200299988899800686899870000246523999038768887841018999989997308
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~ 172 (907)
+++.|+|++++++ .+|+. .++|+.|+|++|+|+.+ |..+ .+|+.|++++|+++.. +. + .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~~--~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PELP--QSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCCC--TTCCEEECCSSCCSCC-CS-C--CTTCCEEECCS
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCCCC-CCCH--HHHHHHHHHHCCCCHH-HH-H--CCCCCCCCCCC
T ss_conf 9989993799988-78898---78988898999979633-6203--3203326655143203-21-0--22111113345
Q ss_pred CCCCCCCCHHHHCCCCCCEEEECCCCCCCCCC------------------CCCCCCCCCCEEECCCCCCCCCCC------
Q ss_conf 85899998001067554500301331453479------------------000199999905333574567773------
Q 002566 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP------------------AELTKLTNLNDLRISDNNFSGKIP------ 228 (907)
Q Consensus 173 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p------------------~~l~~l~~L~~L~Ls~N~l~~~~p------ 228 (907)
|.++ .+|. +..+++|+.|++++|.+..... ..+..++.++.++++.|.+.....
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~ 185 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLE 185 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred CCCC-CCCC-HHHHCCCEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCC
T ss_conf 5432-2210-0110131231135651001322333321000012222233320001222001112334432222122222
Q ss_pred ------------CCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf ------------00167433453450166577775264316999988986898799887651122455469834542655
Q 002566 229 ------------EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296 (907)
Q Consensus 229 ------------~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~ 296 (907)
..+..++.|+.+++++|.... .+. ...++..+.+..+.+....... ..+....+..|.+.+
T Consensus 186 ~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~ 258 (353)
T d1jl5a_ 186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFSG 258 (353)
T ss_dssp EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC---CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCC
T ss_conf 233444322221223455533312225422234-553---2334333222333334443334---432222222233322
Q ss_pred C----------------CCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEE
Q ss_conf 6----------------781336989725894579989999914441599879699128857899734444069841121
Q 002566 297 E----------------IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 360 (907)
Q Consensus 297 ~----------------~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls 360 (907)
. ++.....+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ...++.++++
T Consensus 259 l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~-~~~L~~L~L~ 332 (353)
T d1jl5a_ 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL-PQNLKQLHVE 332 (353)
T ss_dssp ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC-CTTCCEEECC
T ss_pred CCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC-CCCCCEEECC
T ss_conf 234530001233335753234566898898979799168-3566---5487998989999687-54532-2888989876
Q ss_pred CCCCCCCCC
Q ss_conf 277647999
Q 002566 361 LNNFTWESS 369 (907)
Q Consensus 361 ~N~~~~~~~ 369 (907)
+|+++.++.
T Consensus 333 ~N~L~~lp~ 341 (353)
T d1jl5a_ 333 YNPLREFPD 341 (353)
T ss_dssp SSCCSSCCC
T ss_pred CCCCCCCCC
T ss_conf 991897776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=5.1e-22 Score=141.21 Aligned_cols=184 Identities=18% Similarity=0.261 Sum_probs=77.8
Q ss_pred CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 52399903876888784101899998999730885899998001067554500301331453479000199999905333
Q 002566 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 219 (907)
+|+.|++.+|.|+.. + .+..+++|+.|++++|++++..+ +..+++|+.+++++|.++ .+ ..+.++++|+.++++
T Consensus 42 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i-~~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CC-GGGTTCTTCCEEECT
T ss_pred CCCEEECCCCCCCCC-H-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 868997779999766-4-57448888376357853202543--112334320121112222-22-222222222122122
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 57456777300167433453450166577775264316999988986898799887651122455469834542655678
Q 002566 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (907)
Q Consensus 220 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p 299 (907)
++...+. ..+...+.+..+.++.+.+.... .+..+++|+.|++++|.+..... .-...+|+.|+|++|++++..
T Consensus 116 ~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~- 189 (227)
T d1h6ua2 116 STQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDIS- 189 (227)
T ss_dssp TSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-
T ss_pred CCCCCCC--CHHCCCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCCHH-HCCCCCCEECCCCCCCCCCCH-
T ss_conf 2443311--00000230122200000000000--00102111002333333331001-056463356445888417785-
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEC
Q ss_conf 133698972589457998999991444159987969912
Q 002566 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 338 (907)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls 338 (907)
.+..+++|++|+|++|+|++..| +.++++|+.|+++
T Consensus 190 -~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 190 -PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp -GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred -HHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEE
T ss_conf -34479999989795996899802--0369998989712
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=2.7e-23 Score=148.61 Aligned_cols=126 Identities=22% Similarity=0.335 Sum_probs=58.7
Q ss_pred EEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCC-CCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECC
Q ss_conf 982359975422882002999888998006868998-70000246-5239990387688878410189999899973088
Q 002566 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (907)
Q Consensus 96 ~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N 173 (907)
.+++++++++ .+|..+. +++++|+|++|.|+.. .+..|..+ +|+.|+|++|.+....+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 9997089967-0298989--787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 589999800106755450030133145347900019999990533357456
Q 002566 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224 (907)
Q Consensus 174 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 224 (907)
+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 344349799807974655245774535359778568753342000364434
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=6.4e-22 Score=140.59 Aligned_cols=203 Identities=17% Similarity=0.215 Sum_probs=126.2
Q ss_pred EEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 99903876888784101899998999730885899998001067554500301331453479000199999905333574
Q 002566 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222 (907)
Q Consensus 143 ~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 222 (907)
.++++.+++++.. .++.+.+|+.|++.+|.++. ++ .+..+++|++|++++|++++.. .+..+++|+++++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCC
T ss_pred HHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCC--CCCCCCCCCCCCCCCCC
T ss_conf 9984888767757--98784886899777999976-64-5744888837635785320254--31123343201211122
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 56777300167433453450166577775264316999988986898799887651122455469834542655678133
Q 002566 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI 302 (907)
Q Consensus 223 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~ 302 (907)
++. + ..+.++++|+.+.++.+...+. ..+...+.+..+.++.+.+..... .....+|+.|++++|.+.... .+
T Consensus 97 ~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 97 LKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp CSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--GG
T ss_pred CCC-C-CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHHH-HCCCCCCCCCCCCCCCCCCCH--HH
T ss_conf 222-2-2222222221221222443311--000002301222000000000000-010211100233333333100--10
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEE
Q ss_conf 6989725894579989999914441599879699128857899734444069841121
Q 002566 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 360 (907)
Q Consensus 303 ~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls 360 (907)
.++++|+.|+|++|++++. + .+..+++|++|+|++|++++..|-.-++.++.++++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEE
T ss_pred CCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEE
T ss_conf 5646335644588841778-5-344799999897959968998020369998989712
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.87 E-value=2.9e-22 Score=142.57 Aligned_cols=53 Identities=23% Similarity=0.276 Sum_probs=28.6
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCC
Q ss_conf 83454265567813369897258945799899999144415998796991288
Q 002566 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340 (907)
Q Consensus 288 ~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N 340 (907)
+|++|+|+.+.+..|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|
T Consensus 84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred EECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 00355344349799807974655245774535359778568753342000364
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=5e-21 Score=135.42 Aligned_cols=163 Identities=21% Similarity=0.297 Sum_probs=87.1
Q ss_pred CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 52399903876888784101899998999730885899998001067554500301331453479000199999905333
Q 002566 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 219 (907)
+|+.|++++|.+.... .+..+++|++|+|++|++++.. .+..+++|+.|++++|+++. ++ .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCC
T ss_conf 8458978279888744--4764899898769896025860--11358621201433333212-22-12122211122345
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 57456777300167433453450166577775264316999988986898799887651122455469834542655678
Q 002566 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (907)
Q Consensus 220 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p 299 (907)
+|.+.. ...+..++.++.++++.|.+++. ..+..++ +|+.+++++|++++..
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~-----------------------~L~~l~l~~n~l~~i~- 172 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLT-----------------------KLDTLSLEDNQISDIV- 172 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCT-----------------------TCSEEECCSSCCCCCG-
T ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCC-----------------------CCCCCCCCCCCCCCCC-
T ss_conf 653221--12201111122211222333454--3100013-----------------------3210013464302564-
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECC
Q ss_conf 1336989725894579989999914441599879699128
Q 002566 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339 (907)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~ 339 (907)
.+.++++|+.|+|++|+|+. ++ .+.++++|+.|+|++
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred -CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCC
T ss_conf -53678989999897998998-72-116999989997118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.3e-23 Score=150.44 Aligned_cols=108 Identities=22% Similarity=0.291 Sum_probs=46.2
Q ss_pred EEEEEECCCCCCCCCC-CHHCCCCCCCCEEEEECCCCCCCCC----HHCCCC-CCCEEEECCCCCCCC----CCHHCC-C
Q ss_conf 6999823599754228-8200299988899800686899870----000246-523999038768887----841018-9
Q 002566 93 HVVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNCLTGSFS----PQWASL-QLVELSVMGNRLSGP----FPKVLT-N 161 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~i-p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l-~L~~L~Ls~N~l~~~----~p~~l~-~ 161 (907)
++..|+++++++++.- ..-+..+++++.|+|++|.|+.... ..+... +|+.|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEEEECCCCCCC----CCHHHHCCCCCCEEEECCCCCC
Q ss_conf 99989997308858999----9800106755450030133145
Q 002566 162 ITTLKNLSIEGNLFTGS----IPPDIRKLINLQKLILSSNSFT 200 (907)
Q Consensus 162 L~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 200 (907)
..+|+.|+|++|++++. ++..+..+++|++|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.9e-20 Score=132.08 Aligned_cols=142 Identities=20% Similarity=0.407 Sum_probs=68.9
Q ss_pred CCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 18999989997308858999980010675545003013314534790001999999053335745677730016743345
Q 002566 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238 (907)
Q Consensus 159 l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 238 (907)
++.+++|++|+|++|++++..+ +.++++|+.|++++|.+.. ++ .+.++++|+.|++++|.+... ..+..+++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHH
T ss_conf 2137886757545655667640--1677522311112222222-21-111122322211122222232--1000122367
Q ss_pred EEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 34501665777752643169999889868987998876511224554698345426556781336989725894579989
Q 002566 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318 (907)
Q Consensus 239 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L 318 (907)
.|++++|++... + .+..++ +|+.|++++|++++.. .+.++++|+.|++++|++
T Consensus 132 ~L~l~~n~l~~~-~-~l~~~~-----------------------~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 132 RLELSSNTISDI-S-ALSGLT-----------------------SLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EEECCSSCCCCC-G-GGTTCT-----------------------TCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHHHHHHHHCCC-C-CCCCCC-----------------------CCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCC
T ss_conf 764311110023-4-333211-----------------------1111223455556770--116799899997879979
Q ss_pred CCCCCHHHHCCCCCCEE
Q ss_conf 99991444159987969
Q 002566 319 TGGIPTTFEKLAKTNFM 335 (907)
Q Consensus 319 ~~~~p~~~~~l~~L~~L 335 (907)
++ ++ .+..+++|+.|
T Consensus 185 ~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 185 SD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CC-CG-GGGGCTTCSEE
T ss_pred CC-CC-CCCCCCCCCCC
T ss_conf 98-81-01278998949
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=2e-20 Score=131.95 Aligned_cols=138 Identities=20% Similarity=0.342 Sum_probs=62.1
Q ss_pred CCCCCEEEEECCCCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEE
Q ss_conf 9988899800686899870000246-523999038768887841018999989997308858999980010675545003
Q 002566 115 LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI 193 (907)
Q Consensus 115 l~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 193 (907)
+..|+.|++++|.++.... +..+ +|++|+|++|.+++.. .++.+++|+.|++++|++++ ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 5484589782798887444--764899898769896025860--11358621201433333212-22-121222111223
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEE
Q ss_conf 01331453479000199999905333574567773001674334534501665777752643169999889
Q 002566 194 LSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264 (907)
Q Consensus 194 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 264 (907)
+++|.+.. ...+..+++++.++++.|.+++ +..+..+++|+.+++++|++++.. .+.++++|+.|
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L 183 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNL 183 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEE
T ss_conf 45653221--1220111112221122233345--431000133210013464302564--53678989999
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=5.9e-18 Score=117.63 Aligned_cols=227 Identities=22% Similarity=0.252 Sum_probs=121.0
Q ss_pred EEEEEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCCCCHHCCCCCCCCEEEEEC
Q ss_conf 69998235997542288200299988899800686899870000246523999038768887841018999989997308
Q 002566 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (907)
Q Consensus 93 ~v~~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~ 172 (907)
+++.|+|++++|+ .+|..+ .+|+.|++++|+++.+.. + ...|++|++++|.+... |. +..+++|+.|++++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~--l-p~~L~~L~L~~n~l~~l-p~-~~~l~~L~~L~l~~ 129 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSD--L-PPLLEYLGVSNNQLEKL-PE-LQNSSFLKIIDVDN 129 (353)
T ss_dssp TCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCS--C-CTTCCEEECCSSCCSSC-CC-CTTCTTCCEEECCS
T ss_pred CCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCHHHH--H-CCCCCCCCCCCCCCCCC-CC-HHHHCCCEEECCCC
T ss_conf 9888989999796-336203---320332665514320321--0-22111113345543222-10-01101312311356
Q ss_pred CCCCCCCC------------------HHHHCCCCCCEEEECCCCCCCCC------------------CCCCCCCCCCCEE
Q ss_conf 85899998------------------00106755450030133145347------------------9000199999905
Q 002566 173 NLFTGSIP------------------PDIRKLINLQKLILSSNSFTGEL------------------PAELTKLTNLNDL 216 (907)
Q Consensus 173 N~l~~~~p------------------~~l~~l~~L~~L~L~~N~l~~~~------------------p~~l~~l~~L~~L 216 (907)
|.+..... ..+..++.++.+.+++|.+.... ...+..++.|+.+
T Consensus 130 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l 209 (353)
T d1jl5a_ 130 NSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209 (353)
T ss_dssp SCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 51001322333321000012222233320001222001112334432222122222233444322221223455533312
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECC--------------------CCCCCCCCC
Q ss_conf 333574567773001674334534501665777752643169999889868--------------------987998876
Q 002566 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS--------------------DLKGSESAF 276 (907)
Q Consensus 217 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls--------------------~n~~~~~~~ 276 (907)
++++|.... .+.. ..++..+.+..|.+.... .. ...+...++. .+.+.....
T Consensus 210 ~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~~-~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~ 281 (353)
T d1jl5a_ 210 YADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP-EL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCD 281 (353)
T ss_dssp ECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECC
T ss_pred CCCCCCCCC-CCCC---CCCCCCCCCCCCCCCCCC-CC---CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCC
T ss_conf 225422234-5532---334333222333334443-33---443222222223332223453000123333575323456
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCH
Q ss_conf 511224554698345426556781336989725894579989999914441599879699128857899734
Q 002566 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348 (907)
Q Consensus 277 ~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~ 348 (907)
...+|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.
T Consensus 282 ---~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 282 ---LPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp ---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-SCCC
T ss_pred ---CCCCCCEEECCCCCCCC-CCC---CCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCC
T ss_conf ---68988989797991683-566---5487998989999687-5453---2288898987699189-7776
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=7.4e-19 Score=122.87 Aligned_cols=149 Identities=19% Similarity=0.277 Sum_probs=70.1
Q ss_pred CCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 99998999730885899998001067554500301331453479000199999905333574567773001674334534
Q 002566 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (907)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 240 (907)
.+.+|+.|++++|.++.. ..+..+++|++|++++|++++.. .+.++++|++|++++|.+... + .+.+++.|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCC
T ss_conf 946878998999999775--20213788675754565566764--016775223111122222222-1-11112232221
Q ss_pred ECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 50166577775264316999988986898799887651122455469834542655678133698972589457998999
Q 002566 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (907)
Q Consensus 241 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~ 320 (907)
++++|.+.... .+..++ +|+.|++++|++... ..+..+++|+.|++++|++++
T Consensus 112 ~l~~~~~~~~~--~~~~l~-----------------------~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 112 TLFNNQITDID--PLKNLT-----------------------NLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp ECCSSCCCCCG--GGTTCT-----------------------TCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCCCC--CCCHHH-----------------------HHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCCCCC
T ss_conf 11222222321--000122-----------------------367764311110023--433321111112234555567
Q ss_pred CCCHHHHCCCCCCEEEECCCCCCC
Q ss_conf 991444159987969912885789
Q 002566 321 GIPTTFEKLAKTNFMYLTGNKLTG 344 (907)
Q Consensus 321 ~~p~~~~~l~~L~~L~Ls~N~L~~ 344 (907)
.. .+.++++|+.|++++|+++.
T Consensus 165 l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 165 LK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCC
T ss_pred CC--CCCCCCCCCEEECCCCCCCC
T ss_conf 70--11679989999787997998
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.3e-20 Score=132.99 Aligned_cols=246 Identities=17% Similarity=0.266 Sum_probs=116.8
Q ss_pred EEECCCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCEEEECCCCCCCC-CCHHCCCCCCCCEEEEECCC
Q ss_conf 98235997542288200299988899800686899870000246523999038768887-84101899998999730885
Q 002566 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNL 174 (907)
Q Consensus 96 ~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~-~p~~l~~L~~L~~L~Ls~N~ 174 (907)
.+|++++++.......+.. ..+..+.++...+.......+...+|++|+|+++.++.. +...+..+++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCCHHHHHHHH-CCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 7978999788147999874-554274652333455224425678788788989845777999999748776514523467
Q ss_pred CCCCCCHHHHCCCCCCEEEECCC-CCCCCC-CCCCCCCCCCCEEECCCC-CCCCC-CCCCCCC-CCCCCEEECCCC--CC
Q ss_conf 89999800106755450030133-145347-900019999990533357-45677-7300167-433453450166--57
Q 002566 175 FTGSIPPDIRKLINLQKLILSSN-SFTGEL-PAELTKLTNLNDLRISDN-NFSGK-IPEFIGK-WKKIQKLHIQGS--SL 247 (907)
Q Consensus 175 l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~-p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~l~~-l~~L~~L~L~~N--~l 247 (907)
+++..+..+..+++|++|+++++ .++... .....++++|++|+++++ .++.. ....+.. .+.|+.|++++. .+
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i 162 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred CCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCC
T ss_conf 98678999851899757151001341235540365788743565224533233322000100011111012213554244
Q ss_pred CCC-CHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCH
Q ss_conf 777-526431699998898689879988765112245546983454-265567813369897258945799-89999914
Q 002566 248 EGP-IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFN-NLTGGIPT 324 (907)
Q Consensus 248 ~~~-~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N-~L~~~~p~ 324 (907)
+.. +...+..++ +|+.|++++| .++......+..+++|++|+|+++ .+++....
T Consensus 163 ~~~~l~~l~~~~~-----------------------~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~ 219 (284)
T d2astb2 163 QKSDLSTLVRRCP-----------------------NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219 (284)
T ss_dssp CHHHHHHHHHHCT-----------------------TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGG
T ss_pred CCCCCCCCCCCCC-----------------------CCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHH
T ss_conf 4443434232322-----------------------21235532234778303333213576877989999978737899
Q ss_pred HHHCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEECCCCCC
Q ss_conf 441599879699128857899734444069841121277647
Q 002566 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (907)
Q Consensus 325 ~~~~l~~L~~L~Ls~N~L~~~~p~~~~~~l~~l~ls~N~~~~ 366 (907)
.+..+++|+.|+++++ ++...-..+...+..+++..+.++.
T Consensus 220 ~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~ 260 (284)
T d2astb2 220 ELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTT 260 (284)
T ss_dssp GGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCC
T ss_pred HHHCCCCCCEEEEECC-CCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 9726999898964488-8989999999768436616865877
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.81 E-value=2.6e-21 Score=137.09 Aligned_cols=238 Identities=16% Similarity=0.191 Sum_probs=144.9
Q ss_pred CCCHHCCCCCCCCEEEEECCCCCCCCCHHCC----CC-CCCEEEECCCCCCCC----------CCHHCCCCCCCCEEEEE
Q ss_conf 2882002999888998006868998700002----46-523999038768887----------84101899998999730
Q 002566 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWA----SL-QLVELSVMGNRLSGP----------FPKVLTNITTLKNLSIE 171 (907)
Q Consensus 107 ~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~~----~l-~L~~L~Ls~N~l~~~----------~p~~l~~L~~L~~L~Ls 171 (907)
.+..++...+.|+.|+|++|.|.......++ .. +|+.|+++.+..... +...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 99999963899788978498377899999999998589988888877754334542106787999887547775633000
Q ss_pred CCCCCCCCCH----HHHCCCCCCEEEECCCCCCCCCCC-------------CCCCCCCCCEEECCCCCCCCCC----CCC
Q ss_conf 8858999980----010675545003013314534790-------------0019999990533357456777----300
Q 002566 172 GNLFTGSIPP----DIRKLINLQKLILSSNSFTGELPA-------------ELTKLTNLNDLRISDNNFSGKI----PEF 230 (907)
Q Consensus 172 ~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~p~-------------~l~~l~~L~~L~Ls~N~l~~~~----p~~ 230 (907)
+|.+...... .+...++|++|++++|.+...... .....+.|+.+.+++|+++... ...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 01345543331011100234321000002466665431111212222110001467642111013650135543322111
Q ss_pred CCCCCCCCEEECCCCCCCCC-----CHHHHHCCCCCCEEECCCCCCCCCCCCC----C-CCCCCCEEECCCCCCCCCCCC
Q ss_conf 16743345345016657777-----5264316999988986898799887651----1-224554698345426556781
Q 002566 231 IGKWKKIQKLHIQGSSLEGP-----IPASISALTSLTDLRISDLKGSESAFPK----L-DKMNLKTLILTKCLIHGEIPD 300 (907)
Q Consensus 231 l~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~Ls~n~~~~~~~~~----~-~~~~L~~L~Ls~N~i~~~~p~ 300 (907)
+...+.|+.|+|++|++... +...+..+++|+.|++++|.+....... + ...+|+.|+|++|.|+.....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHH
T ss_conf 12333213354333222222232002433211012112223333222222223444332322111103004756715667
Q ss_pred CC----C--CCCCCCEEECCCCCCCCCC----CHHHH-CCCCCCEEEECCCCCCC
Q ss_conf 33----6--9897258945799899999----14441-59987969912885789
Q 002566 301 YI----G--DMTKLKNIDLSFNNLTGGI----PTTFE-KLAKTNFMYLTGNKLTG 344 (907)
Q Consensus 301 ~~----~--~l~~L~~L~Ls~N~L~~~~----p~~~~-~l~~L~~L~Ls~N~L~~ 344 (907)
.+ . ..+.|++|++++|+|+... ...+. +.++|+.|+|++|++..
T Consensus 262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 8887763156888898989898698089999999997038999989787980898
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.4e-22 Score=141.56 Aligned_cols=273 Identities=17% Similarity=0.217 Sum_probs=133.1
Q ss_pred EEEEEECCCCCCCC----CCCHHCCCCCCCCEEEEECCCCCCCCCHHC----CC--CCCCEEEECCCCCCCC----CCHH
Q ss_conf 69998235997542----288200299988899800686899870000----24--6523999038768887----8410
Q 002566 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQW----AS--LQLVELSVMGNRLSGP----FPKV 158 (907)
Q Consensus 93 ~v~~L~L~~~~l~g----~ip~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~--l~L~~L~Ls~N~l~~~----~p~~ 158 (907)
+++.|+|.+++++. .+..++...++|+.|||++|.|+......+ .. .+|+.|+|++|.++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 99999828999988999999999853999888979598597289999999984378877887788877543221012110
Q ss_pred CCCCCCCCEEEEECCCCCCCCCHH---------------------------------HHCCCCCCEEEECCCCCCCC---
Q ss_conf 189999899973088589999800---------------------------------10675545003013314534---
Q 002566 159 LTNITTLKNLSIEGNLFTGSIPPD---------------------------------IRKLINLQKLILSSNSFTGE--- 202 (907)
Q Consensus 159 l~~L~~L~~L~Ls~N~l~~~~p~~---------------------------------l~~l~~L~~L~L~~N~l~~~--- 202 (907)
+..+++|++|+|++|.++...... +.....++.++++++.+...
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 00034320024443320234555544301355433322222232220011001122233332222233222212455554
Q ss_pred ------------------------------CCCCCCCCCCCCEEECCCCCCCC-----CCCCCCCCCCCCCEEECCCCCC
Q ss_conf ------------------------------79000199999905333574567-----7730016743345345016657
Q 002566 203 ------------------------------LPAELTKLTNLNDLRISDNNFSG-----KIPEFIGKWKKIQKLHIQGSSL 247 (907)
Q Consensus 203 ------------------------------~p~~l~~l~~L~~L~Ls~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l 247 (907)
....+...+.++.++++.|++.. ...........++.+++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 32343321122100124112454210110122332222221001002112233442011000111111100001345433
Q ss_pred CCC----CHHHHHCCCCCCEEECCCCCCCCCCCCCC------CCCCCCEEECCCCCCCCCCCC----CCCCCCCCCEEEC
Q ss_conf 777----52643169999889868987998876511------224554698345426556781----3369897258945
Q 002566 248 EGP----IPASISALTSLTDLRISDLKGSESAFPKL------DKMNLKTLILTKCLIHGEIPD----YIGDMTKLKNIDL 313 (907)
Q Consensus 248 ~~~----~p~~l~~l~~L~~L~Ls~n~~~~~~~~~~------~~~~L~~L~Ls~N~i~~~~p~----~~~~l~~L~~L~L 313 (907)
... ....+...+.++.++++.|.+.......+ ....|+.+++++|.++..... .+...++|++|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHE
T ss_conf 21233433221112343334444433322456421110123334443333233341023344321332211011113201
Q ss_pred CCCCCCCCCCH----HHH-CCCCCCEEEECCCCCCCCCCH----HH--HCCCCCCEEECCCCC
Q ss_conf 79989999914----441-599879699128857899734----44--406984112127764
Q 002566 314 SFNNLTGGIPT----TFE-KLAKTNFMYLTGNKLTGPVPK----YI--FNSNKNVDISLNNFT 365 (907)
Q Consensus 314 s~N~L~~~~p~----~~~-~l~~L~~L~Ls~N~L~~~~p~----~~--~~~l~~l~ls~N~~~ 365 (907)
++|+|++.... .+. ..+.|+.|+|++|.|+..... .+ .+.++.+|+++|+++
T Consensus 348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred EEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 210135766400111220456777889897997975999999999962998898989999698
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=2.4e-19 Score=125.65 Aligned_cols=209 Identities=20% Similarity=0.212 Sum_probs=102.0
Q ss_pred CCCCCCEEEEECCCCCCCCC-HHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECC-CCCCCC-CHHHHCCCCC
Q ss_conf 99988899800686899870-000246-5239990387688878410189999899973088-589999-8001067554
Q 002566 114 KLRYLKQLDLSRNCLTGSFS-PQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN-LFTGSI-PPDIRKLINL 189 (907)
Q Consensus 114 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N-~l~~~~-p~~l~~l~~L 189 (907)
....|++|||+++.++.... ..+..+ +|++|+|+++.++...+..+..+++|+.|+|+++ .++... ...+..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf 67878878898984577799999974877651452346798678999851899757151001341235540365788743
Q ss_pred CEEEECCC-CCCCC-CCCCCC-CCCCCCEEECCCC--CCCCC-CCCCCCCCCCCCEEECCCC-CCCCCCHHHHHCCCCCC
Q ss_conf 50030133-14534-790001-9999990533357--45677-7300167433453450166-57777526431699998
Q 002566 190 QKLILSSN-SFTGE-LPAELT-KLTNLNDLRISDN--NFSGK-IPEFIGKWKKIQKLHIQGS-SLEGPIPASISALTSLT 262 (907)
Q Consensus 190 ~~L~L~~N-~l~~~-~p~~l~-~l~~L~~L~Ls~N--~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~ 262 (907)
++|+++++ .++.. +...+. ..++|+.|++++. .++.. +.....++++|++|++++| .+++.....+..+++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 56522453323332200010001111101221355424444434342323222123553223477830333321357687
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCHHHHCCCCCCEEEECCCC
Q ss_conf 8986898799887651122455469834542655678133698972589457998999-991444159987969912885
Q 002566 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNK 341 (907)
Q Consensus 263 ~L~Ls~n~~~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~L~~-~~p~~~~~l~~L~~L~Ls~N~ 341 (907)
.|+++++. .|+......++.+++|+.|+++++ ++. ..+.....+++| .+..++
T Consensus 204 ~L~L~~C~----------------------~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ 257 (284)
T d2astb2 204 HLSLSRCY----------------------DIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSH 257 (284)
T ss_dssp EEECTTCT----------------------TCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCC
T ss_pred EEECCCCC----------------------CCCHHHHHHHHCCCCCCEEEEECC-CCHHHHHHHHHHCCCC---CCCCCC
T ss_conf 79899999----------------------787378999726999898964488-8989999999768436---616865
Q ss_pred CCCCCCH
Q ss_conf 7899734
Q 002566 342 LTGPVPK 348 (907)
Q Consensus 342 L~~~~p~ 348 (907)
++...+.
T Consensus 258 ls~~~~~ 264 (284)
T d2astb2 258 FTTIARP 264 (284)
T ss_dssp SCCTTCS
T ss_pred CCCCCCC
T ss_conf 8777788
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.75 E-value=1.5e-19 Score=126.88 Aligned_cols=226 Identities=15% Similarity=0.115 Sum_probs=137.6
Q ss_pred CCCEEEECCCCCCCC----CCHHCCCCCCCCEEEEECCCCCCCC----------CHHHHCCCCCCEEEECCCCCCCC---
Q ss_conf 523999038768887----8410189999899973088589999----------80010675545003013314534---
Q 002566 140 QLVELSVMGNRLSGP----FPKVLTNITTLKNLSIEGNLFTGSI----------PPDIRKLINLQKLILSSNSFTGE--- 202 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~----~p~~l~~L~~L~~L~Ls~N~l~~~~----------p~~l~~l~~L~~L~L~~N~l~~~--- 202 (907)
.|+.|+|++|.+... +...+...++|+.|+++++.+.... ...+...++|+.|+|++|.+...
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 97889784983778999999999985899888888777543345421067879998875477756330000134554333
Q ss_pred -CCCCCCCCCCCCEEECCCCCCCCCCCCC-------------CCCCCCCCEEECCCCCCCCCC----HHHHHCCCCCCEE
Q ss_conf -7900019999990533357456777300-------------167433453450166577775----2643169999889
Q 002566 203 -LPAELTKLTNLNDLRISDNNFSGKIPEF-------------IGKWKKIQKLHIQGSSLEGPI----PASISALTSLTDL 264 (907)
Q Consensus 203 -~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-------------l~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L 264 (907)
+...+...++|+.|++++|.+....... ....+.|+.+.+++|++.... ...+...+.|+.|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred CHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf 10111002343210000024666654311112122221100014676421110136501355433221111233321335
Q ss_pred ECCCCCCCCCCC-----CCC-CCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCHHH----HC--
Q ss_conf 868987998876-----511-224554698345426556----78133698972589457998999991444----15--
Q 002566 265 RISDLKGSESAF-----PKL-DKMNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTF----EK-- 328 (907)
Q Consensus 265 ~Ls~n~~~~~~~-----~~~-~~~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~----~~-- 328 (907)
+++.|.+..... ..+ ...+|+.|+|++|.|+.. +...+..+++|++|+|++|.|++.....+ ..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~ 271 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred CCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHCC
T ss_conf 43332222222320024332110121122233332222222234443323221111030047567156678887763156
Q ss_pred CCCCCEEEECCCCCCCCCCHHH-------HCCCCCCEEECCCCC
Q ss_conf 9987969912885789973444-------406984112127764
Q 002566 329 LAKTNFMYLTGNKLTGPVPKYI-------FNSNKNVDISLNNFT 365 (907)
Q Consensus 329 l~~L~~L~Ls~N~L~~~~p~~~-------~~~l~~l~ls~N~~~ 365 (907)
.+.|+.|++++|+++......+ ...++.+++++|+|.
T Consensus 272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 88889898989869808999999999703899998978798089
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.8e-18 Score=118.74 Aligned_cols=117 Identities=17% Similarity=0.179 Sum_probs=72.5
Q ss_pred CCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHHC--CCCCCEE
Q ss_conf 5546983454-265567813369897258945799899999144415998796991288578997344440--6984112
Q 002566 283 NLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVDI 359 (907)
Q Consensus 283 ~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~l~~L~~L~Ls~N~L~~~~p~~~~~--~l~~l~l 359 (907)
+|+.|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|++|+|+ .+|...+. .++.+++
T Consensus 32 ~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L 110 (156)
T d2ifga3 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110 (156)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEEC
T ss_pred CCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCC
T ss_conf 65743168986644369212256666672162021247742011124554333322678785-15745633532124335
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 1277647999988889998332002478888788776866778789999787643
Q 002566 360 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 414 (907)
Q Consensus 360 s~N~~~~~~~~p~~C~c~~~~l~~~~~~~~~~~~~~~~~~~~~~~C~~p~~~~~~ 414 (907)
++| ||.|+|.+.|+..|+......+. .....|.+|..+++.
T Consensus 111 ~~N--------p~~C~C~~~~l~~~~~~~~~~~~------~~~~~C~~p~~l~~~ 151 (156)
T d2ifga3 111 SGN--------PLHCSCALRWLQRWEEEGLGGVP------EQKLQCHGQGPLAHM 151 (156)
T ss_dssp CSS--------CCCCCGGGHHHHHHHHTTCSSCG------GGCCCCSSSSCSSCC
T ss_pred CCC--------CCCCCCHHHHHHHHHHHCCCCCC------CCCCEECCCHHHCCC
T ss_conf 798--------63388117999999985657667------578577968688849
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=4.2e-17 Score=112.67 Aligned_cols=87 Identities=14% Similarity=0.194 Sum_probs=30.0
Q ss_pred CCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCC
Q ss_conf 899998999730885899998001067554500301331453479000199999905333574567773-0016743345
Q 002566 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQ 238 (907)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~ 238 (907)
..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+.|++++|+++.... ..+..+++|+
T Consensus 38 ~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~ 115 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115 (162)
T ss_dssp GGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCC
T ss_pred CCCCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 041459989897997876-47-7445761306431021345777632233453443420300016654211001365320
Q ss_pred EEECCCCCCC
Q ss_conf 3450166577
Q 002566 239 KLHIQGSSLE 248 (907)
Q Consensus 239 ~L~L~~N~l~ 248 (907)
.|++++|.++
T Consensus 116 ~L~l~~N~i~ 125 (162)
T d1a9na_ 116 YLCILRNPVT 125 (162)
T ss_dssp EEECCSSGGG
T ss_pred HHHCCCCCCC
T ss_conf 6640799634
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=6.1e-17 Score=111.77 Aligned_cols=83 Identities=23% Similarity=0.186 Sum_probs=27.7
Q ss_pred CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCEEEC
Q ss_conf 52399903876888784101899998999730885899998001067554500301331453479-00019999990533
Q 002566 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRI 218 (907)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L 218 (907)
+|+.|+|++|.|+.. + .|..+++|+.|++++|+++...+..+..+++|+.|++++|+++.... ..+..+++|++|++
T Consensus 42 ~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l 119 (162)
T d1a9na_ 42 QFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119 (162)
T ss_dssp CCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCCCCCC-C-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHC
T ss_conf 599898979978764-7-74457613064310213457776322334534434203000166542110013653206640
Q ss_pred CCCCCC
Q ss_conf 357456
Q 002566 219 SDNNFS 224 (907)
Q Consensus 219 s~N~l~ 224 (907)
++|.++
T Consensus 120 ~~N~i~ 125 (162)
T d1a9na_ 120 LRNPVT 125 (162)
T ss_dssp CSSGGG
T ss_pred CCCCCC
T ss_conf 799634
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=1.9e-15 Score=103.06 Aligned_cols=101 Identities=21% Similarity=0.308 Sum_probs=46.8
Q ss_pred EEEECCCCCCCCCCHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 99903876888784101899998999730885899998001067554500301331453479000199999905333574
Q 002566 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222 (907)
Q Consensus 143 ~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 222 (907)
.|+|++|+++.. + .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|+. ++ .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf 898689989887-1-0105898898979787168-652156554313545324321123-57-41233555768888986
Q ss_pred CCCCC-CCCCCCCCCCCEEECCCCCCC
Q ss_conf 56777-300167433453450166577
Q 002566 223 FSGKI-PEFIGKWKKIQKLHIQGSSLE 248 (907)
Q Consensus 223 l~~~~-p~~l~~l~~L~~L~L~~N~l~ 248 (907)
++... ...+..+++|+.|++++|.++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 588888256537999999989799688
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=6.1e-15 Score=100.15 Aligned_cols=63 Identities=22% Similarity=0.336 Sum_probs=20.6
Q ss_pred CCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCC
Q ss_conf 1899998999730885899998001067554500301331453479-0001999999053335745
Q 002566 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNF 223 (907)
Q Consensus 159 l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 223 (907)
+..+++|+.|++++|.|++ ++ .+..+++|+.|++++|+|+.... ..+..+++|+.|++++|.+
T Consensus 39 ~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 39 LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred HHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCC
T ss_conf 6554313545324321123-57-4123355576888898658888825653799999998979968
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=5.7e-15 Score=100.32 Aligned_cols=80 Identities=15% Similarity=0.118 Sum_probs=41.8
Q ss_pred EEECCCCCCCCCCCHHCCCCCCCCEEEEECC-CCCCCCCHHCCCC-CCCEEEECCCCCCCCCCHHCCCCCCCCEEEEECC
Q ss_conf 9823599754228820029998889980068-6899870000246-5239990387688878410189999899973088
Q 002566 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRN-CLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (907)
Q Consensus 96 ~L~L~~~~l~g~ip~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~l~~L~~L~~L~Ls~N 173 (907)
.+++.+++++ ..|..+..+++|++|+|++| .|+.+.+..|..+ +|+.|+|++|+|+.+.+..|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf 6985289976-586002576565743168986644369212256666672162021247742011124554333322678
Q ss_pred CCC
Q ss_conf 589
Q 002566 174 LFT 176 (907)
Q Consensus 174 ~l~ 176 (907)
+|+
T Consensus 91 ~l~ 93 (156)
T d2ifga3 91 ALE 93 (156)
T ss_dssp CCS
T ss_pred CCC
T ss_conf 785
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.56 E-value=4.7e-17 Score=112.40 Aligned_cols=19 Identities=42% Similarity=0.492 Sum_probs=7.2
Q ss_pred HCCCCCCCCEEEEECCCCC
Q ss_conf 0029998889980068689
Q 002566 111 ELSKLRYLKQLDLSRNCLT 129 (907)
Q Consensus 111 ~l~~l~~L~~L~Ls~N~l~ 129 (907)
++..+++|+.|+|++|+|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~ 61 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE 61 (198)
T ss_dssp HHHHTTTCCEEECSEEEES
T ss_pred HHHCCCCCCEEECCCCCCC
T ss_conf 7762604615199446899
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.54 E-value=1.1e-16 Score=110.38 Aligned_cols=88 Identities=20% Similarity=0.251 Sum_probs=37.8
Q ss_pred CHHCCCCCCCCEEEEECCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 41018999989997308858999980010675545003013314534790001999999053335745677730016743
Q 002566 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK 235 (907)
Q Consensus 156 p~~l~~L~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 235 (907)
+..+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .++..+..+++|+.|++++|+++.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred HHHHHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCC
T ss_conf 4677626046151994468998-64-4247825357341353432-1000033221233333333222222--2222222
Q ss_pred CCCEEECCCCCCC
Q ss_conf 3453450166577
Q 002566 236 KIQKLHIQGSSLE 248 (907)
Q Consensus 236 ~L~~L~L~~N~l~ 248 (907)
+|+.|++++|+++
T Consensus 116 ~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 116 NLRVLYMSNNKIT 128 (198)
T ss_dssp HSSEEEESEEECC
T ss_pred CCCCCCCCCCHHC
T ss_conf 3411123410212
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.09 E-value=2e-09 Score=68.20 Aligned_cols=150 Identities=14% Similarity=0.102 Sum_probs=99.4
Q ss_pred HHHHHHHCCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEE
Q ss_conf 89999834988678241139659999998799399999904666102588999999997159-99623487587408646
Q 002566 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQL 747 (907)
Q Consensus 669 ~~i~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 747 (907)
+++...-..|...+..+.+..+.||+... +++.+.+|+...........+.+|..++..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------
Q ss_conf 8886413689424555158742245899899999999999999999847-------------------------------
Q 002566 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------------------------------- 796 (907)
Q Consensus 748 ~LV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------- 796 (907)
++||+++++..+.+..... .....++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEECCCCCCCCCCCCC----------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 9999860433435433440----------269999998999999985568421435764465655577899877655554
Q ss_pred -------------------------CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------------999838708899997874999399963488500
Q 002566 797 -------------------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 797 -------------------------~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.80 E-value=3.9e-08 Score=60.70 Aligned_cols=132 Identities=16% Similarity=0.129 Sum_probs=84.3
Q ss_pred CEEECCCC-EEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCEEEEEEEECCCCC
Q ss_conf 82411396-59999998799399999904666102588999999997159--9962348758740864688864136894
Q 002566 682 NKVGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (907)
Q Consensus 682 ~~IG~G~f-G~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~LV~E~~~~gs 758 (907)
+.+..|.. +.||+....++..+.+|....... ..+..|...++.+. .-.+.+++++..+++..++||+++++..
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 876786547758999938987899995896677---68999999999998659998861322245661599987441355
Q ss_pred HHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q ss_conf 2455515874224589989999999999999999984-------------------------------------------
Q 002566 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE------------------------------------------- 795 (907)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~------------------------------------------- 795 (907)
+.... .. ...++.++++.+.-||.
T Consensus 93 ~~~~~----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 93 LLSSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp TTTSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCCCC----------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf 43221----------26---899999999999987368854488755412468899999987541101134011213799
Q ss_pred --------C----CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --------7----999838708899997874999399963488500
Q 002566 796 --------D----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 796 --------~----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
. .++.++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9999998718765795678678887635773796589998533265
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=2.2e-09 Score=67.93 Aligned_cols=121 Identities=15% Similarity=0.085 Sum_probs=0.0
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CHHHHHCCCCCCEE
Q ss_conf 5545003013314534790001999999053335745677730016743345345016657777--52643169999889
Q 002566 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--IPASISALTSLTDL 264 (907)
Q Consensus 187 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L 264 (907)
...+.|++++++ ....+..+..+..+...+|... .++..+..++.|++|+|++|+|+.. .+..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l~----~~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGLR----SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCCS----SCTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCCC----CCCHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 330865343598----9821554664011225556766-60788974878788637776666773158898658856100
Q ss_pred ECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 868987998876-5112245546983454265567813-------36989725894
Q 002566 265 RISDLKGSESAF-PKLDKMNLKTLILTKCLIHGEIPDY-------IGDMTKLKNID 312 (907)
Q Consensus 265 ~Ls~n~~~~~~~-~~~~~~~L~~L~Ls~N~i~~~~p~~-------~~~l~~L~~L~ 312 (907)
++++|.++.... ..+...+|+.|+|++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=1.8e-06 Score=51.10 Aligned_cols=77 Identities=13% Similarity=0.148 Sum_probs=48.2
Q ss_pred CCEEECCCCEEEEEEEECC-CCEEEEEEECCCC-------CHHHHHHHHHHHHHHHC-CC--CCEEEEEEEEEECCEEEE
Q ss_conf 7824113965999999879-9399999904666-------10258899999999715-99--962348758740864688
Q 002566 681 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-------RQGNREFVNEIGMISAQ-QH--PNLVKLYGCCVEGNQLLL 749 (907)
Q Consensus 681 ~~~IG~G~fG~Vyk~~~~~-g~~VAVK~~~~~~-------~~~~~~f~~E~~~l~~l-~H--~nIv~l~g~~~~~~~~~L 749 (907)
.+.||.|....||+....+ ++.+++|.-.+.. +....+...|.+.+..+ .+ ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred EEEECCCCCH
Q ss_conf 8641368942
Q 002566 750 VYEYMKNNCL 759 (907)
Q Consensus 750 V~E~~~~gsL 759 (907)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.18 E-value=5.9e-07 Score=53.89 Aligned_cols=10 Identities=0% Similarity=0.019 Sum_probs=3.3
Q ss_pred CCCEEECCCC
Q ss_conf 7258945799
Q 002566 307 KLKNIDLSFN 316 (907)
Q Consensus 307 ~L~~L~Ls~N 316 (907)
.|++|+|++|
T Consensus 101 sL~~L~l~~n 110 (167)
T d1pgva_ 101 SIVEFKADNQ 110 (167)
T ss_dssp CCSEEECCCC
T ss_pred CCCEEECCCC
T ss_conf 3898778877
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.95 E-value=3.5e-05 Score=43.61 Aligned_cols=74 Identities=18% Similarity=0.167 Sum_probs=47.4
Q ss_pred CCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEEEEEE
Q ss_conf 7824113965999999879--------9399999904666102588999999997159-996234875874086468886
Q 002566 681 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (907)
Q Consensus 681 ~~~IG~G~fG~Vyk~~~~~--------g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 751 (907)
.+.|+.|-.-.+|++...+ .+.|.+++..... ......+|..+++.+. +.-..++++++.. ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 9991785334348999688775445789817999659961--165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 413689424
Q 002566 752 EYMKNNCLS 760 (907)
Q Consensus 752 E~~~~gsL~ 760 (907)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.93 E-value=2.8e-05 Score=44.14 Aligned_cols=137 Identities=12% Similarity=0.041 Sum_probs=69.7
Q ss_pred EEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEECCEEEEEEEECCCCCHH--
Q ss_conf 599999987993999999046661025889999999971599962--34875-----874086468886413689424--
Q 002566 690 GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL--VKLYG-----CCVEGNQLLLVYEYMKNNCLS-- 760 (907)
Q Consensus 690 G~Vyk~~~~~g~~VAVK~~~~~~~~~~~~f~~E~~~l~~l~H~nI--v~l~g-----~~~~~~~~~LV~E~~~~gsL~-- 760 (907)
-.||++...+|+.+++|+...... ...++.+|...+..+....+ +..+. .....+..+.+++++++..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 026999838999799998478778-8999999999999998559987875206898056653479999865277688999
Q ss_pred ----------------HHHHCCCCCCCCCCC-------------------H---HHHHHHHHHHHHHHHHHH-HCCCCCE
Q ss_conf ----------------555158742245899-------------------8---999999999999999998-4799983
Q 002566 761 ----------------RAIFGKDTEYRLKLD-------------------W---PTRKKICIGIARGLAYLH-EDSRIKI 801 (907)
Q Consensus 761 ----------------~~l~~~~~~~~~~l~-------------------~---~~~~~i~~~ia~aL~yLH-~~~~~~i 801 (907)
..........+...+ . ......+..+...+.-.- +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred EECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 8708899997874999399963488500
Q 002566 802 VHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (907)
Q Consensus 802 iH~Dikp~NILl~~~~~~kl~DFGla~~ 829 (907)
+|+|+.+.|||++.+ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.63 E-value=0.00099 Score=35.18 Aligned_cols=33 Identities=24% Similarity=0.234 Sum_probs=28.0
Q ss_pred CCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 998387088999978749993999634885001
Q 002566 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (907)
Q Consensus 798 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 830 (907)
+.++||+|+.+.||+++.+...-|+||+.+...
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~ 214 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACND 214 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCCC
T ss_conf 450333786365640204541267422212364
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.53 E-value=2.7e-06 Score=50.01 Aligned_cols=123 Identities=19% Similarity=0.226 Sum_probs=0.0
Q ss_pred CCCCCCCCCCHHCCCCCCCCEEEEEC-CCCCCCCCHHCCCC-----CCCEEEECCCCCCCC----CCHHCCCCCCCCEEE
Q ss_conf 59975422882002999888998006-86899870000246-----523999038768887----841018999989997
Q 002566 100 KAQNLTGTLPTELSKLRYLKQLDLSR-NCLTGSFSPQWASL-----QLVELSVMGNRLSGP----FPKVLTNITTLKNLS 169 (907)
Q Consensus 100 ~~~~l~g~ip~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l-----~L~~L~Ls~N~l~~~----~p~~l~~L~~L~~L~ 169 (907)
...++...+.....+.+.|++|+|++ +.++......+... .|++|+|++|.++.. +...+...+.++.|+
T Consensus 1 ~~~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~ 80 (166)
T d1io0a_ 1 NSTDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLN 80 (166)
T ss_dssp CCCCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEE
T ss_pred CCCCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHH
T ss_conf 97639999999995599986887689999898999999988841982574301589611778999998775212210121
Q ss_pred EECCCCC----CCCCHHHHCCCCCCE--EEECCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf 3088589----999800106755450--0301331453----479000199999905333574
Q 002566 170 IEGNLFT----GSIPPDIRKLINLQK--LILSSNSFTG----ELPAELTKLTNLNDLRISDNN 222 (907)
Q Consensus 170 Ls~N~l~----~~~p~~l~~l~~L~~--L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~ 222 (907)
+++|.++ ..+...+...++|+. |+++.|.+.. .+...+...++|+.|+++.+.
T Consensus 81 l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 81 VESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 025432201478899999848652477321677867679999999999849984788581898
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=92.89 E-value=0.15 Score=22.57 Aligned_cols=65 Identities=18% Similarity=0.226 Sum_probs=45.3
Q ss_pred EEEEEECCCEEEEEEEEEEEEEECCCCCCCCCCCEEEEEEECCEECCCCCCHHHHCCCCCCCEEEECCCCCCCCEEEEEE
Q ss_conf 37642115802999995467784178531135631679985132021345411220897963687013101243378999
Q 002566 499 TYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL 578 (907)
Q Consensus 499 ~~~~~~~~~~~~~~~l~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~ 578 (907)
++|..-+.||+|.|++.|++... .++.+.+..+...+ .+....+.|++.|++..|.|++
T Consensus 65 ~~f~v~vPnG~Y~Vtv~~Gd~~~-------------~~~~~eg~~~~~~~--------~g~~~~~~~~V~VtDG~L~l~f 123 (146)
T d2o14a1 65 NTFNVDLPNGLYEVKVTLGNTAR-------------ASVAAEGVFQVINM--------TGDGAEDTFQIPVTDGQLNLLV 123 (146)
T ss_dssp CCEEEECCSEEEEEEEEESSCSE-------------EEEEETTEEEEEEE--------ESTTCEEEEEEEECSSEEEEEE
T ss_pred CEEEEECCCCEEEEEEEEECCCC-------------CCEEEEEEEECCCC--------CCCCEEEEEEEEEECCEEEEEE
T ss_conf 66999889971899999936777-------------62778517800266--------8731778999998799487998
Q ss_pred EECCCC
Q ss_conf 650788
Q 002566 579 YWAGRG 584 (907)
Q Consensus 579 ~~~g~g 584 (907)
--+..|
T Consensus 124 t~~~~G 129 (146)
T d2o14a1 124 TEGKAG 129 (146)
T ss_dssp EESSTT
T ss_pred ECCCCC
T ss_conf 437789
|